data_2p3m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2p3m _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.8 mm . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 109.118 -0.697 . . . . 1.1000000000000001 109.118 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.9 mt -130.01 149.57 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 108.861 -0.792 . . . . 1.0700000000000001 108.861 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -105.19 141.95 35.82 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.2 -0.296 . . . . 0.85999999999999999 110.2 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.7 149.41 20.17 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.595 -1.402 . . . . 0.080000000000000002 109.595 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -106.09 142.09 36.37 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 117.251 0.525 . . . . 0.85999999999999999 110.185 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.5 t -62.97 122.0 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 N-CA-C 109.82 -0.437 . . . . 1.04 109.82 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.35 157.12 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 110.084 -0.339 . . . . 1.0800000000000001 110.084 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 N--CA 1.499 2.006 0 N-CA-C 110.222 -0.288 . . . . 1.5 110.222 -179.102 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 . . . . . 0 N--CA 1.501 2.112 0 N-CA-C 110.325 -0.25 . . . . 0.87 110.325 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -65.77 -29.99 70.57 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 122.205 -0.31 . . . . 2.1800000000000002 110.78 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -68.97 -40.58 78.76 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 120.689 -0.404 . . . . 2.8100000000000001 110.609 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.2 mt -81.1 -38.53 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.406 -0.59 . . . . 1.0700000000000001 109.406 -175.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.1 mt -104.11 -26.14 12.68 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 122.144 -0.348 . . . . 1.05 111.558 -174.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.34 14.74 70.6 Favored Glycine 0 N--CA 1.495 2.589 0 CA-C-O 119.408 -0.662 . . . . 0.32000000000000001 111.48 -171.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -152.79 164.51 37.67 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 119.057 1.428 . . . . 0.28999999999999998 110.618 170.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -95.73 113.04 61.14 Favored Pre-proline 0 N--CA 1.497 1.891 0 CA-C-O 118.466 -0.778 . . . . 1.3500000000000001 109.869 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -67.74 159.52 52.36 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 O-C-N 123.314 1.165 . . . . 0.20000000000000001 110.539 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -74.29 164.52 26.5 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 110.075 -0.343 . . . . 1.04 110.075 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -80.37 79.58 6.94 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.459 0.647 . . . . 1.4099999999999999 109.721 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.8 176.54 48.05 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.536 -1.426 . . . . 0.34000000000000002 109.536 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -137.99 157.53 46.18 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 117.269 0.535 . . . . 1.01 110.763 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.2 tp -110.31 115.05 28.99 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.514 -0.921 . . . . 1.0600000000000001 108.514 168.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.71 121.31 41.43 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 110.001 -0.37 . . . . 0.16 110.001 -175.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.4 mt -121.49 135.49 55.03 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 120.698 0.285 . . . . 0.98999999999999999 110.667 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -95.89 133.55 39.93 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.151 -0.685 . . . . 1.8799999999999999 109.151 172.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.7 mt -111.89 160.2 17.63 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 120.609 0.243 . . . . 0.97999999999999998 110.411 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.43 13.04 14.68 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 111.911 0.337 . . . . 0.17999999999999999 111.911 172.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -146.53 141.37 26.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.699 -0.625 . . . . 2.6000000000000001 109.505 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -62.93 149.27 45.08 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.168 -0.332 . . . . 1.9399999999999999 110.724 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -131.8 137.83 48.29 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 120.647 0.26 . . . . 0.5 110.545 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -138.03 122.51 18.43 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.809 -0.441 . . . . 1.3999999999999999 109.809 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.3 tt -63.28 -22.91 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 C-N-CA 120.97 -0.292 . . . . 1.0600000000000001 111.363 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -74.43 -1.02 19.25 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.982 -0.449 . . . . 1.55 112.143 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -90.61 -14.37 32.54 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 118.902 0.774 . . . . 2.2000000000000002 111.444 170.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -116.11 175.1 5.7 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.668 0.667 . . . . 0.38 109.512 173.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -92.07 103.93 16.38 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 110.097 -0.335 . . . . 2.2999999999999998 110.097 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -109.73 176.99 4.87 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 120.517 0.199 . . . . 0.89000000000000001 110.574 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.19 130.77 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.29 -1.004 . . . . 1.05 108.29 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -105.89 142.73 35.11 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 110.187 -0.301 . . . . 1.23 110.187 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.1 p -119.31 134.2 55.34 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 120.621 0.248 . . . . 1.0900000000000001 110.443 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.51 172.68 12.57 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 120.716 0.293 . . . . 1.29 111.502 -170.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -67.63 139.18 56.82 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.415 -0.587 . . . . 0.33000000000000002 109.415 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -139.09 167.82 21.21 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.934 -0.306 . . . . 0.27000000000000002 110.684 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -125.33 149.61 47.94 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 120.873 0.368 . . . . 0.80000000000000004 110.506 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -147.79 134.39 19.84 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.197 -0.668 . . . . 0.59999999999999998 109.197 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 51.67 33.21 10.46 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.69 -0.631 . . . . 1.7 112.089 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.47 16.98 78.58 Favored Glycine 0 N--CA 1.497 2.721 0 CA-C-O 119.601 -0.555 . . . . 0.46000000000000002 111.925 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -122.29 141.67 51.28 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 118.668 1.234 . . . . 2.3900000000000001 109.756 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -93.49 133.37 36.85 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 121.021 -0.272 . . . . 1.71 110.55 -176.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -123.04 145.18 48.75 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.887 -0.412 . . . . 0.41999999999999998 109.887 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -86.98 153.76 21.31 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 120.783 0.325 . . . . 0.40999999999999998 110.573 -168.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.09 158.62 51.85 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.976 -1.25 . . . . 0.22 109.976 -177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.79 159.18 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 122.228 -0.572 . . . . 1.1399999999999999 110.53 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -117.66 137.0 52.95 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.7 -0.482 . . . . 1.49 109.7 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.8 t -134.03 141.5 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 109.358 -0.608 . . . . 1.04 109.358 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.4 tp -137.41 125.61 14.49 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.627 -0.701 . . . . 1.02 110.087 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.0 149.91 90.21 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 121.033 1.155 . . . . 0.11 111.472 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.3 pt -141.54 170.0 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 120.716 0.293 . . . . 1.02 110.313 171.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -114.88 130.77 56.96 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.121 -0.696 . . . . 2.0600000000000001 109.121 168.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.69 123.91 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.836 -0.801 . . . . 1.0 108.836 -174.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.9 mt -108.54 116.96 32.95 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 110.284 -0.265 . . . . 1.04 110.284 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.4 mt -129.86 121.95 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.186 -1.042 . . . . 1.02 108.186 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.76 -120.37 18.58 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.868 -1.293 . . . . 0.16 109.868 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -111.12 17.13 20.66 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 122.382 -0.481 . . . . 2.71 111.831 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -119.83 145.46 46.62 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 118.559 0.618 . . . . 1.9299999999999999 110.505 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -123.07 130.87 53.35 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 110.251 -0.277 . . . . 1.99 110.251 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.9 mt -126.16 146.55 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 108.737 -0.838 . . . . 1.01 108.737 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.52 136.84 44.13 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 109.902 -0.407 . . . . 0.40999999999999998 109.902 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.51 -169.25 13.6 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.286 -1.526 . . . . 0.11 109.286 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.17 154.62 25.75 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 117.196 0.498 . . . . 1.03 110.159 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.5 mt -108.66 140.78 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.292 -1.003 . . . . 1.04 108.292 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.79 131.82 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 109.347 -0.612 . . . . 1.0800000000000001 109.347 -175.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.2 t -143.21 138.6 15.79 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 108.545 -0.909 . . . . 1.05 108.545 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -56.69 155.57 26.25 Favored 'Trans proline' 0 N--CA 1.504 2.097 0 C-N-CA 121.09 1.194 . . . . 0.28000000000000003 111.942 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -64.38 -34.14 77.49 Favored 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 121.141 -0.224 . . . . 1.6899999999999999 110.702 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -87.96 116.76 26.36 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 121.001 -0.28 . . . . 3.0800000000000001 110.254 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.0 m -130.98 136.64 48.71 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.016 -0.364 . . . . 1.9199999999999999 110.016 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -97.92 -54.63 3.03 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 110.31 -0.256 . . . . 4.8300000000000001 110.31 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -131.64 179.27 6.15 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 110.306 -0.257 . . . . 3.6699999999999999 110.306 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.9 m -100.14 148.9 24.08 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 110.135 -0.32 . . . . 1.49 110.135 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.0 m -135.01 175.0 9.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 122.292 -0.255 . . . . 1.47 110.387 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -107.91 27.07 9.6 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.418 -0.176 . . . . 0.93999999999999995 110.977 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -122.92 127.58 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.047 -0.723 . . . . 1.03 109.047 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.7 pt -125.44 143.68 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 110.109 -0.33 . . . . 1.01 110.109 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -115.03 130.85 57.03 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.963 -0.384 . . . . 1.3600000000000001 109.963 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.8 mt -115.92 151.39 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.434 -0.58 . . . . 1.02 109.434 -173.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.8 pt -116.44 154.24 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 109.433 -0.58 . . . . 1.0600000000000001 109.433 168.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.58 165.59 24.2 Favored Pre-proline 0 N--CA 1.496 1.836 0 CA-C-O 119.043 -0.503 . . . . 1.05 110.222 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.81 -31.41 93.9 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.069 1.179 . . . . 0.22 111.602 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.61 167.07 23.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.35 -0.219 . . . . 1.1100000000000001 110.664 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -71.65 104.01 3.22 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 109.975 -0.38 . . . . 2.6099999999999999 109.975 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.6 mt -59.37 -33.03 70.67 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 122.069 -0.394 . . . . 1.0600000000000001 111.449 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -63.1 -35.02 78.87 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 122.191 -0.318 . . . . 2.9700000000000002 110.904 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -78.25 -47.86 17.03 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.194 -0.669 . . . . 1.8200000000000001 109.194 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -62.28 -34.03 75.77 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.194 -0.317 . . . . 1.6599999999999999 111.112 -172.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -108.06 9.36 28.42 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 112.534 0.568 . . . . 0.33000000000000002 112.534 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.83 46.24 26.89 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.074 -1.016 . . . . 1.8400000000000001 111.887 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -91.89 138.2 31.74 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.878 -0.513 . . . . 1.1200000000000001 110.889 -171.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -114.99 158.2 22.38 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.844 -0.428 . . . . 2.8799999999999999 109.844 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -55.97 137.94 49.83 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.872 -0.517 . . . . 0.5 111.431 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.95 -22.96 37.36 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 111.151 -0.78 . . . . 0.14999999999999999 111.151 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -65.45 155.56 35.14 Favored 'General case' 0 N--CA 1.505 2.311 0 CA-C-N 118.631 1.216 . . . . 0.13 109.968 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -112.63 134.25 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.428 -0.582 . . . . 1.03 109.428 -174.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.2 pt -129.38 161.33 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 109.554 -0.536 . . . . 1.02 109.554 174.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -110.0 138.26 46.62 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 110.141 -0.318 . . . . 1.8899999999999999 110.141 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.8 pt -114.68 137.15 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 120.845 0.355 . . . . 1.04 110.184 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.9 tt . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 109.861 -0.422 . . . . 1.5800000000000001 109.861 -179.807 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.1 mm . . . . . 0 N--CA 1.498 1.949 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.5 mt -129.7 148.91 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -105.32 140.05 39.03 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.33 151.08 20.42 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -106.83 141.64 37.74 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.346 -0.503 . . . . 0.0 110.26 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.18 122.28 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.4 146.03 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 N--CA 1.498 1.956 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.983 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 N--CA 1.501 2.122 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -65.76 -30.31 70.94 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.24 -0.288 . . . . 0.0 110.814 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -68.94 -40.69 78.85 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.622 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -81.26 -38.02 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.3 mt -103.97 -26.2 12.72 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 122.2 -0.313 . . . . 0.0 111.61 -174.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.03 15.02 70.81 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -172.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -152.83 164.33 38.06 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 119.027 1.413 . . . . 0.0 110.67 170.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -95.07 110.87 52.47 Favored Pre-proline 0 N--CA 1.496 1.844 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.725 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.33 159.9 50.17 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 O-C-N 123.253 1.133 . . . . 0.0 110.526 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -73.96 163.71 27.55 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -80.29 79.6 6.85 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.488 0.661 . . . . 0.0 109.653 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.16 173.24 45.37 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 p -138.05 157.87 45.47 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 117.241 0.52 . . . . 0.0 110.708 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.2 tp -110.31 114.98 28.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -99.04 119.84 38.47 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.1 mt -119.97 136.1 54.66 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 120.726 0.298 . . . . 0.0 110.717 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -95.9 133.61 39.88 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.6 mt -112.51 160.25 17.99 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 120.657 0.265 . . . . 0.0 110.417 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.26 13.06 14.3 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 172.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -146.39 142.68 28.44 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 118.533 0.606 . . . . 0.0 109.586 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -64.29 149.43 48.13 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 122.196 -0.315 . . . . 0.0 110.505 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -131.79 138.0 48.37 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 120.701 0.286 . . . . 0.0 110.437 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -138.02 123.07 19.1 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.16 -22.84 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.389 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -74.56 -0.93 19.28 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -90.49 -14.27 33.06 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 118.901 0.773 . . . . 0.0 111.485 171.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -117.19 175.12 5.75 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 118.618 0.645 . . . . 0.0 109.431 173.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -91.31 104.07 16.65 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -110.39 176.65 4.96 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 120.516 0.198 . . . . 0.0 110.532 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.16 131.46 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -105.97 144.06 33.22 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.6 p -120.9 134.73 55.29 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.653 0.264 . . . . 0.0 110.547 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -77.01 172.6 12.94 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 120.77 0.319 . . . . 0.0 111.644 -170.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -67.9 140.22 56.5 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -142.34 166.31 25.02 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.699 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -123.67 149.1 45.87 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 120.787 0.327 . . . . 0.0 110.465 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -149.01 135.72 19.63 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 51.7 33.16 10.45 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.724 -0.61 . . . . 0.0 112.095 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.18 17.01 78.88 Favored Glycine 0 N--CA 1.497 2.712 0 CA-C-O 119.613 -0.548 . . . . 0.0 111.896 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -121.82 140.43 52.38 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 118.647 1.223 . . . . 0.0 109.712 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -93.49 131.44 38.71 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.355 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -121.22 141.97 50.36 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -86.93 156.46 19.81 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 120.741 0.305 . . . . 0.0 110.454 -168.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.55 156.53 52.39 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.3 157.81 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 122.329 -0.512 . . . . 0.0 110.471 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -114.97 138.78 50.44 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.6 t -133.96 140.19 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -176.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.7 tp -137.69 125.69 14.23 Favored Pre-proline 0 N--CA 1.496 1.868 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.114 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -62.9 149.14 92.37 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 120.968 1.112 . . . . 0.0 111.586 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.8 pt -141.98 170.06 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 122.28 -0.263 . . . . 0.0 110.322 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -114.6 131.77 56.58 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 168.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -106.0 123.97 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -109.28 117.02 32.98 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.5 mt -130.09 121.96 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.38 -119.95 17.55 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -111.19 17.08 20.66 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 122.349 -0.501 . . . . 0.0 111.855 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -119.54 143.04 47.82 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 118.591 0.632 . . . . 0.0 110.482 -175.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -123.16 130.28 52.55 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 120.683 0.277 . . . . 0.0 110.309 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -126.31 144.93 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.83 138.07 44.21 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.92 -165.36 11.91 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.69 155.64 26.4 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 117.307 0.553 . . . . 0.0 110.236 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.69 141.22 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.7 t -121.7 130.78 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.3 t -141.11 134.07 14.41 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -57.24 155.42 29.61 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 121.042 1.162 . . . . 0.0 111.939 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -64.35 -34.02 77.18 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 122.321 -0.237 . . . . 0.0 110.685 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -90.11 123.2 33.76 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.337 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.2 m -130.23 142.97 50.52 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -94.9 -60.01 1.79 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -137.75 171.65 14.13 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.5 m -70.85 146.86 49.38 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.8 m -135.01 161.71 34.52 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.571 0.224 . . . . 0.0 110.464 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -107.64 27.08 9.51 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.375 -0.203 . . . . 0.0 110.833 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -123.73 127.52 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.5 pt -125.49 143.64 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -113.84 130.16 56.5 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.1 mt -115.5 150.33 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -174.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.8 pt -117.25 155.94 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 168.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.55 161.15 48.31 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-O 119.073 -0.489 . . . . 0.0 110.29 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.73 -30.88 93.18 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 121.105 1.203 . . . . 0.0 111.74 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.4 167.09 23.3 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.262 -0.274 . . . . 0.0 110.761 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -73.62 103.77 4.34 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.98 -35.39 78.34 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.145 -0.347 . . . . 0.0 111.136 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -62.22 -32.9 73.62 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.13 -0.356 . . . . 0.0 110.944 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -78.23 -50.89 11.05 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -63.06 -32.43 73.8 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.158 -172.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -105.97 7.84 32.2 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.87 47.45 24.75 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.014 -1.054 . . . . 0.0 111.841 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.4 mt -91.52 138.24 31.73 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.896 -0.502 . . . . 0.0 110.923 -170.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -116.82 158.66 23.57 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.22 50.08 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.846 -0.534 . . . . 0.0 111.474 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.77 -22.96 37.46 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.39 154.01 39.62 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 118.608 1.204 . . . . 0.0 110.018 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t -111.81 133.38 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -174.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 21.6 pt -128.68 160.83 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -109.63 138.09 46.5 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 pt -113.56 137.5 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 10.1 tt . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.86 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.7 mm . . . . . 0 N--CA 1.499 2.014 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.0 mt -129.86 149.58 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -104.96 143.21 33.48 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.286 -0.259 . . . . 0.0 110.37 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.22 151.16 20.68 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.57 142.62 34.99 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 117.253 0.526 . . . . 0.0 110.221 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.7 122.79 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.57 163.39 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.498 1.967 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.194 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 N--CA 1.501 2.108 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -65.25 -30.92 71.85 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 122.211 -0.306 . . . . 0.0 110.871 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -68.62 -41.21 79.81 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.668 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.3 mt -81.6 -36.46 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.8 mt -103.78 -26.13 12.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.192 -0.317 . . . . 0.0 111.668 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.57 14.69 72.84 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -172.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -152.82 162.43 41.29 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 119.062 1.431 . . . . 0.0 110.571 171.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -94.13 108.91 38.98 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.562 -0.733 . . . . 0.0 109.683 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -67.04 159.09 53.65 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 O-C-N 123.254 1.134 . . . . 0.0 110.536 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -73.81 162.97 28.55 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -80.29 79.6 6.84 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.497 0.665 . . . . 0.0 109.672 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.29 171.15 43.49 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -138.05 156.94 47.3 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 117.331 0.566 . . . . 0.0 110.856 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 tp -110.42 117.07 32.61 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 170.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -99.66 120.87 40.38 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt -120.02 135.77 54.8 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 120.728 0.299 . . . . 0.0 110.651 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -96.15 133.55 40.3 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.4 mt -111.59 160.2 17.43 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 120.605 0.24 . . . . 0.0 110.46 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.04 12.95 14.12 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 172.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -145.47 141.89 28.76 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.687 -0.633 . . . . 0.0 109.363 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.37 146.84 53.8 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 122.231 -0.293 . . . . 0.0 110.427 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -131.95 137.36 47.91 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 120.617 0.246 . . . . 0.0 110.553 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -138.02 124.19 20.38 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.49 -22.92 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 122.21 -0.306 . . . . 0.0 111.314 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -72.75 -5.0 34.85 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 122.024 -0.423 . . . . 0.0 112.083 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -90.59 -14.36 32.61 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 118.833 0.742 . . . . 0.0 111.538 172.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -114.64 175.07 5.65 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 118.558 0.617 . . . . 0.0 109.409 173.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -92.1 102.31 14.85 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -109.97 178.64 4.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 122.316 -0.24 . . . . 0.0 110.606 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.0 mt -111.8 130.69 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 174.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -105.93 141.66 36.96 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.0 p -118.07 134.84 54.61 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 120.703 0.287 . . . . 0.0 110.461 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.17 172.71 12.37 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 120.826 0.346 . . . . 0.0 111.535 -170.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -67.29 139.56 57.3 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -138.95 167.13 22.72 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.203 -0.311 . . . . 0.0 110.643 -174.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -124.23 149.19 46.71 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.87 0.367 . . . . 0.0 110.599 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -148.22 134.47 19.44 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 51.76 33.3 10.92 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.736 -0.603 . . . . 0.0 112.142 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.32 16.77 79.06 Favored Glycine 0 N--CA 1.497 2.746 0 CA-C-O 119.664 -0.52 . . . . 0.0 111.937 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -122.33 141.67 51.31 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 118.665 1.233 . . . . 0.0 109.694 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -93.45 132.21 37.92 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 121.13 -0.228 . . . . 0.0 110.483 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -123.18 146.84 47.45 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -86.92 155.21 20.31 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.73 0.3 . . . . 0.0 110.454 -168.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.36 161.18 48.45 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.67 157.09 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 122.372 -0.487 . . . . 0.0 110.412 -174.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -115.48 136.65 52.86 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -134.11 140.19 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.0 tp -137.04 125.65 14.94 Favored Pre-proline 0 N--CA 1.497 1.898 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.057 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -63.6 148.47 92.33 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 121.008 1.139 . . . . 0.0 111.383 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.6 pt -141.96 170.0 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 122.266 -0.271 . . . . 0.0 110.414 172.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -115.07 131.84 56.79 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 167.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.2 mt -105.68 123.7 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.1 mt -108.38 116.99 33.0 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -177.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.4 mt -130.06 121.99 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.24 -120.01 17.94 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -111.2 17.03 20.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.298 -0.531 . . . . 0.0 111.829 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -119.32 143.56 47.31 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.669 -0.644 . . . . 0.0 110.468 -175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -123.11 129.96 52.14 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 120.671 0.272 . . . . 0.0 110.294 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.6 mt -125.4 143.82 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.82 137.49 43.87 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.98 -165.35 11.93 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.64 156.62 28.2 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.18 -0.6 . . . . 0.0 110.303 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.8 mt -108.72 142.01 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.5 130.73 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -143.18 136.66 14.15 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -57.22 153.85 37.51 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 121.013 1.142 . . . . 0.0 111.927 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -64.78 -34.38 78.22 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 122.307 -0.246 . . . . 0.0 110.736 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -86.93 116.11 24.77 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.395 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.8 p -131.6 159.53 37.98 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -126.52 -48.34 1.55 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -128.77 175.42 8.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 95.1 p -98.18 149.96 21.99 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.2 m -134.96 170.8 15.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.323 -0.235 . . . . 0.0 110.371 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -107.17 27.08 9.4 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.356 -0.215 . . . . 0.0 110.93 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.0 mm -123.75 127.89 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 pt -126.49 143.1 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -112.83 131.82 55.54 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.9 mt -116.87 150.98 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -174.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.2 pt -116.04 154.32 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.55 166.02 21.99 Favored Pre-proline 0 N--CA 1.494 1.767 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.292 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -60.0 -31.91 94.21 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 121.104 1.203 . . . . 0.0 111.519 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.69 167.09 23.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.305 -0.247 . . . . 0.0 110.69 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -70.61 104.58 2.85 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.64 -33.39 71.46 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 122.099 -0.375 . . . . 0.0 111.463 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -62.75 -35.3 79.36 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 122.155 -0.341 . . . . 0.0 110.907 -174.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.25 -47.85 17.02 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -62.63 -33.69 75.53 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.152 -0.342 . . . . 0.0 111.122 -172.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -108.12 9.27 28.31 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 112.503 0.556 . . . . 0.0 112.503 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.91 45.86 27.55 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.066 -1.021 . . . . 0.0 111.845 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -92.18 138.18 31.75 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.908 -0.495 . . . . 0.0 110.974 -171.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -114.96 160.61 19.36 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.34 49.87 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.918 -0.489 . . . . 0.0 111.482 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.53 -23.49 35.6 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.44 152.65 43.41 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 118.665 1.233 . . . . 0.0 110.076 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.21 133.82 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.1 pt -129.19 161.31 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 174.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -109.91 138.4 46.35 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -112.88 137.93 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.6 tt . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.241 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.1 mm . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.3 mt -130.11 150.09 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -107.08 143.36 35.34 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.55 150.56 20.83 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -106.4 142.9 35.32 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.307 -0.525 . . . . 0.0 110.26 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.73 122.45 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.07 142.86 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 175.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.2 t . . . . . 0 N--CA 1.498 1.971 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.279 -178.653 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 N--CA 1.502 2.156 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -65.47 -31.3 72.31 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.783 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -68.56 -40.42 80.63 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.628 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.32 -37.02 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.0 mt -103.23 -26.29 13.03 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.268 -0.27 . . . . 0.0 111.695 -174.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.98 14.82 74.16 Favored Glycine 0 N--CA 1.493 2.471 0 CA-C-O 119.382 -0.677 . . . . 0.0 111.46 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -151.39 161.45 42.68 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 119.118 1.459 . . . . 0.0 110.651 170.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -94.68 107.84 33.24 Favored Pre-proline 0 N--CA 1.495 1.821 0 CA-C-O 118.637 -0.697 . . . . 0.0 109.856 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -67.31 158.23 57.97 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 O-C-N 123.219 1.115 . . . . 0.0 110.557 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.23 163.76 27.44 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -80.22 79.63 6.76 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.488 0.661 . . . . 0.0 109.675 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.6 172.97 45.37 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 175.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 p -138.05 157.03 47.18 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 117.397 0.599 . . . . 0.0 110.932 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.9 tp -109.63 115.71 30.39 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -99.26 120.96 40.4 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.6 mt -120.07 136.01 54.73 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.701 0.286 . . . . 0.0 110.607 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -96.36 134.24 39.75 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 173.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.3 mt -111.53 160.28 17.32 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 120.671 0.272 . . . . 0.0 110.45 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.14 13.0 14.2 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 171.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -145.21 142.27 29.4 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 118.567 0.622 . . . . 0.0 109.416 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -64.5 146.83 53.96 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 122.221 -0.299 . . . . 0.0 110.339 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -132.46 136.67 46.87 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 120.736 0.303 . . . . 0.0 110.602 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -138.04 127.4 24.67 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.33 -23.98 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.385 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -74.27 -1.07 19.05 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.944 -0.472 . . . . 0.0 112.182 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -91.02 -14.26 31.73 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 118.838 0.745 . . . . 0.0 111.481 169.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -116.23 175.06 5.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.665 -0.647 . . . . 0.0 109.43 174.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -91.98 102.93 15.5 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -110.63 178.46 4.36 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 120.579 0.228 . . . . 0.0 110.548 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -112.36 131.64 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -105.87 144.13 33.04 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.2 p -123.24 138.52 54.61 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 120.783 0.325 . . . . 0.0 110.786 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -77.29 172.71 12.86 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -167.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -67.6 141.36 56.81 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -136.59 167.28 21.68 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.535 -176.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -124.19 146.92 48.39 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 120.807 0.337 . . . . 0.0 110.667 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -149.8 138.65 20.99 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.6 m120 52.14 30.0 7.13 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.708 -0.62 . . . . 0.0 112.135 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.17 16.19 80.87 Favored Glycine 0 N--CA 1.497 2.736 0 CA-C-O 119.528 -0.596 . . . . 0.0 111.749 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -121.08 144.07 48.75 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 118.783 1.291 . . . . 0.0 109.617 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.13 131.36 38.26 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.53 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -120.17 144.72 47.53 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -85.81 156.97 20.35 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 120.845 0.355 . . . . 0.0 110.554 -167.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.43 162.01 44.72 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.42 156.71 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 122.409 -0.465 . . . . 0.0 110.351 -175.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -116.07 137.55 52.02 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.9 t -134.01 140.7 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -176.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.5 tp -136.72 125.65 15.31 Favored Pre-proline 0 N--CA 1.497 1.884 0 CA-C-O 118.553 -0.737 . . . . 0.0 110.109 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -63.78 149.12 91.48 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 120.937 1.091 . . . . 0.0 111.357 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.3 pt -141.79 169.64 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 120.692 0.282 . . . . 0.0 110.298 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -114.83 131.26 56.88 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 167.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.4 mt -105.71 123.29 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -175.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.6 mt -107.77 116.48 32.03 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.1 mt -129.75 121.91 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.64 -120.24 18.28 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -111.09 16.98 20.82 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.311 -0.523 . . . . 0.0 111.832 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -119.65 144.4 47.18 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 118.609 0.64 . . . . 0.0 110.464 -175.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -123.12 129.98 52.16 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 120.668 0.271 . . . . 0.0 110.282 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.3 mt -125.54 144.91 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.89 136.83 43.39 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.67 -167.17 12.71 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.37 155.68 27.15 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 117.277 0.538 . . . . 0.0 110.363 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -108.72 141.84 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.03 131.56 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.8 t -141.87 130.63 12.13 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -58.75 155.02 39.76 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 121.02 1.147 . . . . 0.0 111.633 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -64.92 -34.41 78.34 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.301 -0.25 . . . . 0.0 110.574 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -87.98 121.09 29.99 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.3 t -142.38 152.45 42.86 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.344 -0.223 . . . . 0.0 110.407 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -98.9 -58.65 1.9 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -136.76 170.62 15.77 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.1 p -82.74 150.63 26.58 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.1 m -135.17 174.98 10.01 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 120.577 0.227 . . . . 0.0 110.408 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -106.4 27.22 8.95 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.374 -0.204 . . . . 0.0 110.932 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.0 mm -123.73 127.82 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.5 pt -125.2 145.1 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -115.92 130.21 56.73 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.2 mt -115.6 151.02 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.6 pt -116.56 154.78 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 169.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.59 165.97 22.2 Favored Pre-proline 0 N--CA 1.496 1.829 0 CA-C-O 119.049 -0.5 . . . . 0.0 110.307 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.9 -32.64 95.51 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 121.078 1.185 . . . . 0.0 111.404 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.98 161.54 39.13 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.695 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -63.36 105.81 0.8 Allowed 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 121.267 0.556 . . . . 0.0 111.038 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.4 mt -59.84 -33.35 71.67 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.861 -0.524 . . . . 0.0 111.445 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 93.1 mtm-85 -62.55 -35.36 79.22 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 122.131 -0.355 . . . . 0.0 110.967 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -78.22 -48.03 16.71 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -62.46 -34.24 76.43 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 122.192 -0.318 . . . . 0.0 111.102 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -108.03 9.0 28.56 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 51.85 50.43 18.64 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.137 -0.977 . . . . 0.0 111.934 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.6 mt -90.41 138.12 31.8 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.868 -0.52 . . . . 0.0 110.909 -171.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -116.32 156.96 25.75 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.08 138.04 50.23 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.863 -0.523 . . . . 0.0 111.5 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.68 -22.87 37.91 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -65.38 150.74 47.79 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-N 118.725 1.262 . . . . 0.0 110.041 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.96 133.39 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -173.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.0 pt -128.21 160.39 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -109.3 138.19 46.04 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.0 pt -111.82 136.77 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.495 1.786 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -177.024 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.2 mm . . . . . 0 N--CA 1.498 1.934 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.2 mt -129.52 148.33 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -105.73 140.39 38.86 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.12 150.51 20.01 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -105.39 142.45 35.13 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 122.354 -0.497 . . . . 0.0 110.205 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.69 123.25 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.76 163.84 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 N--CA 1.498 1.957 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.22 -178.7 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -65.57 -31.42 72.46 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.225 -0.297 . . . . 0.0 110.855 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -68.71 -40.4 79.98 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.576 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.4 mt -81.35 -36.94 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.6 mt -104.04 -26.24 12.68 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.228 -0.295 . . . . 0.0 111.611 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.44 14.89 72.7 Favored Glycine 0 N--CA 1.494 2.504 0 CA-C-O 119.322 -0.71 . . . . 0.0 111.421 -172.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -151.84 161.17 43.09 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 119.097 1.449 . . . . 0.0 110.7 170.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -94.1 108.4 35.32 Favored Pre-proline 0 N--CA 1.496 1.874 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.821 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -67.3 157.94 59.37 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 O-C-N 123.279 1.147 . . . . 0.0 110.45 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -73.61 164.0 27.25 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -80.24 79.56 6.79 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.502 0.668 . . . . 0.0 109.612 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.76 172.18 44.44 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 p -138.01 157.18 46.89 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 117.315 0.558 . . . . 0.0 110.691 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.7 tp -109.4 116.14 31.27 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 170.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.34 120.44 38.76 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 61.0 mt -120.03 136.15 54.67 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 120.683 0.278 . . . . 0.0 110.658 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -96.05 132.77 41.06 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.6 mt -111.82 160.22 17.56 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 120.681 0.277 . . . . 0.0 110.427 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.1 13.14 13.78 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 172.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -145.86 142.03 28.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.657 -0.652 . . . . 0.0 109.566 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -64.23 148.88 49.13 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 122.297 -0.252 . . . . 0.0 110.395 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -131.78 137.03 48.0 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 120.688 0.28 . . . . 0.0 110.5 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -138.0 124.05 20.25 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.3 tt -64.25 -22.94 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.226 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -72.52 -4.19 29.03 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 118.257 0.48 . . . . 0.0 112.074 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -90.53 -14.26 32.96 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 118.833 0.742 . . . . 0.0 111.427 172.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -115.68 175.08 5.69 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 118.673 0.67 . . . . 0.0 109.34 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -91.42 101.98 14.66 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -108.64 175.96 5.28 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.313 -0.242 . . . . 0.0 110.623 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.7 mt -110.34 131.08 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -105.93 143.12 34.52 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.5 p -122.48 134.53 54.57 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.65 0.262 . . . . 0.0 110.618 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -76.86 172.62 12.84 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 120.803 0.335 . . . . 0.0 111.686 -169.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -67.96 140.29 56.41 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -141.09 165.48 27.42 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.755 -175.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -123.28 149.07 45.26 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.803 0.335 . . . . 0.0 110.533 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -149.87 135.52 18.42 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 51.69 32.91 10.01 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.654 -0.654 . . . . 0.0 112.1 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.27 17.32 78.24 Favored Glycine 0 N--CA 1.498 2.796 0 CA-C-O 119.683 -0.509 . . . . 0.0 111.835 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -122.75 141.13 52.14 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.628 1.214 . . . . 0.0 109.767 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.68 131.73 38.71 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.424 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -121.81 143.96 49.1 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -86.99 155.73 20.05 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 120.812 0.339 . . . . 0.0 110.482 -168.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.45 158.28 51.19 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.3 155.09 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 122.268 -0.548 . . . . 0.0 110.37 -174.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -113.26 137.45 51.47 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.1 t -133.24 140.27 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 tp -137.21 125.71 14.79 Favored Pre-proline 0 N--CA 1.497 1.878 0 CA-C-O 118.522 -0.752 . . . . 0.0 110.073 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -63.21 149.81 90.33 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 120.916 1.077 . . . . 0.0 111.542 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.5 pt -142.13 170.05 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 171.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -114.31 131.98 56.34 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 167.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.46 122.88 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -107.47 116.89 32.74 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 74.5 mt -129.97 121.9 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.52 -119.94 17.33 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -111.21 17.01 20.7 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.359 -0.494 . . . . 0.0 111.788 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -119.74 143.94 47.52 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 118.536 0.607 . . . . 0.0 110.468 -175.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -123.14 129.64 51.7 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 120.674 0.273 . . . . 0.0 110.286 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.4 mt -125.53 145.11 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.79 136.72 43.59 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.42 -166.32 12.09 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.72 155.54 26.16 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 117.348 0.574 . . . . 0.0 110.385 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.73 141.19 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.35 132.11 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.1 t -142.16 129.04 11.17 Favored Pre-proline 0 N--CA 1.498 1.934 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.97 154.35 51.25 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.027 1.151 . . . . 0.0 111.412 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -61.81 -30.84 71.09 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 122.262 -0.274 . . . . 0.0 111.402 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -84.85 107.98 17.28 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.299 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.5 m -131.05 145.41 52.01 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -94.06 -59.74 1.9 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -139.53 170.32 16.14 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.4 m -68.43 145.96 53.63 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.2 m -135.0 166.23 23.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.352 -0.218 . . . . 0.0 110.462 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -107.4 27.1 9.43 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.379 -0.201 . . . . 0.0 110.865 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.7 mm -123.16 127.34 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.2 pt -125.83 144.4 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -114.21 129.58 56.63 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.7 mt -114.78 150.67 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -174.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 pt -116.52 154.85 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 168.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.51 166.07 21.79 Favored Pre-proline 0 N--CA 1.496 1.831 0 CA-C-O 119.099 -0.477 . . . . 0.0 110.257 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.79 -32.12 95.04 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 121.135 1.223 . . . . 0.0 111.468 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.9 160.49 41.22 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.334 -0.229 . . . . 0.0 110.695 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.5 pttt -63.07 105.85 0.76 Allowed 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.297 0.57 . . . . 0.0 111.106 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.7 mt -59.79 -33.44 71.71 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.843 -0.535 . . . . 0.0 111.413 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -62.81 -35.13 78.91 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 122.092 -0.38 . . . . 0.0 111.021 -173.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -78.19 -48.4 15.95 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -62.44 -34.33 76.58 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 122.223 -0.298 . . . . 0.0 111.129 -172.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -108.14 8.87 28.27 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.86 50.39 18.73 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.1 -1.0 . . . . 0.0 111.942 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 45.5 mt -90.35 138.22 31.72 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.757 -0.589 . . . . 0.0 110.952 -171.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -116.39 157.32 25.27 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.99 138.14 49.59 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 121.889 -0.507 . . . . 0.0 111.524 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.68 -22.93 37.65 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -65.47 152.43 43.97 Favored 'General case' 0 N--CA 1.505 2.31 0 CA-C-N 118.597 1.199 . . . . 0.0 110.033 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -111.03 133.93 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -174.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.4 pt -128.85 159.75 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -109.71 137.97 46.76 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 pt -112.82 137.83 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -178.201 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.5 mm . . . . . 0 N--CA 1.497 1.92 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.1 mt -129.84 148.75 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -105.11 141.53 36.5 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.26 151.34 20.48 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.77 141.85 36.49 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 117.184 0.492 . . . . 0.0 110.212 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.65 123.86 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.71 146.43 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.498 1.936 0 O-C-N 122.311 -0.243 . . . . 0.0 110.451 -178.488 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 N--CA 1.501 2.125 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -65.32 -32.39 74.02 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 122.189 -0.319 . . . . 0.0 110.681 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -68.65 -39.57 80.63 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.687 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.7 mt -81.04 -37.52 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -176.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.4 mt -103.42 -26.14 13.0 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.196 -0.315 . . . . 0.0 111.735 -173.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.57 14.75 75.27 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -150.96 160.67 43.77 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 119.107 1.453 . . . . 0.0 110.547 170.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -94.82 108.8 40.11 Favored Pre-proline 0 N--CA 1.495 1.822 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.808 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.23 158.89 54.76 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 O-C-N 123.283 1.149 . . . . 0.0 110.508 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -73.74 163.89 27.36 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -80.21 79.54 6.76 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.544 0.688 . . . . 0.0 109.617 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.06 171.61 43.66 Favored Glycine 0 N--CA 1.496 2.633 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -138.1 157.93 45.34 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 117.356 0.578 . . . . 0.0 110.59 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.2 tp -109.9 116.54 31.82 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -98.94 123.45 43.22 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 74.8 mt -120.62 135.57 55.07 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 120.641 0.258 . . . . 0.0 110.602 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -96.17 133.12 40.86 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.4 mt -112.3 160.27 17.83 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 120.701 0.286 . . . . 0.0 110.464 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -89.57 13.46 13.95 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 172.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -145.41 141.82 28.76 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.763 -0.585 . . . . 0.0 109.423 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -64.47 146.81 53.96 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 122.201 -0.312 . . . . 0.0 110.396 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -134.97 136.41 42.2 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 120.714 0.292 . . . . 0.0 110.588 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -138.04 131.02 30.03 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.48 -23.08 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.533 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -74.86 -0.94 20.12 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.895 -0.503 . . . . 0.0 112.253 -176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -90.04 -14.51 33.71 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 118.946 0.794 . . . . 0.0 111.575 171.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -117.77 175.12 5.8 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.68 -0.637 . . . . 0.0 109.403 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -90.89 103.59 16.28 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -109.73 178.14 4.51 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 120.587 0.232 . . . . 0.0 110.5 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.0 mt -111.15 131.03 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -105.95 146.02 30.56 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.3 p -122.6 137.22 54.96 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 120.688 0.28 . . . . 0.0 110.649 176.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -76.59 172.7 12.59 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 120.895 0.378 . . . . 0.0 111.711 -168.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -67.37 140.23 57.2 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -139.54 166.73 23.81 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 122.221 -0.299 . . . . 0.0 110.598 -174.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -124.22 148.75 47.08 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 120.891 0.377 . . . . 0.0 110.488 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -148.97 136.73 20.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.91 32.27 9.67 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.703 -0.623 . . . . 0.0 112.101 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.07 16.85 79.23 Favored Glycine 0 N--CA 1.496 2.692 0 CA-C-O 119.587 -0.563 . . . . 0.0 111.874 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -123.22 143.13 50.24 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 118.651 1.225 . . . . 0.0 109.731 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.37 132.2 37.83 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 121.066 -0.253 . . . . 0.0 110.366 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -121.78 144.91 48.53 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -86.03 156.52 20.39 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.4 -169.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.14 161.22 44.85 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.93 156.92 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 122.354 -0.498 . . . . 0.0 110.327 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -118.77 137.24 53.5 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.8 t -134.04 141.11 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -176.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.4 tp -137.25 125.65 14.7 Favored Pre-proline 0 N--CA 1.496 1.851 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.13 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -63.35 149.46 91.17 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 120.936 1.09 . . . . 0.0 111.477 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 44.2 pt -141.53 170.09 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 122.209 -0.307 . . . . 0.0 110.256 171.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -114.67 131.56 56.69 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 167.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.05 123.17 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -175.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.1 mt -108.37 117.09 33.24 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.96 121.94 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.29 -119.93 17.58 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -111.16 17.0 20.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.343 -0.504 . . . . 0.0 111.981 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -119.94 144.01 47.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.749 -0.594 . . . . 0.0 110.512 -175.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -123.15 130.76 53.19 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.9 mt -125.78 145.27 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.79 137.83 44.13 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.16 -167.7 13.73 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.6 156.92 28.82 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 117.354 0.577 . . . . 0.0 110.443 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.7 mt -108.63 141.25 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.98 131.05 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.9 t -143.67 136.52 13.7 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -58.11 154.21 41.0 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 120.989 1.126 . . . . 0.0 111.757 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -65.9 -34.87 79.13 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 122.282 -0.261 . . . . 0.0 110.468 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -92.05 125.7 36.84 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -137.26 155.51 49.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 122.33 -0.231 . . . . 0.0 110.421 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -97.01 -59.43 1.8 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -138.94 170.33 16.18 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.3 p -80.74 147.53 30.51 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.4 m -134.98 174.03 11.07 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 120.583 0.23 . . . . 0.0 110.481 -177.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -107.23 27.61 8.89 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 122.36 -0.212 . . . . 0.0 110.862 177.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -123.3 127.74 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.4 pt -125.97 145.12 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -116.35 130.06 56.58 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.1 mt -114.58 150.41 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -175.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 pt -115.92 153.97 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 169.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.58 166.04 21.82 Favored Pre-proline 0 N--CA 1.494 1.738 0 CA-C-O 119.074 -0.489 . . . . 0.0 110.293 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.75 -31.3 93.88 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.08 1.187 . . . . 0.0 111.68 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.71 167.09 23.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 122.338 -0.226 . . . . 0.0 110.921 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -67.74 107.04 2.43 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.05 -35.82 75.96 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 122.081 -0.387 . . . . 0.0 111.373 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 71.8 mtt85 -62.39 -35.29 78.73 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 122.175 -0.328 . . . . 0.0 110.981 -175.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -78.2 -47.3 18.32 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.6 -34.85 77.83 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 122.191 -0.318 . . . . 0.0 111.036 -172.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -108.01 8.61 28.4 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 51.73 46.81 25.95 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.072 -1.017 . . . . 0.0 111.96 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.37 138.18 31.78 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.956 -0.465 . . . . 0.0 110.969 -170.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -114.79 158.25 22.14 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.78 138.08 48.62 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.866 -0.521 . . . . 0.0 111.541 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.63 -22.93 37.66 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.52 151.86 45.4 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 118.635 1.217 . . . . 0.0 109.982 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.52 134.09 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.2 pt -129.24 161.32 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -110.4 137.89 47.51 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -113.02 137.6 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 176.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.0 tt . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -178.373 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.6 mm . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.7 mt -129.58 148.5 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -106.98 142.37 36.7 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 122.27 -0.269 . . . . 0.0 110.466 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.69 151.57 20.95 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -106.07 142.69 35.34 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 117.247 0.524 . . . . 0.0 110.259 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.64 124.32 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.73 156.12 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.499 1.981 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.4 -176.536 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.504 2.227 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -64.51 -31.45 72.68 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 122.157 -0.339 . . . . 0.0 110.767 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -67.98 -40.34 83.12 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.657 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 59.6 mt -80.94 -37.27 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.0 mt -102.53 -26.29 13.29 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 122.189 -0.319 . . . . 0.0 111.568 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.35 14.33 74.34 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-O 119.26 -0.745 . . . . 0.0 111.411 -172.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -152.31 161.23 42.91 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 119.243 1.521 . . . . 0.0 110.641 170.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -94.32 107.95 32.87 Favored Pre-proline 0 N--CA 1.496 1.841 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.737 177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.4 155.48 70.2 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 O-C-N 123.327 1.172 . . . . 0.0 110.462 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -73.82 164.17 26.98 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.24 79.55 6.8 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.489 0.661 . . . . 0.0 109.663 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.55 171.74 44.03 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 p -138.05 156.74 47.49 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 117.41 0.605 . . . . 0.0 110.884 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.2 tp -109.91 118.58 36.84 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 170.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.95 122.34 42.08 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.8 mt -119.96 136.08 54.67 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 120.686 0.279 . . . . 0.0 110.562 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -96.23 133.39 40.61 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 173.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.9 mt -112.16 160.18 17.82 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 120.561 0.22 . . . . 0.0 110.482 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.2 13.16 13.94 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -145.34 141.21 28.3 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 118.604 0.638 . . . . 0.0 109.418 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -64.18 146.84 53.59 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 122.253 -0.279 . . . . 0.0 110.392 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -132.02 137.41 47.83 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 120.705 0.288 . . . . 0.0 110.638 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -138.07 128.34 26.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.72 -24.08 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.327 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -74.33 -1.05 19.11 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 122.0 -0.437 . . . . 0.0 112.156 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -91.22 -14.35 31.16 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 118.874 0.761 . . . . 0.0 111.441 169.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -116.07 175.02 5.73 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.644 -0.66 . . . . 0.0 109.396 175.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -92.07 101.97 14.51 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -177.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -110.18 176.71 4.95 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 120.535 0.207 . . . . 0.0 110.489 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.6 mt -110.98 134.43 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -105.75 142.47 35.43 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.3 p -116.7 133.66 55.75 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -77.18 172.63 12.94 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 120.803 0.335 . . . . 0.0 111.345 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -68.6 139.98 55.54 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -138.35 166.6 23.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.251 -0.281 . . . . 0.0 110.67 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -125.44 145.81 49.9 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 120.749 0.309 . . . . 0.0 110.544 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -149.57 141.82 24.12 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.0 m120 52.17 29.95 7.15 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.667 -0.646 . . . . 0.0 112.085 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.41 16.39 80.76 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -121.51 142.54 49.97 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 118.699 1.25 . . . . 0.0 109.666 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -93.14 131.7 37.95 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.477 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -120.85 143.73 48.74 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -86.89 151.9 22.91 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 120.763 0.316 . . . . 0.0 110.382 -169.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.74 167.18 42.01 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.99 162.76 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 122.312 -0.523 . . . . 0.0 110.488 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -112.23 137.37 50.42 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 173.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -132.47 138.33 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.2 tp -136.94 125.65 15.06 Favored Pre-proline 0 N--CA 1.497 1.925 0 CA-C-O 118.663 -0.684 . . . . 0.0 110.097 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -63.59 149.39 91.06 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 120.993 1.128 . . . . 0.0 111.395 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.1 pt -142.15 170.03 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 171.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -115.28 131.99 56.75 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 167.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.6 mt -106.26 123.48 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.5 mt -107.86 116.76 32.55 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.4 mt -129.92 121.98 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.35 -120.13 18.26 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -178.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -111.07 16.95 20.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.366 -0.491 . . . . 0.0 111.926 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -119.72 144.0 47.47 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 118.577 0.626 . . . . 0.0 110.496 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -123.1 129.72 51.82 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 120.651 0.262 . . . . 0.0 110.308 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.2 mt -125.96 143.44 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.96 138.2 44.04 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.23 -164.34 11.32 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.88 156.19 26.92 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 117.351 0.576 . . . . 0.0 110.417 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.7 mt -108.77 141.53 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 176.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.57 130.77 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.6 t -140.39 126.8 11.92 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -57.7 155.83 30.27 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 121.024 1.149 . . . . 0.0 111.883 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -63.76 -33.88 76.65 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 122.31 -0.244 . . . . 0.0 110.78 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -86.65 116.15 24.57 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.1 m -130.83 142.64 50.4 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -93.8 -50.37 5.39 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -147.8 -179.48 6.92 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.9 p -91.18 145.52 24.6 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.5 m -135.08 174.96 10.03 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 120.586 0.231 . . . . 0.0 110.562 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -107.07 27.42 9.04 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 122.458 -0.151 . . . . 0.0 110.929 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.7 mm -122.64 127.4 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.5 pt -125.43 144.05 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 110.137 -0.319 . . . . 0.0 110.137 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -114.55 130.15 56.73 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.9 mt -115.28 151.06 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -174.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.5 pt -115.74 155.72 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.48 162.02 44.2 Favored Pre-proline 0 N--CA 1.495 1.791 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.214 -176.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.21 -34.47 94.01 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.065 1.177 . . . . 0.0 111.462 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -145.03 159.07 43.53 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.348 -0.22 . . . . 0.0 110.684 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.7 pttt -63.72 103.97 0.62 Allowed 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.495 0.665 . . . . 0.0 111.23 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.46 -31.98 69.82 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.927 -0.483 . . . . 0.0 111.373 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -61.29 -34.98 76.1 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.008 -0.432 . . . . 0.0 111.211 -173.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -78.25 -49.07 14.41 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -61.89 -33.8 74.88 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.217 -172.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -108.11 9.02 28.38 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.79 50.54 18.44 Favored 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.005 -1.059 . . . . 0.0 111.85 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 44.9 mt -89.49 138.14 31.71 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.878 -0.514 . . . . 0.0 110.951 -169.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -119.52 157.24 28.74 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -55.95 138.51 48.67 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.84 -0.537 . . . . 0.0 111.474 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.53 -23.02 37.33 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.32 151.44 46.24 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 118.702 1.251 . . . . 0.0 110.03 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -110.23 133.07 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -174.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.4 pt -128.29 160.13 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -109.25 137.98 46.3 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -175.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.0 pt -110.12 137.6 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.0 tt . . . . . 0 N--CA 1.494 1.757 0 O-C-N 122.314 -0.241 . . . . 0.0 110.359 -175.113 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.3 mm . . . . . 0 N--CA 1.499 1.992 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.3 mt -129.74 148.91 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -105.53 140.14 39.08 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.85 151.1 20.31 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -105.99 141.32 37.57 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 117.229 0.515 . . . . 0.0 110.256 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.3 t -63.22 124.04 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.88 164.02 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 176.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.499 2.003 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.194 -176.981 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 N--CA 1.501 2.123 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -65.74 -31.63 72.73 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.156 -0.34 . . . . 0.0 110.758 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -68.53 -40.44 80.76 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.578 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -81.44 -36.59 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.0 mt -103.27 -26.39 12.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 122.14 -0.35 . . . . 0.0 111.693 -174.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.53 15.36 73.84 Favored Glycine 0 N--CA 1.495 2.586 0 CA-C-O 119.362 -0.688 . . . . 0.0 111.411 -173.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -151.14 162.75 40.29 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 119.145 1.473 . . . . 0.0 110.812 170.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.03 106.52 22.79 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.835 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.48 160.93 47.12 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 O-C-N 123.383 1.201 . . . . 0.0 110.269 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -73.19 160.58 31.73 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -80.23 79.6 6.78 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.479 0.657 . . . . 0.0 109.686 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.28 176.41 47.79 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 p -138.11 156.25 47.95 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 117.331 0.565 . . . . 0.0 110.813 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.6 tp -108.68 116.47 32.05 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 169.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.41 122.13 41.21 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 61.4 mt -120.31 135.59 54.96 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 120.653 0.263 . . . . 0.0 110.535 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -95.9 133.09 40.49 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.6 mt -112.31 160.22 17.88 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 120.653 0.263 . . . . 0.0 110.484 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.06 13.0 14.04 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 172.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -145.99 142.89 29.09 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 118.614 0.643 . . . . 0.0 109.557 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.34 148.63 49.91 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.503 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -131.91 137.44 47.99 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 120.701 0.286 . . . . 0.0 110.44 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -138.09 125.0 21.22 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.5 -23.62 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.266 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -74.24 -1.45 20.61 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.976 -0.453 . . . . 0.0 112.109 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.09 -14.5 31.13 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 118.929 0.786 . . . . 0.0 111.453 170.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -116.67 175.15 5.7 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 118.658 0.663 . . . . 0.0 109.343 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -91.31 102.72 15.42 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -109.44 177.35 4.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 122.323 -0.235 . . . . 0.0 110.563 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.2 mt -111.28 130.91 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -105.97 142.4 35.75 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.2 p -120.69 138.8 53.77 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 120.794 0.331 . . . . 0.0 110.743 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -76.75 172.64 12.75 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 120.847 0.356 . . . . 0.0 111.826 -168.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -67.88 141.21 56.47 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -136.67 164.91 27.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.152 -0.342 . . . . 0.0 110.598 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -123.61 145.95 48.54 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 120.732 0.301 . . . . 0.0 110.469 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -149.88 139.39 21.53 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 52.01 30.34 7.28 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.674 -0.642 . . . . 0.0 112.131 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.36 16.59 80.29 Favored Glycine 0 N--CA 1.497 2.725 0 CA-C-O 119.648 -0.529 . . . . 0.0 111.83 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -122.14 143.45 49.54 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.573 1.187 . . . . 0.0 109.614 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.21 131.41 38.33 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.463 -176.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -120.11 143.49 48.14 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -85.76 157.22 20.32 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 120.715 0.293 . . . . 0.0 110.432 -168.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.29 159.66 47.21 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.93 155.88 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 122.404 -0.468 . . . . 0.0 110.473 -174.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -114.69 138.24 50.94 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.3 t -133.88 140.04 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -177.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 tp -137.12 125.64 14.85 Favored Pre-proline 0 N--CA 1.497 1.88 0 CA-C-O 118.518 -0.753 . . . . 0.0 110.089 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.27 149.27 91.77 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.979 1.12 . . . . 0.0 111.482 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.7 pt -141.95 170.03 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 171.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -114.9 131.17 56.95 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 168.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.2 mt -105.62 124.11 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -174.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.75 116.3 31.71 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -130.01 121.95 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.99 -120.49 18.72 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -111.15 17.09 20.68 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 122.33 -0.512 . . . . 0.0 111.806 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -119.61 144.76 46.95 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 118.609 0.641 . . . . 0.0 110.492 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -123.06 131.15 53.58 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.216 -0.303 . . . . 0.0 110.28 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.79 144.87 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.75 136.57 43.65 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.58 -166.49 12.25 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.41 155.63 26.99 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 117.311 0.555 . . . . 0.0 110.304 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -108.7 141.99 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.1 t -121.43 131.35 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -142.44 136.22 14.52 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -57.28 152.32 46.66 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.1 1.2 . . . . 0.0 111.814 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -66.19 -34.85 78.96 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.394 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -93.89 125.19 38.37 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 t -140.91 154.82 46.29 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -97.64 -57.93 2.12 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -134.61 -177.91 4.83 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.2 p -95.13 150.87 19.73 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.3 m -135.06 174.64 10.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.309 -0.245 . . . . 0.0 110.419 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -107.39 27.49 9.05 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 122.37 -0.206 . . . . 0.0 110.858 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.5 mm -122.91 127.35 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.4 pt -124.95 143.79 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -114.93 129.44 56.71 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 80.9 mt -115.02 152.04 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.4 pt -117.37 155.23 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 167.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.56 165.59 24.21 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.298 -176.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -60.0 -32.04 94.39 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 121.072 1.181 . . . . 0.0 111.576 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.73 167.03 23.54 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.319 -0.238 . . . . 0.0 110.826 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -70.63 104.34 2.79 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.2 mt -59.55 -33.01 70.87 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 122.211 -0.306 . . . . 0.0 111.497 -177.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -62.44 -35.59 79.75 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 122.109 -0.369 . . . . 0.0 110.949 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -78.22 -48.52 15.62 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -62.61 -33.41 74.93 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 122.159 -0.338 . . . . 0.0 111.099 -173.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -107.95 8.33 28.39 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 51.81 45.1 28.75 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 121.096 -1.002 . . . . 0.0 111.934 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -92.67 138.22 31.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.898 -0.501 . . . . 0.0 110.867 -171.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -114.97 159.31 20.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.11 138.18 50.11 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.906 -0.496 . . . . 0.0 111.467 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.63 -22.98 37.45 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.44 156.0 33.76 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-N 118.629 1.214 . . . . 0.0 109.975 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.36 133.87 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.0 pt -128.74 160.52 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -109.75 138.19 46.47 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 pt -112.77 137.58 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -178.17 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.2 mm . . . . . 0 N--CA 1.498 1.956 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 78.8 mt -130.6 147.74 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -110.08 143.96 39.36 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.59 151.56 21.26 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -105.95 142.56 35.46 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 117.231 0.516 . . . . 0.0 110.278 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.5 t -64.78 122.39 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.65 149.18 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.728 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 . . . . . 0 N--CA 1.501 2.106 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -65.76 -30.71 71.4 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 122.224 -0.298 . . . . 0.0 110.797 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -68.77 -40.63 79.61 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.645 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.2 mt -81.45 -37.08 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.7 mt -104.04 -26.25 12.67 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.262 -0.274 . . . . 0.0 111.638 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.77 14.31 73.2 Favored Glycine 0 N--CA 1.494 2.554 0 CA-C-O 119.319 -0.712 . . . . 0.0 111.449 -172.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -152.43 163.46 39.49 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 119.149 1.475 . . . . 0.0 110.691 170.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -94.97 108.42 37.99 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.583 -0.722 . . . . 0.0 109.922 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -67.39 159.64 51.42 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 123.32 1.169 . . . . 0.0 110.492 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -74.0 162.55 28.92 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -80.21 79.59 6.76 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.519 0.676 . . . . 0.0 109.662 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.64 171.86 44.13 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 175.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 p -138.0 157.59 46.06 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 117.382 0.591 . . . . 0.0 110.853 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.2 tp -110.47 116.98 32.35 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -98.97 121.76 41.34 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 65.4 mt -120.49 135.98 54.9 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.72 0.295 . . . . 0.0 110.642 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -96.09 132.06 41.87 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.5 mt -110.6 160.3 16.79 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 120.64 0.257 . . . . 0.0 110.452 -176.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.28 12.85 14.89 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 172.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -145.27 140.48 27.84 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.696 -0.628 . . . . 0.0 109.39 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.33 146.94 52.46 Favored 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.626 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -132.53 137.19 47.06 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 120.724 0.297 . . . . 0.0 110.639 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -138.0 126.9 24.0 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.0 tt -64.37 -23.94 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.135 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -72.74 -3.55 25.88 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 122.006 -0.434 . . . . 0.0 112.053 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -91.12 -13.89 32.19 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 118.815 0.734 . . . . 0.0 111.51 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -114.2 175.08 5.63 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.596 0.634 . . . . 0.0 109.395 173.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -92.06 102.01 14.56 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -109.18 176.88 4.93 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 120.524 0.202 . . . . 0.0 110.574 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -111.0 129.48 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -105.94 140.91 38.21 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.5 p -117.23 134.9 54.24 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 120.721 0.296 . . . . 0.0 110.495 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -75.83 172.69 12.25 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 120.768 0.318 . . . . 0.0 111.472 -170.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -67.71 139.48 56.72 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -139.83 167.44 22.11 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.618 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -124.23 149.12 46.78 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 120.846 0.355 . . . . 0.0 110.528 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -148.24 135.62 20.5 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.82 32.89 10.34 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.739 -0.601 . . . . 0.0 112.098 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.25 16.6 79.38 Favored Glycine 0 N--CA 1.497 2.745 0 CA-C-O 119.606 -0.552 . . . . 0.0 111.907 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -121.99 142.13 50.63 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.74 1.27 . . . . 0.0 109.731 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.3 132.13 37.79 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.431 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -121.84 144.12 49.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -86.41 155.94 20.37 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.483 -168.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.76 159.15 49.13 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -139.24 156.77 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 122.353 -0.498 . . . . 0.0 110.387 -174.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -117.04 136.76 52.72 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.5 t -134.04 141.19 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.9 tp -137.35 125.63 14.57 Favored Pre-proline 0 N--CA 1.497 1.893 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.152 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.22 149.39 91.5 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 120.928 1.085 . . . . 0.0 111.475 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.7 pt -141.79 170.01 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-O 120.638 0.256 . . . . 0.0 110.312 171.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -116.18 130.58 56.86 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 167.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.8 mt -105.74 123.99 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -174.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.9 mt -107.88 117.17 33.41 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.5 mt -130.15 121.95 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.6 -120.05 17.6 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -111.16 17.11 20.65 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 122.418 -0.46 . . . . 0.0 111.78 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -119.65 143.75 47.54 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.558 0.617 . . . . 0.0 110.444 -175.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -123.12 130.0 52.19 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -125.42 145.05 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.77 136.65 43.63 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.86 -167.34 12.92 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.72 155.85 26.7 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 117.304 0.552 . . . . 0.0 110.387 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.8 mt -108.77 141.13 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.0 t -122.27 131.13 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -143.73 138.25 15.07 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.09 153.24 39.9 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 121.116 1.21 . . . . 0.0 111.842 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -65.4 -33.79 76.79 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 121.061 -0.255 . . . . 0.0 110.581 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -87.42 117.29 26.1 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 m -130.56 134.7 47.23 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -96.98 -50.24 4.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -133.41 170.02 16.09 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.7 m -94.61 153.34 17.89 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 93.6 p -135.09 173.45 11.71 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 120.739 0.304 . . . . 0.0 110.468 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -105.78 24.55 12.12 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 119.71 -0.186 . . . . 0.0 110.891 172.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.9 mm -119.85 127.43 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.9 pt -125.93 145.93 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -115.98 130.17 56.7 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.3 mt -115.18 150.83 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -174.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.2 pt -116.22 156.52 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 168.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.52 161.64 45.96 Favored Pre-proline 0 N--CA 1.495 1.806 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.298 -177.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.02 -31.39 93.42 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 121.044 1.163 . . . . 0.0 111.614 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.32 167.13 23.18 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.277 -0.264 . . . . 0.0 110.634 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -74.3 103.87 4.86 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 120.946 0.403 . . . . 0.0 110.176 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 79.0 mt -60.39 -33.25 72.21 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 122.088 -0.383 . . . . 0.0 111.314 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -61.93 -33.3 74.02 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.159 -0.338 . . . . 0.0 110.925 -175.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.24 -50.88 11.06 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -62.63 -32.52 73.56 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.158 -0.339 . . . . 0.0 111.218 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -106.64 8.07 30.94 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.78 47.51 24.65 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.06 -1.025 . . . . 0.0 111.858 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.3 mt -91.15 138.23 31.75 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.874 -0.517 . . . . 0.0 111.094 -169.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -117.55 159.86 22.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.24 138.38 50.44 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.908 -0.495 . . . . 0.0 111.445 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.55 -23.09 37.07 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -65.39 152.7 43.23 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 118.653 1.227 . . . . 0.0 110.061 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -110.81 133.1 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -174.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 33.5 pt -128.16 160.64 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -108.78 139.46 43.57 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.2 pt -110.09 137.9 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 174.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.2 tp . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -173.079 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.7 mm . . . . . 0 N--CA 1.498 1.957 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 78.8 mt -130.72 154.38 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -106.13 146.88 29.64 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.47 150.3 20.99 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -106.3 141.34 37.79 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.267 -0.549 . . . . 0.0 110.141 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.8 t -62.89 123.33 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.59 153.91 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 N--CA 1.498 1.964 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.321 -178.507 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 . . . . . 0 N--CA 1.504 2.266 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -63.95 -34.15 77.34 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.272 -0.268 . . . . 0.0 110.798 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -67.32 -38.3 84.7 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.607 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 59.9 mt -81.2 -37.09 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -175.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.3 mt -101.22 -26.37 13.67 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 122.226 -0.296 . . . . 0.0 111.657 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.66 14.14 76.49 Favored Glycine 0 N--CA 1.494 2.52 0 CA-C-O 119.312 -0.716 . . . . 0.0 111.414 -173.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -152.06 161.45 42.61 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 119.117 1.459 . . . . 0.0 110.609 171.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -94.22 106.44 22.96 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-O 118.611 -0.709 . . . . 0.0 109.901 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.29 158.48 57.35 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 O-C-N 123.303 1.16 . . . . 0.0 110.314 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -73.5 160.92 30.99 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -80.28 79.62 6.83 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.531 0.681 . . . . 0.0 109.538 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.46 177.64 48.35 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 p -138.07 156.04 48.18 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 117.389 0.594 . . . . 0.0 110.931 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.8 tp -109.04 118.59 37.18 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 169.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -99.0 123.36 43.24 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.228 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.1 mt -120.71 136.08 54.96 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.688 0.28 . . . . 0.0 110.441 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -95.81 133.93 39.37 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.7 mt -112.69 160.3 18.05 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 120.62 0.247 . . . . 0.0 110.395 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.01 12.54 15.22 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 173.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -145.69 144.88 30.65 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 118.563 0.62 . . . . 0.0 109.795 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -63.97 150.35 45.34 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 122.222 -0.298 . . . . 0.0 110.477 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -131.86 139.03 48.69 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 120.69 0.281 . . . . 0.0 110.701 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -138.08 122.87 18.79 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.58 -21.13 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.441 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -75.17 -0.77 20.39 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -89.41 -14.47 35.41 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.991 0.814 . . . . 0.0 111.438 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -119.69 175.19 5.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.624 -0.672 . . . . 0.0 109.531 173.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -91.06 103.45 16.15 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -107.27 177.29 4.89 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 122.336 -0.228 . . . . 0.0 110.463 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.0 mt -109.99 131.95 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.99 143.27 34.36 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.0 p -116.07 133.77 55.67 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -76.69 172.58 12.82 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 120.643 0.258 . . . . 0.0 111.316 -172.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -68.42 139.66 55.77 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -142.85 166.58 24.24 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.668 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -122.87 147.31 46.72 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 120.742 0.306 . . . . 0.0 110.525 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -149.65 138.96 21.39 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.9 m120 52.03 30.26 7.23 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.66 -0.65 . . . . 0.0 112.128 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.61 16.21 80.47 Favored Glycine 0 N--CA 1.496 2.697 0 CA-C-O 119.607 -0.552 . . . . 0.0 111.851 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -121.89 143.94 49.14 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 118.685 1.242 . . . . 0.0 109.717 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -93.5 131.72 38.46 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.488 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -121.32 143.82 48.97 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -87.15 155.19 20.21 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.792 0.329 . . . . 0.0 110.378 -170.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.13 160.99 48.16 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.1 m -141.99 160.79 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 122.32 -0.518 . . . . 0.0 110.367 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -116.13 136.76 52.73 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.5 t -132.69 139.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.0 tp -138.3 125.66 13.51 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.136 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -62.68 149.16 92.09 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 O-C-N 123.189 1.099 . . . . 0.0 111.613 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.6 pt -142.16 170.13 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 172.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -118.32 130.29 55.94 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 168.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.38 129.05 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -173.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.7 mt -107.43 117.62 34.58 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 71.7 mt -129.56 121.87 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.68 -119.95 17.15 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -111.08 16.97 20.83 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.412 -0.464 . . . . 0.0 111.872 176.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -120.4 146.13 46.5 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 118.522 0.601 . . . . 0.0 110.521 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -123.13 130.62 53.01 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -125.89 147.57 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.6 139.75 45.73 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -150.3 -165.85 12.98 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.38 155.45 26.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.28 -0.541 . . . . 0.0 110.182 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.5 mt -108.71 141.36 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.05 130.6 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.4 t -142.18 133.92 13.32 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -57.86 153.24 45.08 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 121.046 1.164 . . . . 0.0 111.801 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -65.5 -34.52 78.46 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.587 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -86.78 121.32 29.11 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.3 t -142.98 156.64 44.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.296 -0.253 . . . . 0.0 110.389 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -97.54 -59.95 1.67 Allowed 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -136.3 -172.19 3.08 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.3 p -93.05 149.45 21.21 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.7 m -134.9 173.08 12.11 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 120.576 0.226 . . . . 0.0 110.427 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -107.7 27.18 9.44 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.423 -0.173 . . . . 0.0 110.865 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -122.33 127.84 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.6 pt -124.59 143.71 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -115.04 128.71 56.42 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.2 mt -115.01 152.49 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -173.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.6 pt -116.49 156.0 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 168.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.6 163.88 33.79 Favored Pre-proline 0 N--CA 1.496 1.85 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.249 -176.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.02 -32.56 95.08 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.163 1.242 . . . . 0.0 111.572 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -145.01 167.01 23.68 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.275 -0.266 . . . . 0.0 110.994 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -69.5 103.95 2.19 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.632 0.73 . . . . 0.0 110.465 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.4 mt -60.26 -33.0 71.7 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.664 -0.647 . . . . 0.0 111.641 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -61.48 -37.84 85.09 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 122.054 -0.404 . . . . 0.0 111.296 -171.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -78.35 -45.82 21.58 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.36 -34.15 76.11 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.16 -0.337 . . . . 0.0 111.007 -173.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -108.18 8.27 27.89 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.75 48.06 23.57 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.204 -0.935 . . . . 0.0 111.888 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.4 mt -92.11 138.18 31.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.912 -0.493 . . . . 0.0 110.891 -171.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -117.21 156.19 28.13 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.66 138.02 48.14 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.941 -0.474 . . . . 0.0 111.542 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.97 -22.94 37.42 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.41 152.8 43.02 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-N 118.643 1.222 . . . . 0.0 110.019 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -112.77 134.03 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.3 pt -130.29 165.11 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -107.89 139.86 41.86 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.1 pt -117.04 138.76 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.878 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.0 mm . . . . . 0 N--CA 1.499 1.978 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.9 mt -129.67 148.75 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 176.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -105.7 140.04 39.36 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.43 150.14 20.17 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -105.93 141.68 36.92 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 117.21 0.505 . . . . 0.0 110.221 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.9 t -63.15 122.61 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.23 162.21 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 N--CA 1.5 2.028 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.703 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 N--CA 1.502 2.13 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -65.86 -30.89 71.57 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.736 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -68.69 -40.58 79.97 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.67 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mt -81.39 -36.86 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.5 mt -103.96 -26.29 12.69 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.213 -0.304 . . . . 0.0 111.678 -174.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.49 14.76 72.91 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-O 119.304 -0.72 . . . . 0.0 111.436 -172.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -151.9 162.18 41.47 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 119.155 1.478 . . . . 0.0 110.659 170.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -94.84 108.61 38.84 Favored Pre-proline 0 N--CA 1.497 1.878 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.894 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -67.33 158.54 56.5 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 O-C-N 123.238 1.125 . . . . 0.0 110.55 -176.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -73.81 162.43 29.13 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -80.22 79.67 6.76 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.378 0.609 . . . . 0.0 109.764 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.16 178.94 48.63 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 175.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -137.96 154.37 49.38 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 117.266 0.533 . . . . 0.0 110.801 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.0 tp -109.61 115.47 29.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 168.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -99.66 122.77 43.16 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -175.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.7 mt -120.57 136.26 54.85 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.716 0.293 . . . . 0.0 110.487 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -95.94 132.91 40.76 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.9 mt -112.16 160.28 17.73 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 120.63 0.253 . . . . 0.0 110.508 -175.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.01 12.89 14.25 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 172.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -145.74 142.0 28.53 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 118.594 0.634 . . . . 0.0 109.573 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.04 147.3 51.12 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 122.235 -0.29 . . . . 0.0 110.697 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -131.81 135.87 47.07 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 120.781 0.324 . . . . 0.0 110.675 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -138.06 127.41 24.66 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 173.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.16 -23.49 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.329 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -74.39 -1.08 19.44 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.944 -0.473 . . . . 0.0 112.184 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -91.12 -14.44 31.17 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 118.913 0.779 . . . . 0.0 111.511 170.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -116.28 175.11 5.7 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.593 0.633 . . . . 0.0 109.373 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -91.51 102.14 14.8 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -109.73 179.23 4.18 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 120.526 0.203 . . . . 0.0 110.591 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.5 mt -110.98 132.14 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -105.92 143.56 33.89 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 36.4 p -124.56 135.04 52.83 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 120.83 0.348 . . . . 0.0 110.667 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.88 172.69 12.73 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 120.825 0.345 . . . . 0.0 111.768 -169.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -68.05 141.14 56.27 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -137.52 166.59 23.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 122.195 -0.315 . . . . 0.0 110.656 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -125.78 149.17 48.79 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 120.861 0.362 . . . . 0.0 110.591 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -148.86 135.01 19.22 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 52.17 33.44 12.37 Favored 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.719 -0.613 . . . . 0.0 111.895 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.73 16.25 80.31 Favored Glycine 0 N--CA 1.497 2.709 0 CA-C-O 119.613 -0.548 . . . . 0.0 111.877 176.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -119.94 139.56 52.26 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 118.723 1.262 . . . . 0.0 109.704 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.41 131.82 38.24 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 120.671 0.272 . . . . 0.0 110.416 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -120.21 143.2 48.39 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -86.08 155.05 20.97 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.774 0.321 . . . . 0.0 110.541 -167.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.07 157.29 51.51 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -138.52 159.21 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 122.258 -0.554 . . . . 0.0 110.404 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -117.08 135.84 53.43 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.8 t -132.2 139.61 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -176.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.3 tp -136.45 125.64 15.61 Favored Pre-proline 0 N--CA 1.496 1.871 0 CA-C-O 118.579 -0.725 . . . . 0.0 110.004 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.45 149.15 91.87 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 O-C-N 123.172 1.091 . . . . 0.0 111.426 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.3 pt -141.9 169.85 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 171.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -114.98 131.33 56.95 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 168.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.6 mt -105.32 123.2 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -175.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.1 mt -107.5 115.89 30.97 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.7 mt -130.02 121.95 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.12 -120.59 18.77 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -111.14 17.02 20.75 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.344 -0.503 . . . . 0.0 111.888 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -119.77 145.16 46.83 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 118.586 0.63 . . . . 0.0 110.552 -175.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -123.08 129.5 51.55 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 120.741 0.305 . . . . 0.0 110.295 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.3 mt -125.65 143.4 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.04 137.46 43.41 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.1 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.27 -165.15 11.6 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.46 154.9 25.62 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 117.429 0.615 . . . . 0.0 110.507 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.6 mt -108.7 141.74 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.97 132.49 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -175.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.1 t -145.05 137.05 13.06 Favored Pre-proline 0 N--CA 1.498 1.959 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -58.41 154.59 40.48 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 121.072 1.182 . . . . 0.0 111.687 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -65.17 -34.17 77.74 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.805 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -85.15 116.96 23.81 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.305 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.7 m -131.68 139.57 49.09 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -94.62 -49.61 5.56 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -137.68 172.44 12.95 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -89.22 146.78 24.53 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.0 m -135.03 169.89 16.74 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 120.615 0.245 . . . . 0.0 110.607 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -106.96 27.63 8.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.438 -0.164 . . . . 0.0 110.795 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.5 mm -121.79 126.75 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.0 pt -124.06 143.86 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -115.15 130.88 57.04 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.7 mt -116.11 151.5 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -173.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.4 pt -116.59 153.52 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 167.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.53 164.64 29.51 Favored Pre-proline 0 N--CA 1.495 1.807 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.234 -176.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.21 -31.94 93.74 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.042 1.162 . . . . 0.0 111.584 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.59 167.1 23.34 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.29 -0.256 . . . . 0.0 110.716 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -70.8 104.45 2.9 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.9 mt -59.58 -33.13 71.06 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 122.022 -0.424 . . . . 0.0 111.511 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -62.62 -35.37 79.36 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 122.119 -0.363 . . . . 0.0 110.964 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -78.25 -48.31 16.03 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.43 -33.24 74.4 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 122.163 -0.335 . . . . 0.0 111.074 -173.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -107.99 7.83 28.07 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.88 45.8 27.63 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.025 -1.047 . . . . 0.0 111.876 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.3 mt -92.34 138.21 31.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.862 -0.524 . . . . 0.0 110.93 -171.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -114.79 157.54 23.1 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -55.87 137.94 49.32 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.919 -0.488 . . . . 0.0 111.535 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.95 -22.99 37.23 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -177.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -65.44 156.11 33.42 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 118.621 1.21 . . . . 0.0 110.004 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.6 t -112.36 134.07 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.4 pt -128.98 160.59 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -109.78 138.08 46.66 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -175.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.1 pt -112.12 137.57 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.8 tt . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -177.217 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.4 mm . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 78.0 mt -130.59 147.61 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 171.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -110.23 143.81 39.83 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.318 -0.239 . . . . 0.0 110.405 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.75 152.45 21.7 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -105.8 140.7 38.44 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 117.242 0.521 . . . . 0.0 110.35 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.0 t -63.43 122.49 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.75 137.24 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 173.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.6 p . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -178.963 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -65.49 -32.79 74.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 122.194 -0.316 . . . . 0.0 110.731 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -67.95 -38.31 82.65 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.671 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.9 mt -80.76 -39.08 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.3 mt -99.55 -26.28 14.15 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 122.263 -0.273 . . . . 0.0 111.541 -174.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.65 14.2 76.36 Favored Glycine 0 N--CA 1.496 2.646 0 CA-C-O 119.363 -0.687 . . . . 0.0 111.428 -174.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -152.05 163.37 39.45 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 119.082 1.441 . . . . 0.0 110.709 171.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -95.44 109.59 46.18 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.744 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.53 163.38 35.08 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 123.288 1.151 . . . . 0.0 110.601 -175.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -74.28 163.16 28.15 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -80.36 79.64 6.92 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.463 0.649 . . . . 0.0 109.858 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.5 172.8 44.03 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 174.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -136.51 156.08 49.09 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 117.285 0.542 . . . . 0.0 110.562 173.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.3 tp -108.88 116.41 31.94 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 172.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.31 122.88 42.02 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.04 135.84 54.79 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 120.75 0.31 . . . . 0.0 110.554 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -95.47 132.34 40.65 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.8 mt -111.95 160.25 17.62 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 120.683 0.278 . . . . 0.0 110.4 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.31 13.17 14.13 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 172.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -145.25 140.38 27.8 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 118.568 0.622 . . . . 0.0 109.479 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.27 146.91 52.44 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 122.254 -0.279 . . . . 0.0 110.679 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -132.0 136.75 47.52 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 120.706 0.289 . . . . 0.0 110.584 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -138.06 125.99 22.62 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.57 -23.92 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.341 -177.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -74.22 -0.93 18.4 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.51 -14.13 33.29 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 118.908 0.776 . . . . 0.0 111.457 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -115.84 175.07 5.7 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 118.613 0.642 . . . . 0.0 109.454 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -92.46 103.46 15.88 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -109.85 176.2 5.16 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 120.512 0.196 . . . . 0.0 110.499 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.3 mt -110.25 129.7 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 175.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -105.9 147.4 28.79 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.2 p -125.24 134.96 52.13 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 120.778 0.323 . . . . 0.0 110.768 175.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -75.14 172.72 11.87 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 120.757 0.313 . . . . 0.0 111.707 -170.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -66.99 139.55 57.69 Favored 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -140.63 166.78 23.79 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 122.215 -0.303 . . . . 0.0 110.633 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -124.45 149.06 47.2 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 120.8 0.333 . . . . 0.0 110.559 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -149.09 135.13 19.05 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 52.15 33.96 13.34 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.705 -0.622 . . . . 0.0 111.881 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.82 15.97 80.59 Favored Glycine 0 N--CA 1.497 2.737 0 CA-C-O 119.589 -0.562 . . . . 0.0 111.875 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -121.19 140.97 51.29 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 118.768 1.284 . . . . 0.0 109.717 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -92.87 130.81 38.35 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.368 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -120.14 143.52 48.14 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -85.96 156.18 20.58 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.307 -169.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.44 157.23 50.12 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -138.88 157.93 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 122.448 -0.443 . . . . 0.0 110.456 -174.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -120.52 137.94 54.11 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.4 t -133.98 141.81 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -176.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.4 tp -137.49 125.7 14.46 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.164 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.24 149.59 90.91 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 120.961 1.107 . . . . 0.0 111.496 177.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.7 pt -141.76 170.15 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 171.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -116.44 129.8 56.42 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 168.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.53 125.39 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 86.5 mt -107.87 116.59 32.24 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.9 mt -129.83 122.02 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.03 -120.54 18.82 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -111.09 17.02 20.8 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 122.29 -0.535 . . . . 0.0 111.988 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -119.89 145.82 46.34 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 118.449 0.568 . . . . 0.0 110.513 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -122.96 130.82 53.31 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.42 145.81 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.51 136.92 44.15 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.05 -167.34 12.99 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 177.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.69 155.08 25.43 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 117.35 0.575 . . . . 0.0 110.363 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.0 mt -108.72 142.62 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.7 t -121.48 131.48 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.7 t -142.53 136.66 14.75 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -58.01 154.97 35.86 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 121.077 1.184 . . . . 0.0 111.81 176.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -65.6 -37.41 86.54 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.317 -0.239 . . . . 0.0 110.43 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -94.64 120.59 35.11 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.0 p -130.22 155.07 46.87 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -98.07 -57.86 2.12 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -136.6 170.87 15.36 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.4 p -85.68 148.22 25.99 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.1 m -135.01 175.01 9.97 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 120.57 0.224 . . . . 0.0 110.489 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -107.4 27.93 8.61 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 122.415 -0.178 . . . . 0.0 110.851 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.0 mm -123.4 126.7 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.3 pt -125.64 145.77 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -114.6 131.68 56.61 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.9 mt -117.56 149.31 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 pt -119.13 155.33 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 168.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.56 165.98 22.15 Favored Pre-proline 0 N--CA 1.496 1.846 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.246 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -59.14 -30.34 92.87 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 121.151 1.234 . . . . 0.0 111.716 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.23 167.06 23.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 122.248 -0.282 . . . . 0.0 110.732 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -71.15 105.96 3.59 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.61 -33.4 71.44 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 122.067 -0.396 . . . . 0.0 111.402 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -62.65 -35.34 79.31 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 122.182 -0.324 . . . . 0.0 110.954 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -78.18 -48.07 16.67 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -62.61 -33.64 75.4 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.193 -0.317 . . . . 0.0 111.063 -172.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -108.01 8.15 28.18 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.81 46.03 27.24 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 120.979 -1.076 . . . . 0.0 111.819 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.9 mt -91.98 138.22 31.72 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.89 -0.506 . . . . 0.0 110.961 -171.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -114.92 157.49 23.29 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.72 137.77 48.92 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.888 -0.508 . . . . 0.0 111.491 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.92 -22.88 37.73 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -178.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.44 157.42 29.49 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 118.645 1.222 . . . . 0.0 109.952 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.3 t -112.19 133.17 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -174.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 33.8 pt -128.51 160.59 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -109.06 139.65 43.66 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.302 -175.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.1 pt -109.87 138.44 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.5 tp . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -172.84 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.7 mm . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 78.6 mt -130.76 148.31 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -110.78 144.76 39.27 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.5 151.15 21.42 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -106.77 141.85 37.35 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 117.217 0.508 . . . . 0.0 110.263 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.3 121.16 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.75 148.49 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 177.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.4 p . . . . . 0 N--CA 1.499 1.987 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.662 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 . . . . . 0 N--CA 1.502 2.153 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -65.7 -32.63 74.29 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 122.219 -0.301 . . . . 0.0 110.785 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -68.89 -40.25 79.3 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.641 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.0 mt -81.66 -36.37 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.4 mt -104.0 -26.35 12.65 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.197 -0.314 . . . . 0.0 111.622 -173.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.02 15.15 73.22 Favored Glycine 0 N--CA 1.495 2.599 0 CA-C-O 119.371 -0.683 . . . . 0.0 111.459 -172.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -151.42 161.43 42.7 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 119.143 1.472 . . . . 0.0 110.765 170.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -94.15 107.88 31.81 Favored Pre-proline 0 N--CA 1.496 1.865 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.834 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.53 158.16 58.39 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 O-C-N 123.272 1.143 . . . . 0.0 110.403 -176.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -74.07 162.95 28.48 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -80.14 79.63 6.67 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.429 0.633 . . . . 0.0 109.732 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.66 172.1 44.39 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 175.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 p -138.01 156.51 47.74 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 117.391 0.596 . . . . 0.0 110.85 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.9 tp -109.4 117.29 33.65 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.98 122.24 41.98 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -176.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 61.2 mt -120.58 135.79 54.99 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 120.75 0.31 . . . . 0.0 110.617 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -95.97 133.55 40.04 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.6 mt -112.05 160.3 17.63 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 120.633 0.254 . . . . 0.0 110.544 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.61 13.56 13.74 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 171.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -145.44 139.38 26.85 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 118.552 0.614 . . . . 0.0 109.63 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -62.16 147.24 48.27 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 122.115 -0.366 . . . . 0.0 110.901 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -131.95 136.51 47.4 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 120.766 0.317 . . . . 0.0 110.45 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -137.96 125.6 22.24 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.89 -24.73 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.219 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -73.53 -1.83 20.2 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -91.33 -14.04 31.48 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 118.787 0.721 . . . . 0.0 111.484 169.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -114.5 175.13 5.62 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.614 -0.679 . . . . 0.0 109.315 174.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -92.49 101.99 14.44 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -110.54 177.39 4.7 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 120.638 0.256 . . . . 0.0 110.672 -177.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.6 mt -112.09 132.88 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -105.9 143.87 33.43 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.3 p -121.95 136.44 54.92 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 120.624 0.25 . . . . 0.0 110.679 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.55 172.72 12.52 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 120.786 0.327 . . . . 0.0 111.642 -170.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -67.97 140.16 56.39 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -138.6 163.57 31.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.218 -0.301 . . . . 0.0 110.758 -175.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -123.66 147.47 47.37 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 122.281 -0.262 . . . . 0.0 110.401 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -149.77 136.92 19.7 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.7 32.2 9.04 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.82 -0.55 . . . . 0.0 112.162 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.22 17.59 77.82 Favored Glycine 0 N--CA 1.497 2.727 0 CA-C-O 119.614 -0.548 . . . . 0.0 111.823 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -123.08 140.95 52.49 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.577 1.188 . . . . 0.0 109.803 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.86 132.56 38.16 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 120.618 0.247 . . . . 0.0 110.421 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.22 142.7 49.66 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -86.29 157.81 19.83 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 120.737 0.303 . . . . 0.0 110.336 -169.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.5 157.49 50.02 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -139.51 157.13 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 122.388 -0.478 . . . . 0.0 110.488 -174.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -114.22 138.42 50.5 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.6 t -133.63 139.05 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.4 tp -137.09 125.6 14.85 Favored Pre-proline 0 N--CA 1.497 1.887 0 CA-C-O 118.533 -0.746 . . . . 0.0 110.125 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -63.39 149.63 90.67 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 O-C-N 123.158 1.083 . . . . 0.0 111.457 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.5 pt -141.9 170.01 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 122.286 -0.259 . . . . 0.0 110.38 171.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -115.31 130.03 56.78 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 168.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.68 124.17 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.3 mt -107.99 116.82 32.66 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.5 mt -129.93 121.93 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.76 -120.23 18.09 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -111.18 17.1 20.64 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 122.354 -0.498 . . . . 0.0 111.806 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -119.76 144.62 47.18 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 118.604 0.638 . . . . 0.0 110.497 -175.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -123.12 129.91 52.08 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -125.75 146.09 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.59 136.24 43.95 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.74 -168.2 13.02 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.56 154.98 25.54 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 117.307 0.553 . . . . 0.0 110.369 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -108.71 141.53 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.42 130.83 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -141.6 134.37 14.1 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -57.33 154.81 32.96 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 121.055 1.17 . . . . 0.0 111.91 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -64.85 -34.5 78.52 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.688 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -86.71 117.75 25.67 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 m -132.76 139.86 47.78 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -96.23 -57.54 2.31 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -132.6 -176.78 4.21 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.2 p -93.54 150.03 20.76 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.3 m -135.06 170.09 16.44 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.652 0.263 . . . . 0.0 110.294 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -107.82 27.72 8.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.363 -0.211 . . . . 0.0 110.875 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -123.9 127.87 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 27.7 pt -126.19 145.35 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 177.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -114.94 130.61 56.96 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.5 mt -115.7 150.98 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -174.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.2 pt -116.47 155.64 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 168.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.49 164.92 27.93 Favored Pre-proline 0 N--CA 1.496 1.83 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.315 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.57 -30.75 93.15 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.071 1.181 . . . . 0.0 111.653 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.43 167.06 23.39 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.322 -0.236 . . . . 0.0 110.773 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -71.29 105.22 3.4 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 120.875 0.369 . . . . 0.0 110.042 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.45 -33.58 71.45 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.043 -0.41 . . . . 0.0 111.535 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -62.96 -35.34 79.82 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 122.11 -0.369 . . . . 0.0 110.929 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -78.3 -47.94 16.75 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -62.54 -34.15 76.36 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 122.221 -0.299 . . . . 0.0 111.028 -172.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -108.1 8.49 28.17 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 51.83 47.23 25.19 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.148 -0.97 . . . . 0.0 111.849 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.9 mt -92.09 138.14 31.78 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.917 -0.49 . . . . 0.0 111.036 -170.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -115.67 158.95 22.0 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -56.06 138.17 49.86 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.893 -0.504 . . . . 0.0 111.506 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.58 -22.95 37.6 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.4 154.93 37.02 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 118.597 1.198 . . . . 0.0 110.026 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.6 t -112.05 133.94 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.8 pt -128.82 160.35 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -109.2 140.3 42.99 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.237 -175.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.0 pt -111.84 138.1 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.2 tp . . . . . 0 N--CA 1.493 1.723 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -173.692 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.2 mm . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 70.3 mt -128.16 147.73 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -106.01 138.56 41.98 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.248 -0.283 . . . . 0.0 110.276 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.34 149.09 19.72 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -106.58 142.16 36.69 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 117.237 0.519 . . . . 0.0 110.226 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.19 122.49 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.97 151.27 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.5 p . . . . . 0 N--CA 1.499 1.985 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -178.578 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 N--CA 1.501 2.108 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -65.57 -31.79 73.03 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 122.225 -0.297 . . . . 0.0 110.791 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -68.72 -40.16 80.08 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.586 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.1 mt -81.65 -36.64 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.5 mt -103.91 -26.22 12.74 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.255 -0.278 . . . . 0.0 111.609 -174.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.08 15.46 72.25 Favored Glycine 0 N--CA 1.495 2.595 0 CA-C-O 119.312 -0.715 . . . . 0.0 111.415 -172.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -151.28 160.84 43.59 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.169 1.484 . . . . 0.0 110.751 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -93.53 108.16 31.9 Favored Pre-proline 0 N--CA 1.496 1.857 0 CA-C-O 118.629 -0.701 . . . . 0.0 109.747 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.08 158.2 58.0 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 O-C-N 123.237 1.124 . . . . 0.0 110.534 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -73.6 163.41 28.04 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.29 79.56 6.86 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.541 0.686 . . . . 0.0 109.607 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.39 171.22 43.02 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -138.01 158.46 44.27 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 117.441 0.62 . . . . 0.0 110.818 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.8 tp -109.1 116.01 31.14 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 170.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.26 121.58 40.37 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.5 mt -120.67 136.81 54.74 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.703 0.287 . . . . 0.0 110.639 -177.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -96.03 131.91 41.93 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.6 mt -110.7 160.25 16.88 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 120.603 0.239 . . . . 0.0 110.472 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.11 13.1 13.91 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 172.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -145.63 141.69 28.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.712 -0.618 . . . . 0.0 109.542 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -64.11 147.04 53.15 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.196 -0.315 . . . . 0.0 110.497 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -131.83 135.67 46.91 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 120.749 0.309 . . . . 0.0 110.543 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -138.04 125.39 21.83 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.3 tt -63.52 -23.13 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.397 -176.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -73.33 -2.85 23.75 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 122.014 -0.429 . . . . 0.0 112.079 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -90.56 -13.93 33.56 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.878 0.763 . . . . 0.0 111.462 171.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -114.75 175.02 5.67 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 118.579 0.627 . . . . 0.0 109.338 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -92.54 101.98 14.42 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -109.32 176.39 5.1 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 120.563 0.221 . . . . 0.0 110.538 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -110.8 131.57 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -105.89 142.89 34.83 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.5 p -121.42 138.68 54.17 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.808 0.337 . . . . 0.0 110.688 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -76.79 172.71 12.65 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 120.858 0.361 . . . . 0.0 111.762 -168.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -67.96 141.22 56.37 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -135.95 167.13 21.79 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.557 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -125.75 149.01 48.9 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.888 0.375 . . . . 0.0 110.6 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -148.86 135.75 19.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 51.96 32.83 10.63 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.69 -0.631 . . . . 0.0 112.114 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.06 17.0 79.04 Favored Glycine 0 N--CA 1.496 2.682 0 CA-C-O 119.635 -0.536 . . . . 0.0 111.846 176.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -121.75 140.62 52.11 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 118.6 1.2 . . . . 0.0 109.699 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -93.57 131.97 38.32 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.393 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -121.25 145.33 47.97 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -85.72 156.61 20.56 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.808 0.337 . . . . 0.0 110.448 -167.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.42 162.93 43.49 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.61 155.52 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 122.4 -0.471 . . . . 0.0 110.38 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -114.43 137.29 52.02 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.2 t -134.0 140.93 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.1 tp -136.84 125.62 15.15 Favored Pre-proline 0 N--CA 1.496 1.86 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.108 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -63.39 149.75 90.35 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 120.971 1.114 . . . . 0.0 111.441 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.5 pt -141.88 170.0 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 120.712 0.291 . . . . 0.0 110.317 171.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -113.95 131.87 56.16 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 167.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.0 mt -106.64 123.17 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -175.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.7 mt -107.94 116.86 32.72 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.3 mt -130.06 121.98 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.28 -119.68 16.66 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -111.09 17.0 20.81 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.373 -0.486 . . . . 0.0 111.841 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -120.42 143.91 48.22 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 118.575 0.625 . . . . 0.0 110.52 -174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -123.1 129.44 51.45 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -125.88 146.54 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.52 136.38 44.09 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.92 -168.52 12.83 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.54 154.92 25.49 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 117.309 0.554 . . . . 0.0 110.286 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.3 mt -108.62 141.61 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.8 t -120.73 132.28 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -175.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.0 t -142.37 133.27 12.8 Favored Pre-proline 0 N--CA 1.497 1.88 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.54 155.73 29.86 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 121.081 1.187 . . . . 0.0 111.885 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -64.59 -34.05 77.35 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 122.298 -0.251 . . . . 0.0 110.659 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -89.13 111.29 22.03 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.284 -0.26 . . . . 0.0 110.325 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.5 m -131.77 134.73 46.15 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -97.08 -56.16 2.63 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.31 -0.244 . . . . 0.0 110.344 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -121.99 -179.36 4.12 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.7 m -104.87 152.73 22.26 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.7 p -135.01 172.81 12.49 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 120.664 0.269 . . . . 0.0 110.562 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -105.63 24.62 11.93 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.854 172.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.9 mm -121.08 126.98 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.42 148.41 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -116.62 130.86 56.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.4 mt -115.08 150.42 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.0 pt -115.99 155.88 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.53 165.84 22.95 Favored Pre-proline 0 N--CA 1.496 1.831 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.279 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.37 -30.37 92.54 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 121.084 1.189 . . . . 0.0 111.667 177.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.42 167.05 23.41 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 122.28 -0.262 . . . . 0.0 110.652 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -71.02 105.5 3.34 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.63 -33.93 72.15 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 122.105 -0.372 . . . . 0.0 111.462 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -63.16 -34.75 78.29 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 122.143 -0.348 . . . . 0.0 110.892 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -78.2 -48.99 14.63 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -62.51 -34.09 76.19 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 122.188 -0.32 . . . . 0.0 111.102 -172.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -108.05 8.15 28.1 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.85 50.15 19.25 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 120.986 -1.071 . . . . 0.0 111.917 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 48.2 mt -91.08 138.19 31.79 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.871 -0.518 . . . . 0.0 110.857 -172.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -115.19 156.74 24.77 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.77 137.95 48.84 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.9 -0.5 . . . . 0.0 111.5 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.9 -22.91 37.59 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.39 153.99 39.68 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-N 118.641 1.221 . . . . 0.0 110.005 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.09 134.01 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.7 pt -130.3 162.25 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -110.02 139.18 45.42 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.365 -174.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 pt -111.73 137.75 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.5 tt . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -175.954 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.4 mm . . . . . 0 N--CA 1.499 2.0 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.9 mt -130.02 148.32 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -105.45 140.95 37.77 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.16 150.71 20.27 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -106.27 141.74 37.12 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 117.176 0.488 . . . . 0.0 110.186 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.15 121.78 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.32 158.84 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 177.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.499 1.988 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.332 -179.007 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 N--CA 1.501 2.114 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.405 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 35.7 ttpt -65.33 -36.93 85.53 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 122.151 -0.343 . . . . 0.0 110.366 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -68.24 -38.67 82.09 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.505 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.2 mt -81.16 -35.68 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.3 mt -103.92 -26.26 12.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.102 -0.373 . . . . 0.0 111.696 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.39 12.94 79.7 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -171.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -150.91 160.57 43.82 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 119.068 1.434 . . . . 0.0 110.306 170.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -93.39 109.35 39.87 Favored Pre-proline 0 N--CA 1.496 1.849 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.816 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -67.25 159.76 50.73 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 O-C-N 123.274 1.144 . . . . 0.0 110.502 -176.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -73.81 163.29 28.14 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -80.25 79.56 6.81 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.511 0.672 . . . . 0.0 109.64 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.48 172.89 45.32 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 175.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 p -138.09 157.41 46.38 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 117.343 0.571 . . . . 0.0 110.804 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.6 tp -109.61 115.02 29.13 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 170.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.72 120.05 38.49 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.6 mt -119.98 135.95 54.72 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 120.697 0.284 . . . . 0.0 110.631 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -95.98 132.17 41.59 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.8 mt -110.95 160.27 16.96 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 120.605 0.24 . . . . 0.0 110.475 -176.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -88.93 12.73 14.52 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 172.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -145.49 142.44 29.23 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 118.555 0.616 . . . . 0.0 109.466 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -64.43 146.92 53.75 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.413 178.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -134.4 137.14 43.83 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.733 0.301 . . . . 0.0 110.654 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -138.16 129.58 27.71 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.2 tt -63.95 -22.22 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.337 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -74.42 -0.97 19.06 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.933 -0.479 . . . . 0.0 112.235 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -91.04 -14.74 30.78 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 118.918 0.781 . . . . 0.0 111.445 170.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -117.21 175.11 5.76 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 118.679 0.672 . . . . 0.0 109.467 174.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -90.85 102.75 15.51 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -109.67 177.03 4.86 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 120.546 0.212 . . . . 0.0 110.471 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -110.46 130.8 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -106.0 143.75 33.7 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.8 p -121.69 138.02 54.52 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.74 0.305 . . . . 0.0 110.751 177.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.87 172.67 12.76 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 120.864 0.364 . . . . 0.0 111.687 -169.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -67.59 140.79 56.93 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -136.97 167.01 22.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 122.208 -0.308 . . . . 0.0 110.544 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -125.11 149.08 48.22 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 120.861 0.362 . . . . 0.0 110.607 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -148.35 135.24 20.03 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 51.73 33.44 11.07 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.806 -0.559 . . . . 0.0 112.082 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.09 16.94 79.09 Favored Glycine 0 N--CA 1.498 2.771 0 CA-C-O 119.599 -0.556 . . . . 0.0 111.782 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -122.28 140.94 52.04 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 118.694 1.247 . . . . 0.0 109.649 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -93.25 131.85 37.98 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 120.653 0.264 . . . . 0.0 110.493 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -120.76 144.08 48.47 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -86.37 156.72 20.08 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 120.784 0.326 . . . . 0.0 110.481 -168.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.18 161.86 44.12 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.39 156.0 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 122.294 -0.533 . . . . 0.0 110.364 -174.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -116.57 137.19 52.37 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.7 t -134.12 142.1 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.0 tp -137.39 125.64 14.54 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-O 118.61 -0.71 . . . . 0.0 110.094 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -63.43 148.71 92.48 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 120.955 1.103 . . . . 0.0 111.42 177.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.8 pt -141.38 170.06 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 120.674 0.274 . . . . 0.0 110.356 172.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -114.45 131.76 56.5 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 168.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.9 mt -106.25 124.04 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -175.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -109.08 116.26 31.61 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.2 mt -130.0 121.93 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.41 -119.78 16.87 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -111.07 17.0 20.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.208 -0.584 . . . . 0.0 111.868 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -120.79 144.25 48.41 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 118.547 0.612 . . . . 0.0 110.503 -174.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -123.17 130.19 52.42 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -126.45 148.33 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.51 137.58 44.51 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.23 -169.9 14.46 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 177.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.32 154.88 25.86 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 117.339 0.57 . . . . 0.0 110.235 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.6 mt -108.79 142.26 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.35 131.56 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -142.25 132.53 12.57 Favored Pre-proline 0 N--CA 1.498 1.926 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -58.09 154.86 37.04 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 121.063 1.175 . . . . 0.0 111.796 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -64.99 -33.61 76.45 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.228 -0.295 . . . . 0.0 110.77 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -87.64 114.44 24.26 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 m -132.2 138.83 48.12 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -96.63 -57.04 2.4 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -129.42 -178.73 4.79 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.6 m -98.03 153.04 18.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.7 t -134.98 172.22 13.31 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 120.586 0.232 . . . . 0.0 110.563 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -105.69 24.43 12.27 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.963 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -120.65 127.13 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.4 pt -125.83 145.76 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -115.39 130.91 57.04 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.3 mt -116.47 151.63 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -174.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.7 pt -117.73 156.12 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 168.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.52 165.65 24.0 Favored Pre-proline 0 N--CA 1.494 1.75 0 CA-C-O 119.078 -0.487 . . . . 0.0 110.311 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -59.48 -30.8 93.46 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 121.117 1.211 . . . . 0.0 111.576 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.31 167.02 23.44 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 122.299 -0.25 . . . . 0.0 110.701 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -71.57 105.24 3.57 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.52 -33.67 71.66 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 122.144 -0.347 . . . . 0.0 111.471 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -63.04 -34.91 78.58 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 122.124 -0.36 . . . . 0.0 110.951 -175.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.2 -47.7 17.46 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -62.45 -34.99 77.89 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 122.211 -0.305 . . . . 0.0 111.038 -172.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -108.03 9.94 28.35 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 51.81 47.92 23.84 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.226 -0.921 . . . . 0.0 111.972 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 48.6 mt -91.37 138.25 31.73 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.958 -0.464 . . . . 0.0 110.798 -172.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -114.12 158.62 21.04 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.87 138.07 49.11 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.794 -0.566 . . . . 0.0 111.429 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.53 -22.96 37.59 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.4 155.59 34.93 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-N 118.648 1.224 . . . . 0.0 110.039 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.41 134.09 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -174.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.3 pt -128.76 160.73 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -109.9 137.63 47.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.205 -0.31 . . . . 0.0 110.179 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -113.11 137.25 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.2 tt . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -178.594 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.0 mm . . . . . 0 N--CA 1.499 1.996 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.2 mt -129.81 149.73 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -105.85 141.87 36.54 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.25 150.45 20.45 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.52 142.18 36.6 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 117.217 0.508 . . . . 0.0 110.278 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.1 t -63.04 123.22 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -122.37 155.13 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.4 p . . . . . 0 N--CA 1.499 2.001 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.352 -177.302 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 N--CA 1.501 2.109 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -65.76 -32.64 74.29 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.73 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -68.7 -40.15 80.17 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.605 178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.8 mt -81.56 -35.78 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -176.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.1 mt -103.31 -26.29 12.99 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.183 -0.323 . . . . 0.0 111.767 -173.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.7 15.3 75.97 Favored Glycine 0 N--CA 1.493 2.492 0 CA-C-O 119.3 -0.722 . . . . 0.0 111.371 -173.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -150.83 162.31 40.99 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 119.166 1.483 . . . . 0.0 110.775 171.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -94.15 106.74 24.3 Favored Pre-proline 0 N--CA 1.497 1.888 0 CA-C-O 118.707 -0.663 . . . . 0.0 109.854 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.9 158.72 56.77 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 O-C-N 123.245 1.129 . . . . 0.0 110.302 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -73.8 160.4 31.53 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -80.29 79.67 6.83 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.518 0.675 . . . . 0.0 109.778 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.19 175.8 47.66 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 175.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 p -138.02 154.53 49.3 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 117.367 0.584 . . . . 0.0 110.774 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.6 tp -109.32 119.08 38.4 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 170.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.64 122.69 43.73 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.168 -175.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.2 mt -120.53 136.19 54.85 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 120.66 0.267 . . . . 0.0 110.549 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -96.24 133.92 39.98 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.5 mt -111.95 160.22 17.64 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 120.617 0.246 . . . . 0.0 110.465 -176.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.04 12.8 14.55 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 172.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -145.79 141.98 28.45 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.661 -0.649 . . . . 0.0 109.388 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.24 146.81 52.62 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 122.225 -0.297 . . . . 0.0 110.628 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -132.16 137.45 47.65 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 120.699 0.285 . . . . 0.0 110.663 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -138.0 125.53 22.09 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 174.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.2 -22.51 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.384 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -74.48 -1.08 19.69 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.978 -0.451 . . . . 0.0 112.187 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -90.75 -14.48 31.99 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 118.922 0.783 . . . . 0.0 111.524 170.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.96 175.18 5.7 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 118.597 0.635 . . . . 0.0 109.463 174.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -91.74 103.24 15.83 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -110.59 178.84 4.24 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 120.587 0.232 . . . . 0.0 110.435 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -111.74 130.2 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.97 142.65 35.32 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.2 p -122.79 136.35 54.84 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 120.762 0.315 . . . . 0.0 110.78 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -75.34 172.67 12.05 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 120.909 0.385 . . . . 0.0 111.754 -170.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -67.8 141.15 56.6 Favored 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -137.04 167.0 22.37 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.543 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -125.58 149.52 48.28 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 120.907 0.384 . . . . 0.0 110.548 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -147.9 134.15 19.47 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 51.69 33.82 11.69 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.702 -0.624 . . . . 0.0 112.157 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.18 16.64 79.39 Favored Glycine 0 N--CA 1.496 2.682 0 CA-C-O 119.623 -0.543 . . . . 0.0 111.875 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -121.15 139.84 52.81 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.677 1.239 . . . . 0.0 109.623 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.51 132.48 37.76 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 121.091 -0.243 . . . . 0.0 110.505 -176.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -121.24 144.14 48.77 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -86.08 157.04 20.15 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.53 -168.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.56 158.59 49.11 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -176.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.49 154.98 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 122.351 -0.499 . . . . 0.0 110.445 -174.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -116.04 136.43 53.04 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.4 t -133.98 139.95 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -175.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.7 tp -137.12 125.65 14.86 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.053 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -63.4 149.76 90.31 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 O-C-N 123.182 1.096 . . . . 0.0 111.444 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.1 pt -141.7 170.08 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 171.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -113.9 130.42 56.5 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 168.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -105.96 123.64 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -174.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.5 mt -108.52 116.32 31.75 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -129.87 121.91 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.72 -120.29 18.34 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -111.18 17.05 20.69 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 122.316 -0.52 . . . . 0.0 111.932 175.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -119.34 143.99 47.1 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 118.465 0.575 . . . . 0.0 110.498 -175.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -123.16 130.08 52.29 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.3 mt -126.81 146.32 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.83 135.98 43.47 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.01 -167.29 12.12 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -160.1 155.95 26.03 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 117.374 0.587 . . . . 0.0 110.447 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.5 mt -108.73 141.9 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -121.88 131.42 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.1 t -141.01 133.87 14.41 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -57.82 155.04 34.47 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 120.996 1.131 . . . . 0.0 111.877 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -64.78 -34.52 78.55 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 122.365 -0.209 . . . . 0.0 110.723 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -87.33 118.39 26.73 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.35 -176.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.2 p -131.98 160.37 36.02 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -126.77 -42.91 1.74 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.308 -0.245 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -136.88 176.71 8.46 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.2 m -99.61 147.75 25.04 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.0 m -135.07 171.99 13.64 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 120.594 0.235 . . . . 0.0 110.517 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -107.19 27.14 9.34 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.408 -0.183 . . . . 0.0 110.94 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -122.91 127.19 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.6 pt -124.81 143.75 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -114.77 131.56 56.75 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.9 mt -117.22 152.05 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -173.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.5 pt -116.18 156.17 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 168.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.59 164.15 32.27 Favored Pre-proline 0 N--CA 1.496 1.827 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.334 -176.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.15 -32.41 94.54 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 121.062 1.175 . . . . 0.0 111.479 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.98 159.26 43.21 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.266 -0.272 . . . . 0.0 110.862 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.6 pttt -62.5 103.92 0.46 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.413 0.625 . . . . 0.0 111.203 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.7 mt -59.6 -32.51 70.46 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.869 -0.519 . . . . 0.0 111.692 -177.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -61.9 -37.28 84.02 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 122.098 -0.376 . . . . 0.0 111.204 -171.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -78.27 -46.41 20.34 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -62.37 -34.59 76.99 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 122.208 -0.307 . . . . 0.0 111.024 -172.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -108.13 8.23 27.97 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -177.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 51.72 50.65 18.27 Favored 'General case' 0 N--CA 1.508 2.436 0 CA-C-N 119.309 0.959 . . . . 0.0 111.945 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 48.2 mt -90.39 138.16 31.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.832 -0.542 . . . . 0.0 110.818 -171.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -117.03 155.29 29.46 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 175.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -55.99 138.01 49.8 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.857 -0.527 . . . . 0.0 111.468 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.98 -22.97 37.32 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.31 154.59 37.83 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 118.655 1.227 . . . . 0.0 110.038 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -111.92 133.78 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.4 pt -128.56 160.95 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -109.93 138.13 46.73 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -112.26 137.17 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 10.0 tt . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -177.8 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.2 mm . . . . . 0 N--CA 1.499 1.981 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 77.6 mt -129.69 149.02 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -104.69 140.76 37.58 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.07 150.41 19.98 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -105.63 142.36 35.5 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 117.28 0.54 . . . . 0.0 110.227 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.71 120.99 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.45 137.78 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 122.308 -0.245 . . . . 0.0 110.375 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.882 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 N--CA 1.503 2.186 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -65.3 -32.35 73.96 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.83 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -68.45 -39.33 81.51 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.85 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.3 mt -81.46 -36.82 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.0 mt -103.97 -26.22 12.71 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.206 -0.309 . . . . 0.0 111.642 -174.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.7 14.17 73.75 Favored Glycine 0 N--CA 1.495 2.603 0 CA-C-O 119.368 -0.685 . . . . 0.0 111.48 -172.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -152.39 161.68 42.26 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 119.163 1.481 . . . . 0.0 110.554 170.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -94.47 107.45 29.92 Favored Pre-proline 0 N--CA 1.496 1.846 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.8 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -67.38 156.51 65.88 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 O-C-N 123.242 1.127 . . . . 0.0 110.526 -176.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -73.37 162.59 29.15 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -80.31 79.46 6.89 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.537 0.684 . . . . 0.0 109.509 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.85 176.12 47.26 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 p -138.07 157.2 46.81 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 117.349 0.575 . . . . 0.0 110.842 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.8 tp -108.92 118.37 36.62 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.95 122.85 42.74 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -175.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 61.1 mt -121.29 136.24 55.0 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.732 0.301 . . . . 0.0 110.521 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -96.13 132.51 41.45 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.5 mt -111.47 160.23 17.32 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 120.703 0.287 . . . . 0.0 110.382 -176.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -88.94 12.44 15.34 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 173.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -146.39 140.91 26.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.687 -0.633 . . . . 0.0 109.662 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.1 146.9 52.27 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 122.182 -0.324 . . . . 0.0 110.75 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -132.37 138.71 47.83 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.64 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -138.04 123.89 20.01 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 176.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.62 -23.08 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.395 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -74.6 -0.97 19.53 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.897 -0.502 . . . . 0.0 112.214 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -89.92 -14.21 34.65 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 118.961 0.8 . . . . 0.0 111.542 171.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -117.0 175.15 5.72 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 118.603 0.638 . . . . 0.0 109.582 173.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -91.87 104.86 17.24 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -109.49 177.3 4.78 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.4 mt -110.37 133.67 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -105.84 142.1 36.13 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.3 p -116.5 133.23 56.26 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -77.47 172.5 13.24 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 120.75 0.309 . . . . 0.0 111.388 -171.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -69.28 139.86 54.39 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -140.64 164.86 29.05 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.743 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -122.01 146.44 47.16 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 120.699 0.285 . . . . 0.0 110.271 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -150.71 141.83 23.1 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 172.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.2 m120 52.11 29.98 7.06 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.69 -0.631 . . . . 0.0 112.126 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.56 16.08 81.03 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -120.45 143.29 48.57 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 118.706 1.253 . . . . 0.0 109.636 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -92.42 131.76 37.32 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.349 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -119.94 141.0 50.03 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -87.4 151.9 22.69 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 120.843 0.354 . . . . 0.0 110.595 -167.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.68 158.71 51.21 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -142.65 161.48 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 122.252 -0.558 . . . . 0.0 110.514 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -113.5 135.21 54.13 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.8 t -131.07 138.25 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -176.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.7 tp -137.44 125.65 14.49 Favored Pre-proline 0 N--CA 1.496 1.85 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.055 178.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -62.68 149.33 91.56 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 120.98 1.12 . . . . 0.0 111.731 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.6 pt -141.82 170.17 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 122.253 -0.279 . . . . 0.0 110.321 171.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -113.53 130.26 56.39 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 168.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -106.24 123.57 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -108.63 116.99 33.02 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.8 mt -130.1 121.96 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.79 -120.46 18.89 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -111.1 16.97 20.82 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 122.266 -0.55 . . . . 0.0 111.933 175.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -118.68 143.2 47.0 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 118.518 0.599 . . . . 0.0 110.482 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -123.09 129.89 52.06 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -127.06 149.05 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.31 136.01 44.44 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.99 -168.4 12.35 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.35 155.22 26.39 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 117.305 0.553 . . . . 0.0 110.325 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.8 mt -108.71 140.72 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -125.07 129.52 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.7 t -139.92 133.88 15.6 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -56.65 153.67 34.92 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 121.037 1.158 . . . . 0.0 112.046 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -64.5 -34.45 78.24 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 122.269 -0.269 . . . . 0.0 110.606 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.1 tttp -90.97 121.05 32.47 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.2 t -141.84 151.89 43.17 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 122.32 -0.237 . . . . 0.0 110.401 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -98.42 -58.93 1.85 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -134.91 169.77 16.89 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.0 m -82.81 154.39 24.72 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 96.3 p -135.02 175.05 9.94 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 120.645 0.259 . . . . 0.0 110.495 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -104.8 25.0 10.94 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 121.28 -0.168 . . . . 0.0 110.95 172.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -120.89 126.88 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.9 pt -125.36 145.59 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -115.55 130.23 56.8 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.6 mt -116.06 152.27 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -174.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 pt -116.68 155.91 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 168.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.52 162.16 43.39 Favored Pre-proline 0 N--CA 1.495 1.823 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.358 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.54 -30.67 93.02 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 121.075 1.183 . . . . 0.0 111.728 177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.44 167.0 23.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.279 -0.263 . . . . 0.0 110.933 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -69.92 104.33 2.48 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 85.0 mt -59.93 -34.25 72.98 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 122.138 -0.351 . . . . 0.0 111.349 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -62.97 -35.57 80.59 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 122.203 -0.311 . . . . 0.0 110.922 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -78.36 -48.76 14.88 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -62.65 -33.63 75.43 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 122.231 -0.293 . . . . 0.0 111.11 -172.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -108.05 7.75 27.9 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 51.8 46.97 25.69 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.108 -0.995 . . . . 0.0 111.878 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.4 mt -92.28 138.19 31.73 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.893 -0.504 . . . . 0.0 111.007 -170.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -115.66 160.61 19.82 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.17 50.17 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.966 -0.459 . . . . 0.0 111.569 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.48 -22.94 37.7 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.59 151.59 46.12 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 118.627 1.213 . . . . 0.0 110.018 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.3 t -110.45 133.66 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -173.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.8 pt -128.46 160.16 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -109.65 138.07 46.55 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.2 pt -113.62 137.87 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.7 tt . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.035 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.7 mm . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -129.77 148.9 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -105.37 141.53 36.72 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.73 150.61 20.38 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -106.33 142.1 36.56 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 117.265 0.532 . . . . 0.0 110.301 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.11 121.08 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.22 144.2 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 N--CA 1.499 1.984 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.306 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 N--CA 1.501 2.113 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -66.18 -29.62 69.93 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.735 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -68.89 -40.82 79.0 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.733 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.9 mt -81.31 -38.04 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -175.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.1 mt -104.01 -26.2 12.71 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.231 -0.293 . . . . 0.0 111.711 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.16 13.66 73.67 Favored Glycine 0 N--CA 1.495 2.592 0 CA-C-O 119.369 -0.684 . . . . 0.0 111.466 -171.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -152.52 165.65 34.46 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 119.158 1.479 . . . . 0.0 110.614 170.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -96.41 112.31 59.57 Favored Pre-proline 0 N--CA 1.496 1.851 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.835 175.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -67.52 159.92 50.33 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 O-C-N 123.266 1.14 . . . . 0.0 110.631 -176.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -74.3 164.54 26.48 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -80.23 79.57 6.78 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.476 0.655 . . . . 0.0 109.729 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.09 170.42 42.14 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 p -138.08 157.41 46.38 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 117.295 0.547 . . . . 0.0 110.674 177.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.5 tp -109.76 116.67 32.11 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 171.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.57 120.9 39.78 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.6 mt -119.96 135.71 54.8 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.71 0.29 . . . . 0.0 110.656 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -96.21 133.46 40.49 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.7 mt -110.95 160.38 16.86 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 120.649 0.262 . . . . 0.0 110.481 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.09 12.75 14.78 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -145.89 141.4 27.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.701 -0.624 . . . . 0.0 109.488 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -63.32 146.92 52.48 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 122.203 -0.311 . . . . 0.0 110.682 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -132.09 138.17 48.02 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 120.719 0.295 . . . . 0.0 110.622 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -138.02 126.41 23.27 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.9 tt -63.28 -22.73 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.348 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -74.65 -0.94 19.59 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.97 -0.457 . . . . 0.0 112.216 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -90.77 -14.51 31.87 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 118.902 0.774 . . . . 0.0 111.488 171.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -117.63 175.18 5.76 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 118.7 0.682 . . . . 0.0 109.469 174.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -90.64 103.88 16.53 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -177.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -110.42 179.25 4.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.371 -0.206 . . . . 0.0 110.537 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.5 mt -112.6 131.8 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.95 143.17 34.47 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.4 p -123.28 137.07 54.94 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 120.761 0.315 . . . . 0.0 110.769 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -77.3 172.61 13.02 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 120.824 0.345 . . . . 0.0 111.849 -168.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -68.21 141.31 56.0 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -138.69 164.99 28.12 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 122.186 -0.321 . . . . 0.0 110.675 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -124.92 148.31 48.41 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.787 0.327 . . . . 0.0 110.381 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -149.53 136.45 19.6 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 52.23 32.96 11.58 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.747 -0.595 . . . . 0.0 111.832 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 16.42 80.15 Favored Glycine 0 N--CA 1.497 2.733 0 CA-C-O 119.584 -0.565 . . . . 0.0 111.798 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -120.16 138.99 53.28 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 118.728 1.264 . . . . 0.0 109.701 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.19 131.47 38.24 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.358 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -119.69 140.93 49.88 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -86.03 155.9 20.65 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 120.761 0.315 . . . . 0.0 110.388 -168.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.94 156.86 51.64 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -176.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.09 156.86 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 122.347 -0.502 . . . . 0.0 110.486 -173.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -115.79 137.0 52.5 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.2 t -134.06 141.06 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -175.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 tp -137.54 125.72 14.42 Favored Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.082 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -63.31 148.56 92.8 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 120.987 1.125 . . . . 0.0 111.396 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.9 pt -141.78 170.06 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 122.304 -0.248 . . . . 0.0 110.412 173.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -114.28 131.51 56.48 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 168.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.2 mt -105.74 123.33 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.22 116.47 32.02 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.7 mt -129.83 121.92 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.56 -120.16 18.09 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -111.21 17.04 20.67 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 117.161 0.48 . . . . 0.0 111.784 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -119.43 144.12 47.11 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.557 0.617 . . . . 0.0 110.46 -175.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -123.13 130.15 52.39 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 122.263 -0.273 . . . . 0.0 110.275 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.6 mt -126.35 147.05 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.42 137.46 44.62 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.6 -168.32 13.51 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 178.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.12 154.26 25.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.266 -0.549 . . . . 0.0 110.258 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.2 mt -108.65 140.62 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -123.07 130.28 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.98 133.9 14.45 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -57.75 153.63 42.17 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 120.996 1.13 . . . . 0.0 111.813 177.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -65.53 -34.91 79.37 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 122.279 -0.263 . . . . 0.0 110.487 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -89.17 121.01 31.07 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.267 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -141.64 151.56 43.17 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -98.01 -55.89 2.65 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -136.84 169.63 17.43 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.1 m -82.19 151.11 27.04 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.0 m -134.91 175.0 9.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.295 -0.253 . . . . 0.0 110.526 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -107.28 27.22 9.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.378 -0.201 . . . . 0.0 110.839 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.1 mm -124.1 127.51 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.5 pt -125.98 145.52 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -114.81 130.08 56.81 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.5 mt -115.04 149.95 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -174.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 pt -115.95 155.57 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 169.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.55 165.97 22.24 Favored Pre-proline 0 N--CA 1.496 1.843 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.326 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.76 -30.94 93.24 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 O-C-N 123.292 1.154 . . . . 0.0 111.623 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.39 167.06 23.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.293 -0.255 . . . . 0.0 110.751 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -70.88 105.24 3.19 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.3 mt -59.52 -33.61 71.59 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 122.151 -0.343 . . . . 0.0 111.449 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -62.83 -35.35 79.65 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 122.108 -0.37 . . . . 0.0 111.006 -174.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -78.11 -48.28 16.37 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.47 -34.3 76.55 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 122.153 -0.342 . . . . 0.0 111.135 -172.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -108.1 8.53 28.18 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 51.79 50.5 18.53 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 121.103 -0.998 . . . . 0.0 111.895 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 47.4 mt -90.3 138.17 31.75 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.879 -0.513 . . . . 0.0 110.899 -171.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -116.19 155.16 28.76 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.48 137.91 47.45 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.906 -0.496 . . . . 0.0 111.533 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.02 -22.98 37.22 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -65.32 154.6 37.81 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-N 118.704 1.252 . . . . 0.0 110.05 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.38 134.03 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -174.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.6 pt -128.9 160.41 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -109.83 138.28 46.43 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.8 pt -114.21 137.61 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 176.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.2 tt . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.721 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.3 mm . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.3 mt -129.97 149.23 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -105.9 142.12 36.15 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.42 150.95 20.4 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -106.16 142.38 35.95 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 117.266 0.533 . . . . 0.0 110.245 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.74 123.6 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.24 157.87 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.499 2.005 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.271 -178.268 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 N--CA 1.503 2.176 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -65.42 -37.51 87.15 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 122.212 -0.305 . . . . 0.0 110.319 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -68.03 -38.26 82.34 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.537 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.7 mt -81.18 -35.81 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.62 -26.1 12.92 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 122.141 -0.349 . . . . 0.0 111.573 -173.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.8 13.12 78.65 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -172.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -151.62 160.56 43.6 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 118.955 1.377 . . . . 0.0 110.222 170.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -93.12 108.0 29.45 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.857 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -67.6 160.12 49.47 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 O-C-N 123.249 1.131 . . . . 0.0 110.355 -176.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -73.62 161.62 30.1 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -80.32 79.6 6.88 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.496 0.665 . . . . 0.0 109.654 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.71 172.68 45.01 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 175.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 p -138.04 156.87 47.36 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 117.348 0.574 . . . . 0.0 110.775 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.7 tp -110.71 118.18 35.47 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 170.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -98.94 122.15 41.82 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -176.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 59.3 mt -120.14 136.13 54.72 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 120.662 0.268 . . . . 0.0 110.585 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.8 tttp -96.21 133.27 40.73 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.0 mt -111.1 160.27 17.04 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 120.664 0.269 . . . . 0.0 110.448 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.14 12.74 14.93 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 172.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -145.76 142.39 28.87 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 118.496 0.589 . . . . 0.0 109.428 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -64.37 146.76 53.93 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 122.196 -0.315 . . . . 0.0 110.324 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -133.11 137.57 46.37 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 120.686 0.279 . . . . 0.0 110.755 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -138.06 128.28 25.98 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 174.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.43 -23.05 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.271 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -74.58 -0.92 19.32 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -90.53 -14.52 32.45 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 118.905 0.775 . . . . 0.0 111.429 170.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -117.79 175.18 5.78 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 118.64 0.654 . . . . 0.0 109.497 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -91.1 103.8 16.45 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -109.81 178.39 4.43 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 120.572 0.225 . . . . 0.0 110.47 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -111.43 131.17 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -105.97 144.56 32.52 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.1 p -124.27 138.09 54.43 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.821 0.343 . . . . 0.0 110.764 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -77.0 172.77 12.66 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 120.902 0.382 . . . . 0.0 111.869 -168.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -67.45 140.82 57.11 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -136.78 167.35 21.6 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.221 -0.299 . . . . 0.0 110.553 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -125.3 149.53 47.97 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 120.836 0.35 . . . . 0.0 110.56 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -148.66 133.65 18.14 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 52.11 33.46 12.24 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.63 -0.668 . . . . 0.0 111.879 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.21 15.77 80.56 Favored Glycine 0 N--CA 1.497 2.721 0 CA-C-O 119.578 -0.568 . . . . 0.0 111.892 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -120.13 140.89 50.4 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.778 1.289 . . . . 0.0 109.691 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.47 132.04 38.11 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 121.081 -0.247 . . . . 0.0 110.489 -176.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -121.19 144.87 48.36 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -86.11 156.18 20.48 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 120.799 0.333 . . . . 0.0 110.508 -167.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.79 159.46 48.88 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -176.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.77 158.17 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 122.355 -0.497 . . . . 0.0 110.338 -174.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -118.35 137.3 53.19 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.03 141.27 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.1 tp -137.25 125.64 14.7 Favored Pre-proline 0 N--CA 1.495 1.823 0 CA-C-O 118.524 -0.75 . . . . 0.0 110.092 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -63.68 149.73 90.15 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 120.965 1.11 . . . . 0.0 111.332 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.1 pt -141.85 170.06 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 120.635 0.255 . . . . 0.0 110.385 171.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -114.35 131.14 56.65 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 168.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.24 123.05 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -174.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.4 mt -107.97 116.4 31.89 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.9 mt -129.85 121.9 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.69 -120.14 17.83 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -111.22 17.08 20.63 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.33 -0.512 . . . . 0.0 111.897 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -119.76 144.21 47.4 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 118.52 0.6 . . . . 0.0 110.435 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -123.06 129.9 52.09 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 120.697 0.284 . . . . 0.0 110.298 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.4 mt -126.43 147.46 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.56 136.71 44.04 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.91 -168.89 13.05 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.49 154.47 24.87 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 117.376 0.588 . . . . 0.0 110.305 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.79 141.61 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.8 t -124.4 132.09 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -144.95 137.54 13.54 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -58.15 152.84 49.66 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.05 1.166 . . . . 0.0 111.652 175.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -65.89 -34.32 77.85 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.538 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -88.6 117.31 27.47 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.0 m -129.87 143.26 50.72 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -94.05 -54.23 3.67 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -135.94 -179.73 5.84 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.4 m -96.77 151.71 19.38 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.2 p -134.96 172.32 13.17 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 120.747 0.308 . . . . 0.0 110.647 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.56 24.87 11.5 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.811 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.5 mm -120.81 127.72 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.5 pt -125.93 146.08 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -116.28 129.75 56.43 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 110.037 -0.356 . . . . 0.0 110.037 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.1 mt -115.0 151.55 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.9 pt -115.91 156.17 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 168.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.56 165.97 22.22 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.317 -176.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.13 -32.87 95.22 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 121.064 1.176 . . . . 0.0 111.462 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -145.06 160.14 41.86 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.308 -0.245 . . . . 0.0 110.877 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -62.36 104.7 0.52 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.367 0.604 . . . . 0.0 111.229 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.56 -32.86 70.74 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.94 -0.475 . . . . 0.0 111.662 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -61.87 -37.42 84.5 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 122.07 -0.394 . . . . 0.0 111.199 -171.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -78.27 -45.16 23.51 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -62.25 -34.79 77.21 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 122.143 -0.348 . . . . 0.0 111.085 -173.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -108.15 8.39 28.01 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 51.86 48.27 23.13 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.084 -1.01 . . . . 0.0 111.879 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.3 mt -91.71 138.12 31.82 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.887 -0.508 . . . . 0.0 110.993 -171.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.25 158.99 22.48 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -56.16 138.22 50.29 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.889 -0.507 . . . . 0.0 111.459 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.59 -22.97 37.52 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.43 151.8 45.45 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-N 118.672 1.236 . . . . 0.0 110.011 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.8 t -110.76 133.64 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -174.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.2 pt -128.28 160.38 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -109.72 137.81 47.0 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.5 pt -113.13 137.2 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.1 tt . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.934 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.8 mm . . . . . 0 N--CA 1.499 1.988 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.5 mt -129.67 149.38 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -105.81 141.84 36.56 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.32 150.83 20.59 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -106.19 141.5 37.45 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 117.31 0.555 . . . . 0.0 110.269 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.11 123.51 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -123.55 156.94 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 N--CA 1.499 1.996 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.284 -178.333 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 . . . . . 0 N--CA 1.501 2.116 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -65.71 -31.01 71.77 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 122.197 -0.314 . . . . 0.0 110.814 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -68.93 -40.44 79.03 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.581 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -81.45 -37.04 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -175.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.8 mt -104.0 -26.19 12.72 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 122.231 -0.293 . . . . 0.0 111.683 -174.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.39 14.76 73.17 Favored Glycine 0 N--CA 1.495 2.593 0 CA-C-O 119.304 -0.72 . . . . 0.0 111.443 -172.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -151.76 163.05 39.99 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 119.22 1.51 . . . . 0.0 110.748 170.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -94.58 109.07 41.17 Favored Pre-proline 0 N--CA 1.496 1.866 0 CA-C-O 118.589 -0.72 . . . . 0.0 109.827 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.47 159.47 52.3 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 O-C-N 123.219 1.115 . . . . 0.0 110.493 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -73.87 162.85 28.66 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -80.22 79.52 6.78 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.467 0.651 . . . . 0.0 109.726 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.5 172.65 45.06 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 175.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.1 p -138.02 157.67 45.88 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 117.408 0.604 . . . . 0.0 110.806 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.9 tp -109.55 114.98 29.07 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.24 120.12 38.1 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.8 mt -120.01 135.95 54.73 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 120.708 0.29 . . . . 0.0 110.664 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -95.99 133.04 40.68 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.8 mt -111.71 160.23 17.48 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 120.663 0.268 . . . . 0.0 110.407 -176.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.06 12.88 14.35 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 172.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -145.91 142.19 28.51 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.65 0.659 . . . . 0.0 109.482 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -64.46 146.89 53.83 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 122.218 -0.301 . . . . 0.0 110.424 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -132.37 136.72 47.02 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 120.659 0.266 . . . . 0.0 110.607 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -138.01 126.44 23.32 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.1 tt -64.2 -23.86 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.173 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -74.05 -1.0 18.17 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.888 -0.508 . . . . 0.0 112.128 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.28 -14.44 30.85 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 118.889 0.768 . . . . 0.0 111.429 169.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -115.82 175.09 5.69 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 118.618 0.644 . . . . 0.0 109.463 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -91.64 102.76 15.4 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -177.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -110.45 178.36 4.4 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.34 -0.225 . . . . 0.0 110.546 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.6 mt -112.35 131.76 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -105.94 142.49 35.56 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.6 p -120.7 138.08 54.15 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 120.745 0.307 . . . . 0.0 110.687 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.94 172.58 12.95 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 120.812 0.339 . . . . 0.0 111.795 -168.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -67.9 141.16 56.46 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -137.23 165.96 24.89 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.22 -0.3 . . . . 0.0 110.636 -176.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -125.43 148.29 48.87 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.734 0.302 . . . . 0.0 110.543 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -149.28 137.2 20.51 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 174.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 51.63 33.0 9.97 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.691 -0.631 . . . . 0.0 112.12 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 17.6 78.59 Favored Glycine 0 N--CA 1.497 2.717 0 CA-C-O 119.625 -0.542 . . . . 0.0 111.803 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -122.52 139.89 53.39 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 118.64 1.22 . . . . 0.0 109.646 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -93.26 131.94 37.91 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.37 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -121.06 143.84 48.86 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -86.14 155.95 20.55 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 120.763 0.316 . . . . 0.0 110.474 -168.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.73 160.85 47.17 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.33 156.67 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 122.358 -0.495 . . . . 0.0 110.381 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -114.99 137.17 52.31 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 176.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.7 t -134.05 141.44 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.5 tp -137.76 125.58 14.08 Favored Pre-proline 0 N--CA 1.497 1.915 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.201 177.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -63.31 148.87 92.55 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.939 1.092 . . . . 0.0 111.491 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.3 pt -142.15 170.09 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 122.257 -0.277 . . . . 0.0 110.419 171.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -115.21 131.91 56.78 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 167.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -105.91 123.85 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.8 mt -108.19 116.77 32.57 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.1 mt -130.2 121.94 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.62 -120.12 17.84 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -178.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -111.17 17.08 20.67 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.377 -0.484 . . . . 0.0 111.811 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -119.62 143.65 47.56 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.55 0.614 . . . . 0.0 110.473 -175.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -123.15 129.5 51.52 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -125.85 143.67 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.0 137.98 43.82 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.87 -164.29 11.21 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.82 156.15 26.98 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 117.328 0.564 . . . . 0.0 110.424 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.2 mt -108.7 141.42 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -123.03 130.63 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -175.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 63.0 t -142.48 135.9 14.25 Favored Pre-proline 0 N--CA 1.497 1.904 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -57.31 153.57 39.6 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 121.093 1.195 . . . . 0.0 111.849 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -65.47 -34.92 79.4 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.512 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -91.42 124.27 35.47 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -142.91 155.21 44.69 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -98.02 -59.99 1.65 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -134.27 -173.38 3.25 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -97.67 149.96 21.7 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m -134.94 175.02 9.96 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 122.307 -0.245 . . . . 0.0 110.379 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -107.35 27.42 9.1 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 122.38 -0.2 . . . . 0.0 110.866 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.7 mm -124.14 127.36 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.3 pt -126.15 145.66 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -115.38 130.1 56.79 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 80.9 mt -115.52 151.31 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.0 pt -116.38 155.19 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 168.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.46 161.93 44.68 Favored Pre-proline 0 N--CA 1.496 1.874 0 CA-C-O 119.128 -0.463 . . . . 0.0 110.457 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -60.44 -31.54 92.69 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 121.09 1.193 . . . . 0.0 111.613 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.15 167.09 23.24 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.182 -0.324 . . . . 0.0 110.996 -175.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -68.18 105.39 2.08 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.68 -38.47 87.9 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.167 -0.333 . . . . 0.0 111.069 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -64.65 -36.88 85.7 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 122.158 -0.339 . . . . 0.0 110.539 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -78.16 -50.36 12.11 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -62.53 -32.56 73.53 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 122.178 -0.326 . . . . 0.0 111.16 -173.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -108.05 8.11 28.08 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.8 43.73 29.84 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.123 -0.986 . . . . 0.0 111.928 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.52 138.25 31.99 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.999 -0.438 . . . . 0.0 110.868 -171.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -113.51 160.68 18.23 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.15 50.22 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.874 -0.516 . . . . 0.0 111.508 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.61 -23.18 36.7 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.53 155.15 36.57 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 118.579 1.19 . . . . 0.0 109.914 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.3 t -112.02 134.0 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.3 pt -128.69 160.14 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 174.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -109.36 138.33 45.88 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.2 pt -112.63 137.9 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.0 tt . . . . . 0 N--CA 1.495 1.792 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.261 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mmm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 110.244 -0.28 . . . . 7.0300000000000002 110.244 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 p -131.51 141.18 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 110.015 -0.365 . . . . 3.8199999999999998 110.015 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -98.96 122.19 41.9 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.155 -0.313 . . . . 4.3099999999999996 110.155 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.5 mt -110.96 149.66 30.35 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 110.101 -0.333 . . . . 1.8 110.101 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.7 ttm -138.48 146.88 42.58 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 110.109 -0.33 . . . . 2.3500000000000001 110.109 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.8 mm -125.83 131.01 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.118 -0.697 . . . . 1.1000000000000001 109.118 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.9 mt -130.01 149.57 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 108.861 -0.792 . . . . 1.0700000000000001 108.861 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -105.19 141.95 35.82 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.2 -0.296 . . . . 0.85999999999999999 110.2 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.7 149.41 20.17 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.595 -1.402 . . . . 0.080000000000000002 109.595 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -106.09 142.09 36.37 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 117.251 0.525 . . . . 0.85999999999999999 110.185 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.5 t -62.97 122.0 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 N-CA-C 109.82 -0.437 . . . . 1.04 109.82 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.35 157.12 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 110.084 -0.339 . . . . 1.0800000000000001 110.084 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.2 t -86.14 129.96 34.68 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 110.222 -0.288 . . . . 1.5 110.222 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.99 119.96 0.84 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.559 -1.416 . . . . 1.1599999999999999 109.559 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.2 tt -155.16 -46.69 0.08 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.332 -0.511 . . . . 2.7599999999999998 110.346 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.41 -31.16 79.8 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 110.714 -0.955 . . . . 3.6899999999999999 110.714 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -64.89 -34.72 79.07 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-N 117.661 0.731 . . . . 3.7000000000000002 110.32 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.49 130.01 10.1 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.288 -1.525 . . . . 2.8399999999999999 109.288 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -130.14 102.04 6.06 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 117.257 0.528 . . . . 6.1699999999999999 110.437 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -155.03 170.66 21.25 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.244 -0.28 . . . . 3.23 110.244 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -112.01 138.32 48.81 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 110.345 -0.243 . . . . 2.8500000000000001 110.345 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.2 mt -110.01 -30.43 7.79 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.374 -0.204 . . . . 1.8300000000000001 111.001 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -60.75 -30.67 70.15 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 122.037 -0.414 . . . . 1.8799999999999999 111.578 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.0 155.69 82.97 Favored Pre-proline 0 N--CA 1.503 2.22 0 CA-C-O 119.236 -0.412 . . . . 2.2000000000000002 110.523 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -57.25 -55.79 2.3 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 121.055 1.17 . . . . 0.56000000000000005 113.195 -172.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.84 -30.79 90.82 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 O-C-N 122.766 0.877 . . . . 0.96999999999999997 111.633 -162.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -66.37 -45.97 78.27 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 120.862 -0.335 . . . . 1.3999999999999999 110.204 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.58 -36.17 82.96 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 122.186 -0.321 . . . . 2.6000000000000001 110.22 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -66.01 -48.24 71.82 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 120.97 -0.292 . . . . 2.3100000000000001 110.476 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.1 tt -68.7 -36.58 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 C-N-CA 120.693 -0.403 . . . . 1.3600000000000001 110.06 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -65.87 -44.46 85.3 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 122.051 -0.405 . . . . 0.87 110.325 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -65.77 -29.99 70.57 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 122.205 -0.31 . . . . 2.1800000000000002 110.78 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -68.97 -40.58 78.76 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 120.689 -0.404 . . . . 2.8100000000000001 110.609 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.2 mt -81.1 -38.53 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.406 -0.59 . . . . 1.0700000000000001 109.406 -175.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.1 mt -104.11 -26.14 12.68 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 122.144 -0.348 . . . . 1.05 111.558 -174.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.34 14.74 70.6 Favored Glycine 0 N--CA 1.495 2.589 0 CA-C-O 119.408 -0.662 . . . . 0.32000000000000001 111.48 -171.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -152.79 164.51 37.67 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 119.057 1.428 . . . . 0.28999999999999998 110.618 170.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -95.73 113.04 61.14 Favored Pre-proline 0 N--CA 1.497 1.891 0 CA-C-O 118.466 -0.778 . . . . 1.3500000000000001 109.869 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -67.74 159.52 52.36 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 O-C-N 123.314 1.165 . . . . 0.20000000000000001 110.539 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -74.29 164.52 26.5 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 110.075 -0.343 . . . . 1.04 110.075 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -80.37 79.58 6.94 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.459 0.647 . . . . 1.4099999999999999 109.721 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.8 176.54 48.05 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.536 -1.426 . . . . 0.34000000000000002 109.536 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -137.99 157.53 46.18 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 117.269 0.535 . . . . 1.01 110.763 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.2 tp -110.31 115.05 28.99 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.514 -0.921 . . . . 1.0600000000000001 108.514 168.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.71 121.31 41.43 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 110.001 -0.37 . . . . 0.16 110.001 -175.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.4 mt -121.49 135.49 55.03 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 120.698 0.285 . . . . 0.98999999999999999 110.667 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -95.89 133.55 39.93 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.151 -0.685 . . . . 1.8799999999999999 109.151 172.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.7 mt -111.89 160.2 17.63 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 120.609 0.243 . . . . 0.97999999999999998 110.411 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.43 13.04 14.68 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 111.911 0.337 . . . . 0.17999999999999999 111.911 172.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -146.53 141.37 26.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.699 -0.625 . . . . 2.6000000000000001 109.505 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -62.93 149.27 45.08 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.168 -0.332 . . . . 1.9399999999999999 110.724 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -131.8 137.83 48.29 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 120.647 0.26 . . . . 0.5 110.545 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -138.03 122.51 18.43 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.809 -0.441 . . . . 1.3999999999999999 109.809 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.3 tt -63.28 -22.91 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 C-N-CA 120.97 -0.292 . . . . 1.0600000000000001 111.363 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -74.43 -1.02 19.25 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.982 -0.449 . . . . 1.55 112.143 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -90.61 -14.37 32.54 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 118.902 0.774 . . . . 2.2000000000000002 111.444 170.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -116.11 175.1 5.7 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.668 0.667 . . . . 0.38 109.512 173.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -92.07 103.93 16.38 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 110.097 -0.335 . . . . 2.2999999999999998 110.097 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -109.73 176.99 4.87 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 120.517 0.199 . . . . 0.89000000000000001 110.574 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.19 130.77 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.29 -1.004 . . . . 1.05 108.29 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -105.89 142.73 35.11 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 110.187 -0.301 . . . . 1.23 110.187 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.1 p -119.31 134.2 55.34 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 120.621 0.248 . . . . 1.0900000000000001 110.443 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.51 172.68 12.57 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 120.716 0.293 . . . . 1.29 111.502 -170.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -67.63 139.18 56.82 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.415 -0.587 . . . . 0.33000000000000002 109.415 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -139.09 167.82 21.21 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.934 -0.306 . . . . 0.27000000000000002 110.684 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -125.33 149.61 47.94 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 120.873 0.368 . . . . 0.80000000000000004 110.506 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -147.79 134.39 19.84 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.197 -0.668 . . . . 0.59999999999999998 109.197 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 51.67 33.21 10.46 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.69 -0.631 . . . . 1.7 112.089 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.47 16.98 78.58 Favored Glycine 0 N--CA 1.497 2.721 0 CA-C-O 119.601 -0.555 . . . . 0.46000000000000002 111.925 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -122.29 141.67 51.28 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 118.668 1.234 . . . . 2.3900000000000001 109.756 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -93.49 133.37 36.85 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 121.021 -0.272 . . . . 1.71 110.55 -176.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -123.04 145.18 48.75 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.887 -0.412 . . . . 0.41999999999999998 109.887 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -86.98 153.76 21.31 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 120.783 0.325 . . . . 0.40999999999999998 110.573 -168.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.09 158.62 51.85 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.976 -1.25 . . . . 0.22 109.976 -177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.79 159.18 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 122.228 -0.572 . . . . 1.1399999999999999 110.53 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -117.66 137.0 52.95 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.7 -0.482 . . . . 1.49 109.7 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.8 t -134.03 141.5 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 109.358 -0.608 . . . . 1.04 109.358 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.4 tp -137.41 125.61 14.49 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.627 -0.701 . . . . 1.02 110.087 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.0 149.91 90.21 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 121.033 1.155 . . . . 0.11 111.472 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.3 pt -141.54 170.0 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 120.716 0.293 . . . . 1.02 110.313 171.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -114.88 130.77 56.96 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.121 -0.696 . . . . 2.0600000000000001 109.121 168.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.69 123.91 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.836 -0.801 . . . . 1.0 108.836 -174.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.9 mt -108.54 116.96 32.95 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 110.284 -0.265 . . . . 1.04 110.284 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.4 mt -129.86 121.95 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.186 -1.042 . . . . 1.02 108.186 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.76 -120.37 18.58 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.868 -1.293 . . . . 0.16 109.868 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -111.12 17.13 20.66 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 122.382 -0.481 . . . . 2.71 111.831 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -119.83 145.46 46.62 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 118.559 0.618 . . . . 1.9299999999999999 110.505 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -123.07 130.87 53.35 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 110.251 -0.277 . . . . 1.99 110.251 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.9 mt -126.16 146.55 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 108.737 -0.838 . . . . 1.01 108.737 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.52 136.84 44.13 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 109.902 -0.407 . . . . 0.40999999999999998 109.902 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.51 -169.25 13.6 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.286 -1.526 . . . . 0.11 109.286 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.17 154.62 25.75 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 117.196 0.498 . . . . 1.03 110.159 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.5 mt -108.66 140.78 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.292 -1.003 . . . . 1.04 108.292 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.79 131.82 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 109.347 -0.612 . . . . 1.0800000000000001 109.347 -175.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.2 t -143.21 138.6 15.79 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 108.545 -0.909 . . . . 1.05 108.545 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -56.69 155.57 26.25 Favored 'Trans proline' 0 N--CA 1.504 2.097 0 C-N-CA 121.09 1.194 . . . . 0.28000000000000003 111.942 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -64.38 -34.14 77.49 Favored 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 121.141 -0.224 . . . . 1.6899999999999999 110.702 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -87.96 116.76 26.36 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 121.001 -0.28 . . . . 3.0800000000000001 110.254 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.0 m -130.98 136.64 48.71 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.016 -0.364 . . . . 1.9199999999999999 110.016 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -97.92 -54.63 3.03 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 110.31 -0.256 . . . . 4.8300000000000001 110.31 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -131.64 179.27 6.15 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 110.306 -0.257 . . . . 3.6699999999999999 110.306 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.9 m -100.14 148.9 24.08 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 110.135 -0.32 . . . . 1.49 110.135 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.0 m -135.01 175.0 9.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 122.292 -0.255 . . . . 1.47 110.387 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -107.91 27.07 9.6 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.418 -0.176 . . . . 0.93999999999999995 110.977 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -122.92 127.58 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.047 -0.723 . . . . 1.03 109.047 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.7 pt -125.44 143.68 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 110.109 -0.33 . . . . 1.01 110.109 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -115.03 130.85 57.03 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.963 -0.384 . . . . 1.3600000000000001 109.963 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.8 mt -115.92 151.39 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.434 -0.58 . . . . 1.02 109.434 -173.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.8 pt -116.44 154.24 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 109.433 -0.58 . . . . 1.0600000000000001 109.433 168.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.58 165.59 24.2 Favored Pre-proline 0 N--CA 1.496 1.836 0 CA-C-O 119.043 -0.503 . . . . 1.05 110.222 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.81 -31.41 93.9 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.069 1.179 . . . . 0.22 111.602 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.61 167.07 23.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.35 -0.219 . . . . 1.1100000000000001 110.664 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -71.65 104.01 3.22 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 109.975 -0.38 . . . . 2.6099999999999999 109.975 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.6 mt -59.37 -33.03 70.67 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 122.069 -0.394 . . . . 1.0600000000000001 111.449 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -63.1 -35.02 78.87 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 122.191 -0.318 . . . . 2.9700000000000002 110.904 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -78.25 -47.86 17.03 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.194 -0.669 . . . . 1.8200000000000001 109.194 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -62.28 -34.03 75.77 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.194 -0.317 . . . . 1.6599999999999999 111.112 -172.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -108.06 9.36 28.42 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 112.534 0.568 . . . . 0.33000000000000002 112.534 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.83 46.24 26.89 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.074 -1.016 . . . . 1.8400000000000001 111.887 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -91.89 138.2 31.74 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.878 -0.513 . . . . 1.1200000000000001 110.889 -171.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -114.99 158.2 22.38 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.844 -0.428 . . . . 2.8799999999999999 109.844 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -55.97 137.94 49.83 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.872 -0.517 . . . . 0.5 111.431 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.95 -22.96 37.36 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 111.151 -0.78 . . . . 0.14999999999999999 111.151 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -65.45 155.56 35.14 Favored 'General case' 0 N--CA 1.505 2.311 0 CA-C-N 118.631 1.216 . . . . 0.13 109.968 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -112.63 134.25 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.428 -0.582 . . . . 1.03 109.428 -174.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.2 pt -129.38 161.33 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 109.554 -0.536 . . . . 1.02 109.554 174.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -110.0 138.26 46.62 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 110.141 -0.318 . . . . 1.8899999999999999 110.141 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.8 pt -114.68 137.15 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 120.845 0.355 . . . . 1.04 110.184 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.9 tt -109.67 127.59 54.67 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.861 -0.422 . . . . 1.5800000000000001 109.861 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.69 132.09 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.858 -0.793 . . . . 1.24 108.858 -177.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -93.32 144.69 25.07 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 110.025 -0.361 . . . . 2.6400000000000001 110.025 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.07 179.88 32.52 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.678 -1.369 . . . . 1.3100000000000001 109.678 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -148.05 153.66 39.22 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 122.388 -0.478 . . . . 3.1499999999999999 110.203 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -124.67 131.7 53.45 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 110.105 -0.332 . . . . 8.1799999999999997 110.105 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.42 -36.35 81.07 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 120.952 -0.299 . . . . 6.5 110.204 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 N--CA 1.506 2.333 0 CA-C-O 118.279 -0.867 . . . . 9.0199999999999996 111.696 -179.414 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 110.38 -0.229 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.71 157.13 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -129.15 126.49 39.38 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.7 mt -110.86 151.32 27.99 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 22.4 ttt -134.63 147.27 50.14 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.1 mm -124.91 133.09 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.5 mt -129.7 148.91 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -105.32 140.05 39.03 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.33 151.08 20.42 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -106.83 141.64 37.74 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.346 -0.503 . . . . 0.0 110.26 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.18 122.28 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.4 146.03 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.1 m -86.14 103.77 15.1 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.02 132.23 2.46 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.2 mt -101.32 30.5 4.16 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.346 -0.502 . . . . 0.0 110.674 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.93 -171.73 54.39 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -91.26 -45.94 8.34 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.355 -0.497 . . . . 0.0 110.057 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -94.05 -172.89 38.98 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -146.72 156.79 43.43 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 122.315 -0.521 . . . . 0.0 110.428 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -146.36 170.73 16.2 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -109.3 141.14 42.04 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.2 mt -110.04 -29.29 8.29 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.391 -0.193 . . . . 0.0 111.184 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -60.87 -30.98 70.47 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.993 -0.442 . . . . 0.0 111.58 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 mp -65.18 156.6 80.59 Favored Pre-proline 0 N--CA 1.503 2.177 0 CA-C-O 119.197 -0.43 . . . . 0.0 110.579 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -57.0 -55.9 2.3 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.165 1.243 . . . . 0.0 113.179 -172.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.32 -30.78 91.78 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 O-C-N 122.658 0.82 . . . . 0.0 111.689 -163.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -66.55 -46.59 75.58 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.281 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -65.67 -36.25 83.1 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.177 -0.327 . . . . 0.0 110.275 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.93 -48.52 71.12 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 122.239 -0.288 . . . . 0.0 110.466 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.2 tt -68.72 -37.16 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.006 -176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -66.01 -44.36 84.99 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 122.111 -0.368 . . . . 0.0 110.352 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -65.76 -30.31 70.94 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.24 -0.288 . . . . 0.0 110.814 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -68.94 -40.69 78.85 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.622 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -81.26 -38.02 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.3 mt -103.97 -26.2 12.72 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 122.2 -0.313 . . . . 0.0 111.61 -174.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.03 15.02 70.81 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -172.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -152.83 164.33 38.06 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 119.027 1.413 . . . . 0.0 110.67 170.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -95.07 110.87 52.47 Favored Pre-proline 0 N--CA 1.496 1.844 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.725 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.33 159.9 50.17 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 O-C-N 123.253 1.133 . . . . 0.0 110.526 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -73.96 163.71 27.55 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -80.29 79.6 6.85 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.488 0.661 . . . . 0.0 109.653 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.16 173.24 45.37 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 p -138.05 157.87 45.47 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 117.241 0.52 . . . . 0.0 110.708 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.2 tp -110.31 114.98 28.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -99.04 119.84 38.47 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.1 mt -119.97 136.1 54.66 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 120.726 0.298 . . . . 0.0 110.717 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -95.9 133.61 39.88 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.6 mt -112.51 160.25 17.99 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 120.657 0.265 . . . . 0.0 110.417 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.26 13.06 14.3 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 172.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -146.39 142.68 28.44 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 118.533 0.606 . . . . 0.0 109.586 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -64.29 149.43 48.13 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 122.196 -0.315 . . . . 0.0 110.505 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -131.79 138.0 48.37 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 120.701 0.286 . . . . 0.0 110.437 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -138.02 123.07 19.1 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.16 -22.84 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.389 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -74.56 -0.93 19.28 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -90.49 -14.27 33.06 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 118.901 0.773 . . . . 0.0 111.485 171.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -117.19 175.12 5.75 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 118.618 0.645 . . . . 0.0 109.431 173.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -91.31 104.07 16.65 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -110.39 176.65 4.96 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 120.516 0.198 . . . . 0.0 110.532 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.16 131.46 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -105.97 144.06 33.22 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.6 p -120.9 134.73 55.29 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.653 0.264 . . . . 0.0 110.547 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -77.01 172.6 12.94 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 120.77 0.319 . . . . 0.0 111.644 -170.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -67.9 140.22 56.5 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -142.34 166.31 25.02 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.699 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -123.67 149.1 45.87 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 120.787 0.327 . . . . 0.0 110.465 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -149.01 135.72 19.63 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 51.7 33.16 10.45 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.724 -0.61 . . . . 0.0 112.095 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.18 17.01 78.88 Favored Glycine 0 N--CA 1.497 2.712 0 CA-C-O 119.613 -0.548 . . . . 0.0 111.896 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -121.82 140.43 52.38 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 118.647 1.223 . . . . 0.0 109.712 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -93.49 131.44 38.71 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.355 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -121.22 141.97 50.36 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -86.93 156.46 19.81 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 120.741 0.305 . . . . 0.0 110.454 -168.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.55 156.53 52.39 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.3 157.81 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 122.329 -0.512 . . . . 0.0 110.471 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -114.97 138.78 50.44 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.6 t -133.96 140.19 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -176.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.7 tp -137.69 125.69 14.23 Favored Pre-proline 0 N--CA 1.496 1.868 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.114 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -62.9 149.14 92.37 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 120.968 1.112 . . . . 0.0 111.586 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.8 pt -141.98 170.06 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 122.28 -0.263 . . . . 0.0 110.322 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -114.6 131.77 56.58 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 168.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -106.0 123.97 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -109.28 117.02 32.98 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.5 mt -130.09 121.96 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.38 -119.95 17.55 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -111.19 17.08 20.66 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 122.349 -0.501 . . . . 0.0 111.855 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -119.54 143.04 47.82 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 118.591 0.632 . . . . 0.0 110.482 -175.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -123.16 130.28 52.55 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 120.683 0.277 . . . . 0.0 110.309 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -126.31 144.93 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.83 138.07 44.21 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.92 -165.36 11.91 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.69 155.64 26.4 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 117.307 0.553 . . . . 0.0 110.236 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.69 141.22 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.7 t -121.7 130.78 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.3 t -141.11 134.07 14.41 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -57.24 155.42 29.61 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 121.042 1.162 . . . . 0.0 111.939 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -64.35 -34.02 77.18 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 122.321 -0.237 . . . . 0.0 110.685 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -90.11 123.2 33.76 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.337 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.2 m -130.23 142.97 50.52 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -94.9 -60.01 1.79 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -137.75 171.65 14.13 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.5 m -70.85 146.86 49.38 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.8 m -135.01 161.71 34.52 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.571 0.224 . . . . 0.0 110.464 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -107.64 27.08 9.51 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.375 -0.203 . . . . 0.0 110.833 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -123.73 127.52 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.5 pt -125.49 143.64 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -113.84 130.16 56.5 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.1 mt -115.5 150.33 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -174.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.8 pt -117.25 155.94 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 168.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.55 161.15 48.31 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-O 119.073 -0.489 . . . . 0.0 110.29 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.73 -30.88 93.18 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 121.105 1.203 . . . . 0.0 111.74 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.4 167.09 23.3 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.262 -0.274 . . . . 0.0 110.761 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -73.62 103.77 4.34 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.98 -35.39 78.34 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.145 -0.347 . . . . 0.0 111.136 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -62.22 -32.9 73.62 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.13 -0.356 . . . . 0.0 110.944 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -78.23 -50.89 11.05 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -63.06 -32.43 73.8 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.158 -172.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -105.97 7.84 32.2 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.87 47.45 24.75 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.014 -1.054 . . . . 0.0 111.841 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.4 mt -91.52 138.24 31.73 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.896 -0.502 . . . . 0.0 110.923 -170.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -116.82 158.66 23.57 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.22 50.08 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.846 -0.534 . . . . 0.0 111.474 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.77 -22.96 37.46 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.39 154.01 39.62 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 118.608 1.204 . . . . 0.0 110.018 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t -111.81 133.38 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -174.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 21.6 pt -128.68 160.83 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -109.63 138.09 46.5 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 pt -113.56 137.5 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 10.1 tt -109.03 128.5 55.02 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.1 mt -119.45 135.18 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -92.96 150.98 20.19 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.02 131.93 3.09 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.63 -33.95 14.89 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 117.192 0.496 . . . . 0.0 110.275 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -97.69 135.61 39.24 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -93.38 117.72 30.42 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.163 -179.925 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.64 155.02 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -102.39 122.19 43.79 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.1 mt -110.88 149.47 30.57 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 20.2 ttt -107.88 143.65 36.19 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.7 mm -126.22 129.92 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.0 mt -129.86 149.58 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -104.96 143.21 33.48 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.286 -0.259 . . . . 0.0 110.37 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.22 151.16 20.68 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.57 142.62 34.99 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 117.253 0.526 . . . . 0.0 110.221 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.7 122.79 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.57 163.39 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 t -85.19 122.17 28.99 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.02 124.1 1.12 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 tt -154.97 -47.45 0.08 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.32 -0.518 . . . . 0.0 110.367 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.09 35.86 4.59 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -69.82 -35.19 74.59 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 117.275 0.538 . . . . 0.0 109.988 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.3 -139.95 4.5 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -97.85 141.13 31.22 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 117.254 0.527 . . . . 0.0 110.187 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -126.16 119.4 27.41 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -148.24 33.67 0.81 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.9 mt -63.01 -30.57 71.71 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 122.127 -0.358 . . . . 0.0 111.15 -175.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.9 p -60.95 -26.62 67.65 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 122.115 -0.366 . . . . 0.0 111.629 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 mp -65.39 156.67 81.14 Favored Pre-proline 0 N--CA 1.503 2.197 0 CA-C-O 119.188 -0.434 . . . . 0.0 110.501 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -58.05 -56.03 1.9 Allowed 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 121.14 1.227 . . . . 0.0 113.029 -173.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.09 -32.05 91.23 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 O-C-N 122.65 0.816 . . . . 0.0 111.54 -162.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -66.32 -43.49 86.04 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.356 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -65.57 -37.53 86.93 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 122.136 -0.352 . . . . 0.0 110.247 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -65.41 -47.11 77.42 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 121.019 -0.273 . . . . 0.0 110.466 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.9 tt -68.75 -34.34 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.036 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -65.79 -43.62 88.18 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 122.054 -0.403 . . . . 0.0 110.29 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -65.25 -30.92 71.85 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 122.211 -0.306 . . . . 0.0 110.871 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -68.62 -41.21 79.81 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.668 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.3 mt -81.6 -36.46 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.8 mt -103.78 -26.13 12.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.192 -0.317 . . . . 0.0 111.668 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.57 14.69 72.84 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -172.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -152.82 162.43 41.29 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 119.062 1.431 . . . . 0.0 110.571 171.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -94.13 108.91 38.98 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.562 -0.733 . . . . 0.0 109.683 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -67.04 159.09 53.65 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 O-C-N 123.254 1.134 . . . . 0.0 110.536 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -73.81 162.97 28.55 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -80.29 79.6 6.84 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.497 0.665 . . . . 0.0 109.672 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.29 171.15 43.49 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -138.05 156.94 47.3 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 117.331 0.566 . . . . 0.0 110.856 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 tp -110.42 117.07 32.61 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 170.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -99.66 120.87 40.38 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt -120.02 135.77 54.8 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 120.728 0.299 . . . . 0.0 110.651 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -96.15 133.55 40.3 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.4 mt -111.59 160.2 17.43 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 120.605 0.24 . . . . 0.0 110.46 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.04 12.95 14.12 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 172.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -145.47 141.89 28.76 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.687 -0.633 . . . . 0.0 109.363 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.37 146.84 53.8 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 122.231 -0.293 . . . . 0.0 110.427 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -131.95 137.36 47.91 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 120.617 0.246 . . . . 0.0 110.553 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -138.02 124.19 20.38 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.49 -22.92 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 122.21 -0.306 . . . . 0.0 111.314 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -72.75 -5.0 34.85 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 122.024 -0.423 . . . . 0.0 112.083 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -90.59 -14.36 32.61 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 118.833 0.742 . . . . 0.0 111.538 172.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -114.64 175.07 5.65 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 118.558 0.617 . . . . 0.0 109.409 173.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -92.1 102.31 14.85 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -109.97 178.64 4.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 122.316 -0.24 . . . . 0.0 110.606 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.0 mt -111.8 130.69 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 174.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -105.93 141.66 36.96 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.0 p -118.07 134.84 54.61 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 120.703 0.287 . . . . 0.0 110.461 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.17 172.71 12.37 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 120.826 0.346 . . . . 0.0 111.535 -170.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -67.29 139.56 57.3 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -138.95 167.13 22.72 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.203 -0.311 . . . . 0.0 110.643 -174.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -124.23 149.19 46.71 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.87 0.367 . . . . 0.0 110.599 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -148.22 134.47 19.44 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 51.76 33.3 10.92 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.736 -0.603 . . . . 0.0 112.142 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.32 16.77 79.06 Favored Glycine 0 N--CA 1.497 2.746 0 CA-C-O 119.664 -0.52 . . . . 0.0 111.937 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -122.33 141.67 51.31 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 118.665 1.233 . . . . 0.0 109.694 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -93.45 132.21 37.92 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 121.13 -0.228 . . . . 0.0 110.483 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -123.18 146.84 47.45 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -86.92 155.21 20.31 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.73 0.3 . . . . 0.0 110.454 -168.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.36 161.18 48.45 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.67 157.09 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 122.372 -0.487 . . . . 0.0 110.412 -174.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -115.48 136.65 52.86 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -134.11 140.19 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.0 tp -137.04 125.65 14.94 Favored Pre-proline 0 N--CA 1.497 1.898 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.057 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -63.6 148.47 92.33 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 121.008 1.139 . . . . 0.0 111.383 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.6 pt -141.96 170.0 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 122.266 -0.271 . . . . 0.0 110.414 172.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -115.07 131.84 56.79 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 167.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.2 mt -105.68 123.7 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.1 mt -108.38 116.99 33.0 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -177.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.4 mt -130.06 121.99 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.24 -120.01 17.94 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -111.2 17.03 20.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.298 -0.531 . . . . 0.0 111.829 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -119.32 143.56 47.31 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.669 -0.644 . . . . 0.0 110.468 -175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -123.11 129.96 52.14 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 120.671 0.272 . . . . 0.0 110.294 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.6 mt -125.4 143.82 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.82 137.49 43.87 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.98 -165.35 11.93 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.64 156.62 28.2 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.18 -0.6 . . . . 0.0 110.303 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.8 mt -108.72 142.01 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.5 130.73 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -143.18 136.66 14.15 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -57.22 153.85 37.51 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 121.013 1.142 . . . . 0.0 111.927 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -64.78 -34.38 78.22 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 122.307 -0.246 . . . . 0.0 110.736 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -86.93 116.11 24.77 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.395 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.8 p -131.6 159.53 37.98 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -126.52 -48.34 1.55 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -128.77 175.42 8.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 95.1 p -98.18 149.96 21.99 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.2 m -134.96 170.8 15.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.323 -0.235 . . . . 0.0 110.371 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -107.17 27.08 9.4 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.356 -0.215 . . . . 0.0 110.93 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.0 mm -123.75 127.89 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 pt -126.49 143.1 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -112.83 131.82 55.54 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.9 mt -116.87 150.98 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -174.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.2 pt -116.04 154.32 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.55 166.02 21.99 Favored Pre-proline 0 N--CA 1.494 1.767 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.292 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -60.0 -31.91 94.21 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 121.104 1.203 . . . . 0.0 111.519 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.69 167.09 23.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.305 -0.247 . . . . 0.0 110.69 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -70.61 104.58 2.85 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.64 -33.39 71.46 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 122.099 -0.375 . . . . 0.0 111.463 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -62.75 -35.3 79.36 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 122.155 -0.341 . . . . 0.0 110.907 -174.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.25 -47.85 17.02 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -62.63 -33.69 75.53 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.152 -0.342 . . . . 0.0 111.122 -172.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -108.12 9.27 28.31 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 112.503 0.556 . . . . 0.0 112.503 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.91 45.86 27.55 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.066 -1.021 . . . . 0.0 111.845 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -92.18 138.18 31.75 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.908 -0.495 . . . . 0.0 110.974 -171.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -114.96 160.61 19.36 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.34 49.87 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.918 -0.489 . . . . 0.0 111.482 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.53 -23.49 35.6 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.44 152.65 43.41 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 118.665 1.233 . . . . 0.0 110.076 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.21 133.82 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.1 pt -129.19 161.31 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 174.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -109.91 138.4 46.35 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -112.88 137.93 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.6 tt -108.74 128.61 55.02 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 36.0 mt -116.46 139.55 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -90.73 149.58 21.98 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.09 175.5 34.55 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -112.27 -35.49 5.59 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 122.266 -0.55 . . . . 0.0 110.453 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -154.27 -59.82 0.12 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -101.68 31.51 3.78 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.281 -0.262 . . . . 0.0 110.566 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.206 -179.089 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 mtt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 m -108.0 -30.56 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 122.37 -0.206 . . . . 0.0 110.666 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -139.24 109.01 6.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.142 -0.349 . . . . 0.0 110.278 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.0 mt -110.87 149.59 30.39 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 21.1 ttt -138.42 145.34 40.85 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.479 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.1 mm -126.19 133.69 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.3 mt -130.11 150.09 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -107.08 143.36 35.34 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.55 150.56 20.83 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -106.4 142.9 35.32 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.307 -0.525 . . . . 0.0 110.26 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.73 122.45 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.07 142.86 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 175.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.2 t -87.52 130.57 34.67 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.279 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.04 119.94 0.84 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.9 mt -132.96 148.42 52.27 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.349 -0.5 . . . . 0.0 110.196 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.95 36.1 25.98 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -101.91 130.87 48.51 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.255 -0.556 . . . . 0.0 109.948 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.83 -140.01 32.36 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -113.84 132.23 55.96 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 117.234 0.517 . . . . 0.0 110.06 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -120.32 121.22 38.14 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -154.81 35.35 0.4 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.8 mt -62.12 -27.71 69.12 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 122.088 -0.383 . . . . 0.0 111.154 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.4 m -60.07 -25.51 65.44 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 122.075 -0.391 . . . . 0.0 111.549 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.7 tp -62.81 138.9 97.13 Favored Pre-proline 0 N--CA 1.506 2.349 0 CA-C-O 118.774 -0.631 . . . . 0.0 110.267 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -51.94 -53.7 6.53 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 121.179 1.253 . . . . 0.0 113.913 -174.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.14 -31.12 90.05 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 O-C-N 122.687 0.835 . . . . 0.0 111.446 -164.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -65.97 -42.71 89.54 Favored 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.44 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -65.55 -38.35 89.35 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.155 -0.341 . . . . 0.0 110.186 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.46 -46.0 81.54 Favored 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.595 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.8 tt -69.22 -33.43 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.916 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -65.67 -44.11 87.26 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 122.02 -0.425 . . . . 0.0 110.269 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -65.47 -31.3 72.31 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.783 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -68.56 -40.42 80.63 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.628 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.32 -37.02 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.0 mt -103.23 -26.29 13.03 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.268 -0.27 . . . . 0.0 111.695 -174.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.98 14.82 74.16 Favored Glycine 0 N--CA 1.493 2.471 0 CA-C-O 119.382 -0.677 . . . . 0.0 111.46 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -151.39 161.45 42.68 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 119.118 1.459 . . . . 0.0 110.651 170.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -94.68 107.84 33.24 Favored Pre-proline 0 N--CA 1.495 1.821 0 CA-C-O 118.637 -0.697 . . . . 0.0 109.856 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -67.31 158.23 57.97 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 O-C-N 123.219 1.115 . . . . 0.0 110.557 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.23 163.76 27.44 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -80.22 79.63 6.76 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.488 0.661 . . . . 0.0 109.675 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.6 172.97 45.37 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 175.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 p -138.05 157.03 47.18 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 117.397 0.599 . . . . 0.0 110.932 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.9 tp -109.63 115.71 30.39 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -99.26 120.96 40.4 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.6 mt -120.07 136.01 54.73 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.701 0.286 . . . . 0.0 110.607 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -96.36 134.24 39.75 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 173.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.3 mt -111.53 160.28 17.32 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 120.671 0.272 . . . . 0.0 110.45 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.14 13.0 14.2 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 171.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -145.21 142.27 29.4 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 118.567 0.622 . . . . 0.0 109.416 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -64.5 146.83 53.96 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 122.221 -0.299 . . . . 0.0 110.339 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -132.46 136.67 46.87 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 120.736 0.303 . . . . 0.0 110.602 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -138.04 127.4 24.67 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.33 -23.98 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.385 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -74.27 -1.07 19.05 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.944 -0.472 . . . . 0.0 112.182 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -91.02 -14.26 31.73 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 118.838 0.745 . . . . 0.0 111.481 169.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -116.23 175.06 5.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.665 -0.647 . . . . 0.0 109.43 174.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -91.98 102.93 15.5 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -110.63 178.46 4.36 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 120.579 0.228 . . . . 0.0 110.548 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -112.36 131.64 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -105.87 144.13 33.04 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.2 p -123.24 138.52 54.61 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 120.783 0.325 . . . . 0.0 110.786 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -77.29 172.71 12.86 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -167.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -67.6 141.36 56.81 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -136.59 167.28 21.68 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.535 -176.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -124.19 146.92 48.39 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 120.807 0.337 . . . . 0.0 110.667 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -149.8 138.65 20.99 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.6 m120 52.14 30.0 7.13 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.708 -0.62 . . . . 0.0 112.135 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.17 16.19 80.87 Favored Glycine 0 N--CA 1.497 2.736 0 CA-C-O 119.528 -0.596 . . . . 0.0 111.749 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -121.08 144.07 48.75 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 118.783 1.291 . . . . 0.0 109.617 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.13 131.36 38.26 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.53 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -120.17 144.72 47.53 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -85.81 156.97 20.35 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 120.845 0.355 . . . . 0.0 110.554 -167.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.43 162.01 44.72 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.42 156.71 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 122.409 -0.465 . . . . 0.0 110.351 -175.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -116.07 137.55 52.02 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.9 t -134.01 140.7 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -176.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.5 tp -136.72 125.65 15.31 Favored Pre-proline 0 N--CA 1.497 1.884 0 CA-C-O 118.553 -0.737 . . . . 0.0 110.109 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -63.78 149.12 91.48 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 120.937 1.091 . . . . 0.0 111.357 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.3 pt -141.79 169.64 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 120.692 0.282 . . . . 0.0 110.298 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -114.83 131.26 56.88 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 167.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.4 mt -105.71 123.29 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -175.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.6 mt -107.77 116.48 32.03 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.1 mt -129.75 121.91 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.64 -120.24 18.28 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -111.09 16.98 20.82 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.311 -0.523 . . . . 0.0 111.832 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -119.65 144.4 47.18 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 118.609 0.64 . . . . 0.0 110.464 -175.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -123.12 129.98 52.16 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 120.668 0.271 . . . . 0.0 110.282 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.3 mt -125.54 144.91 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.89 136.83 43.39 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.67 -167.17 12.71 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.37 155.68 27.15 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 117.277 0.538 . . . . 0.0 110.363 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -108.72 141.84 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.03 131.56 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.8 t -141.87 130.63 12.13 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -58.75 155.02 39.76 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 121.02 1.147 . . . . 0.0 111.633 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -64.92 -34.41 78.34 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.301 -0.25 . . . . 0.0 110.574 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -87.98 121.09 29.99 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.3 t -142.38 152.45 42.86 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.344 -0.223 . . . . 0.0 110.407 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -98.9 -58.65 1.9 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -136.76 170.62 15.77 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.1 p -82.74 150.63 26.58 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.1 m -135.17 174.98 10.01 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 120.577 0.227 . . . . 0.0 110.408 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -106.4 27.22 8.95 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.374 -0.204 . . . . 0.0 110.932 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.0 mm -123.73 127.82 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.5 pt -125.2 145.1 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -115.92 130.21 56.73 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.2 mt -115.6 151.02 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.6 pt -116.56 154.78 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 169.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.59 165.97 22.2 Favored Pre-proline 0 N--CA 1.496 1.829 0 CA-C-O 119.049 -0.5 . . . . 0.0 110.307 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.9 -32.64 95.51 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 121.078 1.185 . . . . 0.0 111.404 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.98 161.54 39.13 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.695 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -63.36 105.81 0.8 Allowed 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 121.267 0.556 . . . . 0.0 111.038 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.4 mt -59.84 -33.35 71.67 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.861 -0.524 . . . . 0.0 111.445 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 93.1 mtm-85 -62.55 -35.36 79.22 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 122.131 -0.355 . . . . 0.0 110.967 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -78.22 -48.03 16.71 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -62.46 -34.24 76.43 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 122.192 -0.318 . . . . 0.0 111.102 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -108.03 9.0 28.56 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 51.85 50.43 18.64 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.137 -0.977 . . . . 0.0 111.934 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.6 mt -90.41 138.12 31.8 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.868 -0.52 . . . . 0.0 110.909 -171.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -116.32 156.96 25.75 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.08 138.04 50.23 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.863 -0.523 . . . . 0.0 111.5 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.68 -22.87 37.91 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -65.38 150.74 47.79 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-N 118.725 1.262 . . . . 0.0 110.041 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.96 133.39 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -173.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.0 pt -128.21 160.39 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -109.3 138.19 46.04 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.0 pt -111.82 136.77 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.4 tt -110.33 126.17 53.94 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 48.2 mt -112.1 119.67 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -95.45 155.06 16.9 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.11 122.91 1.22 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -155.04 -60.05 0.11 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 122.318 -0.519 . . . . 0.0 110.187 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -133.47 143.63 48.94 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -66.44 -37.77 85.9 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.286 -0.259 . . . . 0.0 110.347 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.177 179.465 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.9 mtp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.25 -38.24 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -99.18 104.13 16.07 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.1 mt -110.94 154.21 24.43 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 7.2 tpt -104.37 141.44 36.33 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.2 mm -128.18 130.95 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.2 mt -129.52 148.33 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -105.73 140.39 38.86 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.12 150.51 20.01 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -105.39 142.45 35.13 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 122.354 -0.497 . . . . 0.0 110.205 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.69 123.25 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.76 163.84 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.3 t -84.66 122.52 29.19 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.22 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.0 140.19 5.92 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.1 tp -155.07 -52.57 0.09 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 117.196 0.498 . . . . 0.0 110.151 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.28 35.59 4.78 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -68.94 -37.87 79.14 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 117.339 0.57 . . . . 0.0 109.843 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.09 -176.34 42.25 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -119.92 34.66 5.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.368 -0.489 . . . . 0.0 110.059 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -120.34 151.52 39.12 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.171 -0.331 . . . . 0.0 110.467 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.79 140.09 47.87 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.3 mt -97.96 0.07 45.73 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.4 p -82.42 -27.32 32.06 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 118.945 0.793 . . . . 0.0 111.399 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.9 mt -65.35 156.17 82.58 Favored Pre-proline 0 N--CA 1.502 2.158 0 CA-C-O 119.108 -0.472 . . . . 0.0 110.77 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -56.95 -55.36 2.71 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.184 1.256 . . . . 0.0 113.168 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.0 -30.15 89.31 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 O-C-N 122.656 0.819 . . . . 0.0 111.626 -163.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -65.94 -42.34 90.16 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.452 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -65.39 -38.86 91.27 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 122.068 -0.395 . . . . 0.0 110.26 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.08 -45.61 84.55 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.621 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.7 tt -69.58 -33.63 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.004 -177.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -65.3 -43.46 91.05 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 122.024 -0.422 . . . . 0.0 110.274 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -65.57 -31.42 72.46 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.225 -0.297 . . . . 0.0 110.855 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -68.71 -40.4 79.98 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.576 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.4 mt -81.35 -36.94 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.6 mt -104.04 -26.24 12.68 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.228 -0.295 . . . . 0.0 111.611 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.44 14.89 72.7 Favored Glycine 0 N--CA 1.494 2.504 0 CA-C-O 119.322 -0.71 . . . . 0.0 111.421 -172.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -151.84 161.17 43.09 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 119.097 1.449 . . . . 0.0 110.7 170.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -94.1 108.4 35.32 Favored Pre-proline 0 N--CA 1.496 1.874 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.821 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -67.3 157.94 59.37 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 O-C-N 123.279 1.147 . . . . 0.0 110.45 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -73.61 164.0 27.25 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -80.24 79.56 6.79 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.502 0.668 . . . . 0.0 109.612 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.76 172.18 44.44 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 p -138.01 157.18 46.89 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 117.315 0.558 . . . . 0.0 110.691 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.7 tp -109.4 116.14 31.27 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 170.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.34 120.44 38.76 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 61.0 mt -120.03 136.15 54.67 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 120.683 0.278 . . . . 0.0 110.658 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -96.05 132.77 41.06 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.6 mt -111.82 160.22 17.56 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 120.681 0.277 . . . . 0.0 110.427 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.1 13.14 13.78 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 172.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -145.86 142.03 28.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.657 -0.652 . . . . 0.0 109.566 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -64.23 148.88 49.13 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 122.297 -0.252 . . . . 0.0 110.395 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -131.78 137.03 48.0 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 120.688 0.28 . . . . 0.0 110.5 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -138.0 124.05 20.25 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.3 tt -64.25 -22.94 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.226 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -72.52 -4.19 29.03 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 118.257 0.48 . . . . 0.0 112.074 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -90.53 -14.26 32.96 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 118.833 0.742 . . . . 0.0 111.427 172.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -115.68 175.08 5.69 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 118.673 0.67 . . . . 0.0 109.34 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -91.42 101.98 14.66 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -108.64 175.96 5.28 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.313 -0.242 . . . . 0.0 110.623 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.7 mt -110.34 131.08 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -105.93 143.12 34.52 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.5 p -122.48 134.53 54.57 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.65 0.262 . . . . 0.0 110.618 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -76.86 172.62 12.84 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 120.803 0.335 . . . . 0.0 111.686 -169.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -67.96 140.29 56.41 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -141.09 165.48 27.42 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.755 -175.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -123.28 149.07 45.26 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.803 0.335 . . . . 0.0 110.533 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -149.87 135.52 18.42 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 51.69 32.91 10.01 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.654 -0.654 . . . . 0.0 112.1 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.27 17.32 78.24 Favored Glycine 0 N--CA 1.498 2.796 0 CA-C-O 119.683 -0.509 . . . . 0.0 111.835 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -122.75 141.13 52.14 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.628 1.214 . . . . 0.0 109.767 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.68 131.73 38.71 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.424 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -121.81 143.96 49.1 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -86.99 155.73 20.05 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 120.812 0.339 . . . . 0.0 110.482 -168.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.45 158.28 51.19 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.3 155.09 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 122.268 -0.548 . . . . 0.0 110.37 -174.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -113.26 137.45 51.47 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.1 t -133.24 140.27 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 tp -137.21 125.71 14.79 Favored Pre-proline 0 N--CA 1.497 1.878 0 CA-C-O 118.522 -0.752 . . . . 0.0 110.073 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -63.21 149.81 90.33 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 120.916 1.077 . . . . 0.0 111.542 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.5 pt -142.13 170.05 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 171.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -114.31 131.98 56.34 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 167.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.46 122.88 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -107.47 116.89 32.74 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 74.5 mt -129.97 121.9 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.52 -119.94 17.33 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -111.21 17.01 20.7 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.359 -0.494 . . . . 0.0 111.788 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -119.74 143.94 47.52 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 118.536 0.607 . . . . 0.0 110.468 -175.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -123.14 129.64 51.7 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 120.674 0.273 . . . . 0.0 110.286 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.4 mt -125.53 145.11 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.79 136.72 43.59 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.42 -166.32 12.09 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.72 155.54 26.16 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 117.348 0.574 . . . . 0.0 110.385 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.73 141.19 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.35 132.11 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.1 t -142.16 129.04 11.17 Favored Pre-proline 0 N--CA 1.498 1.934 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.97 154.35 51.25 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.027 1.151 . . . . 0.0 111.412 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -61.81 -30.84 71.09 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 122.262 -0.274 . . . . 0.0 111.402 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -84.85 107.98 17.28 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.299 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.5 m -131.05 145.41 52.01 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -94.06 -59.74 1.9 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -139.53 170.32 16.14 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.4 m -68.43 145.96 53.63 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.2 m -135.0 166.23 23.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.352 -0.218 . . . . 0.0 110.462 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -107.4 27.1 9.43 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.379 -0.201 . . . . 0.0 110.865 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.7 mm -123.16 127.34 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.2 pt -125.83 144.4 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -114.21 129.58 56.63 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.7 mt -114.78 150.67 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -174.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 pt -116.52 154.85 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 168.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.51 166.07 21.79 Favored Pre-proline 0 N--CA 1.496 1.831 0 CA-C-O 119.099 -0.477 . . . . 0.0 110.257 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.79 -32.12 95.04 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 121.135 1.223 . . . . 0.0 111.468 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.9 160.49 41.22 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.334 -0.229 . . . . 0.0 110.695 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.5 pttt -63.07 105.85 0.76 Allowed 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.297 0.57 . . . . 0.0 111.106 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.7 mt -59.79 -33.44 71.71 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.843 -0.535 . . . . 0.0 111.413 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -62.81 -35.13 78.91 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 122.092 -0.38 . . . . 0.0 111.021 -173.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -78.19 -48.4 15.95 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -62.44 -34.33 76.58 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 122.223 -0.298 . . . . 0.0 111.129 -172.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -108.14 8.87 28.27 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.86 50.39 18.73 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.1 -1.0 . . . . 0.0 111.942 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 45.5 mt -90.35 138.22 31.72 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.757 -0.589 . . . . 0.0 110.952 -171.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -116.39 157.32 25.27 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.99 138.14 49.59 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 121.889 -0.507 . . . . 0.0 111.524 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.68 -22.93 37.65 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -65.47 152.43 43.97 Favored 'General case' 0 N--CA 1.505 2.31 0 CA-C-N 118.597 1.199 . . . . 0.0 110.033 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -111.03 133.93 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -174.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.4 pt -128.85 159.75 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -109.71 137.97 46.76 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 pt -112.82 137.83 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.4 tt -109.59 133.38 53.17 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 35.7 mt -125.12 131.74 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -177.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -92.35 137.86 32.01 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.09 165.21 33.16 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -99.23 -34.29 10.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 122.38 -0.482 . . . . 0.0 110.377 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -98.15 137.87 36.28 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -97.39 118.58 34.18 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.094 179.794 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 mtt . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.3 t -115.26 133.52 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -100.89 139.07 37.09 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.3 mt -110.81 153.59 25.16 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 41.3 ttm -104.13 141.94 35.36 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.5 mm -126.71 129.78 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.1 mt -129.84 148.75 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -105.11 141.53 36.5 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.26 151.34 20.48 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.77 141.85 36.49 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 117.184 0.492 . . . . 0.0 110.212 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.65 123.86 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.71 146.43 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 t -87.76 134.98 33.57 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 122.311 -0.243 . . . . 0.0 110.451 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.01 119.81 0.83 Allowed Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.8 mt -143.04 -49.04 0.33 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 117.235 0.517 . . . . 0.0 110.33 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.28 -35.21 90.0 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -67.1 142.62 57.04 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 117.334 0.567 . . . . 0.0 110.377 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.37 -177.95 45.4 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -129.85 140.0 51.08 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 122.304 -0.527 . . . . 0.0 110.1 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -122.57 132.83 54.49 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.285 -0.259 . . . . 0.0 110.526 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -132.04 33.58 3.9 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.68 -30.71 71.78 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 122.185 -0.322 . . . . 0.0 111.1 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.4 p -60.7 -26.52 67.2 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 122.082 -0.386 . . . . 0.0 111.733 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.6 mp -65.15 156.22 81.73 Favored Pre-proline 0 N--CA 1.503 2.185 0 CA-C-O 119.178 -0.439 . . . . 0.0 110.614 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -57.56 -55.95 2.1 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 121.214 1.276 . . . . 0.0 113.083 -173.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.23 -32.15 90.22 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 O-C-N 122.683 0.833 . . . . 0.0 111.546 -163.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -66.29 -43.3 86.74 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.4 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -65.36 -37.95 88.57 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 122.105 -0.372 . . . . 0.0 110.324 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -65.18 -46.6 80.13 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.189 -0.319 . . . . 0.0 110.528 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.8 tt -68.78 -34.04 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.027 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -65.8 -43.52 88.44 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 122.062 -0.399 . . . . 0.0 110.376 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -65.32 -32.39 74.02 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 122.189 -0.319 . . . . 0.0 110.681 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -68.65 -39.57 80.63 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.687 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.7 mt -81.04 -37.52 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -176.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.4 mt -103.42 -26.14 13.0 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.196 -0.315 . . . . 0.0 111.735 -173.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.57 14.75 75.27 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -150.96 160.67 43.77 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 119.107 1.453 . . . . 0.0 110.547 170.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -94.82 108.8 40.11 Favored Pre-proline 0 N--CA 1.495 1.822 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.808 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.23 158.89 54.76 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 O-C-N 123.283 1.149 . . . . 0.0 110.508 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -73.74 163.89 27.36 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -80.21 79.54 6.76 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.544 0.688 . . . . 0.0 109.617 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.06 171.61 43.66 Favored Glycine 0 N--CA 1.496 2.633 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -138.1 157.93 45.34 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 117.356 0.578 . . . . 0.0 110.59 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.2 tp -109.9 116.54 31.82 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -98.94 123.45 43.22 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 74.8 mt -120.62 135.57 55.07 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 120.641 0.258 . . . . 0.0 110.602 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -96.17 133.12 40.86 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.4 mt -112.3 160.27 17.83 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 120.701 0.286 . . . . 0.0 110.464 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -89.57 13.46 13.95 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 172.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -145.41 141.82 28.76 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.763 -0.585 . . . . 0.0 109.423 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -64.47 146.81 53.96 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 122.201 -0.312 . . . . 0.0 110.396 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -134.97 136.41 42.2 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 120.714 0.292 . . . . 0.0 110.588 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -138.04 131.02 30.03 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.48 -23.08 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.533 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -74.86 -0.94 20.12 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.895 -0.503 . . . . 0.0 112.253 -176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -90.04 -14.51 33.71 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 118.946 0.794 . . . . 0.0 111.575 171.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -117.77 175.12 5.8 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.68 -0.637 . . . . 0.0 109.403 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -90.89 103.59 16.28 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -109.73 178.14 4.51 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 120.587 0.232 . . . . 0.0 110.5 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.0 mt -111.15 131.03 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -105.95 146.02 30.56 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.3 p -122.6 137.22 54.96 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 120.688 0.28 . . . . 0.0 110.649 176.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -76.59 172.7 12.59 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 120.895 0.378 . . . . 0.0 111.711 -168.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -67.37 140.23 57.2 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -139.54 166.73 23.81 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 122.221 -0.299 . . . . 0.0 110.598 -174.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -124.22 148.75 47.08 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 120.891 0.377 . . . . 0.0 110.488 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -148.97 136.73 20.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.91 32.27 9.67 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.703 -0.623 . . . . 0.0 112.101 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.07 16.85 79.23 Favored Glycine 0 N--CA 1.496 2.692 0 CA-C-O 119.587 -0.563 . . . . 0.0 111.874 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -123.22 143.13 50.24 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 118.651 1.225 . . . . 0.0 109.731 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.37 132.2 37.83 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 121.066 -0.253 . . . . 0.0 110.366 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -121.78 144.91 48.53 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -86.03 156.52 20.39 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.4 -169.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.14 161.22 44.85 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.93 156.92 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 122.354 -0.498 . . . . 0.0 110.327 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -118.77 137.24 53.5 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.8 t -134.04 141.11 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -176.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.4 tp -137.25 125.65 14.7 Favored Pre-proline 0 N--CA 1.496 1.851 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.13 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -63.35 149.46 91.17 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 120.936 1.09 . . . . 0.0 111.477 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 44.2 pt -141.53 170.09 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 122.209 -0.307 . . . . 0.0 110.256 171.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -114.67 131.56 56.69 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 167.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.05 123.17 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -175.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.1 mt -108.37 117.09 33.24 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.96 121.94 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.29 -119.93 17.58 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -111.16 17.0 20.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.343 -0.504 . . . . 0.0 111.981 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -119.94 144.01 47.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.749 -0.594 . . . . 0.0 110.512 -175.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -123.15 130.76 53.19 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.9 mt -125.78 145.27 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.79 137.83 44.13 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.16 -167.7 13.73 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.6 156.92 28.82 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 117.354 0.577 . . . . 0.0 110.443 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.7 mt -108.63 141.25 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.98 131.05 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.9 t -143.67 136.52 13.7 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -58.11 154.21 41.0 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 120.989 1.126 . . . . 0.0 111.757 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -65.9 -34.87 79.13 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 122.282 -0.261 . . . . 0.0 110.468 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -92.05 125.7 36.84 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -137.26 155.51 49.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 122.33 -0.231 . . . . 0.0 110.421 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -97.01 -59.43 1.8 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -138.94 170.33 16.18 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.3 p -80.74 147.53 30.51 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.4 m -134.98 174.03 11.07 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 120.583 0.23 . . . . 0.0 110.481 -177.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -107.23 27.61 8.89 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 122.36 -0.212 . . . . 0.0 110.862 177.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -123.3 127.74 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.4 pt -125.97 145.12 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -116.35 130.06 56.58 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.1 mt -114.58 150.41 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -175.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 pt -115.92 153.97 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 169.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.58 166.04 21.82 Favored Pre-proline 0 N--CA 1.494 1.738 0 CA-C-O 119.074 -0.489 . . . . 0.0 110.293 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.75 -31.3 93.88 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.08 1.187 . . . . 0.0 111.68 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.71 167.09 23.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 122.338 -0.226 . . . . 0.0 110.921 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -67.74 107.04 2.43 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.05 -35.82 75.96 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 122.081 -0.387 . . . . 0.0 111.373 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 71.8 mtt85 -62.39 -35.29 78.73 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 122.175 -0.328 . . . . 0.0 110.981 -175.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -78.2 -47.3 18.32 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.6 -34.85 77.83 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 122.191 -0.318 . . . . 0.0 111.036 -172.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -108.01 8.61 28.4 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 51.73 46.81 25.95 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.072 -1.017 . . . . 0.0 111.96 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.37 138.18 31.78 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.956 -0.465 . . . . 0.0 110.969 -170.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -114.79 158.25 22.14 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.78 138.08 48.62 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.866 -0.521 . . . . 0.0 111.541 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.63 -22.93 37.66 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.52 151.86 45.4 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 118.635 1.217 . . . . 0.0 109.982 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.52 134.09 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.2 pt -129.24 161.32 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -110.4 137.89 47.51 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -113.02 137.6 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 176.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.0 tt -109.71 128.22 55.12 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 37.8 mt -116.41 129.38 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -92.9 149.81 21.0 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.07 169.11 34.14 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.97 -33.52 11.54 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 122.364 -0.492 . . . . 0.0 110.371 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -96.05 138.66 33.35 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -67.85 -35.04 77.87 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.189 179.866 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.1 mtp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p -131.95 141.57 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -102.67 121.61 42.78 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 81.2 mt -110.87 147.44 34.56 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 43.6 ttm -113.08 143.67 43.95 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.6 mm -129.35 131.43 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.7 mt -129.58 148.5 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -106.98 142.37 36.7 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 122.27 -0.269 . . . . 0.0 110.466 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.69 151.57 20.95 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -106.07 142.69 35.34 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 117.247 0.524 . . . . 0.0 110.259 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.64 124.32 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.73 156.12 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.9 t -85.67 131.58 34.31 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.4 -176.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.96 119.89 0.84 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.1 tp -142.62 135.82 28.52 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 117.232 0.516 . . . . 0.0 110.236 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.44 36.87 32.79 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -100.53 140.35 34.91 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.335 -0.509 . . . . 0.0 110.136 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.02 173.96 42.35 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -118.04 33.34 5.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 122.34 -0.506 . . . . 0.0 110.33 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -116.25 144.13 44.61 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.181 -0.324 . . . . 0.0 110.409 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -114.49 139.54 49.46 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.4 mt -98.59 0.04 44.08 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.3 t -83.41 -31.2 26.79 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 119.033 0.833 . . . . 0.0 110.981 -174.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.5 mp -65.62 152.45 92.65 Favored Pre-proline 0 N--CA 1.503 2.195 0 CA-C-O 119.051 -0.499 . . . . 0.0 110.492 -176.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -53.57 -50.77 12.68 Favored 'Trans proline' 0 N--CA 1.501 1.96 0 C-N-CA 121.158 1.238 . . . . 0.0 113.891 -174.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -55.54 -35.16 91.97 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 120.619 0.879 . . . . 0.0 112.312 -168.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -67.1 -50.23 62.26 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.26 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -64.71 -40.76 95.91 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 122.125 -0.359 . . . . 0.0 110.533 -176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.83 -49.94 64.17 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 122.166 -0.334 . . . . 0.0 110.391 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.0 tt -70.75 -32.67 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.205 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.81 -40.89 95.95 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 122.019 -0.425 . . . . 0.0 110.285 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -64.51 -31.45 72.68 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 122.157 -0.339 . . . . 0.0 110.767 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -67.98 -40.34 83.12 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.657 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 59.6 mt -80.94 -37.27 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.0 mt -102.53 -26.29 13.29 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 122.189 -0.319 . . . . 0.0 111.568 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.35 14.33 74.34 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-O 119.26 -0.745 . . . . 0.0 111.411 -172.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -152.31 161.23 42.91 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 119.243 1.521 . . . . 0.0 110.641 170.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -94.32 107.95 32.87 Favored Pre-proline 0 N--CA 1.496 1.841 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.737 177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.4 155.48 70.2 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 O-C-N 123.327 1.172 . . . . 0.0 110.462 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -73.82 164.17 26.98 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.24 79.55 6.8 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.489 0.661 . . . . 0.0 109.663 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.55 171.74 44.03 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 p -138.05 156.74 47.49 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 117.41 0.605 . . . . 0.0 110.884 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.2 tp -109.91 118.58 36.84 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 170.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.95 122.34 42.08 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.8 mt -119.96 136.08 54.67 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 120.686 0.279 . . . . 0.0 110.562 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -96.23 133.39 40.61 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 173.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.9 mt -112.16 160.18 17.82 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 120.561 0.22 . . . . 0.0 110.482 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.2 13.16 13.94 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -145.34 141.21 28.3 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 118.604 0.638 . . . . 0.0 109.418 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -64.18 146.84 53.59 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 122.253 -0.279 . . . . 0.0 110.392 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -132.02 137.41 47.83 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 120.705 0.288 . . . . 0.0 110.638 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -138.07 128.34 26.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.72 -24.08 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.327 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -74.33 -1.05 19.11 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 122.0 -0.437 . . . . 0.0 112.156 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -91.22 -14.35 31.16 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 118.874 0.761 . . . . 0.0 111.441 169.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -116.07 175.02 5.73 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.644 -0.66 . . . . 0.0 109.396 175.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -92.07 101.97 14.51 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -177.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -110.18 176.71 4.95 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 120.535 0.207 . . . . 0.0 110.489 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.6 mt -110.98 134.43 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -105.75 142.47 35.43 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.3 p -116.7 133.66 55.75 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -77.18 172.63 12.94 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 120.803 0.335 . . . . 0.0 111.345 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -68.6 139.98 55.54 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -138.35 166.6 23.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.251 -0.281 . . . . 0.0 110.67 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -125.44 145.81 49.9 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 120.749 0.309 . . . . 0.0 110.544 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -149.57 141.82 24.12 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.0 m120 52.17 29.95 7.15 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.667 -0.646 . . . . 0.0 112.085 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.41 16.39 80.76 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -121.51 142.54 49.97 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 118.699 1.25 . . . . 0.0 109.666 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -93.14 131.7 37.95 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.477 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -120.85 143.73 48.74 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -86.89 151.9 22.91 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 120.763 0.316 . . . . 0.0 110.382 -169.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.74 167.18 42.01 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.99 162.76 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 122.312 -0.523 . . . . 0.0 110.488 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -112.23 137.37 50.42 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 173.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -132.47 138.33 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.2 tp -136.94 125.65 15.06 Favored Pre-proline 0 N--CA 1.497 1.925 0 CA-C-O 118.663 -0.684 . . . . 0.0 110.097 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -63.59 149.39 91.06 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 120.993 1.128 . . . . 0.0 111.395 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.1 pt -142.15 170.03 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 171.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -115.28 131.99 56.75 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 167.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.6 mt -106.26 123.48 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.5 mt -107.86 116.76 32.55 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.4 mt -129.92 121.98 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.35 -120.13 18.26 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -178.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -111.07 16.95 20.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.366 -0.491 . . . . 0.0 111.926 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -119.72 144.0 47.47 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 118.577 0.626 . . . . 0.0 110.496 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -123.1 129.72 51.82 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 120.651 0.262 . . . . 0.0 110.308 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.2 mt -125.96 143.44 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.96 138.2 44.04 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.23 -164.34 11.32 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.88 156.19 26.92 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 117.351 0.576 . . . . 0.0 110.417 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.7 mt -108.77 141.53 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 176.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.57 130.77 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.6 t -140.39 126.8 11.92 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -57.7 155.83 30.27 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 121.024 1.149 . . . . 0.0 111.883 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -63.76 -33.88 76.65 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 122.31 -0.244 . . . . 0.0 110.78 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -86.65 116.15 24.57 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.1 m -130.83 142.64 50.4 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -93.8 -50.37 5.39 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -147.8 -179.48 6.92 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.9 p -91.18 145.52 24.6 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.5 m -135.08 174.96 10.03 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 120.586 0.231 . . . . 0.0 110.562 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -107.07 27.42 9.04 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 122.458 -0.151 . . . . 0.0 110.929 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.7 mm -122.64 127.4 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.5 pt -125.43 144.05 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 110.137 -0.319 . . . . 0.0 110.137 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -114.55 130.15 56.73 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.9 mt -115.28 151.06 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -174.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.5 pt -115.74 155.72 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.48 162.02 44.2 Favored Pre-proline 0 N--CA 1.495 1.791 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.214 -176.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.21 -34.47 94.01 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.065 1.177 . . . . 0.0 111.462 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -145.03 159.07 43.53 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.348 -0.22 . . . . 0.0 110.684 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.7 pttt -63.72 103.97 0.62 Allowed 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.495 0.665 . . . . 0.0 111.23 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.46 -31.98 69.82 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.927 -0.483 . . . . 0.0 111.373 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -61.29 -34.98 76.1 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.008 -0.432 . . . . 0.0 111.211 -173.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -78.25 -49.07 14.41 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -61.89 -33.8 74.88 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.217 -172.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -108.11 9.02 28.38 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.79 50.54 18.44 Favored 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.005 -1.059 . . . . 0.0 111.85 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 44.9 mt -89.49 138.14 31.71 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.878 -0.514 . . . . 0.0 110.951 -169.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -119.52 157.24 28.74 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -55.95 138.51 48.67 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.84 -0.537 . . . . 0.0 111.474 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.53 -23.02 37.33 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.32 151.44 46.24 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 118.702 1.251 . . . . 0.0 110.03 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -110.23 133.07 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -174.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.4 pt -128.29 160.13 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -109.25 137.98 46.3 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -175.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.0 pt -110.12 137.6 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.0 tt -110.85 130.76 55.49 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 122.314 -0.241 . . . . 0.0 110.359 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 47.6 mt -115.6 120.01 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -93.56 147.55 22.89 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.15 123.04 1.24 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -154.99 33.31 0.39 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.376 -0.485 . . . . 0.0 110.372 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -135.68 133.72 38.42 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -148.11 169.65 19.53 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.353 -0.217 . . . . 0.0 110.472 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.163 -179.915 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 mtt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.4 t -70.3 -39.17 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -106.27 136.19 46.43 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.6 mt -110.94 160.11 17.1 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.2 ttt -102.37 140.9 36.03 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.3 mm -127.9 130.5 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.3 mt -129.74 148.91 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -105.53 140.14 39.08 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.85 151.1 20.31 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -105.99 141.32 37.57 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 117.229 0.515 . . . . 0.0 110.256 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.3 t -63.22 124.04 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.88 164.02 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 176.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.9 t -83.71 116.51 22.7 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.194 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.0 133.72 2.91 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.7 tt -153.55 -60.05 0.13 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 117.297 0.549 . . . . 0.0 110.262 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.27 35.11 5.24 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.21 -31.16 70.48 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 117.375 0.588 . . . . 0.0 110.649 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.55 -177.87 41.27 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -116.55 33.09 5.75 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 122.297 -0.531 . . . . 0.0 110.359 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -117.59 141.79 47.96 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.135 -0.353 . . . . 0.0 110.458 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -114.53 134.39 55.07 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 tt -89.95 -29.42 18.5 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 122.378 -0.201 . . . . 0.0 110.868 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.5 t -52.45 -23.59 6.39 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.604 -0.685 . . . . 0.0 112.439 -175.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.9 mt -66.25 157.7 80.41 Favored Pre-proline 0 N--CA 1.501 2.114 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.208 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -56.24 -55.08 3.13 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 121.159 1.239 . . . . 0.0 113.242 -174.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.93 -30.41 89.92 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 O-C-N 122.723 0.854 . . . . 0.0 111.625 -164.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -66.73 -44.47 81.49 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.309 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -65.94 -37.81 87.0 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 122.108 -0.37 . . . . 0.0 110.195 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.23 -46.85 78.98 Favored 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.592 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.2 tt -69.3 -36.09 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.043 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -65.82 -44.43 85.64 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 122.03 -0.419 . . . . 0.0 110.438 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -65.74 -31.63 72.73 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.156 -0.34 . . . . 0.0 110.758 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -68.53 -40.44 80.76 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.578 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -81.44 -36.59 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.0 mt -103.27 -26.39 12.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 122.14 -0.35 . . . . 0.0 111.693 -174.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.53 15.36 73.84 Favored Glycine 0 N--CA 1.495 2.586 0 CA-C-O 119.362 -0.688 . . . . 0.0 111.411 -173.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -151.14 162.75 40.29 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 119.145 1.473 . . . . 0.0 110.812 170.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.03 106.52 22.79 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.835 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.48 160.93 47.12 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 O-C-N 123.383 1.201 . . . . 0.0 110.269 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -73.19 160.58 31.73 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -80.23 79.6 6.78 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.479 0.657 . . . . 0.0 109.686 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.28 176.41 47.79 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 p -138.11 156.25 47.95 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 117.331 0.565 . . . . 0.0 110.813 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.6 tp -108.68 116.47 32.05 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 169.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.41 122.13 41.21 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 61.4 mt -120.31 135.59 54.96 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 120.653 0.263 . . . . 0.0 110.535 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -95.9 133.09 40.49 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.6 mt -112.31 160.22 17.88 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 120.653 0.263 . . . . 0.0 110.484 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.06 13.0 14.04 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 172.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -145.99 142.89 29.09 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 118.614 0.643 . . . . 0.0 109.557 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.34 148.63 49.91 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.503 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -131.91 137.44 47.99 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 120.701 0.286 . . . . 0.0 110.44 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -138.09 125.0 21.22 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.5 -23.62 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.266 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -74.24 -1.45 20.61 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.976 -0.453 . . . . 0.0 112.109 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.09 -14.5 31.13 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 118.929 0.786 . . . . 0.0 111.453 170.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -116.67 175.15 5.7 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 118.658 0.663 . . . . 0.0 109.343 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -91.31 102.72 15.42 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -109.44 177.35 4.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 122.323 -0.235 . . . . 0.0 110.563 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.2 mt -111.28 130.91 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -105.97 142.4 35.75 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.2 p -120.69 138.8 53.77 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 120.794 0.331 . . . . 0.0 110.743 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -76.75 172.64 12.75 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 120.847 0.356 . . . . 0.0 111.826 -168.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -67.88 141.21 56.47 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -136.67 164.91 27.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.152 -0.342 . . . . 0.0 110.598 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -123.61 145.95 48.54 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 120.732 0.301 . . . . 0.0 110.469 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -149.88 139.39 21.53 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 52.01 30.34 7.28 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.674 -0.642 . . . . 0.0 112.131 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.36 16.59 80.29 Favored Glycine 0 N--CA 1.497 2.725 0 CA-C-O 119.648 -0.529 . . . . 0.0 111.83 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -122.14 143.45 49.54 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.573 1.187 . . . . 0.0 109.614 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.21 131.41 38.33 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.463 -176.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -120.11 143.49 48.14 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -85.76 157.22 20.32 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 120.715 0.293 . . . . 0.0 110.432 -168.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.29 159.66 47.21 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.93 155.88 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 122.404 -0.468 . . . . 0.0 110.473 -174.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -114.69 138.24 50.94 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.3 t -133.88 140.04 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -177.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 tp -137.12 125.64 14.85 Favored Pre-proline 0 N--CA 1.497 1.88 0 CA-C-O 118.518 -0.753 . . . . 0.0 110.089 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.27 149.27 91.77 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.979 1.12 . . . . 0.0 111.482 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.7 pt -141.95 170.03 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 171.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -114.9 131.17 56.95 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 168.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.2 mt -105.62 124.11 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -174.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.75 116.3 31.71 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -130.01 121.95 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.99 -120.49 18.72 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -111.15 17.09 20.68 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 122.33 -0.512 . . . . 0.0 111.806 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -119.61 144.76 46.95 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 118.609 0.641 . . . . 0.0 110.492 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -123.06 131.15 53.58 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.216 -0.303 . . . . 0.0 110.28 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.79 144.87 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.75 136.57 43.65 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.58 -166.49 12.25 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.41 155.63 26.99 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 117.311 0.555 . . . . 0.0 110.304 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -108.7 141.99 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.1 t -121.43 131.35 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -142.44 136.22 14.52 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -57.28 152.32 46.66 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.1 1.2 . . . . 0.0 111.814 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -66.19 -34.85 78.96 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.394 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -93.89 125.19 38.37 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 t -140.91 154.82 46.29 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -97.64 -57.93 2.12 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -134.61 -177.91 4.83 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.2 p -95.13 150.87 19.73 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.3 m -135.06 174.64 10.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.309 -0.245 . . . . 0.0 110.419 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -107.39 27.49 9.05 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 122.37 -0.206 . . . . 0.0 110.858 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.5 mm -122.91 127.35 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.4 pt -124.95 143.79 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -114.93 129.44 56.71 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 80.9 mt -115.02 152.04 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.4 pt -117.37 155.23 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 167.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.56 165.59 24.21 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.298 -176.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -60.0 -32.04 94.39 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 121.072 1.181 . . . . 0.0 111.576 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.73 167.03 23.54 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.319 -0.238 . . . . 0.0 110.826 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -70.63 104.34 2.79 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.2 mt -59.55 -33.01 70.87 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 122.211 -0.306 . . . . 0.0 111.497 -177.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -62.44 -35.59 79.75 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 122.109 -0.369 . . . . 0.0 110.949 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -78.22 -48.52 15.62 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -62.61 -33.41 74.93 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 122.159 -0.338 . . . . 0.0 111.099 -173.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -107.95 8.33 28.39 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 51.81 45.1 28.75 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 121.096 -1.002 . . . . 0.0 111.934 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -92.67 138.22 31.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.898 -0.501 . . . . 0.0 110.867 -171.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -114.97 159.31 20.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.11 138.18 50.11 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.906 -0.496 . . . . 0.0 111.467 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.63 -22.98 37.45 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.44 156.0 33.76 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-N 118.629 1.214 . . . . 0.0 109.975 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.36 133.87 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.0 pt -128.74 160.52 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -109.75 138.19 46.47 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 pt -112.77 137.58 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.4 tt -110.19 128.76 55.66 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 36.6 mt -117.62 130.02 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -93.26 141.1 28.81 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.09 174.1 34.67 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -115.07 31.74 6.5 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.356 -0.497 . . . . 0.0 110.504 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -99.21 139.55 34.69 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 122.12 -0.362 . . . . 0.0 110.21 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -67.52 -34.37 76.97 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 120.726 0.298 . . . . 0.0 110.335 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 N--CA 1.506 2.327 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.759 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.4 mtt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p -132.17 141.1 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -101.83 132.65 47.47 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.6 mt -110.82 153.01 26.0 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.5 ttm -134.65 145.57 48.7 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.2 mm -126.47 135.46 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -175.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 78.8 mt -130.6 147.74 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -110.08 143.96 39.36 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.59 151.56 21.26 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -105.95 142.56 35.46 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 117.231 0.516 . . . . 0.0 110.278 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.5 t -64.78 122.39 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.65 149.18 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 t -86.6 111.76 20.94 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.07 126.75 1.38 Allowed Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.4 mt -99.4 30.76 3.39 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.326 -0.514 . . . . 0.0 110.677 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.89 177.34 51.49 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -68.68 -34.99 76.61 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 117.219 0.51 . . . . 0.0 109.936 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.38 -175.72 14.03 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -118.7 150.2 40.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.31 -0.523 . . . . 0.0 110.265 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -136.55 167.42 21.42 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -102.5 127.95 49.34 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 120.586 0.232 . . . . 0.0 110.451 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 23.9 mt -103.79 -29.66 10.88 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.342 -0.224 . . . . 0.0 110.94 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.4 p -60.26 -26.57 66.57 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 122.103 -0.373 . . . . 0.0 111.8 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.7 mt -64.79 155.97 80.74 Favored Pre-proline 0 N--CA 1.503 2.19 0 CA-C-O 119.158 -0.449 . . . . 0.0 110.571 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -57.66 -56.11 1.96 Allowed 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 121.159 1.239 . . . . 0.0 113.129 -172.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.59 -32.73 93.75 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 O-C-N 122.689 0.836 . . . . 0.0 111.574 -162.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -66.51 -44.38 82.7 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.291 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -65.41 -37.81 88.08 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 122.207 -0.308 . . . . 0.0 110.386 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -65.68 -47.44 75.43 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.549 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.1 tt -68.75 -36.52 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.078 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -66.07 -44.95 83.03 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 122.109 -0.369 . . . . 0.0 110.391 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -65.76 -30.71 71.4 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 122.224 -0.298 . . . . 0.0 110.797 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -68.77 -40.63 79.61 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.645 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.2 mt -81.45 -37.08 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.7 mt -104.04 -26.25 12.67 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.262 -0.274 . . . . 0.0 111.638 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.77 14.31 73.2 Favored Glycine 0 N--CA 1.494 2.554 0 CA-C-O 119.319 -0.712 . . . . 0.0 111.449 -172.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -152.43 163.46 39.49 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 119.149 1.475 . . . . 0.0 110.691 170.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -94.97 108.42 37.99 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.583 -0.722 . . . . 0.0 109.922 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -67.39 159.64 51.42 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 123.32 1.169 . . . . 0.0 110.492 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -74.0 162.55 28.92 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -80.21 79.59 6.76 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.519 0.676 . . . . 0.0 109.662 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.64 171.86 44.13 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 175.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 p -138.0 157.59 46.06 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 117.382 0.591 . . . . 0.0 110.853 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.2 tp -110.47 116.98 32.35 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -98.97 121.76 41.34 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 65.4 mt -120.49 135.98 54.9 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.72 0.295 . . . . 0.0 110.642 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -96.09 132.06 41.87 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.5 mt -110.6 160.3 16.79 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 120.64 0.257 . . . . 0.0 110.452 -176.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.28 12.85 14.89 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 172.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -145.27 140.48 27.84 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.696 -0.628 . . . . 0.0 109.39 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.33 146.94 52.46 Favored 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.626 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -132.53 137.19 47.06 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 120.724 0.297 . . . . 0.0 110.639 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -138.0 126.9 24.0 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.0 tt -64.37 -23.94 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.135 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -72.74 -3.55 25.88 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 122.006 -0.434 . . . . 0.0 112.053 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -91.12 -13.89 32.19 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 118.815 0.734 . . . . 0.0 111.51 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -114.2 175.08 5.63 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.596 0.634 . . . . 0.0 109.395 173.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -92.06 102.01 14.56 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -109.18 176.88 4.93 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 120.524 0.202 . . . . 0.0 110.574 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -111.0 129.48 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -105.94 140.91 38.21 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.5 p -117.23 134.9 54.24 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 120.721 0.296 . . . . 0.0 110.495 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -75.83 172.69 12.25 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 120.768 0.318 . . . . 0.0 111.472 -170.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -67.71 139.48 56.72 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -139.83 167.44 22.11 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.618 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -124.23 149.12 46.78 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 120.846 0.355 . . . . 0.0 110.528 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -148.24 135.62 20.5 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.82 32.89 10.34 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.739 -0.601 . . . . 0.0 112.098 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.25 16.6 79.38 Favored Glycine 0 N--CA 1.497 2.745 0 CA-C-O 119.606 -0.552 . . . . 0.0 111.907 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -121.99 142.13 50.63 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.74 1.27 . . . . 0.0 109.731 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.3 132.13 37.79 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.431 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -121.84 144.12 49.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -86.41 155.94 20.37 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.483 -168.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.76 159.15 49.13 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -139.24 156.77 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 122.353 -0.498 . . . . 0.0 110.387 -174.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -117.04 136.76 52.72 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.5 t -134.04 141.19 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.9 tp -137.35 125.63 14.57 Favored Pre-proline 0 N--CA 1.497 1.893 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.152 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.22 149.39 91.5 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 120.928 1.085 . . . . 0.0 111.475 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.7 pt -141.79 170.01 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-O 120.638 0.256 . . . . 0.0 110.312 171.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -116.18 130.58 56.86 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 167.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.8 mt -105.74 123.99 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -174.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.9 mt -107.88 117.17 33.41 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.5 mt -130.15 121.95 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.6 -120.05 17.6 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -111.16 17.11 20.65 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 122.418 -0.46 . . . . 0.0 111.78 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -119.65 143.75 47.54 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.558 0.617 . . . . 0.0 110.444 -175.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -123.12 130.0 52.19 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -125.42 145.05 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.77 136.65 43.63 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.86 -167.34 12.92 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.72 155.85 26.7 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 117.304 0.552 . . . . 0.0 110.387 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.8 mt -108.77 141.13 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.0 t -122.27 131.13 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -143.73 138.25 15.07 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.09 153.24 39.9 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 121.116 1.21 . . . . 0.0 111.842 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -65.4 -33.79 76.79 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 121.061 -0.255 . . . . 0.0 110.581 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -87.42 117.29 26.1 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 m -130.56 134.7 47.23 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -96.98 -50.24 4.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -133.41 170.02 16.09 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.7 m -94.61 153.34 17.89 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 93.6 p -135.09 173.45 11.71 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 120.739 0.304 . . . . 0.0 110.468 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -105.78 24.55 12.12 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 119.71 -0.186 . . . . 0.0 110.891 172.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.9 mm -119.85 127.43 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.9 pt -125.93 145.93 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -115.98 130.17 56.7 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.3 mt -115.18 150.83 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -174.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.2 pt -116.22 156.52 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 168.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.52 161.64 45.96 Favored Pre-proline 0 N--CA 1.495 1.806 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.298 -177.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.02 -31.39 93.42 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 121.044 1.163 . . . . 0.0 111.614 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.32 167.13 23.18 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.277 -0.264 . . . . 0.0 110.634 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -74.3 103.87 4.86 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 120.946 0.403 . . . . 0.0 110.176 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 79.0 mt -60.39 -33.25 72.21 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 122.088 -0.383 . . . . 0.0 111.314 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -61.93 -33.3 74.02 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.159 -0.338 . . . . 0.0 110.925 -175.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.24 -50.88 11.06 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -62.63 -32.52 73.56 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.158 -0.339 . . . . 0.0 111.218 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -106.64 8.07 30.94 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.78 47.51 24.65 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.06 -1.025 . . . . 0.0 111.858 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.3 mt -91.15 138.23 31.75 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.874 -0.517 . . . . 0.0 111.094 -169.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -117.55 159.86 22.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.24 138.38 50.44 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.908 -0.495 . . . . 0.0 111.445 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.55 -23.09 37.07 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -65.39 152.7 43.23 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 118.653 1.227 . . . . 0.0 110.061 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -110.81 133.1 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -174.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 33.5 pt -128.16 160.64 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -108.78 139.46 43.57 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.2 pt -110.09 137.9 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 174.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.2 tp -107.75 134.19 51.07 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -173.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 49.4 mt -125.06 125.49 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.34 149.04 21.62 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 175.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.09 131.98 3.1 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -94.08 -34.57 12.94 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.306 -0.526 . . . . 0.0 110.165 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -123.58 139.13 54.32 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -93.42 -34.34 13.48 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 120.706 0.288 . . . . 0.0 110.307 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 . . . . . 0 N--CA 1.507 2.38 0 CA-C-O 117.823 -1.084 . . . . 0.0 111.763 -179.44 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 ttm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.9 t -113.61 132.85 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -107.43 122.84 47.42 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.1 mt -110.88 143.26 41.78 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.1 ttm -144.56 146.87 32.58 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 120.681 0.276 . . . . 0.0 110.567 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.7 mm -131.26 124.55 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 78.8 mt -130.72 154.38 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -106.13 146.88 29.64 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.47 150.3 20.99 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -106.3 141.34 37.79 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.267 -0.549 . . . . 0.0 110.141 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.8 t -62.89 123.33 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.59 153.91 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.5 t -86.15 125.88 33.82 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.321 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.07 119.94 0.84 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.7 mt -130.41 131.32 45.2 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.345 -0.503 . . . . 0.0 110.259 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.42 35.72 76.42 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -68.68 -36.79 78.97 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 117.245 0.523 . . . . 0.0 109.922 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.66 -178.57 43.77 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -115.03 32.53 5.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 122.32 -0.517 . . . . 0.0 110.46 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -119.36 143.77 47.24 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.099 -0.376 . . . . 0.0 110.368 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -111.13 128.39 55.87 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.9 mt -94.84 -15.56 23.62 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.4 m -59.38 -28.7 67.12 Favored 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 118.647 0.658 . . . . 0.0 111.451 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 mp -66.77 157.79 82.37 Favored Pre-proline 0 N--CA 1.501 2.089 0 CA-C-O 119.243 -0.408 . . . . 0.0 110.369 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -56.71 -55.92 2.36 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 121.298 1.332 . . . . 0.0 113.366 -174.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.64 -32.45 96.8 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 120.533 0.822 . . . . 0.0 111.936 -162.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -66.33 -47.75 72.51 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.369 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -65.01 -41.82 95.0 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 120.896 -0.321 . . . . 0.0 110.352 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -66.43 -50.17 64.29 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.479 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.7 tt -71.16 -32.86 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.217 -175.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -65.26 -38.96 91.95 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 122.063 -0.398 . . . . 0.0 110.169 175.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -63.95 -34.15 77.34 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.272 -0.268 . . . . 0.0 110.798 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -67.32 -38.3 84.7 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.607 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 59.9 mt -81.2 -37.09 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -175.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.3 mt -101.22 -26.37 13.67 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 122.226 -0.296 . . . . 0.0 111.657 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.66 14.14 76.49 Favored Glycine 0 N--CA 1.494 2.52 0 CA-C-O 119.312 -0.716 . . . . 0.0 111.414 -173.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -152.06 161.45 42.61 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 119.117 1.459 . . . . 0.0 110.609 171.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -94.22 106.44 22.96 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-O 118.611 -0.709 . . . . 0.0 109.901 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.29 158.48 57.35 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 O-C-N 123.303 1.16 . . . . 0.0 110.314 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -73.5 160.92 30.99 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -80.28 79.62 6.83 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.531 0.681 . . . . 0.0 109.538 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.46 177.64 48.35 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 p -138.07 156.04 48.18 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 117.389 0.594 . . . . 0.0 110.931 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.8 tp -109.04 118.59 37.18 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 169.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -99.0 123.36 43.24 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.228 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.1 mt -120.71 136.08 54.96 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.688 0.28 . . . . 0.0 110.441 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -95.81 133.93 39.37 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.7 mt -112.69 160.3 18.05 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 120.62 0.247 . . . . 0.0 110.395 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.01 12.54 15.22 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 173.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -145.69 144.88 30.65 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 118.563 0.62 . . . . 0.0 109.795 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -63.97 150.35 45.34 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 122.222 -0.298 . . . . 0.0 110.477 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -131.86 139.03 48.69 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 120.69 0.281 . . . . 0.0 110.701 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -138.08 122.87 18.79 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.58 -21.13 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.441 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -75.17 -0.77 20.39 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -89.41 -14.47 35.41 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.991 0.814 . . . . 0.0 111.438 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -119.69 175.19 5.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.624 -0.672 . . . . 0.0 109.531 173.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -91.06 103.45 16.15 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -107.27 177.29 4.89 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 122.336 -0.228 . . . . 0.0 110.463 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.0 mt -109.99 131.95 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.99 143.27 34.36 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.0 p -116.07 133.77 55.67 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -76.69 172.58 12.82 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 120.643 0.258 . . . . 0.0 111.316 -172.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -68.42 139.66 55.77 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -142.85 166.58 24.24 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.668 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -122.87 147.31 46.72 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 120.742 0.306 . . . . 0.0 110.525 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -149.65 138.96 21.39 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.9 m120 52.03 30.26 7.23 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.66 -0.65 . . . . 0.0 112.128 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.61 16.21 80.47 Favored Glycine 0 N--CA 1.496 2.697 0 CA-C-O 119.607 -0.552 . . . . 0.0 111.851 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -121.89 143.94 49.14 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 118.685 1.242 . . . . 0.0 109.717 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -93.5 131.72 38.46 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.488 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -121.32 143.82 48.97 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -87.15 155.19 20.21 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.792 0.329 . . . . 0.0 110.378 -170.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.13 160.99 48.16 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.1 m -141.99 160.79 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 122.32 -0.518 . . . . 0.0 110.367 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -116.13 136.76 52.73 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.5 t -132.69 139.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.0 tp -138.3 125.66 13.51 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.136 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -62.68 149.16 92.09 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 O-C-N 123.189 1.099 . . . . 0.0 111.613 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.6 pt -142.16 170.13 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 172.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -118.32 130.29 55.94 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 168.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.38 129.05 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -173.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.7 mt -107.43 117.62 34.58 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 71.7 mt -129.56 121.87 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.68 -119.95 17.15 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -111.08 16.97 20.83 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.412 -0.464 . . . . 0.0 111.872 176.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -120.4 146.13 46.5 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 118.522 0.601 . . . . 0.0 110.521 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -123.13 130.62 53.01 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -125.89 147.57 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.6 139.75 45.73 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -150.3 -165.85 12.98 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.38 155.45 26.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.28 -0.541 . . . . 0.0 110.182 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.5 mt -108.71 141.36 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.05 130.6 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.4 t -142.18 133.92 13.32 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -57.86 153.24 45.08 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 121.046 1.164 . . . . 0.0 111.801 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -65.5 -34.52 78.46 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.587 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -86.78 121.32 29.11 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.3 t -142.98 156.64 44.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.296 -0.253 . . . . 0.0 110.389 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -97.54 -59.95 1.67 Allowed 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -136.3 -172.19 3.08 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.3 p -93.05 149.45 21.21 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.7 m -134.9 173.08 12.11 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 120.576 0.226 . . . . 0.0 110.427 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -107.7 27.18 9.44 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.423 -0.173 . . . . 0.0 110.865 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -122.33 127.84 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.6 pt -124.59 143.71 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -115.04 128.71 56.42 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.2 mt -115.01 152.49 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -173.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.6 pt -116.49 156.0 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 168.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.6 163.88 33.79 Favored Pre-proline 0 N--CA 1.496 1.85 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.249 -176.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.02 -32.56 95.08 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.163 1.242 . . . . 0.0 111.572 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -145.01 167.01 23.68 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.275 -0.266 . . . . 0.0 110.994 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -69.5 103.95 2.19 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.632 0.73 . . . . 0.0 110.465 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.4 mt -60.26 -33.0 71.7 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.664 -0.647 . . . . 0.0 111.641 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -61.48 -37.84 85.09 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 122.054 -0.404 . . . . 0.0 111.296 -171.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -78.35 -45.82 21.58 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.36 -34.15 76.11 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.16 -0.337 . . . . 0.0 111.007 -173.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -108.18 8.27 27.89 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.75 48.06 23.57 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.204 -0.935 . . . . 0.0 111.888 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.4 mt -92.11 138.18 31.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.912 -0.493 . . . . 0.0 110.891 -171.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -117.21 156.19 28.13 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.66 138.02 48.14 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.941 -0.474 . . . . 0.0 111.542 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.97 -22.94 37.42 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.41 152.8 43.02 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-N 118.643 1.222 . . . . 0.0 110.019 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -112.77 134.03 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.3 pt -130.29 165.11 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -107.89 139.86 41.86 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.1 pt -117.04 138.76 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 12.9 mt -99.03 141.34 31.91 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.0 mt -129.98 124.09 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -147.09 155.08 41.89 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.06 122.94 1.23 Allowed Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -155.07 78.86 1.05 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 122.282 -0.54 . . . . 0.0 110.315 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -95.03 -44.88 7.48 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.01 -0.431 . . . . 0.0 110.167 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -67.34 -34.88 78.25 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.193 179.806 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.1 mtm . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.299 0.571 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.52 135.82 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -98.13 124.03 42.47 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.7 mt -110.86 150.14 29.59 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.8 ttm -105.47 142.89 34.44 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.0 mm -128.56 132.18 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.9 mt -129.67 148.75 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 176.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -105.7 140.04 39.36 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.43 150.14 20.17 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -105.93 141.68 36.92 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 117.21 0.505 . . . . 0.0 110.221 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.9 t -63.15 122.61 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.23 162.21 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.1 t -84.88 130.87 34.59 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.99 119.94 0.84 Allowed Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.5 tt -155.11 -45.69 0.08 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 117.081 0.44 . . . . 0.0 110.149 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.35 -29.05 73.38 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -62.76 -30.5 71.5 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-N 117.766 0.783 . . . . 0.0 110.879 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.85 129.97 24.75 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 -117.25 32.6 6.07 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 122.317 -0.52 . . . . 0.0 110.772 -175.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -129.53 153.04 48.41 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.13 -0.356 . . . . 0.0 110.406 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -108.04 120.34 42.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.1 mt -77.63 -27.35 51.08 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.151 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.3 m -57.1 -24.7 55.89 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.859 -0.525 . . . . 0.0 112.029 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.4 tp -63.91 138.92 97.54 Favored Pre-proline 0 N--CA 1.504 2.255 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.273 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -53.48 -49.61 16.76 Favored 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 121.011 1.141 . . . . 0.0 113.748 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.54 -39.11 92.9 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 120.575 0.85 . . . . 0.0 112.257 -169.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -65.41 -43.05 91.8 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 122.227 -0.295 . . . . 0.0 110.691 -175.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -65.43 -40.05 92.83 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 122.085 -0.384 . . . . 0.0 110.262 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -65.33 -46.2 81.21 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.553 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.1 tt -69.92 -34.49 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -176.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -65.5 -44.28 87.52 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 122.08 -0.387 . . . . 0.0 110.347 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -65.86 -30.89 71.57 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.736 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -68.69 -40.58 79.97 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.67 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mt -81.39 -36.86 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.5 mt -103.96 -26.29 12.69 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.213 -0.304 . . . . 0.0 111.678 -174.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.49 14.76 72.91 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-O 119.304 -0.72 . . . . 0.0 111.436 -172.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -151.9 162.18 41.47 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 119.155 1.478 . . . . 0.0 110.659 170.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -94.84 108.61 38.84 Favored Pre-proline 0 N--CA 1.497 1.878 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.894 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -67.33 158.54 56.5 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 O-C-N 123.238 1.125 . . . . 0.0 110.55 -176.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -73.81 162.43 29.13 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -80.22 79.67 6.76 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.378 0.609 . . . . 0.0 109.764 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.16 178.94 48.63 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 175.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -137.96 154.37 49.38 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 117.266 0.533 . . . . 0.0 110.801 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.0 tp -109.61 115.47 29.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 168.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -99.66 122.77 43.16 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -175.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.7 mt -120.57 136.26 54.85 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.716 0.293 . . . . 0.0 110.487 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -95.94 132.91 40.76 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.9 mt -112.16 160.28 17.73 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 120.63 0.253 . . . . 0.0 110.508 -175.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.01 12.89 14.25 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 172.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -145.74 142.0 28.53 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 118.594 0.634 . . . . 0.0 109.573 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.04 147.3 51.12 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 122.235 -0.29 . . . . 0.0 110.697 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -131.81 135.87 47.07 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 120.781 0.324 . . . . 0.0 110.675 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -138.06 127.41 24.66 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 173.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.16 -23.49 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.329 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -74.39 -1.08 19.44 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.944 -0.473 . . . . 0.0 112.184 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -91.12 -14.44 31.17 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 118.913 0.779 . . . . 0.0 111.511 170.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -116.28 175.11 5.7 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.593 0.633 . . . . 0.0 109.373 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -91.51 102.14 14.8 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -109.73 179.23 4.18 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 120.526 0.203 . . . . 0.0 110.591 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.5 mt -110.98 132.14 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -105.92 143.56 33.89 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 36.4 p -124.56 135.04 52.83 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 120.83 0.348 . . . . 0.0 110.667 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.88 172.69 12.73 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 120.825 0.345 . . . . 0.0 111.768 -169.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -68.05 141.14 56.27 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -137.52 166.59 23.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 122.195 -0.315 . . . . 0.0 110.656 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -125.78 149.17 48.79 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 120.861 0.362 . . . . 0.0 110.591 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -148.86 135.01 19.22 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 52.17 33.44 12.37 Favored 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.719 -0.613 . . . . 0.0 111.895 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.73 16.25 80.31 Favored Glycine 0 N--CA 1.497 2.709 0 CA-C-O 119.613 -0.548 . . . . 0.0 111.877 176.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -119.94 139.56 52.26 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 118.723 1.262 . . . . 0.0 109.704 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.41 131.82 38.24 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 120.671 0.272 . . . . 0.0 110.416 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -120.21 143.2 48.39 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -86.08 155.05 20.97 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.774 0.321 . . . . 0.0 110.541 -167.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.07 157.29 51.51 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -138.52 159.21 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 122.258 -0.554 . . . . 0.0 110.404 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -117.08 135.84 53.43 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.8 t -132.2 139.61 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -176.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.3 tp -136.45 125.64 15.61 Favored Pre-proline 0 N--CA 1.496 1.871 0 CA-C-O 118.579 -0.725 . . . . 0.0 110.004 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.45 149.15 91.87 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 O-C-N 123.172 1.091 . . . . 0.0 111.426 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.3 pt -141.9 169.85 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 171.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -114.98 131.33 56.95 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 168.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.6 mt -105.32 123.2 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -175.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.1 mt -107.5 115.89 30.97 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.7 mt -130.02 121.95 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.12 -120.59 18.77 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -111.14 17.02 20.75 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.344 -0.503 . . . . 0.0 111.888 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -119.77 145.16 46.83 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 118.586 0.63 . . . . 0.0 110.552 -175.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -123.08 129.5 51.55 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 120.741 0.305 . . . . 0.0 110.295 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.3 mt -125.65 143.4 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.04 137.46 43.41 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.1 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.27 -165.15 11.6 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.46 154.9 25.62 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 117.429 0.615 . . . . 0.0 110.507 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.6 mt -108.7 141.74 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.97 132.49 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -175.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.1 t -145.05 137.05 13.06 Favored Pre-proline 0 N--CA 1.498 1.959 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -58.41 154.59 40.48 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 121.072 1.182 . . . . 0.0 111.687 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -65.17 -34.17 77.74 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.805 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -85.15 116.96 23.81 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.305 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.7 m -131.68 139.57 49.09 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -94.62 -49.61 5.56 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -137.68 172.44 12.95 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -89.22 146.78 24.53 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.0 m -135.03 169.89 16.74 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 120.615 0.245 . . . . 0.0 110.607 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -106.96 27.63 8.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.438 -0.164 . . . . 0.0 110.795 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.5 mm -121.79 126.75 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.0 pt -124.06 143.86 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -115.15 130.88 57.04 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.7 mt -116.11 151.5 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -173.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.4 pt -116.59 153.52 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 167.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.53 164.64 29.51 Favored Pre-proline 0 N--CA 1.495 1.807 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.234 -176.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.21 -31.94 93.74 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.042 1.162 . . . . 0.0 111.584 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.59 167.1 23.34 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.29 -0.256 . . . . 0.0 110.716 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -70.8 104.45 2.9 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.9 mt -59.58 -33.13 71.06 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 122.022 -0.424 . . . . 0.0 111.511 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -62.62 -35.37 79.36 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 122.119 -0.363 . . . . 0.0 110.964 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -78.25 -48.31 16.03 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.43 -33.24 74.4 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 122.163 -0.335 . . . . 0.0 111.074 -173.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -107.99 7.83 28.07 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.88 45.8 27.63 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.025 -1.047 . . . . 0.0 111.876 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.3 mt -92.34 138.21 31.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.862 -0.524 . . . . 0.0 110.93 -171.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -114.79 157.54 23.1 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -55.87 137.94 49.32 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.919 -0.488 . . . . 0.0 111.535 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.95 -22.99 37.23 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -177.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -65.44 156.11 33.42 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 118.621 1.21 . . . . 0.0 110.004 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.6 t -112.36 134.07 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.4 pt -128.98 160.59 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -109.78 138.08 46.66 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -175.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.1 pt -112.12 137.57 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.8 tt -110.79 131.69 54.83 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.2 mt -120.47 130.51 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -92.47 153.99 18.77 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.03 178.12 33.58 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -99.72 134.85 42.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 122.276 -0.544 . . . . 0.0 110.265 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -68.28 -45.98 71.64 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -67.52 -34.44 77.12 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 120.731 0.3 . . . . 0.0 110.338 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 . . . . . 0 N--CA 1.506 2.367 0 CA-C-O 118.053 -0.975 . . . . 0.0 111.732 -178.998 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p -133.04 145.26 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -94.52 123.77 38.15 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.5 mt -110.84 152.92 26.11 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 9.3 tpt -125.91 145.68 50.16 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.4 mm -128.34 135.35 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -175.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 78.0 mt -130.59 147.61 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 171.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -110.23 143.81 39.83 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.318 -0.239 . . . . 0.0 110.405 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.75 152.45 21.7 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -105.8 140.7 38.44 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 117.242 0.521 . . . . 0.0 110.35 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.0 t -63.43 122.49 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.75 137.24 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 173.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.6 p -86.87 101.74 13.67 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.17 173.13 44.17 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.2 mt -121.57 156.8 32.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 122.302 -0.528 . . . . 0.0 109.859 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.43 -40.03 94.3 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -172.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -163.53 100.5 0.92 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 117.417 0.608 . . . . 0.0 110.385 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.88 -139.89 35.44 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -140.96 145.79 36.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.379 -0.483 . . . . 0.0 110.522 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -144.74 161.31 39.55 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -106.48 130.53 54.26 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 120.576 0.226 . . . . 0.0 110.629 -175.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.2 mt -95.39 -27.73 15.29 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 122.364 -0.21 . . . . 0.0 111.059 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.1 p -60.13 -22.37 62.74 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 122.029 -0.419 . . . . 0.0 112.043 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.5 mt -61.92 155.12 64.64 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 121.832 -0.542 . . . . 0.0 110.771 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -56.21 -54.46 3.95 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 121.099 1.199 . . . . 0.0 113.32 -172.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -62.22 -40.99 37.44 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 O-C-N 122.72 0.853 . . . . 0.0 111.197 -166.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -65.8 -44.55 85.34 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.517 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -66.11 -41.63 90.34 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 122.134 -0.354 . . . . 0.0 110.413 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.88 -50.01 63.82 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.345 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.7 tt -69.11 -34.27 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.01 -175.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -65.09 -41.85 94.61 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 122.039 -0.413 . . . . 0.0 110.319 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -65.49 -32.79 74.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 122.194 -0.316 . . . . 0.0 110.731 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -67.95 -38.31 82.65 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.671 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.9 mt -80.76 -39.08 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.3 mt -99.55 -26.28 14.15 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 122.263 -0.273 . . . . 0.0 111.541 -174.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.65 14.2 76.36 Favored Glycine 0 N--CA 1.496 2.646 0 CA-C-O 119.363 -0.687 . . . . 0.0 111.428 -174.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -152.05 163.37 39.45 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 119.082 1.441 . . . . 0.0 110.709 171.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -95.44 109.59 46.18 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.744 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.53 163.38 35.08 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 123.288 1.151 . . . . 0.0 110.601 -175.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -74.28 163.16 28.15 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -80.36 79.64 6.92 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.463 0.649 . . . . 0.0 109.858 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.5 172.8 44.03 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 174.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -136.51 156.08 49.09 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 117.285 0.542 . . . . 0.0 110.562 173.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.3 tp -108.88 116.41 31.94 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 172.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.31 122.88 42.02 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 59.0 mt -120.04 135.84 54.79 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 120.75 0.31 . . . . 0.0 110.554 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -95.47 132.34 40.65 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.8 mt -111.95 160.25 17.62 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 120.683 0.278 . . . . 0.0 110.4 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.31 13.17 14.13 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 172.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -145.25 140.38 27.8 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 118.568 0.622 . . . . 0.0 109.479 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.27 146.91 52.44 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 122.254 -0.279 . . . . 0.0 110.679 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -132.0 136.75 47.52 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 120.706 0.289 . . . . 0.0 110.584 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -138.06 125.99 22.62 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.57 -23.92 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.341 -177.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -74.22 -0.93 18.4 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.51 -14.13 33.29 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 118.908 0.776 . . . . 0.0 111.457 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -115.84 175.07 5.7 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 118.613 0.642 . . . . 0.0 109.454 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -92.46 103.46 15.88 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -109.85 176.2 5.16 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 120.512 0.196 . . . . 0.0 110.499 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.3 mt -110.25 129.7 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 175.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -105.9 147.4 28.79 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.2 p -125.24 134.96 52.13 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 120.778 0.323 . . . . 0.0 110.768 175.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -75.14 172.72 11.87 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 120.757 0.313 . . . . 0.0 111.707 -170.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -66.99 139.55 57.69 Favored 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -140.63 166.78 23.79 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 122.215 -0.303 . . . . 0.0 110.633 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -124.45 149.06 47.2 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 120.8 0.333 . . . . 0.0 110.559 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -149.09 135.13 19.05 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 52.15 33.96 13.34 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.705 -0.622 . . . . 0.0 111.881 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.82 15.97 80.59 Favored Glycine 0 N--CA 1.497 2.737 0 CA-C-O 119.589 -0.562 . . . . 0.0 111.875 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -121.19 140.97 51.29 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 118.768 1.284 . . . . 0.0 109.717 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -92.87 130.81 38.35 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.368 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -120.14 143.52 48.14 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -85.96 156.18 20.58 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.307 -169.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.44 157.23 50.12 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -138.88 157.93 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 122.448 -0.443 . . . . 0.0 110.456 -174.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -120.52 137.94 54.11 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.4 t -133.98 141.81 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -176.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.4 tp -137.49 125.7 14.46 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.164 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.24 149.59 90.91 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 120.961 1.107 . . . . 0.0 111.496 177.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.7 pt -141.76 170.15 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 171.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -116.44 129.8 56.42 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 168.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.53 125.39 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 86.5 mt -107.87 116.59 32.24 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.9 mt -129.83 122.02 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.03 -120.54 18.82 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -111.09 17.02 20.8 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 122.29 -0.535 . . . . 0.0 111.988 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -119.89 145.82 46.34 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 118.449 0.568 . . . . 0.0 110.513 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -122.96 130.82 53.31 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.42 145.81 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.51 136.92 44.15 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.05 -167.34 12.99 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 177.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.69 155.08 25.43 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 117.35 0.575 . . . . 0.0 110.363 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.0 mt -108.72 142.62 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.7 t -121.48 131.48 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.7 t -142.53 136.66 14.75 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -58.01 154.97 35.86 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 121.077 1.184 . . . . 0.0 111.81 176.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -65.6 -37.41 86.54 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.317 -0.239 . . . . 0.0 110.43 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -94.64 120.59 35.11 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.0 p -130.22 155.07 46.87 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -98.07 -57.86 2.12 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -136.6 170.87 15.36 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.4 p -85.68 148.22 25.99 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.1 m -135.01 175.01 9.97 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 120.57 0.224 . . . . 0.0 110.489 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -107.4 27.93 8.61 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 122.415 -0.178 . . . . 0.0 110.851 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.0 mm -123.4 126.7 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.3 pt -125.64 145.77 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -114.6 131.68 56.61 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.9 mt -117.56 149.31 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 pt -119.13 155.33 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 168.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.56 165.98 22.15 Favored Pre-proline 0 N--CA 1.496 1.846 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.246 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -59.14 -30.34 92.87 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 121.151 1.234 . . . . 0.0 111.716 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.23 167.06 23.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 122.248 -0.282 . . . . 0.0 110.732 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -71.15 105.96 3.59 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.61 -33.4 71.44 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 122.067 -0.396 . . . . 0.0 111.402 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -62.65 -35.34 79.31 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 122.182 -0.324 . . . . 0.0 110.954 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -78.18 -48.07 16.67 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -62.61 -33.64 75.4 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.193 -0.317 . . . . 0.0 111.063 -172.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -108.01 8.15 28.18 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.81 46.03 27.24 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 120.979 -1.076 . . . . 0.0 111.819 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.9 mt -91.98 138.22 31.72 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.89 -0.506 . . . . 0.0 110.961 -171.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -114.92 157.49 23.29 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.72 137.77 48.92 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.888 -0.508 . . . . 0.0 111.491 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.92 -22.88 37.73 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -178.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.44 157.42 29.49 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 118.645 1.222 . . . . 0.0 109.952 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.3 t -112.19 133.17 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -174.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 33.8 pt -128.51 160.59 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -109.06 139.65 43.66 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.302 -175.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.1 pt -109.87 138.44 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.5 tp -108.01 135.56 49.17 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -172.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 52.1 mt -125.5 122.89 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -93.93 147.88 22.68 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.1 172.41 34.61 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -155.06 173.14 16.99 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 122.355 -0.497 . . . . 0.0 110.353 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -65.01 139.08 58.72 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.674 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -94.39 117.74 30.57 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 N--CA 1.505 2.296 0 CA-C-O 117.912 -1.042 . . . . 0.0 111.707 -179.617 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.7 mtm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.7 t -70.23 -38.9 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -127.14 118.21 23.9 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.7 mt -110.86 155.01 23.21 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.41 ' HB2' ' HE3' ' A' ' 5' ' ' MET . 43.0 ttm -136.2 145.15 45.39 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.7 mm -126.09 134.35 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -176.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 78.6 mt -130.76 148.31 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -110.78 144.76 39.27 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.5 151.15 21.42 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -106.77 141.85 37.35 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 117.217 0.508 . . . . 0.0 110.263 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.3 121.16 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.75 148.49 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 177.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.4 p -87.08 130.92 34.29 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.05 119.84 0.83 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.1 mt -139.96 33.28 1.96 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 117.205 0.503 . . . . 0.0 110.29 178.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.6 52.49 0.64 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -99.77 32.48 2.86 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 117.179 0.489 . . . . 0.0 110.515 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.21 -139.99 23.25 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -100.94 128.66 46.88 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 117.215 0.507 . . . . 0.0 110.138 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -155.0 98.56 2.04 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -108.68 128.9 55.26 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.3 mt -100.93 -20.88 15.26 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.7 p -57.51 -23.32 49.5 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.722 -0.611 . . . . 0.0 111.702 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.9 tp -65.51 139.44 97.22 Favored Pre-proline 0 N--CA 1.504 2.253 0 CA-C-O 118.735 -0.65 . . . . 0.0 109.908 174.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -51.25 -54.29 5.67 Favored 'Trans proline' 0 N--CA 1.502 2.019 0 C-N-CA 121.188 1.259 . . . . 0.0 114.155 -175.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.81 -25.94 71.4 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 120.48 0.786 . . . . 0.0 112.303 -163.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -66.31 -47.38 73.75 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.275 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -65.68 -35.57 81.14 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 122.11 -0.369 . . . . 0.0 110.169 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -65.84 -48.3 72.08 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 120.961 -0.295 . . . . 0.0 110.469 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.2 tt -69.06 -36.91 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 C-N-CA 120.64 -0.424 . . . . 0.0 109.936 -176.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -65.65 -42.04 91.86 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 122.18 -0.325 . . . . 0.0 110.479 177.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -65.7 -32.63 74.29 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 122.219 -0.301 . . . . 0.0 110.785 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -68.89 -40.25 79.3 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.641 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.0 mt -81.66 -36.37 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.4 mt -104.0 -26.35 12.65 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.197 -0.314 . . . . 0.0 111.622 -173.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.02 15.15 73.22 Favored Glycine 0 N--CA 1.495 2.599 0 CA-C-O 119.371 -0.683 . . . . 0.0 111.459 -172.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -151.42 161.43 42.7 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 119.143 1.472 . . . . 0.0 110.765 170.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -94.15 107.88 31.81 Favored Pre-proline 0 N--CA 1.496 1.865 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.834 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.53 158.16 58.39 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 O-C-N 123.272 1.143 . . . . 0.0 110.403 -176.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -74.07 162.95 28.48 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -80.14 79.63 6.67 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.429 0.633 . . . . 0.0 109.732 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.66 172.1 44.39 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 175.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 p -138.01 156.51 47.74 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 117.391 0.596 . . . . 0.0 110.85 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.9 tp -109.4 117.29 33.65 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.98 122.24 41.98 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -176.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 61.2 mt -120.58 135.79 54.99 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 120.75 0.31 . . . . 0.0 110.617 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -95.97 133.55 40.04 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.6 mt -112.05 160.3 17.63 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 120.633 0.254 . . . . 0.0 110.544 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.61 13.56 13.74 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 171.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -145.44 139.38 26.85 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 118.552 0.614 . . . . 0.0 109.63 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -62.16 147.24 48.27 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 122.115 -0.366 . . . . 0.0 110.901 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -131.95 136.51 47.4 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 120.766 0.317 . . . . 0.0 110.45 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -137.96 125.6 22.24 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.89 -24.73 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.219 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -73.53 -1.83 20.2 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -91.33 -14.04 31.48 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 118.787 0.721 . . . . 0.0 111.484 169.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -114.5 175.13 5.62 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.614 -0.679 . . . . 0.0 109.315 174.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -92.49 101.99 14.44 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -110.54 177.39 4.7 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 120.638 0.256 . . . . 0.0 110.672 -177.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.6 mt -112.09 132.88 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -105.9 143.87 33.43 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.3 p -121.95 136.44 54.92 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 120.624 0.25 . . . . 0.0 110.679 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.55 172.72 12.52 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 120.786 0.327 . . . . 0.0 111.642 -170.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -67.97 140.16 56.39 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -138.6 163.57 31.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.218 -0.301 . . . . 0.0 110.758 -175.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -123.66 147.47 47.37 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 122.281 -0.262 . . . . 0.0 110.401 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -149.77 136.92 19.7 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.7 32.2 9.04 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.82 -0.55 . . . . 0.0 112.162 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.22 17.59 77.82 Favored Glycine 0 N--CA 1.497 2.727 0 CA-C-O 119.614 -0.548 . . . . 0.0 111.823 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -123.08 140.95 52.49 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.577 1.188 . . . . 0.0 109.803 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.86 132.56 38.16 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 120.618 0.247 . . . . 0.0 110.421 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.22 142.7 49.66 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -86.29 157.81 19.83 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 120.737 0.303 . . . . 0.0 110.336 -169.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.5 157.49 50.02 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -139.51 157.13 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 122.388 -0.478 . . . . 0.0 110.488 -174.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -114.22 138.42 50.5 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.6 t -133.63 139.05 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.4 tp -137.09 125.6 14.85 Favored Pre-proline 0 N--CA 1.497 1.887 0 CA-C-O 118.533 -0.746 . . . . 0.0 110.125 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -63.39 149.63 90.67 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 O-C-N 123.158 1.083 . . . . 0.0 111.457 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.5 pt -141.9 170.01 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 122.286 -0.259 . . . . 0.0 110.38 171.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -115.31 130.03 56.78 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 168.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.68 124.17 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.3 mt -107.99 116.82 32.66 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.5 mt -129.93 121.93 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.76 -120.23 18.09 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -111.18 17.1 20.64 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 122.354 -0.498 . . . . 0.0 111.806 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -119.76 144.62 47.18 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 118.604 0.638 . . . . 0.0 110.497 -175.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -123.12 129.91 52.08 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -125.75 146.09 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.59 136.24 43.95 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.74 -168.2 13.02 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.56 154.98 25.54 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 117.307 0.553 . . . . 0.0 110.369 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -108.71 141.53 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.42 130.83 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -141.6 134.37 14.1 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -57.33 154.81 32.96 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 121.055 1.17 . . . . 0.0 111.91 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -64.85 -34.5 78.52 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.688 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -86.71 117.75 25.67 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 m -132.76 139.86 47.78 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -96.23 -57.54 2.31 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -132.6 -176.78 4.21 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.2 p -93.54 150.03 20.76 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.3 m -135.06 170.09 16.44 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.652 0.263 . . . . 0.0 110.294 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -107.82 27.72 8.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.363 -0.211 . . . . 0.0 110.875 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -123.9 127.87 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 27.7 pt -126.19 145.35 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 177.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -114.94 130.61 56.96 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.5 mt -115.7 150.98 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -174.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.2 pt -116.47 155.64 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 168.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.49 164.92 27.93 Favored Pre-proline 0 N--CA 1.496 1.83 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.315 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.57 -30.75 93.15 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.071 1.181 . . . . 0.0 111.653 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.43 167.06 23.39 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.322 -0.236 . . . . 0.0 110.773 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -71.29 105.22 3.4 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 120.875 0.369 . . . . 0.0 110.042 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.45 -33.58 71.45 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.043 -0.41 . . . . 0.0 111.535 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -62.96 -35.34 79.82 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 122.11 -0.369 . . . . 0.0 110.929 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -78.3 -47.94 16.75 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -62.54 -34.15 76.36 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 122.221 -0.299 . . . . 0.0 111.028 -172.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -108.1 8.49 28.17 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 51.83 47.23 25.19 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.148 -0.97 . . . . 0.0 111.849 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.9 mt -92.09 138.14 31.78 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.917 -0.49 . . . . 0.0 111.036 -170.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -115.67 158.95 22.0 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -56.06 138.17 49.86 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.893 -0.504 . . . . 0.0 111.506 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.58 -22.95 37.6 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.4 154.93 37.02 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 118.597 1.198 . . . . 0.0 110.026 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.6 t -112.05 133.94 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.8 pt -128.82 160.35 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -109.2 140.3 42.99 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.237 -175.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.0 pt -111.84 138.1 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.2 tp -109.03 132.78 53.78 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 48.2 mt -125.75 130.86 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -93.09 155.09 17.72 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -156.95 123.04 1.24 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -141.41 129.31 21.83 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 122.378 -0.484 . . . . 0.0 109.844 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -66.61 -37.74 85.51 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.621 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -67.42 -35.34 79.07 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.285 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.116 179.728 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptp . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.5 t -116.38 135.65 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -127.95 132.24 49.25 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 81.8 mt -110.84 147.51 34.38 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -110.0 141.0 43.4 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.2 mm -126.19 135.59 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 70.3 mt -128.16 147.73 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -106.01 138.56 41.98 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.248 -0.283 . . . . 0.0 110.276 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.34 149.09 19.72 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -106.58 142.16 36.69 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 117.237 0.519 . . . . 0.0 110.226 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.19 122.49 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.97 151.27 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.5 p -86.27 135.18 33.65 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.11 119.91 0.84 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.9 tp -155.11 -46.84 0.08 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.333 -0.51 . . . . 0.0 110.399 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.8 -33.11 86.36 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -92.44 135.17 34.27 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 117.344 0.572 . . . . 0.0 109.741 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.48 70.02 1.31 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -176.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -85.49 135.41 33.85 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 122.305 -0.526 . . . . 0.0 110.437 -174.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -155.02 159.21 40.15 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -114.81 127.51 55.76 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.309 -0.244 . . . . 0.0 110.437 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.2 mt -99.84 -25.59 14.3 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 122.368 -0.208 . . . . 0.0 111.296 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.5 p -57.84 -20.22 34.68 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.924 -0.485 . . . . 0.0 112.244 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.6 tp -63.1 138.69 97.4 Favored Pre-proline 0 N--CA 1.504 2.274 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.256 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -52.8 -48.83 19.98 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 121.099 1.199 . . . . 0.0 113.829 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.71 -37.26 95.68 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 120.653 0.902 . . . . 0.0 112.232 -171.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -65.84 -43.35 88.76 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 122.201 -0.312 . . . . 0.0 110.573 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -66.11 -38.73 88.94 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 122.057 -0.402 . . . . 0.0 110.186 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -65.65 -45.83 81.49 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 122.204 -0.31 . . . . 0.0 110.578 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.1 tt -68.91 -34.77 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -177.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -65.87 -44.67 84.7 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 122.121 -0.362 . . . . 0.0 110.384 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -65.57 -31.79 73.03 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 122.225 -0.297 . . . . 0.0 110.791 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -68.72 -40.16 80.08 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.586 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.1 mt -81.65 -36.64 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.5 mt -103.91 -26.22 12.74 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.255 -0.278 . . . . 0.0 111.609 -174.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.08 15.46 72.25 Favored Glycine 0 N--CA 1.495 2.595 0 CA-C-O 119.312 -0.715 . . . . 0.0 111.415 -172.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -151.28 160.84 43.59 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.169 1.484 . . . . 0.0 110.751 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -93.53 108.16 31.9 Favored Pre-proline 0 N--CA 1.496 1.857 0 CA-C-O 118.629 -0.701 . . . . 0.0 109.747 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.08 158.2 58.0 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 O-C-N 123.237 1.124 . . . . 0.0 110.534 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -73.6 163.41 28.04 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.29 79.56 6.86 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.541 0.686 . . . . 0.0 109.607 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.39 171.22 43.02 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -138.01 158.46 44.27 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 117.441 0.62 . . . . 0.0 110.818 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.8 tp -109.1 116.01 31.14 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 170.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.26 121.58 40.37 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.5 mt -120.67 136.81 54.74 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.703 0.287 . . . . 0.0 110.639 -177.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -96.03 131.91 41.93 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.6 mt -110.7 160.25 16.88 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 120.603 0.239 . . . . 0.0 110.472 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.11 13.1 13.91 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 172.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -145.63 141.69 28.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.712 -0.618 . . . . 0.0 109.542 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -64.11 147.04 53.15 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.196 -0.315 . . . . 0.0 110.497 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -131.83 135.67 46.91 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 120.749 0.309 . . . . 0.0 110.543 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -138.04 125.39 21.83 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.3 tt -63.52 -23.13 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.397 -176.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -73.33 -2.85 23.75 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 122.014 -0.429 . . . . 0.0 112.079 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -90.56 -13.93 33.56 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.878 0.763 . . . . 0.0 111.462 171.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -114.75 175.02 5.67 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 118.579 0.627 . . . . 0.0 109.338 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -92.54 101.98 14.42 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -109.32 176.39 5.1 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 120.563 0.221 . . . . 0.0 110.538 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -110.8 131.57 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -105.89 142.89 34.83 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.5 p -121.42 138.68 54.17 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.808 0.337 . . . . 0.0 110.688 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -76.79 172.71 12.65 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 120.858 0.361 . . . . 0.0 111.762 -168.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -67.96 141.22 56.37 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -135.95 167.13 21.79 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.557 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -125.75 149.01 48.9 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.888 0.375 . . . . 0.0 110.6 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -148.86 135.75 19.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 51.96 32.83 10.63 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.69 -0.631 . . . . 0.0 112.114 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.06 17.0 79.04 Favored Glycine 0 N--CA 1.496 2.682 0 CA-C-O 119.635 -0.536 . . . . 0.0 111.846 176.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -121.75 140.62 52.11 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 118.6 1.2 . . . . 0.0 109.699 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -93.57 131.97 38.32 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.393 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -121.25 145.33 47.97 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -85.72 156.61 20.56 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.808 0.337 . . . . 0.0 110.448 -167.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.42 162.93 43.49 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.61 155.52 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 122.4 -0.471 . . . . 0.0 110.38 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -114.43 137.29 52.02 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.2 t -134.0 140.93 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.1 tp -136.84 125.62 15.15 Favored Pre-proline 0 N--CA 1.496 1.86 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.108 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -63.39 149.75 90.35 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 120.971 1.114 . . . . 0.0 111.441 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.5 pt -141.88 170.0 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 120.712 0.291 . . . . 0.0 110.317 171.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -113.95 131.87 56.16 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 167.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.0 mt -106.64 123.17 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -175.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.7 mt -107.94 116.86 32.72 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.3 mt -130.06 121.98 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.28 -119.68 16.66 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -111.09 17.0 20.81 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.373 -0.486 . . . . 0.0 111.841 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -120.42 143.91 48.22 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 118.575 0.625 . . . . 0.0 110.52 -174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -123.1 129.44 51.45 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -125.88 146.54 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.52 136.38 44.09 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.92 -168.52 12.83 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.54 154.92 25.49 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 117.309 0.554 . . . . 0.0 110.286 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.3 mt -108.62 141.61 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.8 t -120.73 132.28 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -175.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.0 t -142.37 133.27 12.8 Favored Pre-proline 0 N--CA 1.497 1.88 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.54 155.73 29.86 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 121.081 1.187 . . . . 0.0 111.885 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -64.59 -34.05 77.35 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 122.298 -0.251 . . . . 0.0 110.659 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -89.13 111.29 22.03 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.284 -0.26 . . . . 0.0 110.325 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.5 m -131.77 134.73 46.15 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -97.08 -56.16 2.63 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.31 -0.244 . . . . 0.0 110.344 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -121.99 -179.36 4.12 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.7 m -104.87 152.73 22.26 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.7 p -135.01 172.81 12.49 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 120.664 0.269 . . . . 0.0 110.562 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -105.63 24.62 11.93 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.854 172.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.9 mm -121.08 126.98 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.42 148.41 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -116.62 130.86 56.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.4 mt -115.08 150.42 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.0 pt -115.99 155.88 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.53 165.84 22.95 Favored Pre-proline 0 N--CA 1.496 1.831 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.279 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.37 -30.37 92.54 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 121.084 1.189 . . . . 0.0 111.667 177.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.42 167.05 23.41 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 122.28 -0.262 . . . . 0.0 110.652 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -71.02 105.5 3.34 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.63 -33.93 72.15 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 122.105 -0.372 . . . . 0.0 111.462 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -63.16 -34.75 78.29 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 122.143 -0.348 . . . . 0.0 110.892 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -78.2 -48.99 14.63 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -62.51 -34.09 76.19 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 122.188 -0.32 . . . . 0.0 111.102 -172.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -108.05 8.15 28.1 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.85 50.15 19.25 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 120.986 -1.071 . . . . 0.0 111.917 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 48.2 mt -91.08 138.19 31.79 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.871 -0.518 . . . . 0.0 110.857 -172.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -115.19 156.74 24.77 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.77 137.95 48.84 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.9 -0.5 . . . . 0.0 111.5 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.9 -22.91 37.59 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.39 153.99 39.68 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-N 118.641 1.221 . . . . 0.0 110.005 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.09 134.01 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.7 pt -130.3 162.25 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -110.02 139.18 45.42 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.365 -174.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 pt -111.73 137.75 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.5 tt -111.0 133.36 53.45 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 43.6 mt -119.98 122.69 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -93.53 152.6 18.94 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.07 123.01 1.23 Allowed Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -94.36 -34.33 12.83 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 117.205 0.503 . . . . 0.0 110.282 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -109.62 145.3 36.66 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -138.34 -48.26 0.53 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.42 179.904 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.7 mtp . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -152.53 68.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 120.931 0.396 . . . . 0.0 110.043 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -98.91 130.69 45.31 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.121 -0.362 . . . . 0.0 110.165 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.4 mt -110.92 149.54 30.49 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.5 ttm -106.4 144.51 32.98 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.4 mm -128.9 128.8 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -177.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.9 mt -130.02 148.32 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -105.45 140.95 37.77 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.16 150.71 20.27 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -106.27 141.74 37.12 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 117.176 0.488 . . . . 0.0 110.186 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.15 121.78 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.32 158.84 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 177.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.4 t -86.11 126.12 33.97 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.332 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.06 119.99 0.84 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.3 tp -155.11 -47.8 0.08 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 122.352 -0.499 . . . . 0.0 110.427 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -100.73 37.38 3.61 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -68.52 -35.32 77.29 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 117.306 0.553 . . . . 0.0 109.975 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -150.02 -159.23 8.58 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -97.12 109.49 22.23 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 122.327 -0.513 . . . . 0.0 109.958 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -155.03 112.16 3.32 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.22 135.5 53.84 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.2 mt -104.87 0.08 27.61 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.2 p -95.21 24.89 4.62 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 119.008 0.822 . . . . 0.0 111.614 -174.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 mp -105.07 157.51 34.11 Favored Pre-proline 0 N--CA 1.496 1.831 0 CA-C-O 118.94 -0.552 . . . . 0.0 109.962 176.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.85 -49.42 16.76 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 121.107 1.205 . . . . 0.0 113.479 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -56.32 -44.81 42.74 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 120.557 0.838 . . . . 0.0 112.183 -171.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -65.34 -41.52 93.84 Favored 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.658 -174.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.02 -40.83 91.39 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 122.033 -0.417 . . . . 0.0 110.311 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -65.26 -45.99 82.31 Favored 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.562 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.2 tt -68.79 -37.02 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.013 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -65.98 -41.89 90.55 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.075 -0.391 . . . . 0.0 110.471 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.405 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 35.7 ttpt -65.33 -36.93 85.53 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 122.151 -0.343 . . . . 0.0 110.366 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -68.24 -38.67 82.09 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.505 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.2 mt -81.16 -35.68 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.3 mt -103.92 -26.26 12.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.102 -0.373 . . . . 0.0 111.696 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.39 12.94 79.7 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -171.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -150.91 160.57 43.82 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 119.068 1.434 . . . . 0.0 110.306 170.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -93.39 109.35 39.87 Favored Pre-proline 0 N--CA 1.496 1.849 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.816 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -67.25 159.76 50.73 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 O-C-N 123.274 1.144 . . . . 0.0 110.502 -176.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -73.81 163.29 28.14 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -80.25 79.56 6.81 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.511 0.672 . . . . 0.0 109.64 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.48 172.89 45.32 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 175.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 p -138.09 157.41 46.38 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 117.343 0.571 . . . . 0.0 110.804 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.6 tp -109.61 115.02 29.13 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 170.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.72 120.05 38.49 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.6 mt -119.98 135.95 54.72 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 120.697 0.284 . . . . 0.0 110.631 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -95.98 132.17 41.59 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.8 mt -110.95 160.27 16.96 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 120.605 0.24 . . . . 0.0 110.475 -176.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -88.93 12.73 14.52 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 172.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -145.49 142.44 29.23 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 118.555 0.616 . . . . 0.0 109.466 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -64.43 146.92 53.75 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.413 178.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -134.4 137.14 43.83 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.733 0.301 . . . . 0.0 110.654 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -138.16 129.58 27.71 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.2 tt -63.95 -22.22 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.337 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -74.42 -0.97 19.06 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.933 -0.479 . . . . 0.0 112.235 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -91.04 -14.74 30.78 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 118.918 0.781 . . . . 0.0 111.445 170.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -117.21 175.11 5.76 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 118.679 0.672 . . . . 0.0 109.467 174.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -90.85 102.75 15.51 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -109.67 177.03 4.86 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 120.546 0.212 . . . . 0.0 110.471 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -110.46 130.8 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -106.0 143.75 33.7 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.8 p -121.69 138.02 54.52 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.74 0.305 . . . . 0.0 110.751 177.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.87 172.67 12.76 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 120.864 0.364 . . . . 0.0 111.687 -169.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -67.59 140.79 56.93 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -136.97 167.01 22.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 122.208 -0.308 . . . . 0.0 110.544 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -125.11 149.08 48.22 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 120.861 0.362 . . . . 0.0 110.607 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -148.35 135.24 20.03 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 51.73 33.44 11.07 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.806 -0.559 . . . . 0.0 112.082 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.09 16.94 79.09 Favored Glycine 0 N--CA 1.498 2.771 0 CA-C-O 119.599 -0.556 . . . . 0.0 111.782 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -122.28 140.94 52.04 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 118.694 1.247 . . . . 0.0 109.649 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -93.25 131.85 37.98 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 120.653 0.264 . . . . 0.0 110.493 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -120.76 144.08 48.47 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -86.37 156.72 20.08 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 120.784 0.326 . . . . 0.0 110.481 -168.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.18 161.86 44.12 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.39 156.0 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 122.294 -0.533 . . . . 0.0 110.364 -174.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -116.57 137.19 52.37 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.7 t -134.12 142.1 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.0 tp -137.39 125.64 14.54 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-O 118.61 -0.71 . . . . 0.0 110.094 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -63.43 148.71 92.48 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 120.955 1.103 . . . . 0.0 111.42 177.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.8 pt -141.38 170.06 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 120.674 0.274 . . . . 0.0 110.356 172.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -114.45 131.76 56.5 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 168.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.9 mt -106.25 124.04 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -175.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -109.08 116.26 31.61 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.2 mt -130.0 121.93 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.41 -119.78 16.87 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -111.07 17.0 20.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.208 -0.584 . . . . 0.0 111.868 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -120.79 144.25 48.41 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 118.547 0.612 . . . . 0.0 110.503 -174.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -123.17 130.19 52.42 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -126.45 148.33 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.51 137.58 44.51 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.23 -169.9 14.46 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 177.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.32 154.88 25.86 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 117.339 0.57 . . . . 0.0 110.235 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.6 mt -108.79 142.26 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.35 131.56 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -142.25 132.53 12.57 Favored Pre-proline 0 N--CA 1.498 1.926 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -58.09 154.86 37.04 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 121.063 1.175 . . . . 0.0 111.796 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -64.99 -33.61 76.45 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.228 -0.295 . . . . 0.0 110.77 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -87.64 114.44 24.26 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 m -132.2 138.83 48.12 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -96.63 -57.04 2.4 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -129.42 -178.73 4.79 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.6 m -98.03 153.04 18.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.7 t -134.98 172.22 13.31 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 120.586 0.232 . . . . 0.0 110.563 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -105.69 24.43 12.27 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.963 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -120.65 127.13 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.4 pt -125.83 145.76 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -115.39 130.91 57.04 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.3 mt -116.47 151.63 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -174.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.7 pt -117.73 156.12 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 168.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.52 165.65 24.0 Favored Pre-proline 0 N--CA 1.494 1.75 0 CA-C-O 119.078 -0.487 . . . . 0.0 110.311 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -59.48 -30.8 93.46 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 121.117 1.211 . . . . 0.0 111.576 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.31 167.02 23.44 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 122.299 -0.25 . . . . 0.0 110.701 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -71.57 105.24 3.57 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.52 -33.67 71.66 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 122.144 -0.347 . . . . 0.0 111.471 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -63.04 -34.91 78.58 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 122.124 -0.36 . . . . 0.0 110.951 -175.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.2 -47.7 17.46 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -62.45 -34.99 77.89 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 122.211 -0.305 . . . . 0.0 111.038 -172.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -108.03 9.94 28.35 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 51.81 47.92 23.84 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.226 -0.921 . . . . 0.0 111.972 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 48.6 mt -91.37 138.25 31.73 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.958 -0.464 . . . . 0.0 110.798 -172.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -114.12 158.62 21.04 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.87 138.07 49.11 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.794 -0.566 . . . . 0.0 111.429 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.53 -22.96 37.59 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.4 155.59 34.93 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-N 118.648 1.224 . . . . 0.0 110.039 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.41 134.09 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -174.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.3 pt -128.76 160.73 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -109.9 137.63 47.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.205 -0.31 . . . . 0.0 110.179 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -113.11 137.25 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.2 tt -110.26 126.76 54.5 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.8 mt -114.52 126.67 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.11 145.49 24.36 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.12 174.59 34.69 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -143.88 135.87 26.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 122.362 -0.493 . . . . 0.0 110.199 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -108.5 142.55 38.73 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -98.34 149.89 22.15 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.212 179.927 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.4 t -113.02 133.77 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -99.79 154.97 17.91 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.0 mt -133.34 150.87 51.83 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.7 ttm -128.35 146.42 50.78 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.0 mm -126.24 133.34 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -177.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.2 mt -129.81 149.73 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -105.85 141.87 36.54 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.25 150.45 20.45 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.52 142.18 36.6 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 117.217 0.508 . . . . 0.0 110.278 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.1 t -63.04 123.22 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -122.37 155.13 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.4 p -85.48 132.82 34.14 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.352 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.0 119.96 0.84 Allowed Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -153.29 137.92 16.9 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 117.208 0.504 . . . . 0.0 110.239 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.21 36.08 32.18 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -107.86 149.27 28.48 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 117.174 0.487 . . . . 0.0 110.123 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.12 -163.75 39.88 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -141.79 38.69 1.65 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 117.215 0.508 . . . . 0.0 110.432 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -116.59 132.09 56.77 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 122.249 -0.282 . . . . 0.0 110.438 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -104.26 123.81 48.02 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.8 mt -89.34 -27.02 20.77 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 121.171 -0.211 . . . . 0.0 111.34 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.7 p -58.84 -24.07 61.52 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.907 -0.495 . . . . 0.0 111.878 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.5 mt -64.6 154.9 83.44 Favored Pre-proline 0 N--CA 1.502 2.163 0 CA-C-O 119.087 -0.482 . . . . 0.0 110.648 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -54.74 -49.45 16.7 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 O-C-N 123.429 1.226 . . . . 0.0 113.77 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.13 -45.5 38.7 Favored 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 120.92 1.08 . . . . 0.0 113.166 -169.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -64.83 -42.92 94.55 Favored 'General case' 0 N--CA 1.504 2.275 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.681 -175.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.8 tttp -65.38 -40.14 93.13 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 122.109 -0.369 . . . . 0.0 110.283 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -65.7 -46.63 78.29 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 122.226 -0.296 . . . . 0.0 110.53 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.1 tt -69.21 -35.53 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 C-N-CA 120.632 -0.427 . . . . 0.0 109.989 -176.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -65.89 -43.65 87.64 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 122.195 -0.316 . . . . 0.0 110.589 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -65.76 -32.64 74.29 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.73 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -68.7 -40.15 80.17 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.605 178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.8 mt -81.56 -35.78 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -176.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.1 mt -103.31 -26.29 12.99 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.183 -0.323 . . . . 0.0 111.767 -173.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.7 15.3 75.97 Favored Glycine 0 N--CA 1.493 2.492 0 CA-C-O 119.3 -0.722 . . . . 0.0 111.371 -173.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -150.83 162.31 40.99 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 119.166 1.483 . . . . 0.0 110.775 171.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -94.15 106.74 24.3 Favored Pre-proline 0 N--CA 1.497 1.888 0 CA-C-O 118.707 -0.663 . . . . 0.0 109.854 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.9 158.72 56.77 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 O-C-N 123.245 1.129 . . . . 0.0 110.302 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -73.8 160.4 31.53 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -80.29 79.67 6.83 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.518 0.675 . . . . 0.0 109.778 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.19 175.8 47.66 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 175.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 p -138.02 154.53 49.3 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 117.367 0.584 . . . . 0.0 110.774 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.6 tp -109.32 119.08 38.4 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 170.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.64 122.69 43.73 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.168 -175.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.2 mt -120.53 136.19 54.85 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 120.66 0.267 . . . . 0.0 110.549 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -96.24 133.92 39.98 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.5 mt -111.95 160.22 17.64 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 120.617 0.246 . . . . 0.0 110.465 -176.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.04 12.8 14.55 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 172.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -145.79 141.98 28.45 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.661 -0.649 . . . . 0.0 109.388 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.24 146.81 52.62 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 122.225 -0.297 . . . . 0.0 110.628 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -132.16 137.45 47.65 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 120.699 0.285 . . . . 0.0 110.663 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -138.0 125.53 22.09 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 174.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.2 -22.51 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.384 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -74.48 -1.08 19.69 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.978 -0.451 . . . . 0.0 112.187 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -90.75 -14.48 31.99 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 118.922 0.783 . . . . 0.0 111.524 170.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.96 175.18 5.7 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 118.597 0.635 . . . . 0.0 109.463 174.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -91.74 103.24 15.83 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -110.59 178.84 4.24 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 120.587 0.232 . . . . 0.0 110.435 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -111.74 130.2 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.97 142.65 35.32 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.2 p -122.79 136.35 54.84 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 120.762 0.315 . . . . 0.0 110.78 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -75.34 172.67 12.05 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 120.909 0.385 . . . . 0.0 111.754 -170.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -67.8 141.15 56.6 Favored 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -137.04 167.0 22.37 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.543 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -125.58 149.52 48.28 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 120.907 0.384 . . . . 0.0 110.548 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -147.9 134.15 19.47 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 51.69 33.82 11.69 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.702 -0.624 . . . . 0.0 112.157 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.18 16.64 79.39 Favored Glycine 0 N--CA 1.496 2.682 0 CA-C-O 119.623 -0.543 . . . . 0.0 111.875 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -121.15 139.84 52.81 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.677 1.239 . . . . 0.0 109.623 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.51 132.48 37.76 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 121.091 -0.243 . . . . 0.0 110.505 -176.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -121.24 144.14 48.77 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -86.08 157.04 20.15 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.53 -168.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.56 158.59 49.11 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -176.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.49 154.98 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 122.351 -0.499 . . . . 0.0 110.445 -174.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -116.04 136.43 53.04 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.4 t -133.98 139.95 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -175.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.7 tp -137.12 125.65 14.86 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.053 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -63.4 149.76 90.31 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 O-C-N 123.182 1.096 . . . . 0.0 111.444 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.1 pt -141.7 170.08 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 171.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -113.9 130.42 56.5 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 168.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -105.96 123.64 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -174.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.5 mt -108.52 116.32 31.75 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -129.87 121.91 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.72 -120.29 18.34 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -111.18 17.05 20.69 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 122.316 -0.52 . . . . 0.0 111.932 175.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -119.34 143.99 47.1 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 118.465 0.575 . . . . 0.0 110.498 -175.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -123.16 130.08 52.29 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.3 mt -126.81 146.32 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.83 135.98 43.47 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.01 -167.29 12.12 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -160.1 155.95 26.03 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 117.374 0.587 . . . . 0.0 110.447 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.5 mt -108.73 141.9 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -121.88 131.42 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.1 t -141.01 133.87 14.41 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -57.82 155.04 34.47 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 120.996 1.131 . . . . 0.0 111.877 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -64.78 -34.52 78.55 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 122.365 -0.209 . . . . 0.0 110.723 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -87.33 118.39 26.73 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.35 -176.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.2 p -131.98 160.37 36.02 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -126.77 -42.91 1.74 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.308 -0.245 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -136.88 176.71 8.46 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.2 m -99.61 147.75 25.04 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.0 m -135.07 171.99 13.64 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 120.594 0.235 . . . . 0.0 110.517 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -107.19 27.14 9.34 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.408 -0.183 . . . . 0.0 110.94 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -122.91 127.19 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.6 pt -124.81 143.75 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -114.77 131.56 56.75 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.9 mt -117.22 152.05 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -173.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.5 pt -116.18 156.17 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 168.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.59 164.15 32.27 Favored Pre-proline 0 N--CA 1.496 1.827 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.334 -176.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.15 -32.41 94.54 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 121.062 1.175 . . . . 0.0 111.479 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.98 159.26 43.21 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.266 -0.272 . . . . 0.0 110.862 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.6 pttt -62.5 103.92 0.46 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.413 0.625 . . . . 0.0 111.203 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.7 mt -59.6 -32.51 70.46 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.869 -0.519 . . . . 0.0 111.692 -177.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -61.9 -37.28 84.02 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 122.098 -0.376 . . . . 0.0 111.204 -171.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -78.27 -46.41 20.34 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -62.37 -34.59 76.99 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 122.208 -0.307 . . . . 0.0 111.024 -172.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -108.13 8.23 27.97 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -177.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 51.72 50.65 18.27 Favored 'General case' 0 N--CA 1.508 2.436 0 CA-C-N 119.309 0.959 . . . . 0.0 111.945 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 48.2 mt -90.39 138.16 31.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.832 -0.542 . . . . 0.0 110.818 -171.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -117.03 155.29 29.46 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 175.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -55.99 138.01 49.8 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.857 -0.527 . . . . 0.0 111.468 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.98 -22.97 37.32 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.31 154.59 37.83 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 118.655 1.227 . . . . 0.0 110.038 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -111.92 133.78 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.4 pt -128.56 160.95 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -109.93 138.13 46.73 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -112.26 137.17 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 10.0 tt -110.54 126.39 54.35 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 38.3 mt -114.09 127.96 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -94.34 120.88 35.24 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.15 -177.34 30.18 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -134.27 122.19 22.36 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 117.144 0.472 . . . . 0.0 110.11 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -131.23 128.74 40.55 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -100.03 147.07 26.02 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.518 179.801 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mmm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.1 t -117.62 136.2 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -98.36 125.51 43.52 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.9 mt -110.92 154.06 24.61 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 43.1 ttm -103.57 142.74 33.78 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.2 mm -125.55 130.01 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 77.6 mt -129.69 149.02 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -104.69 140.76 37.58 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.07 150.41 19.98 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -105.63 142.36 35.5 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 117.28 0.54 . . . . 0.0 110.227 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.71 120.99 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.45 137.78 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 122.308 -0.245 . . . . 0.0 110.375 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.1 m -88.04 111.85 21.98 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.06 120.02 0.84 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -139.88 108.01 5.76 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 122.426 -0.455 . . . . 0.0 109.928 177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.99 51.38 0.53 Allowed Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -99.95 32.64 2.85 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 117.194 0.497 . . . . 0.0 110.357 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.16 -139.92 21.66 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 51.4 mtm180 -92.51 130.63 38.12 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 117.177 0.489 . . . . 0.0 109.988 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -117.86 130.87 56.52 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -153.25 97.85 2.21 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 tt -90.61 -14.32 32.66 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 122.283 -0.261 . . . . 0.0 111.591 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 m -54.73 -22.47 14.12 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.334 -0.854 . . . . 0.0 112.285 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.0 tp -59.86 137.71 90.44 Favored Pre-proline 0 N--CA 1.507 2.398 0 CA-C-O 118.736 -0.65 . . . . 0.0 110.584 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -51.92 -47.54 26.04 Favored 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 121.099 1.199 . . . . 0.0 113.973 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.18 -32.08 85.99 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 CA-C-N 119.472 0.847 . . . . 0.0 112.09 -172.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -67.47 -52.07 43.69 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.197 -176.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -64.77 -39.83 94.26 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.49 -176.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -66.7 -50.06 64.07 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.417 -176.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.6 tt -71.37 -32.74 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.229 -174.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -64.72 -41.97 95.58 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 122.079 -0.388 . . . . 0.0 110.257 175.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -65.3 -32.35 73.96 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.83 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -68.45 -39.33 81.51 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.85 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.3 mt -81.46 -36.82 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.0 mt -103.97 -26.22 12.71 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.206 -0.309 . . . . 0.0 111.642 -174.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.7 14.17 73.75 Favored Glycine 0 N--CA 1.495 2.603 0 CA-C-O 119.368 -0.685 . . . . 0.0 111.48 -172.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -152.39 161.68 42.26 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 119.163 1.481 . . . . 0.0 110.554 170.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -94.47 107.45 29.92 Favored Pre-proline 0 N--CA 1.496 1.846 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.8 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -67.38 156.51 65.88 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 O-C-N 123.242 1.127 . . . . 0.0 110.526 -176.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -73.37 162.59 29.15 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -80.31 79.46 6.89 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.537 0.684 . . . . 0.0 109.509 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.85 176.12 47.26 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 p -138.07 157.2 46.81 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 117.349 0.575 . . . . 0.0 110.842 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.8 tp -108.92 118.37 36.62 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.95 122.85 42.74 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -175.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 61.1 mt -121.29 136.24 55.0 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.732 0.301 . . . . 0.0 110.521 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -96.13 132.51 41.45 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.5 mt -111.47 160.23 17.32 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 120.703 0.287 . . . . 0.0 110.382 -176.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -88.94 12.44 15.34 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 173.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -146.39 140.91 26.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.687 -0.633 . . . . 0.0 109.662 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.1 146.9 52.27 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 122.182 -0.324 . . . . 0.0 110.75 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -132.37 138.71 47.83 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.64 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -138.04 123.89 20.01 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 176.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.62 -23.08 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.395 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -74.6 -0.97 19.53 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.897 -0.502 . . . . 0.0 112.214 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -89.92 -14.21 34.65 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 118.961 0.8 . . . . 0.0 111.542 171.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -117.0 175.15 5.72 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 118.603 0.638 . . . . 0.0 109.582 173.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -91.87 104.86 17.24 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -109.49 177.3 4.78 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.4 mt -110.37 133.67 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -105.84 142.1 36.13 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.3 p -116.5 133.23 56.26 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -77.47 172.5 13.24 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 120.75 0.309 . . . . 0.0 111.388 -171.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -69.28 139.86 54.39 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -140.64 164.86 29.05 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.743 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -122.01 146.44 47.16 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 120.699 0.285 . . . . 0.0 110.271 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -150.71 141.83 23.1 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 172.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.2 m120 52.11 29.98 7.06 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.69 -0.631 . . . . 0.0 112.126 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.56 16.08 81.03 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -120.45 143.29 48.57 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 118.706 1.253 . . . . 0.0 109.636 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -92.42 131.76 37.32 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.349 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -119.94 141.0 50.03 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -87.4 151.9 22.69 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 120.843 0.354 . . . . 0.0 110.595 -167.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.68 158.71 51.21 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -142.65 161.48 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 122.252 -0.558 . . . . 0.0 110.514 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -113.5 135.21 54.13 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.8 t -131.07 138.25 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -176.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.7 tp -137.44 125.65 14.49 Favored Pre-proline 0 N--CA 1.496 1.85 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.055 178.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -62.68 149.33 91.56 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 120.98 1.12 . . . . 0.0 111.731 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.6 pt -141.82 170.17 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 122.253 -0.279 . . . . 0.0 110.321 171.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -113.53 130.26 56.39 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 168.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -106.24 123.57 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -108.63 116.99 33.02 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.8 mt -130.1 121.96 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.79 -120.46 18.89 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -111.1 16.97 20.82 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 122.266 -0.55 . . . . 0.0 111.933 175.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -118.68 143.2 47.0 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 118.518 0.599 . . . . 0.0 110.482 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -123.09 129.89 52.06 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -127.06 149.05 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.31 136.01 44.44 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.99 -168.4 12.35 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.35 155.22 26.39 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 117.305 0.553 . . . . 0.0 110.325 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.8 mt -108.71 140.72 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -125.07 129.52 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.7 t -139.92 133.88 15.6 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -56.65 153.67 34.92 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 121.037 1.158 . . . . 0.0 112.046 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -64.5 -34.45 78.24 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 122.269 -0.269 . . . . 0.0 110.606 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.1 tttp -90.97 121.05 32.47 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.2 t -141.84 151.89 43.17 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 122.32 -0.237 . . . . 0.0 110.401 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -98.42 -58.93 1.85 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -134.91 169.77 16.89 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.0 m -82.81 154.39 24.72 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 96.3 p -135.02 175.05 9.94 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 120.645 0.259 . . . . 0.0 110.495 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -104.8 25.0 10.94 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 121.28 -0.168 . . . . 0.0 110.95 172.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -120.89 126.88 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.9 pt -125.36 145.59 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -115.55 130.23 56.8 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.6 mt -116.06 152.27 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -174.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 pt -116.68 155.91 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 168.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.52 162.16 43.39 Favored Pre-proline 0 N--CA 1.495 1.823 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.358 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.54 -30.67 93.02 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 121.075 1.183 . . . . 0.0 111.728 177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.44 167.0 23.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.279 -0.263 . . . . 0.0 110.933 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -69.92 104.33 2.48 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 85.0 mt -59.93 -34.25 72.98 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 122.138 -0.351 . . . . 0.0 111.349 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -62.97 -35.57 80.59 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 122.203 -0.311 . . . . 0.0 110.922 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -78.36 -48.76 14.88 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -62.65 -33.63 75.43 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 122.231 -0.293 . . . . 0.0 111.11 -172.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -108.05 7.75 27.9 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 51.8 46.97 25.69 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.108 -0.995 . . . . 0.0 111.878 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.4 mt -92.28 138.19 31.73 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.893 -0.504 . . . . 0.0 111.007 -170.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -115.66 160.61 19.82 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.17 50.17 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.966 -0.459 . . . . 0.0 111.569 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.48 -22.94 37.7 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.59 151.59 46.12 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 118.627 1.213 . . . . 0.0 110.018 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.3 t -110.45 133.66 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -173.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.8 pt -128.46 160.16 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -109.65 138.07 46.55 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.2 pt -113.62 137.87 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.7 tt -108.99 127.7 54.3 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 32.5 mt -118.31 135.72 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -91.66 149.01 21.84 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.07 -170.26 21.81 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -98.72 168.67 10.0 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 122.334 -0.51 . . . . 0.0 110.176 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -65.02 -36.34 84.08 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.253 -0.279 . . . . 0.0 110.619 -177.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -104.69 -32.75 8.74 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 122.332 -0.23 . . . . 0.0 110.654 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.169 179.326 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.2 t -70.08 -40.74 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -134.02 128.31 34.06 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 81.3 mt -110.86 148.3 32.73 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 10.7 tpp -109.4 144.01 38.18 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.7 mm -125.77 129.36 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -129.77 148.9 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -105.37 141.53 36.72 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.73 150.61 20.38 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -106.33 142.1 36.56 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 117.265 0.532 . . . . 0.0 110.301 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.11 121.08 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.22 144.2 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.5 m -86.48 114.83 23.56 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.07 120.01 0.84 Allowed Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.7 tp -110.93 137.38 48.64 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 122.341 -0.505 . . . . 0.0 109.904 177.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.83 -40.08 95.39 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -174.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -123.78 153.85 40.37 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 117.327 0.563 . . . . 0.0 110.411 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.63 -35.32 85.87 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -112.93 144.27 42.78 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 117.217 0.509 . . . . 0.0 109.985 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -124.75 126.73 46.12 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -144.49 96.63 2.9 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 tt -102.92 0.33 32.23 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.2 m -94.65 31.25 1.83 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.26 -0.9 . . . . 0.0 111.533 -172.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.9 tp -88.56 139.88 29.84 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 171.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -50.15 -43.77 41.2 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 121.081 1.187 . . . . 0.0 114.059 -172.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.27 -36.81 99.03 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 CA-C-N 119.567 0.881 . . . . 0.0 111.941 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -66.14 -46.19 78.38 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.469 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -66.06 -37.42 85.77 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.337 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -65.57 -48.92 70.71 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.438 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.6 tt -68.72 -38.63 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.089 -176.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -66.37 -47.07 74.57 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 122.118 -0.363 . . . . 0.0 110.387 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -66.18 -29.62 69.93 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.735 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -68.89 -40.82 79.0 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.733 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.9 mt -81.31 -38.04 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -175.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.1 mt -104.01 -26.2 12.71 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.231 -0.293 . . . . 0.0 111.711 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.16 13.66 73.67 Favored Glycine 0 N--CA 1.495 2.592 0 CA-C-O 119.369 -0.684 . . . . 0.0 111.466 -171.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -152.52 165.65 34.46 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 119.158 1.479 . . . . 0.0 110.614 170.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -96.41 112.31 59.57 Favored Pre-proline 0 N--CA 1.496 1.851 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.835 175.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -67.52 159.92 50.33 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 O-C-N 123.266 1.14 . . . . 0.0 110.631 -176.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -74.3 164.54 26.48 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -80.23 79.57 6.78 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.476 0.655 . . . . 0.0 109.729 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.09 170.42 42.14 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 p -138.08 157.41 46.38 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 117.295 0.547 . . . . 0.0 110.674 177.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.5 tp -109.76 116.67 32.11 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 171.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.57 120.9 39.78 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.6 mt -119.96 135.71 54.8 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.71 0.29 . . . . 0.0 110.656 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -96.21 133.46 40.49 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.7 mt -110.95 160.38 16.86 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 120.649 0.262 . . . . 0.0 110.481 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.09 12.75 14.78 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -145.89 141.4 27.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.701 -0.624 . . . . 0.0 109.488 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -63.32 146.92 52.48 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 122.203 -0.311 . . . . 0.0 110.682 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -132.09 138.17 48.02 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 120.719 0.295 . . . . 0.0 110.622 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -138.02 126.41 23.27 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.9 tt -63.28 -22.73 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.348 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -74.65 -0.94 19.59 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.97 -0.457 . . . . 0.0 112.216 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -90.77 -14.51 31.87 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 118.902 0.774 . . . . 0.0 111.488 171.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -117.63 175.18 5.76 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 118.7 0.682 . . . . 0.0 109.469 174.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -90.64 103.88 16.53 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -177.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -110.42 179.25 4.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.371 -0.206 . . . . 0.0 110.537 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.5 mt -112.6 131.8 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.95 143.17 34.47 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.4 p -123.28 137.07 54.94 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 120.761 0.315 . . . . 0.0 110.769 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -77.3 172.61 13.02 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 120.824 0.345 . . . . 0.0 111.849 -168.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -68.21 141.31 56.0 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -138.69 164.99 28.12 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 122.186 -0.321 . . . . 0.0 110.675 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -124.92 148.31 48.41 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.787 0.327 . . . . 0.0 110.381 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -149.53 136.45 19.6 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 52.23 32.96 11.58 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.747 -0.595 . . . . 0.0 111.832 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 16.42 80.15 Favored Glycine 0 N--CA 1.497 2.733 0 CA-C-O 119.584 -0.565 . . . . 0.0 111.798 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -120.16 138.99 53.28 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 118.728 1.264 . . . . 0.0 109.701 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.19 131.47 38.24 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.358 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -119.69 140.93 49.88 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -86.03 155.9 20.65 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 120.761 0.315 . . . . 0.0 110.388 -168.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.94 156.86 51.64 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -176.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.09 156.86 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 122.347 -0.502 . . . . 0.0 110.486 -173.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -115.79 137.0 52.5 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.2 t -134.06 141.06 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -175.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 tp -137.54 125.72 14.42 Favored Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.082 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -63.31 148.56 92.8 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 120.987 1.125 . . . . 0.0 111.396 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.9 pt -141.78 170.06 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 122.304 -0.248 . . . . 0.0 110.412 173.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -114.28 131.51 56.48 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 168.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.2 mt -105.74 123.33 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.22 116.47 32.02 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.7 mt -129.83 121.92 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.56 -120.16 18.09 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -111.21 17.04 20.67 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 117.161 0.48 . . . . 0.0 111.784 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -119.43 144.12 47.11 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.557 0.617 . . . . 0.0 110.46 -175.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -123.13 130.15 52.39 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 122.263 -0.273 . . . . 0.0 110.275 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.6 mt -126.35 147.05 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.42 137.46 44.62 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.6 -168.32 13.51 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 178.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.12 154.26 25.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.266 -0.549 . . . . 0.0 110.258 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.2 mt -108.65 140.62 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -123.07 130.28 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.98 133.9 14.45 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -57.75 153.63 42.17 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 120.996 1.13 . . . . 0.0 111.813 177.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -65.53 -34.91 79.37 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 122.279 -0.263 . . . . 0.0 110.487 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -89.17 121.01 31.07 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.267 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -141.64 151.56 43.17 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -98.01 -55.89 2.65 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -136.84 169.63 17.43 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.1 m -82.19 151.11 27.04 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.0 m -134.91 175.0 9.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.295 -0.253 . . . . 0.0 110.526 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -107.28 27.22 9.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.378 -0.201 . . . . 0.0 110.839 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.1 mm -124.1 127.51 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.5 pt -125.98 145.52 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -114.81 130.08 56.81 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.5 mt -115.04 149.95 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -174.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 pt -115.95 155.57 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 169.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.55 165.97 22.24 Favored Pre-proline 0 N--CA 1.496 1.843 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.326 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.76 -30.94 93.24 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 O-C-N 123.292 1.154 . . . . 0.0 111.623 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.39 167.06 23.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.293 -0.255 . . . . 0.0 110.751 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -70.88 105.24 3.19 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.3 mt -59.52 -33.61 71.59 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 122.151 -0.343 . . . . 0.0 111.449 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -62.83 -35.35 79.65 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 122.108 -0.37 . . . . 0.0 111.006 -174.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -78.11 -48.28 16.37 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.47 -34.3 76.55 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 122.153 -0.342 . . . . 0.0 111.135 -172.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -108.1 8.53 28.18 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 51.79 50.5 18.53 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 121.103 -0.998 . . . . 0.0 111.895 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 47.4 mt -90.3 138.17 31.75 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.879 -0.513 . . . . 0.0 110.899 -171.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -116.19 155.16 28.76 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.48 137.91 47.45 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.906 -0.496 . . . . 0.0 111.533 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.02 -22.98 37.22 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -65.32 154.6 37.81 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-N 118.704 1.252 . . . . 0.0 110.05 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.38 134.03 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -174.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.6 pt -128.9 160.41 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -109.83 138.28 46.43 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.8 pt -114.21 137.61 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 176.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.2 tt -109.02 127.75 54.37 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.8 mt -118.57 134.68 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -91.83 133.65 35.45 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.19 175.18 34.69 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -154.96 165.92 35.19 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.336 -0.508 . . . . 0.0 110.501 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -115.9 145.82 42.57 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -138.77 163.98 30.79 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.145 179.993 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.5 mtt . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 p -132.4 142.18 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -140.84 50.58 1.65 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.035 0.445 . . . . 0.0 110.267 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.2 mt -110.9 149.12 31.07 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.089 -0.382 . . . . 0.0 110.088 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 51.6 ttm -107.74 144.76 34.43 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.3 mm -127.72 129.21 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.3 mt -129.97 149.23 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -105.9 142.12 36.15 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.42 150.95 20.4 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -106.16 142.38 35.95 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 117.266 0.533 . . . . 0.0 110.245 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.74 123.6 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.24 157.87 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -85.07 107.56 17.23 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.271 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.02 120.41 0.86 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.3 tp -81.89 -53.72 5.93 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 117.316 0.558 . . . . 0.0 109.974 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.09 168.79 30.14 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -100.04 -56.47 2.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 122.383 -0.48 . . . . 0.0 109.97 177.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.77 -170.53 41.81 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -100.19 107.68 19.6 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 117.131 0.465 . . . . 0.0 110.13 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -155.01 154.88 33.2 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -128.63 154.03 46.66 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.8 mt -97.65 -11.82 23.11 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.5 m -61.61 -29.25 69.93 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 118.823 0.738 . . . . 0.0 111.48 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.6 tp -64.22 139.29 97.66 Favored Pre-proline 0 N--CA 1.505 2.309 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.27 -177.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -53.54 -49.34 17.69 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 121.058 1.172 . . . . 0.0 113.706 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -54.84 -33.1 80.2 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 120.634 0.89 . . . . 0.0 112.482 -170.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -66.44 -45.57 79.39 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.465 -177.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -66.5 -37.61 85.42 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 122.101 -0.374 . . . . 0.0 110.251 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -65.61 -47.41 75.78 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 122.201 -0.312 . . . . 0.0 110.454 -178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.2 tt -68.95 -37.96 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.045 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -65.46 -40.36 93.11 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 122.137 -0.352 . . . . 0.0 110.417 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -65.42 -37.51 87.15 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 122.212 -0.305 . . . . 0.0 110.319 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -68.03 -38.26 82.34 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.537 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.7 mt -81.18 -35.81 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.62 -26.1 12.92 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 122.141 -0.349 . . . . 0.0 111.573 -173.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.8 13.12 78.65 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -172.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -151.62 160.56 43.6 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 118.955 1.377 . . . . 0.0 110.222 170.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -93.12 108.0 29.45 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.857 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -67.6 160.12 49.47 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 O-C-N 123.249 1.131 . . . . 0.0 110.355 -176.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -73.62 161.62 30.1 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -80.32 79.6 6.88 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.496 0.665 . . . . 0.0 109.654 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.71 172.68 45.01 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 175.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 p -138.04 156.87 47.36 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 117.348 0.574 . . . . 0.0 110.775 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.7 tp -110.71 118.18 35.47 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 170.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -98.94 122.15 41.82 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -176.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 59.3 mt -120.14 136.13 54.72 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 120.662 0.268 . . . . 0.0 110.585 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.8 tttp -96.21 133.27 40.73 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.0 mt -111.1 160.27 17.04 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 120.664 0.269 . . . . 0.0 110.448 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.14 12.74 14.93 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 172.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -145.76 142.39 28.87 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 118.496 0.589 . . . . 0.0 109.428 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -64.37 146.76 53.93 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 122.196 -0.315 . . . . 0.0 110.324 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -133.11 137.57 46.37 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 120.686 0.279 . . . . 0.0 110.755 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -138.06 128.28 25.98 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 174.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.43 -23.05 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.271 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -74.58 -0.92 19.32 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -90.53 -14.52 32.45 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 118.905 0.775 . . . . 0.0 111.429 170.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -117.79 175.18 5.78 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 118.64 0.654 . . . . 0.0 109.497 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -91.1 103.8 16.45 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -109.81 178.39 4.43 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 120.572 0.225 . . . . 0.0 110.47 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -111.43 131.17 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -105.97 144.56 32.52 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.1 p -124.27 138.09 54.43 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.821 0.343 . . . . 0.0 110.764 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -77.0 172.77 12.66 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 120.902 0.382 . . . . 0.0 111.869 -168.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -67.45 140.82 57.11 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -136.78 167.35 21.6 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.221 -0.299 . . . . 0.0 110.553 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -125.3 149.53 47.97 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 120.836 0.35 . . . . 0.0 110.56 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -148.66 133.65 18.14 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 52.11 33.46 12.24 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.63 -0.668 . . . . 0.0 111.879 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.21 15.77 80.56 Favored Glycine 0 N--CA 1.497 2.721 0 CA-C-O 119.578 -0.568 . . . . 0.0 111.892 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -120.13 140.89 50.4 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.778 1.289 . . . . 0.0 109.691 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.47 132.04 38.11 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 121.081 -0.247 . . . . 0.0 110.489 -176.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -121.19 144.87 48.36 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -86.11 156.18 20.48 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 120.799 0.333 . . . . 0.0 110.508 -167.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.79 159.46 48.88 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -176.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.77 158.17 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 122.355 -0.497 . . . . 0.0 110.338 -174.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -118.35 137.3 53.19 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.03 141.27 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.1 tp -137.25 125.64 14.7 Favored Pre-proline 0 N--CA 1.495 1.823 0 CA-C-O 118.524 -0.75 . . . . 0.0 110.092 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -63.68 149.73 90.15 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 120.965 1.11 . . . . 0.0 111.332 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.1 pt -141.85 170.06 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 120.635 0.255 . . . . 0.0 110.385 171.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -114.35 131.14 56.65 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 168.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.24 123.05 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -174.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.4 mt -107.97 116.4 31.89 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.9 mt -129.85 121.9 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.69 -120.14 17.83 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -111.22 17.08 20.63 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.33 -0.512 . . . . 0.0 111.897 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -119.76 144.21 47.4 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 118.52 0.6 . . . . 0.0 110.435 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -123.06 129.9 52.09 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 120.697 0.284 . . . . 0.0 110.298 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.4 mt -126.43 147.46 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.56 136.71 44.04 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.91 -168.89 13.05 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.49 154.47 24.87 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 117.376 0.588 . . . . 0.0 110.305 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.79 141.61 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.8 t -124.4 132.09 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -144.95 137.54 13.54 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -58.15 152.84 49.66 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.05 1.166 . . . . 0.0 111.652 175.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -65.89 -34.32 77.85 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.538 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -88.6 117.31 27.47 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.0 m -129.87 143.26 50.72 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -94.05 -54.23 3.67 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -135.94 -179.73 5.84 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.4 m -96.77 151.71 19.38 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.2 p -134.96 172.32 13.17 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 120.747 0.308 . . . . 0.0 110.647 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.56 24.87 11.5 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.811 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.5 mm -120.81 127.72 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.5 pt -125.93 146.08 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -116.28 129.75 56.43 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 110.037 -0.356 . . . . 0.0 110.037 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.1 mt -115.0 151.55 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.9 pt -115.91 156.17 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 168.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.56 165.97 22.22 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.317 -176.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.13 -32.87 95.22 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 121.064 1.176 . . . . 0.0 111.462 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -145.06 160.14 41.86 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.308 -0.245 . . . . 0.0 110.877 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -62.36 104.7 0.52 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.367 0.604 . . . . 0.0 111.229 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.56 -32.86 70.74 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.94 -0.475 . . . . 0.0 111.662 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -61.87 -37.42 84.5 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 122.07 -0.394 . . . . 0.0 111.199 -171.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -78.27 -45.16 23.51 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -62.25 -34.79 77.21 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 122.143 -0.348 . . . . 0.0 111.085 -173.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -108.15 8.39 28.01 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 51.86 48.27 23.13 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.084 -1.01 . . . . 0.0 111.879 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.3 mt -91.71 138.12 31.82 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.887 -0.508 . . . . 0.0 110.993 -171.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.25 158.99 22.48 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -56.16 138.22 50.29 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.889 -0.507 . . . . 0.0 111.459 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.59 -22.97 37.52 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.43 151.8 45.45 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-N 118.672 1.236 . . . . 0.0 110.011 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.8 t -110.76 133.64 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -174.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.2 pt -128.28 160.38 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -109.72 137.81 47.0 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.5 pt -113.13 137.2 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.1 tt -109.76 126.58 53.89 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 36.7 mt -115.17 132.32 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -91.56 145.22 24.78 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.09 -171.03 22.68 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -140.0 176.67 8.56 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.315 -0.521 . . . . 0.0 110.398 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -96.24 132.18 41.96 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -67.58 -36.31 80.64 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.174 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.202 179.899 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.1 ttp . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t -114.38 133.55 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -110.12 151.46 27.23 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.1 mt -110.85 149.34 30.73 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.2 ttm -106.75 144.0 34.03 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.8 mm -128.32 130.25 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.5 mt -129.67 149.38 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -105.81 141.84 36.56 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.32 150.83 20.59 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -106.19 141.5 37.45 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 117.31 0.555 . . . . 0.0 110.269 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.11 123.51 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -123.55 156.94 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.5 t -85.91 132.43 34.09 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.284 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.08 119.94 0.84 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.8 mt -143.39 -48.68 0.31 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.326 -0.514 . . . . 0.0 110.218 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.22 36.35 4.26 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -93.3 -56.62 2.88 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 117.273 0.537 . . . . 0.0 110.034 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.75 179.36 35.58 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 178.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -130.73 109.74 10.84 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 117.214 0.507 . . . . 0.0 110.124 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -155.03 156.5 36.05 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.54 132.25 55.71 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.4 mt -110.0 0.04 18.32 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.2 m -89.53 -32.11 17.31 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 118.971 0.805 . . . . 0.0 110.92 -173.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.6 mt -65.39 156.06 83.09 Favored Pre-proline 0 N--CA 1.502 2.156 0 CA-C-O 119.146 -0.454 . . . . 0.0 110.599 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -53.72 -50.53 13.45 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 121.2 1.267 . . . . 0.0 113.78 -175.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.92 -35.74 94.63 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 120.577 0.851 . . . . 0.0 112.33 -168.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -66.66 -45.85 77.59 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.414 -175.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -66.23 -36.82 84.03 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 122.043 -0.41 . . . . 0.0 110.239 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.68 -47.7 74.57 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.481 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.9 tt -68.88 -36.31 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -176.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.99 -45.25 82.29 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 122.095 -0.378 . . . . 0.0 110.393 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -65.71 -31.01 71.77 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 122.197 -0.314 . . . . 0.0 110.814 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -68.93 -40.44 79.03 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.581 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -81.45 -37.04 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -175.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.8 mt -104.0 -26.19 12.72 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 122.231 -0.293 . . . . 0.0 111.683 -174.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.39 14.76 73.17 Favored Glycine 0 N--CA 1.495 2.593 0 CA-C-O 119.304 -0.72 . . . . 0.0 111.443 -172.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -151.76 163.05 39.99 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 119.22 1.51 . . . . 0.0 110.748 170.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -94.58 109.07 41.17 Favored Pre-proline 0 N--CA 1.496 1.866 0 CA-C-O 118.589 -0.72 . . . . 0.0 109.827 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.47 159.47 52.3 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 O-C-N 123.219 1.115 . . . . 0.0 110.493 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -73.87 162.85 28.66 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -80.22 79.52 6.78 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.467 0.651 . . . . 0.0 109.726 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.5 172.65 45.06 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 175.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.1 p -138.02 157.67 45.88 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 117.408 0.604 . . . . 0.0 110.806 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.9 tp -109.55 114.98 29.07 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.24 120.12 38.1 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.8 mt -120.01 135.95 54.73 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 120.708 0.29 . . . . 0.0 110.664 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -95.99 133.04 40.68 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.8 mt -111.71 160.23 17.48 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 120.663 0.268 . . . . 0.0 110.407 -176.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.06 12.88 14.35 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 172.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -145.91 142.19 28.51 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.65 0.659 . . . . 0.0 109.482 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -64.46 146.89 53.83 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 122.218 -0.301 . . . . 0.0 110.424 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -132.37 136.72 47.02 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 120.659 0.266 . . . . 0.0 110.607 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -138.01 126.44 23.32 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.1 tt -64.2 -23.86 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.173 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -74.05 -1.0 18.17 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.888 -0.508 . . . . 0.0 112.128 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.28 -14.44 30.85 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 118.889 0.768 . . . . 0.0 111.429 169.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -115.82 175.09 5.69 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 118.618 0.644 . . . . 0.0 109.463 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -91.64 102.76 15.4 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -177.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -110.45 178.36 4.4 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.34 -0.225 . . . . 0.0 110.546 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.6 mt -112.35 131.76 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -105.94 142.49 35.56 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.6 p -120.7 138.08 54.15 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 120.745 0.307 . . . . 0.0 110.687 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.94 172.58 12.95 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 120.812 0.339 . . . . 0.0 111.795 -168.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -67.9 141.16 56.46 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -137.23 165.96 24.89 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.22 -0.3 . . . . 0.0 110.636 -176.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -125.43 148.29 48.87 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.734 0.302 . . . . 0.0 110.543 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -149.28 137.2 20.51 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 174.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 51.63 33.0 9.97 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.691 -0.631 . . . . 0.0 112.12 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 17.6 78.59 Favored Glycine 0 N--CA 1.497 2.717 0 CA-C-O 119.625 -0.542 . . . . 0.0 111.803 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -122.52 139.89 53.39 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 118.64 1.22 . . . . 0.0 109.646 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -93.26 131.94 37.91 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.37 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -121.06 143.84 48.86 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -86.14 155.95 20.55 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 120.763 0.316 . . . . 0.0 110.474 -168.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.73 160.85 47.17 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.33 156.67 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 122.358 -0.495 . . . . 0.0 110.381 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -114.99 137.17 52.31 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 176.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.7 t -134.05 141.44 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.5 tp -137.76 125.58 14.08 Favored Pre-proline 0 N--CA 1.497 1.915 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.201 177.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -63.31 148.87 92.55 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.939 1.092 . . . . 0.0 111.491 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.3 pt -142.15 170.09 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 122.257 -0.277 . . . . 0.0 110.419 171.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -115.21 131.91 56.78 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 167.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -105.91 123.85 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.8 mt -108.19 116.77 32.57 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.1 mt -130.2 121.94 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.62 -120.12 17.84 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -178.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -111.17 17.08 20.67 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.377 -0.484 . . . . 0.0 111.811 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -119.62 143.65 47.56 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.55 0.614 . . . . 0.0 110.473 -175.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -123.15 129.5 51.52 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -125.85 143.67 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.0 137.98 43.82 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.87 -164.29 11.21 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.82 156.15 26.98 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 117.328 0.564 . . . . 0.0 110.424 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.2 mt -108.7 141.42 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -123.03 130.63 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -175.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 63.0 t -142.48 135.9 14.25 Favored Pre-proline 0 N--CA 1.497 1.904 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -57.31 153.57 39.6 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 121.093 1.195 . . . . 0.0 111.849 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -65.47 -34.92 79.4 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.512 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -91.42 124.27 35.47 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -142.91 155.21 44.69 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -98.02 -59.99 1.65 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -134.27 -173.38 3.25 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -97.67 149.96 21.7 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m -134.94 175.02 9.96 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 122.307 -0.245 . . . . 0.0 110.379 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -107.35 27.42 9.1 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 122.38 -0.2 . . . . 0.0 110.866 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.7 mm -124.14 127.36 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.3 pt -126.15 145.66 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -115.38 130.1 56.79 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 80.9 mt -115.52 151.31 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.0 pt -116.38 155.19 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 168.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.46 161.93 44.68 Favored Pre-proline 0 N--CA 1.496 1.874 0 CA-C-O 119.128 -0.463 . . . . 0.0 110.457 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -60.44 -31.54 92.69 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 121.09 1.193 . . . . 0.0 111.613 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.15 167.09 23.24 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.182 -0.324 . . . . 0.0 110.996 -175.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -68.18 105.39 2.08 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.68 -38.47 87.9 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.167 -0.333 . . . . 0.0 111.069 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -64.65 -36.88 85.7 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 122.158 -0.339 . . . . 0.0 110.539 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -78.16 -50.36 12.11 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -62.53 -32.56 73.53 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 122.178 -0.326 . . . . 0.0 111.16 -173.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -108.05 8.11 28.08 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.8 43.73 29.84 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.123 -0.986 . . . . 0.0 111.928 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.52 138.25 31.99 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.999 -0.438 . . . . 0.0 110.868 -171.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -113.51 160.68 18.23 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.15 50.22 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.874 -0.516 . . . . 0.0 111.508 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.61 -23.18 36.7 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.53 155.15 36.57 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 118.579 1.19 . . . . 0.0 109.914 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.3 t -112.02 134.0 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.3 pt -128.69 160.14 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 174.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -109.36 138.33 45.88 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.2 pt -112.63 137.9 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.0 tt -109.41 130.43 55.5 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.6 mt -119.82 129.82 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -177.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -92.43 137.74 32.1 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.21 -176.87 29.76 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -147.63 153.83 39.87 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.353 -0.498 . . . . 0.0 110.137 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.69 -34.71 78.47 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 121.051 -0.259 . . . . 0.0 110.313 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -96.72 143.63 27.49 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 110.243 -0.281 . . . . 0.0 110.243 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.152 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.8 mm . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 109.118 -0.697 . . . . 0.44 109.118 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.532 HG22 HD22 ' A' ' 48' ' ' LEU . 71.9 mt -130.01 149.57 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 108.861 -0.792 . . . . 0.22 108.861 177.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -105.19 141.95 35.82 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.2 -0.296 . . . . 0.85999999999999999 110.2 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.7 149.41 20.17 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.595 -1.402 . . . . 0.080000000000000002 109.595 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -106.09 142.09 36.37 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 117.251 0.525 . . . . 0.85999999999999999 110.185 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.5 t -62.97 122.0 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 N-CA-C 109.82 -0.437 . . . . 0.14999999999999999 109.82 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.35 157.12 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 110.084 -0.339 . . . . 0.32000000000000001 110.084 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 N--CA 1.499 2.006 0 N-CA-C 110.222 -0.288 . . . . 1.2 110.222 -179.102 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 . . . . . 0 N--CA 1.501 2.112 0 N-CA-C 110.325 -0.25 . . . . 0.66000000000000003 110.325 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -65.77 -29.99 70.57 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 122.205 -0.31 . . . . 1.72 110.78 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -68.97 -40.58 78.76 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 120.689 -0.404 . . . . 2.3700000000000001 110.609 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.2 mt -81.1 -38.53 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.406 -0.59 . . . . 0.29999999999999999 109.406 -175.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.1 mt -104.11 -26.14 12.68 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 122.144 -0.348 . . . . 0.25 111.558 -174.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.34 14.74 70.6 Favored Glycine 0 N--CA 1.495 2.589 0 CA-C-O 119.408 -0.662 . . . . 0.32000000000000001 111.48 -171.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -152.79 164.51 37.67 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 119.057 1.428 . . . . 0.25 110.618 170.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -95.73 113.04 61.14 Favored Pre-proline 0 N--CA 1.497 1.891 0 CA-C-O 118.466 -0.778 . . . . 1.3500000000000001 109.869 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.408 ' HB3' HD12 ' A' ' 109' ' ' ILE . 68.9 Cg_endo -67.74 159.52 52.36 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 O-C-N 123.314 1.165 . . . . 0.17999999999999999 110.539 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -74.29 164.52 26.5 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 110.075 -0.343 . . . . 0.40000000000000002 110.075 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -80.37 79.58 6.94 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.459 0.647 . . . . 1.4099999999999999 109.721 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.8 176.54 48.05 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.536 -1.426 . . . . 0.29999999999999999 109.536 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -137.99 157.53 46.18 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 117.269 0.535 . . . . 0.23999999999999999 110.763 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.5 HD22 HD12 ' A' ' 114' ' ' LEU . 28.2 tp -110.31 115.05 28.99 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.514 -0.921 . . . . 0.22 108.514 168.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.71 121.31 41.43 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 110.001 -0.37 . . . . 0.14999999999999999 110.001 -175.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.763 HD11 HD11 ' A' ' 126' ' ' ILE . 62.4 mt -121.49 135.49 55.03 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 120.698 0.285 . . . . 0.080000000000000002 110.667 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -95.89 133.55 39.93 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.151 -0.685 . . . . 1.3300000000000001 109.151 172.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.532 HD22 HG22 ' A' ' 7' ' ' ILE . 82.7 mt -111.89 160.2 17.63 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 120.609 0.243 . . . . 0.11 110.411 -176.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.43 13.04 14.68 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 111.911 0.337 . . . . 0.17999999999999999 111.911 172.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -146.53 141.37 26.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.699 -0.625 . . . . 2.0600000000000001 109.505 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -62.93 149.27 45.08 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.168 -0.332 . . . . 1.9399999999999999 110.724 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -131.8 137.83 48.29 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 120.647 0.26 . . . . 0.32000000000000001 110.545 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -138.03 122.51 18.43 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.809 -0.441 . . . . 1.3999999999999999 109.809 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.3 tt -63.28 -22.91 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 C-N-CA 120.97 -0.292 . . . . 0.17000000000000001 111.363 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -74.43 -1.02 19.25 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.982 -0.449 . . . . 0.93000000000000005 112.143 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -90.61 -14.37 32.54 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 118.902 0.774 . . . . 1.52 111.444 170.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -116.11 175.1 5.7 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.668 0.667 . . . . 0.34999999999999998 109.512 173.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -92.07 103.93 16.38 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 110.097 -0.335 . . . . 1.8 110.097 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -109.73 176.99 4.87 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 120.517 0.199 . . . . 0.16 110.574 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.19 130.77 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.29 -1.004 . . . . 0.16 108.29 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -105.89 142.73 35.11 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 110.187 -0.301 . . . . 1.23 110.187 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.1 p -119.31 134.2 55.34 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 120.621 0.248 . . . . 0.35999999999999999 110.443 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.51 172.68 12.57 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 120.716 0.293 . . . . 1.29 111.502 -170.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -67.63 139.18 56.82 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.415 -0.587 . . . . 0.33000000000000002 109.415 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -139.09 167.82 21.21 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.934 -0.306 . . . . 0.23999999999999999 110.684 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -125.33 149.61 47.94 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 120.873 0.368 . . . . 0.80000000000000004 110.506 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -147.79 134.39 19.84 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.197 -0.668 . . . . 0.5 109.197 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 51.67 33.21 10.46 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.69 -0.631 . . . . 1.3100000000000001 112.089 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.47 16.98 78.58 Favored Glycine 0 N--CA 1.497 2.721 0 CA-C-O 119.601 -0.555 . . . . 0.46000000000000002 111.925 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -122.29 141.67 51.28 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 118.668 1.234 . . . . 1.8899999999999999 109.756 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -93.49 133.37 36.85 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 121.021 -0.272 . . . . 1.47 110.55 -176.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -123.04 145.18 48.75 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.887 -0.412 . . . . 0.38 109.887 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -86.98 153.76 21.31 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 120.783 0.325 . . . . 0.38 110.573 -168.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.09 158.62 51.85 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.976 -1.25 . . . . 0.20999999999999999 109.976 -177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.79 159.18 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 122.228 -0.572 . . . . 0.27000000000000002 110.53 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -117.66 137.0 52.95 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.7 -0.482 . . . . 0.95999999999999996 109.7 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.8 t -134.03 141.5 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 109.358 -0.608 . . . . 0.12 109.358 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.4 tp -137.41 125.61 14.49 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.627 -0.701 . . . . 0.14000000000000001 110.087 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.0 149.91 90.21 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 121.033 1.155 . . . . 0.10000000000000001 111.472 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.53 HD13 HG13 ' A' ' 93' ' ' ILE . 43.3 pt -141.54 170.0 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 120.716 0.293 . . . . 0.080000000000000002 110.313 171.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -114.88 130.77 56.96 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.121 -0.696 . . . . 1.4199999999999999 109.121 168.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.69 123.91 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.836 -0.801 . . . . 0.11 108.836 -174.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.9 mt -108.54 116.96 32.95 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 110.284 -0.265 . . . . 0.14999999999999999 110.284 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.4 mt -129.86 121.95 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.186 -1.042 . . . . 0.13 108.186 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.76 -120.37 18.58 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.868 -1.293 . . . . 0.16 109.868 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -111.12 17.13 20.66 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 122.382 -0.481 . . . . 2.0299999999999998 111.831 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -119.83 145.46 46.62 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 118.559 0.618 . . . . 1.3600000000000001 110.505 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -123.07 130.87 53.35 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 110.251 -0.277 . . . . 1.4199999999999999 110.251 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.9 mt -126.16 146.55 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 108.737 -0.838 . . . . 0.13 108.737 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.52 136.84 44.13 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 109.902 -0.407 . . . . 0.40999999999999998 109.902 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.51 -169.25 13.6 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.286 -1.526 . . . . 0.10000000000000001 109.286 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.17 154.62 25.75 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 117.196 0.498 . . . . 0.10000000000000001 110.159 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.53 HG13 HD13 ' A' ' 80' ' ' ILE . 68.5 mt -108.66 140.78 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.292 -1.003 . . . . 0.10000000000000001 108.292 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.79 131.82 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 109.347 -0.612 . . . . 0.14999999999999999 109.347 -175.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.2 t -143.21 138.6 15.79 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 108.545 -0.909 . . . . 0.20000000000000001 108.545 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -56.69 155.57 26.25 Favored 'Trans proline' 0 N--CA 1.504 2.097 0 C-N-CA 121.09 1.194 . . . . 0.23999999999999999 111.942 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -64.38 -34.14 77.49 Favored 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 121.141 -0.224 . . . . 1.1899999999999999 110.702 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -87.96 116.76 26.36 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 121.001 -0.28 . . . . 2.6699999999999999 110.254 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.0 m -130.98 136.64 48.71 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.016 -0.364 . . . . 1.4299999999999999 110.016 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -97.92 -54.63 3.03 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 110.31 -0.256 . . . . 4.6100000000000003 110.31 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -131.64 179.27 6.15 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 110.306 -0.257 . . . . 3.0 110.306 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.9 m -100.14 148.9 24.08 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 110.135 -0.32 . . . . 1.21 110.135 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.0 m -135.01 175.0 9.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 122.292 -0.255 . . . . 1.1699999999999999 110.387 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -107.91 27.07 9.6 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.418 -0.176 . . . . 0.93999999999999995 110.977 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -122.92 127.58 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.047 -0.723 . . . . 0.13 109.047 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.501 HD13 HD11 ' A' ' 48' ' ' LEU . 34.7 pt -125.44 143.68 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 110.109 -0.33 . . . . 0.11 110.109 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -115.03 130.85 57.03 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.963 -0.384 . . . . 1.3600000000000001 109.963 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.455 HD12 HD12 ' A' ' 46' ' ' LEU . 81.8 mt -115.92 151.39 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.434 -0.58 . . . . 0.11 109.434 -173.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 39' ' ' PRO . 13.8 pt -116.44 154.24 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 109.433 -0.58 . . . . 0.14000000000000001 109.433 168.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.58 165.59 24.2 Favored Pre-proline 0 N--CA 1.496 1.836 0 CA-C-O 119.043 -0.503 . . . . 0.13 110.222 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.81 -31.41 93.9 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.069 1.179 . . . . 0.19 111.602 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.61 167.07 23.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.35 -0.219 . . . . 0.28999999999999998 110.664 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -71.65 104.01 3.22 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 109.975 -0.38 . . . . 2.1800000000000002 109.975 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.5 HD12 HD22 ' A' ' 44' ' ' LEU . 81.6 mt -59.37 -33.03 70.67 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 122.069 -0.394 . . . . 0.25 111.449 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -63.1 -35.02 78.87 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 122.191 -0.318 . . . . 2.52 110.904 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -78.25 -47.86 17.03 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.194 -0.669 . . . . 1.8200000000000001 109.194 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -62.28 -34.03 75.77 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.194 -0.317 . . . . 1.28 111.112 -172.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -108.06 9.36 28.42 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 112.534 0.568 . . . . 0.26000000000000001 112.534 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.83 46.24 26.89 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.074 -1.016 . . . . 1.05 111.887 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -91.89 138.2 31.74 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.878 -0.513 . . . . 0.38 110.889 -171.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -114.99 158.2 22.38 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.844 -0.428 . . . . 2.4300000000000002 109.844 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -55.97 137.94 49.83 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.872 -0.517 . . . . 0.5 111.431 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.95 -22.96 37.36 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 111.151 -0.78 . . . . 0.14000000000000001 111.151 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -65.45 155.56 35.14 Favored 'General case' 0 N--CA 1.505 2.311 0 CA-C-N 118.631 1.216 . . . . 0.13 109.968 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -112.63 134.25 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.428 -0.582 . . . . 0.11 109.428 -174.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 46' ' ' LEU . 34.2 pt -129.38 161.33 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 109.554 -0.536 . . . . 0.13 109.554 174.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -110.0 138.26 46.62 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 110.141 -0.318 . . . . 1.3400000000000001 110.141 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.8 pt -114.68 137.15 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 120.845 0.355 . . . . 0.17000000000000001 110.184 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.466 HD23 ' C ' ' A' ' 129' ' ' LEU . 9.9 tt . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 109.861 -0.422 . . . . 0.97999999999999998 109.861 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.1 mm . . . . . 0 N--CA 1.498 1.949 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.496 HG22 HD22 ' A' ' 48' ' ' LEU . 74.5 mt -129.7 148.91 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -105.32 140.05 39.03 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.33 151.08 20.42 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -106.83 141.64 37.74 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.346 -0.503 . . . . 0.0 110.26 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.18 122.28 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -124.4 146.03 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 N--CA 1.498 1.956 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.983 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 N--CA 1.501 2.122 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -65.76 -30.31 70.94 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.24 -0.288 . . . . 0.0 110.814 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -68.94 -40.69 78.85 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.622 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -81.26 -38.02 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' A' ' 92' ' ' ALA . 52.3 mt -103.97 -26.2 12.72 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 122.2 -0.313 . . . . 0.0 111.61 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.03 15.02 70.81 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -172.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -152.83 164.33 38.06 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 119.027 1.413 . . . . 0.0 110.67 170.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -95.07 110.87 52.47 Favored Pre-proline 0 N--CA 1.496 1.844 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.725 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.33 159.9 50.17 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 O-C-N 123.253 1.133 . . . . 0.0 110.526 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -73.96 163.71 27.55 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -80.29 79.6 6.85 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.488 0.661 . . . . 0.0 109.653 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.16 173.24 45.37 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 p -138.05 157.87 45.47 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 117.241 0.52 . . . . 0.0 110.708 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.2 tp -110.31 114.98 28.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.439 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.6 m120 -99.04 119.84 38.47 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.845 HD11 HD11 ' A' ' 126' ' ' ILE . 62.1 mt -119.97 136.1 54.66 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 120.726 0.298 . . . . 0.0 110.717 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HB2' HG11 ' A' ' 12' ' ' VAL . 76.6 tttt -95.9 133.61 39.88 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 173.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.496 HD22 HG22 ' A' ' 7' ' ' ILE . 83.6 mt -112.51 160.25 17.99 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 120.657 0.265 . . . . 0.0 110.417 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.26 13.06 14.3 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 172.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -146.39 142.68 28.44 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 118.533 0.606 . . . . 0.0 109.586 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -64.29 149.43 48.13 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 122.196 -0.315 . . . . 0.0 110.505 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -131.79 138.0 48.37 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 120.701 0.286 . . . . 0.0 110.437 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -138.02 123.07 19.1 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.16 -22.84 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.389 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -74.56 -0.93 19.28 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -90.49 -14.27 33.06 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 118.901 0.773 . . . . 0.0 111.485 171.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -117.19 175.12 5.75 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 118.618 0.645 . . . . 0.0 109.431 173.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -91.31 104.07 16.65 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -110.39 176.65 4.96 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 120.516 0.198 . . . . 0.0 110.532 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.16 131.46 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -105.97 144.06 33.22 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.6 p -120.9 134.73 55.29 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.653 0.264 . . . . 0.0 110.547 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -77.01 172.6 12.94 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 120.77 0.319 . . . . 0.0 111.644 -170.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -67.9 140.22 56.5 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -142.34 166.31 25.02 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.699 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -123.67 149.1 45.87 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 120.787 0.327 . . . . 0.0 110.465 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -149.01 135.72 19.63 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 51.7 33.16 10.45 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.724 -0.61 . . . . 0.0 112.095 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.18 17.01 78.88 Favored Glycine 0 N--CA 1.497 2.712 0 CA-C-O 119.613 -0.548 . . . . 0.0 111.896 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -121.82 140.43 52.38 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 118.647 1.223 . . . . 0.0 109.712 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -93.49 131.44 38.71 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.355 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -121.22 141.97 50.36 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -86.93 156.46 19.81 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 120.741 0.305 . . . . 0.0 110.454 -168.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.55 156.53 52.39 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.3 157.81 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 122.329 -0.512 . . . . 0.0 110.471 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -114.97 138.78 50.44 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.6 t -133.96 140.19 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -176.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.7 tp -137.69 125.69 14.23 Favored Pre-proline 0 N--CA 1.496 1.868 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.114 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -62.9 149.14 92.37 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 120.968 1.112 . . . . 0.0 111.586 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.603 HD13 HG13 ' A' ' 93' ' ' ILE . 43.8 pt -141.98 170.06 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 122.28 -0.263 . . . . 0.0 110.322 172.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -114.6 131.77 56.58 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 168.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -106.0 123.97 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -109.28 117.02 32.98 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.5 mt -130.09 121.96 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.38 -119.95 17.55 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -111.19 17.08 20.66 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 122.349 -0.501 . . . . 0.0 111.855 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -119.54 143.04 47.82 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 118.591 0.632 . . . . 0.0 110.482 -175.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -123.16 130.28 52.55 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 120.683 0.277 . . . . 0.0 110.309 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -126.31 144.93 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.83 138.07 44.21 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.92 -165.36 11.91 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.579 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.69 155.64 26.4 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 117.307 0.553 . . . . 0.0 110.236 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.603 HG13 HD13 ' A' ' 80' ' ' ILE . 70.1 mt -108.69 141.22 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.7 t -121.7 130.78 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.3 t -141.11 134.07 14.41 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -57.24 155.42 29.61 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 121.042 1.162 . . . . 0.0 111.939 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -64.35 -34.02 77.18 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 122.321 -0.237 . . . . 0.0 110.685 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -90.11 123.2 33.76 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.337 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.2 m -130.23 142.97 50.52 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -94.9 -60.01 1.79 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -137.75 171.65 14.13 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.5 m -70.85 146.86 49.38 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.8 m -135.01 161.71 34.52 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.571 0.224 . . . . 0.0 110.464 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -107.64 27.08 9.51 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.375 -0.203 . . . . 0.0 110.833 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -123.73 127.52 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.491 HD13 HD11 ' A' ' 48' ' ' LEU . 34.5 pt -125.49 143.64 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 178.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -113.84 130.16 56.5 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.49 HD12 HD12 ' A' ' 46' ' ' LEU . 82.1 mt -115.5 150.33 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -174.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.8 pt -117.25 155.94 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 168.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.55 161.15 48.31 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-O 119.073 -0.489 . . . . 0.0 110.29 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.73 -30.88 93.18 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 121.105 1.203 . . . . 0.0 111.74 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.4 167.09 23.3 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.262 -0.274 . . . . 0.0 110.761 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -73.62 103.77 4.34 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.98 -35.39 78.34 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.145 -0.347 . . . . 0.0 111.136 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -62.22 -32.9 73.62 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.13 -0.356 . . . . 0.0 110.944 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -78.23 -50.89 11.05 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -63.06 -32.43 73.8 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.158 -172.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -105.97 7.84 32.2 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.87 47.45 24.75 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.014 -1.054 . . . . 0.0 111.841 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.4 mt -91.52 138.24 31.73 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.896 -0.502 . . . . 0.0 110.923 -170.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -116.82 158.66 23.57 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.22 50.08 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.846 -0.534 . . . . 0.0 111.474 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.77 -22.96 37.46 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.39 154.01 39.62 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 118.608 1.204 . . . . 0.0 110.018 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t -111.81 133.38 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -174.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.845 HD11 HD11 ' A' ' 46' ' ' LEU . 21.6 pt -128.68 160.83 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -109.63 138.09 46.5 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 pt -113.56 137.5 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 129' ' ' LEU . 10.1 tt . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.7 mm . . . . . 0 N--CA 1.499 2.014 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.0 mt -129.86 149.58 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -104.96 143.21 33.48 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.286 -0.259 . . . . 0.0 110.37 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.22 151.16 20.68 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.57 142.62 34.99 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 117.253 0.526 . . . . 0.0 110.221 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.7 122.79 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.8 m -126.57 163.39 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 177.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.498 1.967 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.194 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 N--CA 1.501 2.108 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -65.25 -30.92 71.85 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 122.211 -0.306 . . . . 0.0 110.871 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -68.62 -41.21 79.81 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.668 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.3 mt -81.6 -36.46 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.588 HD21 ' HB2' ' A' ' 92' ' ' ALA . 55.8 mt -103.78 -26.13 12.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.192 -0.317 . . . . 0.0 111.668 -174.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.57 14.69 72.84 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -172.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -152.82 162.43 41.29 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 119.062 1.431 . . . . 0.0 110.571 171.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -94.13 108.91 38.98 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.562 -0.733 . . . . 0.0 109.683 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -67.04 159.09 53.65 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 O-C-N 123.254 1.134 . . . . 0.0 110.536 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -73.81 162.97 28.55 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -80.29 79.6 6.84 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.497 0.665 . . . . 0.0 109.672 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.29 171.15 43.49 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -138.05 156.94 47.3 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 117.331 0.566 . . . . 0.0 110.856 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 tp -110.42 117.07 32.61 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 170.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.481 ' O ' HG22 ' A' ' 12' ' ' VAL . 5.9 m120 -99.66 120.87 40.38 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -177.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.737 HD11 HD11 ' A' ' 126' ' ' ILE . 68.3 mt -120.02 135.77 54.8 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 120.728 0.299 . . . . 0.0 110.651 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' HG11 ' A' ' 12' ' ' VAL . 84.7 tttt -96.15 133.55 40.3 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.4 mt -111.59 160.2 17.43 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 120.605 0.24 . . . . 0.0 110.46 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.04 12.95 14.12 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 172.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -145.47 141.89 28.76 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.687 -0.633 . . . . 0.0 109.363 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.37 146.84 53.8 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 122.231 -0.293 . . . . 0.0 110.427 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -131.95 137.36 47.91 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 120.617 0.246 . . . . 0.0 110.553 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -138.02 124.19 20.38 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.49 -22.92 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 122.21 -0.306 . . . . 0.0 111.314 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -72.75 -5.0 34.85 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 122.024 -0.423 . . . . 0.0 112.083 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -90.59 -14.36 32.61 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 118.833 0.742 . . . . 0.0 111.538 172.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -114.64 175.07 5.65 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 118.558 0.617 . . . . 0.0 109.409 173.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -92.1 102.31 14.85 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -109.97 178.64 4.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 122.316 -0.24 . . . . 0.0 110.606 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.0 mt -111.8 130.69 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 174.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -105.93 141.66 36.96 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.0 p -118.07 134.84 54.61 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 120.703 0.287 . . . . 0.0 110.461 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.17 172.71 12.37 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 120.826 0.346 . . . . 0.0 111.535 -170.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -67.29 139.56 57.3 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -138.95 167.13 22.72 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.203 -0.311 . . . . 0.0 110.643 -174.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -124.23 149.19 46.71 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.87 0.367 . . . . 0.0 110.599 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -148.22 134.47 19.44 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 51.76 33.3 10.92 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.736 -0.603 . . . . 0.0 112.142 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.32 16.77 79.06 Favored Glycine 0 N--CA 1.497 2.746 0 CA-C-O 119.664 -0.52 . . . . 0.0 111.937 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -122.33 141.67 51.31 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 118.665 1.233 . . . . 0.0 109.694 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -93.45 132.21 37.92 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 121.13 -0.228 . . . . 0.0 110.483 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -123.18 146.84 47.45 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -86.92 155.21 20.31 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.73 0.3 . . . . 0.0 110.454 -168.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.36 161.18 48.45 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.67 157.09 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 122.372 -0.487 . . . . 0.0 110.412 -174.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -115.48 136.65 52.86 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -134.11 140.19 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.0 tp -137.04 125.65 14.94 Favored Pre-proline 0 N--CA 1.497 1.898 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.057 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -63.6 148.47 92.33 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 121.008 1.139 . . . . 0.0 111.383 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.546 HD13 HG13 ' A' ' 93' ' ' ILE . 43.6 pt -141.96 170.0 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 122.266 -0.271 . . . . 0.0 110.414 172.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -115.07 131.84 56.79 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 167.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.2 mt -105.68 123.7 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.1 mt -108.38 116.99 33.0 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -177.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.4 mt -130.06 121.99 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.24 -120.01 17.94 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -111.2 17.03 20.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.298 -0.531 . . . . 0.0 111.829 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -119.32 143.56 47.31 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.669 -0.644 . . . . 0.0 110.468 -175.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -123.11 129.96 52.14 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 120.671 0.272 . . . . 0.0 110.294 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.6 mt -125.4 143.82 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.82 137.49 43.87 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.98 -165.35 11.93 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.588 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.64 156.62 28.2 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.18 -0.6 . . . . 0.0 110.303 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.546 HG13 HD13 ' A' ' 80' ' ' ILE . 68.8 mt -108.72 142.01 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.5 130.73 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -143.18 136.66 14.15 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -57.22 153.85 37.51 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 121.013 1.142 . . . . 0.0 111.927 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -64.78 -34.38 78.22 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 122.307 -0.246 . . . . 0.0 110.736 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -86.93 116.11 24.77 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.395 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.8 p -131.6 159.53 37.98 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -126.52 -48.34 1.55 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -128.77 175.42 8.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 95.1 p -98.18 149.96 21.99 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.2 m -134.96 170.8 15.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.323 -0.235 . . . . 0.0 110.371 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -107.17 27.08 9.4 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.356 -0.215 . . . . 0.0 110.93 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.0 mm -123.75 127.89 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 pt -126.49 143.1 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -112.83 131.82 55.54 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.48 HD12 HD12 ' A' ' 46' ' ' LEU . 82.9 mt -116.87 150.98 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -174.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.2 pt -116.04 154.32 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.55 166.02 21.99 Favored Pre-proline 0 N--CA 1.494 1.767 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.292 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -60.0 -31.91 94.21 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 121.104 1.203 . . . . 0.0 111.519 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.69 167.09 23.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.305 -0.247 . . . . 0.0 110.69 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -70.61 104.58 2.85 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.64 -33.39 71.46 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 122.099 -0.375 . . . . 0.0 111.463 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -62.75 -35.3 79.36 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 122.155 -0.341 . . . . 0.0 110.907 -174.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.25 -47.85 17.02 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -62.63 -33.69 75.53 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.152 -0.342 . . . . 0.0 111.122 -172.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -108.12 9.27 28.31 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 112.503 0.556 . . . . 0.0 112.503 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.91 45.86 27.55 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.066 -1.021 . . . . 0.0 111.845 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -92.18 138.18 31.75 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.908 -0.495 . . . . 0.0 110.974 -171.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -114.96 160.61 19.36 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.34 49.87 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.918 -0.489 . . . . 0.0 111.482 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.53 -23.49 35.6 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.44 152.65 43.41 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 118.665 1.233 . . . . 0.0 110.076 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.21 133.82 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.737 HD11 HD11 ' A' ' 46' ' ' LEU . 34.1 pt -129.19 161.31 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 174.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -109.91 138.4 46.35 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -112.88 137.93 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.468 HD23 ' C ' ' A' ' 129' ' ' LEU . 8.6 tt . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.1 mm . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.431 HG22 HD22 ' A' ' 48' ' ' LEU . 71.3 mt -130.11 150.09 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.406 ' O ' HD23 ' A' ' 48' ' ' LEU . 51.3 mt-10 -107.08 143.36 35.34 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.55 150.56 20.83 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -106.4 142.9 35.32 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.307 -0.525 . . . . 0.0 110.26 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.73 122.45 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -124.07 142.86 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 175.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.2 t . . . . . 0 N--CA 1.498 1.971 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.279 -178.653 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 N--CA 1.502 2.156 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -65.47 -31.3 72.31 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.783 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -68.56 -40.42 80.63 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.628 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.32 -37.02 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 92' ' ' ALA . 49.0 mt -103.23 -26.29 13.03 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.268 -0.27 . . . . 0.0 111.695 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.98 14.82 74.16 Favored Glycine 0 N--CA 1.493 2.471 0 CA-C-O 119.382 -0.677 . . . . 0.0 111.46 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -151.39 161.45 42.68 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 119.118 1.459 . . . . 0.0 110.651 170.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -94.68 107.84 33.24 Favored Pre-proline 0 N--CA 1.495 1.821 0 CA-C-O 118.637 -0.697 . . . . 0.0 109.856 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -67.31 158.23 57.97 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 O-C-N 123.219 1.115 . . . . 0.0 110.557 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.23 163.76 27.44 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -80.22 79.63 6.76 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.488 0.661 . . . . 0.0 109.675 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.6 172.97 45.37 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 175.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 p -138.05 157.03 47.18 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 117.397 0.599 . . . . 0.0 110.932 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.405 HD22 HD12 ' A' ' 114' ' ' LEU . 22.9 tp -109.63 115.71 30.39 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.436 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.6 m120 -99.26 120.96 40.4 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -176.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.788 HD11 HD11 ' A' ' 126' ' ' ILE . 57.6 mt -120.07 136.01 54.73 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.701 0.286 . . . . 0.0 110.607 -178.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HB2' HG11 ' A' ' 12' ' ' VAL . 48.3 tttm -96.36 134.24 39.75 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 173.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.431 HD22 HG22 ' A' ' 7' ' ' ILE . 84.3 mt -111.53 160.28 17.32 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 120.671 0.272 . . . . 0.0 110.45 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.14 13.0 14.2 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 171.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -145.21 142.27 29.4 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 118.567 0.622 . . . . 0.0 109.416 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -64.5 146.83 53.96 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 122.221 -0.299 . . . . 0.0 110.339 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -132.46 136.67 46.87 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 120.736 0.303 . . . . 0.0 110.602 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -138.04 127.4 24.67 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.33 -23.98 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.385 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -74.27 -1.07 19.05 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.944 -0.472 . . . . 0.0 112.182 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -91.02 -14.26 31.73 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 118.838 0.745 . . . . 0.0 111.481 169.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -116.23 175.06 5.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.665 -0.647 . . . . 0.0 109.43 174.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -91.98 102.93 15.5 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -110.63 178.46 4.36 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 120.579 0.228 . . . . 0.0 110.548 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -112.36 131.64 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 174.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -105.87 144.13 33.04 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.2 p -123.24 138.52 54.61 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 120.783 0.325 . . . . 0.0 110.786 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -77.29 172.71 12.86 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -167.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -67.6 141.36 56.81 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -136.59 167.28 21.68 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.535 -176.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -124.19 146.92 48.39 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 120.807 0.337 . . . . 0.0 110.667 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -149.8 138.65 20.99 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.6 m120 52.14 30.0 7.13 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.708 -0.62 . . . . 0.0 112.135 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.17 16.19 80.87 Favored Glycine 0 N--CA 1.497 2.736 0 CA-C-O 119.528 -0.596 . . . . 0.0 111.749 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -121.08 144.07 48.75 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 118.783 1.291 . . . . 0.0 109.617 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.13 131.36 38.26 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.53 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -120.17 144.72 47.53 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -85.81 156.97 20.35 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 120.845 0.355 . . . . 0.0 110.554 -167.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.43 162.01 44.72 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.42 156.71 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 122.409 -0.465 . . . . 0.0 110.351 -175.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -116.07 137.55 52.02 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.9 t -134.01 140.7 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -176.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.5 tp -136.72 125.65 15.31 Favored Pre-proline 0 N--CA 1.497 1.884 0 CA-C-O 118.553 -0.737 . . . . 0.0 110.109 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -63.78 149.12 91.48 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 120.937 1.091 . . . . 0.0 111.357 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.533 HD13 HG13 ' A' ' 93' ' ' ILE . 43.3 pt -141.79 169.64 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 120.692 0.282 . . . . 0.0 110.298 171.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -114.83 131.26 56.88 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 167.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.4 mt -105.71 123.29 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -175.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.6 mt -107.77 116.48 32.03 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.1 mt -129.75 121.91 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.64 -120.24 18.28 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -111.09 16.98 20.82 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.311 -0.523 . . . . 0.0 111.832 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -119.65 144.4 47.18 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 118.609 0.64 . . . . 0.0 110.464 -175.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -123.12 129.98 52.16 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 120.668 0.271 . . . . 0.0 110.282 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.3 mt -125.54 144.91 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.89 136.83 43.39 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.67 -167.17 12.71 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.59 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.37 155.68 27.15 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 117.277 0.538 . . . . 0.0 110.363 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.533 HG13 HD13 ' A' ' 80' ' ' ILE . 68.1 mt -108.72 141.84 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.03 131.56 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.8 t -141.87 130.63 12.13 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -58.75 155.02 39.76 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 121.02 1.147 . . . . 0.0 111.633 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -64.92 -34.41 78.34 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.301 -0.25 . . . . 0.0 110.574 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -87.98 121.09 29.99 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.3 t -142.38 152.45 42.86 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.344 -0.223 . . . . 0.0 110.407 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -98.9 -58.65 1.9 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -136.76 170.62 15.77 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.1 p -82.74 150.63 26.58 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.1 m -135.17 174.98 10.01 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 120.577 0.227 . . . . 0.0 110.408 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -106.4 27.22 8.95 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.374 -0.204 . . . . 0.0 110.932 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.0 mm -123.73 127.82 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.5 pt -125.2 145.1 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -115.92 130.21 56.73 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.467 HD12 HD12 ' A' ' 46' ' ' LEU . 82.2 mt -115.6 151.02 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -173.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.6 pt -116.56 154.78 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 169.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.59 165.97 22.2 Favored Pre-proline 0 N--CA 1.496 1.829 0 CA-C-O 119.049 -0.5 . . . . 0.0 110.307 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.9 -32.64 95.51 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 121.078 1.185 . . . . 0.0 111.404 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.98 161.54 39.13 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.695 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -63.36 105.81 0.8 Allowed 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 121.267 0.556 . . . . 0.0 111.038 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.405 HD12 HD22 ' A' ' 44' ' ' LEU . 82.4 mt -59.84 -33.35 71.67 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.861 -0.524 . . . . 0.0 111.445 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 93.1 mtm-85 -62.55 -35.36 79.22 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 122.131 -0.355 . . . . 0.0 110.967 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -78.22 -48.03 16.71 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -62.46 -34.24 76.43 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 122.192 -0.318 . . . . 0.0 111.102 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -108.03 9.0 28.56 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 51.85 50.43 18.64 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.137 -0.977 . . . . 0.0 111.934 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.6 mt -90.41 138.12 31.8 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.868 -0.52 . . . . 0.0 110.909 -171.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -116.32 156.96 25.75 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.08 138.04 50.23 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.863 -0.523 . . . . 0.0 111.5 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.68 -22.87 37.91 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -65.38 150.74 47.79 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-N 118.725 1.262 . . . . 0.0 110.041 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.96 133.39 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -173.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.788 HD11 HD11 ' A' ' 46' ' ' LEU . 34.0 pt -128.21 160.39 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -109.3 138.19 46.04 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.0 pt -111.82 136.77 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.462 HD23 ' C ' ' A' ' 129' ' ' LEU . 9.4 tt . . . . . 0 N--CA 1.495 1.786 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.2 mm . . . . . 0 N--CA 1.498 1.934 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.511 HG22 HD22 ' A' ' 48' ' ' LEU . 73.2 mt -129.52 148.33 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -105.73 140.39 38.86 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.12 150.51 20.01 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -105.39 142.45 35.13 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 122.354 -0.497 . . . . 0.0 110.205 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.69 123.25 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 45' ' ' ASN . 27.0 m -124.76 163.84 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 N--CA 1.498 1.957 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.22 -178.7 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -65.57 -31.42 72.46 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.225 -0.297 . . . . 0.0 110.855 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -68.71 -40.4 79.98 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.576 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.4 mt -81.35 -36.94 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 92' ' ' ALA . 49.6 mt -104.04 -26.24 12.68 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.228 -0.295 . . . . 0.0 111.611 -174.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.44 14.89 72.7 Favored Glycine 0 N--CA 1.494 2.504 0 CA-C-O 119.322 -0.71 . . . . 0.0 111.421 -172.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -151.84 161.17 43.09 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 119.097 1.449 . . . . 0.0 110.7 170.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -94.1 108.4 35.32 Favored Pre-proline 0 N--CA 1.496 1.874 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.821 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -67.3 157.94 59.37 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 O-C-N 123.279 1.147 . . . . 0.0 110.45 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -73.61 164.0 27.25 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -80.24 79.56 6.79 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.502 0.668 . . . . 0.0 109.612 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.76 172.18 44.44 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 p -138.01 157.18 46.89 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 117.315 0.558 . . . . 0.0 110.691 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.7 tp -109.4 116.14 31.27 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 170.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.54 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.7 m120 -98.34 120.44 38.76 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -177.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.833 HD11 HD11 ' A' ' 126' ' ' ILE . 61.0 mt -120.03 136.15 54.67 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 120.683 0.278 . . . . 0.0 110.658 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HB2' HG11 ' A' ' 12' ' ' VAL . 63.8 tttt -96.05 132.77 41.06 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.511 HD22 HG22 ' A' ' 7' ' ' ILE . 83.6 mt -111.82 160.22 17.56 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 120.681 0.277 . . . . 0.0 110.427 -176.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.1 13.14 13.78 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 172.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -145.86 142.03 28.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.657 -0.652 . . . . 0.0 109.566 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -64.23 148.88 49.13 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 122.297 -0.252 . . . . 0.0 110.395 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -131.78 137.03 48.0 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 120.688 0.28 . . . . 0.0 110.5 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -138.0 124.05 20.25 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.3 tt -64.25 -22.94 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.226 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -72.52 -4.19 29.03 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 118.257 0.48 . . . . 0.0 112.074 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -90.53 -14.26 32.96 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 118.833 0.742 . . . . 0.0 111.427 172.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -115.68 175.08 5.69 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 118.673 0.67 . . . . 0.0 109.34 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -91.42 101.98 14.66 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -108.64 175.96 5.28 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.313 -0.242 . . . . 0.0 110.623 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.7 mt -110.34 131.08 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -105.93 143.12 34.52 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.5 p -122.48 134.53 54.57 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.65 0.262 . . . . 0.0 110.618 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -76.86 172.62 12.84 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 120.803 0.335 . . . . 0.0 111.686 -169.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -67.96 140.29 56.41 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -141.09 165.48 27.42 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.755 -175.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -123.28 149.07 45.26 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.803 0.335 . . . . 0.0 110.533 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -149.87 135.52 18.42 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 51.69 32.91 10.01 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.654 -0.654 . . . . 0.0 112.1 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.27 17.32 78.24 Favored Glycine 0 N--CA 1.498 2.796 0 CA-C-O 119.683 -0.509 . . . . 0.0 111.835 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -122.75 141.13 52.14 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.628 1.214 . . . . 0.0 109.767 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.68 131.73 38.71 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.424 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -121.81 143.96 49.1 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -86.99 155.73 20.05 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 120.812 0.339 . . . . 0.0 110.482 -168.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.45 158.28 51.19 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.3 155.09 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 122.268 -0.548 . . . . 0.0 110.37 -174.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -113.26 137.45 51.47 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.1 t -133.24 140.27 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 tp -137.21 125.71 14.79 Favored Pre-proline 0 N--CA 1.497 1.878 0 CA-C-O 118.522 -0.752 . . . . 0.0 110.073 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -63.21 149.81 90.33 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 120.916 1.077 . . . . 0.0 111.542 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.568 HD13 HG13 ' A' ' 93' ' ' ILE . 43.5 pt -142.13 170.05 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -114.31 131.98 56.34 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 167.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.46 122.88 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -107.47 116.89 32.74 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 74.5 mt -129.97 121.9 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.52 -119.94 17.33 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -111.21 17.01 20.7 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.359 -0.494 . . . . 0.0 111.788 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -119.74 143.94 47.52 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 118.536 0.607 . . . . 0.0 110.468 -175.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -123.14 129.64 51.7 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 120.674 0.273 . . . . 0.0 110.286 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.4 mt -125.53 145.11 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.79 136.72 43.59 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.42 -166.32 12.09 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.72 155.54 26.16 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 117.348 0.574 . . . . 0.0 110.385 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.568 HG13 HD13 ' A' ' 80' ' ' ILE . 69.0 mt -108.73 141.19 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.35 132.11 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.1 t -142.16 129.04 11.17 Favored Pre-proline 0 N--CA 1.498 1.934 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.97 154.35 51.25 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.027 1.151 . . . . 0.0 111.412 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -61.81 -30.84 71.09 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 122.262 -0.274 . . . . 0.0 111.402 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -84.85 107.98 17.28 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.299 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.5 m -131.05 145.41 52.01 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -94.06 -59.74 1.9 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -139.53 170.32 16.14 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.4 m -68.43 145.96 53.63 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.2 m -135.0 166.23 23.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.352 -0.218 . . . . 0.0 110.462 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -107.4 27.1 9.43 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.379 -0.201 . . . . 0.0 110.865 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.7 mm -123.16 127.34 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.467 HD13 HD11 ' A' ' 48' ' ' LEU . 34.2 pt -125.83 144.4 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -114.21 129.58 56.63 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.502 HD12 HD12 ' A' ' 46' ' ' LEU . 82.7 mt -114.78 150.67 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -174.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 pt -116.52 154.85 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 168.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.51 166.07 21.79 Favored Pre-proline 0 N--CA 1.496 1.831 0 CA-C-O 119.099 -0.477 . . . . 0.0 110.257 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.79 -32.12 95.04 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 121.135 1.223 . . . . 0.0 111.468 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.9 160.49 41.22 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.334 -0.229 . . . . 0.0 110.695 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.5 pttt -63.07 105.85 0.76 Allowed 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.297 0.57 . . . . 0.0 111.106 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.7 mt -59.79 -33.44 71.71 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.843 -0.535 . . . . 0.0 111.413 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -62.81 -35.13 78.91 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 122.092 -0.38 . . . . 0.0 111.021 -173.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -78.19 -48.4 15.95 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -62.44 -34.33 76.58 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 122.223 -0.298 . . . . 0.0 111.129 -172.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -108.14 8.87 28.27 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.86 50.39 18.73 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.1 -1.0 . . . . 0.0 111.942 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 45.5 mt -90.35 138.22 31.72 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.757 -0.589 . . . . 0.0 110.952 -171.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -116.39 157.32 25.27 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.99 138.14 49.59 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 121.889 -0.507 . . . . 0.0 111.524 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.68 -22.93 37.65 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -65.47 152.43 43.97 Favored 'General case' 0 N--CA 1.505 2.31 0 CA-C-N 118.597 1.199 . . . . 0.0 110.033 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -111.03 133.93 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -174.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.833 HD11 HD11 ' A' ' 46' ' ' LEU . 34.4 pt -128.85 159.75 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -109.71 137.97 46.76 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 pt -112.82 137.83 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 176.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.466 HD23 ' C ' ' A' ' 129' ' ' LEU . 9.4 tt . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.5 mm . . . . . 0 N--CA 1.497 1.92 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.1 mt -129.84 148.75 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -105.11 141.53 36.5 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.26 151.34 20.48 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.77 141.85 36.49 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 117.184 0.492 . . . . 0.0 110.212 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.65 123.86 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 45' ' ' ASN . 27.0 m -123.71 146.43 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.498 1.936 0 O-C-N 122.311 -0.243 . . . . 0.0 110.451 -178.488 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 N--CA 1.501 2.125 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -65.32 -32.39 74.02 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 122.189 -0.319 . . . . 0.0 110.681 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -68.65 -39.57 80.63 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.687 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.7 mt -81.04 -37.52 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -176.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' A' ' 92' ' ' ALA . 46.4 mt -103.42 -26.14 13.0 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.196 -0.315 . . . . 0.0 111.735 -173.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.57 14.75 75.27 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -150.96 160.67 43.77 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 119.107 1.453 . . . . 0.0 110.547 170.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -94.82 108.8 40.11 Favored Pre-proline 0 N--CA 1.495 1.822 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.808 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.23 158.89 54.76 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 O-C-N 123.283 1.149 . . . . 0.0 110.508 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -73.74 163.89 27.36 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -80.21 79.54 6.76 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.544 0.688 . . . . 0.0 109.617 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.06 171.61 43.66 Favored Glycine 0 N--CA 1.496 2.633 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -138.1 157.93 45.34 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 117.356 0.578 . . . . 0.0 110.59 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.545 HD22 ' CD1' ' A' ' 114' ' ' LEU . 28.2 tp -109.9 116.54 31.82 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.533 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.4 m120 -98.94 123.45 43.22 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -176.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.648 HD11 HD11 ' A' ' 126' ' ' ILE . 74.8 mt -120.62 135.57 55.07 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 120.641 0.258 . . . . 0.0 110.602 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HB2' HG11 ' A' ' 12' ' ' VAL . 36.3 ttmt -96.17 133.12 40.86 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.428 HD11 HD13 ' A' ' 106' ' ' ILE . 83.4 mt -112.3 160.27 17.83 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 120.701 0.286 . . . . 0.0 110.464 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -89.57 13.46 13.95 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 172.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -145.41 141.82 28.76 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.763 -0.585 . . . . 0.0 109.423 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -64.47 146.81 53.96 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 122.201 -0.312 . . . . 0.0 110.396 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -134.97 136.41 42.2 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 120.714 0.292 . . . . 0.0 110.588 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -138.04 131.02 30.03 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.48 -23.08 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.533 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -74.86 -0.94 20.12 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.895 -0.503 . . . . 0.0 112.253 -176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -90.04 -14.51 33.71 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 118.946 0.794 . . . . 0.0 111.575 171.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -117.77 175.12 5.8 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.68 -0.637 . . . . 0.0 109.403 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -90.89 103.59 16.28 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -109.73 178.14 4.51 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 120.587 0.232 . . . . 0.0 110.5 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.0 mt -111.15 131.03 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -105.95 146.02 30.56 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.3 p -122.6 137.22 54.96 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 120.688 0.28 . . . . 0.0 110.649 176.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -76.59 172.7 12.59 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 120.895 0.378 . . . . 0.0 111.711 -168.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -67.37 140.23 57.2 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -139.54 166.73 23.81 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 122.221 -0.299 . . . . 0.0 110.598 -174.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -124.22 148.75 47.08 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 120.891 0.377 . . . . 0.0 110.488 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -148.97 136.73 20.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.91 32.27 9.67 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.703 -0.623 . . . . 0.0 112.101 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.07 16.85 79.23 Favored Glycine 0 N--CA 1.496 2.692 0 CA-C-O 119.587 -0.563 . . . . 0.0 111.874 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -123.22 143.13 50.24 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 118.651 1.225 . . . . 0.0 109.731 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.37 132.2 37.83 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 121.066 -0.253 . . . . 0.0 110.366 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -121.78 144.91 48.53 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -86.03 156.52 20.39 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.4 -169.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.14 161.22 44.85 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.93 156.92 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 122.354 -0.498 . . . . 0.0 110.327 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -118.77 137.24 53.5 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.8 t -134.04 141.11 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -176.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.4 tp -137.25 125.65 14.7 Favored Pre-proline 0 N--CA 1.496 1.851 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.13 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -63.35 149.46 91.17 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 120.936 1.09 . . . . 0.0 111.477 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.514 HD13 HG13 ' A' ' 93' ' ' ILE . 44.2 pt -141.53 170.09 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 122.209 -0.307 . . . . 0.0 110.256 171.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -114.67 131.56 56.69 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 167.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.05 123.17 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -175.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.1 mt -108.37 117.09 33.24 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.96 121.94 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.29 -119.93 17.58 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -111.16 17.0 20.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.343 -0.504 . . . . 0.0 111.981 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -119.94 144.01 47.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.749 -0.594 . . . . 0.0 110.512 -175.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -123.15 130.76 53.19 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.9 mt -125.78 145.27 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.79 137.83 44.13 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.16 -167.7 13.73 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.424 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.6 156.92 28.82 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 117.354 0.577 . . . . 0.0 110.443 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.514 HG13 HD13 ' A' ' 80' ' ' ILE . 68.7 mt -108.63 141.25 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.98 131.05 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.9 t -143.67 136.52 13.7 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -58.11 154.21 41.0 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 120.989 1.126 . . . . 0.0 111.757 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -65.9 -34.87 79.13 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 122.282 -0.261 . . . . 0.0 110.468 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -92.05 125.7 36.84 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -137.26 155.51 49.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 122.33 -0.231 . . . . 0.0 110.421 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -97.01 -59.43 1.8 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -138.94 170.33 16.18 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.3 p -80.74 147.53 30.51 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.4 m -134.98 174.03 11.07 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 120.583 0.23 . . . . 0.0 110.481 -177.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -107.23 27.61 8.89 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 122.36 -0.212 . . . . 0.0 110.862 177.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -123.3 127.74 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.428 HD13 HD11 ' A' ' 48' ' ' LEU . 34.4 pt -125.97 145.12 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -116.35 130.06 56.58 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.444 HD12 HD12 ' A' ' 46' ' ' LEU . 83.1 mt -114.58 150.41 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -175.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 pt -115.92 153.97 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 169.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.58 166.04 21.82 Favored Pre-proline 0 N--CA 1.494 1.738 0 CA-C-O 119.074 -0.489 . . . . 0.0 110.293 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.75 -31.3 93.88 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.08 1.187 . . . . 0.0 111.68 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.71 167.09 23.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 122.338 -0.226 . . . . 0.0 110.921 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -67.74 107.04 2.43 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.545 ' CD1' HD22 ' A' ' 44' ' ' LEU . 81.3 mt -60.05 -35.82 75.96 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 122.081 -0.387 . . . . 0.0 111.373 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 71.8 mtt85 -62.39 -35.29 78.73 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 122.175 -0.328 . . . . 0.0 110.981 -175.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -78.2 -47.3 18.32 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.6 -34.85 77.83 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 122.191 -0.318 . . . . 0.0 111.036 -172.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -108.01 8.61 28.4 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 51.73 46.81 25.95 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.072 -1.017 . . . . 0.0 111.96 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.37 138.18 31.78 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.956 -0.465 . . . . 0.0 110.969 -170.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -114.79 158.25 22.14 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.78 138.08 48.62 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.866 -0.521 . . . . 0.0 111.541 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.63 -22.93 37.66 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.52 151.86 45.4 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 118.635 1.217 . . . . 0.0 109.982 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.52 134.09 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.648 HD11 HD11 ' A' ' 46' ' ' LEU . 34.2 pt -129.24 161.32 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -110.4 137.89 47.51 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -113.02 137.6 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 176.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 129' ' ' LEU . 9.0 tt . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.6 mm . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.7 mt -129.58 148.5 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -106.98 142.37 36.7 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 122.27 -0.269 . . . . 0.0 110.466 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.69 151.57 20.95 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -106.07 142.69 35.34 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 117.247 0.524 . . . . 0.0 110.259 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.64 124.32 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 45' ' ' ASN . 27.1 m -123.73 156.12 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.499 1.981 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.4 -176.536 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.504 2.227 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -64.51 -31.45 72.68 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 122.157 -0.339 . . . . 0.0 110.767 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -67.98 -40.34 83.12 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.657 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.549 HG23 HD12 ' A' ' 60' ' ' ILE . 59.6 mt -80.94 -37.27 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -175.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 92' ' ' ALA . 58.0 mt -102.53 -26.29 13.29 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 122.189 -0.319 . . . . 0.0 111.568 -174.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.35 14.33 74.34 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-O 119.26 -0.745 . . . . 0.0 111.411 -172.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -152.31 161.23 42.91 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 119.243 1.521 . . . . 0.0 110.641 170.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -94.32 107.95 32.87 Favored Pre-proline 0 N--CA 1.496 1.841 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.737 177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.413 ' CB ' HD12 ' A' ' 109' ' ' ILE . 65.1 Cg_endo -67.4 155.48 70.2 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 O-C-N 123.327 1.172 . . . . 0.0 110.462 -176.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -73.82 164.17 26.98 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.24 79.55 6.8 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.489 0.661 . . . . 0.0 109.663 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.55 171.74 44.03 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 p -138.05 156.74 47.49 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 117.41 0.605 . . . . 0.0 110.884 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.2 tp -109.91 118.58 36.84 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 170.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.545 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.7 m120 -98.95 122.34 42.08 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -176.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.822 HD11 HD11 ' A' ' 126' ' ' ILE . 60.8 mt -119.96 136.08 54.67 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 120.686 0.279 . . . . 0.0 110.562 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HB2' HG11 ' A' ' 12' ' ' VAL . 67.4 tttt -96.23 133.39 40.61 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 173.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.477 HD11 HD13 ' A' ' 106' ' ' ILE . 82.9 mt -112.16 160.18 17.82 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 120.561 0.22 . . . . 0.0 110.482 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.2 13.16 13.94 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -145.34 141.21 28.3 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 118.604 0.638 . . . . 0.0 109.418 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -64.18 146.84 53.59 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 122.253 -0.279 . . . . 0.0 110.392 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -132.02 137.41 47.83 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 120.705 0.288 . . . . 0.0 110.638 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -138.07 128.34 26.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.613 HD13 ' HB3' ' A' ' 76' ' ' LYS . 20.0 tt -63.72 -24.08 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.327 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -74.33 -1.05 19.11 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 122.0 -0.437 . . . . 0.0 112.156 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -91.22 -14.35 31.16 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 118.874 0.761 . . . . 0.0 111.441 169.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -116.07 175.02 5.73 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.644 -0.66 . . . . 0.0 109.396 175.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -92.07 101.97 14.51 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -177.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -110.18 176.71 4.95 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 120.535 0.207 . . . . 0.0 110.489 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.549 HD12 HG23 ' A' ' 34' ' ' ILE . 77.6 mt -110.98 134.43 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -105.75 142.47 35.43 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.3 p -116.7 133.66 55.75 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -77.18 172.63 12.94 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 120.803 0.335 . . . . 0.0 111.345 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -68.6 139.98 55.54 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -138.35 166.6 23.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.251 -0.281 . . . . 0.0 110.67 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -125.44 145.81 49.9 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 120.749 0.309 . . . . 0.0 110.544 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -149.57 141.82 24.12 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.0 m120 52.17 29.95 7.15 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.667 -0.646 . . . . 0.0 112.085 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.41 16.39 80.76 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -121.51 142.54 49.97 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 118.699 1.25 . . . . 0.0 109.666 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -93.14 131.7 37.95 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.477 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -120.85 143.73 48.74 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -86.89 151.9 22.91 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 120.763 0.316 . . . . 0.0 110.382 -169.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.74 167.18 42.01 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.99 162.76 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 122.312 -0.523 . . . . 0.0 110.488 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.613 ' HB3' HD13 ' A' ' 54' ' ' ILE . 61.7 mttp -112.23 137.37 50.42 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 173.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -132.47 138.33 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.2 tp -136.94 125.65 15.06 Favored Pre-proline 0 N--CA 1.497 1.925 0 CA-C-O 118.663 -0.684 . . . . 0.0 110.097 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -63.59 149.39 91.06 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 120.993 1.128 . . . . 0.0 111.395 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.555 HD13 HG13 ' A' ' 93' ' ' ILE . 43.1 pt -142.15 170.03 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 171.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -115.28 131.99 56.75 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 167.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.6 mt -106.26 123.48 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.636 HD11 HD12 ' A' ' 129' ' ' LEU . 85.5 mt -107.86 116.76 32.55 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.4 mt -129.92 121.98 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.35 -120.13 18.26 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -178.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -111.07 16.95 20.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.366 -0.491 . . . . 0.0 111.926 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -119.72 144.0 47.47 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 118.577 0.626 . . . . 0.0 110.496 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -123.1 129.72 51.82 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 120.651 0.262 . . . . 0.0 110.308 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.2 mt -125.96 143.44 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.96 138.2 44.04 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.23 -164.34 11.32 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.541 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.88 156.19 26.92 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 117.351 0.576 . . . . 0.0 110.417 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.555 HG13 HD13 ' A' ' 80' ' ' ILE . 69.7 mt -108.77 141.53 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.57 130.77 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.6 t -140.39 126.8 11.92 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -57.7 155.83 30.27 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 121.024 1.149 . . . . 0.0 111.883 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -63.76 -33.88 76.65 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 122.31 -0.244 . . . . 0.0 110.78 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -86.65 116.15 24.57 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.1 m -130.83 142.64 50.4 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -93.8 -50.37 5.39 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -147.8 -179.48 6.92 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.9 p -91.18 145.52 24.6 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.5 m -135.08 174.96 10.03 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 120.586 0.231 . . . . 0.0 110.562 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -107.07 27.42 9.04 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 122.458 -0.151 . . . . 0.0 110.929 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.7 mm -122.64 127.4 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.477 HD13 HD11 ' A' ' 48' ' ' LEU . 34.5 pt -125.43 144.05 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 110.137 -0.319 . . . . 0.0 110.137 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -114.55 130.15 56.73 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.483 HD12 HD12 ' A' ' 46' ' ' LEU . 82.9 mt -115.28 151.06 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -174.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.413 HD12 ' CB ' ' A' ' 39' ' ' PRO . 12.5 pt -115.74 155.72 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 169.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.48 162.02 44.2 Favored Pre-proline 0 N--CA 1.495 1.791 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.214 -176.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.21 -34.47 94.01 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.065 1.177 . . . . 0.0 111.462 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -145.03 159.07 43.53 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.348 -0.22 . . . . 0.0 110.684 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.7 pttt -63.72 103.97 0.62 Allowed 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.495 0.665 . . . . 0.0 111.23 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.46 -31.98 69.82 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.927 -0.483 . . . . 0.0 111.373 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.411 ' HA ' HD12 ' A' ' 120' ' ' LEU . 76.6 mtm180 -61.29 -34.98 76.1 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.008 -0.432 . . . . 0.0 111.211 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -78.25 -49.07 14.41 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -61.89 -33.8 74.88 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.217 -172.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -108.11 9.02 28.38 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.79 50.54 18.44 Favored 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.005 -1.059 . . . . 0.0 111.85 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 115' ' ' ARG . 44.9 mt -89.49 138.14 31.71 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.878 -0.514 . . . . 0.0 110.951 -169.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -119.52 157.24 28.74 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -55.95 138.51 48.67 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.84 -0.537 . . . . 0.0 111.474 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.53 -23.02 37.33 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.32 151.44 46.24 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 118.702 1.251 . . . . 0.0 110.03 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -110.23 133.07 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -174.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.822 HD11 HD11 ' A' ' 46' ' ' LEU . 34.4 pt -128.29 160.13 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -109.25 137.98 46.3 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -175.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.0 pt -110.12 137.6 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.636 HD12 HD11 ' A' ' 83' ' ' LEU . 8.0 tt . . . . . 0 N--CA 1.494 1.757 0 O-C-N 122.314 -0.241 . . . . 0.0 110.359 -175.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.3 mm . . . . . 0 N--CA 1.499 1.992 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.495 HG22 HD22 ' A' ' 48' ' ' LEU . 75.3 mt -129.74 148.91 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -105.53 140.14 39.08 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.85 151.1 20.31 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -105.99 141.32 37.57 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 117.229 0.515 . . . . 0.0 110.256 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.3 t -63.22 124.04 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 45' ' ' ASN . 27.0 m -123.88 164.02 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 176.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.499 2.003 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.194 -176.981 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 N--CA 1.501 2.123 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -65.74 -31.63 72.73 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.156 -0.34 . . . . 0.0 110.758 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -68.53 -40.44 80.76 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.578 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -81.44 -36.59 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 92' ' ' ALA . 46.0 mt -103.27 -26.39 12.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 122.14 -0.35 . . . . 0.0 111.693 -174.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.53 15.36 73.84 Favored Glycine 0 N--CA 1.495 2.586 0 CA-C-O 119.362 -0.688 . . . . 0.0 111.411 -173.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -151.14 162.75 40.29 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 119.145 1.473 . . . . 0.0 110.812 170.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.03 106.52 22.79 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.835 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.427 ' CB ' HD12 ' A' ' 109' ' ' ILE . 72.9 Cg_endo -68.48 160.93 47.12 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 O-C-N 123.383 1.201 . . . . 0.0 110.269 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -73.19 160.58 31.73 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -80.23 79.6 6.78 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.479 0.657 . . . . 0.0 109.686 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.28 176.41 47.79 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 p -138.11 156.25 47.95 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 117.331 0.565 . . . . 0.0 110.813 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.501 HD22 HD12 ' A' ' 114' ' ' LEU . 31.6 tp -108.68 116.47 32.05 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 169.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.548 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.6 m120 -98.41 122.13 41.21 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -176.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.796 HD11 HD11 ' A' ' 126' ' ' ILE . 61.4 mt -120.31 135.59 54.96 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 120.653 0.263 . . . . 0.0 110.535 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -95.9 133.09 40.49 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.52 HD11 HD13 ' A' ' 106' ' ' ILE . 83.6 mt -112.31 160.22 17.88 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 120.653 0.263 . . . . 0.0 110.484 -175.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.06 13.0 14.04 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 172.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -145.99 142.89 29.09 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 118.614 0.643 . . . . 0.0 109.557 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.34 148.63 49.91 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.503 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -131.91 137.44 47.99 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 120.701 0.286 . . . . 0.0 110.44 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -138.09 125.0 21.22 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.5 -23.62 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.266 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -74.24 -1.45 20.61 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.976 -0.453 . . . . 0.0 112.109 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.09 -14.5 31.13 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 118.929 0.786 . . . . 0.0 111.453 170.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -116.67 175.15 5.7 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 118.658 0.663 . . . . 0.0 109.343 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -91.31 102.72 15.42 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -109.44 177.35 4.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 122.323 -0.235 . . . . 0.0 110.563 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.2 mt -111.28 130.91 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -105.97 142.4 35.75 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.2 p -120.69 138.8 53.77 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 120.794 0.331 . . . . 0.0 110.743 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -76.75 172.64 12.75 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 120.847 0.356 . . . . 0.0 111.826 -168.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -67.88 141.21 56.47 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -136.67 164.91 27.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.152 -0.342 . . . . 0.0 110.598 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -123.61 145.95 48.54 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 120.732 0.301 . . . . 0.0 110.469 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -149.88 139.39 21.53 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 52.01 30.34 7.28 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.674 -0.642 . . . . 0.0 112.131 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.36 16.59 80.29 Favored Glycine 0 N--CA 1.497 2.725 0 CA-C-O 119.648 -0.529 . . . . 0.0 111.83 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -122.14 143.45 49.54 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.573 1.187 . . . . 0.0 109.614 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.21 131.41 38.33 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.463 -176.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -120.11 143.49 48.14 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -85.76 157.22 20.32 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 120.715 0.293 . . . . 0.0 110.432 -168.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.29 159.66 47.21 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.93 155.88 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 122.404 -0.468 . . . . 0.0 110.473 -174.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -114.69 138.24 50.94 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.3 t -133.88 140.04 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -177.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 tp -137.12 125.64 14.85 Favored Pre-proline 0 N--CA 1.497 1.88 0 CA-C-O 118.518 -0.753 . . . . 0.0 110.089 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.27 149.27 91.77 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.979 1.12 . . . . 0.0 111.482 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.571 HD13 HG13 ' A' ' 93' ' ' ILE . 43.7 pt -141.95 170.03 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 171.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -114.9 131.17 56.95 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 168.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.2 mt -105.62 124.11 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -174.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.75 116.3 31.71 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -130.01 121.95 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.99 -120.49 18.72 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -111.15 17.09 20.68 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 122.33 -0.512 . . . . 0.0 111.806 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -119.61 144.76 46.95 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 118.609 0.641 . . . . 0.0 110.492 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -123.06 131.15 53.58 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.216 -0.303 . . . . 0.0 110.28 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.79 144.87 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.75 136.57 43.65 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.58 -166.49 12.25 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.593 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.41 155.63 26.99 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 117.311 0.555 . . . . 0.0 110.304 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.571 HG13 HD13 ' A' ' 80' ' ' ILE . 69.3 mt -108.7 141.99 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.1 t -121.43 131.35 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -142.44 136.22 14.52 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -57.28 152.32 46.66 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.1 1.2 . . . . 0.0 111.814 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -66.19 -34.85 78.96 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.394 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -93.89 125.19 38.37 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 t -140.91 154.82 46.29 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -97.64 -57.93 2.12 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -134.61 -177.91 4.83 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.2 p -95.13 150.87 19.73 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.3 m -135.06 174.64 10.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.309 -0.245 . . . . 0.0 110.419 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -107.39 27.49 9.05 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 122.37 -0.206 . . . . 0.0 110.858 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.5 mm -122.91 127.35 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.52 HD13 HD11 ' A' ' 48' ' ' LEU . 34.4 pt -124.95 143.79 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 177.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -114.93 129.44 56.71 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.486 HD12 HD12 ' A' ' 46' ' ' LEU . 80.9 mt -115.02 152.04 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -174.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.427 HD12 ' CB ' ' A' ' 39' ' ' PRO . 11.4 pt -117.37 155.23 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 167.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.56 165.59 24.21 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.298 -176.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -60.0 -32.04 94.39 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 121.072 1.181 . . . . 0.0 111.576 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.73 167.03 23.54 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.319 -0.238 . . . . 0.0 110.826 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -70.63 104.34 2.79 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.501 HD12 HD22 ' A' ' 44' ' ' LEU . 81.2 mt -59.55 -33.01 70.87 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 122.211 -0.306 . . . . 0.0 111.497 -177.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -62.44 -35.59 79.75 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 122.109 -0.369 . . . . 0.0 110.949 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -78.22 -48.52 15.62 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -62.61 -33.41 74.93 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 122.159 -0.338 . . . . 0.0 111.099 -173.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -107.95 8.33 28.39 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 51.81 45.1 28.75 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 121.096 -1.002 . . . . 0.0 111.934 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -92.67 138.22 31.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.898 -0.501 . . . . 0.0 110.867 -171.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -114.97 159.31 20.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.11 138.18 50.11 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.906 -0.496 . . . . 0.0 111.467 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.63 -22.98 37.45 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.44 156.0 33.76 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-N 118.629 1.214 . . . . 0.0 109.975 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.36 133.87 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.796 HD11 HD11 ' A' ' 46' ' ' LEU . 34.0 pt -128.74 160.52 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -109.75 138.19 46.47 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 pt -112.77 137.58 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 129' ' ' LEU . 9.4 tt . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.2 mm . . . . . 0 N--CA 1.498 1.956 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.445 HG22 HD22 ' A' ' 48' ' ' LEU . 78.8 mt -130.6 147.74 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -110.08 143.96 39.36 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.59 151.56 21.26 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -105.95 142.56 35.46 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 117.231 0.516 . . . . 0.0 110.278 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.5 t -64.78 122.39 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -126.65 149.18 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.728 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 . . . . . 0 N--CA 1.501 2.106 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -65.76 -30.71 71.4 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 122.224 -0.298 . . . . 0.0 110.797 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -68.77 -40.63 79.61 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.645 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.2 mt -81.45 -37.08 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 92' ' ' ALA . 45.7 mt -104.04 -26.25 12.67 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.262 -0.274 . . . . 0.0 111.638 -174.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.77 14.31 73.2 Favored Glycine 0 N--CA 1.494 2.554 0 CA-C-O 119.319 -0.712 . . . . 0.0 111.449 -172.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -152.43 163.46 39.49 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 119.149 1.475 . . . . 0.0 110.691 170.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -94.97 108.42 37.99 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.583 -0.722 . . . . 0.0 109.922 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.418 ' CB ' HD12 ' A' ' 109' ' ' ILE . 65.8 Cg_endo -67.39 159.64 51.42 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 123.32 1.169 . . . . 0.0 110.492 -176.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -74.0 162.55 28.92 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -80.21 79.59 6.76 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.519 0.676 . . . . 0.0 109.662 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.64 171.86 44.13 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 175.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 p -138.0 157.59 46.06 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 117.382 0.591 . . . . 0.0 110.853 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.2 tp -110.47 116.98 32.35 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.416 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.5 m120 -98.97 121.76 41.34 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -176.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 126' ' ' ILE . 65.4 mt -120.49 135.98 54.9 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.72 0.295 . . . . 0.0 110.642 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -96.09 132.06 41.87 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.445 HD22 HG22 ' A' ' 7' ' ' ILE . 83.5 mt -110.6 160.3 16.79 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 120.64 0.257 . . . . 0.0 110.452 -176.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.28 12.85 14.89 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 172.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -145.27 140.48 27.84 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.696 -0.628 . . . . 0.0 109.39 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.33 146.94 52.46 Favored 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.626 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -132.53 137.19 47.06 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 120.724 0.297 . . . . 0.0 110.639 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -138.0 126.9 24.0 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.0 tt -64.37 -23.94 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.135 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -72.74 -3.55 25.88 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 122.006 -0.434 . . . . 0.0 112.053 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -91.12 -13.89 32.19 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 118.815 0.734 . . . . 0.0 111.51 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -114.2 175.08 5.63 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.596 0.634 . . . . 0.0 109.395 173.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -92.06 102.01 14.56 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -109.18 176.88 4.93 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 120.524 0.202 . . . . 0.0 110.574 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -111.0 129.48 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -105.94 140.91 38.21 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.5 p -117.23 134.9 54.24 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 120.721 0.296 . . . . 0.0 110.495 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -75.83 172.69 12.25 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 120.768 0.318 . . . . 0.0 111.472 -170.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -67.71 139.48 56.72 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -139.83 167.44 22.11 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.618 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -124.23 149.12 46.78 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 120.846 0.355 . . . . 0.0 110.528 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -148.24 135.62 20.5 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.82 32.89 10.34 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.739 -0.601 . . . . 0.0 112.098 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.25 16.6 79.38 Favored Glycine 0 N--CA 1.497 2.745 0 CA-C-O 119.606 -0.552 . . . . 0.0 111.907 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -121.99 142.13 50.63 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.74 1.27 . . . . 0.0 109.731 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.3 132.13 37.79 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.431 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -121.84 144.12 49.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -86.41 155.94 20.37 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.483 -168.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.76 159.15 49.13 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -139.24 156.77 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 122.353 -0.498 . . . . 0.0 110.387 -174.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -117.04 136.76 52.72 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.5 t -134.04 141.19 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.9 tp -137.35 125.63 14.57 Favored Pre-proline 0 N--CA 1.497 1.893 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.152 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.22 149.39 91.5 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 120.928 1.085 . . . . 0.0 111.475 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.538 HD13 HG13 ' A' ' 93' ' ' ILE . 43.7 pt -141.79 170.01 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-O 120.638 0.256 . . . . 0.0 110.312 171.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -116.18 130.58 56.86 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 167.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.8 mt -105.74 123.99 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -174.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.526 HD11 HD13 ' A' ' 129' ' ' LEU . 84.9 mt -107.88 117.17 33.41 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.5 mt -130.15 121.95 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.6 -120.05 17.6 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -111.16 17.11 20.65 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 122.418 -0.46 . . . . 0.0 111.78 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -119.65 143.75 47.54 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.558 0.617 . . . . 0.0 110.444 -175.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -123.12 130.0 52.19 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -125.42 145.05 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.77 136.65 43.63 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.86 -167.34 12.92 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.585 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.72 155.85 26.7 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 117.304 0.552 . . . . 0.0 110.387 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.538 HG13 HD13 ' A' ' 80' ' ' ILE . 69.8 mt -108.77 141.13 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.0 t -122.27 131.13 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -143.73 138.25 15.07 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.09 153.24 39.9 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 121.116 1.21 . . . . 0.0 111.842 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -65.4 -33.79 76.79 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 121.061 -0.255 . . . . 0.0 110.581 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -87.42 117.29 26.1 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 m -130.56 134.7 47.23 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -96.98 -50.24 4.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -133.41 170.02 16.09 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.7 m -94.61 153.34 17.89 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 93.6 p -135.09 173.45 11.71 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 120.739 0.304 . . . . 0.0 110.468 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -105.78 24.55 12.12 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 119.71 -0.186 . . . . 0.0 110.891 172.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.9 mm -119.85 127.43 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.9 pt -125.93 145.93 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -115.98 130.17 56.7 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.487 HD12 HD12 ' A' ' 46' ' ' LEU . 81.3 mt -115.18 150.83 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -174.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.418 HD12 ' CB ' ' A' ' 39' ' ' PRO . 11.2 pt -116.22 156.52 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 168.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.52 161.64 45.96 Favored Pre-proline 0 N--CA 1.495 1.806 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.298 -177.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.02 -31.39 93.42 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 121.044 1.163 . . . . 0.0 111.614 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.32 167.13 23.18 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.277 -0.264 . . . . 0.0 110.634 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -74.3 103.87 4.86 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 120.946 0.403 . . . . 0.0 110.176 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 79.0 mt -60.39 -33.25 72.21 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 122.088 -0.383 . . . . 0.0 111.314 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -61.93 -33.3 74.02 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.159 -0.338 . . . . 0.0 110.925 -175.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.24 -50.88 11.06 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -62.63 -32.52 73.56 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.158 -0.339 . . . . 0.0 111.218 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -106.64 8.07 30.94 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.78 47.51 24.65 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.06 -1.025 . . . . 0.0 111.858 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.3 mt -91.15 138.23 31.75 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.874 -0.517 . . . . 0.0 111.094 -169.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -117.55 159.86 22.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.24 138.38 50.44 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.908 -0.495 . . . . 0.0 111.445 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.55 -23.09 37.07 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -65.39 152.7 43.23 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 118.653 1.227 . . . . 0.0 110.061 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -110.81 133.1 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -174.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.783 HD11 HD11 ' A' ' 46' ' ' LEU . 33.5 pt -128.16 160.64 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -108.78 139.46 43.57 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.2 pt -110.09 137.9 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 174.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.526 HD13 HD11 ' A' ' 83' ' ' LEU . 6.2 tp . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -173.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.722 HD12 HD23 ' A' ' 129' ' ' LEU . 36.7 mm . . . . . 0 N--CA 1.498 1.957 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 78.8 mt -130.72 154.38 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -106.13 146.88 29.64 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.47 150.3 20.99 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -106.3 141.34 37.79 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.267 -0.549 . . . . 0.0 110.141 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.8 t -62.89 123.33 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -123.59 153.91 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 N--CA 1.498 1.964 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.321 -178.507 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 . . . . . 0 N--CA 1.504 2.266 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -63.95 -34.15 77.34 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.272 -0.268 . . . . 0.0 110.798 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -67.32 -38.3 84.7 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.607 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.54 HG23 HD12 ' A' ' 60' ' ' ILE . 59.9 mt -81.2 -37.09 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.5 ' CD2' ' HB2' ' A' ' 92' ' ' ALA . 58.3 mt -101.22 -26.37 13.67 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 122.226 -0.296 . . . . 0.0 111.657 -174.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.66 14.14 76.49 Favored Glycine 0 N--CA 1.494 2.52 0 CA-C-O 119.312 -0.716 . . . . 0.0 111.414 -173.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -152.06 161.45 42.61 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 119.117 1.459 . . . . 0.0 110.609 171.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -94.22 106.44 22.96 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-O 118.611 -0.709 . . . . 0.0 109.901 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.418 ' CB ' HD12 ' A' ' 109' ' ' ILE . 71.5 Cg_endo -68.29 158.48 57.35 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 O-C-N 123.303 1.16 . . . . 0.0 110.314 -177.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -73.5 160.92 30.99 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -80.28 79.62 6.83 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.531 0.681 . . . . 0.0 109.538 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.46 177.64 48.35 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 p -138.07 156.04 48.18 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 117.389 0.594 . . . . 0.0 110.931 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.504 HD22 HD12 ' A' ' 114' ' ' LEU . 27.8 tp -109.04 118.59 37.18 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 169.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.537 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.7 m120 -99.0 123.36 43.24 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.228 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.539 HD11 HD11 ' A' ' 126' ' ' ILE . 56.1 mt -120.71 136.08 54.96 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.688 0.28 . . . . 0.0 110.441 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.511 ' HB2' HG11 ' A' ' 12' ' ' VAL . 39.2 tttp -95.81 133.93 39.37 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.554 HD11 HD13 ' A' ' 106' ' ' ILE . 83.7 mt -112.69 160.3 18.05 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 120.62 0.247 . . . . 0.0 110.395 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.01 12.54 15.22 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 173.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -145.69 144.88 30.65 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 118.563 0.62 . . . . 0.0 109.795 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -63.97 150.35 45.34 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 122.222 -0.298 . . . . 0.0 110.477 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -131.86 139.03 48.69 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 120.69 0.281 . . . . 0.0 110.701 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -138.08 122.87 18.79 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.58 -21.13 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.441 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -75.17 -0.77 20.39 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -89.41 -14.47 35.41 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.991 0.814 . . . . 0.0 111.438 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -119.69 175.19 5.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.624 -0.672 . . . . 0.0 109.531 173.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -91.06 103.45 16.15 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -107.27 177.29 4.89 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 122.336 -0.228 . . . . 0.0 110.463 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.54 HD12 HG23 ' A' ' 34' ' ' ILE . 77.0 mt -109.99 131.95 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.99 143.27 34.36 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.0 p -116.07 133.77 55.67 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -76.69 172.58 12.82 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 120.643 0.258 . . . . 0.0 111.316 -172.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -68.42 139.66 55.77 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -142.85 166.58 24.24 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.668 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -122.87 147.31 46.72 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 120.742 0.306 . . . . 0.0 110.525 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -149.65 138.96 21.39 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.9 m120 52.03 30.26 7.23 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.66 -0.65 . . . . 0.0 112.128 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.61 16.21 80.47 Favored Glycine 0 N--CA 1.496 2.697 0 CA-C-O 119.607 -0.552 . . . . 0.0 111.851 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -121.89 143.94 49.14 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 118.685 1.242 . . . . 0.0 109.717 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -93.5 131.72 38.46 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.488 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -121.32 143.82 48.97 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -87.15 155.19 20.21 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.792 0.329 . . . . 0.0 110.378 -170.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.13 160.99 48.16 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.1 m -141.99 160.79 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 122.32 -0.518 . . . . 0.0 110.367 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -116.13 136.76 52.73 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.5 t -132.69 139.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.0 tp -138.3 125.66 13.51 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.136 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -62.68 149.16 92.09 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 O-C-N 123.189 1.099 . . . . 0.0 111.613 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.617 HD13 HG13 ' A' ' 93' ' ' ILE . 43.6 pt -142.16 170.13 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 172.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -118.32 130.29 55.94 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 168.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.38 129.05 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -173.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.62 HD11 HD21 ' A' ' 129' ' ' LEU . 91.7 mt -107.43 117.62 34.58 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 71.7 mt -129.56 121.87 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.68 -119.95 17.15 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -111.08 16.97 20.83 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.412 -0.464 . . . . 0.0 111.872 176.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -120.4 146.13 46.5 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 118.522 0.601 . . . . 0.0 110.521 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -123.13 130.62 53.01 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -125.89 147.57 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.6 139.75 45.73 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -150.3 -165.85 12.98 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.5 ' HB2' ' CD2' ' A' ' 35' ' ' LEU . . . -159.38 155.45 26.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.28 -0.541 . . . . 0.0 110.182 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.617 HG13 HD13 ' A' ' 80' ' ' ILE . 71.5 mt -108.71 141.36 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.05 130.6 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.4 t -142.18 133.92 13.32 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -57.86 153.24 45.08 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 121.046 1.164 . . . . 0.0 111.801 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -65.5 -34.52 78.46 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.587 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -86.78 121.32 29.11 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.3 t -142.98 156.64 44.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.296 -0.253 . . . . 0.0 110.389 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -97.54 -59.95 1.67 Allowed 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -136.3 -172.19 3.08 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.3 p -93.05 149.45 21.21 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.7 m -134.9 173.08 12.11 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 120.576 0.226 . . . . 0.0 110.427 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -107.7 27.18 9.44 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.423 -0.173 . . . . 0.0 110.865 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -122.33 127.84 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.554 HD13 HD11 ' A' ' 48' ' ' LEU . 34.6 pt -124.59 143.71 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -115.04 128.71 56.42 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.51 HD12 HD12 ' A' ' 46' ' ' LEU . 82.2 mt -115.01 152.49 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -173.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.418 HD12 ' CB ' ' A' ' 39' ' ' PRO . 11.6 pt -116.49 156.0 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 168.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.6 163.88 33.79 Favored Pre-proline 0 N--CA 1.496 1.85 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.249 -176.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.02 -32.56 95.08 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.163 1.242 . . . . 0.0 111.572 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -145.01 167.01 23.68 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.275 -0.266 . . . . 0.0 110.994 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -69.5 103.95 2.19 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.632 0.73 . . . . 0.0 110.465 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.504 HD12 HD22 ' A' ' 44' ' ' LEU . 83.4 mt -60.26 -33.0 71.7 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.664 -0.647 . . . . 0.0 111.641 -178.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -61.48 -37.84 85.09 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 122.054 -0.404 . . . . 0.0 111.296 -171.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -78.35 -45.82 21.58 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.36 -34.15 76.11 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.16 -0.337 . . . . 0.0 111.007 -173.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -108.18 8.27 27.89 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.75 48.06 23.57 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.204 -0.935 . . . . 0.0 111.888 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.4 mt -92.11 138.18 31.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.912 -0.493 . . . . 0.0 110.891 -171.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -117.21 156.19 28.13 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.66 138.02 48.14 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.941 -0.474 . . . . 0.0 111.542 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.97 -22.94 37.42 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.41 152.8 43.02 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-N 118.643 1.222 . . . . 0.0 110.019 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -112.77 134.03 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.539 HD11 HD11 ' A' ' 46' ' ' LEU . 34.3 pt -130.29 165.11 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -107.89 139.86 41.86 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.1 pt -117.04 138.76 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.722 HD23 HD12 ' A' ' 6' ' ' ILE . 12.9 mt . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.0 mm . . . . . 0 N--CA 1.499 1.978 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.488 HG22 HD22 ' A' ' 48' ' ' LEU . 72.9 mt -129.67 148.75 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -105.7 140.04 39.36 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.43 150.14 20.17 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -105.93 141.68 36.92 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 117.21 0.505 . . . . 0.0 110.221 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.9 t -63.15 122.61 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -127.23 162.21 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 N--CA 1.5 2.028 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.703 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 N--CA 1.502 2.13 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -65.86 -30.89 71.57 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.736 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -68.69 -40.58 79.97 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.67 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mt -81.39 -36.86 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 92' ' ' ALA . 50.5 mt -103.96 -26.29 12.69 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.213 -0.304 . . . . 0.0 111.678 -174.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.49 14.76 72.91 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-O 119.304 -0.72 . . . . 0.0 111.436 -172.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -151.9 162.18 41.47 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 119.155 1.478 . . . . 0.0 110.659 170.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -94.84 108.61 38.84 Favored Pre-proline 0 N--CA 1.497 1.878 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.894 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.419 ' CB ' HD12 ' A' ' 109' ' ' ILE . 67.1 Cg_endo -67.33 158.54 56.5 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 O-C-N 123.238 1.125 . . . . 0.0 110.55 -176.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -73.81 162.43 29.13 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -80.22 79.67 6.76 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.378 0.609 . . . . 0.0 109.764 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.16 178.94 48.63 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 175.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -137.96 154.37 49.38 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 117.266 0.533 . . . . 0.0 110.801 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.669 HD22 HD12 ' A' ' 114' ' ' LEU . 31.0 tp -109.61 115.47 29.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 168.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.445 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.4 m120 -99.66 122.77 43.16 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.807 HD11 HD11 ' A' ' 126' ' ' ILE . 53.7 mt -120.57 136.26 54.85 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.716 0.293 . . . . 0.0 110.487 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -95.94 132.91 40.76 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.565 HD11 HD13 ' A' ' 106' ' ' ILE . 83.9 mt -112.16 160.28 17.73 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 120.63 0.253 . . . . 0.0 110.508 -175.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.01 12.89 14.25 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 172.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -145.74 142.0 28.53 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 118.594 0.634 . . . . 0.0 109.573 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.04 147.3 51.12 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 122.235 -0.29 . . . . 0.0 110.697 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -131.81 135.87 47.07 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 120.781 0.324 . . . . 0.0 110.675 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -138.06 127.41 24.66 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 173.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.434 HD13 ' HB3' ' A' ' 76' ' ' LYS . 20.1 tt -63.16 -23.49 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.329 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -74.39 -1.08 19.44 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.944 -0.473 . . . . 0.0 112.184 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -91.12 -14.44 31.17 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 118.913 0.779 . . . . 0.0 111.511 170.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -116.28 175.11 5.7 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.593 0.633 . . . . 0.0 109.373 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -91.51 102.14 14.8 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -109.73 179.23 4.18 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 120.526 0.203 . . . . 0.0 110.591 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.5 mt -110.98 132.14 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -105.92 143.56 33.89 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 36.4 p -124.56 135.04 52.83 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 120.83 0.348 . . . . 0.0 110.667 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.88 172.69 12.73 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 120.825 0.345 . . . . 0.0 111.768 -169.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -68.05 141.14 56.27 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -137.52 166.59 23.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 122.195 -0.315 . . . . 0.0 110.656 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -125.78 149.17 48.79 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 120.861 0.362 . . . . 0.0 110.591 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -148.86 135.01 19.22 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 52.17 33.44 12.37 Favored 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.719 -0.613 . . . . 0.0 111.895 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.73 16.25 80.31 Favored Glycine 0 N--CA 1.497 2.709 0 CA-C-O 119.613 -0.548 . . . . 0.0 111.877 176.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -119.94 139.56 52.26 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 118.723 1.262 . . . . 0.0 109.704 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.41 131.82 38.24 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 120.671 0.272 . . . . 0.0 110.416 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -120.21 143.2 48.39 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -86.08 155.05 20.97 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.774 0.321 . . . . 0.0 110.541 -167.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.07 157.29 51.51 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -138.52 159.21 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 122.258 -0.554 . . . . 0.0 110.404 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.434 ' HB3' HD13 ' A' ' 54' ' ' ILE . 96.9 mttt -117.08 135.84 53.43 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.8 t -132.2 139.61 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -176.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.3 tp -136.45 125.64 15.61 Favored Pre-proline 0 N--CA 1.496 1.871 0 CA-C-O 118.579 -0.725 . . . . 0.0 110.004 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.45 149.15 91.87 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 O-C-N 123.172 1.091 . . . . 0.0 111.426 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.592 HD13 HG13 ' A' ' 93' ' ' ILE . 43.3 pt -141.9 169.85 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 171.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -114.98 131.33 56.95 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 168.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.6 mt -105.32 123.2 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -175.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.1 mt -107.5 115.89 30.97 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.7 mt -130.02 121.95 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.12 -120.59 18.77 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -111.14 17.02 20.75 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.344 -0.503 . . . . 0.0 111.888 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -119.77 145.16 46.83 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 118.586 0.63 . . . . 0.0 110.552 -175.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -123.08 129.5 51.55 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 120.741 0.305 . . . . 0.0 110.295 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.3 mt -125.65 143.4 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.04 137.46 43.41 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.1 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.27 -165.15 11.6 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.572 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.46 154.9 25.62 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 117.429 0.615 . . . . 0.0 110.507 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.592 HG13 HD13 ' A' ' 80' ' ' ILE . 68.6 mt -108.7 141.74 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.97 132.49 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -175.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.1 t -145.05 137.05 13.06 Favored Pre-proline 0 N--CA 1.498 1.959 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -58.41 154.59 40.48 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 121.072 1.182 . . . . 0.0 111.687 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -65.17 -34.17 77.74 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.805 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -85.15 116.96 23.81 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.305 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.7 m -131.68 139.57 49.09 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -94.62 -49.61 5.56 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -137.68 172.44 12.95 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -89.22 146.78 24.53 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.0 m -135.03 169.89 16.74 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 120.615 0.245 . . . . 0.0 110.607 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -106.96 27.63 8.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.438 -0.164 . . . . 0.0 110.795 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.5 mm -121.79 126.75 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.565 HD13 HD11 ' A' ' 48' ' ' LEU . 34.0 pt -124.06 143.86 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -115.15 130.88 57.04 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.439 HD12 HD12 ' A' ' 46' ' ' LEU . 81.7 mt -116.11 151.5 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -173.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.419 HD12 ' CB ' ' A' ' 39' ' ' PRO . 13.4 pt -116.59 153.52 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 167.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.53 164.64 29.51 Favored Pre-proline 0 N--CA 1.495 1.807 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.234 -176.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.21 -31.94 93.74 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.042 1.162 . . . . 0.0 111.584 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.59 167.1 23.34 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.29 -0.256 . . . . 0.0 110.716 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -70.8 104.45 2.9 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.669 HD12 HD22 ' A' ' 44' ' ' LEU . 80.9 mt -59.58 -33.13 71.06 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 122.022 -0.424 . . . . 0.0 111.511 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -62.62 -35.37 79.36 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 122.119 -0.363 . . . . 0.0 110.964 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -78.25 -48.31 16.03 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.43 -33.24 74.4 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 122.163 -0.335 . . . . 0.0 111.074 -173.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -107.99 7.83 28.07 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.88 45.8 27.63 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.025 -1.047 . . . . 0.0 111.876 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.3 mt -92.34 138.21 31.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.862 -0.524 . . . . 0.0 110.93 -171.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -114.79 157.54 23.1 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -55.87 137.94 49.32 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.919 -0.488 . . . . 0.0 111.535 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.95 -22.99 37.23 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -177.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -65.44 156.11 33.42 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 118.621 1.21 . . . . 0.0 110.004 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.6 t -112.36 134.07 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.807 HD11 HD11 ' A' ' 46' ' ' LEU . 34.4 pt -128.98 160.59 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -109.78 138.08 46.66 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -175.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.1 pt -112.12 137.57 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.463 HD23 ' C ' ' A' ' 129' ' ' LEU . 8.8 tt . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.4 mm . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.408 HG22 HD22 ' A' ' 48' ' ' LEU . 78.0 mt -130.59 147.61 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 171.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -110.23 143.81 39.83 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.318 -0.239 . . . . 0.0 110.405 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.75 152.45 21.7 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -105.8 140.7 38.44 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 117.242 0.521 . . . . 0.0 110.35 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.0 t -63.43 122.49 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.75 137.24 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 173.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.6 p . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -178.963 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -65.49 -32.79 74.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 122.194 -0.316 . . . . 0.0 110.731 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -67.95 -38.31 82.65 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.671 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.9 mt -80.76 -39.08 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.3 mt -99.55 -26.28 14.15 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 122.263 -0.273 . . . . 0.0 111.541 -174.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.65 14.2 76.36 Favored Glycine 0 N--CA 1.496 2.646 0 CA-C-O 119.363 -0.687 . . . . 0.0 111.428 -174.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -152.05 163.37 39.45 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 119.082 1.441 . . . . 0.0 110.709 171.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -95.44 109.59 46.18 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.744 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.53 163.38 35.08 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 123.288 1.151 . . . . 0.0 110.601 -175.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -74.28 163.16 28.15 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -80.36 79.64 6.92 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.463 0.649 . . . . 0.0 109.858 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.5 172.8 44.03 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 174.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -136.51 156.08 49.09 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 117.285 0.542 . . . . 0.0 110.562 173.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.3 tp -108.88 116.41 31.94 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 172.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.31 122.88 42.02 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.831 HD11 HD11 ' A' ' 126' ' ' ILE . 59.0 mt -120.04 135.84 54.79 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 120.75 0.31 . . . . 0.0 110.554 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -95.47 132.34 40.65 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.478 HD11 ' CD1' ' A' ' 106' ' ' ILE . 83.8 mt -111.95 160.25 17.62 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 120.683 0.278 . . . . 0.0 110.4 -175.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.31 13.17 14.13 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 172.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -145.25 140.38 27.8 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 118.568 0.622 . . . . 0.0 109.479 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.27 146.91 52.44 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 122.254 -0.279 . . . . 0.0 110.679 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -132.0 136.75 47.52 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 120.706 0.289 . . . . 0.0 110.584 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -138.06 125.99 22.62 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.57 -23.92 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.341 -177.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -74.22 -0.93 18.4 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.51 -14.13 33.29 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 118.908 0.776 . . . . 0.0 111.457 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -115.84 175.07 5.7 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 118.613 0.642 . . . . 0.0 109.454 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -92.46 103.46 15.88 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -109.85 176.2 5.16 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 120.512 0.196 . . . . 0.0 110.499 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.3 mt -110.25 129.7 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 175.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -105.9 147.4 28.79 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.2 p -125.24 134.96 52.13 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 120.778 0.323 . . . . 0.0 110.768 175.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -75.14 172.72 11.87 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 120.757 0.313 . . . . 0.0 111.707 -170.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -66.99 139.55 57.69 Favored 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -140.63 166.78 23.79 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 122.215 -0.303 . . . . 0.0 110.633 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -124.45 149.06 47.2 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 120.8 0.333 . . . . 0.0 110.559 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -149.09 135.13 19.05 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 m120 52.15 33.96 13.34 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.705 -0.622 . . . . 0.0 111.881 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.82 15.97 80.59 Favored Glycine 0 N--CA 1.497 2.737 0 CA-C-O 119.589 -0.562 . . . . 0.0 111.875 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -121.19 140.97 51.29 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 118.768 1.284 . . . . 0.0 109.717 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -92.87 130.81 38.35 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.368 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -120.14 143.52 48.14 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -85.96 156.18 20.58 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.307 -169.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.44 157.23 50.12 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -138.88 157.93 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 122.448 -0.443 . . . . 0.0 110.456 -174.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -120.52 137.94 54.11 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.4 t -133.98 141.81 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -176.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.4 tp -137.49 125.7 14.46 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.164 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.24 149.59 90.91 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 120.961 1.107 . . . . 0.0 111.496 177.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.564 HD13 HG13 ' A' ' 93' ' ' ILE . 43.7 pt -141.76 170.15 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 171.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -116.44 129.8 56.42 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 168.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.53 125.39 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.603 HD11 HD13 ' A' ' 129' ' ' LEU . 86.5 mt -107.87 116.59 32.24 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 -178.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.9 mt -129.83 122.02 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.03 -120.54 18.82 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -111.09 17.02 20.8 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 122.29 -0.535 . . . . 0.0 111.988 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -119.89 145.82 46.34 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 118.449 0.568 . . . . 0.0 110.513 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -122.96 130.82 53.31 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.42 145.81 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.51 136.92 44.15 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.05 -167.34 12.99 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 177.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.69 155.08 25.43 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 117.35 0.575 . . . . 0.0 110.363 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.564 HG13 HD13 ' A' ' 80' ' ' ILE . 70.0 mt -108.72 142.62 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.7 t -121.48 131.48 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.7 t -142.53 136.66 14.75 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -58.01 154.97 35.86 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 121.077 1.184 . . . . 0.0 111.81 176.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -65.6 -37.41 86.54 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.317 -0.239 . . . . 0.0 110.43 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -94.64 120.59 35.11 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.0 p -130.22 155.07 46.87 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -98.07 -57.86 2.12 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -136.6 170.87 15.36 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.4 p -85.68 148.22 25.99 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.1 m -135.01 175.01 9.97 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 120.57 0.224 . . . . 0.0 110.489 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -107.4 27.93 8.61 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 122.415 -0.178 . . . . 0.0 110.851 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.0 mm -123.4 126.7 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.478 ' CD1' HD11 ' A' ' 48' ' ' LEU . 34.3 pt -125.64 145.77 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -114.6 131.68 56.61 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.498 HD12 HD12 ' A' ' 46' ' ' LEU . 81.9 mt -117.56 149.31 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 pt -119.13 155.33 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 168.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.56 165.98 22.15 Favored Pre-proline 0 N--CA 1.496 1.846 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.246 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -59.14 -30.34 92.87 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 121.151 1.234 . . . . 0.0 111.716 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.23 167.06 23.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 122.248 -0.282 . . . . 0.0 110.732 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -71.15 105.96 3.59 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.61 -33.4 71.44 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 122.067 -0.396 . . . . 0.0 111.402 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -62.65 -35.34 79.31 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 122.182 -0.324 . . . . 0.0 110.954 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -78.18 -48.07 16.67 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -62.61 -33.64 75.4 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.193 -0.317 . . . . 0.0 111.063 -172.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -108.01 8.15 28.18 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.81 46.03 27.24 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 120.979 -1.076 . . . . 0.0 111.819 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.9 mt -91.98 138.22 31.72 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.89 -0.506 . . . . 0.0 110.961 -171.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -114.92 157.49 23.29 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.72 137.77 48.92 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.888 -0.508 . . . . 0.0 111.491 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.92 -22.88 37.73 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -178.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.44 157.42 29.49 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 118.645 1.222 . . . . 0.0 109.952 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.3 t -112.19 133.17 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -174.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.831 HD11 HD11 ' A' ' 46' ' ' LEU . 33.8 pt -128.51 160.59 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -109.06 139.65 43.66 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.302 -175.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.1 pt -109.87 138.44 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.603 HD13 HD11 ' A' ' 83' ' ' LEU . 6.5 tp . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -172.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.7 mm . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.449 HG22 HD22 ' A' ' 48' ' ' LEU . 78.6 mt -130.76 148.31 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -110.78 144.76 39.27 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.5 151.15 21.42 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -106.77 141.85 37.35 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 117.217 0.508 . . . . 0.0 110.263 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.3 121.16 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.75 148.49 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 177.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.4 p . . . . . 0 N--CA 1.499 1.987 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.662 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.466 ' CE1' HD13 ' A' ' 109' ' ' ILE . 4.2 m-85 . . . . . 0 N--CA 1.502 2.153 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -65.7 -32.63 74.29 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 122.219 -0.301 . . . . 0.0 110.785 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -68.89 -40.25 79.3 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.641 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.0 mt -81.66 -36.37 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' A' ' 92' ' ' ALA . 48.4 mt -104.0 -26.35 12.65 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.197 -0.314 . . . . 0.0 111.622 -173.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.02 15.15 73.22 Favored Glycine 0 N--CA 1.495 2.599 0 CA-C-O 119.371 -0.683 . . . . 0.0 111.459 -172.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -151.42 161.43 42.7 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 119.143 1.472 . . . . 0.0 110.765 170.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -94.15 107.88 31.81 Favored Pre-proline 0 N--CA 1.496 1.865 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.834 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.53 158.16 58.39 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 O-C-N 123.272 1.143 . . . . 0.0 110.403 -176.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -74.07 162.95 28.48 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -80.14 79.63 6.67 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.429 0.633 . . . . 0.0 109.732 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.66 172.1 44.39 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 175.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 p -138.01 156.51 47.74 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 117.391 0.596 . . . . 0.0 110.85 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.9 tp -109.4 117.29 33.65 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.98 122.24 41.98 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -176.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.838 HD11 HD11 ' A' ' 126' ' ' ILE . 61.2 mt -120.58 135.79 54.99 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 120.75 0.31 . . . . 0.0 110.617 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -95.97 133.55 40.04 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.449 HD22 HG22 ' A' ' 7' ' ' ILE . 84.6 mt -112.05 160.3 17.63 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 120.633 0.254 . . . . 0.0 110.544 -176.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.61 13.56 13.74 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 171.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -145.44 139.38 26.85 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 118.552 0.614 . . . . 0.0 109.63 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -62.16 147.24 48.27 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 122.115 -0.366 . . . . 0.0 110.901 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -131.95 136.51 47.4 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 120.766 0.317 . . . . 0.0 110.45 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -137.96 125.6 22.24 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 76' ' ' LYS . 20.2 tt -63.89 -24.73 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.219 -177.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -73.53 -1.83 20.2 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -91.33 -14.04 31.48 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 118.787 0.721 . . . . 0.0 111.484 169.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -114.5 175.13 5.62 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.614 -0.679 . . . . 0.0 109.315 174.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -92.49 101.99 14.44 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -110.54 177.39 4.7 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 120.638 0.256 . . . . 0.0 110.672 -177.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.6 mt -112.09 132.88 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -105.9 143.87 33.43 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.3 p -121.95 136.44 54.92 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 120.624 0.25 . . . . 0.0 110.679 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.55 172.72 12.52 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 120.786 0.327 . . . . 0.0 111.642 -170.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -67.97 140.16 56.39 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -138.6 163.57 31.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.218 -0.301 . . . . 0.0 110.758 -175.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -123.66 147.47 47.37 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 122.281 -0.262 . . . . 0.0 110.401 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -149.77 136.92 19.7 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.7 32.2 9.04 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.82 -0.55 . . . . 0.0 112.162 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.22 17.59 77.82 Favored Glycine 0 N--CA 1.497 2.727 0 CA-C-O 119.614 -0.548 . . . . 0.0 111.823 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -123.08 140.95 52.49 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.577 1.188 . . . . 0.0 109.803 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.86 132.56 38.16 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 120.618 0.247 . . . . 0.0 110.421 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.22 142.7 49.66 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -86.29 157.81 19.83 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 120.737 0.303 . . . . 0.0 110.336 -169.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.5 157.49 50.02 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -139.51 157.13 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 122.388 -0.478 . . . . 0.0 110.488 -174.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HB3' HD13 ' A' ' 54' ' ' ILE . 68.8 mttt -114.22 138.42 50.5 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.6 t -133.63 139.05 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.4 tp -137.09 125.6 14.85 Favored Pre-proline 0 N--CA 1.497 1.887 0 CA-C-O 118.533 -0.746 . . . . 0.0 110.125 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -63.39 149.63 90.67 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 O-C-N 123.158 1.083 . . . . 0.0 111.457 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.54 HD13 HG13 ' A' ' 93' ' ' ILE . 43.5 pt -141.9 170.01 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 122.286 -0.259 . . . . 0.0 110.38 171.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -115.31 130.03 56.78 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 168.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.68 124.17 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.412 HD11 HD13 ' A' ' 129' ' ' LEU . 84.3 mt -107.99 116.82 32.66 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.5 mt -129.93 121.93 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.76 -120.23 18.09 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -111.18 17.1 20.64 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 122.354 -0.498 . . . . 0.0 111.806 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -119.76 144.62 47.18 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 118.604 0.638 . . . . 0.0 110.497 -175.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -123.12 129.91 52.08 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -125.75 146.09 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.59 136.24 43.95 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.74 -168.2 13.02 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.591 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.56 154.98 25.54 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 117.307 0.553 . . . . 0.0 110.369 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.54 HG13 HD13 ' A' ' 80' ' ' ILE . 69.3 mt -108.71 141.53 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.42 130.83 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -141.6 134.37 14.1 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -57.33 154.81 32.96 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 121.055 1.17 . . . . 0.0 111.91 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -64.85 -34.5 78.52 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.688 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -86.71 117.75 25.67 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 m -132.76 139.86 47.78 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -96.23 -57.54 2.31 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -132.6 -176.78 4.21 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.2 p -93.54 150.03 20.76 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.3 m -135.06 170.09 16.44 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.652 0.263 . . . . 0.0 110.294 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -107.82 27.72 8.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.363 -0.211 . . . . 0.0 110.875 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -123.9 127.87 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 27.7 pt -126.19 145.35 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 177.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -114.94 130.61 56.96 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.47 HD12 HD12 ' A' ' 46' ' ' LEU . 82.5 mt -115.7 150.98 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -174.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.466 HD13 ' CE1' ' A' ' 31' ' ' PHE . 11.2 pt -116.47 155.64 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 168.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.49 164.92 27.93 Favored Pre-proline 0 N--CA 1.496 1.83 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.315 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.57 -30.75 93.15 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.071 1.181 . . . . 0.0 111.653 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.43 167.06 23.39 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.322 -0.236 . . . . 0.0 110.773 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -71.29 105.22 3.4 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 120.875 0.369 . . . . 0.0 110.042 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.45 -33.58 71.45 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.043 -0.41 . . . . 0.0 111.535 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -62.96 -35.34 79.82 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 122.11 -0.369 . . . . 0.0 110.929 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -78.3 -47.94 16.75 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -62.54 -34.15 76.36 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 122.221 -0.299 . . . . 0.0 111.028 -172.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -108.1 8.49 28.17 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 51.83 47.23 25.19 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.148 -0.97 . . . . 0.0 111.849 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.9 mt -92.09 138.14 31.78 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.917 -0.49 . . . . 0.0 111.036 -170.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -115.67 158.95 22.0 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -56.06 138.17 49.86 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.893 -0.504 . . . . 0.0 111.506 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.58 -22.95 37.6 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.4 154.93 37.02 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 118.597 1.198 . . . . 0.0 110.026 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.6 t -112.05 133.94 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.838 HD11 HD11 ' A' ' 46' ' ' LEU . 34.8 pt -128.82 160.35 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -109.2 140.3 42.99 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.237 -175.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.0 pt -111.84 138.1 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.412 HD13 HD11 ' A' ' 83' ' ' LEU . 6.2 tp . . . . . 0 N--CA 1.493 1.723 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -173.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.2 mm . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.496 HG22 HD22 ' A' ' 48' ' ' LEU . 70.3 mt -128.16 147.73 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -106.01 138.56 41.98 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.248 -0.283 . . . . 0.0 110.276 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.34 149.09 19.72 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -106.58 142.16 36.69 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 117.237 0.519 . . . . 0.0 110.226 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.19 122.49 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.8 m -124.97 151.27 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 176.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.5 p . . . . . 0 N--CA 1.499 1.985 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -178.578 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CE1' HD13 ' A' ' 109' ' ' ILE . 3.6 m-85 . . . . . 0 N--CA 1.501 2.108 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -65.57 -31.79 73.03 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 122.225 -0.297 . . . . 0.0 110.791 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -68.72 -40.16 80.08 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.586 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.1 mt -81.65 -36.64 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' A' ' 92' ' ' ALA . 46.5 mt -103.91 -26.22 12.74 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.255 -0.278 . . . . 0.0 111.609 -174.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.08 15.46 72.25 Favored Glycine 0 N--CA 1.495 2.595 0 CA-C-O 119.312 -0.715 . . . . 0.0 111.415 -172.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -151.28 160.84 43.59 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.169 1.484 . . . . 0.0 110.751 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -93.53 108.16 31.9 Favored Pre-proline 0 N--CA 1.496 1.857 0 CA-C-O 118.629 -0.701 . . . . 0.0 109.747 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.08 158.2 58.0 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 O-C-N 123.237 1.124 . . . . 0.0 110.534 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -73.6 163.41 28.04 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.29 79.56 6.86 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.541 0.686 . . . . 0.0 109.607 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.39 171.22 43.02 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -138.01 158.46 44.27 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 117.441 0.62 . . . . 0.0 110.818 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.8 tp -109.1 116.01 31.14 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 170.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.456 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.7 m120 -98.26 121.58 40.37 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -177.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.539 HD11 HD11 ' A' ' 126' ' ' ILE . 60.5 mt -120.67 136.81 54.74 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.703 0.287 . . . . 0.0 110.639 -177.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' HG11 ' A' ' 12' ' ' VAL . 65.5 tttt -96.03 131.91 41.93 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.496 HD22 HG22 ' A' ' 7' ' ' ILE . 83.6 mt -110.7 160.25 16.88 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 120.603 0.239 . . . . 0.0 110.472 -176.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.11 13.1 13.91 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 172.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -145.63 141.69 28.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.712 -0.618 . . . . 0.0 109.542 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -64.11 147.04 53.15 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.196 -0.315 . . . . 0.0 110.497 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -131.83 135.67 46.91 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 120.749 0.309 . . . . 0.0 110.543 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -138.04 125.39 21.83 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.3 tt -63.52 -23.13 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.397 -176.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -73.33 -2.85 23.75 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 122.014 -0.429 . . . . 0.0 112.079 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -90.56 -13.93 33.56 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.878 0.763 . . . . 0.0 111.462 171.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -114.75 175.02 5.67 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 118.579 0.627 . . . . 0.0 109.338 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -92.54 101.98 14.42 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -109.32 176.39 5.1 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 120.563 0.221 . . . . 0.0 110.538 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -110.8 131.57 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -105.89 142.89 34.83 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.5 p -121.42 138.68 54.17 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.808 0.337 . . . . 0.0 110.688 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -76.79 172.71 12.65 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 120.858 0.361 . . . . 0.0 111.762 -168.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -67.96 141.22 56.37 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -135.95 167.13 21.79 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.557 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -125.75 149.01 48.9 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.888 0.375 . . . . 0.0 110.6 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -148.86 135.75 19.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 51.96 32.83 10.63 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.69 -0.631 . . . . 0.0 112.114 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.06 17.0 79.04 Favored Glycine 0 N--CA 1.496 2.682 0 CA-C-O 119.635 -0.536 . . . . 0.0 111.846 176.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -121.75 140.62 52.11 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 118.6 1.2 . . . . 0.0 109.699 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -93.57 131.97 38.32 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.393 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -121.25 145.33 47.97 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -85.72 156.61 20.56 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.808 0.337 . . . . 0.0 110.448 -167.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.42 162.93 43.49 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.61 155.52 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 122.4 -0.471 . . . . 0.0 110.38 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -114.43 137.29 52.02 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.2 t -134.0 140.93 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.1 tp -136.84 125.62 15.15 Favored Pre-proline 0 N--CA 1.496 1.86 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.108 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -63.39 149.75 90.35 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 120.971 1.114 . . . . 0.0 111.441 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.528 HD13 HG13 ' A' ' 93' ' ' ILE . 43.5 pt -141.88 170.0 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 120.712 0.291 . . . . 0.0 110.317 171.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -113.95 131.87 56.16 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 167.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.0 mt -106.64 123.17 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -175.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.434 HD11 HD12 ' A' ' 129' ' ' LEU . 85.7 mt -107.94 116.86 32.72 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.3 mt -130.06 121.98 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.28 -119.68 16.66 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -111.09 17.0 20.81 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.373 -0.486 . . . . 0.0 111.841 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -120.42 143.91 48.22 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 118.575 0.625 . . . . 0.0 110.52 -174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -123.1 129.44 51.45 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -125.88 146.54 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.52 136.38 44.09 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.92 -168.52 12.83 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.622 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.54 154.92 25.49 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 117.309 0.554 . . . . 0.0 110.286 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.528 HG13 HD13 ' A' ' 80' ' ' ILE . 67.3 mt -108.62 141.61 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.8 t -120.73 132.28 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -175.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.0 t -142.37 133.27 12.8 Favored Pre-proline 0 N--CA 1.497 1.88 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.54 155.73 29.86 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 121.081 1.187 . . . . 0.0 111.885 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -64.59 -34.05 77.35 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 122.298 -0.251 . . . . 0.0 110.659 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -89.13 111.29 22.03 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.284 -0.26 . . . . 0.0 110.325 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.5 m -131.77 134.73 46.15 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -97.08 -56.16 2.63 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.31 -0.244 . . . . 0.0 110.344 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -121.99 -179.36 4.12 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.7 m -104.87 152.73 22.26 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.7 p -135.01 172.81 12.49 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 120.664 0.269 . . . . 0.0 110.562 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -105.63 24.62 11.93 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.854 172.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.9 mm -121.08 126.98 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.486 ' CD1' HD11 ' A' ' 48' ' ' LEU . 34.5 pt -127.42 148.41 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -116.62 130.86 56.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.517 HD12 HD12 ' A' ' 46' ' ' LEU . 82.4 mt -115.08 150.42 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -175.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.463 HD13 ' CE1' ' A' ' 31' ' ' PHE . 11.0 pt -115.99 155.88 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 168.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.53 165.84 22.95 Favored Pre-proline 0 N--CA 1.496 1.831 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.279 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.37 -30.37 92.54 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 121.084 1.189 . . . . 0.0 111.667 177.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.42 167.05 23.41 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 122.28 -0.262 . . . . 0.0 110.652 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -71.02 105.5 3.34 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.63 -33.93 72.15 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 122.105 -0.372 . . . . 0.0 111.462 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -63.16 -34.75 78.29 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 122.143 -0.348 . . . . 0.0 110.892 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -78.2 -48.99 14.63 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -62.51 -34.09 76.19 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 122.188 -0.32 . . . . 0.0 111.102 -172.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -108.05 8.15 28.1 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.85 50.15 19.25 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 120.986 -1.071 . . . . 0.0 111.917 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 48.2 mt -91.08 138.19 31.79 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.871 -0.518 . . . . 0.0 110.857 -172.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -115.19 156.74 24.77 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.77 137.95 48.84 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.9 -0.5 . . . . 0.0 111.5 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.9 -22.91 37.59 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.39 153.99 39.68 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-N 118.641 1.221 . . . . 0.0 110.005 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.09 134.01 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.539 HD11 HD11 ' A' ' 46' ' ' LEU . 34.7 pt -130.3 162.25 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 174.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -110.02 139.18 45.42 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.365 -174.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 pt -111.73 137.75 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.462 HD23 ' C ' ' A' ' 129' ' ' LEU . 8.5 tt . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -175.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.4 mm . . . . . 0 N--CA 1.499 2.0 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.517 HG22 HD22 ' A' ' 48' ' ' LEU . 72.9 mt -130.02 148.32 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 176.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -105.45 140.95 37.77 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.16 150.71 20.27 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -106.27 141.74 37.12 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 117.176 0.488 . . . . 0.0 110.186 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.15 121.78 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.8 m -126.32 158.84 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 177.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.499 1.988 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.332 -179.007 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 N--CA 1.501 2.114 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -65.33 -36.93 85.53 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 122.151 -0.343 . . . . 0.0 110.366 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -68.24 -38.67 82.09 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.505 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.2 mt -81.16 -35.68 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' A' ' 92' ' ' ALA . 45.3 mt -103.92 -26.26 12.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.102 -0.373 . . . . 0.0 111.696 -173.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.39 12.94 79.7 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -171.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -150.91 160.57 43.82 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 119.068 1.434 . . . . 0.0 110.306 170.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -93.39 109.35 39.87 Favored Pre-proline 0 N--CA 1.496 1.849 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.816 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.422 ' CB ' HD12 ' A' ' 109' ' ' ILE . 64.2 Cg_endo -67.25 159.76 50.73 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 O-C-N 123.274 1.144 . . . . 0.0 110.502 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -73.81 163.29 28.14 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -80.25 79.56 6.81 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.511 0.672 . . . . 0.0 109.64 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.48 172.89 45.32 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 175.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 p -138.09 157.41 46.38 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 117.343 0.571 . . . . 0.0 110.804 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.414 HD22 HD12 ' A' ' 114' ' ' LEU . 32.6 tp -109.61 115.02 29.13 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 170.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.423 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.6 m120 -98.72 120.05 38.49 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.78 HD11 HD11 ' A' ' 126' ' ' ILE . 62.6 mt -119.98 135.95 54.72 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 120.697 0.284 . . . . 0.0 110.631 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HB2' HG11 ' A' ' 12' ' ' VAL . 79.3 tttt -95.98 132.17 41.59 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.517 HD22 HG22 ' A' ' 7' ' ' ILE . 83.8 mt -110.95 160.27 16.96 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 120.605 0.24 . . . . 0.0 110.475 -176.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -88.93 12.73 14.52 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 172.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -145.49 142.44 29.23 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 118.555 0.616 . . . . 0.0 109.466 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -64.43 146.92 53.75 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.413 178.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -134.4 137.14 43.83 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.733 0.301 . . . . 0.0 110.654 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -138.16 129.58 27.71 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.2 tt -63.95 -22.22 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.337 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -74.42 -0.97 19.06 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.933 -0.479 . . . . 0.0 112.235 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -91.04 -14.74 30.78 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 118.918 0.781 . . . . 0.0 111.445 170.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -117.21 175.11 5.76 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 118.679 0.672 . . . . 0.0 109.467 174.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -90.85 102.75 15.51 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -109.67 177.03 4.86 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 120.546 0.212 . . . . 0.0 110.471 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -110.46 130.8 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -106.0 143.75 33.7 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.8 p -121.69 138.02 54.52 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.74 0.305 . . . . 0.0 110.751 177.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.87 172.67 12.76 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 120.864 0.364 . . . . 0.0 111.687 -169.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -67.59 140.79 56.93 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -136.97 167.01 22.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 122.208 -0.308 . . . . 0.0 110.544 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -125.11 149.08 48.22 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 120.861 0.362 . . . . 0.0 110.607 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -148.35 135.24 20.03 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 51.73 33.44 11.07 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.806 -0.559 . . . . 0.0 112.082 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.09 16.94 79.09 Favored Glycine 0 N--CA 1.498 2.771 0 CA-C-O 119.599 -0.556 . . . . 0.0 111.782 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -122.28 140.94 52.04 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 118.694 1.247 . . . . 0.0 109.649 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -93.25 131.85 37.98 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 120.653 0.264 . . . . 0.0 110.493 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -120.76 144.08 48.47 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -86.37 156.72 20.08 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 120.784 0.326 . . . . 0.0 110.481 -168.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.18 161.86 44.12 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.39 156.0 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 122.294 -0.533 . . . . 0.0 110.364 -174.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -116.57 137.19 52.37 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.7 t -134.12 142.1 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.0 tp -137.39 125.64 14.54 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-O 118.61 -0.71 . . . . 0.0 110.094 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -63.43 148.71 92.48 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 120.955 1.103 . . . . 0.0 111.42 177.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.548 HD13 HG13 ' A' ' 93' ' ' ILE . 43.8 pt -141.38 170.06 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 120.674 0.274 . . . . 0.0 110.356 172.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -114.45 131.76 56.5 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 168.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.9 mt -106.25 124.04 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -175.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -109.08 116.26 31.61 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.2 mt -130.0 121.93 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.41 -119.78 16.87 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -111.07 17.0 20.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.208 -0.584 . . . . 0.0 111.868 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -120.79 144.25 48.41 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 118.547 0.612 . . . . 0.0 110.503 -174.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -123.17 130.19 52.42 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -126.45 148.33 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.51 137.58 44.51 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.23 -169.9 14.46 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 177.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.552 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.32 154.88 25.86 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 117.339 0.57 . . . . 0.0 110.235 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.548 HG13 HD13 ' A' ' 80' ' ' ILE . 70.6 mt -108.79 142.26 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.35 131.56 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -142.25 132.53 12.57 Favored Pre-proline 0 N--CA 1.498 1.926 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -58.09 154.86 37.04 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 121.063 1.175 . . . . 0.0 111.796 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -64.99 -33.61 76.45 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.228 -0.295 . . . . 0.0 110.77 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -87.64 114.44 24.26 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 m -132.2 138.83 48.12 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -96.63 -57.04 2.4 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -129.42 -178.73 4.79 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.6 m -98.03 153.04 18.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.7 t -134.98 172.22 13.31 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 120.586 0.232 . . . . 0.0 110.563 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -105.69 24.43 12.27 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.963 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -120.65 127.13 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.465 HD13 HD11 ' A' ' 48' ' ' LEU . 34.4 pt -125.83 145.76 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -115.39 130.91 57.04 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.498 HD12 HD12 ' A' ' 46' ' ' LEU . 81.3 mt -116.47 151.63 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -174.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.422 HD12 ' CB ' ' A' ' 39' ' ' PRO . 11.7 pt -117.73 156.12 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 168.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.52 165.65 24.0 Favored Pre-proline 0 N--CA 1.494 1.75 0 CA-C-O 119.078 -0.487 . . . . 0.0 110.311 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -59.48 -30.8 93.46 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 121.117 1.211 . . . . 0.0 111.576 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.31 167.02 23.44 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 122.299 -0.25 . . . . 0.0 110.701 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -71.57 105.24 3.57 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.414 HD12 HD22 ' A' ' 44' ' ' LEU . 80.3 mt -59.52 -33.67 71.66 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 122.144 -0.347 . . . . 0.0 111.471 -177.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -63.04 -34.91 78.58 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 122.124 -0.36 . . . . 0.0 110.951 -175.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.2 -47.7 17.46 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -62.45 -34.99 77.89 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 122.211 -0.305 . . . . 0.0 111.038 -172.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -108.03 9.94 28.35 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 51.81 47.92 23.84 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.226 -0.921 . . . . 0.0 111.972 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 48.6 mt -91.37 138.25 31.73 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.958 -0.464 . . . . 0.0 110.798 -172.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -114.12 158.62 21.04 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.87 138.07 49.11 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.794 -0.566 . . . . 0.0 111.429 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.53 -22.96 37.59 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.4 155.59 34.93 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-N 118.648 1.224 . . . . 0.0 110.039 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.41 134.09 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -174.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.78 HD11 HD11 ' A' ' 46' ' ' LEU . 34.3 pt -128.76 160.73 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -109.9 137.63 47.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.205 -0.31 . . . . 0.0 110.179 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -113.11 137.25 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.468 HD23 ' C ' ' A' ' 129' ' ' LEU . 9.2 tt . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.0 mm . . . . . 0 N--CA 1.499 1.996 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.2 mt -129.81 149.73 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -105.85 141.87 36.54 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.25 150.45 20.45 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.52 142.18 36.6 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 117.217 0.508 . . . . 0.0 110.278 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.1 t -63.04 123.22 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -122.37 155.13 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 176.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.4 p . . . . . 0 N--CA 1.499 2.001 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.352 -177.302 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 N--CA 1.501 2.109 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -65.76 -32.64 74.29 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.73 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -68.7 -40.15 80.17 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.605 178.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.8 mt -81.56 -35.78 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -176.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.428 HD21 ' HB2' ' A' ' 92' ' ' ALA . 47.1 mt -103.31 -26.29 12.99 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.183 -0.323 . . . . 0.0 111.767 -173.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.7 15.3 75.97 Favored Glycine 0 N--CA 1.493 2.492 0 CA-C-O 119.3 -0.722 . . . . 0.0 111.371 -173.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -150.83 162.31 40.99 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 119.166 1.483 . . . . 0.0 110.775 171.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -94.15 106.74 24.3 Favored Pre-proline 0 N--CA 1.497 1.888 0 CA-C-O 118.707 -0.663 . . . . 0.0 109.854 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.9 158.72 56.77 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 O-C-N 123.245 1.129 . . . . 0.0 110.302 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -73.8 160.4 31.53 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -80.29 79.67 6.83 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.518 0.675 . . . . 0.0 109.778 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.19 175.8 47.66 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 175.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 p -138.02 154.53 49.3 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 117.367 0.584 . . . . 0.0 110.774 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.506 HD22 HD12 ' A' ' 114' ' ' LEU . 30.6 tp -109.32 119.08 38.4 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 170.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.536 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.5 m120 -100.64 122.69 43.73 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.168 -175.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.806 HD11 HD11 ' A' ' 126' ' ' ILE . 56.2 mt -120.53 136.19 54.85 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 120.66 0.267 . . . . 0.0 110.549 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HB2' HG11 ' A' ' 12' ' ' VAL . 63.5 tttt -96.24 133.92 39.98 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.493 HD11 HD13 ' A' ' 106' ' ' ILE . 83.5 mt -111.95 160.22 17.64 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 120.617 0.246 . . . . 0.0 110.465 -176.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.04 12.8 14.55 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 172.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -145.79 141.98 28.45 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.661 -0.649 . . . . 0.0 109.388 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.24 146.81 52.62 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 122.225 -0.297 . . . . 0.0 110.628 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -132.16 137.45 47.65 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 120.699 0.285 . . . . 0.0 110.663 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -138.0 125.53 22.09 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 174.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.2 -22.51 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.384 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -74.48 -1.08 19.69 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.978 -0.451 . . . . 0.0 112.187 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -90.75 -14.48 31.99 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 118.922 0.783 . . . . 0.0 111.524 170.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.96 175.18 5.7 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 118.597 0.635 . . . . 0.0 109.463 174.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -91.74 103.24 15.83 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -110.59 178.84 4.24 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 120.587 0.232 . . . . 0.0 110.435 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -111.74 130.2 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.97 142.65 35.32 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.2 p -122.79 136.35 54.84 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 120.762 0.315 . . . . 0.0 110.78 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -75.34 172.67 12.05 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 120.909 0.385 . . . . 0.0 111.754 -170.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -67.8 141.15 56.6 Favored 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -137.04 167.0 22.37 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.543 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -125.58 149.52 48.28 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 120.907 0.384 . . . . 0.0 110.548 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -147.9 134.15 19.47 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 51.69 33.82 11.69 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.702 -0.624 . . . . 0.0 112.157 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.18 16.64 79.39 Favored Glycine 0 N--CA 1.496 2.682 0 CA-C-O 119.623 -0.543 . . . . 0.0 111.875 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -121.15 139.84 52.81 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.677 1.239 . . . . 0.0 109.623 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.51 132.48 37.76 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 121.091 -0.243 . . . . 0.0 110.505 -176.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -121.24 144.14 48.77 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -86.08 157.04 20.15 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.53 -168.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.56 158.59 49.11 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -176.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.49 154.98 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 122.351 -0.499 . . . . 0.0 110.445 -174.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -116.04 136.43 53.04 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.4 t -133.98 139.95 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -175.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.7 tp -137.12 125.65 14.86 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.053 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -63.4 149.76 90.31 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 O-C-N 123.182 1.096 . . . . 0.0 111.444 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.507 HD13 HG13 ' A' ' 93' ' ' ILE . 43.1 pt -141.7 170.08 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 171.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -113.9 130.42 56.5 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 168.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -105.96 123.64 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -174.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.5 mt -108.52 116.32 31.75 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -129.87 121.91 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.72 -120.29 18.34 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -111.18 17.05 20.69 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 122.316 -0.52 . . . . 0.0 111.932 175.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -119.34 143.99 47.1 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 118.465 0.575 . . . . 0.0 110.498 -175.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -123.16 130.08 52.29 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.3 mt -126.81 146.32 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.83 135.98 43.47 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.01 -167.29 12.12 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.428 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -160.1 155.95 26.03 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 117.374 0.587 . . . . 0.0 110.447 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.507 HG13 HD13 ' A' ' 80' ' ' ILE . 67.5 mt -108.73 141.9 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -121.88 131.42 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.1 t -141.01 133.87 14.41 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -57.82 155.04 34.47 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 120.996 1.131 . . . . 0.0 111.877 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -64.78 -34.52 78.55 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 122.365 -0.209 . . . . 0.0 110.723 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -87.33 118.39 26.73 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.35 -176.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.2 p -131.98 160.37 36.02 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -126.77 -42.91 1.74 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.308 -0.245 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -136.88 176.71 8.46 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.2 m -99.61 147.75 25.04 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.0 m -135.07 171.99 13.64 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 120.594 0.235 . . . . 0.0 110.517 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -107.19 27.14 9.34 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.408 -0.183 . . . . 0.0 110.94 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -122.91 127.19 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.493 HD13 HD11 ' A' ' 48' ' ' LEU . 34.6 pt -124.81 143.75 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 177.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -114.77 131.56 56.75 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.477 HD12 HD12 ' A' ' 46' ' ' LEU . 81.9 mt -117.22 152.05 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -173.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.5 pt -116.18 156.17 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 168.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.59 164.15 32.27 Favored Pre-proline 0 N--CA 1.496 1.827 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.334 -176.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.15 -32.41 94.54 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 121.062 1.175 . . . . 0.0 111.479 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.98 159.26 43.21 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.266 -0.272 . . . . 0.0 110.862 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.6 pttt -62.5 103.92 0.46 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.413 0.625 . . . . 0.0 111.203 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.506 HD12 HD22 ' A' ' 44' ' ' LEU . 82.7 mt -59.6 -32.51 70.46 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.869 -0.519 . . . . 0.0 111.692 -177.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -61.9 -37.28 84.02 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 122.098 -0.376 . . . . 0.0 111.204 -171.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -78.27 -46.41 20.34 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -62.37 -34.59 76.99 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 122.208 -0.307 . . . . 0.0 111.024 -172.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -108.13 8.23 27.97 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 51.72 50.65 18.27 Favored 'General case' 0 N--CA 1.508 2.436 0 CA-C-N 119.309 0.959 . . . . 0.0 111.945 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 48.2 mt -90.39 138.16 31.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.832 -0.542 . . . . 0.0 110.818 -171.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -117.03 155.29 29.46 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 175.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -55.99 138.01 49.8 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.857 -0.527 . . . . 0.0 111.468 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.98 -22.97 37.32 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.31 154.59 37.83 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 118.655 1.227 . . . . 0.0 110.038 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -111.92 133.78 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.806 HD11 HD11 ' A' ' 46' ' ' LEU . 34.4 pt -128.56 160.95 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -109.93 138.13 46.73 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -112.26 137.17 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.463 HD23 ' C ' ' A' ' 129' ' ' LEU . 10.0 tt . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.2 mm . . . . . 0 N--CA 1.499 1.981 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.437 HG22 HD22 ' A' ' 48' ' ' LEU . 77.6 mt -129.69 149.02 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -104.69 140.76 37.58 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.07 150.41 19.98 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -105.63 142.36 35.5 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 117.28 0.54 . . . . 0.0 110.227 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.71 120.99 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.45 137.78 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 122.308 -0.245 . . . . 0.0 110.375 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.882 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 N--CA 1.503 2.186 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -65.3 -32.35 73.96 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.83 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -68.45 -39.33 81.51 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.85 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.544 HG23 HD12 ' A' ' 60' ' ' ILE . 48.3 mt -81.46 -36.82 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -175.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.508 ' CD2' ' HB2' ' A' ' 92' ' ' ALA . 61.0 mt -103.97 -26.22 12.71 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.206 -0.309 . . . . 0.0 111.642 -174.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.7 14.17 73.75 Favored Glycine 0 N--CA 1.495 2.603 0 CA-C-O 119.368 -0.685 . . . . 0.0 111.48 -172.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -152.39 161.68 42.26 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 119.163 1.481 . . . . 0.0 110.554 170.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -94.47 107.45 29.92 Favored Pre-proline 0 N--CA 1.496 1.846 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.8 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -67.38 156.51 65.88 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 O-C-N 123.242 1.127 . . . . 0.0 110.526 -176.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -73.37 162.59 29.15 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -80.31 79.46 6.89 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.537 0.684 . . . . 0.0 109.509 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.85 176.12 47.26 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 p -138.07 157.2 46.81 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 117.349 0.575 . . . . 0.0 110.842 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.458 HD22 HD12 ' A' ' 114' ' ' LEU . 33.8 tp -108.92 118.37 36.62 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.95 122.85 42.74 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -175.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.823 HD11 HD11 ' A' ' 126' ' ' ILE . 61.1 mt -121.29 136.24 55.0 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.732 0.301 . . . . 0.0 110.521 -178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -96.13 132.51 41.45 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.437 HD22 HG22 ' A' ' 7' ' ' ILE . 84.5 mt -111.47 160.23 17.32 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 120.703 0.287 . . . . 0.0 110.382 -176.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -88.94 12.44 15.34 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 173.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -146.39 140.91 26.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.687 -0.633 . . . . 0.0 109.662 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.1 146.9 52.27 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 122.182 -0.324 . . . . 0.0 110.75 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -132.37 138.71 47.83 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.64 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -138.04 123.89 20.01 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 176.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.62 -23.08 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.395 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -74.6 -0.97 19.53 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.897 -0.502 . . . . 0.0 112.214 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -89.92 -14.21 34.65 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 118.961 0.8 . . . . 0.0 111.542 171.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -117.0 175.15 5.72 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 118.603 0.638 . . . . 0.0 109.582 173.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -91.87 104.86 17.24 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -109.49 177.3 4.78 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.544 HD12 HG23 ' A' ' 34' ' ' ILE . 79.4 mt -110.37 133.67 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -105.84 142.1 36.13 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.3 p -116.5 133.23 56.26 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -77.47 172.5 13.24 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 120.75 0.309 . . . . 0.0 111.388 -171.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -69.28 139.86 54.39 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -140.64 164.86 29.05 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.743 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -122.01 146.44 47.16 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 120.699 0.285 . . . . 0.0 110.271 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -150.71 141.83 23.1 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 172.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.2 m120 52.11 29.98 7.06 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.69 -0.631 . . . . 0.0 112.126 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.56 16.08 81.03 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -120.45 143.29 48.57 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 118.706 1.253 . . . . 0.0 109.636 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -92.42 131.76 37.32 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.349 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -119.94 141.0 50.03 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -87.4 151.9 22.69 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 120.843 0.354 . . . . 0.0 110.595 -167.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.68 158.71 51.21 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -142.65 161.48 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 122.252 -0.558 . . . . 0.0 110.514 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -113.5 135.21 54.13 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.8 t -131.07 138.25 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -176.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.7 tp -137.44 125.65 14.49 Favored Pre-proline 0 N--CA 1.496 1.85 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.055 178.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -62.68 149.33 91.56 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 120.98 1.12 . . . . 0.0 111.731 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.581 HD13 HG13 ' A' ' 93' ' ' ILE . 43.6 pt -141.82 170.17 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 122.253 -0.279 . . . . 0.0 110.321 171.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -113.53 130.26 56.39 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 168.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -106.24 123.57 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -108.63 116.99 33.02 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.8 mt -130.1 121.96 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.79 -120.46 18.89 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -111.1 16.97 20.82 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 122.266 -0.55 . . . . 0.0 111.933 175.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -118.68 143.2 47.0 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 118.518 0.599 . . . . 0.0 110.482 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -123.09 129.89 52.06 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -127.06 149.05 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.31 136.01 44.44 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.99 -168.4 12.35 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.508 ' HB2' ' CD2' ' A' ' 35' ' ' LEU . . . -159.35 155.22 26.39 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 117.305 0.553 . . . . 0.0 110.325 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.581 HG13 HD13 ' A' ' 80' ' ' ILE . 73.8 mt -108.71 140.72 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -125.07 129.52 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.7 t -139.92 133.88 15.6 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -56.65 153.67 34.92 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 121.037 1.158 . . . . 0.0 112.046 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -64.5 -34.45 78.24 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 122.269 -0.269 . . . . 0.0 110.606 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.1 tttp -90.97 121.05 32.47 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.2 t -141.84 151.89 43.17 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 122.32 -0.237 . . . . 0.0 110.401 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -98.42 -58.93 1.85 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -134.91 169.77 16.89 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.0 m -82.81 154.39 24.72 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 96.3 p -135.02 175.05 9.94 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 120.645 0.259 . . . . 0.0 110.495 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -104.8 25.0 10.94 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 121.28 -0.168 . . . . 0.0 110.95 172.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -120.89 126.88 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.9 pt -125.36 145.59 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -115.55 130.23 56.8 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.545 HD12 HD12 ' A' ' 46' ' ' LEU . 83.6 mt -116.06 152.27 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -174.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 pt -116.68 155.91 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 168.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.52 162.16 43.39 Favored Pre-proline 0 N--CA 1.495 1.823 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.358 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.54 -30.67 93.02 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 121.075 1.183 . . . . 0.0 111.728 177.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.44 167.0 23.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.279 -0.263 . . . . 0.0 110.933 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -69.92 104.33 2.48 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.458 HD12 HD22 ' A' ' 44' ' ' LEU . 85.0 mt -59.93 -34.25 72.98 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 122.138 -0.351 . . . . 0.0 111.349 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -62.97 -35.57 80.59 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 122.203 -0.311 . . . . 0.0 110.922 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -78.36 -48.76 14.88 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -62.65 -33.63 75.43 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 122.231 -0.293 . . . . 0.0 111.11 -172.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -108.05 7.75 27.9 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 51.8 46.97 25.69 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.108 -0.995 . . . . 0.0 111.878 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.4 mt -92.28 138.19 31.73 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.893 -0.504 . . . . 0.0 111.007 -170.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -115.66 160.61 19.82 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.17 50.17 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.966 -0.459 . . . . 0.0 111.569 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.48 -22.94 37.7 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.59 151.59 46.12 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 118.627 1.213 . . . . 0.0 110.018 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.3 t -110.45 133.66 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -173.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.823 HD11 HD11 ' A' ' 46' ' ' LEU . 34.8 pt -128.46 160.16 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -109.65 138.07 46.55 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.2 pt -113.62 137.87 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.465 HD23 ' C ' ' A' ' 129' ' ' LEU . 9.7 tt . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.7 mm . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.501 HG22 HD22 ' A' ' 48' ' ' LEU . 73.7 mt -129.77 148.9 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -105.37 141.53 36.72 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.73 150.61 20.38 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -106.33 142.1 36.56 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 117.265 0.532 . . . . 0.0 110.301 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.11 121.08 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.22 144.2 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 N--CA 1.499 1.984 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.306 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 N--CA 1.501 2.113 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -66.18 -29.62 69.93 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.735 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -68.89 -40.82 79.0 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.733 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.9 mt -81.31 -38.04 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -175.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 92' ' ' ALA . 46.1 mt -104.01 -26.2 12.71 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.231 -0.293 . . . . 0.0 111.711 -174.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.16 13.66 73.67 Favored Glycine 0 N--CA 1.495 2.592 0 CA-C-O 119.369 -0.684 . . . . 0.0 111.466 -171.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -152.52 165.65 34.46 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 119.158 1.479 . . . . 0.0 110.614 170.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -96.41 112.31 59.57 Favored Pre-proline 0 N--CA 1.496 1.851 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.835 175.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -67.52 159.92 50.33 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 O-C-N 123.266 1.14 . . . . 0.0 110.631 -176.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -74.3 164.54 26.48 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -80.23 79.57 6.78 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.476 0.655 . . . . 0.0 109.729 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.09 170.42 42.14 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 p -138.08 157.41 46.38 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 117.295 0.547 . . . . 0.0 110.674 177.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.5 tp -109.76 116.67 32.11 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 171.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.57 120.9 39.78 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 126' ' ' ILE . 60.6 mt -119.96 135.71 54.8 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.71 0.29 . . . . 0.0 110.656 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -96.21 133.46 40.49 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.501 HD22 HG22 ' A' ' 7' ' ' ILE . 84.7 mt -110.95 160.38 16.86 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 120.649 0.262 . . . . 0.0 110.481 -177.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.09 12.75 14.78 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -145.89 141.4 27.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.701 -0.624 . . . . 0.0 109.488 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -63.32 146.92 52.48 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 122.203 -0.311 . . . . 0.0 110.682 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -132.09 138.17 48.02 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 120.719 0.295 . . . . 0.0 110.622 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -138.02 126.41 23.27 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.9 tt -63.28 -22.73 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.348 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -74.65 -0.94 19.59 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.97 -0.457 . . . . 0.0 112.216 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -90.77 -14.51 31.87 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 118.902 0.774 . . . . 0.0 111.488 171.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -117.63 175.18 5.76 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 118.7 0.682 . . . . 0.0 109.469 174.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -90.64 103.88 16.53 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -177.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -110.42 179.25 4.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.371 -0.206 . . . . 0.0 110.537 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.5 mt -112.6 131.8 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.95 143.17 34.47 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.4 p -123.28 137.07 54.94 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 120.761 0.315 . . . . 0.0 110.769 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -77.3 172.61 13.02 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 120.824 0.345 . . . . 0.0 111.849 -168.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -68.21 141.31 56.0 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -138.69 164.99 28.12 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 122.186 -0.321 . . . . 0.0 110.675 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -124.92 148.31 48.41 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.787 0.327 . . . . 0.0 110.381 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -149.53 136.45 19.6 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 52.23 32.96 11.58 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.747 -0.595 . . . . 0.0 111.832 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 16.42 80.15 Favored Glycine 0 N--CA 1.497 2.733 0 CA-C-O 119.584 -0.565 . . . . 0.0 111.798 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -120.16 138.99 53.28 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 118.728 1.264 . . . . 0.0 109.701 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.19 131.47 38.24 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.358 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -119.69 140.93 49.88 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -86.03 155.9 20.65 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 120.761 0.315 . . . . 0.0 110.388 -168.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.94 156.86 51.64 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -176.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.09 156.86 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 122.347 -0.502 . . . . 0.0 110.486 -173.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -115.79 137.0 52.5 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.2 t -134.06 141.06 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -175.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 tp -137.54 125.72 14.42 Favored Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.082 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -63.31 148.56 92.8 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 120.987 1.125 . . . . 0.0 111.396 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.617 HD13 HG13 ' A' ' 93' ' ' ILE . 43.9 pt -141.78 170.06 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 122.304 -0.248 . . . . 0.0 110.412 173.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -114.28 131.51 56.48 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 168.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.2 mt -105.74 123.33 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.22 116.47 32.02 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.7 mt -129.83 121.92 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.56 -120.16 18.09 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -177.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -111.21 17.04 20.67 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 117.161 0.48 . . . . 0.0 111.784 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -119.43 144.12 47.11 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.557 0.617 . . . . 0.0 110.46 -175.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -123.13 130.15 52.39 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 122.263 -0.273 . . . . 0.0 110.275 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.6 mt -126.35 147.05 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.42 137.46 44.62 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.6 -168.32 13.51 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 178.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.644 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.12 154.26 25.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.266 -0.549 . . . . 0.0 110.258 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.617 HG13 HD13 ' A' ' 80' ' ' ILE . 70.2 mt -108.65 140.62 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -123.07 130.28 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.98 133.9 14.45 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -57.75 153.63 42.17 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 120.996 1.13 . . . . 0.0 111.813 177.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -65.53 -34.91 79.37 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 122.279 -0.263 . . . . 0.0 110.487 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -89.17 121.01 31.07 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.267 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -141.64 151.56 43.17 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -98.01 -55.89 2.65 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -136.84 169.63 17.43 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.1 m -82.19 151.11 27.04 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.0 m -134.91 175.0 9.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.295 -0.253 . . . . 0.0 110.526 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -107.28 27.22 9.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.378 -0.201 . . . . 0.0 110.839 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.1 mm -124.1 127.51 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.5 pt -125.98 145.52 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -114.81 130.08 56.81 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.507 HD12 HD12 ' A' ' 46' ' ' LEU . 83.5 mt -115.04 149.95 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -174.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 pt -115.95 155.57 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 169.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.55 165.97 22.24 Favored Pre-proline 0 N--CA 1.496 1.843 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.326 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.76 -30.94 93.24 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 O-C-N 123.292 1.154 . . . . 0.0 111.623 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.39 167.06 23.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.293 -0.255 . . . . 0.0 110.751 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -70.88 105.24 3.19 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.3 mt -59.52 -33.61 71.59 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 122.151 -0.343 . . . . 0.0 111.449 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -62.83 -35.35 79.65 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 122.108 -0.37 . . . . 0.0 111.006 -174.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -78.11 -48.28 16.37 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.47 -34.3 76.55 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 122.153 -0.342 . . . . 0.0 111.135 -172.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -108.1 8.53 28.18 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 51.79 50.5 18.53 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 121.103 -0.998 . . . . 0.0 111.895 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 47.4 mt -90.3 138.17 31.75 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.879 -0.513 . . . . 0.0 110.899 -171.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -116.19 155.16 28.76 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.48 137.91 47.45 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.906 -0.496 . . . . 0.0 111.533 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.02 -22.98 37.22 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -65.32 154.6 37.81 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-N 118.704 1.252 . . . . 0.0 110.05 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.38 134.03 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -174.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.815 HD11 HD11 ' A' ' 46' ' ' LEU . 34.6 pt -128.9 160.41 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -109.83 138.28 46.43 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.8 pt -114.21 137.61 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 176.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.466 HD23 ' C ' ' A' ' 129' ' ' LEU . 9.2 tt . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.3 mm . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.487 HG22 HD22 ' A' ' 48' ' ' LEU . 73.3 mt -129.97 149.23 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -105.9 142.12 36.15 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.42 150.95 20.4 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -106.16 142.38 35.95 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 117.266 0.533 . . . . 0.0 110.245 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.74 123.6 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -123.24 157.87 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 176.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.499 2.005 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.271 -178.268 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 N--CA 1.503 2.176 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -65.42 -37.51 87.15 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 122.212 -0.305 . . . . 0.0 110.319 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -68.03 -38.26 82.34 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.537 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.7 mt -81.18 -35.81 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.62 -26.1 12.92 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 122.141 -0.349 . . . . 0.0 111.573 -173.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.8 13.12 78.65 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -172.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -151.62 160.56 43.6 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 118.955 1.377 . . . . 0.0 110.222 170.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -93.12 108.0 29.45 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.857 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.456 ' CB ' HD12 ' A' ' 109' ' ' ILE . 66.7 Cg_endo -67.6 160.12 49.47 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 O-C-N 123.249 1.131 . . . . 0.0 110.355 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -73.62 161.62 30.1 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -80.32 79.6 6.88 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.496 0.665 . . . . 0.0 109.654 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.71 172.68 45.01 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 175.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 p -138.04 156.87 47.36 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 117.348 0.574 . . . . 0.0 110.775 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.497 HD22 HD12 ' A' ' 114' ' ' LEU . 30.7 tp -110.71 118.18 35.47 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 170.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.539 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.5 m120 -98.94 122.15 41.82 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -176.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 126' ' ' ILE . 59.3 mt -120.14 136.13 54.72 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 120.662 0.268 . . . . 0.0 110.585 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HB2' HG11 ' A' ' 12' ' ' VAL . 39.8 tttp -96.21 133.27 40.73 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 173.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.487 HD22 HG22 ' A' ' 7' ' ' ILE . 83.0 mt -111.1 160.27 17.04 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 120.664 0.269 . . . . 0.0 110.448 -177.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.14 12.74 14.93 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 172.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -145.76 142.39 28.87 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 118.496 0.589 . . . . 0.0 109.428 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -64.37 146.76 53.93 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 122.196 -0.315 . . . . 0.0 110.324 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -133.11 137.57 46.37 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 120.686 0.279 . . . . 0.0 110.755 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -138.06 128.28 25.98 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 174.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.43 -23.05 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.271 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -74.58 -0.92 19.32 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -90.53 -14.52 32.45 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 118.905 0.775 . . . . 0.0 111.429 170.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -117.79 175.18 5.78 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 118.64 0.654 . . . . 0.0 109.497 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -91.1 103.8 16.45 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -109.81 178.39 4.43 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 120.572 0.225 . . . . 0.0 110.47 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -111.43 131.17 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -105.97 144.56 32.52 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.1 p -124.27 138.09 54.43 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.821 0.343 . . . . 0.0 110.764 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -77.0 172.77 12.66 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 120.902 0.382 . . . . 0.0 111.869 -168.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -67.45 140.82 57.11 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -136.78 167.35 21.6 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.221 -0.299 . . . . 0.0 110.553 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -125.3 149.53 47.97 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 120.836 0.35 . . . . 0.0 110.56 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -148.66 133.65 18.14 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 52.11 33.46 12.24 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.63 -0.668 . . . . 0.0 111.879 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.21 15.77 80.56 Favored Glycine 0 N--CA 1.497 2.721 0 CA-C-O 119.578 -0.568 . . . . 0.0 111.892 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -120.13 140.89 50.4 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.778 1.289 . . . . 0.0 109.691 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.47 132.04 38.11 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 121.081 -0.247 . . . . 0.0 110.489 -176.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -121.19 144.87 48.36 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -86.11 156.18 20.48 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 120.799 0.333 . . . . 0.0 110.508 -167.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.79 159.46 48.88 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -176.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.77 158.17 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 122.355 -0.497 . . . . 0.0 110.338 -174.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -118.35 137.3 53.19 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.03 141.27 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.1 tp -137.25 125.64 14.7 Favored Pre-proline 0 N--CA 1.495 1.823 0 CA-C-O 118.524 -0.75 . . . . 0.0 110.092 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -63.68 149.73 90.15 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 120.965 1.11 . . . . 0.0 111.332 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.536 HD13 HG13 ' A' ' 93' ' ' ILE . 43.1 pt -141.85 170.06 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 120.635 0.255 . . . . 0.0 110.385 171.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -114.35 131.14 56.65 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 168.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.24 123.05 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -174.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.4 mt -107.97 116.4 31.89 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.9 mt -129.85 121.9 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.69 -120.14 17.83 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -111.22 17.08 20.63 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.33 -0.512 . . . . 0.0 111.897 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -119.76 144.21 47.4 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 118.52 0.6 . . . . 0.0 110.435 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -123.06 129.9 52.09 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 120.697 0.284 . . . . 0.0 110.298 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.4 mt -126.43 147.46 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.56 136.71 44.04 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.91 -168.89 13.05 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.49 154.47 24.87 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 117.376 0.588 . . . . 0.0 110.305 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.536 HG13 HD13 ' A' ' 80' ' ' ILE . 69.9 mt -108.79 141.61 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.8 t -124.4 132.09 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -144.95 137.54 13.54 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -58.15 152.84 49.66 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.05 1.166 . . . . 0.0 111.652 175.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -65.89 -34.32 77.85 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.538 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -88.6 117.31 27.47 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.0 m -129.87 143.26 50.72 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -94.05 -54.23 3.67 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -135.94 -179.73 5.84 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.4 m -96.77 151.71 19.38 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.2 p -134.96 172.32 13.17 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 120.747 0.308 . . . . 0.0 110.647 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.56 24.87 11.5 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.811 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.5 mm -120.81 127.72 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.442 HD13 HD11 ' A' ' 48' ' ' LEU . 34.5 pt -125.93 146.08 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 177.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -116.28 129.75 56.43 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 110.037 -0.356 . . . . 0.0 110.037 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.5 HD12 HD12 ' A' ' 46' ' ' LEU . 82.1 mt -115.0 151.55 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.456 HD12 ' CB ' ' A' ' 39' ' ' PRO . 11.9 pt -115.91 156.17 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 168.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.56 165.97 22.22 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.317 -176.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.13 -32.87 95.22 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 121.064 1.176 . . . . 0.0 111.462 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -145.06 160.14 41.86 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.308 -0.245 . . . . 0.0 110.877 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -62.36 104.7 0.52 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.367 0.604 . . . . 0.0 111.229 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.497 HD12 HD22 ' A' ' 44' ' ' LEU . 81.4 mt -59.56 -32.86 70.74 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.94 -0.475 . . . . 0.0 111.662 -176.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -61.87 -37.42 84.5 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 122.07 -0.394 . . . . 0.0 111.199 -171.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -78.27 -45.16 23.51 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -62.25 -34.79 77.21 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 122.143 -0.348 . . . . 0.0 111.085 -173.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -108.15 8.39 28.01 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 51.86 48.27 23.13 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.084 -1.01 . . . . 0.0 111.879 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.3 mt -91.71 138.12 31.82 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.887 -0.508 . . . . 0.0 110.993 -171.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.25 158.99 22.48 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -56.16 138.22 50.29 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.889 -0.507 . . . . 0.0 111.459 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.59 -22.97 37.52 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.43 151.8 45.45 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-N 118.672 1.236 . . . . 0.0 110.011 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.8 t -110.76 133.64 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -174.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.815 HD11 HD11 ' A' ' 46' ' ' LEU . 34.2 pt -128.28 160.38 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -109.72 137.81 47.0 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.5 pt -113.13 137.2 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.466 HD23 ' C ' ' A' ' 129' ' ' LEU . 9.1 tt . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.8 mm . . . . . 0 N--CA 1.499 1.988 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.409 HG22 HD22 ' A' ' 48' ' ' LEU . 74.5 mt -129.67 149.38 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -105.81 141.84 36.56 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.32 150.83 20.59 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -106.19 141.5 37.45 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 117.31 0.555 . . . . 0.0 110.269 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.11 123.51 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.8 m -123.55 156.94 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 N--CA 1.499 1.996 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.284 -178.333 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.433 ' CE1' HD13 ' A' ' 109' ' ' ILE . 3.7 m-85 . . . . . 0 N--CA 1.501 2.116 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -65.71 -31.01 71.77 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 122.197 -0.314 . . . . 0.0 110.814 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -68.93 -40.44 79.03 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.581 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -81.45 -37.04 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -175.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.64 HD21 ' HB2' ' A' ' 92' ' ' ALA . 45.8 mt -104.0 -26.19 12.72 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 122.231 -0.293 . . . . 0.0 111.683 -174.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.39 14.76 73.17 Favored Glycine 0 N--CA 1.495 2.593 0 CA-C-O 119.304 -0.72 . . . . 0.0 111.443 -172.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -151.76 163.05 39.99 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 119.22 1.51 . . . . 0.0 110.748 170.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -94.58 109.07 41.17 Favored Pre-proline 0 N--CA 1.496 1.866 0 CA-C-O 118.589 -0.72 . . . . 0.0 109.827 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.47 159.47 52.3 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 O-C-N 123.219 1.115 . . . . 0.0 110.493 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -73.87 162.85 28.66 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -80.22 79.52 6.78 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.467 0.651 . . . . 0.0 109.726 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.5 172.65 45.06 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 175.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.1 p -138.02 157.67 45.88 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 117.408 0.604 . . . . 0.0 110.806 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.9 tp -109.55 114.98 29.07 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.539 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.7 m120 -98.24 120.12 38.1 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 126' ' ' ILE . 63.8 mt -120.01 135.95 54.73 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 120.708 0.29 . . . . 0.0 110.664 -177.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HB2' HG11 ' A' ' 12' ' ' VAL . 40.4 tttp -95.99 133.04 40.68 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.421 HD11 HD13 ' A' ' 106' ' ' ILE . 83.8 mt -111.71 160.23 17.48 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 120.663 0.268 . . . . 0.0 110.407 -176.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.06 12.88 14.35 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 172.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -145.91 142.19 28.51 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.65 0.659 . . . . 0.0 109.482 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -64.46 146.89 53.83 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 122.218 -0.301 . . . . 0.0 110.424 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -132.37 136.72 47.02 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 120.659 0.266 . . . . 0.0 110.607 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -138.01 126.44 23.32 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.1 tt -64.2 -23.86 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.173 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -74.05 -1.0 18.17 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.888 -0.508 . . . . 0.0 112.128 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.28 -14.44 30.85 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 118.889 0.768 . . . . 0.0 111.429 169.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -115.82 175.09 5.69 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 118.618 0.644 . . . . 0.0 109.463 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -91.64 102.76 15.4 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -177.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -110.45 178.36 4.4 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.34 -0.225 . . . . 0.0 110.546 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.6 mt -112.35 131.76 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -105.94 142.49 35.56 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.6 p -120.7 138.08 54.15 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 120.745 0.307 . . . . 0.0 110.687 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.94 172.58 12.95 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 120.812 0.339 . . . . 0.0 111.795 -168.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -67.9 141.16 56.46 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -137.23 165.96 24.89 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.22 -0.3 . . . . 0.0 110.636 -176.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -125.43 148.29 48.87 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.734 0.302 . . . . 0.0 110.543 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -149.28 137.2 20.51 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 174.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 51.63 33.0 9.97 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.691 -0.631 . . . . 0.0 112.12 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 17.6 78.59 Favored Glycine 0 N--CA 1.497 2.717 0 CA-C-O 119.625 -0.542 . . . . 0.0 111.803 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -122.52 139.89 53.39 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 118.64 1.22 . . . . 0.0 109.646 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -93.26 131.94 37.91 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.37 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -121.06 143.84 48.86 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -86.14 155.95 20.55 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 120.763 0.316 . . . . 0.0 110.474 -168.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.73 160.85 47.17 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.33 156.67 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 122.358 -0.495 . . . . 0.0 110.381 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -114.99 137.17 52.31 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 176.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.7 t -134.05 141.44 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.5 tp -137.76 125.58 14.08 Favored Pre-proline 0 N--CA 1.497 1.915 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.201 177.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -63.31 148.87 92.55 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.939 1.092 . . . . 0.0 111.491 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.57 HD13 HG13 ' A' ' 93' ' ' ILE . 43.3 pt -142.15 170.09 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 122.257 -0.277 . . . . 0.0 110.419 171.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -115.21 131.91 56.78 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 167.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -105.91 123.85 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.8 mt -108.19 116.77 32.57 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.419 HG21 HD11 ' A' ' 120' ' ' LEU . 77.1 mt -130.2 121.94 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.62 -120.12 17.84 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -178.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -111.17 17.08 20.67 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.377 -0.484 . . . . 0.0 111.811 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -119.62 143.65 47.56 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.55 0.614 . . . . 0.0 110.473 -175.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -123.15 129.5 51.52 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -125.85 143.67 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.0 137.98 43.82 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.87 -164.29 11.21 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.64 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.82 156.15 26.98 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 117.328 0.564 . . . . 0.0 110.424 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.57 HG13 HD13 ' A' ' 80' ' ' ILE . 70.2 mt -108.7 141.42 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -123.03 130.63 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -175.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 63.0 t -142.48 135.9 14.25 Favored Pre-proline 0 N--CA 1.497 1.904 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -57.31 153.57 39.6 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 121.093 1.195 . . . . 0.0 111.849 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -65.47 -34.92 79.4 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.512 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -91.42 124.27 35.47 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -142.91 155.21 44.69 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -98.02 -59.99 1.65 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -134.27 -173.38 3.25 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -97.67 149.96 21.7 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m -134.94 175.02 9.96 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 122.307 -0.245 . . . . 0.0 110.379 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -107.35 27.42 9.1 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 122.38 -0.2 . . . . 0.0 110.866 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.7 mm -124.14 127.36 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.421 HD13 HD11 ' A' ' 48' ' ' LEU . 34.3 pt -126.15 145.66 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 177.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -115.38 130.1 56.79 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.492 HD12 HD12 ' A' ' 46' ' ' LEU . 80.9 mt -115.52 151.31 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.433 HD13 ' CE1' ' A' ' 31' ' ' PHE . 12.0 pt -116.38 155.19 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 168.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.46 161.93 44.68 Favored Pre-proline 0 N--CA 1.496 1.874 0 CA-C-O 119.128 -0.463 . . . . 0.0 110.457 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -60.44 -31.54 92.69 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 121.09 1.193 . . . . 0.0 111.613 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.15 167.09 23.24 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.182 -0.324 . . . . 0.0 110.996 -175.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -68.18 105.39 2.08 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.68 -38.47 87.9 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.167 -0.333 . . . . 0.0 111.069 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -64.65 -36.88 85.7 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 122.158 -0.339 . . . . 0.0 110.539 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -78.16 -50.36 12.11 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -62.53 -32.56 73.53 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 122.178 -0.326 . . . . 0.0 111.16 -173.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -108.05 8.11 28.08 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.8 43.73 29.84 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.123 -0.986 . . . . 0.0 111.928 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.419 HD11 HG21 ' A' ' 84' ' ' ILE . 78.5 mt -93.52 138.25 31.99 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.999 -0.438 . . . . 0.0 110.868 -171.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -113.51 160.68 18.23 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.15 50.22 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.874 -0.516 . . . . 0.0 111.508 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.61 -23.18 36.7 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.53 155.15 36.57 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 118.579 1.19 . . . . 0.0 109.914 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.3 t -112.02 134.0 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.813 HD11 HD11 ' A' ' 46' ' ' LEU . 34.3 pt -128.69 160.14 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 174.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -109.36 138.33 45.88 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.2 pt -112.63 137.9 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 129' ' ' LEU . 9.0 tt . . . . . 0 N--CA 1.495 1.792 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mmm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 110.244 -0.28 . . . . 6.6399999999999997 110.244 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 p -131.51 141.18 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 110.015 -0.365 . . . . 3.3300000000000001 110.015 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -98.96 122.19 41.9 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.155 -0.313 . . . . 4.0199999999999996 110.155 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.5 mt -110.96 149.66 30.35 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 110.101 -0.333 . . . . 1.3 110.101 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.7 ttm -138.48 146.88 42.58 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 110.109 -0.33 . . . . 1.71 110.109 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.8 mm -125.83 131.01 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.118 -0.697 . . . . 0.44 109.118 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.532 HG22 HD22 ' A' ' 48' ' ' LEU . 71.9 mt -130.01 149.57 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 108.861 -0.792 . . . . 0.22 108.861 177.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -105.19 141.95 35.82 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.2 -0.296 . . . . 0.85999999999999999 110.2 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.7 149.41 20.17 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.595 -1.402 . . . . 0.080000000000000002 109.595 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -106.09 142.09 36.37 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 117.251 0.525 . . . . 0.85999999999999999 110.185 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.5 t -62.97 122.0 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 N-CA-C 109.82 -0.437 . . . . 0.14999999999999999 109.82 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.35 157.12 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 110.084 -0.339 . . . . 0.32000000000000001 110.084 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.2 t -86.14 129.96 34.68 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 110.222 -0.288 . . . . 1.2 110.222 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.99 119.96 0.84 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.559 -1.416 . . . . 1.1599999999999999 109.559 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 15' ' ' LEU . 6.2 tt -155.16 -46.69 0.08 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.332 -0.511 . . . . 2.4700000000000002 110.346 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.41 -31.16 79.8 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 110.714 -0.955 . . . . 3.0800000000000001 110.714 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -64.89 -34.72 79.07 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-N 117.661 0.731 . . . . 3.7000000000000002 110.32 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.49 130.01 10.1 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.288 -1.525 . . . . 2.3199999999999998 109.288 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -130.14 102.04 6.06 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 117.257 0.528 . . . . 5.5999999999999996 110.437 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -155.03 170.66 21.25 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.244 -0.28 . . . . 3.1800000000000002 110.244 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -112.01 138.32 48.81 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 110.345 -0.243 . . . . 2.4500000000000002 110.345 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 41' ' ' GLU . 64.2 mt -110.01 -30.43 7.79 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.374 -0.204 . . . . 1.3300000000000001 111.001 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -60.75 -30.67 70.15 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 122.037 -0.414 . . . . 1.4399999999999999 111.578 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.0 155.69 82.97 Favored Pre-proline 0 N--CA 1.503 2.22 0 CA-C-O 119.236 -0.412 . . . . 1.6699999999999999 110.523 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -57.25 -55.79 2.3 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 121.055 1.17 . . . . 0.54000000000000004 113.195 -172.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.84 -30.79 90.82 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 O-C-N 122.766 0.877 . . . . 0.67000000000000004 111.633 -162.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -66.37 -45.97 78.27 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 120.862 -0.335 . . . . 1.01 110.204 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.58 -36.17 82.96 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 122.186 -0.321 . . . . 1.97 110.22 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -66.01 -48.24 71.82 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 120.97 -0.292 . . . . 2.3100000000000001 110.476 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.1 tt -68.7 -36.58 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 C-N-CA 120.693 -0.403 . . . . 0.80000000000000004 110.06 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -65.87 -44.46 85.3 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 122.051 -0.405 . . . . 0.66000000000000003 110.325 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -65.77 -29.99 70.57 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 122.205 -0.31 . . . . 1.72 110.78 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -68.97 -40.58 78.76 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 120.689 -0.404 . . . . 2.3700000000000001 110.609 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.2 mt -81.1 -38.53 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.406 -0.59 . . . . 0.29999999999999999 109.406 -175.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.1 mt -104.11 -26.14 12.68 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 122.144 -0.348 . . . . 0.25 111.558 -174.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.34 14.74 70.6 Favored Glycine 0 N--CA 1.495 2.589 0 CA-C-O 119.408 -0.662 . . . . 0.32000000000000001 111.48 -171.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -152.79 164.51 37.67 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 119.057 1.428 . . . . 0.25 110.618 170.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -95.73 113.04 61.14 Favored Pre-proline 0 N--CA 1.497 1.891 0 CA-C-O 118.466 -0.778 . . . . 1.3500000000000001 109.869 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.408 ' HB3' HD12 ' A' ' 109' ' ' ILE . 68.9 Cg_endo -67.74 159.52 52.36 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 O-C-N 123.314 1.165 . . . . 0.17999999999999999 110.539 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -74.29 164.52 26.5 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 110.075 -0.343 . . . . 0.40000000000000002 110.075 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.423 ' HA ' HD13 ' A' ' 22' ' ' LEU . 55.6 mt-10 -80.37 79.58 6.94 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.459 0.647 . . . . 1.4099999999999999 109.721 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.8 176.54 48.05 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.536 -1.426 . . . . 0.29999999999999999 109.536 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -137.99 157.53 46.18 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 117.269 0.535 . . . . 0.23999999999999999 110.763 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.5 HD22 HD12 ' A' ' 114' ' ' LEU . 28.2 tp -110.31 115.05 28.99 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.514 -0.921 . . . . 0.22 108.514 168.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.71 121.31 41.43 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 110.001 -0.37 . . . . 0.14999999999999999 110.001 -175.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.763 HD11 HD11 ' A' ' 126' ' ' ILE . 62.4 mt -121.49 135.49 55.03 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 120.698 0.285 . . . . 0.080000000000000002 110.667 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -95.89 133.55 39.93 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.151 -0.685 . . . . 1.3300000000000001 109.151 172.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.532 HD22 HG22 ' A' ' 7' ' ' ILE . 82.7 mt -111.89 160.2 17.63 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 120.609 0.243 . . . . 0.11 110.411 -176.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.43 13.04 14.68 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 111.911 0.337 . . . . 0.17999999999999999 111.911 172.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -146.53 141.37 26.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.699 -0.625 . . . . 2.0600000000000001 109.505 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -62.93 149.27 45.08 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.168 -0.332 . . . . 1.9399999999999999 110.724 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -131.8 137.83 48.29 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 120.647 0.26 . . . . 0.32000000000000001 110.545 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -138.03 122.51 18.43 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.809 -0.441 . . . . 1.3999999999999999 109.809 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.3 tt -63.28 -22.91 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 C-N-CA 120.97 -0.292 . . . . 0.17000000000000001 111.363 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -74.43 -1.02 19.25 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.982 -0.449 . . . . 0.93000000000000005 112.143 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -90.61 -14.37 32.54 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 118.902 0.774 . . . . 1.52 111.444 170.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -116.11 175.1 5.7 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.668 0.667 . . . . 0.34999999999999998 109.512 173.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -92.07 103.93 16.38 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 110.097 -0.335 . . . . 1.8 110.097 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -109.73 176.99 4.87 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 120.517 0.199 . . . . 0.16 110.574 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.19 130.77 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.29 -1.004 . . . . 0.16 108.29 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -105.89 142.73 35.11 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 110.187 -0.301 . . . . 1.23 110.187 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.1 p -119.31 134.2 55.34 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 120.621 0.248 . . . . 0.35999999999999999 110.443 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.51 172.68 12.57 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 120.716 0.293 . . . . 1.29 111.502 -170.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -67.63 139.18 56.82 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.415 -0.587 . . . . 0.33000000000000002 109.415 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -139.09 167.82 21.21 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.934 -0.306 . . . . 0.23999999999999999 110.684 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -125.33 149.61 47.94 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 120.873 0.368 . . . . 0.80000000000000004 110.506 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -147.79 134.39 19.84 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.197 -0.668 . . . . 0.5 109.197 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 51.67 33.21 10.46 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.69 -0.631 . . . . 1.3100000000000001 112.089 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.47 16.98 78.58 Favored Glycine 0 N--CA 1.497 2.721 0 CA-C-O 119.601 -0.555 . . . . 0.46000000000000002 111.925 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -122.29 141.67 51.28 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 118.668 1.234 . . . . 1.8899999999999999 109.756 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -93.49 133.37 36.85 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 121.021 -0.272 . . . . 1.47 110.55 -176.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -123.04 145.18 48.75 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.887 -0.412 . . . . 0.38 109.887 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -86.98 153.76 21.31 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 120.783 0.325 . . . . 0.38 110.573 -168.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.09 158.62 51.85 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.976 -1.25 . . . . 0.20999999999999999 109.976 -177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.79 159.18 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 122.228 -0.572 . . . . 0.27000000000000002 110.53 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -117.66 137.0 52.95 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.7 -0.482 . . . . 0.95999999999999996 109.7 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.8 t -134.03 141.5 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 109.358 -0.608 . . . . 0.12 109.358 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.4 tp -137.41 125.61 14.49 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.627 -0.701 . . . . 0.14000000000000001 110.087 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.0 149.91 90.21 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 121.033 1.155 . . . . 0.10000000000000001 111.472 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.53 HD13 HG13 ' A' ' 93' ' ' ILE . 43.3 pt -141.54 170.0 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 120.716 0.293 . . . . 0.080000000000000002 110.313 171.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -114.88 130.77 56.96 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.121 -0.696 . . . . 1.4199999999999999 109.121 168.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.69 123.91 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.836 -0.801 . . . . 0.11 108.836 -174.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.9 mt -108.54 116.96 32.95 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 110.284 -0.265 . . . . 0.14999999999999999 110.284 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.4 mt -129.86 121.95 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.186 -1.042 . . . . 0.13 108.186 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.76 -120.37 18.58 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.868 -1.293 . . . . 0.16 109.868 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -111.12 17.13 20.66 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 122.382 -0.481 . . . . 2.0299999999999998 111.831 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -119.83 145.46 46.62 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 118.559 0.618 . . . . 1.3600000000000001 110.505 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -123.07 130.87 53.35 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 110.251 -0.277 . . . . 1.4199999999999999 110.251 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.9 mt -126.16 146.55 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 108.737 -0.838 . . . . 0.13 108.737 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.52 136.84 44.13 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 109.902 -0.407 . . . . 0.40999999999999998 109.902 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.51 -169.25 13.6 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.286 -1.526 . . . . 0.10000000000000001 109.286 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.17 154.62 25.75 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 117.196 0.498 . . . . 0.10000000000000001 110.159 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.53 HG13 HD13 ' A' ' 80' ' ' ILE . 68.5 mt -108.66 140.78 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.292 -1.003 . . . . 0.10000000000000001 108.292 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.79 131.82 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 109.347 -0.612 . . . . 0.14999999999999999 109.347 -175.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.2 t -143.21 138.6 15.79 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 108.545 -0.909 . . . . 0.20000000000000001 108.545 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -56.69 155.57 26.25 Favored 'Trans proline' 0 N--CA 1.504 2.097 0 C-N-CA 121.09 1.194 . . . . 0.23999999999999999 111.942 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -64.38 -34.14 77.49 Favored 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 121.141 -0.224 . . . . 1.1899999999999999 110.702 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -87.96 116.76 26.36 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 121.001 -0.28 . . . . 2.6699999999999999 110.254 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.0 m -130.98 136.64 48.71 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.016 -0.364 . . . . 1.4299999999999999 110.016 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -97.92 -54.63 3.03 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 110.31 -0.256 . . . . 4.6100000000000003 110.31 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -131.64 179.27 6.15 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 110.306 -0.257 . . . . 3.0 110.306 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.9 m -100.14 148.9 24.08 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 110.135 -0.32 . . . . 1.21 110.135 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.0 m -135.01 175.0 9.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 122.292 -0.255 . . . . 1.1699999999999999 110.387 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -107.91 27.07 9.6 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.418 -0.176 . . . . 0.93999999999999995 110.977 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -122.92 127.58 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.047 -0.723 . . . . 0.13 109.047 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.501 HD13 HD11 ' A' ' 48' ' ' LEU . 34.7 pt -125.44 143.68 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 110.109 -0.33 . . . . 0.11 110.109 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -115.03 130.85 57.03 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.963 -0.384 . . . . 1.3600000000000001 109.963 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.455 HD12 HD12 ' A' ' 46' ' ' LEU . 81.8 mt -115.92 151.39 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.434 -0.58 . . . . 0.11 109.434 -173.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 39' ' ' PRO . 13.8 pt -116.44 154.24 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 109.433 -0.58 . . . . 0.14000000000000001 109.433 168.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.58 165.59 24.2 Favored Pre-proline 0 N--CA 1.496 1.836 0 CA-C-O 119.043 -0.503 . . . . 0.13 110.222 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.81 -31.41 93.9 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.069 1.179 . . . . 0.19 111.602 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.61 167.07 23.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.35 -0.219 . . . . 0.28999999999999998 110.664 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -71.65 104.01 3.22 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 109.975 -0.38 . . . . 2.1800000000000002 109.975 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.5 HD12 HD22 ' A' ' 44' ' ' LEU . 81.6 mt -59.37 -33.03 70.67 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 122.069 -0.394 . . . . 0.25 111.449 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -63.1 -35.02 78.87 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 122.191 -0.318 . . . . 2.52 110.904 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -78.25 -47.86 17.03 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.194 -0.669 . . . . 1.8200000000000001 109.194 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -62.28 -34.03 75.77 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.194 -0.317 . . . . 1.28 111.112 -172.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -108.06 9.36 28.42 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 112.534 0.568 . . . . 0.26000000000000001 112.534 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.83 46.24 26.89 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.074 -1.016 . . . . 1.05 111.887 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -91.89 138.2 31.74 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.878 -0.513 . . . . 0.38 110.889 -171.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -114.99 158.2 22.38 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.844 -0.428 . . . . 2.4300000000000002 109.844 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -55.97 137.94 49.83 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.872 -0.517 . . . . 0.5 111.431 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.95 -22.96 37.36 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 111.151 -0.78 . . . . 0.14000000000000001 111.151 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -65.45 155.56 35.14 Favored 'General case' 0 N--CA 1.505 2.311 0 CA-C-N 118.631 1.216 . . . . 0.13 109.968 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -112.63 134.25 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.428 -0.582 . . . . 0.11 109.428 -174.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 46' ' ' LEU . 34.2 pt -129.38 161.33 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 109.554 -0.536 . . . . 0.13 109.554 174.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -110.0 138.26 46.62 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 110.141 -0.318 . . . . 1.3400000000000001 110.141 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.8 pt -114.68 137.15 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 120.845 0.355 . . . . 0.17000000000000001 110.184 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.466 HD23 ' C ' ' A' ' 129' ' ' LEU . 9.9 tt -109.67 127.59 54.67 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.861 -0.422 . . . . 0.97999999999999998 109.861 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.69 132.09 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.858 -0.793 . . . . 0.56999999999999995 108.858 -177.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -93.32 144.69 25.07 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 110.025 -0.361 . . . . 2.1000000000000001 110.025 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.07 179.88 32.52 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.678 -1.369 . . . . 1.3100000000000001 109.678 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -148.05 153.66 39.22 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 122.388 -0.478 . . . . 3.1499999999999999 110.203 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -124.67 131.7 53.45 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 110.105 -0.332 . . . . 7.8499999999999996 110.105 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.42 -36.35 81.07 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 120.952 -0.299 . . . . 6.5 110.204 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 N--CA 1.506 2.333 0 CA-C-O 118.279 -0.867 . . . . 9.0199999999999996 111.696 -179.414 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 110.38 -0.229 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.71 157.13 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -129.15 126.49 39.38 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 131' ' ' LYS . 83.7 mt -110.86 151.32 27.99 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 22.4 ttt -134.63 147.27 50.14 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.1 mm -124.91 133.09 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.496 HG22 HD22 ' A' ' 48' ' ' LEU . 74.5 mt -129.7 148.91 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -105.32 140.05 39.03 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.33 151.08 20.42 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -106.83 141.64 37.74 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.346 -0.503 . . . . 0.0 110.26 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.18 122.28 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -124.4 146.03 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.1 m -86.14 103.77 15.1 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.02 132.23 2.46 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.2 mt -101.32 30.5 4.16 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.346 -0.502 . . . . 0.0 110.674 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.93 -171.73 54.39 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -91.26 -45.94 8.34 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.355 -0.497 . . . . 0.0 110.057 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -94.05 -172.89 38.98 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -146.72 156.79 43.43 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 122.315 -0.521 . . . . 0.0 110.428 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -146.36 170.73 16.2 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -109.3 141.14 42.04 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 41' ' ' GLU . 39.2 mt -110.04 -29.29 8.29 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.391 -0.193 . . . . 0.0 111.184 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -60.87 -30.98 70.47 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.993 -0.442 . . . . 0.0 111.58 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 mp -65.18 156.6 80.59 Favored Pre-proline 0 N--CA 1.503 2.177 0 CA-C-O 119.197 -0.43 . . . . 0.0 110.579 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -57.0 -55.9 2.3 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.165 1.243 . . . . 0.0 113.179 -172.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.32 -30.78 91.78 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 O-C-N 122.658 0.82 . . . . 0.0 111.689 -163.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -66.55 -46.59 75.58 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.281 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -65.67 -36.25 83.1 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.177 -0.327 . . . . 0.0 110.275 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.93 -48.52 71.12 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 122.239 -0.288 . . . . 0.0 110.466 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.2 tt -68.72 -37.16 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.006 -176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -66.01 -44.36 84.99 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 122.111 -0.368 . . . . 0.0 110.352 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -65.76 -30.31 70.94 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.24 -0.288 . . . . 0.0 110.814 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -68.94 -40.69 78.85 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.622 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -81.26 -38.02 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' A' ' 92' ' ' ALA . 52.3 mt -103.97 -26.2 12.72 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 122.2 -0.313 . . . . 0.0 111.61 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.03 15.02 70.81 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -172.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -152.83 164.33 38.06 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 119.027 1.413 . . . . 0.0 110.67 170.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -95.07 110.87 52.47 Favored Pre-proline 0 N--CA 1.496 1.844 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.725 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.33 159.9 50.17 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 O-C-N 123.253 1.133 . . . . 0.0 110.526 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -73.96 163.71 27.55 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.447 ' HA ' HD13 ' A' ' 22' ' ' LEU . 55.7 mt-10 -80.29 79.6 6.85 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.488 0.661 . . . . 0.0 109.653 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.16 173.24 45.37 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 p -138.05 157.87 45.47 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 117.241 0.52 . . . . 0.0 110.708 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.2 tp -110.31 114.98 28.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.439 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.6 m120 -99.04 119.84 38.47 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.845 HD11 HD11 ' A' ' 126' ' ' ILE . 62.1 mt -119.97 136.1 54.66 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 120.726 0.298 . . . . 0.0 110.717 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HB2' HG11 ' A' ' 12' ' ' VAL . 76.6 tttt -95.9 133.61 39.88 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 173.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.496 HD22 HG22 ' A' ' 7' ' ' ILE . 83.6 mt -112.51 160.25 17.99 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 120.657 0.265 . . . . 0.0 110.417 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.26 13.06 14.3 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 172.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -146.39 142.68 28.44 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 118.533 0.606 . . . . 0.0 109.586 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -64.29 149.43 48.13 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 122.196 -0.315 . . . . 0.0 110.505 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -131.79 138.0 48.37 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 120.701 0.286 . . . . 0.0 110.437 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -138.02 123.07 19.1 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.16 -22.84 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.389 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -74.56 -0.93 19.28 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -90.49 -14.27 33.06 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 118.901 0.773 . . . . 0.0 111.485 171.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -117.19 175.12 5.75 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 118.618 0.645 . . . . 0.0 109.431 173.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -91.31 104.07 16.65 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -110.39 176.65 4.96 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 120.516 0.198 . . . . 0.0 110.532 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.16 131.46 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -105.97 144.06 33.22 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.6 p -120.9 134.73 55.29 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.653 0.264 . . . . 0.0 110.547 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -77.01 172.6 12.94 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 120.77 0.319 . . . . 0.0 111.644 -170.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -67.9 140.22 56.5 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -142.34 166.31 25.02 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.699 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -123.67 149.1 45.87 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 120.787 0.327 . . . . 0.0 110.465 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -149.01 135.72 19.63 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 51.7 33.16 10.45 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.724 -0.61 . . . . 0.0 112.095 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.18 17.01 78.88 Favored Glycine 0 N--CA 1.497 2.712 0 CA-C-O 119.613 -0.548 . . . . 0.0 111.896 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -121.82 140.43 52.38 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 118.647 1.223 . . . . 0.0 109.712 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -93.49 131.44 38.71 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.355 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -121.22 141.97 50.36 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -86.93 156.46 19.81 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 120.741 0.305 . . . . 0.0 110.454 -168.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.55 156.53 52.39 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.3 157.81 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 122.329 -0.512 . . . . 0.0 110.471 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -114.97 138.78 50.44 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.6 t -133.96 140.19 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -176.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.7 tp -137.69 125.69 14.23 Favored Pre-proline 0 N--CA 1.496 1.868 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.114 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -62.9 149.14 92.37 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 120.968 1.112 . . . . 0.0 111.586 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.603 HD13 HG13 ' A' ' 93' ' ' ILE . 43.8 pt -141.98 170.06 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 122.28 -0.263 . . . . 0.0 110.322 172.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -114.6 131.77 56.58 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 168.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -106.0 123.97 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -109.28 117.02 32.98 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.5 mt -130.09 121.96 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.38 -119.95 17.55 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -111.19 17.08 20.66 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 122.349 -0.501 . . . . 0.0 111.855 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -119.54 143.04 47.82 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 118.591 0.632 . . . . 0.0 110.482 -175.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -123.16 130.28 52.55 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 120.683 0.277 . . . . 0.0 110.309 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -126.31 144.93 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.83 138.07 44.21 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.92 -165.36 11.91 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.579 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.69 155.64 26.4 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 117.307 0.553 . . . . 0.0 110.236 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.603 HG13 HD13 ' A' ' 80' ' ' ILE . 70.1 mt -108.69 141.22 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.7 t -121.7 130.78 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.3 t -141.11 134.07 14.41 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -57.24 155.42 29.61 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 121.042 1.162 . . . . 0.0 111.939 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -64.35 -34.02 77.18 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 122.321 -0.237 . . . . 0.0 110.685 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -90.11 123.2 33.76 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.337 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.2 m -130.23 142.97 50.52 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -94.9 -60.01 1.79 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -137.75 171.65 14.13 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.5 m -70.85 146.86 49.38 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.8 m -135.01 161.71 34.52 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.571 0.224 . . . . 0.0 110.464 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -107.64 27.08 9.51 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.375 -0.203 . . . . 0.0 110.833 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -123.73 127.52 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.491 HD13 HD11 ' A' ' 48' ' ' LEU . 34.5 pt -125.49 143.64 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 178.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -113.84 130.16 56.5 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.49 HD12 HD12 ' A' ' 46' ' ' LEU . 82.1 mt -115.5 150.33 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -174.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.8 pt -117.25 155.94 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 168.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.55 161.15 48.31 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-O 119.073 -0.489 . . . . 0.0 110.29 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.73 -30.88 93.18 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 121.105 1.203 . . . . 0.0 111.74 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.4 167.09 23.3 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.262 -0.274 . . . . 0.0 110.761 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -73.62 103.77 4.34 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.98 -35.39 78.34 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.145 -0.347 . . . . 0.0 111.136 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -62.22 -32.9 73.62 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.13 -0.356 . . . . 0.0 110.944 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -78.23 -50.89 11.05 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -63.06 -32.43 73.8 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.158 -172.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -105.97 7.84 32.2 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.87 47.45 24.75 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.014 -1.054 . . . . 0.0 111.841 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.4 mt -91.52 138.24 31.73 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.896 -0.502 . . . . 0.0 110.923 -170.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -116.82 158.66 23.57 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.22 50.08 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.846 -0.534 . . . . 0.0 111.474 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.77 -22.96 37.46 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.39 154.01 39.62 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 118.608 1.204 . . . . 0.0 110.018 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t -111.81 133.38 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -174.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.845 HD11 HD11 ' A' ' 46' ' ' LEU . 21.6 pt -128.68 160.83 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -109.63 138.09 46.5 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 pt -113.56 137.5 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 129' ' ' LEU . 10.1 tt -109.03 128.5 55.02 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.1 mt -119.45 135.18 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.402 ' HA ' HD23 ' A' ' 4' ' ' LEU . 50.2 mttp -92.96 150.98 20.19 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.02 131.93 3.09 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.63 -33.95 14.89 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 117.192 0.496 . . . . 0.0 110.275 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -97.69 135.61 39.24 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -93.38 117.72 30.42 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.163 -179.925 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.64 155.02 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -102.39 122.19 43.79 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.1 mt -110.88 149.47 30.57 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 20.2 ttt -107.88 143.65 36.19 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.7 mm -126.22 129.92 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.0 mt -129.86 149.58 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -104.96 143.21 33.48 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.286 -0.259 . . . . 0.0 110.37 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.22 151.16 20.68 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.57 142.62 34.99 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 117.253 0.526 . . . . 0.0 110.221 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.7 122.79 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.8 m -126.57 163.39 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 177.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 t -85.19 122.17 28.99 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.02 124.1 1.12 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.443 HD23 ' C ' ' A' ' 15' ' ' LEU . 6.5 tt -154.97 -47.45 0.08 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.32 -0.518 . . . . 0.0 110.367 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.09 35.86 4.59 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -69.82 -35.19 74.59 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 117.275 0.538 . . . . 0.0 109.988 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.3 -139.95 4.5 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -97.85 141.13 31.22 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 117.254 0.527 . . . . 0.0 110.187 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.672 ' CE1' HD12 ' A' ' 22' ' ' LEU . 60.3 t80 -126.16 119.4 27.41 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -148.24 33.67 0.81 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.672 HD12 ' CE1' ' A' ' 20' ' ' TYR . 78.9 mt -63.01 -30.57 71.71 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 122.127 -0.358 . . . . 0.0 111.15 -175.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.9 p -60.95 -26.62 67.65 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 122.115 -0.366 . . . . 0.0 111.629 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.8 mp -65.39 156.67 81.14 Favored Pre-proline 0 N--CA 1.503 2.197 0 CA-C-O 119.188 -0.434 . . . . 0.0 110.501 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -58.05 -56.03 1.9 Allowed 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 121.14 1.227 . . . . 0.0 113.029 -173.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.09 -32.05 91.23 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 O-C-N 122.65 0.816 . . . . 0.0 111.54 -162.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.404 ' O ' HG22 ' A' ' 30' ' ' ILE . 58.7 m-85 -66.32 -43.49 86.04 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.356 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -65.57 -37.53 86.93 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 122.136 -0.352 . . . . 0.0 110.247 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -65.41 -47.11 77.42 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 121.019 -0.273 . . . . 0.0 110.466 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 27' ' ' TYR . 17.9 tt -68.75 -34.34 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.036 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -65.79 -43.62 88.18 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 122.054 -0.403 . . . . 0.0 110.29 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -65.25 -30.92 71.85 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 122.211 -0.306 . . . . 0.0 110.871 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -68.62 -41.21 79.81 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.668 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.3 mt -81.6 -36.46 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.588 HD21 ' HB2' ' A' ' 92' ' ' ALA . 55.8 mt -103.78 -26.13 12.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.192 -0.317 . . . . 0.0 111.668 -174.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.57 14.69 72.84 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -172.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -152.82 162.43 41.29 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 119.062 1.431 . . . . 0.0 110.571 171.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -94.13 108.91 38.98 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.562 -0.733 . . . . 0.0 109.683 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -67.04 159.09 53.65 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 O-C-N 123.254 1.134 . . . . 0.0 110.536 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -73.81 162.97 28.55 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -80.29 79.6 6.84 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.497 0.665 . . . . 0.0 109.672 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.29 171.15 43.49 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -138.05 156.94 47.3 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 117.331 0.566 . . . . 0.0 110.856 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 tp -110.42 117.07 32.61 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 170.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.481 ' O ' HG22 ' A' ' 12' ' ' VAL . 5.9 m120 -99.66 120.87 40.38 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -177.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.737 HD11 HD11 ' A' ' 126' ' ' ILE . 68.3 mt -120.02 135.77 54.8 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 120.728 0.299 . . . . 0.0 110.651 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' HG11 ' A' ' 12' ' ' VAL . 84.7 tttt -96.15 133.55 40.3 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.4 mt -111.59 160.2 17.43 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 120.605 0.24 . . . . 0.0 110.46 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.04 12.95 14.12 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 172.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -145.47 141.89 28.76 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.687 -0.633 . . . . 0.0 109.363 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.37 146.84 53.8 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 122.231 -0.293 . . . . 0.0 110.427 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -131.95 137.36 47.91 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 120.617 0.246 . . . . 0.0 110.553 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -138.02 124.19 20.38 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.49 -22.92 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 122.21 -0.306 . . . . 0.0 111.314 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -72.75 -5.0 34.85 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 122.024 -0.423 . . . . 0.0 112.083 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -90.59 -14.36 32.61 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 118.833 0.742 . . . . 0.0 111.538 172.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -114.64 175.07 5.65 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 118.558 0.617 . . . . 0.0 109.409 173.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -92.1 102.31 14.85 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -109.97 178.64 4.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 122.316 -0.24 . . . . 0.0 110.606 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.0 mt -111.8 130.69 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 174.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -105.93 141.66 36.96 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.0 p -118.07 134.84 54.61 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 120.703 0.287 . . . . 0.0 110.461 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.17 172.71 12.37 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 120.826 0.346 . . . . 0.0 111.535 -170.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -67.29 139.56 57.3 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -138.95 167.13 22.72 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.203 -0.311 . . . . 0.0 110.643 -174.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -124.23 149.19 46.71 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.87 0.367 . . . . 0.0 110.599 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -148.22 134.47 19.44 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 51.76 33.3 10.92 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.736 -0.603 . . . . 0.0 112.142 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.32 16.77 79.06 Favored Glycine 0 N--CA 1.497 2.746 0 CA-C-O 119.664 -0.52 . . . . 0.0 111.937 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -122.33 141.67 51.31 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 118.665 1.233 . . . . 0.0 109.694 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -93.45 132.21 37.92 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 121.13 -0.228 . . . . 0.0 110.483 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -123.18 146.84 47.45 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -86.92 155.21 20.31 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.73 0.3 . . . . 0.0 110.454 -168.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.36 161.18 48.45 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.67 157.09 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 122.372 -0.487 . . . . 0.0 110.412 -174.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -115.48 136.65 52.86 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -134.11 140.19 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.0 tp -137.04 125.65 14.94 Favored Pre-proline 0 N--CA 1.497 1.898 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.057 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -63.6 148.47 92.33 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 121.008 1.139 . . . . 0.0 111.383 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.546 HD13 HG13 ' A' ' 93' ' ' ILE . 43.6 pt -141.96 170.0 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 122.266 -0.271 . . . . 0.0 110.414 172.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -115.07 131.84 56.79 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 167.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.2 mt -105.68 123.7 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.1 mt -108.38 116.99 33.0 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -177.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.4 mt -130.06 121.99 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.24 -120.01 17.94 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -111.2 17.03 20.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.298 -0.531 . . . . 0.0 111.829 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -119.32 143.56 47.31 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.669 -0.644 . . . . 0.0 110.468 -175.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -123.11 129.96 52.14 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 120.671 0.272 . . . . 0.0 110.294 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.6 mt -125.4 143.82 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.82 137.49 43.87 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.98 -165.35 11.93 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.588 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.64 156.62 28.2 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.18 -0.6 . . . . 0.0 110.303 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.546 HG13 HD13 ' A' ' 80' ' ' ILE . 68.8 mt -108.72 142.01 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.5 130.73 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -143.18 136.66 14.15 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -57.22 153.85 37.51 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 121.013 1.142 . . . . 0.0 111.927 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -64.78 -34.38 78.22 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 122.307 -0.246 . . . . 0.0 110.736 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -86.93 116.11 24.77 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.395 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.8 p -131.6 159.53 37.98 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -126.52 -48.34 1.55 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -128.77 175.42 8.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 95.1 p -98.18 149.96 21.99 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.2 m -134.96 170.8 15.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.323 -0.235 . . . . 0.0 110.371 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -107.17 27.08 9.4 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.356 -0.215 . . . . 0.0 110.93 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.0 mm -123.75 127.89 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 pt -126.49 143.1 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -112.83 131.82 55.54 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.48 HD12 HD12 ' A' ' 46' ' ' LEU . 82.9 mt -116.87 150.98 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -174.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.2 pt -116.04 154.32 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.55 166.02 21.99 Favored Pre-proline 0 N--CA 1.494 1.767 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.292 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -60.0 -31.91 94.21 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 121.104 1.203 . . . . 0.0 111.519 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.69 167.09 23.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.305 -0.247 . . . . 0.0 110.69 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -70.61 104.58 2.85 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.64 -33.39 71.46 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 122.099 -0.375 . . . . 0.0 111.463 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -62.75 -35.3 79.36 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 122.155 -0.341 . . . . 0.0 110.907 -174.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.25 -47.85 17.02 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -62.63 -33.69 75.53 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.152 -0.342 . . . . 0.0 111.122 -172.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -108.12 9.27 28.31 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 112.503 0.556 . . . . 0.0 112.503 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.91 45.86 27.55 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.066 -1.021 . . . . 0.0 111.845 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -92.18 138.18 31.75 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.908 -0.495 . . . . 0.0 110.974 -171.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -114.96 160.61 19.36 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.34 49.87 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.918 -0.489 . . . . 0.0 111.482 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.53 -23.49 35.6 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.44 152.65 43.41 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 118.665 1.233 . . . . 0.0 110.076 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.21 133.82 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.737 HD11 HD11 ' A' ' 46' ' ' LEU . 34.1 pt -129.19 161.31 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 174.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -109.91 138.4 46.35 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -112.88 137.93 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.468 HD23 ' C ' ' A' ' 129' ' ' LEU . 8.6 tt -108.74 128.61 55.02 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 36.0 mt -116.46 139.55 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -90.73 149.58 21.98 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.09 175.5 34.55 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -112.27 -35.49 5.59 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 122.266 -0.55 . . . . 0.0 110.453 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -154.27 -59.82 0.12 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -101.68 31.51 3.78 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.281 -0.262 . . . . 0.0 110.566 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.206 -179.089 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 mtt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.404 HG13 ' OD1' ' A' ' 133' ' ' ASP . 27.8 m -108.0 -30.56 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 122.37 -0.206 . . . . 0.0 110.666 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -139.24 109.01 6.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.142 -0.349 . . . . 0.0 110.278 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 131' ' ' LYS . 83.0 mt -110.87 149.59 30.39 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 21.1 ttt -138.42 145.34 40.85 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.479 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.1 mm -126.19 133.69 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.431 HG22 HD22 ' A' ' 48' ' ' LEU . 71.3 mt -130.11 150.09 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.406 ' O ' HD23 ' A' ' 48' ' ' LEU . 51.3 mt-10 -107.08 143.36 35.34 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.55 150.56 20.83 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -106.4 142.9 35.32 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.307 -0.525 . . . . 0.0 110.26 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.73 122.45 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -124.07 142.86 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 175.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.2 t -87.52 130.57 34.67 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.279 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.04 119.94 0.84 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.9 mt -132.96 148.42 52.27 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.349 -0.5 . . . . 0.0 110.196 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.95 36.1 25.98 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -101.91 130.87 48.51 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.255 -0.556 . . . . 0.0 109.948 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.83 -140.01 32.36 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -113.84 132.23 55.96 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 117.234 0.517 . . . . 0.0 110.06 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.472 ' CE1' HD12 ' A' ' 22' ' ' LEU . 65.1 t80 -120.32 121.22 38.14 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -154.81 35.35 0.4 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.472 HD12 ' CE1' ' A' ' 20' ' ' TYR . 78.8 mt -62.12 -27.71 69.12 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 122.088 -0.383 . . . . 0.0 111.154 -175.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.4 m -60.07 -25.51 65.44 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 122.075 -0.391 . . . . 0.0 111.549 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.7 tp -62.81 138.9 97.13 Favored Pre-proline 0 N--CA 1.506 2.349 0 CA-C-O 118.774 -0.631 . . . . 0.0 110.267 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -51.94 -53.7 6.53 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 121.179 1.253 . . . . 0.0 113.913 -174.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.14 -31.12 90.05 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 O-C-N 122.687 0.835 . . . . 0.0 111.446 -164.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.42 ' O ' HG22 ' A' ' 30' ' ' ILE . 15.6 m-85 -65.97 -42.71 89.54 Favored 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.44 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -65.55 -38.35 89.35 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.155 -0.341 . . . . 0.0 110.186 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.46 -46.0 81.54 Favored 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.595 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 27' ' ' TYR . 17.8 tt -69.22 -33.43 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.916 -176.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -65.67 -44.11 87.26 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 122.02 -0.425 . . . . 0.0 110.269 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -65.47 -31.3 72.31 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.783 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -68.56 -40.42 80.63 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.628 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.32 -37.02 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 92' ' ' ALA . 49.0 mt -103.23 -26.29 13.03 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.268 -0.27 . . . . 0.0 111.695 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.98 14.82 74.16 Favored Glycine 0 N--CA 1.493 2.471 0 CA-C-O 119.382 -0.677 . . . . 0.0 111.46 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -151.39 161.45 42.68 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 119.118 1.459 . . . . 0.0 110.651 170.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -94.68 107.84 33.24 Favored Pre-proline 0 N--CA 1.495 1.821 0 CA-C-O 118.637 -0.697 . . . . 0.0 109.856 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -67.31 158.23 57.97 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 O-C-N 123.219 1.115 . . . . 0.0 110.557 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.23 163.76 27.44 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -80.22 79.63 6.76 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.488 0.661 . . . . 0.0 109.675 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.6 172.97 45.37 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 175.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 p -138.05 157.03 47.18 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 117.397 0.599 . . . . 0.0 110.932 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.405 HD22 HD12 ' A' ' 114' ' ' LEU . 22.9 tp -109.63 115.71 30.39 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.436 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.6 m120 -99.26 120.96 40.4 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -176.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.788 HD11 HD11 ' A' ' 126' ' ' ILE . 57.6 mt -120.07 136.01 54.73 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.701 0.286 . . . . 0.0 110.607 -178.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HB2' HG11 ' A' ' 12' ' ' VAL . 48.3 tttm -96.36 134.24 39.75 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 173.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.431 HD22 HG22 ' A' ' 7' ' ' ILE . 84.3 mt -111.53 160.28 17.32 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 120.671 0.272 . . . . 0.0 110.45 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.14 13.0 14.2 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 171.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -145.21 142.27 29.4 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 118.567 0.622 . . . . 0.0 109.416 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -64.5 146.83 53.96 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 122.221 -0.299 . . . . 0.0 110.339 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -132.46 136.67 46.87 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 120.736 0.303 . . . . 0.0 110.602 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -138.04 127.4 24.67 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.33 -23.98 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.385 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -74.27 -1.07 19.05 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.944 -0.472 . . . . 0.0 112.182 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -91.02 -14.26 31.73 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 118.838 0.745 . . . . 0.0 111.481 169.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.404 ' CE1' HG21 ' A' ' 130' ' ' ILE . 77.6 m-85 -116.23 175.06 5.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.665 -0.647 . . . . 0.0 109.43 174.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -91.98 102.93 15.5 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -110.63 178.46 4.36 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 120.579 0.228 . . . . 0.0 110.548 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -112.36 131.64 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 174.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -105.87 144.13 33.04 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.2 p -123.24 138.52 54.61 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 120.783 0.325 . . . . 0.0 110.786 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -77.29 172.71 12.86 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -167.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -67.6 141.36 56.81 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -136.59 167.28 21.68 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.535 -176.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -124.19 146.92 48.39 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 120.807 0.337 . . . . 0.0 110.667 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -149.8 138.65 20.99 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.6 m120 52.14 30.0 7.13 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.708 -0.62 . . . . 0.0 112.135 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.17 16.19 80.87 Favored Glycine 0 N--CA 1.497 2.736 0 CA-C-O 119.528 -0.596 . . . . 0.0 111.749 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -121.08 144.07 48.75 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 118.783 1.291 . . . . 0.0 109.617 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.13 131.36 38.26 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.53 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -120.17 144.72 47.53 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -85.81 156.97 20.35 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 120.845 0.355 . . . . 0.0 110.554 -167.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.43 162.01 44.72 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.42 156.71 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 122.409 -0.465 . . . . 0.0 110.351 -175.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -116.07 137.55 52.02 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.9 t -134.01 140.7 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -176.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.5 tp -136.72 125.65 15.31 Favored Pre-proline 0 N--CA 1.497 1.884 0 CA-C-O 118.553 -0.737 . . . . 0.0 110.109 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -63.78 149.12 91.48 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 120.937 1.091 . . . . 0.0 111.357 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.533 HD13 HG13 ' A' ' 93' ' ' ILE . 43.3 pt -141.79 169.64 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 120.692 0.282 . . . . 0.0 110.298 171.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -114.83 131.26 56.88 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 167.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.4 mt -105.71 123.29 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -175.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.6 mt -107.77 116.48 32.03 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.1 mt -129.75 121.91 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.64 -120.24 18.28 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -111.09 16.98 20.82 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.311 -0.523 . . . . 0.0 111.832 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -119.65 144.4 47.18 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 118.609 0.64 . . . . 0.0 110.464 -175.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -123.12 129.98 52.16 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 120.668 0.271 . . . . 0.0 110.282 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.3 mt -125.54 144.91 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.89 136.83 43.39 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.67 -167.17 12.71 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.59 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.37 155.68 27.15 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 117.277 0.538 . . . . 0.0 110.363 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.533 HG13 HD13 ' A' ' 80' ' ' ILE . 68.1 mt -108.72 141.84 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.03 131.56 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.8 t -141.87 130.63 12.13 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -58.75 155.02 39.76 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 121.02 1.147 . . . . 0.0 111.633 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -64.92 -34.41 78.34 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.301 -0.25 . . . . 0.0 110.574 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -87.98 121.09 29.99 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.3 t -142.38 152.45 42.86 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.344 -0.223 . . . . 0.0 110.407 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -98.9 -58.65 1.9 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -136.76 170.62 15.77 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.1 p -82.74 150.63 26.58 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.1 m -135.17 174.98 10.01 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 120.577 0.227 . . . . 0.0 110.408 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -106.4 27.22 8.95 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.374 -0.204 . . . . 0.0 110.932 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.0 mm -123.73 127.82 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.5 pt -125.2 145.1 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -115.92 130.21 56.73 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.467 HD12 HD12 ' A' ' 46' ' ' LEU . 82.2 mt -115.6 151.02 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -173.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.6 pt -116.56 154.78 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 169.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.59 165.97 22.2 Favored Pre-proline 0 N--CA 1.496 1.829 0 CA-C-O 119.049 -0.5 . . . . 0.0 110.307 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.9 -32.64 95.51 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 121.078 1.185 . . . . 0.0 111.404 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.98 161.54 39.13 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.695 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -63.36 105.81 0.8 Allowed 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 121.267 0.556 . . . . 0.0 111.038 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.405 HD12 HD22 ' A' ' 44' ' ' LEU . 82.4 mt -59.84 -33.35 71.67 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.861 -0.524 . . . . 0.0 111.445 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 93.1 mtm-85 -62.55 -35.36 79.22 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 122.131 -0.355 . . . . 0.0 110.967 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -78.22 -48.03 16.71 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -62.46 -34.24 76.43 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 122.192 -0.318 . . . . 0.0 111.102 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -108.03 9.0 28.56 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 51.85 50.43 18.64 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.137 -0.977 . . . . 0.0 111.934 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.6 mt -90.41 138.12 31.8 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.868 -0.52 . . . . 0.0 110.909 -171.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -116.32 156.96 25.75 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.08 138.04 50.23 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.863 -0.523 . . . . 0.0 111.5 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.68 -22.87 37.91 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -65.38 150.74 47.79 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-N 118.725 1.262 . . . . 0.0 110.041 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.96 133.39 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -173.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.788 HD11 HD11 ' A' ' 46' ' ' LEU . 34.0 pt -128.21 160.39 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -109.3 138.19 46.04 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.0 pt -111.82 136.77 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.462 HD23 ' C ' ' A' ' 129' ' ' LEU . 9.4 tt -110.33 126.17 53.94 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -177.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.404 HG21 ' CE1' ' A' ' 57' ' ' PHE . 48.2 mt -112.1 119.67 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.445 ' HA ' HD23 ' A' ' 4' ' ' LEU . 98.3 mttt -95.45 155.06 16.9 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.11 122.91 1.22 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.404 ' OD1' HG13 ' A' ' 2' ' ' VAL . 19.4 t70 -155.04 -60.05 0.11 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 122.318 -0.519 . . . . 0.0 110.187 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -133.47 143.63 48.94 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -66.44 -37.77 85.9 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.286 -0.259 . . . . 0.0 110.347 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.177 179.465 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.9 mtp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.25 -38.24 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -99.18 104.13 16.07 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.1 mt -110.94 154.21 24.43 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 7.2 tpt -104.37 141.44 36.33 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.2 mm -128.18 130.95 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.511 HG22 HD22 ' A' ' 48' ' ' LEU . 73.2 mt -129.52 148.33 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -105.73 140.39 38.86 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.12 150.51 20.01 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -105.39 142.45 35.13 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 122.354 -0.497 . . . . 0.0 110.205 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.69 123.25 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 45' ' ' ASN . 27.0 m -124.76 163.84 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.3 t -84.66 122.52 29.19 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.22 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.0 140.19 5.92 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.1 tp -155.07 -52.57 0.09 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 117.196 0.498 . . . . 0.0 110.151 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.28 35.59 4.78 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -68.94 -37.87 79.14 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 117.339 0.57 . . . . 0.0 109.843 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.09 -176.34 42.25 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -119.92 34.66 5.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.368 -0.489 . . . . 0.0 110.059 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -120.34 151.52 39.12 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.171 -0.331 . . . . 0.0 110.467 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.79 140.09 47.87 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.3 mt -97.96 0.07 45.73 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.4 p -82.42 -27.32 32.06 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 118.945 0.793 . . . . 0.0 111.399 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.9 mt -65.35 156.17 82.58 Favored Pre-proline 0 N--CA 1.502 2.158 0 CA-C-O 119.108 -0.472 . . . . 0.0 110.77 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -56.95 -55.36 2.71 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.184 1.256 . . . . 0.0 113.168 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.0 -30.15 89.31 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 O-C-N 122.656 0.819 . . . . 0.0 111.626 -163.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.402 ' O ' HG22 ' A' ' 30' ' ' ILE . 15.2 m-85 -65.94 -42.34 90.16 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.452 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -65.39 -38.86 91.27 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 122.068 -0.395 . . . . 0.0 110.26 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.08 -45.61 84.55 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.621 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 27' ' ' TYR . 17.7 tt -69.58 -33.63 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.004 -177.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -65.3 -43.46 91.05 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 122.024 -0.422 . . . . 0.0 110.274 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -65.57 -31.42 72.46 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.225 -0.297 . . . . 0.0 110.855 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -68.71 -40.4 79.98 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.576 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.4 mt -81.35 -36.94 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 92' ' ' ALA . 49.6 mt -104.04 -26.24 12.68 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.228 -0.295 . . . . 0.0 111.611 -174.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.44 14.89 72.7 Favored Glycine 0 N--CA 1.494 2.504 0 CA-C-O 119.322 -0.71 . . . . 0.0 111.421 -172.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -151.84 161.17 43.09 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 119.097 1.449 . . . . 0.0 110.7 170.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -94.1 108.4 35.32 Favored Pre-proline 0 N--CA 1.496 1.874 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.821 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -67.3 157.94 59.37 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 O-C-N 123.279 1.147 . . . . 0.0 110.45 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -73.61 164.0 27.25 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -80.24 79.56 6.79 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.502 0.668 . . . . 0.0 109.612 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.76 172.18 44.44 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 p -138.01 157.18 46.89 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 117.315 0.558 . . . . 0.0 110.691 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.7 tp -109.4 116.14 31.27 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 170.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.54 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.7 m120 -98.34 120.44 38.76 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -177.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.833 HD11 HD11 ' A' ' 126' ' ' ILE . 61.0 mt -120.03 136.15 54.67 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 120.683 0.278 . . . . 0.0 110.658 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HB2' HG11 ' A' ' 12' ' ' VAL . 63.8 tttt -96.05 132.77 41.06 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.511 HD22 HG22 ' A' ' 7' ' ' ILE . 83.6 mt -111.82 160.22 17.56 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 120.681 0.277 . . . . 0.0 110.427 -176.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.1 13.14 13.78 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 172.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -145.86 142.03 28.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.657 -0.652 . . . . 0.0 109.566 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -64.23 148.88 49.13 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 122.297 -0.252 . . . . 0.0 110.395 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -131.78 137.03 48.0 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 120.688 0.28 . . . . 0.0 110.5 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -138.0 124.05 20.25 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.3 tt -64.25 -22.94 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.226 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -72.52 -4.19 29.03 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 118.257 0.48 . . . . 0.0 112.074 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -90.53 -14.26 32.96 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 118.833 0.742 . . . . 0.0 111.427 172.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -115.68 175.08 5.69 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 118.673 0.67 . . . . 0.0 109.34 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -91.42 101.98 14.66 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -108.64 175.96 5.28 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.313 -0.242 . . . . 0.0 110.623 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.7 mt -110.34 131.08 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -105.93 143.12 34.52 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.5 p -122.48 134.53 54.57 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.65 0.262 . . . . 0.0 110.618 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -76.86 172.62 12.84 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 120.803 0.335 . . . . 0.0 111.686 -169.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -67.96 140.29 56.41 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -141.09 165.48 27.42 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.755 -175.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -123.28 149.07 45.26 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.803 0.335 . . . . 0.0 110.533 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -149.87 135.52 18.42 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 51.69 32.91 10.01 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.654 -0.654 . . . . 0.0 112.1 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.27 17.32 78.24 Favored Glycine 0 N--CA 1.498 2.796 0 CA-C-O 119.683 -0.509 . . . . 0.0 111.835 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -122.75 141.13 52.14 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.628 1.214 . . . . 0.0 109.767 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.68 131.73 38.71 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.424 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -121.81 143.96 49.1 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -86.99 155.73 20.05 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 120.812 0.339 . . . . 0.0 110.482 -168.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.45 158.28 51.19 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.3 155.09 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 122.268 -0.548 . . . . 0.0 110.37 -174.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -113.26 137.45 51.47 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.1 t -133.24 140.27 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 tp -137.21 125.71 14.79 Favored Pre-proline 0 N--CA 1.497 1.878 0 CA-C-O 118.522 -0.752 . . . . 0.0 110.073 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -63.21 149.81 90.33 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 120.916 1.077 . . . . 0.0 111.542 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.568 HD13 HG13 ' A' ' 93' ' ' ILE . 43.5 pt -142.13 170.05 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -114.31 131.98 56.34 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 167.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.46 122.88 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -107.47 116.89 32.74 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 74.5 mt -129.97 121.9 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.52 -119.94 17.33 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -111.21 17.01 20.7 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.359 -0.494 . . . . 0.0 111.788 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -119.74 143.94 47.52 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 118.536 0.607 . . . . 0.0 110.468 -175.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -123.14 129.64 51.7 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 120.674 0.273 . . . . 0.0 110.286 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.4 mt -125.53 145.11 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.79 136.72 43.59 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.42 -166.32 12.09 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.72 155.54 26.16 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 117.348 0.574 . . . . 0.0 110.385 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.568 HG13 HD13 ' A' ' 80' ' ' ILE . 69.0 mt -108.73 141.19 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.35 132.11 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.1 t -142.16 129.04 11.17 Favored Pre-proline 0 N--CA 1.498 1.934 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.97 154.35 51.25 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.027 1.151 . . . . 0.0 111.412 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -61.81 -30.84 71.09 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 122.262 -0.274 . . . . 0.0 111.402 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -84.85 107.98 17.28 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.299 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.5 m -131.05 145.41 52.01 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -94.06 -59.74 1.9 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -139.53 170.32 16.14 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.4 m -68.43 145.96 53.63 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.2 m -135.0 166.23 23.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.352 -0.218 . . . . 0.0 110.462 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -107.4 27.1 9.43 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.379 -0.201 . . . . 0.0 110.865 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.7 mm -123.16 127.34 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.467 HD13 HD11 ' A' ' 48' ' ' LEU . 34.2 pt -125.83 144.4 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -114.21 129.58 56.63 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.502 HD12 HD12 ' A' ' 46' ' ' LEU . 82.7 mt -114.78 150.67 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -174.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 pt -116.52 154.85 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 168.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.51 166.07 21.79 Favored Pre-proline 0 N--CA 1.496 1.831 0 CA-C-O 119.099 -0.477 . . . . 0.0 110.257 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.79 -32.12 95.04 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 121.135 1.223 . . . . 0.0 111.468 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.9 160.49 41.22 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.334 -0.229 . . . . 0.0 110.695 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.5 pttt -63.07 105.85 0.76 Allowed 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.297 0.57 . . . . 0.0 111.106 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.7 mt -59.79 -33.44 71.71 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.843 -0.535 . . . . 0.0 111.413 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -62.81 -35.13 78.91 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 122.092 -0.38 . . . . 0.0 111.021 -173.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -78.19 -48.4 15.95 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -62.44 -34.33 76.58 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 122.223 -0.298 . . . . 0.0 111.129 -172.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -108.14 8.87 28.27 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.86 50.39 18.73 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.1 -1.0 . . . . 0.0 111.942 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 45.5 mt -90.35 138.22 31.72 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.757 -0.589 . . . . 0.0 110.952 -171.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -116.39 157.32 25.27 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.99 138.14 49.59 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 121.889 -0.507 . . . . 0.0 111.524 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.68 -22.93 37.65 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -65.47 152.43 43.97 Favored 'General case' 0 N--CA 1.505 2.31 0 CA-C-N 118.597 1.199 . . . . 0.0 110.033 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -111.03 133.93 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -174.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.833 HD11 HD11 ' A' ' 46' ' ' LEU . 34.4 pt -128.85 159.75 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -109.71 137.97 46.76 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 pt -112.82 137.83 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 176.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.466 HD23 ' C ' ' A' ' 129' ' ' LEU . 9.4 tt -109.59 133.38 53.17 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 35.7 mt -125.12 131.74 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -177.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -92.35 137.86 32.01 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.09 165.21 33.16 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -99.23 -34.29 10.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 122.38 -0.482 . . . . 0.0 110.377 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -98.15 137.87 36.28 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -97.39 118.58 34.18 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.094 179.794 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 mtt . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.3 t -115.26 133.52 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -100.89 139.07 37.09 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.3 mt -110.81 153.59 25.16 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 41.3 ttm -104.13 141.94 35.36 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.5 mm -126.71 129.78 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.1 mt -129.84 148.75 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -105.11 141.53 36.5 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.26 151.34 20.48 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.77 141.85 36.49 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 117.184 0.492 . . . . 0.0 110.212 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.65 123.86 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 45' ' ' ASN . 27.0 m -123.71 146.43 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 t -87.76 134.98 33.57 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 122.311 -0.243 . . . . 0.0 110.451 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.01 119.81 0.83 Allowed Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.8 mt -143.04 -49.04 0.33 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 117.235 0.517 . . . . 0.0 110.33 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.28 -35.21 90.0 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -67.1 142.62 57.04 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 117.334 0.567 . . . . 0.0 110.377 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.37 -177.95 45.4 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -129.85 140.0 51.08 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 122.304 -0.527 . . . . 0.0 110.1 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -122.57 132.83 54.49 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.285 -0.259 . . . . 0.0 110.526 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -132.04 33.58 3.9 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.68 -30.71 71.78 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 122.185 -0.322 . . . . 0.0 111.1 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.4 p -60.7 -26.52 67.2 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 122.082 -0.386 . . . . 0.0 111.733 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.6 mp -65.15 156.22 81.73 Favored Pre-proline 0 N--CA 1.503 2.185 0 CA-C-O 119.178 -0.439 . . . . 0.0 110.614 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -57.56 -55.95 2.1 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 121.214 1.276 . . . . 0.0 113.083 -173.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.23 -32.15 90.22 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 O-C-N 122.683 0.833 . . . . 0.0 111.546 -163.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.406 ' O ' HG22 ' A' ' 30' ' ' ILE . 47.7 m-85 -66.29 -43.3 86.74 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.4 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -65.36 -37.95 88.57 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 122.105 -0.372 . . . . 0.0 110.324 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -65.18 -46.6 80.13 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.189 -0.319 . . . . 0.0 110.528 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 27' ' ' TYR . 17.8 tt -68.78 -34.04 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.027 -176.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -65.8 -43.52 88.44 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 122.062 -0.399 . . . . 0.0 110.376 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -65.32 -32.39 74.02 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 122.189 -0.319 . . . . 0.0 110.681 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -68.65 -39.57 80.63 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.687 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.7 mt -81.04 -37.52 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -176.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' A' ' 92' ' ' ALA . 46.4 mt -103.42 -26.14 13.0 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.196 -0.315 . . . . 0.0 111.735 -173.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.57 14.75 75.27 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -150.96 160.67 43.77 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 119.107 1.453 . . . . 0.0 110.547 170.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -94.82 108.8 40.11 Favored Pre-proline 0 N--CA 1.495 1.822 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.808 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.23 158.89 54.76 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 O-C-N 123.283 1.149 . . . . 0.0 110.508 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -73.74 163.89 27.36 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -80.21 79.54 6.76 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.544 0.688 . . . . 0.0 109.617 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.06 171.61 43.66 Favored Glycine 0 N--CA 1.496 2.633 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -138.1 157.93 45.34 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 117.356 0.578 . . . . 0.0 110.59 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.545 HD22 ' CD1' ' A' ' 114' ' ' LEU . 28.2 tp -109.9 116.54 31.82 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.533 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.4 m120 -98.94 123.45 43.22 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -176.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.648 HD11 HD11 ' A' ' 126' ' ' ILE . 74.8 mt -120.62 135.57 55.07 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 120.641 0.258 . . . . 0.0 110.602 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HB2' HG11 ' A' ' 12' ' ' VAL . 36.3 ttmt -96.17 133.12 40.86 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.428 HD11 HD13 ' A' ' 106' ' ' ILE . 83.4 mt -112.3 160.27 17.83 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 120.701 0.286 . . . . 0.0 110.464 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -89.57 13.46 13.95 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 172.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -145.41 141.82 28.76 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.763 -0.585 . . . . 0.0 109.423 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -64.47 146.81 53.96 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 122.201 -0.312 . . . . 0.0 110.396 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -134.97 136.41 42.2 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 120.714 0.292 . . . . 0.0 110.588 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -138.04 131.02 30.03 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.48 -23.08 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.533 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -74.86 -0.94 20.12 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.895 -0.503 . . . . 0.0 112.253 -176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -90.04 -14.51 33.71 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 118.946 0.794 . . . . 0.0 111.575 171.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -117.77 175.12 5.8 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.68 -0.637 . . . . 0.0 109.403 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -90.89 103.59 16.28 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -109.73 178.14 4.51 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 120.587 0.232 . . . . 0.0 110.5 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.0 mt -111.15 131.03 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -105.95 146.02 30.56 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.3 p -122.6 137.22 54.96 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 120.688 0.28 . . . . 0.0 110.649 176.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -76.59 172.7 12.59 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 120.895 0.378 . . . . 0.0 111.711 -168.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -67.37 140.23 57.2 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -139.54 166.73 23.81 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 122.221 -0.299 . . . . 0.0 110.598 -174.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -124.22 148.75 47.08 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 120.891 0.377 . . . . 0.0 110.488 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -148.97 136.73 20.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.91 32.27 9.67 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.703 -0.623 . . . . 0.0 112.101 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.07 16.85 79.23 Favored Glycine 0 N--CA 1.496 2.692 0 CA-C-O 119.587 -0.563 . . . . 0.0 111.874 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -123.22 143.13 50.24 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 118.651 1.225 . . . . 0.0 109.731 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.37 132.2 37.83 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 121.066 -0.253 . . . . 0.0 110.366 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -121.78 144.91 48.53 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -86.03 156.52 20.39 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.4 -169.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.14 161.22 44.85 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.93 156.92 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 122.354 -0.498 . . . . 0.0 110.327 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -118.77 137.24 53.5 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.8 t -134.04 141.11 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -176.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.4 tp -137.25 125.65 14.7 Favored Pre-proline 0 N--CA 1.496 1.851 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.13 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -63.35 149.46 91.17 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 120.936 1.09 . . . . 0.0 111.477 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.514 HD13 HG13 ' A' ' 93' ' ' ILE . 44.2 pt -141.53 170.09 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 122.209 -0.307 . . . . 0.0 110.256 171.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -114.67 131.56 56.69 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 167.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.05 123.17 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -175.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.1 mt -108.37 117.09 33.24 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.96 121.94 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.29 -119.93 17.58 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -111.16 17.0 20.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.343 -0.504 . . . . 0.0 111.981 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -119.94 144.01 47.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.749 -0.594 . . . . 0.0 110.512 -175.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -123.15 130.76 53.19 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.9 mt -125.78 145.27 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.79 137.83 44.13 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.16 -167.7 13.73 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.424 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.6 156.92 28.82 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 117.354 0.577 . . . . 0.0 110.443 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.514 HG13 HD13 ' A' ' 80' ' ' ILE . 68.7 mt -108.63 141.25 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.98 131.05 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.9 t -143.67 136.52 13.7 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -58.11 154.21 41.0 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 120.989 1.126 . . . . 0.0 111.757 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -65.9 -34.87 79.13 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 122.282 -0.261 . . . . 0.0 110.468 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -92.05 125.7 36.84 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -137.26 155.51 49.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 122.33 -0.231 . . . . 0.0 110.421 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -97.01 -59.43 1.8 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -138.94 170.33 16.18 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.3 p -80.74 147.53 30.51 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.4 m -134.98 174.03 11.07 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 120.583 0.23 . . . . 0.0 110.481 -177.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -107.23 27.61 8.89 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 122.36 -0.212 . . . . 0.0 110.862 177.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -123.3 127.74 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.428 HD13 HD11 ' A' ' 48' ' ' LEU . 34.4 pt -125.97 145.12 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -116.35 130.06 56.58 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.444 HD12 HD12 ' A' ' 46' ' ' LEU . 83.1 mt -114.58 150.41 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -175.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 pt -115.92 153.97 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 169.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.58 166.04 21.82 Favored Pre-proline 0 N--CA 1.494 1.738 0 CA-C-O 119.074 -0.489 . . . . 0.0 110.293 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.75 -31.3 93.88 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.08 1.187 . . . . 0.0 111.68 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.71 167.09 23.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 122.338 -0.226 . . . . 0.0 110.921 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -67.74 107.04 2.43 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.545 ' CD1' HD22 ' A' ' 44' ' ' LEU . 81.3 mt -60.05 -35.82 75.96 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 122.081 -0.387 . . . . 0.0 111.373 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 71.8 mtt85 -62.39 -35.29 78.73 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 122.175 -0.328 . . . . 0.0 110.981 -175.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -78.2 -47.3 18.32 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.6 -34.85 77.83 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 122.191 -0.318 . . . . 0.0 111.036 -172.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -108.01 8.61 28.4 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 51.73 46.81 25.95 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.072 -1.017 . . . . 0.0 111.96 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.37 138.18 31.78 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.956 -0.465 . . . . 0.0 110.969 -170.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -114.79 158.25 22.14 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.78 138.08 48.62 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.866 -0.521 . . . . 0.0 111.541 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.63 -22.93 37.66 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.52 151.86 45.4 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 118.635 1.217 . . . . 0.0 109.982 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.52 134.09 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.648 HD11 HD11 ' A' ' 46' ' ' LEU . 34.2 pt -129.24 161.32 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -110.4 137.89 47.51 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -113.02 137.6 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 176.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 129' ' ' LEU . 9.0 tt -109.71 128.22 55.12 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 37.8 mt -116.41 129.38 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -92.9 149.81 21.0 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.07 169.11 34.14 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.97 -33.52 11.54 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 122.364 -0.492 . . . . 0.0 110.371 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -96.05 138.66 33.35 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -67.85 -35.04 77.87 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.189 179.866 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.1 mtp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p -131.95 141.57 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -102.67 121.61 42.78 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 81.2 mt -110.87 147.44 34.56 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.402 ' O ' HD13 ' A' ' 6' ' ' ILE . 43.6 ttm -113.08 143.67 43.95 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.402 HD13 ' O ' ' A' ' 5' ' ' MET . 50.6 mm -129.35 131.43 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.7 mt -129.58 148.5 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -106.98 142.37 36.7 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 122.27 -0.269 . . . . 0.0 110.466 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.69 151.57 20.95 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -106.07 142.69 35.34 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 117.247 0.524 . . . . 0.0 110.259 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.64 124.32 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 45' ' ' ASN . 27.1 m -123.73 156.12 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.9 t -85.67 131.58 34.31 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.4 -176.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.96 119.89 0.84 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.1 tp -142.62 135.82 28.52 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 117.232 0.516 . . . . 0.0 110.236 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.44 36.87 32.79 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -100.53 140.35 34.91 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.335 -0.509 . . . . 0.0 110.136 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.02 173.96 42.35 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -118.04 33.34 5.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 122.34 -0.506 . . . . 0.0 110.33 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -116.25 144.13 44.61 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.181 -0.324 . . . . 0.0 110.409 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -114.49 139.54 49.46 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.4 mt -98.59 0.04 44.08 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.3 t -83.41 -31.2 26.79 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 119.033 0.833 . . . . 0.0 110.981 -174.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.5 mp -65.62 152.45 92.65 Favored Pre-proline 0 N--CA 1.503 2.195 0 CA-C-O 119.051 -0.499 . . . . 0.0 110.492 -176.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -53.57 -50.77 12.68 Favored 'Trans proline' 0 N--CA 1.501 1.96 0 C-N-CA 121.158 1.238 . . . . 0.0 113.891 -174.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.618 ' O ' HG22 ' A' ' 30' ' ' ILE . 31.2 Cg_exo -55.54 -35.16 91.97 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 120.619 0.879 . . . . 0.0 112.312 -168.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -67.1 -50.23 62.26 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.26 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -64.71 -40.76 95.91 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 122.125 -0.359 . . . . 0.0 110.533 -176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.83 -49.94 64.17 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 122.166 -0.334 . . . . 0.0 110.391 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 26' ' ' PRO . 11.0 tt -70.75 -32.67 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.205 -175.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.81 -40.89 95.95 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 122.019 -0.425 . . . . 0.0 110.285 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -64.51 -31.45 72.68 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 122.157 -0.339 . . . . 0.0 110.767 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -67.98 -40.34 83.12 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.657 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.549 HG23 HD12 ' A' ' 60' ' ' ILE . 59.6 mt -80.94 -37.27 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -175.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 92' ' ' ALA . 58.0 mt -102.53 -26.29 13.29 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 122.189 -0.319 . . . . 0.0 111.568 -174.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.35 14.33 74.34 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-O 119.26 -0.745 . . . . 0.0 111.411 -172.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -152.31 161.23 42.91 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 119.243 1.521 . . . . 0.0 110.641 170.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -94.32 107.95 32.87 Favored Pre-proline 0 N--CA 1.496 1.841 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.737 177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.413 ' CB ' HD12 ' A' ' 109' ' ' ILE . 65.1 Cg_endo -67.4 155.48 70.2 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 O-C-N 123.327 1.172 . . . . 0.0 110.462 -176.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -73.82 164.17 26.98 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.24 79.55 6.8 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.489 0.661 . . . . 0.0 109.663 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.55 171.74 44.03 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 p -138.05 156.74 47.49 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 117.41 0.605 . . . . 0.0 110.884 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.2 tp -109.91 118.58 36.84 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 170.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.545 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.7 m120 -98.95 122.34 42.08 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -176.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.822 HD11 HD11 ' A' ' 126' ' ' ILE . 60.8 mt -119.96 136.08 54.67 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 120.686 0.279 . . . . 0.0 110.562 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HB2' HG11 ' A' ' 12' ' ' VAL . 67.4 tttt -96.23 133.39 40.61 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 173.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.477 HD11 HD13 ' A' ' 106' ' ' ILE . 82.9 mt -112.16 160.18 17.82 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 120.561 0.22 . . . . 0.0 110.482 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.2 13.16 13.94 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -145.34 141.21 28.3 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 118.604 0.638 . . . . 0.0 109.418 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -64.18 146.84 53.59 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 122.253 -0.279 . . . . 0.0 110.392 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -132.02 137.41 47.83 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 120.705 0.288 . . . . 0.0 110.638 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -138.07 128.34 26.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.613 HD13 ' HB3' ' A' ' 76' ' ' LYS . 20.0 tt -63.72 -24.08 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.327 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -74.33 -1.05 19.11 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 122.0 -0.437 . . . . 0.0 112.156 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -91.22 -14.35 31.16 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 118.874 0.761 . . . . 0.0 111.441 169.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -116.07 175.02 5.73 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.644 -0.66 . . . . 0.0 109.396 175.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -92.07 101.97 14.51 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -177.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -110.18 176.71 4.95 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 120.535 0.207 . . . . 0.0 110.489 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.549 HD12 HG23 ' A' ' 34' ' ' ILE . 77.6 mt -110.98 134.43 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -105.75 142.47 35.43 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.3 p -116.7 133.66 55.75 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -77.18 172.63 12.94 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 120.803 0.335 . . . . 0.0 111.345 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -68.6 139.98 55.54 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -138.35 166.6 23.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.251 -0.281 . . . . 0.0 110.67 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -125.44 145.81 49.9 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 120.749 0.309 . . . . 0.0 110.544 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -149.57 141.82 24.12 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.0 m120 52.17 29.95 7.15 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.667 -0.646 . . . . 0.0 112.085 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.41 16.39 80.76 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -121.51 142.54 49.97 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 118.699 1.25 . . . . 0.0 109.666 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -93.14 131.7 37.95 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.477 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -120.85 143.73 48.74 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -86.89 151.9 22.91 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 120.763 0.316 . . . . 0.0 110.382 -169.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.74 167.18 42.01 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.99 162.76 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 122.312 -0.523 . . . . 0.0 110.488 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.613 ' HB3' HD13 ' A' ' 54' ' ' ILE . 61.7 mttp -112.23 137.37 50.42 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 173.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -132.47 138.33 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.2 tp -136.94 125.65 15.06 Favored Pre-proline 0 N--CA 1.497 1.925 0 CA-C-O 118.663 -0.684 . . . . 0.0 110.097 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -63.59 149.39 91.06 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 120.993 1.128 . . . . 0.0 111.395 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.555 HD13 HG13 ' A' ' 93' ' ' ILE . 43.1 pt -142.15 170.03 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 171.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -115.28 131.99 56.75 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 167.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.6 mt -106.26 123.48 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.636 HD11 HD12 ' A' ' 129' ' ' LEU . 85.5 mt -107.86 116.76 32.55 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.4 mt -129.92 121.98 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.35 -120.13 18.26 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -178.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -111.07 16.95 20.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.366 -0.491 . . . . 0.0 111.926 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -119.72 144.0 47.47 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 118.577 0.626 . . . . 0.0 110.496 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -123.1 129.72 51.82 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 120.651 0.262 . . . . 0.0 110.308 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.2 mt -125.96 143.44 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.96 138.2 44.04 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.23 -164.34 11.32 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.541 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.88 156.19 26.92 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 117.351 0.576 . . . . 0.0 110.417 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.555 HG13 HD13 ' A' ' 80' ' ' ILE . 69.7 mt -108.77 141.53 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.57 130.77 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.6 t -140.39 126.8 11.92 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -57.7 155.83 30.27 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 121.024 1.149 . . . . 0.0 111.883 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -63.76 -33.88 76.65 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 122.31 -0.244 . . . . 0.0 110.78 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -86.65 116.15 24.57 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.1 m -130.83 142.64 50.4 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -93.8 -50.37 5.39 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -147.8 -179.48 6.92 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.9 p -91.18 145.52 24.6 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.5 m -135.08 174.96 10.03 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 120.586 0.231 . . . . 0.0 110.562 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -107.07 27.42 9.04 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 122.458 -0.151 . . . . 0.0 110.929 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.7 mm -122.64 127.4 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.477 HD13 HD11 ' A' ' 48' ' ' LEU . 34.5 pt -125.43 144.05 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 110.137 -0.319 . . . . 0.0 110.137 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -114.55 130.15 56.73 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.483 HD12 HD12 ' A' ' 46' ' ' LEU . 82.9 mt -115.28 151.06 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -174.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.413 HD12 ' CB ' ' A' ' 39' ' ' PRO . 12.5 pt -115.74 155.72 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 169.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.48 162.02 44.2 Favored Pre-proline 0 N--CA 1.495 1.791 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.214 -176.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.21 -34.47 94.01 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.065 1.177 . . . . 0.0 111.462 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -145.03 159.07 43.53 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.348 -0.22 . . . . 0.0 110.684 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.7 pttt -63.72 103.97 0.62 Allowed 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.495 0.665 . . . . 0.0 111.23 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.46 -31.98 69.82 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.927 -0.483 . . . . 0.0 111.373 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.411 ' HA ' HD12 ' A' ' 120' ' ' LEU . 76.6 mtm180 -61.29 -34.98 76.1 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.008 -0.432 . . . . 0.0 111.211 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -78.25 -49.07 14.41 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -61.89 -33.8 74.88 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.217 -172.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -108.11 9.02 28.38 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.79 50.54 18.44 Favored 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.005 -1.059 . . . . 0.0 111.85 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 115' ' ' ARG . 44.9 mt -89.49 138.14 31.71 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.878 -0.514 . . . . 0.0 110.951 -169.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -119.52 157.24 28.74 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -55.95 138.51 48.67 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.84 -0.537 . . . . 0.0 111.474 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.53 -23.02 37.33 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.32 151.44 46.24 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 118.702 1.251 . . . . 0.0 110.03 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -110.23 133.07 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -174.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.822 HD11 HD11 ' A' ' 46' ' ' LEU . 34.4 pt -128.29 160.13 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -109.25 137.98 46.3 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -175.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.0 pt -110.12 137.6 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.636 HD12 HD11 ' A' ' 83' ' ' LEU . 8.0 tt -110.85 130.76 55.49 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 122.314 -0.241 . . . . 0.0 110.359 -175.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 47.6 mt -115.6 120.01 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -93.56 147.55 22.89 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.15 123.04 1.24 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -154.99 33.31 0.39 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.376 -0.485 . . . . 0.0 110.372 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -135.68 133.72 38.42 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -148.11 169.65 19.53 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.353 -0.217 . . . . 0.0 110.472 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.163 -179.915 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 mtt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.4 t -70.3 -39.17 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -106.27 136.19 46.43 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.465 HD13 HD21 ' A' ' 129' ' ' LEU . 83.6 mt -110.94 160.11 17.1 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.2 ttt -102.37 140.9 36.03 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.3 mm -127.9 130.5 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.495 HG22 HD22 ' A' ' 48' ' ' LEU . 75.3 mt -129.74 148.91 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -105.53 140.14 39.08 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.85 151.1 20.31 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -105.99 141.32 37.57 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 117.229 0.515 . . . . 0.0 110.256 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.3 t -63.22 124.04 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 45' ' ' ASN . 27.0 m -123.88 164.02 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 176.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.9 t -83.71 116.51 22.7 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.194 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.0 133.72 2.91 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.45 HD23 ' C ' ' A' ' 15' ' ' LEU . 6.7 tt -153.55 -60.05 0.13 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 117.297 0.549 . . . . 0.0 110.262 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.27 35.11 5.24 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.21 -31.16 70.48 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 117.375 0.588 . . . . 0.0 110.649 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.55 -177.87 41.27 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -116.55 33.09 5.75 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 122.297 -0.531 . . . . 0.0 110.359 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -117.59 141.79 47.96 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.135 -0.353 . . . . 0.0 110.458 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -114.53 134.39 55.07 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 22' ' ' LEU . 2.3 tt -89.95 -29.42 18.5 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 122.378 -0.201 . . . . 0.0 110.868 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.5 t -52.45 -23.59 6.39 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.604 -0.685 . . . . 0.0 112.439 -175.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.9 mt -66.25 157.7 80.41 Favored Pre-proline 0 N--CA 1.501 2.114 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.208 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -56.24 -55.08 3.13 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 121.159 1.239 . . . . 0.0 113.242 -174.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.93 -30.41 89.92 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 O-C-N 122.723 0.854 . . . . 0.0 111.625 -164.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -66.73 -44.47 81.49 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.309 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -65.94 -37.81 87.0 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 122.108 -0.37 . . . . 0.0 110.195 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.23 -46.85 78.98 Favored 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.592 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.2 tt -69.3 -36.09 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.043 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.424 ' CE2' HD11 ' A' ' 22' ' ' LEU . 3.6 m-85 -65.82 -44.43 85.64 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 122.03 -0.419 . . . . 0.0 110.438 178.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -65.74 -31.63 72.73 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.156 -0.34 . . . . 0.0 110.758 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -68.53 -40.44 80.76 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.578 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -81.44 -36.59 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 92' ' ' ALA . 46.0 mt -103.27 -26.39 12.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 122.14 -0.35 . . . . 0.0 111.693 -174.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.53 15.36 73.84 Favored Glycine 0 N--CA 1.495 2.586 0 CA-C-O 119.362 -0.688 . . . . 0.0 111.411 -173.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -151.14 162.75 40.29 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 119.145 1.473 . . . . 0.0 110.812 170.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.03 106.52 22.79 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.835 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.427 ' CB ' HD12 ' A' ' 109' ' ' ILE . 72.9 Cg_endo -68.48 160.93 47.12 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 O-C-N 123.383 1.201 . . . . 0.0 110.269 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -73.19 160.58 31.73 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -80.23 79.6 6.78 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.479 0.657 . . . . 0.0 109.686 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.28 176.41 47.79 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 p -138.11 156.25 47.95 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 117.331 0.565 . . . . 0.0 110.813 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.501 HD22 HD12 ' A' ' 114' ' ' LEU . 31.6 tp -108.68 116.47 32.05 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 169.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.548 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.6 m120 -98.41 122.13 41.21 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -176.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.796 HD11 HD11 ' A' ' 126' ' ' ILE . 61.4 mt -120.31 135.59 54.96 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 120.653 0.263 . . . . 0.0 110.535 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -95.9 133.09 40.49 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.52 HD11 HD13 ' A' ' 106' ' ' ILE . 83.6 mt -112.31 160.22 17.88 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 120.653 0.263 . . . . 0.0 110.484 -175.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.06 13.0 14.04 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 172.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -145.99 142.89 29.09 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 118.614 0.643 . . . . 0.0 109.557 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.34 148.63 49.91 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.503 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -131.91 137.44 47.99 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 120.701 0.286 . . . . 0.0 110.44 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -138.09 125.0 21.22 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.5 -23.62 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.266 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -74.24 -1.45 20.61 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.976 -0.453 . . . . 0.0 112.109 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.09 -14.5 31.13 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 118.929 0.786 . . . . 0.0 111.453 170.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -116.67 175.15 5.7 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 118.658 0.663 . . . . 0.0 109.343 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -91.31 102.72 15.42 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -109.44 177.35 4.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 122.323 -0.235 . . . . 0.0 110.563 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.2 mt -111.28 130.91 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -105.97 142.4 35.75 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.2 p -120.69 138.8 53.77 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 120.794 0.331 . . . . 0.0 110.743 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -76.75 172.64 12.75 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 120.847 0.356 . . . . 0.0 111.826 -168.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -67.88 141.21 56.47 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -136.67 164.91 27.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.152 -0.342 . . . . 0.0 110.598 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -123.61 145.95 48.54 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 120.732 0.301 . . . . 0.0 110.469 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -149.88 139.39 21.53 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 52.01 30.34 7.28 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.674 -0.642 . . . . 0.0 112.131 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.36 16.59 80.29 Favored Glycine 0 N--CA 1.497 2.725 0 CA-C-O 119.648 -0.529 . . . . 0.0 111.83 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -122.14 143.45 49.54 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.573 1.187 . . . . 0.0 109.614 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.21 131.41 38.33 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.463 -176.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -120.11 143.49 48.14 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -85.76 157.22 20.32 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 120.715 0.293 . . . . 0.0 110.432 -168.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.29 159.66 47.21 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.93 155.88 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 122.404 -0.468 . . . . 0.0 110.473 -174.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -114.69 138.24 50.94 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.3 t -133.88 140.04 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -177.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 tp -137.12 125.64 14.85 Favored Pre-proline 0 N--CA 1.497 1.88 0 CA-C-O 118.518 -0.753 . . . . 0.0 110.089 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.27 149.27 91.77 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.979 1.12 . . . . 0.0 111.482 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.571 HD13 HG13 ' A' ' 93' ' ' ILE . 43.7 pt -141.95 170.03 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 171.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -114.9 131.17 56.95 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 168.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.2 mt -105.62 124.11 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -174.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.75 116.3 31.71 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -130.01 121.95 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.99 -120.49 18.72 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -111.15 17.09 20.68 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 122.33 -0.512 . . . . 0.0 111.806 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -119.61 144.76 46.95 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 118.609 0.641 . . . . 0.0 110.492 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -123.06 131.15 53.58 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.216 -0.303 . . . . 0.0 110.28 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.79 144.87 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.75 136.57 43.65 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.58 -166.49 12.25 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.593 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.41 155.63 26.99 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 117.311 0.555 . . . . 0.0 110.304 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.571 HG13 HD13 ' A' ' 80' ' ' ILE . 69.3 mt -108.7 141.99 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.1 t -121.43 131.35 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -142.44 136.22 14.52 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -57.28 152.32 46.66 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.1 1.2 . . . . 0.0 111.814 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -66.19 -34.85 78.96 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.394 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -93.89 125.19 38.37 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 t -140.91 154.82 46.29 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -97.64 -57.93 2.12 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -134.61 -177.91 4.83 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.2 p -95.13 150.87 19.73 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.3 m -135.06 174.64 10.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.309 -0.245 . . . . 0.0 110.419 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -107.39 27.49 9.05 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 122.37 -0.206 . . . . 0.0 110.858 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.5 mm -122.91 127.35 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.52 HD13 HD11 ' A' ' 48' ' ' LEU . 34.4 pt -124.95 143.79 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 177.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -114.93 129.44 56.71 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.486 HD12 HD12 ' A' ' 46' ' ' LEU . 80.9 mt -115.02 152.04 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -174.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.427 HD12 ' CB ' ' A' ' 39' ' ' PRO . 11.4 pt -117.37 155.23 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 167.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.56 165.59 24.21 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.298 -176.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -60.0 -32.04 94.39 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 121.072 1.181 . . . . 0.0 111.576 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.73 167.03 23.54 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.319 -0.238 . . . . 0.0 110.826 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -70.63 104.34 2.79 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.501 HD12 HD22 ' A' ' 44' ' ' LEU . 81.2 mt -59.55 -33.01 70.87 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 122.211 -0.306 . . . . 0.0 111.497 -177.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -62.44 -35.59 79.75 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 122.109 -0.369 . . . . 0.0 110.949 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -78.22 -48.52 15.62 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -62.61 -33.41 74.93 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 122.159 -0.338 . . . . 0.0 111.099 -173.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -107.95 8.33 28.39 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 51.81 45.1 28.75 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 121.096 -1.002 . . . . 0.0 111.934 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -92.67 138.22 31.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.898 -0.501 . . . . 0.0 110.867 -171.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -114.97 159.31 20.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.11 138.18 50.11 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.906 -0.496 . . . . 0.0 111.467 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.63 -22.98 37.45 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.44 156.0 33.76 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-N 118.629 1.214 . . . . 0.0 109.975 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.36 133.87 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.796 HD11 HD11 ' A' ' 46' ' ' LEU . 34.0 pt -128.74 160.52 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -109.75 138.19 46.47 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 pt -112.77 137.58 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 129' ' ' LEU . 9.4 tt -110.19 128.76 55.66 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 36.6 mt -117.62 130.02 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.4 ' HG2' HD22 ' A' ' 4' ' ' LEU . 98.5 mttt -93.26 141.1 28.81 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.09 174.1 34.67 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -115.07 31.74 6.5 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.356 -0.497 . . . . 0.0 110.504 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -99.21 139.55 34.69 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 122.12 -0.362 . . . . 0.0 110.21 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -67.52 -34.37 76.97 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 120.726 0.298 . . . . 0.0 110.335 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 N--CA 1.506 2.327 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.759 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.4 mtt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p -132.17 141.1 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -101.83 132.65 47.47 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 131' ' ' LYS . 84.6 mt -110.82 153.01 26.0 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.5 ttm -134.65 145.57 48.7 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.2 mm -126.47 135.46 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -175.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.445 HG22 HD22 ' A' ' 48' ' ' LEU . 78.8 mt -130.6 147.74 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -110.08 143.96 39.36 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.59 151.56 21.26 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -105.95 142.56 35.46 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 117.231 0.516 . . . . 0.0 110.278 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.5 t -64.78 122.39 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -126.65 149.18 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 t -86.6 111.76 20.94 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.07 126.75 1.38 Allowed Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.4 mt -99.4 30.76 3.39 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.326 -0.514 . . . . 0.0 110.677 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.89 177.34 51.49 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -68.68 -34.99 76.61 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 117.219 0.51 . . . . 0.0 109.936 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.38 -175.72 14.03 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -118.7 150.2 40.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.31 -0.523 . . . . 0.0 110.265 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -136.55 167.42 21.42 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -102.5 127.95 49.34 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 120.586 0.232 . . . . 0.0 110.451 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' ' 41' ' ' GLU . 23.9 mt -103.79 -29.66 10.88 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.342 -0.224 . . . . 0.0 110.94 177.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.4 p -60.26 -26.57 66.57 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 122.103 -0.373 . . . . 0.0 111.8 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.7 mt -64.79 155.97 80.74 Favored Pre-proline 0 N--CA 1.503 2.19 0 CA-C-O 119.158 -0.449 . . . . 0.0 110.571 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -57.66 -56.11 1.96 Allowed 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 121.159 1.239 . . . . 0.0 113.129 -172.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.59 -32.73 93.75 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 O-C-N 122.689 0.836 . . . . 0.0 111.574 -162.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -66.51 -44.38 82.7 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.291 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -65.41 -37.81 88.08 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 122.207 -0.308 . . . . 0.0 110.386 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -65.68 -47.44 75.43 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.549 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.1 tt -68.75 -36.52 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.078 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -66.07 -44.95 83.03 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 122.109 -0.369 . . . . 0.0 110.391 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -65.76 -30.71 71.4 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 122.224 -0.298 . . . . 0.0 110.797 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -68.77 -40.63 79.61 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.645 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.2 mt -81.45 -37.08 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 92' ' ' ALA . 45.7 mt -104.04 -26.25 12.67 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.262 -0.274 . . . . 0.0 111.638 -174.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.77 14.31 73.2 Favored Glycine 0 N--CA 1.494 2.554 0 CA-C-O 119.319 -0.712 . . . . 0.0 111.449 -172.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -152.43 163.46 39.49 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 119.149 1.475 . . . . 0.0 110.691 170.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -94.97 108.42 37.99 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.583 -0.722 . . . . 0.0 109.922 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.418 ' CB ' HD12 ' A' ' 109' ' ' ILE . 65.8 Cg_endo -67.39 159.64 51.42 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 123.32 1.169 . . . . 0.0 110.492 -176.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -74.0 162.55 28.92 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.474 ' HA ' HD13 ' A' ' 22' ' ' LEU . 53.7 mt-10 -80.21 79.59 6.76 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.519 0.676 . . . . 0.0 109.662 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.64 171.86 44.13 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 175.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 p -138.0 157.59 46.06 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 117.382 0.591 . . . . 0.0 110.853 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.2 tp -110.47 116.98 32.35 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.416 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.5 m120 -98.97 121.76 41.34 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -176.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 126' ' ' ILE . 65.4 mt -120.49 135.98 54.9 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.72 0.295 . . . . 0.0 110.642 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -96.09 132.06 41.87 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.445 HD22 HG22 ' A' ' 7' ' ' ILE . 83.5 mt -110.6 160.3 16.79 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 120.64 0.257 . . . . 0.0 110.452 -176.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.28 12.85 14.89 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 172.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -145.27 140.48 27.84 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.696 -0.628 . . . . 0.0 109.39 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.33 146.94 52.46 Favored 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.626 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -132.53 137.19 47.06 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 120.724 0.297 . . . . 0.0 110.639 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -138.0 126.9 24.0 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.0 tt -64.37 -23.94 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.135 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -72.74 -3.55 25.88 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 122.006 -0.434 . . . . 0.0 112.053 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -91.12 -13.89 32.19 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 118.815 0.734 . . . . 0.0 111.51 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -114.2 175.08 5.63 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.596 0.634 . . . . 0.0 109.395 173.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -92.06 102.01 14.56 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -109.18 176.88 4.93 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 120.524 0.202 . . . . 0.0 110.574 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -111.0 129.48 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -105.94 140.91 38.21 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.5 p -117.23 134.9 54.24 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 120.721 0.296 . . . . 0.0 110.495 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -75.83 172.69 12.25 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 120.768 0.318 . . . . 0.0 111.472 -170.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -67.71 139.48 56.72 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -139.83 167.44 22.11 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.618 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -124.23 149.12 46.78 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 120.846 0.355 . . . . 0.0 110.528 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -148.24 135.62 20.5 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.82 32.89 10.34 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.739 -0.601 . . . . 0.0 112.098 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.25 16.6 79.38 Favored Glycine 0 N--CA 1.497 2.745 0 CA-C-O 119.606 -0.552 . . . . 0.0 111.907 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -121.99 142.13 50.63 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.74 1.27 . . . . 0.0 109.731 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.3 132.13 37.79 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.431 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -121.84 144.12 49.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -86.41 155.94 20.37 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.483 -168.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.76 159.15 49.13 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -139.24 156.77 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 122.353 -0.498 . . . . 0.0 110.387 -174.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -117.04 136.76 52.72 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.5 t -134.04 141.19 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.9 tp -137.35 125.63 14.57 Favored Pre-proline 0 N--CA 1.497 1.893 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.152 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.22 149.39 91.5 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 120.928 1.085 . . . . 0.0 111.475 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.538 HD13 HG13 ' A' ' 93' ' ' ILE . 43.7 pt -141.79 170.01 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-O 120.638 0.256 . . . . 0.0 110.312 171.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -116.18 130.58 56.86 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 167.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.8 mt -105.74 123.99 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -174.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.526 HD11 HD13 ' A' ' 129' ' ' LEU . 84.9 mt -107.88 117.17 33.41 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.5 mt -130.15 121.95 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.6 -120.05 17.6 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -111.16 17.11 20.65 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 122.418 -0.46 . . . . 0.0 111.78 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -119.65 143.75 47.54 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.558 0.617 . . . . 0.0 110.444 -175.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -123.12 130.0 52.19 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -125.42 145.05 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.77 136.65 43.63 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.86 -167.34 12.92 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.585 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.72 155.85 26.7 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 117.304 0.552 . . . . 0.0 110.387 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.538 HG13 HD13 ' A' ' 80' ' ' ILE . 69.8 mt -108.77 141.13 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.0 t -122.27 131.13 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -143.73 138.25 15.07 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.09 153.24 39.9 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 121.116 1.21 . . . . 0.0 111.842 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -65.4 -33.79 76.79 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 121.061 -0.255 . . . . 0.0 110.581 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -87.42 117.29 26.1 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 m -130.56 134.7 47.23 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -96.98 -50.24 4.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -133.41 170.02 16.09 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.7 m -94.61 153.34 17.89 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 93.6 p -135.09 173.45 11.71 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 120.739 0.304 . . . . 0.0 110.468 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -105.78 24.55 12.12 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 119.71 -0.186 . . . . 0.0 110.891 172.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.9 mm -119.85 127.43 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.9 pt -125.93 145.93 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -115.98 130.17 56.7 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.487 HD12 HD12 ' A' ' 46' ' ' LEU . 81.3 mt -115.18 150.83 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -174.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.418 HD12 ' CB ' ' A' ' 39' ' ' PRO . 11.2 pt -116.22 156.52 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 168.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.52 161.64 45.96 Favored Pre-proline 0 N--CA 1.495 1.806 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.298 -177.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.02 -31.39 93.42 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 121.044 1.163 . . . . 0.0 111.614 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.32 167.13 23.18 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.277 -0.264 . . . . 0.0 110.634 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -74.3 103.87 4.86 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 120.946 0.403 . . . . 0.0 110.176 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 79.0 mt -60.39 -33.25 72.21 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 122.088 -0.383 . . . . 0.0 111.314 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -61.93 -33.3 74.02 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.159 -0.338 . . . . 0.0 110.925 -175.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.24 -50.88 11.06 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -62.63 -32.52 73.56 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.158 -0.339 . . . . 0.0 111.218 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -106.64 8.07 30.94 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.78 47.51 24.65 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.06 -1.025 . . . . 0.0 111.858 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.3 mt -91.15 138.23 31.75 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.874 -0.517 . . . . 0.0 111.094 -169.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -117.55 159.86 22.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.24 138.38 50.44 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.908 -0.495 . . . . 0.0 111.445 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.55 -23.09 37.07 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -65.39 152.7 43.23 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 118.653 1.227 . . . . 0.0 110.061 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -110.81 133.1 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -174.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.783 HD11 HD11 ' A' ' 46' ' ' LEU . 33.5 pt -128.16 160.64 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -108.78 139.46 43.57 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.2 pt -110.09 137.9 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 174.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.526 HD13 HD11 ' A' ' 83' ' ' LEU . 6.2 tp -107.75 134.19 51.07 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -173.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 49.4 mt -125.06 125.49 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.428 ' HA ' HD23 ' A' ' 4' ' ' LEU . 98.9 mttt -94.34 149.04 21.62 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 175.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.09 131.98 3.1 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -94.08 -34.57 12.94 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.306 -0.526 . . . . 0.0 110.165 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -123.58 139.13 54.32 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -93.42 -34.34 13.48 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 120.706 0.288 . . . . 0.0 110.307 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 . . . . . 0 N--CA 1.507 2.38 0 CA-C-O 117.823 -1.084 . . . . 0.0 111.763 -179.44 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 ttm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.9 t -113.61 132.85 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -107.43 122.84 47.42 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.1 mt -110.88 143.26 41.78 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.657 ' O ' HD13 ' A' ' 6' ' ' ILE . 48.1 ttm -144.56 146.87 32.58 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 120.681 0.276 . . . . 0.0 110.567 -178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.722 HD12 HD23 ' A' ' 129' ' ' LEU . 36.7 mm -131.26 124.55 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 78.8 mt -130.72 154.38 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -106.13 146.88 29.64 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.47 150.3 20.99 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -106.3 141.34 37.79 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.267 -0.549 . . . . 0.0 110.141 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.8 t -62.89 123.33 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -123.59 153.91 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.5 t -86.15 125.88 33.82 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.321 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.07 119.94 0.84 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.7 mt -130.41 131.32 45.2 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.345 -0.503 . . . . 0.0 110.259 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.42 35.72 76.42 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -68.68 -36.79 78.97 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 117.245 0.523 . . . . 0.0 109.922 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.66 -178.57 43.77 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -115.03 32.53 5.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 122.32 -0.517 . . . . 0.0 110.46 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -119.36 143.77 47.24 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.099 -0.376 . . . . 0.0 110.368 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -111.13 128.39 55.87 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.408 HD23 ' HB3' ' A' ' 27' ' ' TYR . 85.9 mt -94.84 -15.56 23.62 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.4 m -59.38 -28.7 67.12 Favored 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 118.647 0.658 . . . . 0.0 111.451 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.4 mp -66.77 157.79 82.37 Favored Pre-proline 0 N--CA 1.501 2.089 0 CA-C-O 119.243 -0.408 . . . . 0.0 110.369 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -56.71 -55.92 2.36 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 121.298 1.332 . . . . 0.0 113.366 -174.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.62 ' O ' HG22 ' A' ' 30' ' ' ILE . 14.6 Cg_endo -58.64 -32.45 96.8 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 120.533 0.822 . . . . 0.0 111.936 -162.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.408 ' HB3' HD23 ' A' ' 22' ' ' LEU . 97.1 m-85 -66.33 -47.75 72.51 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.369 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -65.01 -41.82 95.0 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 120.896 -0.321 . . . . 0.0 110.352 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -66.43 -50.17 64.29 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.479 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 26' ' ' PRO . 10.7 tt -71.16 -32.86 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.217 -175.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -65.26 -38.96 91.95 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 122.063 -0.398 . . . . 0.0 110.169 175.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -63.95 -34.15 77.34 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.272 -0.268 . . . . 0.0 110.798 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -67.32 -38.3 84.7 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.607 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.54 HG23 HD12 ' A' ' 60' ' ' ILE . 59.9 mt -81.2 -37.09 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.5 ' CD2' ' HB2' ' A' ' 92' ' ' ALA . 58.3 mt -101.22 -26.37 13.67 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 122.226 -0.296 . . . . 0.0 111.657 -174.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.66 14.14 76.49 Favored Glycine 0 N--CA 1.494 2.52 0 CA-C-O 119.312 -0.716 . . . . 0.0 111.414 -173.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -152.06 161.45 42.61 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 119.117 1.459 . . . . 0.0 110.609 171.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -94.22 106.44 22.96 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-O 118.611 -0.709 . . . . 0.0 109.901 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.418 ' CB ' HD12 ' A' ' 109' ' ' ILE . 71.5 Cg_endo -68.29 158.48 57.35 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 O-C-N 123.303 1.16 . . . . 0.0 110.314 -177.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -73.5 160.92 30.99 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -80.28 79.62 6.83 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.531 0.681 . . . . 0.0 109.538 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.46 177.64 48.35 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 p -138.07 156.04 48.18 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 117.389 0.594 . . . . 0.0 110.931 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.504 HD22 HD12 ' A' ' 114' ' ' LEU . 27.8 tp -109.04 118.59 37.18 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 169.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.537 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.7 m120 -99.0 123.36 43.24 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.228 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.539 HD11 HD11 ' A' ' 126' ' ' ILE . 56.1 mt -120.71 136.08 54.96 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.688 0.28 . . . . 0.0 110.441 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.511 ' HB2' HG11 ' A' ' 12' ' ' VAL . 39.2 tttp -95.81 133.93 39.37 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.554 HD11 HD13 ' A' ' 106' ' ' ILE . 83.7 mt -112.69 160.3 18.05 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 120.62 0.247 . . . . 0.0 110.395 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.01 12.54 15.22 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 173.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -145.69 144.88 30.65 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 118.563 0.62 . . . . 0.0 109.795 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -63.97 150.35 45.34 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 122.222 -0.298 . . . . 0.0 110.477 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -131.86 139.03 48.69 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 120.69 0.281 . . . . 0.0 110.701 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -138.08 122.87 18.79 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.58 -21.13 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.441 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -75.17 -0.77 20.39 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -89.41 -14.47 35.41 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.991 0.814 . . . . 0.0 111.438 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -119.69 175.19 5.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.624 -0.672 . . . . 0.0 109.531 173.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -91.06 103.45 16.15 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -107.27 177.29 4.89 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 122.336 -0.228 . . . . 0.0 110.463 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.54 HD12 HG23 ' A' ' 34' ' ' ILE . 77.0 mt -109.99 131.95 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.99 143.27 34.36 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.0 p -116.07 133.77 55.67 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -76.69 172.58 12.82 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 120.643 0.258 . . . . 0.0 111.316 -172.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -68.42 139.66 55.77 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -142.85 166.58 24.24 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.668 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -122.87 147.31 46.72 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 120.742 0.306 . . . . 0.0 110.525 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -149.65 138.96 21.39 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.9 m120 52.03 30.26 7.23 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.66 -0.65 . . . . 0.0 112.128 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.61 16.21 80.47 Favored Glycine 0 N--CA 1.496 2.697 0 CA-C-O 119.607 -0.552 . . . . 0.0 111.851 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -121.89 143.94 49.14 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 118.685 1.242 . . . . 0.0 109.717 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -93.5 131.72 38.46 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.488 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -121.32 143.82 48.97 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -87.15 155.19 20.21 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.792 0.329 . . . . 0.0 110.378 -170.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.13 160.99 48.16 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.1 m -141.99 160.79 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 122.32 -0.518 . . . . 0.0 110.367 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -116.13 136.76 52.73 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.5 t -132.69 139.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.0 tp -138.3 125.66 13.51 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.136 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -62.68 149.16 92.09 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 O-C-N 123.189 1.099 . . . . 0.0 111.613 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.617 HD13 HG13 ' A' ' 93' ' ' ILE . 43.6 pt -142.16 170.13 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 172.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -118.32 130.29 55.94 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 168.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.38 129.05 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -173.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.62 HD11 HD21 ' A' ' 129' ' ' LEU . 91.7 mt -107.43 117.62 34.58 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 71.7 mt -129.56 121.87 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.68 -119.95 17.15 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -111.08 16.97 20.83 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.412 -0.464 . . . . 0.0 111.872 176.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -120.4 146.13 46.5 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 118.522 0.601 . . . . 0.0 110.521 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -123.13 130.62 53.01 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -125.89 147.57 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.6 139.75 45.73 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -150.3 -165.85 12.98 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.5 ' HB2' ' CD2' ' A' ' 35' ' ' LEU . . . -159.38 155.45 26.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.28 -0.541 . . . . 0.0 110.182 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.617 HG13 HD13 ' A' ' 80' ' ' ILE . 71.5 mt -108.71 141.36 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.05 130.6 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.4 t -142.18 133.92 13.32 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -57.86 153.24 45.08 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 121.046 1.164 . . . . 0.0 111.801 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -65.5 -34.52 78.46 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.587 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -86.78 121.32 29.11 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.3 t -142.98 156.64 44.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.296 -0.253 . . . . 0.0 110.389 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -97.54 -59.95 1.67 Allowed 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -136.3 -172.19 3.08 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.3 p -93.05 149.45 21.21 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.7 m -134.9 173.08 12.11 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 120.576 0.226 . . . . 0.0 110.427 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -107.7 27.18 9.44 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.423 -0.173 . . . . 0.0 110.865 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -122.33 127.84 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.554 HD13 HD11 ' A' ' 48' ' ' LEU . 34.6 pt -124.59 143.71 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -115.04 128.71 56.42 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.51 HD12 HD12 ' A' ' 46' ' ' LEU . 82.2 mt -115.01 152.49 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -173.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.418 HD12 ' CB ' ' A' ' 39' ' ' PRO . 11.6 pt -116.49 156.0 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 168.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.6 163.88 33.79 Favored Pre-proline 0 N--CA 1.496 1.85 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.249 -176.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.02 -32.56 95.08 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.163 1.242 . . . . 0.0 111.572 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -145.01 167.01 23.68 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.275 -0.266 . . . . 0.0 110.994 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -69.5 103.95 2.19 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.632 0.73 . . . . 0.0 110.465 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.504 HD12 HD22 ' A' ' 44' ' ' LEU . 83.4 mt -60.26 -33.0 71.7 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.664 -0.647 . . . . 0.0 111.641 -178.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -61.48 -37.84 85.09 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 122.054 -0.404 . . . . 0.0 111.296 -171.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -78.35 -45.82 21.58 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.36 -34.15 76.11 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.16 -0.337 . . . . 0.0 111.007 -173.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -108.18 8.27 27.89 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.75 48.06 23.57 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.204 -0.935 . . . . 0.0 111.888 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.4 mt -92.11 138.18 31.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.912 -0.493 . . . . 0.0 110.891 -171.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -117.21 156.19 28.13 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.66 138.02 48.14 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.941 -0.474 . . . . 0.0 111.542 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.97 -22.94 37.42 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.41 152.8 43.02 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-N 118.643 1.222 . . . . 0.0 110.019 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -112.77 134.03 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.539 HD11 HD11 ' A' ' 46' ' ' LEU . 34.3 pt -130.29 165.11 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -107.89 139.86 41.86 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.1 pt -117.04 138.76 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.722 HD23 HD12 ' A' ' 6' ' ' ILE . 12.9 mt -99.03 141.34 31.91 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.0 mt -129.98 124.09 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -147.09 155.08 41.89 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.06 122.94 1.23 Allowed Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -155.07 78.86 1.05 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 122.282 -0.54 . . . . 0.0 110.315 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -95.03 -44.88 7.48 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.01 -0.431 . . . . 0.0 110.167 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -67.34 -34.88 78.25 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.193 179.806 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.1 mtm . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.299 0.571 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.52 135.82 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -98.13 124.03 42.47 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.7 mt -110.86 150.14 29.59 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.8 ttm -105.47 142.89 34.44 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.0 mm -128.56 132.18 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.488 HG22 HD22 ' A' ' 48' ' ' LEU . 72.9 mt -129.67 148.75 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -105.7 140.04 39.36 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.43 150.14 20.17 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -105.93 141.68 36.92 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 117.21 0.505 . . . . 0.0 110.221 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.9 t -63.15 122.61 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -127.23 162.21 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.1 t -84.88 130.87 34.59 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.99 119.94 0.84 Allowed Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.5 tt -155.11 -45.69 0.08 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 117.081 0.44 . . . . 0.0 110.149 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.35 -29.05 73.38 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -62.76 -30.5 71.5 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-N 117.766 0.783 . . . . 0.0 110.879 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.85 129.97 24.75 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 -117.25 32.6 6.07 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 122.317 -0.52 . . . . 0.0 110.772 -175.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -129.53 153.04 48.41 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.13 -0.356 . . . . 0.0 110.406 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -108.04 120.34 42.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 41' ' ' GLU . 68.1 mt -77.63 -27.35 51.08 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.151 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.3 m -57.1 -24.7 55.89 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.859 -0.525 . . . . 0.0 112.029 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.431 HD21 ' CD2' ' A' ' 67' ' ' PHE . 7.4 tp -63.91 138.92 97.54 Favored Pre-proline 0 N--CA 1.504 2.255 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.273 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -53.48 -49.61 16.76 Favored 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 121.011 1.141 . . . . 0.0 113.748 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.54 -39.11 92.9 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 120.575 0.85 . . . . 0.0 112.257 -169.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -65.41 -43.05 91.8 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 122.227 -0.295 . . . . 0.0 110.691 -175.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -65.43 -40.05 92.83 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 122.085 -0.384 . . . . 0.0 110.262 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -65.33 -46.2 81.21 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.553 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.1 tt -69.92 -34.49 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -176.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -65.5 -44.28 87.52 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 122.08 -0.387 . . . . 0.0 110.347 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -65.86 -30.89 71.57 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.736 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -68.69 -40.58 79.97 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.67 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mt -81.39 -36.86 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 92' ' ' ALA . 50.5 mt -103.96 -26.29 12.69 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.213 -0.304 . . . . 0.0 111.678 -174.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.49 14.76 72.91 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-O 119.304 -0.72 . . . . 0.0 111.436 -172.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -151.9 162.18 41.47 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 119.155 1.478 . . . . 0.0 110.659 170.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -94.84 108.61 38.84 Favored Pre-proline 0 N--CA 1.497 1.878 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.894 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.419 ' CB ' HD12 ' A' ' 109' ' ' ILE . 67.1 Cg_endo -67.33 158.54 56.5 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 O-C-N 123.238 1.125 . . . . 0.0 110.55 -176.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -73.81 162.43 29.13 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.441 ' HA ' HD13 ' A' ' 22' ' ' LEU . 70.2 mt-10 -80.22 79.67 6.76 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.378 0.609 . . . . 0.0 109.764 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.16 178.94 48.63 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 175.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -137.96 154.37 49.38 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 117.266 0.533 . . . . 0.0 110.801 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.669 HD22 HD12 ' A' ' 114' ' ' LEU . 31.0 tp -109.61 115.47 29.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 168.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.445 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.4 m120 -99.66 122.77 43.16 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.807 HD11 HD11 ' A' ' 126' ' ' ILE . 53.7 mt -120.57 136.26 54.85 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.716 0.293 . . . . 0.0 110.487 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -95.94 132.91 40.76 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.565 HD11 HD13 ' A' ' 106' ' ' ILE . 83.9 mt -112.16 160.28 17.73 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 120.63 0.253 . . . . 0.0 110.508 -175.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.01 12.89 14.25 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 172.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -145.74 142.0 28.53 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 118.594 0.634 . . . . 0.0 109.573 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.04 147.3 51.12 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 122.235 -0.29 . . . . 0.0 110.697 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -131.81 135.87 47.07 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 120.781 0.324 . . . . 0.0 110.675 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -138.06 127.41 24.66 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 173.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.434 HD13 ' HB3' ' A' ' 76' ' ' LYS . 20.1 tt -63.16 -23.49 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.329 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -74.39 -1.08 19.44 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.944 -0.473 . . . . 0.0 112.184 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -91.12 -14.44 31.17 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 118.913 0.779 . . . . 0.0 111.511 170.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -116.28 175.11 5.7 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.593 0.633 . . . . 0.0 109.373 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -91.51 102.14 14.8 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -109.73 179.23 4.18 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 120.526 0.203 . . . . 0.0 110.591 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.5 mt -110.98 132.14 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -105.92 143.56 33.89 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 36.4 p -124.56 135.04 52.83 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 120.83 0.348 . . . . 0.0 110.667 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.88 172.69 12.73 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 120.825 0.345 . . . . 0.0 111.768 -169.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -68.05 141.14 56.27 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -137.52 166.59 23.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 122.195 -0.315 . . . . 0.0 110.656 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -125.78 149.17 48.79 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 120.861 0.362 . . . . 0.0 110.591 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.431 ' CD2' HD21 ' A' ' 24' ' ' LEU . 88.3 t80 -148.86 135.01 19.22 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 52.17 33.44 12.37 Favored 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.719 -0.613 . . . . 0.0 111.895 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.73 16.25 80.31 Favored Glycine 0 N--CA 1.497 2.709 0 CA-C-O 119.613 -0.548 . . . . 0.0 111.877 176.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -119.94 139.56 52.26 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 118.723 1.262 . . . . 0.0 109.704 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.41 131.82 38.24 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 120.671 0.272 . . . . 0.0 110.416 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -120.21 143.2 48.39 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -86.08 155.05 20.97 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.774 0.321 . . . . 0.0 110.541 -167.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.07 157.29 51.51 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -138.52 159.21 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 122.258 -0.554 . . . . 0.0 110.404 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.434 ' HB3' HD13 ' A' ' 54' ' ' ILE . 96.9 mttt -117.08 135.84 53.43 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.8 t -132.2 139.61 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -176.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.3 tp -136.45 125.64 15.61 Favored Pre-proline 0 N--CA 1.496 1.871 0 CA-C-O 118.579 -0.725 . . . . 0.0 110.004 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.45 149.15 91.87 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 O-C-N 123.172 1.091 . . . . 0.0 111.426 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.592 HD13 HG13 ' A' ' 93' ' ' ILE . 43.3 pt -141.9 169.85 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 171.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -114.98 131.33 56.95 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 168.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.6 mt -105.32 123.2 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -175.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.1 mt -107.5 115.89 30.97 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.7 mt -130.02 121.95 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.12 -120.59 18.77 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -111.14 17.02 20.75 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.344 -0.503 . . . . 0.0 111.888 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -119.77 145.16 46.83 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 118.586 0.63 . . . . 0.0 110.552 -175.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -123.08 129.5 51.55 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 120.741 0.305 . . . . 0.0 110.295 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.3 mt -125.65 143.4 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.04 137.46 43.41 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.1 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.27 -165.15 11.6 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.572 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.46 154.9 25.62 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 117.429 0.615 . . . . 0.0 110.507 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.592 HG13 HD13 ' A' ' 80' ' ' ILE . 68.6 mt -108.7 141.74 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.97 132.49 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -175.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.1 t -145.05 137.05 13.06 Favored Pre-proline 0 N--CA 1.498 1.959 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -58.41 154.59 40.48 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 121.072 1.182 . . . . 0.0 111.687 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -65.17 -34.17 77.74 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.805 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -85.15 116.96 23.81 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.305 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.7 m -131.68 139.57 49.09 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -94.62 -49.61 5.56 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -137.68 172.44 12.95 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -89.22 146.78 24.53 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.0 m -135.03 169.89 16.74 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 120.615 0.245 . . . . 0.0 110.607 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -106.96 27.63 8.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.438 -0.164 . . . . 0.0 110.795 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.5 mm -121.79 126.75 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.565 HD13 HD11 ' A' ' 48' ' ' LEU . 34.0 pt -124.06 143.86 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -115.15 130.88 57.04 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.439 HD12 HD12 ' A' ' 46' ' ' LEU . 81.7 mt -116.11 151.5 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -173.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.419 HD12 ' CB ' ' A' ' 39' ' ' PRO . 13.4 pt -116.59 153.52 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 167.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.53 164.64 29.51 Favored Pre-proline 0 N--CA 1.495 1.807 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.234 -176.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.21 -31.94 93.74 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.042 1.162 . . . . 0.0 111.584 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.59 167.1 23.34 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.29 -0.256 . . . . 0.0 110.716 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -70.8 104.45 2.9 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.669 HD12 HD22 ' A' ' 44' ' ' LEU . 80.9 mt -59.58 -33.13 71.06 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 122.022 -0.424 . . . . 0.0 111.511 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -62.62 -35.37 79.36 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 122.119 -0.363 . . . . 0.0 110.964 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -78.25 -48.31 16.03 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.43 -33.24 74.4 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 122.163 -0.335 . . . . 0.0 111.074 -173.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -107.99 7.83 28.07 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.88 45.8 27.63 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.025 -1.047 . . . . 0.0 111.876 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.3 mt -92.34 138.21 31.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.862 -0.524 . . . . 0.0 110.93 -171.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -114.79 157.54 23.1 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -55.87 137.94 49.32 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.919 -0.488 . . . . 0.0 111.535 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.95 -22.99 37.23 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -177.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -65.44 156.11 33.42 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 118.621 1.21 . . . . 0.0 110.004 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.6 t -112.36 134.07 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.807 HD11 HD11 ' A' ' 46' ' ' LEU . 34.4 pt -128.98 160.59 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -109.78 138.08 46.66 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -175.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.1 pt -112.12 137.57 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.463 HD23 ' C ' ' A' ' 129' ' ' LEU . 8.8 tt -110.79 131.69 54.83 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -177.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.2 mt -120.47 130.51 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -92.47 153.99 18.77 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.03 178.12 33.58 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -99.72 134.85 42.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 122.276 -0.544 . . . . 0.0 110.265 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -68.28 -45.98 71.64 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -67.52 -34.44 77.12 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 120.731 0.3 . . . . 0.0 110.338 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 . . . . . 0 N--CA 1.506 2.367 0 CA-C-O 118.053 -0.975 . . . . 0.0 111.732 -178.998 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p -133.04 145.26 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -94.52 123.77 38.15 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 131' ' ' LYS . 84.5 mt -110.84 152.92 26.11 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.405 ' O ' HD13 ' A' ' 6' ' ' ILE . 9.3 tpt -125.91 145.68 50.16 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.405 HD13 ' O ' ' A' ' 5' ' ' MET . 45.4 mm -128.34 135.35 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -175.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.408 HG22 HD22 ' A' ' 48' ' ' LEU . 78.0 mt -130.59 147.61 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 171.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -110.23 143.81 39.83 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.318 -0.239 . . . . 0.0 110.405 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.75 152.45 21.7 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -105.8 140.7 38.44 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 117.242 0.521 . . . . 0.0 110.35 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.0 t -63.43 122.49 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.75 137.24 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 173.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.6 p -86.87 101.74 13.67 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.17 173.13 44.17 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.2 mt -121.57 156.8 32.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 122.302 -0.528 . . . . 0.0 109.859 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.43 -40.03 94.3 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -172.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -163.53 100.5 0.92 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 117.417 0.608 . . . . 0.0 110.385 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.88 -139.89 35.44 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -140.96 145.79 36.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.379 -0.483 . . . . 0.0 110.522 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -144.74 161.31 39.55 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -106.48 130.53 54.26 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 120.576 0.226 . . . . 0.0 110.629 -175.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.2 mt -95.39 -27.73 15.29 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 122.364 -0.21 . . . . 0.0 111.059 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.1 p -60.13 -22.37 62.74 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 122.029 -0.419 . . . . 0.0 112.043 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.5 mt -61.92 155.12 64.64 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 121.832 -0.542 . . . . 0.0 110.771 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -56.21 -54.46 3.95 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 121.099 1.199 . . . . 0.0 113.32 -172.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.49 ' O ' HG22 ' A' ' 30' ' ' ILE . 20.0 Cg_endo -62.22 -40.99 37.44 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 O-C-N 122.72 0.853 . . . . 0.0 111.197 -166.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -65.8 -44.55 85.34 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.517 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -66.11 -41.63 90.34 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 122.134 -0.354 . . . . 0.0 110.413 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.88 -50.01 63.82 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.345 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 26' ' ' PRO . 18.7 tt -69.11 -34.27 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.01 -175.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.432 ' HD1' HG23 ' A' ' 30' ' ' ILE . 6.1 m-85 -65.09 -41.85 94.61 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 122.039 -0.413 . . . . 0.0 110.319 176.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -65.49 -32.79 74.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 122.194 -0.316 . . . . 0.0 110.731 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -67.95 -38.31 82.65 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.671 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.9 mt -80.76 -39.08 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.3 mt -99.55 -26.28 14.15 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 122.263 -0.273 . . . . 0.0 111.541 -174.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.65 14.2 76.36 Favored Glycine 0 N--CA 1.496 2.646 0 CA-C-O 119.363 -0.687 . . . . 0.0 111.428 -174.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -152.05 163.37 39.45 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 119.082 1.441 . . . . 0.0 110.709 171.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -95.44 109.59 46.18 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.744 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.53 163.38 35.08 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 123.288 1.151 . . . . 0.0 110.601 -175.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -74.28 163.16 28.15 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -80.36 79.64 6.92 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.463 0.649 . . . . 0.0 109.858 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.5 172.8 44.03 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 174.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -136.51 156.08 49.09 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 117.285 0.542 . . . . 0.0 110.562 173.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.3 tp -108.88 116.41 31.94 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 172.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.31 122.88 42.02 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.831 HD11 HD11 ' A' ' 126' ' ' ILE . 59.0 mt -120.04 135.84 54.79 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 120.75 0.31 . . . . 0.0 110.554 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -95.47 132.34 40.65 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.478 HD11 ' CD1' ' A' ' 106' ' ' ILE . 83.8 mt -111.95 160.25 17.62 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 120.683 0.278 . . . . 0.0 110.4 -175.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.31 13.17 14.13 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 172.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -145.25 140.38 27.8 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 118.568 0.622 . . . . 0.0 109.479 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.27 146.91 52.44 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 122.254 -0.279 . . . . 0.0 110.679 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -132.0 136.75 47.52 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 120.706 0.289 . . . . 0.0 110.584 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -138.06 125.99 22.62 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.57 -23.92 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.341 -177.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -74.22 -0.93 18.4 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.51 -14.13 33.29 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 118.908 0.776 . . . . 0.0 111.457 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -115.84 175.07 5.7 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 118.613 0.642 . . . . 0.0 109.454 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -92.46 103.46 15.88 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -109.85 176.2 5.16 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 120.512 0.196 . . . . 0.0 110.499 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.3 mt -110.25 129.7 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 175.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -105.9 147.4 28.79 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.2 p -125.24 134.96 52.13 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 120.778 0.323 . . . . 0.0 110.768 175.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -75.14 172.72 11.87 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 120.757 0.313 . . . . 0.0 111.707 -170.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -66.99 139.55 57.69 Favored 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -140.63 166.78 23.79 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 122.215 -0.303 . . . . 0.0 110.633 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -124.45 149.06 47.2 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 120.8 0.333 . . . . 0.0 110.559 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -149.09 135.13 19.05 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 m120 52.15 33.96 13.34 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.705 -0.622 . . . . 0.0 111.881 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.82 15.97 80.59 Favored Glycine 0 N--CA 1.497 2.737 0 CA-C-O 119.589 -0.562 . . . . 0.0 111.875 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -121.19 140.97 51.29 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 118.768 1.284 . . . . 0.0 109.717 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -92.87 130.81 38.35 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.368 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -120.14 143.52 48.14 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -85.96 156.18 20.58 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.307 -169.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.44 157.23 50.12 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -138.88 157.93 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 122.448 -0.443 . . . . 0.0 110.456 -174.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -120.52 137.94 54.11 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.4 t -133.98 141.81 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -176.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.4 tp -137.49 125.7 14.46 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.164 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.24 149.59 90.91 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 120.961 1.107 . . . . 0.0 111.496 177.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.564 HD13 HG13 ' A' ' 93' ' ' ILE . 43.7 pt -141.76 170.15 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 171.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -116.44 129.8 56.42 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 168.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.53 125.39 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.603 HD11 HD13 ' A' ' 129' ' ' LEU . 86.5 mt -107.87 116.59 32.24 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 -178.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.9 mt -129.83 122.02 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.03 -120.54 18.82 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -111.09 17.02 20.8 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 122.29 -0.535 . . . . 0.0 111.988 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -119.89 145.82 46.34 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 118.449 0.568 . . . . 0.0 110.513 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -122.96 130.82 53.31 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.42 145.81 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.51 136.92 44.15 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.05 -167.34 12.99 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 177.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.69 155.08 25.43 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 117.35 0.575 . . . . 0.0 110.363 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.564 HG13 HD13 ' A' ' 80' ' ' ILE . 70.0 mt -108.72 142.62 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.7 t -121.48 131.48 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.7 t -142.53 136.66 14.75 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -58.01 154.97 35.86 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 121.077 1.184 . . . . 0.0 111.81 176.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -65.6 -37.41 86.54 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.317 -0.239 . . . . 0.0 110.43 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -94.64 120.59 35.11 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.0 p -130.22 155.07 46.87 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -98.07 -57.86 2.12 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -136.6 170.87 15.36 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.4 p -85.68 148.22 25.99 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.1 m -135.01 175.01 9.97 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 120.57 0.224 . . . . 0.0 110.489 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -107.4 27.93 8.61 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 122.415 -0.178 . . . . 0.0 110.851 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.0 mm -123.4 126.7 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.478 ' CD1' HD11 ' A' ' 48' ' ' LEU . 34.3 pt -125.64 145.77 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -114.6 131.68 56.61 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.498 HD12 HD12 ' A' ' 46' ' ' LEU . 81.9 mt -117.56 149.31 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 pt -119.13 155.33 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 168.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.56 165.98 22.15 Favored Pre-proline 0 N--CA 1.496 1.846 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.246 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -59.14 -30.34 92.87 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 121.151 1.234 . . . . 0.0 111.716 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.23 167.06 23.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 122.248 -0.282 . . . . 0.0 110.732 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -71.15 105.96 3.59 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.61 -33.4 71.44 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 122.067 -0.396 . . . . 0.0 111.402 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -62.65 -35.34 79.31 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 122.182 -0.324 . . . . 0.0 110.954 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -78.18 -48.07 16.67 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -62.61 -33.64 75.4 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.193 -0.317 . . . . 0.0 111.063 -172.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -108.01 8.15 28.18 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.81 46.03 27.24 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 120.979 -1.076 . . . . 0.0 111.819 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.9 mt -91.98 138.22 31.72 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.89 -0.506 . . . . 0.0 110.961 -171.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -114.92 157.49 23.29 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.72 137.77 48.92 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.888 -0.508 . . . . 0.0 111.491 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.92 -22.88 37.73 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -178.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.44 157.42 29.49 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 118.645 1.222 . . . . 0.0 109.952 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.3 t -112.19 133.17 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -174.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.831 HD11 HD11 ' A' ' 46' ' ' LEU . 33.8 pt -128.51 160.59 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -109.06 139.65 43.66 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.302 -175.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.1 pt -109.87 138.44 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.603 HD13 HD11 ' A' ' 83' ' ' LEU . 6.5 tp -108.01 135.56 49.17 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -172.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 52.1 mt -125.5 122.89 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.447 ' HA ' HD23 ' A' ' 4' ' ' LEU . 46.5 mtpt -93.93 147.88 22.68 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 176.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.1 172.41 34.61 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -155.06 173.14 16.99 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 122.355 -0.497 . . . . 0.0 110.353 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -65.01 139.08 58.72 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.674 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -94.39 117.74 30.57 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 N--CA 1.505 2.296 0 CA-C-O 117.912 -1.042 . . . . 0.0 111.707 -179.617 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.7 mtm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.7 t -70.23 -38.9 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -127.14 118.21 23.9 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 131' ' ' LYS . 84.7 mt -110.86 155.01 23.21 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 43.0 ttm -136.2 145.15 45.39 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.7 mm -126.09 134.35 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -176.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.449 HG22 HD22 ' A' ' 48' ' ' LEU . 78.6 mt -130.76 148.31 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -110.78 144.76 39.27 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.5 151.15 21.42 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -106.77 141.85 37.35 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 117.217 0.508 . . . . 0.0 110.263 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.3 121.16 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.75 148.49 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 177.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.4 p -87.08 130.92 34.29 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.05 119.84 0.83 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.1 mt -139.96 33.28 1.96 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 117.205 0.503 . . . . 0.0 110.29 178.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.6 52.49 0.64 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -99.77 32.48 2.86 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 117.179 0.489 . . . . 0.0 110.515 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.21 -139.99 23.25 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -100.94 128.66 46.88 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 117.215 0.507 . . . . 0.0 110.138 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.432 ' HE2' HD11 ' A' ' 22' ' ' LEU . 57.3 t80 -155.0 98.56 2.04 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -108.68 128.9 55.26 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.432 HD11 ' HE2' ' A' ' 20' ' ' TYR . 42.3 mt -100.93 -20.88 15.26 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.7 p -57.51 -23.32 49.5 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.722 -0.611 . . . . 0.0 111.702 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.9 tp -65.51 139.44 97.22 Favored Pre-proline 0 N--CA 1.504 2.253 0 CA-C-O 118.735 -0.65 . . . . 0.0 109.908 174.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -51.25 -54.29 5.67 Favored 'Trans proline' 0 N--CA 1.502 2.019 0 C-N-CA 121.188 1.259 . . . . 0.0 114.155 -175.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.81 -25.94 71.4 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 120.48 0.786 . . . . 0.0 112.303 -163.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -66.31 -47.38 73.75 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.275 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -65.68 -35.57 81.14 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 122.11 -0.369 . . . . 0.0 110.169 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -65.84 -48.3 72.08 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 120.961 -0.295 . . . . 0.0 110.469 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.2 tt -69.06 -36.91 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 C-N-CA 120.64 -0.424 . . . . 0.0 109.936 -176.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.466 ' CE1' HD13 ' A' ' 109' ' ' ILE . 4.2 m-85 -65.65 -42.04 91.86 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 122.18 -0.325 . . . . 0.0 110.479 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -65.7 -32.63 74.29 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 122.219 -0.301 . . . . 0.0 110.785 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -68.89 -40.25 79.3 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.641 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.0 mt -81.66 -36.37 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' A' ' 92' ' ' ALA . 48.4 mt -104.0 -26.35 12.65 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.197 -0.314 . . . . 0.0 111.622 -173.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.02 15.15 73.22 Favored Glycine 0 N--CA 1.495 2.599 0 CA-C-O 119.371 -0.683 . . . . 0.0 111.459 -172.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -151.42 161.43 42.7 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 119.143 1.472 . . . . 0.0 110.765 170.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -94.15 107.88 31.81 Favored Pre-proline 0 N--CA 1.496 1.865 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.834 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.53 158.16 58.39 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 O-C-N 123.272 1.143 . . . . 0.0 110.403 -176.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -74.07 162.95 28.48 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -80.14 79.63 6.67 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.429 0.633 . . . . 0.0 109.732 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.66 172.1 44.39 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 175.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 p -138.01 156.51 47.74 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 117.391 0.596 . . . . 0.0 110.85 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.9 tp -109.4 117.29 33.65 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.98 122.24 41.98 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -176.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.838 HD11 HD11 ' A' ' 126' ' ' ILE . 61.2 mt -120.58 135.79 54.99 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 120.75 0.31 . . . . 0.0 110.617 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -95.97 133.55 40.04 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.449 HD22 HG22 ' A' ' 7' ' ' ILE . 84.6 mt -112.05 160.3 17.63 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 120.633 0.254 . . . . 0.0 110.544 -176.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.61 13.56 13.74 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 171.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -145.44 139.38 26.85 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 118.552 0.614 . . . . 0.0 109.63 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -62.16 147.24 48.27 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 122.115 -0.366 . . . . 0.0 110.901 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -131.95 136.51 47.4 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 120.766 0.317 . . . . 0.0 110.45 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -137.96 125.6 22.24 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 76' ' ' LYS . 20.2 tt -63.89 -24.73 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.219 -177.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -73.53 -1.83 20.2 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -91.33 -14.04 31.48 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 118.787 0.721 . . . . 0.0 111.484 169.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.42 ' CE1' HG21 ' A' ' 130' ' ' ILE . 71.3 m-85 -114.5 175.13 5.62 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.614 -0.679 . . . . 0.0 109.315 174.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -92.49 101.99 14.44 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -110.54 177.39 4.7 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 120.638 0.256 . . . . 0.0 110.672 -177.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.6 mt -112.09 132.88 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -105.9 143.87 33.43 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.3 p -121.95 136.44 54.92 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 120.624 0.25 . . . . 0.0 110.679 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.55 172.72 12.52 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 120.786 0.327 . . . . 0.0 111.642 -170.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -67.97 140.16 56.39 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -138.6 163.57 31.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.218 -0.301 . . . . 0.0 110.758 -175.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -123.66 147.47 47.37 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 122.281 -0.262 . . . . 0.0 110.401 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -149.77 136.92 19.7 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.7 32.2 9.04 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.82 -0.55 . . . . 0.0 112.162 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.22 17.59 77.82 Favored Glycine 0 N--CA 1.497 2.727 0 CA-C-O 119.614 -0.548 . . . . 0.0 111.823 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -123.08 140.95 52.49 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.577 1.188 . . . . 0.0 109.803 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.86 132.56 38.16 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 120.618 0.247 . . . . 0.0 110.421 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.22 142.7 49.66 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -86.29 157.81 19.83 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 120.737 0.303 . . . . 0.0 110.336 -169.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.5 157.49 50.02 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -139.51 157.13 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 122.388 -0.478 . . . . 0.0 110.488 -174.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HB3' HD13 ' A' ' 54' ' ' ILE . 68.8 mttt -114.22 138.42 50.5 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.6 t -133.63 139.05 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.4 tp -137.09 125.6 14.85 Favored Pre-proline 0 N--CA 1.497 1.887 0 CA-C-O 118.533 -0.746 . . . . 0.0 110.125 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -63.39 149.63 90.67 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 O-C-N 123.158 1.083 . . . . 0.0 111.457 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.54 HD13 HG13 ' A' ' 93' ' ' ILE . 43.5 pt -141.9 170.01 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 122.286 -0.259 . . . . 0.0 110.38 171.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -115.31 130.03 56.78 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 168.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.68 124.17 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.412 HD11 HD13 ' A' ' 129' ' ' LEU . 84.3 mt -107.99 116.82 32.66 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.5 mt -129.93 121.93 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.76 -120.23 18.09 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -111.18 17.1 20.64 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 122.354 -0.498 . . . . 0.0 111.806 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -119.76 144.62 47.18 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 118.604 0.638 . . . . 0.0 110.497 -175.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -123.12 129.91 52.08 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -125.75 146.09 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.59 136.24 43.95 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.74 -168.2 13.02 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.591 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.56 154.98 25.54 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 117.307 0.553 . . . . 0.0 110.369 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.54 HG13 HD13 ' A' ' 80' ' ' ILE . 69.3 mt -108.71 141.53 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.42 130.83 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -141.6 134.37 14.1 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -57.33 154.81 32.96 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 121.055 1.17 . . . . 0.0 111.91 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -64.85 -34.5 78.52 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.688 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -86.71 117.75 25.67 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 m -132.76 139.86 47.78 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -96.23 -57.54 2.31 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -132.6 -176.78 4.21 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.2 p -93.54 150.03 20.76 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.3 m -135.06 170.09 16.44 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.652 0.263 . . . . 0.0 110.294 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -107.82 27.72 8.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.363 -0.211 . . . . 0.0 110.875 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -123.9 127.87 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 27.7 pt -126.19 145.35 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 177.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -114.94 130.61 56.96 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.47 HD12 HD12 ' A' ' 46' ' ' LEU . 82.5 mt -115.7 150.98 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -174.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.466 HD13 ' CE1' ' A' ' 31' ' ' PHE . 11.2 pt -116.47 155.64 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 168.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.49 164.92 27.93 Favored Pre-proline 0 N--CA 1.496 1.83 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.315 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.57 -30.75 93.15 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.071 1.181 . . . . 0.0 111.653 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.43 167.06 23.39 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.322 -0.236 . . . . 0.0 110.773 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -71.29 105.22 3.4 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 120.875 0.369 . . . . 0.0 110.042 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.45 -33.58 71.45 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.043 -0.41 . . . . 0.0 111.535 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -62.96 -35.34 79.82 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 122.11 -0.369 . . . . 0.0 110.929 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -78.3 -47.94 16.75 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -62.54 -34.15 76.36 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 122.221 -0.299 . . . . 0.0 111.028 -172.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -108.1 8.49 28.17 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 51.83 47.23 25.19 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.148 -0.97 . . . . 0.0 111.849 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.9 mt -92.09 138.14 31.78 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.917 -0.49 . . . . 0.0 111.036 -170.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -115.67 158.95 22.0 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -56.06 138.17 49.86 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.893 -0.504 . . . . 0.0 111.506 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.58 -22.95 37.6 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.4 154.93 37.02 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 118.597 1.198 . . . . 0.0 110.026 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.6 t -112.05 133.94 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.838 HD11 HD11 ' A' ' 46' ' ' LEU . 34.8 pt -128.82 160.35 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -109.2 140.3 42.99 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.237 -175.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.0 pt -111.84 138.1 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.412 HD13 HD11 ' A' ' 83' ' ' LEU . 6.2 tp -109.03 132.78 53.78 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -173.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.42 HG21 ' CE1' ' A' ' 57' ' ' PHE . 48.2 mt -125.75 130.86 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.429 ' HA ' HD23 ' A' ' 4' ' ' LEU . 83.0 mttt -93.09 155.09 17.72 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 173.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -156.95 123.04 1.24 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -141.41 129.31 21.83 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 122.378 -0.484 . . . . 0.0 109.844 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -66.61 -37.74 85.51 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.621 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -67.42 -35.34 79.07 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.285 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.116 179.728 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptp . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.5 t -116.38 135.65 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -127.95 132.24 49.25 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.409 HD22 ' HG2' ' A' ' 131' ' ' LYS . 81.8 mt -110.84 147.51 34.38 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -110.0 141.0 43.4 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.2 mm -126.19 135.59 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.496 HG22 HD22 ' A' ' 48' ' ' LEU . 70.3 mt -128.16 147.73 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -106.01 138.56 41.98 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.248 -0.283 . . . . 0.0 110.276 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.34 149.09 19.72 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -106.58 142.16 36.69 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 117.237 0.519 . . . . 0.0 110.226 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.19 122.49 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.8 m -124.97 151.27 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 176.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.5 p -86.27 135.18 33.65 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.11 119.91 0.84 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.9 tp -155.11 -46.84 0.08 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.333 -0.51 . . . . 0.0 110.399 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.8 -33.11 86.36 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -92.44 135.17 34.27 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 117.344 0.572 . . . . 0.0 109.741 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.48 70.02 1.31 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -176.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -85.49 135.41 33.85 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 122.305 -0.526 . . . . 0.0 110.437 -174.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -155.02 159.21 40.15 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -114.81 127.51 55.76 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.309 -0.244 . . . . 0.0 110.437 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.2 mt -99.84 -25.59 14.3 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 122.368 -0.208 . . . . 0.0 111.296 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.5 p -57.84 -20.22 34.68 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.924 -0.485 . . . . 0.0 112.244 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.6 tp -63.1 138.69 97.4 Favored Pre-proline 0 N--CA 1.504 2.274 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.256 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -52.8 -48.83 19.98 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 121.099 1.199 . . . . 0.0 113.829 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.71 -37.26 95.68 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 120.653 0.902 . . . . 0.0 112.232 -171.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -65.84 -43.35 88.76 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 122.201 -0.312 . . . . 0.0 110.573 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -66.11 -38.73 88.94 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 122.057 -0.402 . . . . 0.0 110.186 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -65.65 -45.83 81.49 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 122.204 -0.31 . . . . 0.0 110.578 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.1 tt -68.91 -34.77 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -177.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CE1' HD13 ' A' ' 109' ' ' ILE . 3.6 m-85 -65.87 -44.67 84.7 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 122.121 -0.362 . . . . 0.0 110.384 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -65.57 -31.79 73.03 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 122.225 -0.297 . . . . 0.0 110.791 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -68.72 -40.16 80.08 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.586 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.1 mt -81.65 -36.64 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' A' ' 92' ' ' ALA . 46.5 mt -103.91 -26.22 12.74 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.255 -0.278 . . . . 0.0 111.609 -174.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.08 15.46 72.25 Favored Glycine 0 N--CA 1.495 2.595 0 CA-C-O 119.312 -0.715 . . . . 0.0 111.415 -172.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -151.28 160.84 43.59 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.169 1.484 . . . . 0.0 110.751 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -93.53 108.16 31.9 Favored Pre-proline 0 N--CA 1.496 1.857 0 CA-C-O 118.629 -0.701 . . . . 0.0 109.747 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.08 158.2 58.0 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 O-C-N 123.237 1.124 . . . . 0.0 110.534 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -73.6 163.41 28.04 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.29 79.56 6.86 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.541 0.686 . . . . 0.0 109.607 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.39 171.22 43.02 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -138.01 158.46 44.27 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 117.441 0.62 . . . . 0.0 110.818 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.8 tp -109.1 116.01 31.14 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 170.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.456 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.7 m120 -98.26 121.58 40.37 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -177.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.539 HD11 HD11 ' A' ' 126' ' ' ILE . 60.5 mt -120.67 136.81 54.74 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.703 0.287 . . . . 0.0 110.639 -177.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' HG11 ' A' ' 12' ' ' VAL . 65.5 tttt -96.03 131.91 41.93 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.496 HD22 HG22 ' A' ' 7' ' ' ILE . 83.6 mt -110.7 160.25 16.88 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 120.603 0.239 . . . . 0.0 110.472 -176.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.11 13.1 13.91 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 172.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -145.63 141.69 28.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.712 -0.618 . . . . 0.0 109.542 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -64.11 147.04 53.15 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.196 -0.315 . . . . 0.0 110.497 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -131.83 135.67 46.91 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 120.749 0.309 . . . . 0.0 110.543 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -138.04 125.39 21.83 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.3 tt -63.52 -23.13 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.397 -176.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -73.33 -2.85 23.75 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 122.014 -0.429 . . . . 0.0 112.079 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -90.56 -13.93 33.56 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.878 0.763 . . . . 0.0 111.462 171.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.443 ' CE1' HG21 ' A' ' 130' ' ' ILE . 75.8 m-85 -114.75 175.02 5.67 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 118.579 0.627 . . . . 0.0 109.338 174.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -92.54 101.98 14.42 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -109.32 176.39 5.1 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 120.563 0.221 . . . . 0.0 110.538 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -110.8 131.57 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -105.89 142.89 34.83 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.5 p -121.42 138.68 54.17 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.808 0.337 . . . . 0.0 110.688 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -76.79 172.71 12.65 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 120.858 0.361 . . . . 0.0 111.762 -168.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -67.96 141.22 56.37 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -135.95 167.13 21.79 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.557 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -125.75 149.01 48.9 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.888 0.375 . . . . 0.0 110.6 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -148.86 135.75 19.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 51.96 32.83 10.63 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.69 -0.631 . . . . 0.0 112.114 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.06 17.0 79.04 Favored Glycine 0 N--CA 1.496 2.682 0 CA-C-O 119.635 -0.536 . . . . 0.0 111.846 176.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -121.75 140.62 52.11 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 118.6 1.2 . . . . 0.0 109.699 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -93.57 131.97 38.32 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.393 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -121.25 145.33 47.97 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -85.72 156.61 20.56 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.808 0.337 . . . . 0.0 110.448 -167.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.42 162.93 43.49 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.61 155.52 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 122.4 -0.471 . . . . 0.0 110.38 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -114.43 137.29 52.02 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.2 t -134.0 140.93 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.1 tp -136.84 125.62 15.15 Favored Pre-proline 0 N--CA 1.496 1.86 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.108 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -63.39 149.75 90.35 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 120.971 1.114 . . . . 0.0 111.441 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.528 HD13 HG13 ' A' ' 93' ' ' ILE . 43.5 pt -141.88 170.0 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 120.712 0.291 . . . . 0.0 110.317 171.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -113.95 131.87 56.16 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 167.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.0 mt -106.64 123.17 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -175.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.434 HD11 HD12 ' A' ' 129' ' ' LEU . 85.7 mt -107.94 116.86 32.72 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.3 mt -130.06 121.98 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.28 -119.68 16.66 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -111.09 17.0 20.81 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.373 -0.486 . . . . 0.0 111.841 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -120.42 143.91 48.22 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 118.575 0.625 . . . . 0.0 110.52 -174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -123.1 129.44 51.45 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -125.88 146.54 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.52 136.38 44.09 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.92 -168.52 12.83 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.622 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.54 154.92 25.49 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 117.309 0.554 . . . . 0.0 110.286 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.528 HG13 HD13 ' A' ' 80' ' ' ILE . 67.3 mt -108.62 141.61 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.8 t -120.73 132.28 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -175.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.0 t -142.37 133.27 12.8 Favored Pre-proline 0 N--CA 1.497 1.88 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.54 155.73 29.86 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 121.081 1.187 . . . . 0.0 111.885 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -64.59 -34.05 77.35 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 122.298 -0.251 . . . . 0.0 110.659 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -89.13 111.29 22.03 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.284 -0.26 . . . . 0.0 110.325 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.5 m -131.77 134.73 46.15 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -97.08 -56.16 2.63 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.31 -0.244 . . . . 0.0 110.344 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -121.99 -179.36 4.12 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.7 m -104.87 152.73 22.26 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.7 p -135.01 172.81 12.49 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 120.664 0.269 . . . . 0.0 110.562 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -105.63 24.62 11.93 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.854 172.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.9 mm -121.08 126.98 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.486 ' CD1' HD11 ' A' ' 48' ' ' LEU . 34.5 pt -127.42 148.41 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -116.62 130.86 56.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.517 HD12 HD12 ' A' ' 46' ' ' LEU . 82.4 mt -115.08 150.42 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -175.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.463 HD13 ' CE1' ' A' ' 31' ' ' PHE . 11.0 pt -115.99 155.88 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 168.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.53 165.84 22.95 Favored Pre-proline 0 N--CA 1.496 1.831 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.279 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.37 -30.37 92.54 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 121.084 1.189 . . . . 0.0 111.667 177.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.42 167.05 23.41 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 122.28 -0.262 . . . . 0.0 110.652 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -71.02 105.5 3.34 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.63 -33.93 72.15 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 122.105 -0.372 . . . . 0.0 111.462 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -63.16 -34.75 78.29 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 122.143 -0.348 . . . . 0.0 110.892 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -78.2 -48.99 14.63 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -62.51 -34.09 76.19 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 122.188 -0.32 . . . . 0.0 111.102 -172.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -108.05 8.15 28.1 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.85 50.15 19.25 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 120.986 -1.071 . . . . 0.0 111.917 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 48.2 mt -91.08 138.19 31.79 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.871 -0.518 . . . . 0.0 110.857 -172.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -115.19 156.74 24.77 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.77 137.95 48.84 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.9 -0.5 . . . . 0.0 111.5 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.9 -22.91 37.59 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.39 153.99 39.68 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-N 118.641 1.221 . . . . 0.0 110.005 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.09 134.01 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.539 HD11 HD11 ' A' ' 46' ' ' LEU . 34.7 pt -130.3 162.25 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 174.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -110.02 139.18 45.42 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.365 -174.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 pt -111.73 137.75 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.462 HD23 ' C ' ' A' ' 129' ' ' LEU . 8.5 tt -111.0 133.36 53.45 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -175.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.443 HG21 ' CE1' ' A' ' 57' ' ' PHE . 43.6 mt -119.98 122.69 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.409 ' HG2' HD22 ' A' ' 4' ' ' LEU . 90.9 mttt -93.53 152.6 18.94 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.07 123.01 1.23 Allowed Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -94.36 -34.33 12.83 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 117.205 0.503 . . . . 0.0 110.282 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -109.62 145.3 36.66 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -138.34 -48.26 0.53 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.42 179.904 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.7 mtp . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 2' ' ' VAL . 12.2 p -152.53 68.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 120.931 0.396 . . . . 0.0 110.043 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -98.91 130.69 45.31 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.121 -0.362 . . . . 0.0 110.165 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.4 mt -110.92 149.54 30.49 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.443 ' O ' HD13 ' A' ' 6' ' ' ILE . 45.5 ttm -106.4 144.51 32.98 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.443 HD13 ' O ' ' A' ' 5' ' ' MET . 48.4 mm -128.9 128.8 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.517 HG22 HD22 ' A' ' 48' ' ' LEU . 72.9 mt -130.02 148.32 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 176.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -105.45 140.95 37.77 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.16 150.71 20.27 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -106.27 141.74 37.12 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 117.176 0.488 . . . . 0.0 110.186 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.15 121.78 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.8 m -126.32 158.84 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 177.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.4 t -86.11 126.12 33.97 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.332 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.06 119.99 0.84 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.3 tp -155.11 -47.8 0.08 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 122.352 -0.499 . . . . 0.0 110.427 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -100.73 37.38 3.61 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -68.52 -35.32 77.29 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 117.306 0.553 . . . . 0.0 109.975 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -150.02 -159.23 8.58 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -97.12 109.49 22.23 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 122.327 -0.513 . . . . 0.0 109.958 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.446 ' CE1' HD21 ' A' ' 22' ' ' LEU . 56.1 t80 -155.03 112.16 3.32 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -179.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.22 135.5 53.84 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.446 HD21 ' CE1' ' A' ' 20' ' ' TYR . 83.2 mt -104.87 0.08 27.61 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.2 p -95.21 24.89 4.62 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 119.008 0.822 . . . . 0.0 111.614 -174.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.3 mp -105.07 157.51 34.11 Favored Pre-proline 0 N--CA 1.496 1.831 0 CA-C-O 118.94 -0.552 . . . . 0.0 109.962 176.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.85 -49.42 16.76 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 121.107 1.205 . . . . 0.0 113.479 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -56.32 -44.81 42.74 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 120.557 0.838 . . . . 0.0 112.183 -171.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -65.34 -41.52 93.84 Favored 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.658 -174.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.02 -40.83 91.39 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 122.033 -0.417 . . . . 0.0 110.311 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -65.26 -45.99 82.31 Favored 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.562 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.2 tt -68.79 -37.02 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.013 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -65.98 -41.89 90.55 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.075 -0.391 . . . . 0.0 110.471 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -65.33 -36.93 85.53 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 122.151 -0.343 . . . . 0.0 110.366 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -68.24 -38.67 82.09 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.505 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.2 mt -81.16 -35.68 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' A' ' 92' ' ' ALA . 45.3 mt -103.92 -26.26 12.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.102 -0.373 . . . . 0.0 111.696 -173.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.39 12.94 79.7 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -171.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -150.91 160.57 43.82 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 119.068 1.434 . . . . 0.0 110.306 170.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -93.39 109.35 39.87 Favored Pre-proline 0 N--CA 1.496 1.849 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.816 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.422 ' CB ' HD12 ' A' ' 109' ' ' ILE . 64.2 Cg_endo -67.25 159.76 50.73 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 O-C-N 123.274 1.144 . . . . 0.0 110.502 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -73.81 163.29 28.14 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -80.25 79.56 6.81 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.511 0.672 . . . . 0.0 109.64 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.48 172.89 45.32 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 175.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 p -138.09 157.41 46.38 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 117.343 0.571 . . . . 0.0 110.804 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.414 HD22 HD12 ' A' ' 114' ' ' LEU . 32.6 tp -109.61 115.02 29.13 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 170.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.423 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.6 m120 -98.72 120.05 38.49 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.78 HD11 HD11 ' A' ' 126' ' ' ILE . 62.6 mt -119.98 135.95 54.72 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 120.697 0.284 . . . . 0.0 110.631 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HB2' HG11 ' A' ' 12' ' ' VAL . 79.3 tttt -95.98 132.17 41.59 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.517 HD22 HG22 ' A' ' 7' ' ' ILE . 83.8 mt -110.95 160.27 16.96 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 120.605 0.24 . . . . 0.0 110.475 -176.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -88.93 12.73 14.52 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 172.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -145.49 142.44 29.23 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 118.555 0.616 . . . . 0.0 109.466 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -64.43 146.92 53.75 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.413 178.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -134.4 137.14 43.83 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.733 0.301 . . . . 0.0 110.654 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -138.16 129.58 27.71 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.2 tt -63.95 -22.22 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.337 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -74.42 -0.97 19.06 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.933 -0.479 . . . . 0.0 112.235 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -91.04 -14.74 30.78 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 118.918 0.781 . . . . 0.0 111.445 170.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -117.21 175.11 5.76 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 118.679 0.672 . . . . 0.0 109.467 174.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -90.85 102.75 15.51 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -109.67 177.03 4.86 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 120.546 0.212 . . . . 0.0 110.471 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -110.46 130.8 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -106.0 143.75 33.7 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.8 p -121.69 138.02 54.52 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.74 0.305 . . . . 0.0 110.751 177.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.87 172.67 12.76 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 120.864 0.364 . . . . 0.0 111.687 -169.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -67.59 140.79 56.93 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -136.97 167.01 22.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 122.208 -0.308 . . . . 0.0 110.544 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -125.11 149.08 48.22 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 120.861 0.362 . . . . 0.0 110.607 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -148.35 135.24 20.03 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 51.73 33.44 11.07 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.806 -0.559 . . . . 0.0 112.082 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.09 16.94 79.09 Favored Glycine 0 N--CA 1.498 2.771 0 CA-C-O 119.599 -0.556 . . . . 0.0 111.782 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -122.28 140.94 52.04 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 118.694 1.247 . . . . 0.0 109.649 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -93.25 131.85 37.98 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 120.653 0.264 . . . . 0.0 110.493 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -120.76 144.08 48.47 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -86.37 156.72 20.08 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 120.784 0.326 . . . . 0.0 110.481 -168.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.18 161.86 44.12 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.39 156.0 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 122.294 -0.533 . . . . 0.0 110.364 -174.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -116.57 137.19 52.37 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.7 t -134.12 142.1 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.0 tp -137.39 125.64 14.54 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-O 118.61 -0.71 . . . . 0.0 110.094 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -63.43 148.71 92.48 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 120.955 1.103 . . . . 0.0 111.42 177.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.548 HD13 HG13 ' A' ' 93' ' ' ILE . 43.8 pt -141.38 170.06 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 120.674 0.274 . . . . 0.0 110.356 172.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -114.45 131.76 56.5 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 168.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.9 mt -106.25 124.04 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -175.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -109.08 116.26 31.61 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.2 mt -130.0 121.93 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.41 -119.78 16.87 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -111.07 17.0 20.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.208 -0.584 . . . . 0.0 111.868 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -120.79 144.25 48.41 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 118.547 0.612 . . . . 0.0 110.503 -174.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -123.17 130.19 52.42 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -126.45 148.33 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.51 137.58 44.51 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.23 -169.9 14.46 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 177.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.552 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.32 154.88 25.86 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 117.339 0.57 . . . . 0.0 110.235 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.548 HG13 HD13 ' A' ' 80' ' ' ILE . 70.6 mt -108.79 142.26 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.35 131.56 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -142.25 132.53 12.57 Favored Pre-proline 0 N--CA 1.498 1.926 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -58.09 154.86 37.04 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 121.063 1.175 . . . . 0.0 111.796 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -64.99 -33.61 76.45 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.228 -0.295 . . . . 0.0 110.77 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -87.64 114.44 24.26 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 m -132.2 138.83 48.12 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -96.63 -57.04 2.4 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -129.42 -178.73 4.79 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.6 m -98.03 153.04 18.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.7 t -134.98 172.22 13.31 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 120.586 0.232 . . . . 0.0 110.563 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -105.69 24.43 12.27 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.963 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -120.65 127.13 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.465 HD13 HD11 ' A' ' 48' ' ' LEU . 34.4 pt -125.83 145.76 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -115.39 130.91 57.04 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.498 HD12 HD12 ' A' ' 46' ' ' LEU . 81.3 mt -116.47 151.63 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -174.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.422 HD12 ' CB ' ' A' ' 39' ' ' PRO . 11.7 pt -117.73 156.12 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 168.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.52 165.65 24.0 Favored Pre-proline 0 N--CA 1.494 1.75 0 CA-C-O 119.078 -0.487 . . . . 0.0 110.311 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -59.48 -30.8 93.46 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 121.117 1.211 . . . . 0.0 111.576 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.31 167.02 23.44 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 122.299 -0.25 . . . . 0.0 110.701 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -71.57 105.24 3.57 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.414 HD12 HD22 ' A' ' 44' ' ' LEU . 80.3 mt -59.52 -33.67 71.66 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 122.144 -0.347 . . . . 0.0 111.471 -177.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -63.04 -34.91 78.58 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 122.124 -0.36 . . . . 0.0 110.951 -175.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.2 -47.7 17.46 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -62.45 -34.99 77.89 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 122.211 -0.305 . . . . 0.0 111.038 -172.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -108.03 9.94 28.35 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 51.81 47.92 23.84 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.226 -0.921 . . . . 0.0 111.972 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 48.6 mt -91.37 138.25 31.73 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.958 -0.464 . . . . 0.0 110.798 -172.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -114.12 158.62 21.04 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.87 138.07 49.11 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.794 -0.566 . . . . 0.0 111.429 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.53 -22.96 37.59 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.4 155.59 34.93 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-N 118.648 1.224 . . . . 0.0 110.039 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.41 134.09 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -174.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.78 HD11 HD11 ' A' ' 46' ' ' LEU . 34.3 pt -128.76 160.73 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -109.9 137.63 47.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.205 -0.31 . . . . 0.0 110.179 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -113.11 137.25 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.468 HD23 ' C ' ' A' ' 129' ' ' LEU . 9.2 tt -110.26 126.76 54.5 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -178.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.8 mt -114.52 126.67 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.11 145.49 24.36 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.12 174.59 34.69 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -143.88 135.87 26.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 122.362 -0.493 . . . . 0.0 110.199 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -108.5 142.55 38.73 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -98.34 149.89 22.15 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.212 179.927 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.4 t -113.02 133.77 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -99.79 154.97 17.91 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 131' ' ' LYS . 86.0 mt -133.34 150.87 51.83 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.7 ttm -128.35 146.42 50.78 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.0 mm -126.24 133.34 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -177.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.2 mt -129.81 149.73 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -105.85 141.87 36.54 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.25 150.45 20.45 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.52 142.18 36.6 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 117.217 0.508 . . . . 0.0 110.278 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.1 t -63.04 123.22 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -122.37 155.13 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 176.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.4 p -85.48 132.82 34.14 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.352 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.0 119.96 0.84 Allowed Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -153.29 137.92 16.9 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 117.208 0.504 . . . . 0.0 110.239 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.21 36.08 32.18 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -107.86 149.27 28.48 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 117.174 0.487 . . . . 0.0 110.123 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.12 -163.75 39.88 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -141.79 38.69 1.65 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 117.215 0.508 . . . . 0.0 110.432 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -116.59 132.09 56.77 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 122.249 -0.282 . . . . 0.0 110.438 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.45 ' HB2' HD12 ' A' ' 24' ' ' LEU . 97.8 m-85 -104.26 123.81 48.02 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.8 mt -89.34 -27.02 20.77 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 121.171 -0.211 . . . . 0.0 111.34 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.7 p -58.84 -24.07 61.52 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.907 -0.495 . . . . 0.0 111.878 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 21' ' ' PHE . 58.5 mt -64.6 154.9 83.44 Favored Pre-proline 0 N--CA 1.502 2.163 0 CA-C-O 119.087 -0.482 . . . . 0.0 110.648 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -54.74 -49.45 16.7 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 O-C-N 123.429 1.226 . . . . 0.0 113.77 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.13 -45.5 38.7 Favored 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 120.92 1.08 . . . . 0.0 113.166 -169.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -64.83 -42.92 94.55 Favored 'General case' 0 N--CA 1.504 2.275 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.681 -175.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.8 tttp -65.38 -40.14 93.13 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 122.109 -0.369 . . . . 0.0 110.283 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -65.7 -46.63 78.29 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 122.226 -0.296 . . . . 0.0 110.53 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.1 tt -69.21 -35.53 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 C-N-CA 120.632 -0.427 . . . . 0.0 109.989 -176.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -65.89 -43.65 87.64 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 122.195 -0.316 . . . . 0.0 110.589 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -65.76 -32.64 74.29 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.73 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -68.7 -40.15 80.17 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.605 178.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.8 mt -81.56 -35.78 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -176.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.428 HD21 ' HB2' ' A' ' 92' ' ' ALA . 47.1 mt -103.31 -26.29 12.99 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.183 -0.323 . . . . 0.0 111.767 -173.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.7 15.3 75.97 Favored Glycine 0 N--CA 1.493 2.492 0 CA-C-O 119.3 -0.722 . . . . 0.0 111.371 -173.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -150.83 162.31 40.99 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 119.166 1.483 . . . . 0.0 110.775 171.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -94.15 106.74 24.3 Favored Pre-proline 0 N--CA 1.497 1.888 0 CA-C-O 118.707 -0.663 . . . . 0.0 109.854 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.9 158.72 56.77 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 O-C-N 123.245 1.129 . . . . 0.0 110.302 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -73.8 160.4 31.53 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -80.29 79.67 6.83 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.518 0.675 . . . . 0.0 109.778 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.19 175.8 47.66 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 175.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 p -138.02 154.53 49.3 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 117.367 0.584 . . . . 0.0 110.774 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.506 HD22 HD12 ' A' ' 114' ' ' LEU . 30.6 tp -109.32 119.08 38.4 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 170.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.536 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.5 m120 -100.64 122.69 43.73 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.168 -175.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.806 HD11 HD11 ' A' ' 126' ' ' ILE . 56.2 mt -120.53 136.19 54.85 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 120.66 0.267 . . . . 0.0 110.549 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HB2' HG11 ' A' ' 12' ' ' VAL . 63.5 tttt -96.24 133.92 39.98 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.493 HD11 HD13 ' A' ' 106' ' ' ILE . 83.5 mt -111.95 160.22 17.64 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 120.617 0.246 . . . . 0.0 110.465 -176.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.04 12.8 14.55 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 172.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -145.79 141.98 28.45 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.661 -0.649 . . . . 0.0 109.388 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.24 146.81 52.62 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 122.225 -0.297 . . . . 0.0 110.628 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -132.16 137.45 47.65 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 120.699 0.285 . . . . 0.0 110.663 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -138.0 125.53 22.09 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 174.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.2 -22.51 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.384 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -74.48 -1.08 19.69 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.978 -0.451 . . . . 0.0 112.187 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -90.75 -14.48 31.99 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 118.922 0.783 . . . . 0.0 111.524 170.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.96 175.18 5.7 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 118.597 0.635 . . . . 0.0 109.463 174.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -91.74 103.24 15.83 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -110.59 178.84 4.24 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 120.587 0.232 . . . . 0.0 110.435 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -111.74 130.2 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.97 142.65 35.32 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.2 p -122.79 136.35 54.84 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 120.762 0.315 . . . . 0.0 110.78 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -75.34 172.67 12.05 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 120.909 0.385 . . . . 0.0 111.754 -170.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -67.8 141.15 56.6 Favored 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -137.04 167.0 22.37 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.543 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -125.58 149.52 48.28 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 120.907 0.384 . . . . 0.0 110.548 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -147.9 134.15 19.47 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 51.69 33.82 11.69 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.702 -0.624 . . . . 0.0 112.157 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.18 16.64 79.39 Favored Glycine 0 N--CA 1.496 2.682 0 CA-C-O 119.623 -0.543 . . . . 0.0 111.875 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -121.15 139.84 52.81 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.677 1.239 . . . . 0.0 109.623 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.51 132.48 37.76 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 121.091 -0.243 . . . . 0.0 110.505 -176.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -121.24 144.14 48.77 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -86.08 157.04 20.15 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.53 -168.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.56 158.59 49.11 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -176.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.49 154.98 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 122.351 -0.499 . . . . 0.0 110.445 -174.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -116.04 136.43 53.04 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.4 t -133.98 139.95 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -175.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.7 tp -137.12 125.65 14.86 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.053 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -63.4 149.76 90.31 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 O-C-N 123.182 1.096 . . . . 0.0 111.444 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.507 HD13 HG13 ' A' ' 93' ' ' ILE . 43.1 pt -141.7 170.08 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 171.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -113.9 130.42 56.5 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 168.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -105.96 123.64 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -174.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.5 mt -108.52 116.32 31.75 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -129.87 121.91 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.72 -120.29 18.34 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -111.18 17.05 20.69 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 122.316 -0.52 . . . . 0.0 111.932 175.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -119.34 143.99 47.1 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 118.465 0.575 . . . . 0.0 110.498 -175.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -123.16 130.08 52.29 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.3 mt -126.81 146.32 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.83 135.98 43.47 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.01 -167.29 12.12 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.428 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -160.1 155.95 26.03 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 117.374 0.587 . . . . 0.0 110.447 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.507 HG13 HD13 ' A' ' 80' ' ' ILE . 67.5 mt -108.73 141.9 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -121.88 131.42 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.1 t -141.01 133.87 14.41 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -57.82 155.04 34.47 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 120.996 1.131 . . . . 0.0 111.877 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -64.78 -34.52 78.55 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 122.365 -0.209 . . . . 0.0 110.723 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -87.33 118.39 26.73 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.35 -176.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.2 p -131.98 160.37 36.02 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -126.77 -42.91 1.74 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.308 -0.245 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -136.88 176.71 8.46 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.2 m -99.61 147.75 25.04 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.0 m -135.07 171.99 13.64 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 120.594 0.235 . . . . 0.0 110.517 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -107.19 27.14 9.34 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.408 -0.183 . . . . 0.0 110.94 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -122.91 127.19 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.493 HD13 HD11 ' A' ' 48' ' ' LEU . 34.6 pt -124.81 143.75 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 177.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -114.77 131.56 56.75 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.477 HD12 HD12 ' A' ' 46' ' ' LEU . 81.9 mt -117.22 152.05 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -173.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.5 pt -116.18 156.17 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 168.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.59 164.15 32.27 Favored Pre-proline 0 N--CA 1.496 1.827 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.334 -176.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.15 -32.41 94.54 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 121.062 1.175 . . . . 0.0 111.479 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.98 159.26 43.21 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.266 -0.272 . . . . 0.0 110.862 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.6 pttt -62.5 103.92 0.46 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.413 0.625 . . . . 0.0 111.203 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.506 HD12 HD22 ' A' ' 44' ' ' LEU . 82.7 mt -59.6 -32.51 70.46 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.869 -0.519 . . . . 0.0 111.692 -177.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -61.9 -37.28 84.02 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 122.098 -0.376 . . . . 0.0 111.204 -171.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -78.27 -46.41 20.34 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -62.37 -34.59 76.99 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 122.208 -0.307 . . . . 0.0 111.024 -172.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -108.13 8.23 27.97 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 51.72 50.65 18.27 Favored 'General case' 0 N--CA 1.508 2.436 0 CA-C-N 119.309 0.959 . . . . 0.0 111.945 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 48.2 mt -90.39 138.16 31.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.832 -0.542 . . . . 0.0 110.818 -171.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -117.03 155.29 29.46 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 175.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -55.99 138.01 49.8 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.857 -0.527 . . . . 0.0 111.468 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.98 -22.97 37.32 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.31 154.59 37.83 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 118.655 1.227 . . . . 0.0 110.038 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -111.92 133.78 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.806 HD11 HD11 ' A' ' 46' ' ' LEU . 34.4 pt -128.56 160.95 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -109.93 138.13 46.73 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -112.26 137.17 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.463 HD23 ' C ' ' A' ' 129' ' ' LEU . 10.0 tt -110.54 126.39 54.35 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -177.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 38.3 mt -114.09 127.96 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.421 ' HA ' HD23 ' A' ' 4' ' ' LEU . 55.2 mttm -94.34 120.88 35.24 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.15 -177.34 30.18 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -134.27 122.19 22.36 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 117.144 0.472 . . . . 0.0 110.11 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -131.23 128.74 40.55 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -100.03 147.07 26.02 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.518 179.801 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mmm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.1 t -117.62 136.2 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -98.36 125.51 43.52 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.452 HD13 HD21 ' A' ' 129' ' ' LEU . 82.9 mt -110.92 154.06 24.61 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 43.1 ttm -103.57 142.74 33.78 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.2 mm -125.55 130.01 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.437 HG22 HD22 ' A' ' 48' ' ' LEU . 77.6 mt -129.69 149.02 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -104.69 140.76 37.58 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.07 150.41 19.98 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -105.63 142.36 35.5 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 117.28 0.54 . . . . 0.0 110.227 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.71 120.99 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.45 137.78 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 122.308 -0.245 . . . . 0.0 110.375 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.1 m -88.04 111.85 21.98 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.06 120.02 0.84 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -139.88 108.01 5.76 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 122.426 -0.455 . . . . 0.0 109.928 177.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.99 51.38 0.53 Allowed Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -99.95 32.64 2.85 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 117.194 0.497 . . . . 0.0 110.357 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.16 -139.92 21.66 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 51.4 mtm180 -92.51 130.63 38.12 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 117.177 0.489 . . . . 0.0 109.988 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -117.86 130.87 56.52 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -153.25 97.85 2.21 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.658 HD23 ' O ' ' A' ' 22' ' ' LEU . 1.7 tt -90.61 -14.32 32.66 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 122.283 -0.261 . . . . 0.0 111.591 177.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 m -54.73 -22.47 14.12 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.334 -0.854 . . . . 0.0 112.285 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.419 HD21 ' CD2' ' A' ' 67' ' ' PHE . 6.0 tp -59.86 137.71 90.44 Favored Pre-proline 0 N--CA 1.507 2.398 0 CA-C-O 118.736 -0.65 . . . . 0.0 110.584 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -51.92 -47.54 26.04 Favored 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 121.099 1.199 . . . . 0.0 113.973 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.629 ' O ' HG22 ' A' ' 30' ' ' ILE . 31.2 Cg_exo -56.18 -32.08 85.99 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 CA-C-N 119.472 0.847 . . . . 0.0 112.09 -172.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -67.47 -52.07 43.69 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.197 -176.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -64.77 -39.83 94.26 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.49 -176.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -66.7 -50.06 64.07 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.417 -176.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 26' ' ' PRO . 10.6 tt -71.37 -32.74 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.229 -174.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -64.72 -41.97 95.58 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 122.079 -0.388 . . . . 0.0 110.257 175.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -65.3 -32.35 73.96 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.83 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -68.45 -39.33 81.51 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.85 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.544 HG23 HD12 ' A' ' 60' ' ' ILE . 48.3 mt -81.46 -36.82 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -175.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.508 ' CD2' ' HB2' ' A' ' 92' ' ' ALA . 61.0 mt -103.97 -26.22 12.71 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.206 -0.309 . . . . 0.0 111.642 -174.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.7 14.17 73.75 Favored Glycine 0 N--CA 1.495 2.603 0 CA-C-O 119.368 -0.685 . . . . 0.0 111.48 -172.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -152.39 161.68 42.26 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 119.163 1.481 . . . . 0.0 110.554 170.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -94.47 107.45 29.92 Favored Pre-proline 0 N--CA 1.496 1.846 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.8 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -67.38 156.51 65.88 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 O-C-N 123.242 1.127 . . . . 0.0 110.526 -176.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -73.37 162.59 29.15 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -80.31 79.46 6.89 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.537 0.684 . . . . 0.0 109.509 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.85 176.12 47.26 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 p -138.07 157.2 46.81 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 117.349 0.575 . . . . 0.0 110.842 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.458 HD22 HD12 ' A' ' 114' ' ' LEU . 33.8 tp -108.92 118.37 36.62 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.95 122.85 42.74 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -175.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.823 HD11 HD11 ' A' ' 126' ' ' ILE . 61.1 mt -121.29 136.24 55.0 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.732 0.301 . . . . 0.0 110.521 -178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -96.13 132.51 41.45 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.437 HD22 HG22 ' A' ' 7' ' ' ILE . 84.5 mt -111.47 160.23 17.32 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 120.703 0.287 . . . . 0.0 110.382 -176.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -88.94 12.44 15.34 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 173.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -146.39 140.91 26.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.687 -0.633 . . . . 0.0 109.662 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.1 146.9 52.27 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 122.182 -0.324 . . . . 0.0 110.75 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -132.37 138.71 47.83 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.64 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -138.04 123.89 20.01 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 176.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.62 -23.08 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.395 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -74.6 -0.97 19.53 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.897 -0.502 . . . . 0.0 112.214 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -89.92 -14.21 34.65 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 118.961 0.8 . . . . 0.0 111.542 171.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -117.0 175.15 5.72 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 118.603 0.638 . . . . 0.0 109.582 173.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -91.87 104.86 17.24 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -109.49 177.3 4.78 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.544 HD12 HG23 ' A' ' 34' ' ' ILE . 79.4 mt -110.37 133.67 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -105.84 142.1 36.13 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.3 p -116.5 133.23 56.26 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -77.47 172.5 13.24 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 120.75 0.309 . . . . 0.0 111.388 -171.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -69.28 139.86 54.39 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -140.64 164.86 29.05 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.743 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -122.01 146.44 47.16 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 120.699 0.285 . . . . 0.0 110.271 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.419 ' CD2' HD21 ' A' ' 24' ' ' LEU . 47.1 t80 -150.71 141.83 23.1 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 172.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.2 m120 52.11 29.98 7.06 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.69 -0.631 . . . . 0.0 112.126 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.56 16.08 81.03 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -120.45 143.29 48.57 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 118.706 1.253 . . . . 0.0 109.636 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -92.42 131.76 37.32 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.349 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -119.94 141.0 50.03 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -87.4 151.9 22.69 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 120.843 0.354 . . . . 0.0 110.595 -167.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.68 158.71 51.21 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -142.65 161.48 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 122.252 -0.558 . . . . 0.0 110.514 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -113.5 135.21 54.13 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.8 t -131.07 138.25 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -176.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.7 tp -137.44 125.65 14.49 Favored Pre-proline 0 N--CA 1.496 1.85 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.055 178.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -62.68 149.33 91.56 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 120.98 1.12 . . . . 0.0 111.731 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.581 HD13 HG13 ' A' ' 93' ' ' ILE . 43.6 pt -141.82 170.17 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 122.253 -0.279 . . . . 0.0 110.321 171.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -113.53 130.26 56.39 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 168.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -106.24 123.57 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -108.63 116.99 33.02 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.8 mt -130.1 121.96 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.79 -120.46 18.89 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -111.1 16.97 20.82 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 122.266 -0.55 . . . . 0.0 111.933 175.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -118.68 143.2 47.0 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 118.518 0.599 . . . . 0.0 110.482 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -123.09 129.89 52.06 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -127.06 149.05 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.31 136.01 44.44 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.99 -168.4 12.35 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.508 ' HB2' ' CD2' ' A' ' 35' ' ' LEU . . . -159.35 155.22 26.39 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 117.305 0.553 . . . . 0.0 110.325 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.581 HG13 HD13 ' A' ' 80' ' ' ILE . 73.8 mt -108.71 140.72 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -125.07 129.52 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.7 t -139.92 133.88 15.6 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -56.65 153.67 34.92 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 121.037 1.158 . . . . 0.0 112.046 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -64.5 -34.45 78.24 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 122.269 -0.269 . . . . 0.0 110.606 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.1 tttp -90.97 121.05 32.47 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.2 t -141.84 151.89 43.17 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 122.32 -0.237 . . . . 0.0 110.401 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -98.42 -58.93 1.85 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -134.91 169.77 16.89 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.0 m -82.81 154.39 24.72 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 96.3 p -135.02 175.05 9.94 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 120.645 0.259 . . . . 0.0 110.495 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -104.8 25.0 10.94 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 121.28 -0.168 . . . . 0.0 110.95 172.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -120.89 126.88 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.9 pt -125.36 145.59 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -115.55 130.23 56.8 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.545 HD12 HD12 ' A' ' 46' ' ' LEU . 83.6 mt -116.06 152.27 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -174.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 pt -116.68 155.91 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 168.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.52 162.16 43.39 Favored Pre-proline 0 N--CA 1.495 1.823 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.358 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.54 -30.67 93.02 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 121.075 1.183 . . . . 0.0 111.728 177.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.44 167.0 23.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.279 -0.263 . . . . 0.0 110.933 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -69.92 104.33 2.48 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.458 HD12 HD22 ' A' ' 44' ' ' LEU . 85.0 mt -59.93 -34.25 72.98 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 122.138 -0.351 . . . . 0.0 111.349 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -62.97 -35.57 80.59 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 122.203 -0.311 . . . . 0.0 110.922 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -78.36 -48.76 14.88 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -62.65 -33.63 75.43 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 122.231 -0.293 . . . . 0.0 111.11 -172.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -108.05 7.75 27.9 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 51.8 46.97 25.69 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.108 -0.995 . . . . 0.0 111.878 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.4 mt -92.28 138.19 31.73 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.893 -0.504 . . . . 0.0 111.007 -170.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -115.66 160.61 19.82 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.17 50.17 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.966 -0.459 . . . . 0.0 111.569 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.48 -22.94 37.7 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.59 151.59 46.12 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 118.627 1.213 . . . . 0.0 110.018 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.3 t -110.45 133.66 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -173.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.823 HD11 HD11 ' A' ' 46' ' ' LEU . 34.8 pt -128.46 160.16 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -109.65 138.07 46.55 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.2 pt -113.62 137.87 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.465 HD23 ' C ' ' A' ' 129' ' ' LEU . 9.7 tt -108.99 127.7 54.3 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 32.5 mt -118.31 135.72 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -91.66 149.01 21.84 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.07 -170.26 21.81 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -98.72 168.67 10.0 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 122.334 -0.51 . . . . 0.0 110.176 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -65.02 -36.34 84.08 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.253 -0.279 . . . . 0.0 110.619 -177.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -104.69 -32.75 8.74 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 122.332 -0.23 . . . . 0.0 110.654 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.169 179.326 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.2 t -70.08 -40.74 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -134.02 128.31 34.06 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 131' ' ' LYS . 81.3 mt -110.86 148.3 32.73 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 10.7 tpp -109.4 144.01 38.18 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.7 mm -125.77 129.36 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.501 HG22 HD22 ' A' ' 48' ' ' LEU . 73.7 mt -129.77 148.9 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -105.37 141.53 36.72 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.73 150.61 20.38 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -106.33 142.1 36.56 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 117.265 0.532 . . . . 0.0 110.301 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.11 121.08 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.22 144.2 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.5 m -86.48 114.83 23.56 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.07 120.01 0.84 Allowed Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 17' ' ' GLU . 12.7 tp -110.93 137.38 48.64 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 122.341 -0.505 . . . . 0.0 109.904 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.83 -40.08 95.39 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -174.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.595 ' O ' HD23 ' A' ' 15' ' ' LEU . 69.6 mt-10 -123.78 153.85 40.37 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 117.327 0.563 . . . . 0.0 110.411 -177.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.63 -35.32 85.87 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -112.93 144.27 42.78 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 117.217 0.509 . . . . 0.0 109.985 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -124.75 126.73 46.12 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -144.49 96.63 2.9 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 22' ' ' LEU . 1.4 tt -102.92 0.33 32.23 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.2 m -94.65 31.25 1.83 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.26 -0.9 . . . . 0.0 111.533 -172.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.9 tp -88.56 139.88 29.84 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 171.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -50.15 -43.77 41.2 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 121.081 1.187 . . . . 0.0 114.059 -172.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.27 -36.81 99.03 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 CA-C-N 119.567 0.881 . . . . 0.0 111.941 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -66.14 -46.19 78.38 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.469 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -66.06 -37.42 85.77 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.337 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -65.57 -48.92 70.71 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.438 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.6 tt -68.72 -38.63 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.089 -176.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -66.37 -47.07 74.57 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 122.118 -0.363 . . . . 0.0 110.387 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -66.18 -29.62 69.93 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.735 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -68.89 -40.82 79.0 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.733 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.9 mt -81.31 -38.04 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -175.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 92' ' ' ALA . 46.1 mt -104.01 -26.2 12.71 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.231 -0.293 . . . . 0.0 111.711 -174.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.16 13.66 73.67 Favored Glycine 0 N--CA 1.495 2.592 0 CA-C-O 119.369 -0.684 . . . . 0.0 111.466 -171.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -152.52 165.65 34.46 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 119.158 1.479 . . . . 0.0 110.614 170.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -96.41 112.31 59.57 Favored Pre-proline 0 N--CA 1.496 1.851 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.835 175.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -67.52 159.92 50.33 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 O-C-N 123.266 1.14 . . . . 0.0 110.631 -176.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -74.3 164.54 26.48 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -80.23 79.57 6.78 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.476 0.655 . . . . 0.0 109.729 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.09 170.42 42.14 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 p -138.08 157.41 46.38 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 117.295 0.547 . . . . 0.0 110.674 177.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.5 tp -109.76 116.67 32.11 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 171.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.57 120.9 39.78 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 126' ' ' ILE . 60.6 mt -119.96 135.71 54.8 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.71 0.29 . . . . 0.0 110.656 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -96.21 133.46 40.49 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.501 HD22 HG22 ' A' ' 7' ' ' ILE . 84.7 mt -110.95 160.38 16.86 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 120.649 0.262 . . . . 0.0 110.481 -177.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.09 12.75 14.78 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -145.89 141.4 27.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.701 -0.624 . . . . 0.0 109.488 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -63.32 146.92 52.48 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 122.203 -0.311 . . . . 0.0 110.682 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -132.09 138.17 48.02 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 120.719 0.295 . . . . 0.0 110.622 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -138.02 126.41 23.27 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.9 tt -63.28 -22.73 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.348 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -74.65 -0.94 19.59 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.97 -0.457 . . . . 0.0 112.216 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -90.77 -14.51 31.87 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 118.902 0.774 . . . . 0.0 111.488 171.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -117.63 175.18 5.76 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 118.7 0.682 . . . . 0.0 109.469 174.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -90.64 103.88 16.53 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -177.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -110.42 179.25 4.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.371 -0.206 . . . . 0.0 110.537 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.5 mt -112.6 131.8 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.95 143.17 34.47 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.4 p -123.28 137.07 54.94 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 120.761 0.315 . . . . 0.0 110.769 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -77.3 172.61 13.02 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 120.824 0.345 . . . . 0.0 111.849 -168.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -68.21 141.31 56.0 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -138.69 164.99 28.12 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 122.186 -0.321 . . . . 0.0 110.675 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -124.92 148.31 48.41 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.787 0.327 . . . . 0.0 110.381 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -149.53 136.45 19.6 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 52.23 32.96 11.58 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.747 -0.595 . . . . 0.0 111.832 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 16.42 80.15 Favored Glycine 0 N--CA 1.497 2.733 0 CA-C-O 119.584 -0.565 . . . . 0.0 111.798 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -120.16 138.99 53.28 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 118.728 1.264 . . . . 0.0 109.701 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.19 131.47 38.24 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.358 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -119.69 140.93 49.88 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -86.03 155.9 20.65 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 120.761 0.315 . . . . 0.0 110.388 -168.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.94 156.86 51.64 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -176.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.09 156.86 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 122.347 -0.502 . . . . 0.0 110.486 -173.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -115.79 137.0 52.5 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.2 t -134.06 141.06 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -175.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 tp -137.54 125.72 14.42 Favored Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.082 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -63.31 148.56 92.8 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 120.987 1.125 . . . . 0.0 111.396 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.617 HD13 HG13 ' A' ' 93' ' ' ILE . 43.9 pt -141.78 170.06 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 122.304 -0.248 . . . . 0.0 110.412 173.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -114.28 131.51 56.48 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 168.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.2 mt -105.74 123.33 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.22 116.47 32.02 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.7 mt -129.83 121.92 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.56 -120.16 18.09 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -177.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -111.21 17.04 20.67 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 117.161 0.48 . . . . 0.0 111.784 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -119.43 144.12 47.11 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.557 0.617 . . . . 0.0 110.46 -175.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -123.13 130.15 52.39 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 122.263 -0.273 . . . . 0.0 110.275 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.6 mt -126.35 147.05 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.42 137.46 44.62 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.6 -168.32 13.51 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 178.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.644 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.12 154.26 25.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.266 -0.549 . . . . 0.0 110.258 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.617 HG13 HD13 ' A' ' 80' ' ' ILE . 70.2 mt -108.65 140.62 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -123.07 130.28 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.98 133.9 14.45 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -57.75 153.63 42.17 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 120.996 1.13 . . . . 0.0 111.813 177.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -65.53 -34.91 79.37 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 122.279 -0.263 . . . . 0.0 110.487 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -89.17 121.01 31.07 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.267 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -141.64 151.56 43.17 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -98.01 -55.89 2.65 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -136.84 169.63 17.43 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.1 m -82.19 151.11 27.04 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.0 m -134.91 175.0 9.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.295 -0.253 . . . . 0.0 110.526 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -107.28 27.22 9.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.378 -0.201 . . . . 0.0 110.839 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.1 mm -124.1 127.51 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.5 pt -125.98 145.52 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -114.81 130.08 56.81 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.507 HD12 HD12 ' A' ' 46' ' ' LEU . 83.5 mt -115.04 149.95 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -174.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 pt -115.95 155.57 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 169.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.55 165.97 22.24 Favored Pre-proline 0 N--CA 1.496 1.843 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.326 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.76 -30.94 93.24 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 O-C-N 123.292 1.154 . . . . 0.0 111.623 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.39 167.06 23.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.293 -0.255 . . . . 0.0 110.751 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -70.88 105.24 3.19 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.3 mt -59.52 -33.61 71.59 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 122.151 -0.343 . . . . 0.0 111.449 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -62.83 -35.35 79.65 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 122.108 -0.37 . . . . 0.0 111.006 -174.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -78.11 -48.28 16.37 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.47 -34.3 76.55 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 122.153 -0.342 . . . . 0.0 111.135 -172.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -108.1 8.53 28.18 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 51.79 50.5 18.53 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 121.103 -0.998 . . . . 0.0 111.895 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 47.4 mt -90.3 138.17 31.75 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.879 -0.513 . . . . 0.0 110.899 -171.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -116.19 155.16 28.76 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.48 137.91 47.45 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.906 -0.496 . . . . 0.0 111.533 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.02 -22.98 37.22 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -65.32 154.6 37.81 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-N 118.704 1.252 . . . . 0.0 110.05 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.38 134.03 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -174.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.815 HD11 HD11 ' A' ' 46' ' ' LEU . 34.6 pt -128.9 160.41 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -109.83 138.28 46.43 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.8 pt -114.21 137.61 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 176.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.466 HD23 ' C ' ' A' ' 129' ' ' LEU . 9.2 tt -109.02 127.75 54.37 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.8 mt -118.57 134.68 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HA ' HD23 ' A' ' 4' ' ' LEU . 49.9 mttp -91.83 133.65 35.45 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.19 175.18 34.69 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -154.96 165.92 35.19 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.336 -0.508 . . . . 0.0 110.501 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -115.9 145.82 42.57 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -138.77 163.98 30.79 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.145 179.993 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.5 mtt . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 p -132.4 142.18 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -140.84 50.58 1.65 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.035 0.445 . . . . 0.0 110.267 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.2 mt -110.9 149.12 31.07 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.089 -0.382 . . . . 0.0 110.088 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 51.6 ttm -107.74 144.76 34.43 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.3 mm -127.72 129.21 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.487 HG22 HD22 ' A' ' 48' ' ' LEU . 73.3 mt -129.97 149.23 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -105.9 142.12 36.15 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.42 150.95 20.4 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -106.16 142.38 35.95 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 117.266 0.533 . . . . 0.0 110.245 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.74 123.6 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -123.24 157.87 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 176.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -85.07 107.56 17.23 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.271 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.02 120.41 0.86 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.3 tp -81.89 -53.72 5.93 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 117.316 0.558 . . . . 0.0 109.974 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.09 168.79 30.14 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -100.04 -56.47 2.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 122.383 -0.48 . . . . 0.0 109.97 177.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.77 -170.53 41.81 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -100.19 107.68 19.6 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 117.131 0.465 . . . . 0.0 110.13 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -155.01 154.88 33.2 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -128.63 154.03 46.66 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 41' ' ' GLU . 85.8 mt -97.65 -11.82 23.11 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.5 m -61.61 -29.25 69.93 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 118.823 0.738 . . . . 0.0 111.48 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.6 tp -64.22 139.29 97.66 Favored Pre-proline 0 N--CA 1.505 2.309 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.27 -177.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -53.54 -49.34 17.69 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 121.058 1.172 . . . . 0.0 113.706 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -54.84 -33.1 80.2 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 120.634 0.89 . . . . 0.0 112.482 -170.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -66.44 -45.57 79.39 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.465 -177.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -66.5 -37.61 85.42 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 122.101 -0.374 . . . . 0.0 110.251 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -65.61 -47.41 75.78 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 122.201 -0.312 . . . . 0.0 110.454 -178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.2 tt -68.95 -37.96 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.045 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -65.46 -40.36 93.11 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 122.137 -0.352 . . . . 0.0 110.417 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -65.42 -37.51 87.15 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 122.212 -0.305 . . . . 0.0 110.319 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -68.03 -38.26 82.34 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.537 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.7 mt -81.18 -35.81 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.62 -26.1 12.92 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 122.141 -0.349 . . . . 0.0 111.573 -173.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.8 13.12 78.65 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -172.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -151.62 160.56 43.6 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 118.955 1.377 . . . . 0.0 110.222 170.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -93.12 108.0 29.45 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.857 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.456 ' CB ' HD12 ' A' ' 109' ' ' ILE . 66.7 Cg_endo -67.6 160.12 49.47 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 O-C-N 123.249 1.131 . . . . 0.0 110.355 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -73.62 161.62 30.1 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.438 ' HA ' HD13 ' A' ' 22' ' ' LEU . 70.4 mt-10 -80.32 79.6 6.88 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.496 0.665 . . . . 0.0 109.654 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.71 172.68 45.01 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 175.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 p -138.04 156.87 47.36 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 117.348 0.574 . . . . 0.0 110.775 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.497 HD22 HD12 ' A' ' 114' ' ' LEU . 30.7 tp -110.71 118.18 35.47 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 170.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.539 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.5 m120 -98.94 122.15 41.82 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -176.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 126' ' ' ILE . 59.3 mt -120.14 136.13 54.72 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 120.662 0.268 . . . . 0.0 110.585 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HB2' HG11 ' A' ' 12' ' ' VAL . 39.8 tttp -96.21 133.27 40.73 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 173.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.487 HD22 HG22 ' A' ' 7' ' ' ILE . 83.0 mt -111.1 160.27 17.04 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 120.664 0.269 . . . . 0.0 110.448 -177.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.14 12.74 14.93 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 172.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -145.76 142.39 28.87 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 118.496 0.589 . . . . 0.0 109.428 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -64.37 146.76 53.93 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 122.196 -0.315 . . . . 0.0 110.324 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -133.11 137.57 46.37 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 120.686 0.279 . . . . 0.0 110.755 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -138.06 128.28 25.98 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 174.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.43 -23.05 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.271 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -74.58 -0.92 19.32 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -90.53 -14.52 32.45 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 118.905 0.775 . . . . 0.0 111.429 170.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -117.79 175.18 5.78 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 118.64 0.654 . . . . 0.0 109.497 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -91.1 103.8 16.45 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -109.81 178.39 4.43 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 120.572 0.225 . . . . 0.0 110.47 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -111.43 131.17 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -105.97 144.56 32.52 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.1 p -124.27 138.09 54.43 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.821 0.343 . . . . 0.0 110.764 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -77.0 172.77 12.66 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 120.902 0.382 . . . . 0.0 111.869 -168.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -67.45 140.82 57.11 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -136.78 167.35 21.6 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.221 -0.299 . . . . 0.0 110.553 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -125.3 149.53 47.97 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 120.836 0.35 . . . . 0.0 110.56 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -148.66 133.65 18.14 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 52.11 33.46 12.24 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.63 -0.668 . . . . 0.0 111.879 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.21 15.77 80.56 Favored Glycine 0 N--CA 1.497 2.721 0 CA-C-O 119.578 -0.568 . . . . 0.0 111.892 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -120.13 140.89 50.4 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.778 1.289 . . . . 0.0 109.691 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.47 132.04 38.11 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 121.081 -0.247 . . . . 0.0 110.489 -176.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -121.19 144.87 48.36 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -86.11 156.18 20.48 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 120.799 0.333 . . . . 0.0 110.508 -167.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.79 159.46 48.88 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -176.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.77 158.17 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 122.355 -0.497 . . . . 0.0 110.338 -174.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -118.35 137.3 53.19 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.03 141.27 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.1 tp -137.25 125.64 14.7 Favored Pre-proline 0 N--CA 1.495 1.823 0 CA-C-O 118.524 -0.75 . . . . 0.0 110.092 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -63.68 149.73 90.15 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 120.965 1.11 . . . . 0.0 111.332 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.536 HD13 HG13 ' A' ' 93' ' ' ILE . 43.1 pt -141.85 170.06 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 120.635 0.255 . . . . 0.0 110.385 171.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -114.35 131.14 56.65 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 168.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.24 123.05 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -174.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.4 mt -107.97 116.4 31.89 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.9 mt -129.85 121.9 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.69 -120.14 17.83 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -111.22 17.08 20.63 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.33 -0.512 . . . . 0.0 111.897 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -119.76 144.21 47.4 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 118.52 0.6 . . . . 0.0 110.435 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -123.06 129.9 52.09 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 120.697 0.284 . . . . 0.0 110.298 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.4 mt -126.43 147.46 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.56 136.71 44.04 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.91 -168.89 13.05 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.49 154.47 24.87 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 117.376 0.588 . . . . 0.0 110.305 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.536 HG13 HD13 ' A' ' 80' ' ' ILE . 69.9 mt -108.79 141.61 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.8 t -124.4 132.09 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -144.95 137.54 13.54 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -58.15 152.84 49.66 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.05 1.166 . . . . 0.0 111.652 175.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -65.89 -34.32 77.85 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.538 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -88.6 117.31 27.47 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.0 m -129.87 143.26 50.72 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -94.05 -54.23 3.67 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -135.94 -179.73 5.84 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.4 m -96.77 151.71 19.38 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.2 p -134.96 172.32 13.17 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 120.747 0.308 . . . . 0.0 110.647 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.56 24.87 11.5 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.811 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.5 mm -120.81 127.72 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.442 HD13 HD11 ' A' ' 48' ' ' LEU . 34.5 pt -125.93 146.08 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 177.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -116.28 129.75 56.43 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 110.037 -0.356 . . . . 0.0 110.037 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.5 HD12 HD12 ' A' ' 46' ' ' LEU . 82.1 mt -115.0 151.55 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.456 HD12 ' CB ' ' A' ' 39' ' ' PRO . 11.9 pt -115.91 156.17 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 168.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.56 165.97 22.22 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.317 -176.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.13 -32.87 95.22 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 121.064 1.176 . . . . 0.0 111.462 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -145.06 160.14 41.86 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.308 -0.245 . . . . 0.0 110.877 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -62.36 104.7 0.52 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.367 0.604 . . . . 0.0 111.229 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.497 HD12 HD22 ' A' ' 44' ' ' LEU . 81.4 mt -59.56 -32.86 70.74 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.94 -0.475 . . . . 0.0 111.662 -176.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -61.87 -37.42 84.5 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 122.07 -0.394 . . . . 0.0 111.199 -171.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -78.27 -45.16 23.51 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -62.25 -34.79 77.21 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 122.143 -0.348 . . . . 0.0 111.085 -173.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -108.15 8.39 28.01 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 51.86 48.27 23.13 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.084 -1.01 . . . . 0.0 111.879 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.3 mt -91.71 138.12 31.82 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.887 -0.508 . . . . 0.0 110.993 -171.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.25 158.99 22.48 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -56.16 138.22 50.29 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.889 -0.507 . . . . 0.0 111.459 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.59 -22.97 37.52 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.43 151.8 45.45 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-N 118.672 1.236 . . . . 0.0 110.011 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.8 t -110.76 133.64 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -174.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.815 HD11 HD11 ' A' ' 46' ' ' LEU . 34.2 pt -128.28 160.38 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -109.72 137.81 47.0 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.5 pt -113.13 137.2 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.466 HD23 ' C ' ' A' ' 129' ' ' LEU . 9.1 tt -109.76 126.58 53.89 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 36.7 mt -115.17 132.32 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -91.56 145.22 24.78 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.09 -171.03 22.68 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -140.0 176.67 8.56 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.315 -0.521 . . . . 0.0 110.398 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -96.24 132.18 41.96 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -67.58 -36.31 80.64 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.174 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.202 179.899 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.1 ttp . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t -114.38 133.55 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -110.12 151.46 27.23 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.1 mt -110.85 149.34 30.73 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.2 ttm -106.75 144.0 34.03 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.8 mm -128.32 130.25 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.409 HG22 HD22 ' A' ' 48' ' ' LEU . 74.5 mt -129.67 149.38 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -105.81 141.84 36.56 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.32 150.83 20.59 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -106.19 141.5 37.45 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 117.31 0.555 . . . . 0.0 110.269 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.11 123.51 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.8 m -123.55 156.94 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.5 t -85.91 132.43 34.09 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.284 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.08 119.94 0.84 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.8 mt -143.39 -48.68 0.31 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.326 -0.514 . . . . 0.0 110.218 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.22 36.35 4.26 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -93.3 -56.62 2.88 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 117.273 0.537 . . . . 0.0 110.034 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.75 179.36 35.58 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 178.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -130.73 109.74 10.84 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 117.214 0.507 . . . . 0.0 110.124 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -155.03 156.5 36.05 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.54 132.25 55.71 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.4 mt -110.0 0.04 18.32 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.2 m -89.53 -32.11 17.31 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 118.971 0.805 . . . . 0.0 110.92 -173.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.6 mt -65.39 156.06 83.09 Favored Pre-proline 0 N--CA 1.502 2.156 0 CA-C-O 119.146 -0.454 . . . . 0.0 110.599 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -53.72 -50.53 13.45 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 121.2 1.267 . . . . 0.0 113.78 -175.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.92 -35.74 94.63 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 120.577 0.851 . . . . 0.0 112.33 -168.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -66.66 -45.85 77.59 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.414 -175.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -66.23 -36.82 84.03 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 122.043 -0.41 . . . . 0.0 110.239 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.68 -47.7 74.57 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.481 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.9 tt -68.88 -36.31 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -176.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.433 ' CE1' HD13 ' A' ' 109' ' ' ILE . 3.7 m-85 -65.99 -45.25 82.29 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 122.095 -0.378 . . . . 0.0 110.393 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -65.71 -31.01 71.77 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 122.197 -0.314 . . . . 0.0 110.814 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -68.93 -40.44 79.03 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.581 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -81.45 -37.04 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -175.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.64 HD21 ' HB2' ' A' ' 92' ' ' ALA . 45.8 mt -104.0 -26.19 12.72 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 122.231 -0.293 . . . . 0.0 111.683 -174.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.39 14.76 73.17 Favored Glycine 0 N--CA 1.495 2.593 0 CA-C-O 119.304 -0.72 . . . . 0.0 111.443 -172.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -151.76 163.05 39.99 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 119.22 1.51 . . . . 0.0 110.748 170.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -94.58 109.07 41.17 Favored Pre-proline 0 N--CA 1.496 1.866 0 CA-C-O 118.589 -0.72 . . . . 0.0 109.827 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.47 159.47 52.3 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 O-C-N 123.219 1.115 . . . . 0.0 110.493 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -73.87 162.85 28.66 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -80.22 79.52 6.78 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.467 0.651 . . . . 0.0 109.726 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.5 172.65 45.06 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 175.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.1 p -138.02 157.67 45.88 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 117.408 0.604 . . . . 0.0 110.806 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.9 tp -109.55 114.98 29.07 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.539 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.7 m120 -98.24 120.12 38.1 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 126' ' ' ILE . 63.8 mt -120.01 135.95 54.73 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 120.708 0.29 . . . . 0.0 110.664 -177.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HB2' HG11 ' A' ' 12' ' ' VAL . 40.4 tttp -95.99 133.04 40.68 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.421 HD11 HD13 ' A' ' 106' ' ' ILE . 83.8 mt -111.71 160.23 17.48 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 120.663 0.268 . . . . 0.0 110.407 -176.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.06 12.88 14.35 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 172.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -145.91 142.19 28.51 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.65 0.659 . . . . 0.0 109.482 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -64.46 146.89 53.83 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 122.218 -0.301 . . . . 0.0 110.424 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -132.37 136.72 47.02 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 120.659 0.266 . . . . 0.0 110.607 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -138.01 126.44 23.32 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.1 tt -64.2 -23.86 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.173 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -74.05 -1.0 18.17 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.888 -0.508 . . . . 0.0 112.128 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.28 -14.44 30.85 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 118.889 0.768 . . . . 0.0 111.429 169.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -115.82 175.09 5.69 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 118.618 0.644 . . . . 0.0 109.463 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -91.64 102.76 15.4 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -177.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -110.45 178.36 4.4 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.34 -0.225 . . . . 0.0 110.546 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.6 mt -112.35 131.76 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -105.94 142.49 35.56 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.6 p -120.7 138.08 54.15 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 120.745 0.307 . . . . 0.0 110.687 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.94 172.58 12.95 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 120.812 0.339 . . . . 0.0 111.795 -168.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -67.9 141.16 56.46 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -137.23 165.96 24.89 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.22 -0.3 . . . . 0.0 110.636 -176.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -125.43 148.29 48.87 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.734 0.302 . . . . 0.0 110.543 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -149.28 137.2 20.51 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 174.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 51.63 33.0 9.97 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.691 -0.631 . . . . 0.0 112.12 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 17.6 78.59 Favored Glycine 0 N--CA 1.497 2.717 0 CA-C-O 119.625 -0.542 . . . . 0.0 111.803 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -122.52 139.89 53.39 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 118.64 1.22 . . . . 0.0 109.646 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -93.26 131.94 37.91 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.37 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -121.06 143.84 48.86 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -86.14 155.95 20.55 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 120.763 0.316 . . . . 0.0 110.474 -168.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.73 160.85 47.17 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.33 156.67 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 122.358 -0.495 . . . . 0.0 110.381 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -114.99 137.17 52.31 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 176.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.7 t -134.05 141.44 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.5 tp -137.76 125.58 14.08 Favored Pre-proline 0 N--CA 1.497 1.915 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.201 177.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -63.31 148.87 92.55 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.939 1.092 . . . . 0.0 111.491 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.57 HD13 HG13 ' A' ' 93' ' ' ILE . 43.3 pt -142.15 170.09 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 122.257 -0.277 . . . . 0.0 110.419 171.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -115.21 131.91 56.78 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 167.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -105.91 123.85 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.8 mt -108.19 116.77 32.57 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.419 HG21 HD11 ' A' ' 120' ' ' LEU . 77.1 mt -130.2 121.94 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.62 -120.12 17.84 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -178.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -111.17 17.08 20.67 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.377 -0.484 . . . . 0.0 111.811 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -119.62 143.65 47.56 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.55 0.614 . . . . 0.0 110.473 -175.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -123.15 129.5 51.52 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -125.85 143.67 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.0 137.98 43.82 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.87 -164.29 11.21 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.64 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.82 156.15 26.98 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 117.328 0.564 . . . . 0.0 110.424 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.57 HG13 HD13 ' A' ' 80' ' ' ILE . 70.2 mt -108.7 141.42 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -123.03 130.63 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -175.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 63.0 t -142.48 135.9 14.25 Favored Pre-proline 0 N--CA 1.497 1.904 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -57.31 153.57 39.6 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 121.093 1.195 . . . . 0.0 111.849 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -65.47 -34.92 79.4 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.512 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -91.42 124.27 35.47 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -142.91 155.21 44.69 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -98.02 -59.99 1.65 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -134.27 -173.38 3.25 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -97.67 149.96 21.7 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m -134.94 175.02 9.96 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 122.307 -0.245 . . . . 0.0 110.379 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -107.35 27.42 9.1 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 122.38 -0.2 . . . . 0.0 110.866 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.7 mm -124.14 127.36 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.421 HD13 HD11 ' A' ' 48' ' ' LEU . 34.3 pt -126.15 145.66 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 177.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -115.38 130.1 56.79 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.492 HD12 HD12 ' A' ' 46' ' ' LEU . 80.9 mt -115.52 151.31 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.433 HD13 ' CE1' ' A' ' 31' ' ' PHE . 12.0 pt -116.38 155.19 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 168.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.46 161.93 44.68 Favored Pre-proline 0 N--CA 1.496 1.874 0 CA-C-O 119.128 -0.463 . . . . 0.0 110.457 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -60.44 -31.54 92.69 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 121.09 1.193 . . . . 0.0 111.613 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.15 167.09 23.24 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.182 -0.324 . . . . 0.0 110.996 -175.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -68.18 105.39 2.08 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.68 -38.47 87.9 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.167 -0.333 . . . . 0.0 111.069 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -64.65 -36.88 85.7 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 122.158 -0.339 . . . . 0.0 110.539 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -78.16 -50.36 12.11 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -62.53 -32.56 73.53 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 122.178 -0.326 . . . . 0.0 111.16 -173.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -108.05 8.11 28.08 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.8 43.73 29.84 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.123 -0.986 . . . . 0.0 111.928 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.419 HD11 HG21 ' A' ' 84' ' ' ILE . 78.5 mt -93.52 138.25 31.99 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.999 -0.438 . . . . 0.0 110.868 -171.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -113.51 160.68 18.23 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.15 50.22 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.874 -0.516 . . . . 0.0 111.508 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.61 -23.18 36.7 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.53 155.15 36.57 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 118.579 1.19 . . . . 0.0 109.914 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.3 t -112.02 134.0 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.813 HD11 HD11 ' A' ' 46' ' ' LEU . 34.3 pt -128.69 160.14 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 174.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -109.36 138.33 45.88 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.2 pt -112.63 137.9 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 129' ' ' LEU . 9.0 tt -109.41 130.43 55.5 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.6 mt -119.82 129.82 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -177.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -92.43 137.74 32.1 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.21 -176.87 29.76 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -147.63 153.83 39.87 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.353 -0.498 . . . . 0.0 110.137 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.69 -34.71 78.47 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 121.051 -0.259 . . . . 0.0 110.313 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -96.72 143.63 27.49 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 110.243 -0.281 . . . . 0.0 110.243 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.152 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.8 mm . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 109.118 -0.697 . . . . 0.44 109.118 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.532 HG22 HD22 ' A' ' 48' ' ' LEU . 71.9 mt -130.01 149.57 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 108.861 -0.792 . . . . 0.22 108.861 177.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -105.19 141.95 35.82 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.2 -0.296 . . . . 0.86 110.2 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.7 149.41 20.17 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.595 -1.402 . . . . 0.08 109.595 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -106.09 142.09 36.37 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 117.251 0.525 . . . . 0.86 110.185 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.5 t -62.97 122.0 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 N-CA-C 109.82 -0.437 . . . . 0.15 109.82 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.35 157.12 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 110.084 -0.339 . . . . 0.32 110.084 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 N--CA 1.499 2.006 0 N-CA-C 110.222 -0.288 . . . . 1.2 110.222 -179.102 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 . . . . . 0 N--CA 1.501 2.112 0 N-CA-C 110.325 -0.25 . . . . 0.66 110.325 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -65.77 -29.99 70.57 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 122.205 -0.31 . . . . 1.72 110.78 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -68.97 -40.58 78.76 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 120.689 -0.404 . . . . 2.37 110.609 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.2 mt -81.1 -38.53 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.406 -0.59 . . . . 0.3 109.406 -175.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.1 mt -104.11 -26.14 12.68 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 122.144 -0.348 . . . . 0.25 111.558 -174.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.34 14.74 70.6 Favored Glycine 0 N--CA 1.495 2.589 0 CA-C-O 119.408 -0.662 . . . . 0.32 111.48 -171.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -152.79 164.51 37.67 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 119.057 1.428 . . . . 0.25 110.618 170.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -95.73 113.04 61.14 Favored Pre-proline 0 N--CA 1.497 1.891 0 CA-C-O 118.466 -0.778 . . . . 1.35 109.869 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.408 ' HB3' HD12 ' A' ' 109' ' ' ILE . 68.9 Cg_endo -67.74 159.52 52.36 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 O-C-N 123.314 1.165 . . . . 0.18 110.539 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -74.29 164.52 26.5 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 110.075 -0.343 . . . . 0.4 110.075 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -80.37 79.58 6.94 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.459 0.647 . . . . 1.41 109.721 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.8 176.54 48.05 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.536 -1.426 . . . . 0.3 109.536 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -137.99 157.53 46.18 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 117.269 0.535 . . . . 0.24 110.763 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.5 HD22 HD12 ' A' ' 114' ' ' LEU . 28.2 tp -110.31 115.05 28.99 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.514 -0.921 . . . . 0.22 108.514 168.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.71 121.31 41.43 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 110.001 -0.37 . . . . 0.15 110.001 -175.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.763 HD11 HD11 ' A' ' 126' ' ' ILE . 62.4 mt -121.49 135.49 55.03 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 120.698 0.285 . . . . 0.08 110.667 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -95.89 133.55 39.93 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.151 -0.685 . . . . 1.33 109.151 172.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.532 HD22 HG22 ' A' ' 7' ' ' ILE . 82.7 mt -111.89 160.2 17.63 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 120.609 0.243 . . . . 0.11 110.411 -176.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.43 13.04 14.68 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 111.911 0.337 . . . . 0.18 111.911 172.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -146.53 141.37 26.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.699 -0.625 . . . . 2.06 109.505 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -62.93 149.27 45.08 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.168 -0.332 . . . . 1.94 110.724 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -131.8 137.83 48.29 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 120.647 0.26 . . . . 0.32 110.545 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -138.03 122.51 18.43 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.809 -0.441 . . . . 1.4 109.809 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.3 tt -63.28 -22.91 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 C-N-CA 120.97 -0.292 . . . . 0.17 111.363 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -74.43 -1.02 19.25 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.982 -0.449 . . . . 0.93 112.143 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -90.61 -14.37 32.54 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 118.902 0.774 . . . . 1.52 111.444 170.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -116.11 175.1 5.7 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.668 0.667 . . . . 0.35 109.512 173.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -92.07 103.93 16.38 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 110.097 -0.335 . . . . 1.8 110.097 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -109.73 176.99 4.87 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 120.517 0.199 . . . . 0.16 110.574 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.19 130.77 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.29 -1.004 . . . . 0.16 108.29 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -105.89 142.73 35.11 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 110.187 -0.301 . . . . 1.23 110.187 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.1 p -119.31 134.2 55.34 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 120.621 0.248 . . . . 0.36 110.443 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.51 172.68 12.57 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 120.716 0.293 . . . . 1.29 111.502 -170.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -67.63 139.18 56.82 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.415 -0.587 . . . . 0.33 109.415 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -139.09 167.82 21.21 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.934 -0.306 . . . . 0.24 110.684 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -125.33 149.61 47.94 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 120.873 0.368 . . . . 0.8 110.506 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -147.79 134.39 19.84 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.197 -0.668 . . . . 0.5 109.197 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 51.67 33.21 10.46 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.69 -0.631 . . . . 1.31 112.089 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.47 16.98 78.58 Favored Glycine 0 N--CA 1.497 2.721 0 CA-C-O 119.601 -0.555 . . . . 0.46 111.925 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -122.29 141.67 51.28 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 118.668 1.234 . . . . 1.89 109.756 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -93.49 133.37 36.85 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 121.021 -0.272 . . . . 1.47 110.55 -176.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -123.04 145.18 48.75 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.887 -0.412 . . . . 0.38 109.887 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -86.98 153.76 21.31 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 120.783 0.325 . . . . 0.38 110.573 -168.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.09 158.62 51.85 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.976 -1.25 . . . . 0.21 109.976 -177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.79 159.18 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 122.228 -0.572 . . . . 0.27 110.53 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -117.66 137.0 52.95 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.7 -0.482 . . . . 0.96 109.7 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.8 t -134.03 141.5 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 109.358 -0.608 . . . . 0.12 109.358 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.4 tp -137.41 125.61 14.49 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.627 -0.701 . . . . 0.14 110.087 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.0 149.91 90.21 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 121.033 1.155 . . . . 0.1 111.472 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.53 HD13 HG13 ' A' ' 93' ' ' ILE . 43.3 pt -141.54 170.0 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 120.716 0.293 . . . . 0.08 110.313 171.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -114.88 130.77 56.96 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.121 -0.696 . . . . 1.42 109.121 168.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.69 123.91 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.836 -0.801 . . . . 0.11 108.836 -174.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.9 mt -108.54 116.96 32.95 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 110.284 -0.265 . . . . 0.15 110.284 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.4 mt -129.86 121.95 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.186 -1.042 . . . . 0.13 108.186 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.76 -120.37 18.58 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.868 -1.293 . . . . 0.16 109.868 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -111.12 17.13 20.66 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 122.382 -0.481 . . . . 2.03 111.831 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -119.83 145.46 46.62 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 118.559 0.618 . . . . 1.36 110.505 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -123.07 130.87 53.35 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 110.251 -0.277 . . . . 1.42 110.251 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.9 mt -126.16 146.55 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 108.737 -0.838 . . . . 0.13 108.737 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.52 136.84 44.13 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 109.902 -0.407 . . . . 0.41 109.902 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.51 -169.25 13.6 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.286 -1.526 . . . . 0.1 109.286 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.17 154.62 25.75 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 117.196 0.498 . . . . 0.1 110.159 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.53 HG13 HD13 ' A' ' 80' ' ' ILE . 68.5 mt -108.66 140.78 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.292 -1.003 . . . . 0.1 108.292 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.79 131.82 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 109.347 -0.612 . . . . 0.15 109.347 -175.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.2 t -143.21 138.6 15.79 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 108.545 -0.909 . . . . 0.2 108.545 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -56.69 155.57 26.25 Favored 'Trans proline' 0 N--CA 1.504 2.097 0 C-N-CA 121.09 1.194 . . . . 0.24 111.942 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -64.38 -34.14 77.49 Favored 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 121.141 -0.224 . . . . 1.19 110.702 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -87.96 116.76 26.36 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 121.001 -0.28 . . . . 2.67 110.254 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.0 m -130.98 136.64 48.71 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.016 -0.364 . . . . 1.43 110.016 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -97.92 -54.63 3.03 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 110.31 -0.256 . . . . 4.61 110.31 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -131.64 179.27 6.15 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 110.306 -0.257 . . . . 3.0 110.306 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.9 m -100.14 148.9 24.08 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 110.135 -0.32 . . . . 1.21 110.135 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.0 m -135.01 175.0 9.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 122.292 -0.255 . . . . 1.17 110.387 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -107.91 27.07 9.6 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.418 -0.176 . . . . 0.94 110.977 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -122.92 127.58 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.047 -0.723 . . . . 0.13 109.047 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.501 HD13 HD11 ' A' ' 48' ' ' LEU . 34.7 pt -125.44 143.68 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 110.109 -0.33 . . . . 0.11 110.109 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -115.03 130.85 57.03 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.963 -0.384 . . . . 1.36 109.963 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.455 HD12 HD12 ' A' ' 46' ' ' LEU . 81.8 mt -115.92 151.39 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.434 -0.58 . . . . 0.11 109.434 -173.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 39' ' ' PRO . 13.8 pt -116.44 154.24 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 109.433 -0.58 . . . . 0.14 109.433 168.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.58 165.59 24.2 Favored Pre-proline 0 N--CA 1.496 1.836 0 CA-C-O 119.043 -0.503 . . . . 0.13 110.222 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.81 -31.41 93.9 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.069 1.179 . . . . 0.19 111.602 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.61 167.07 23.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.35 -0.219 . . . . 0.29 110.664 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -71.65 104.01 3.22 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 109.975 -0.38 . . . . 2.18 109.975 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.5 HD12 HD22 ' A' ' 44' ' ' LEU . 81.6 mt -59.37 -33.03 70.67 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 122.069 -0.394 . . . . 0.25 111.449 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -63.1 -35.02 78.87 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 122.191 -0.318 . . . . 2.52 110.904 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -78.25 -47.86 17.03 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.194 -0.669 . . . . 1.82 109.194 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -62.28 -34.03 75.77 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.194 -0.317 . . . . 1.28 111.112 -172.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -108.06 9.36 28.42 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 112.534 0.568 . . . . 0.26 112.534 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.83 46.24 26.89 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.074 -1.016 . . . . 1.05 111.887 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -91.89 138.2 31.74 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.878 -0.513 . . . . 0.38 110.889 -171.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -114.99 158.2 22.38 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.844 -0.428 . . . . 2.43 109.844 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -55.97 137.94 49.83 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.872 -0.517 . . . . 0.5 111.431 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.95 -22.96 37.36 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 111.151 -0.78 . . . . 0.14 111.151 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -65.45 155.56 35.14 Favored 'General case' 0 N--CA 1.505 2.311 0 CA-C-N 118.631 1.216 . . . . 0.13 109.968 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -112.63 134.25 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.428 -0.582 . . . . 0.11 109.428 -174.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 46' ' ' LEU . 34.2 pt -129.38 161.33 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 109.554 -0.536 . . . . 0.13 109.554 174.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -110.0 138.26 46.62 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 110.141 -0.318 . . . . 1.34 110.141 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.8 pt -114.68 137.15 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 120.845 0.355 . . . . 0.17 110.184 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.466 ' C ' HD23 ' A' ' 129' ' ' LEU . 9.9 tt . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 109.861 -0.422 . . . . 0.98 109.861 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.1 mm . . . . . 0 N--CA 1.498 1.949 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.496 HG22 HD22 ' A' ' 48' ' ' LEU . 74.5 mt -129.7 148.91 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -105.32 140.05 39.03 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.33 151.08 20.42 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -106.83 141.64 37.74 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.346 -0.503 . . . . 0.0 110.26 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.18 122.28 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -124.4 146.03 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 N--CA 1.498 1.956 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.983 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 N--CA 1.501 2.122 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -65.76 -30.31 70.94 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.24 -0.288 . . . . 0.0 110.814 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -68.94 -40.69 78.85 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.622 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -81.26 -38.02 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' A' ' 92' ' ' ALA . 52.3 mt -103.97 -26.2 12.72 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 122.2 -0.313 . . . . 0.0 111.61 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.03 15.02 70.81 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -172.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -152.83 164.33 38.06 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 119.027 1.413 . . . . 0.0 110.67 170.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -95.07 110.87 52.47 Favored Pre-proline 0 N--CA 1.496 1.844 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.725 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.33 159.9 50.17 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 O-C-N 123.253 1.133 . . . . 0.0 110.526 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -73.96 163.71 27.55 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -80.29 79.6 6.85 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.488 0.661 . . . . 0.0 109.653 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.16 173.24 45.37 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 p -138.05 157.87 45.47 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 117.241 0.52 . . . . 0.0 110.708 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.2 tp -110.31 114.98 28.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.439 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.6 m120 -99.04 119.84 38.47 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.845 HD11 HD11 ' A' ' 126' ' ' ILE . 62.1 mt -119.97 136.1 54.66 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 120.726 0.298 . . . . 0.0 110.717 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HB2' HG11 ' A' ' 12' ' ' VAL . 76.6 tttt -95.9 133.61 39.88 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 173.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.496 HD22 HG22 ' A' ' 7' ' ' ILE . 83.6 mt -112.51 160.25 17.99 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 120.657 0.265 . . . . 0.0 110.417 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.26 13.06 14.3 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 172.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -146.39 142.68 28.44 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 118.533 0.606 . . . . 0.0 109.586 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -64.29 149.43 48.13 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 122.196 -0.315 . . . . 0.0 110.505 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -131.79 138.0 48.37 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 120.701 0.286 . . . . 0.0 110.437 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -138.02 123.07 19.1 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.16 -22.84 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.389 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -74.56 -0.93 19.28 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -90.49 -14.27 33.06 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 118.901 0.773 . . . . 0.0 111.485 171.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -117.19 175.12 5.75 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 118.618 0.645 . . . . 0.0 109.431 173.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -91.31 104.07 16.65 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -110.39 176.65 4.96 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 120.516 0.198 . . . . 0.0 110.532 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.16 131.46 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -105.97 144.06 33.22 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.6 p -120.9 134.73 55.29 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.653 0.264 . . . . 0.0 110.547 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -77.01 172.6 12.94 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 120.77 0.319 . . . . 0.0 111.644 -170.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -67.9 140.22 56.5 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -142.34 166.31 25.02 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.699 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -123.67 149.1 45.87 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 120.787 0.327 . . . . 0.0 110.465 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -149.01 135.72 19.63 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 51.7 33.16 10.45 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.724 -0.61 . . . . 0.0 112.095 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.18 17.01 78.88 Favored Glycine 0 N--CA 1.497 2.712 0 CA-C-O 119.613 -0.548 . . . . 0.0 111.896 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -121.82 140.43 52.38 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 118.647 1.223 . . . . 0.0 109.712 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -93.49 131.44 38.71 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.355 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -121.22 141.97 50.36 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -86.93 156.46 19.81 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 120.741 0.305 . . . . 0.0 110.454 -168.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.55 156.53 52.39 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.3 157.81 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 122.329 -0.512 . . . . 0.0 110.471 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -114.97 138.78 50.44 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.6 t -133.96 140.19 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -176.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.7 tp -137.69 125.69 14.23 Favored Pre-proline 0 N--CA 1.496 1.868 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.114 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -62.9 149.14 92.37 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 120.968 1.112 . . . . 0.0 111.586 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.603 HD13 HG13 ' A' ' 93' ' ' ILE . 43.8 pt -141.98 170.06 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 122.28 -0.263 . . . . 0.0 110.322 172.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -114.6 131.77 56.58 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 168.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -106.0 123.97 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -109.28 117.02 32.98 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.5 mt -130.09 121.96 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.38 -119.95 17.55 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -111.19 17.08 20.66 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 122.349 -0.501 . . . . 0.0 111.855 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -119.54 143.04 47.82 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 118.591 0.632 . . . . 0.0 110.482 -175.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -123.16 130.28 52.55 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 120.683 0.277 . . . . 0.0 110.309 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -126.31 144.93 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.83 138.07 44.21 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.92 -165.36 11.91 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.579 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.69 155.64 26.4 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 117.307 0.553 . . . . 0.0 110.236 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.603 HG13 HD13 ' A' ' 80' ' ' ILE . 70.1 mt -108.69 141.22 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.7 t -121.7 130.78 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.3 t -141.11 134.07 14.41 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -57.24 155.42 29.61 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 121.042 1.162 . . . . 0.0 111.939 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -64.35 -34.02 77.18 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 122.321 -0.237 . . . . 0.0 110.685 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -90.11 123.2 33.76 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.337 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.2 m -130.23 142.97 50.52 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -94.9 -60.01 1.79 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -137.75 171.65 14.13 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.5 m -70.85 146.86 49.38 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.8 m -135.01 161.71 34.52 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.571 0.224 . . . . 0.0 110.464 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -107.64 27.08 9.51 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.375 -0.203 . . . . 0.0 110.833 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -123.73 127.52 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.491 HD13 HD11 ' A' ' 48' ' ' LEU . 34.5 pt -125.49 143.64 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 178.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -113.84 130.16 56.5 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.49 HD12 HD12 ' A' ' 46' ' ' LEU . 82.1 mt -115.5 150.33 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -174.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.8 pt -117.25 155.94 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 168.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.55 161.15 48.31 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-O 119.073 -0.489 . . . . 0.0 110.29 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.73 -30.88 93.18 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 121.105 1.203 . . . . 0.0 111.74 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.4 167.09 23.3 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.262 -0.274 . . . . 0.0 110.761 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -73.62 103.77 4.34 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.98 -35.39 78.34 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.145 -0.347 . . . . 0.0 111.136 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -62.22 -32.9 73.62 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.13 -0.356 . . . . 0.0 110.944 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -78.23 -50.89 11.05 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -63.06 -32.43 73.8 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.158 -172.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -105.97 7.84 32.2 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.87 47.45 24.75 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.014 -1.054 . . . . 0.0 111.841 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.4 mt -91.52 138.24 31.73 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.896 -0.502 . . . . 0.0 110.923 -170.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -116.82 158.66 23.57 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.22 50.08 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.846 -0.534 . . . . 0.0 111.474 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.77 -22.96 37.46 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.39 154.01 39.62 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 118.608 1.204 . . . . 0.0 110.018 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t -111.81 133.38 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -174.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.845 HD11 HD11 ' A' ' 46' ' ' LEU . 21.6 pt -128.68 160.83 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -109.63 138.09 46.5 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 pt -113.56 137.5 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.467 ' C ' HD23 ' A' ' 129' ' ' LEU . 10.1 tt . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.7 mm . . . . . 0 N--CA 1.499 2.014 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.0 mt -129.86 149.58 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -104.96 143.21 33.48 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.286 -0.259 . . . . 0.0 110.37 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.22 151.16 20.68 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.57 142.62 34.99 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 117.253 0.526 . . . . 0.0 110.221 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.7 122.79 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.8 m -126.57 163.39 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 177.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.498 1.967 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.194 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 N--CA 1.501 2.108 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -65.25 -30.92 71.85 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 122.211 -0.306 . . . . 0.0 110.871 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -68.62 -41.21 79.81 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.668 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.3 mt -81.6 -36.46 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.588 HD21 ' HB2' ' A' ' 92' ' ' ALA . 55.8 mt -103.78 -26.13 12.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.192 -0.317 . . . . 0.0 111.668 -174.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.57 14.69 72.84 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -172.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -152.82 162.43 41.29 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 119.062 1.431 . . . . 0.0 110.571 171.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -94.13 108.91 38.98 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.562 -0.733 . . . . 0.0 109.683 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -67.04 159.09 53.65 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 O-C-N 123.254 1.134 . . . . 0.0 110.536 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -73.81 162.97 28.55 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -80.29 79.6 6.84 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.497 0.665 . . . . 0.0 109.672 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.29 171.15 43.49 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -138.05 156.94 47.3 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 117.331 0.566 . . . . 0.0 110.856 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 tp -110.42 117.07 32.61 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 170.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.481 ' O ' HG22 ' A' ' 12' ' ' VAL . 5.9 m120 -99.66 120.87 40.38 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -177.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.737 HD11 HD11 ' A' ' 126' ' ' ILE . 68.3 mt -120.02 135.77 54.8 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 120.728 0.299 . . . . 0.0 110.651 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' HG11 ' A' ' 12' ' ' VAL . 84.7 tttt -96.15 133.55 40.3 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.4 mt -111.59 160.2 17.43 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 120.605 0.24 . . . . 0.0 110.46 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.04 12.95 14.12 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 172.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -145.47 141.89 28.76 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.687 -0.633 . . . . 0.0 109.363 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.37 146.84 53.8 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 122.231 -0.293 . . . . 0.0 110.427 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -131.95 137.36 47.91 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 120.617 0.246 . . . . 0.0 110.553 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -138.02 124.19 20.38 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.49 -22.92 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 122.21 -0.306 . . . . 0.0 111.314 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -72.75 -5.0 34.85 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 122.024 -0.423 . . . . 0.0 112.083 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -90.59 -14.36 32.61 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 118.833 0.742 . . . . 0.0 111.538 172.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -114.64 175.07 5.65 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 118.558 0.617 . . . . 0.0 109.409 173.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -92.1 102.31 14.85 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -109.97 178.64 4.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 122.316 -0.24 . . . . 0.0 110.606 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.0 mt -111.8 130.69 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 174.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -105.93 141.66 36.96 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.0 p -118.07 134.84 54.61 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 120.703 0.287 . . . . 0.0 110.461 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.17 172.71 12.37 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 120.826 0.346 . . . . 0.0 111.535 -170.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -67.29 139.56 57.3 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -138.95 167.13 22.72 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.203 -0.311 . . . . 0.0 110.643 -174.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -124.23 149.19 46.71 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.87 0.367 . . . . 0.0 110.599 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -148.22 134.47 19.44 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 51.76 33.3 10.92 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.736 -0.603 . . . . 0.0 112.142 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.32 16.77 79.06 Favored Glycine 0 N--CA 1.497 2.746 0 CA-C-O 119.664 -0.52 . . . . 0.0 111.937 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -122.33 141.67 51.31 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 118.665 1.233 . . . . 0.0 109.694 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -93.45 132.21 37.92 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 121.13 -0.228 . . . . 0.0 110.483 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -123.18 146.84 47.45 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -86.92 155.21 20.31 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.73 0.3 . . . . 0.0 110.454 -168.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.36 161.18 48.45 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.67 157.09 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 122.372 -0.487 . . . . 0.0 110.412 -174.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -115.48 136.65 52.86 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -134.11 140.19 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.0 tp -137.04 125.65 14.94 Favored Pre-proline 0 N--CA 1.497 1.898 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.057 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -63.6 148.47 92.33 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 121.008 1.139 . . . . 0.0 111.383 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.546 HD13 HG13 ' A' ' 93' ' ' ILE . 43.6 pt -141.96 170.0 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 122.266 -0.271 . . . . 0.0 110.414 172.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -115.07 131.84 56.79 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 167.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.2 mt -105.68 123.7 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.1 mt -108.38 116.99 33.0 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -177.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.4 mt -130.06 121.99 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.24 -120.01 17.94 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -111.2 17.03 20.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.298 -0.531 . . . . 0.0 111.829 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -119.32 143.56 47.31 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.669 -0.644 . . . . 0.0 110.468 -175.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -123.11 129.96 52.14 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 120.671 0.272 . . . . 0.0 110.294 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.6 mt -125.4 143.82 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.82 137.49 43.87 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.98 -165.35 11.93 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.588 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.64 156.62 28.2 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.18 -0.6 . . . . 0.0 110.303 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.546 HG13 HD13 ' A' ' 80' ' ' ILE . 68.8 mt -108.72 142.01 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.5 130.73 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -143.18 136.66 14.15 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -57.22 153.85 37.51 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 121.013 1.142 . . . . 0.0 111.927 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -64.78 -34.38 78.22 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 122.307 -0.246 . . . . 0.0 110.736 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -86.93 116.11 24.77 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.395 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.8 p -131.6 159.53 37.98 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -126.52 -48.34 1.55 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -128.77 175.42 8.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 95.1 p -98.18 149.96 21.99 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.2 m -134.96 170.8 15.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.323 -0.235 . . . . 0.0 110.371 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -107.17 27.08 9.4 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.356 -0.215 . . . . 0.0 110.93 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.0 mm -123.75 127.89 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 pt -126.49 143.1 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -112.83 131.82 55.54 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.48 HD12 HD12 ' A' ' 46' ' ' LEU . 82.9 mt -116.87 150.98 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -174.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.2 pt -116.04 154.32 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.55 166.02 21.99 Favored Pre-proline 0 N--CA 1.494 1.767 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.292 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -60.0 -31.91 94.21 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 121.104 1.203 . . . . 0.0 111.519 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.69 167.09 23.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.305 -0.247 . . . . 0.0 110.69 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -70.61 104.58 2.85 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.64 -33.39 71.46 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 122.099 -0.375 . . . . 0.0 111.463 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -62.75 -35.3 79.36 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 122.155 -0.341 . . . . 0.0 110.907 -174.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.25 -47.85 17.02 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -62.63 -33.69 75.53 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.152 -0.342 . . . . 0.0 111.122 -172.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -108.12 9.27 28.31 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 112.503 0.556 . . . . 0.0 112.503 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.91 45.86 27.55 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.066 -1.021 . . . . 0.0 111.845 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -92.18 138.18 31.75 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.908 -0.495 . . . . 0.0 110.974 -171.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -114.96 160.61 19.36 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.34 49.87 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.918 -0.489 . . . . 0.0 111.482 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.53 -23.49 35.6 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.44 152.65 43.41 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 118.665 1.233 . . . . 0.0 110.076 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.21 133.82 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.737 HD11 HD11 ' A' ' 46' ' ' LEU . 34.1 pt -129.19 161.31 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 174.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -109.91 138.4 46.35 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -112.88 137.93 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 129' ' ' LEU . 8.6 tt . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.1 mm . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.431 HG22 HD22 ' A' ' 48' ' ' LEU . 71.3 mt -130.11 150.09 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.406 ' O ' HD23 ' A' ' 48' ' ' LEU . 51.3 mt-10 -107.08 143.36 35.34 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.55 150.56 20.83 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -106.4 142.9 35.32 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.307 -0.525 . . . . 0.0 110.26 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.73 122.45 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -124.07 142.86 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 175.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.2 t . . . . . 0 N--CA 1.498 1.971 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.279 -178.653 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 N--CA 1.502 2.156 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -65.47 -31.3 72.31 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.783 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -68.56 -40.42 80.63 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.628 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.32 -37.02 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 92' ' ' ALA . 49.0 mt -103.23 -26.29 13.03 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.268 -0.27 . . . . 0.0 111.695 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.98 14.82 74.16 Favored Glycine 0 N--CA 1.493 2.471 0 CA-C-O 119.382 -0.677 . . . . 0.0 111.46 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -151.39 161.45 42.68 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 119.118 1.459 . . . . 0.0 110.651 170.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -94.68 107.84 33.24 Favored Pre-proline 0 N--CA 1.495 1.821 0 CA-C-O 118.637 -0.697 . . . . 0.0 109.856 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -67.31 158.23 57.97 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 O-C-N 123.219 1.115 . . . . 0.0 110.557 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.23 163.76 27.44 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -80.22 79.63 6.76 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.488 0.661 . . . . 0.0 109.675 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.6 172.97 45.37 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 175.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 p -138.05 157.03 47.18 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 117.397 0.599 . . . . 0.0 110.932 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.405 HD22 HD12 ' A' ' 114' ' ' LEU . 22.9 tp -109.63 115.71 30.39 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.436 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.6 m120 -99.26 120.96 40.4 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -176.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.788 HD11 HD11 ' A' ' 126' ' ' ILE . 57.6 mt -120.07 136.01 54.73 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.701 0.286 . . . . 0.0 110.607 -178.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HB2' HG11 ' A' ' 12' ' ' VAL . 48.3 tttm -96.36 134.24 39.75 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 173.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.431 HD22 HG22 ' A' ' 7' ' ' ILE . 84.3 mt -111.53 160.28 17.32 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 120.671 0.272 . . . . 0.0 110.45 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.14 13.0 14.2 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 171.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -145.21 142.27 29.4 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 118.567 0.622 . . . . 0.0 109.416 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -64.5 146.83 53.96 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 122.221 -0.299 . . . . 0.0 110.339 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -132.46 136.67 46.87 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 120.736 0.303 . . . . 0.0 110.602 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -138.04 127.4 24.67 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.33 -23.98 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.385 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -74.27 -1.07 19.05 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.944 -0.472 . . . . 0.0 112.182 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -91.02 -14.26 31.73 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 118.838 0.745 . . . . 0.0 111.481 169.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -116.23 175.06 5.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.665 -0.647 . . . . 0.0 109.43 174.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -91.98 102.93 15.5 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -110.63 178.46 4.36 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 120.579 0.228 . . . . 0.0 110.548 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -112.36 131.64 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 174.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -105.87 144.13 33.04 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.2 p -123.24 138.52 54.61 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 120.783 0.325 . . . . 0.0 110.786 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -77.29 172.71 12.86 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -167.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -67.6 141.36 56.81 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -136.59 167.28 21.68 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.535 -176.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -124.19 146.92 48.39 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 120.807 0.337 . . . . 0.0 110.667 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -149.8 138.65 20.99 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.6 m120 52.14 30.0 7.13 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.708 -0.62 . . . . 0.0 112.135 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.17 16.19 80.87 Favored Glycine 0 N--CA 1.497 2.736 0 CA-C-O 119.528 -0.596 . . . . 0.0 111.749 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -121.08 144.07 48.75 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 118.783 1.291 . . . . 0.0 109.617 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.13 131.36 38.26 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.53 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -120.17 144.72 47.53 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -85.81 156.97 20.35 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 120.845 0.355 . . . . 0.0 110.554 -167.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.43 162.01 44.72 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.42 156.71 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 122.409 -0.465 . . . . 0.0 110.351 -175.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -116.07 137.55 52.02 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.9 t -134.01 140.7 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -176.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.5 tp -136.72 125.65 15.31 Favored Pre-proline 0 N--CA 1.497 1.884 0 CA-C-O 118.553 -0.737 . . . . 0.0 110.109 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -63.78 149.12 91.48 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 120.937 1.091 . . . . 0.0 111.357 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.533 HD13 HG13 ' A' ' 93' ' ' ILE . 43.3 pt -141.79 169.64 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 120.692 0.282 . . . . 0.0 110.298 171.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -114.83 131.26 56.88 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 167.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.4 mt -105.71 123.29 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -175.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.6 mt -107.77 116.48 32.03 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.1 mt -129.75 121.91 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.64 -120.24 18.28 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -111.09 16.98 20.82 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.311 -0.523 . . . . 0.0 111.832 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -119.65 144.4 47.18 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 118.609 0.64 . . . . 0.0 110.464 -175.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -123.12 129.98 52.16 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 120.668 0.271 . . . . 0.0 110.282 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.3 mt -125.54 144.91 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.89 136.83 43.39 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.67 -167.17 12.71 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.59 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.37 155.68 27.15 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 117.277 0.538 . . . . 0.0 110.363 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.533 HG13 HD13 ' A' ' 80' ' ' ILE . 68.1 mt -108.72 141.84 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.03 131.56 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.8 t -141.87 130.63 12.13 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -58.75 155.02 39.76 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 121.02 1.147 . . . . 0.0 111.633 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -64.92 -34.41 78.34 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.301 -0.25 . . . . 0.0 110.574 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -87.98 121.09 29.99 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.3 t -142.38 152.45 42.86 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.344 -0.223 . . . . 0.0 110.407 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -98.9 -58.65 1.9 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -136.76 170.62 15.77 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.1 p -82.74 150.63 26.58 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.1 m -135.17 174.98 10.01 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 120.577 0.227 . . . . 0.0 110.408 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -106.4 27.22 8.95 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.374 -0.204 . . . . 0.0 110.932 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.0 mm -123.73 127.82 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.5 pt -125.2 145.1 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -115.92 130.21 56.73 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.467 HD12 HD12 ' A' ' 46' ' ' LEU . 82.2 mt -115.6 151.02 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -173.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.6 pt -116.56 154.78 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 169.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.59 165.97 22.2 Favored Pre-proline 0 N--CA 1.496 1.829 0 CA-C-O 119.049 -0.5 . . . . 0.0 110.307 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.9 -32.64 95.51 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 121.078 1.185 . . . . 0.0 111.404 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.98 161.54 39.13 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.695 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -63.36 105.81 0.8 Allowed 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 121.267 0.556 . . . . 0.0 111.038 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.405 HD12 HD22 ' A' ' 44' ' ' LEU . 82.4 mt -59.84 -33.35 71.67 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.861 -0.524 . . . . 0.0 111.445 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 93.1 mtm-85 -62.55 -35.36 79.22 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 122.131 -0.355 . . . . 0.0 110.967 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -78.22 -48.03 16.71 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -62.46 -34.24 76.43 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 122.192 -0.318 . . . . 0.0 111.102 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -108.03 9.0 28.56 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 51.85 50.43 18.64 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.137 -0.977 . . . . 0.0 111.934 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.6 mt -90.41 138.12 31.8 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.868 -0.52 . . . . 0.0 110.909 -171.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -116.32 156.96 25.75 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.08 138.04 50.23 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.863 -0.523 . . . . 0.0 111.5 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.68 -22.87 37.91 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -65.38 150.74 47.79 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-N 118.725 1.262 . . . . 0.0 110.041 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.96 133.39 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -173.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.788 HD11 HD11 ' A' ' 46' ' ' LEU . 34.0 pt -128.21 160.39 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -109.3 138.19 46.04 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.0 pt -111.82 136.77 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.462 ' C ' HD23 ' A' ' 129' ' ' LEU . 9.4 tt . . . . . 0 N--CA 1.495 1.786 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.2 mm . . . . . 0 N--CA 1.498 1.934 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.511 HG22 HD22 ' A' ' 48' ' ' LEU . 73.2 mt -129.52 148.33 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -105.73 140.39 38.86 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.12 150.51 20.01 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -105.39 142.45 35.13 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 122.354 -0.497 . . . . 0.0 110.205 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.69 123.25 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 45' ' ' ASN . 27.0 m -124.76 163.84 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 N--CA 1.498 1.957 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.22 -178.7 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -65.57 -31.42 72.46 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.225 -0.297 . . . . 0.0 110.855 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -68.71 -40.4 79.98 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.576 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.4 mt -81.35 -36.94 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 92' ' ' ALA . 49.6 mt -104.04 -26.24 12.68 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.228 -0.295 . . . . 0.0 111.611 -174.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.44 14.89 72.7 Favored Glycine 0 N--CA 1.494 2.504 0 CA-C-O 119.322 -0.71 . . . . 0.0 111.421 -172.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -151.84 161.17 43.09 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 119.097 1.449 . . . . 0.0 110.7 170.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -94.1 108.4 35.32 Favored Pre-proline 0 N--CA 1.496 1.874 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.821 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -67.3 157.94 59.37 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 O-C-N 123.279 1.147 . . . . 0.0 110.45 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -73.61 164.0 27.25 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -80.24 79.56 6.79 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.502 0.668 . . . . 0.0 109.612 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.76 172.18 44.44 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 p -138.01 157.18 46.89 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 117.315 0.558 . . . . 0.0 110.691 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.7 tp -109.4 116.14 31.27 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 170.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.54 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.7 m120 -98.34 120.44 38.76 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -177.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.833 HD11 HD11 ' A' ' 126' ' ' ILE . 61.0 mt -120.03 136.15 54.67 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 120.683 0.278 . . . . 0.0 110.658 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HB2' HG11 ' A' ' 12' ' ' VAL . 63.8 tttt -96.05 132.77 41.06 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.511 HD22 HG22 ' A' ' 7' ' ' ILE . 83.6 mt -111.82 160.22 17.56 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 120.681 0.277 . . . . 0.0 110.427 -176.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.1 13.14 13.78 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 172.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -145.86 142.03 28.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.657 -0.652 . . . . 0.0 109.566 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -64.23 148.88 49.13 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 122.297 -0.252 . . . . 0.0 110.395 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -131.78 137.03 48.0 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 120.688 0.28 . . . . 0.0 110.5 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -138.0 124.05 20.25 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.3 tt -64.25 -22.94 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.226 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -72.52 -4.19 29.03 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 118.257 0.48 . . . . 0.0 112.074 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -90.53 -14.26 32.96 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 118.833 0.742 . . . . 0.0 111.427 172.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -115.68 175.08 5.69 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 118.673 0.67 . . . . 0.0 109.34 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -91.42 101.98 14.66 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -108.64 175.96 5.28 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.313 -0.242 . . . . 0.0 110.623 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.7 mt -110.34 131.08 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -105.93 143.12 34.52 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.5 p -122.48 134.53 54.57 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.65 0.262 . . . . 0.0 110.618 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -76.86 172.62 12.84 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 120.803 0.335 . . . . 0.0 111.686 -169.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -67.96 140.29 56.41 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -141.09 165.48 27.42 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.755 -175.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -123.28 149.07 45.26 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.803 0.335 . . . . 0.0 110.533 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -149.87 135.52 18.42 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 51.69 32.91 10.01 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.654 -0.654 . . . . 0.0 112.1 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.27 17.32 78.24 Favored Glycine 0 N--CA 1.498 2.796 0 CA-C-O 119.683 -0.509 . . . . 0.0 111.835 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -122.75 141.13 52.14 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.628 1.214 . . . . 0.0 109.767 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.68 131.73 38.71 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.424 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -121.81 143.96 49.1 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -86.99 155.73 20.05 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 120.812 0.339 . . . . 0.0 110.482 -168.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.45 158.28 51.19 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.3 155.09 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 122.268 -0.548 . . . . 0.0 110.37 -174.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -113.26 137.45 51.47 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.1 t -133.24 140.27 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 tp -137.21 125.71 14.79 Favored Pre-proline 0 N--CA 1.497 1.878 0 CA-C-O 118.522 -0.752 . . . . 0.0 110.073 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -63.21 149.81 90.33 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 120.916 1.077 . . . . 0.0 111.542 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.568 HD13 HG13 ' A' ' 93' ' ' ILE . 43.5 pt -142.13 170.05 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -114.31 131.98 56.34 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 167.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.46 122.88 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -107.47 116.89 32.74 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 74.5 mt -129.97 121.9 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.52 -119.94 17.33 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -111.21 17.01 20.7 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.359 -0.494 . . . . 0.0 111.788 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -119.74 143.94 47.52 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 118.536 0.607 . . . . 0.0 110.468 -175.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -123.14 129.64 51.7 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 120.674 0.273 . . . . 0.0 110.286 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.4 mt -125.53 145.11 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.79 136.72 43.59 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.42 -166.32 12.09 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.72 155.54 26.16 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 117.348 0.574 . . . . 0.0 110.385 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.568 HG13 HD13 ' A' ' 80' ' ' ILE . 69.0 mt -108.73 141.19 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.35 132.11 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.1 t -142.16 129.04 11.17 Favored Pre-proline 0 N--CA 1.498 1.934 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.97 154.35 51.25 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.027 1.151 . . . . 0.0 111.412 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -61.81 -30.84 71.09 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 122.262 -0.274 . . . . 0.0 111.402 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -84.85 107.98 17.28 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.299 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.5 m -131.05 145.41 52.01 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -94.06 -59.74 1.9 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -139.53 170.32 16.14 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.4 m -68.43 145.96 53.63 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.2 m -135.0 166.23 23.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.352 -0.218 . . . . 0.0 110.462 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -107.4 27.1 9.43 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.379 -0.201 . . . . 0.0 110.865 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.7 mm -123.16 127.34 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.467 HD13 HD11 ' A' ' 48' ' ' LEU . 34.2 pt -125.83 144.4 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -114.21 129.58 56.63 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.502 HD12 HD12 ' A' ' 46' ' ' LEU . 82.7 mt -114.78 150.67 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -174.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 pt -116.52 154.85 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 168.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.51 166.07 21.79 Favored Pre-proline 0 N--CA 1.496 1.831 0 CA-C-O 119.099 -0.477 . . . . 0.0 110.257 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.79 -32.12 95.04 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 121.135 1.223 . . . . 0.0 111.468 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.9 160.49 41.22 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.334 -0.229 . . . . 0.0 110.695 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.5 pttt -63.07 105.85 0.76 Allowed 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.297 0.57 . . . . 0.0 111.106 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.7 mt -59.79 -33.44 71.71 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.843 -0.535 . . . . 0.0 111.413 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -62.81 -35.13 78.91 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 122.092 -0.38 . . . . 0.0 111.021 -173.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -78.19 -48.4 15.95 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -62.44 -34.33 76.58 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 122.223 -0.298 . . . . 0.0 111.129 -172.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -108.14 8.87 28.27 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.86 50.39 18.73 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.1 -1.0 . . . . 0.0 111.942 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 45.5 mt -90.35 138.22 31.72 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.757 -0.589 . . . . 0.0 110.952 -171.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -116.39 157.32 25.27 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.99 138.14 49.59 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 121.889 -0.507 . . . . 0.0 111.524 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.68 -22.93 37.65 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -65.47 152.43 43.97 Favored 'General case' 0 N--CA 1.505 2.31 0 CA-C-N 118.597 1.199 . . . . 0.0 110.033 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -111.03 133.93 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -174.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.833 HD11 HD11 ' A' ' 46' ' ' LEU . 34.4 pt -128.85 159.75 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -109.71 137.97 46.76 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 pt -112.82 137.83 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 176.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.466 ' C ' HD23 ' A' ' 129' ' ' LEU . 9.4 tt . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.5 mm . . . . . 0 N--CA 1.497 1.92 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.1 mt -129.84 148.75 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -105.11 141.53 36.5 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.26 151.34 20.48 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.77 141.85 36.49 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 117.184 0.492 . . . . 0.0 110.212 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.65 123.86 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 45' ' ' ASN . 27.0 m -123.71 146.43 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.498 1.936 0 O-C-N 122.311 -0.243 . . . . 0.0 110.451 -178.488 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 N--CA 1.501 2.125 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -65.32 -32.39 74.02 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 122.189 -0.319 . . . . 0.0 110.681 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -68.65 -39.57 80.63 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.687 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.7 mt -81.04 -37.52 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -176.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' A' ' 92' ' ' ALA . 46.4 mt -103.42 -26.14 13.0 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.196 -0.315 . . . . 0.0 111.735 -173.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.57 14.75 75.27 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -150.96 160.67 43.77 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 119.107 1.453 . . . . 0.0 110.547 170.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -94.82 108.8 40.11 Favored Pre-proline 0 N--CA 1.495 1.822 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.808 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.23 158.89 54.76 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 O-C-N 123.283 1.149 . . . . 0.0 110.508 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -73.74 163.89 27.36 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -80.21 79.54 6.76 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.544 0.688 . . . . 0.0 109.617 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.06 171.61 43.66 Favored Glycine 0 N--CA 1.496 2.633 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -138.1 157.93 45.34 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 117.356 0.578 . . . . 0.0 110.59 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.545 HD22 ' CD1' ' A' ' 114' ' ' LEU . 28.2 tp -109.9 116.54 31.82 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.533 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.4 m120 -98.94 123.45 43.22 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -176.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.648 HD11 HD11 ' A' ' 126' ' ' ILE . 74.8 mt -120.62 135.57 55.07 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 120.641 0.258 . . . . 0.0 110.602 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HB2' HG11 ' A' ' 12' ' ' VAL . 36.3 ttmt -96.17 133.12 40.86 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.428 HD11 HD13 ' A' ' 106' ' ' ILE . 83.4 mt -112.3 160.27 17.83 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 120.701 0.286 . . . . 0.0 110.464 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -89.57 13.46 13.95 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 172.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -145.41 141.82 28.76 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.763 -0.585 . . . . 0.0 109.423 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -64.47 146.81 53.96 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 122.201 -0.312 . . . . 0.0 110.396 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -134.97 136.41 42.2 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 120.714 0.292 . . . . 0.0 110.588 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -138.04 131.02 30.03 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.48 -23.08 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.533 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -74.86 -0.94 20.12 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.895 -0.503 . . . . 0.0 112.253 -176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -90.04 -14.51 33.71 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 118.946 0.794 . . . . 0.0 111.575 171.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -117.77 175.12 5.8 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.68 -0.637 . . . . 0.0 109.403 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -90.89 103.59 16.28 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -109.73 178.14 4.51 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 120.587 0.232 . . . . 0.0 110.5 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.0 mt -111.15 131.03 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -105.95 146.02 30.56 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.3 p -122.6 137.22 54.96 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 120.688 0.28 . . . . 0.0 110.649 176.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -76.59 172.7 12.59 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 120.895 0.378 . . . . 0.0 111.711 -168.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -67.37 140.23 57.2 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -139.54 166.73 23.81 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 122.221 -0.299 . . . . 0.0 110.598 -174.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -124.22 148.75 47.08 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 120.891 0.377 . . . . 0.0 110.488 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -148.97 136.73 20.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.91 32.27 9.67 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.703 -0.623 . . . . 0.0 112.101 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.07 16.85 79.23 Favored Glycine 0 N--CA 1.496 2.692 0 CA-C-O 119.587 -0.563 . . . . 0.0 111.874 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -123.22 143.13 50.24 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 118.651 1.225 . . . . 0.0 109.731 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.37 132.2 37.83 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 121.066 -0.253 . . . . 0.0 110.366 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -121.78 144.91 48.53 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -86.03 156.52 20.39 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.4 -169.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.14 161.22 44.85 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.93 156.92 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 122.354 -0.498 . . . . 0.0 110.327 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -118.77 137.24 53.5 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.8 t -134.04 141.11 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -176.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.4 tp -137.25 125.65 14.7 Favored Pre-proline 0 N--CA 1.496 1.851 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.13 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -63.35 149.46 91.17 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 120.936 1.09 . . . . 0.0 111.477 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.514 HD13 HG13 ' A' ' 93' ' ' ILE . 44.2 pt -141.53 170.09 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 122.209 -0.307 . . . . 0.0 110.256 171.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -114.67 131.56 56.69 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 167.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.05 123.17 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -175.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.1 mt -108.37 117.09 33.24 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.96 121.94 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.29 -119.93 17.58 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -111.16 17.0 20.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.343 -0.504 . . . . 0.0 111.981 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -119.94 144.01 47.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.749 -0.594 . . . . 0.0 110.512 -175.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -123.15 130.76 53.19 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.9 mt -125.78 145.27 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.79 137.83 44.13 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.16 -167.7 13.73 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.424 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.6 156.92 28.82 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 117.354 0.577 . . . . 0.0 110.443 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.514 HG13 HD13 ' A' ' 80' ' ' ILE . 68.7 mt -108.63 141.25 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.98 131.05 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.9 t -143.67 136.52 13.7 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -58.11 154.21 41.0 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 120.989 1.126 . . . . 0.0 111.757 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -65.9 -34.87 79.13 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 122.282 -0.261 . . . . 0.0 110.468 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -92.05 125.7 36.84 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -137.26 155.51 49.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 122.33 -0.231 . . . . 0.0 110.421 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -97.01 -59.43 1.8 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -138.94 170.33 16.18 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.3 p -80.74 147.53 30.51 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.4 m -134.98 174.03 11.07 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 120.583 0.23 . . . . 0.0 110.481 -177.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -107.23 27.61 8.89 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 122.36 -0.212 . . . . 0.0 110.862 177.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -123.3 127.74 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.428 HD13 HD11 ' A' ' 48' ' ' LEU . 34.4 pt -125.97 145.12 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -116.35 130.06 56.58 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.444 HD12 HD12 ' A' ' 46' ' ' LEU . 83.1 mt -114.58 150.41 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -175.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 pt -115.92 153.97 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 169.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.58 166.04 21.82 Favored Pre-proline 0 N--CA 1.494 1.738 0 CA-C-O 119.074 -0.489 . . . . 0.0 110.293 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.75 -31.3 93.88 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.08 1.187 . . . . 0.0 111.68 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.71 167.09 23.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 122.338 -0.226 . . . . 0.0 110.921 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -67.74 107.04 2.43 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.545 ' CD1' HD22 ' A' ' 44' ' ' LEU . 81.3 mt -60.05 -35.82 75.96 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 122.081 -0.387 . . . . 0.0 111.373 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 71.8 mtt85 -62.39 -35.29 78.73 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 122.175 -0.328 . . . . 0.0 110.981 -175.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -78.2 -47.3 18.32 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.6 -34.85 77.83 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 122.191 -0.318 . . . . 0.0 111.036 -172.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -108.01 8.61 28.4 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 51.73 46.81 25.95 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.072 -1.017 . . . . 0.0 111.96 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.37 138.18 31.78 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.956 -0.465 . . . . 0.0 110.969 -170.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -114.79 158.25 22.14 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.78 138.08 48.62 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.866 -0.521 . . . . 0.0 111.541 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.63 -22.93 37.66 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.52 151.86 45.4 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 118.635 1.217 . . . . 0.0 109.982 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.52 134.09 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.648 HD11 HD11 ' A' ' 46' ' ' LEU . 34.2 pt -129.24 161.32 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -110.4 137.89 47.51 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -113.02 137.6 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 176.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.467 ' C ' HD23 ' A' ' 129' ' ' LEU . 9.0 tt . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.6 mm . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.7 mt -129.58 148.5 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -106.98 142.37 36.7 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 122.27 -0.269 . . . . 0.0 110.466 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.69 151.57 20.95 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -106.07 142.69 35.34 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 117.247 0.524 . . . . 0.0 110.259 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.64 124.32 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 45' ' ' ASN . 27.1 m -123.73 156.12 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.499 1.981 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.4 -176.536 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.504 2.227 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -64.51 -31.45 72.68 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 122.157 -0.339 . . . . 0.0 110.767 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -67.98 -40.34 83.12 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.657 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.549 HG23 HD12 ' A' ' 60' ' ' ILE . 59.6 mt -80.94 -37.27 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -175.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 92' ' ' ALA . 58.0 mt -102.53 -26.29 13.29 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 122.189 -0.319 . . . . 0.0 111.568 -174.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.35 14.33 74.34 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-O 119.26 -0.745 . . . . 0.0 111.411 -172.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -152.31 161.23 42.91 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 119.243 1.521 . . . . 0.0 110.641 170.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -94.32 107.95 32.87 Favored Pre-proline 0 N--CA 1.496 1.841 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.737 177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.413 ' CB ' HD12 ' A' ' 109' ' ' ILE . 65.1 Cg_endo -67.4 155.48 70.2 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 O-C-N 123.327 1.172 . . . . 0.0 110.462 -176.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -73.82 164.17 26.98 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.24 79.55 6.8 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.489 0.661 . . . . 0.0 109.663 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.55 171.74 44.03 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 p -138.05 156.74 47.49 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 117.41 0.605 . . . . 0.0 110.884 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.2 tp -109.91 118.58 36.84 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 170.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.545 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.7 m120 -98.95 122.34 42.08 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -176.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.822 HD11 HD11 ' A' ' 126' ' ' ILE . 60.8 mt -119.96 136.08 54.67 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 120.686 0.279 . . . . 0.0 110.562 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HB2' HG11 ' A' ' 12' ' ' VAL . 67.4 tttt -96.23 133.39 40.61 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 173.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.477 HD11 HD13 ' A' ' 106' ' ' ILE . 82.9 mt -112.16 160.18 17.82 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 120.561 0.22 . . . . 0.0 110.482 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.2 13.16 13.94 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -145.34 141.21 28.3 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 118.604 0.638 . . . . 0.0 109.418 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -64.18 146.84 53.59 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 122.253 -0.279 . . . . 0.0 110.392 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -132.02 137.41 47.83 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 120.705 0.288 . . . . 0.0 110.638 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -138.07 128.34 26.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.613 HD13 ' HB3' ' A' ' 76' ' ' LYS . 20.0 tt -63.72 -24.08 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.327 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -74.33 -1.05 19.11 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 122.0 -0.437 . . . . 0.0 112.156 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -91.22 -14.35 31.16 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 118.874 0.761 . . . . 0.0 111.441 169.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -116.07 175.02 5.73 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.644 -0.66 . . . . 0.0 109.396 175.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -92.07 101.97 14.51 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -177.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -110.18 176.71 4.95 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 120.535 0.207 . . . . 0.0 110.489 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.549 HD12 HG23 ' A' ' 34' ' ' ILE . 77.6 mt -110.98 134.43 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -105.75 142.47 35.43 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.3 p -116.7 133.66 55.75 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -77.18 172.63 12.94 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 120.803 0.335 . . . . 0.0 111.345 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -68.6 139.98 55.54 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -138.35 166.6 23.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.251 -0.281 . . . . 0.0 110.67 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -125.44 145.81 49.9 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 120.749 0.309 . . . . 0.0 110.544 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -149.57 141.82 24.12 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.0 m120 52.17 29.95 7.15 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.667 -0.646 . . . . 0.0 112.085 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.41 16.39 80.76 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -121.51 142.54 49.97 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 118.699 1.25 . . . . 0.0 109.666 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -93.14 131.7 37.95 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.477 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -120.85 143.73 48.74 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -86.89 151.9 22.91 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 120.763 0.316 . . . . 0.0 110.382 -169.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.74 167.18 42.01 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.99 162.76 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 122.312 -0.523 . . . . 0.0 110.488 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.613 ' HB3' HD13 ' A' ' 54' ' ' ILE . 61.7 mttp -112.23 137.37 50.42 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 173.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -132.47 138.33 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.2 tp -136.94 125.65 15.06 Favored Pre-proline 0 N--CA 1.497 1.925 0 CA-C-O 118.663 -0.684 . . . . 0.0 110.097 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -63.59 149.39 91.06 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 120.993 1.128 . . . . 0.0 111.395 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.555 HD13 HG13 ' A' ' 93' ' ' ILE . 43.1 pt -142.15 170.03 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 171.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -115.28 131.99 56.75 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 167.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.6 mt -106.26 123.48 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.636 HD11 HD12 ' A' ' 129' ' ' LEU . 85.5 mt -107.86 116.76 32.55 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.4 mt -129.92 121.98 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.35 -120.13 18.26 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -178.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -111.07 16.95 20.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.366 -0.491 . . . . 0.0 111.926 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -119.72 144.0 47.47 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 118.577 0.626 . . . . 0.0 110.496 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -123.1 129.72 51.82 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 120.651 0.262 . . . . 0.0 110.308 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.2 mt -125.96 143.44 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.96 138.2 44.04 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.23 -164.34 11.32 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.541 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.88 156.19 26.92 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 117.351 0.576 . . . . 0.0 110.417 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.555 HG13 HD13 ' A' ' 80' ' ' ILE . 69.7 mt -108.77 141.53 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.57 130.77 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.6 t -140.39 126.8 11.92 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -57.7 155.83 30.27 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 121.024 1.149 . . . . 0.0 111.883 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -63.76 -33.88 76.65 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 122.31 -0.244 . . . . 0.0 110.78 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -86.65 116.15 24.57 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.1 m -130.83 142.64 50.4 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -93.8 -50.37 5.39 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -147.8 -179.48 6.92 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.9 p -91.18 145.52 24.6 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.5 m -135.08 174.96 10.03 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 120.586 0.231 . . . . 0.0 110.562 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -107.07 27.42 9.04 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 122.458 -0.151 . . . . 0.0 110.929 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.7 mm -122.64 127.4 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.477 HD13 HD11 ' A' ' 48' ' ' LEU . 34.5 pt -125.43 144.05 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 110.137 -0.319 . . . . 0.0 110.137 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -114.55 130.15 56.73 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.483 HD12 HD12 ' A' ' 46' ' ' LEU . 82.9 mt -115.28 151.06 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -174.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.413 HD12 ' CB ' ' A' ' 39' ' ' PRO . 12.5 pt -115.74 155.72 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 169.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.48 162.02 44.2 Favored Pre-proline 0 N--CA 1.495 1.791 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.214 -176.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.21 -34.47 94.01 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.065 1.177 . . . . 0.0 111.462 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -145.03 159.07 43.53 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.348 -0.22 . . . . 0.0 110.684 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.7 pttt -63.72 103.97 0.62 Allowed 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.495 0.665 . . . . 0.0 111.23 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.46 -31.98 69.82 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.927 -0.483 . . . . 0.0 111.373 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.411 ' HA ' HD12 ' A' ' 120' ' ' LEU . 76.6 mtm180 -61.29 -34.98 76.1 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.008 -0.432 . . . . 0.0 111.211 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -78.25 -49.07 14.41 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -61.89 -33.8 74.88 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.217 -172.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -108.11 9.02 28.38 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.79 50.54 18.44 Favored 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.005 -1.059 . . . . 0.0 111.85 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 115' ' ' ARG . 44.9 mt -89.49 138.14 31.71 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.878 -0.514 . . . . 0.0 110.951 -169.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -119.52 157.24 28.74 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -55.95 138.51 48.67 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.84 -0.537 . . . . 0.0 111.474 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.53 -23.02 37.33 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.32 151.44 46.24 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 118.702 1.251 . . . . 0.0 110.03 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -110.23 133.07 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -174.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.822 HD11 HD11 ' A' ' 46' ' ' LEU . 34.4 pt -128.29 160.13 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -109.25 137.98 46.3 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -175.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.0 pt -110.12 137.6 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.636 HD12 HD11 ' A' ' 83' ' ' LEU . 8.0 tt . . . . . 0 N--CA 1.494 1.757 0 O-C-N 122.314 -0.241 . . . . 0.0 110.359 -175.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.3 mm . . . . . 0 N--CA 1.499 1.992 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.495 HG22 HD22 ' A' ' 48' ' ' LEU . 75.3 mt -129.74 148.91 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -105.53 140.14 39.08 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.85 151.1 20.31 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -105.99 141.32 37.57 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 117.229 0.515 . . . . 0.0 110.256 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.3 t -63.22 124.04 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 45' ' ' ASN . 27.0 m -123.88 164.02 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 176.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.499 2.003 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.194 -176.981 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 N--CA 1.501 2.123 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -65.74 -31.63 72.73 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.156 -0.34 . . . . 0.0 110.758 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -68.53 -40.44 80.76 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.578 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -81.44 -36.59 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 92' ' ' ALA . 46.0 mt -103.27 -26.39 12.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 122.14 -0.35 . . . . 0.0 111.693 -174.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.53 15.36 73.84 Favored Glycine 0 N--CA 1.495 2.586 0 CA-C-O 119.362 -0.688 . . . . 0.0 111.411 -173.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -151.14 162.75 40.29 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 119.145 1.473 . . . . 0.0 110.812 170.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.03 106.52 22.79 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.835 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.427 ' CB ' HD12 ' A' ' 109' ' ' ILE . 72.9 Cg_endo -68.48 160.93 47.12 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 O-C-N 123.383 1.201 . . . . 0.0 110.269 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -73.19 160.58 31.73 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -80.23 79.6 6.78 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.479 0.657 . . . . 0.0 109.686 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.28 176.41 47.79 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 p -138.11 156.25 47.95 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 117.331 0.565 . . . . 0.0 110.813 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.501 HD22 HD12 ' A' ' 114' ' ' LEU . 31.6 tp -108.68 116.47 32.05 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 169.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.548 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.6 m120 -98.41 122.13 41.21 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -176.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.796 HD11 HD11 ' A' ' 126' ' ' ILE . 61.4 mt -120.31 135.59 54.96 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 120.653 0.263 . . . . 0.0 110.535 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -95.9 133.09 40.49 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.52 HD11 HD13 ' A' ' 106' ' ' ILE . 83.6 mt -112.31 160.22 17.88 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 120.653 0.263 . . . . 0.0 110.484 -175.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.06 13.0 14.04 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 172.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -145.99 142.89 29.09 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 118.614 0.643 . . . . 0.0 109.557 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.34 148.63 49.91 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.503 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -131.91 137.44 47.99 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 120.701 0.286 . . . . 0.0 110.44 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -138.09 125.0 21.22 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.5 -23.62 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.266 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -74.24 -1.45 20.61 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.976 -0.453 . . . . 0.0 112.109 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.09 -14.5 31.13 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 118.929 0.786 . . . . 0.0 111.453 170.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -116.67 175.15 5.7 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 118.658 0.663 . . . . 0.0 109.343 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -91.31 102.72 15.42 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -109.44 177.35 4.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 122.323 -0.235 . . . . 0.0 110.563 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.2 mt -111.28 130.91 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -105.97 142.4 35.75 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.2 p -120.69 138.8 53.77 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 120.794 0.331 . . . . 0.0 110.743 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -76.75 172.64 12.75 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 120.847 0.356 . . . . 0.0 111.826 -168.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -67.88 141.21 56.47 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -136.67 164.91 27.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.152 -0.342 . . . . 0.0 110.598 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -123.61 145.95 48.54 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 120.732 0.301 . . . . 0.0 110.469 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -149.88 139.39 21.53 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 52.01 30.34 7.28 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.674 -0.642 . . . . 0.0 112.131 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.36 16.59 80.29 Favored Glycine 0 N--CA 1.497 2.725 0 CA-C-O 119.648 -0.529 . . . . 0.0 111.83 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -122.14 143.45 49.54 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.573 1.187 . . . . 0.0 109.614 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.21 131.41 38.33 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.463 -176.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -120.11 143.49 48.14 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -85.76 157.22 20.32 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 120.715 0.293 . . . . 0.0 110.432 -168.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.29 159.66 47.21 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.93 155.88 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 122.404 -0.468 . . . . 0.0 110.473 -174.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -114.69 138.24 50.94 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.3 t -133.88 140.04 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -177.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 tp -137.12 125.64 14.85 Favored Pre-proline 0 N--CA 1.497 1.88 0 CA-C-O 118.518 -0.753 . . . . 0.0 110.089 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.27 149.27 91.77 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.979 1.12 . . . . 0.0 111.482 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.571 HD13 HG13 ' A' ' 93' ' ' ILE . 43.7 pt -141.95 170.03 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 171.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -114.9 131.17 56.95 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 168.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.2 mt -105.62 124.11 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -174.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.75 116.3 31.71 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -130.01 121.95 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.99 -120.49 18.72 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -111.15 17.09 20.68 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 122.33 -0.512 . . . . 0.0 111.806 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -119.61 144.76 46.95 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 118.609 0.641 . . . . 0.0 110.492 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -123.06 131.15 53.58 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.216 -0.303 . . . . 0.0 110.28 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.79 144.87 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.75 136.57 43.65 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.58 -166.49 12.25 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.593 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.41 155.63 26.99 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 117.311 0.555 . . . . 0.0 110.304 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.571 HG13 HD13 ' A' ' 80' ' ' ILE . 69.3 mt -108.7 141.99 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.1 t -121.43 131.35 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -142.44 136.22 14.52 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -57.28 152.32 46.66 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.1 1.2 . . . . 0.0 111.814 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -66.19 -34.85 78.96 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.394 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -93.89 125.19 38.37 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 t -140.91 154.82 46.29 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -97.64 -57.93 2.12 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -134.61 -177.91 4.83 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.2 p -95.13 150.87 19.73 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.3 m -135.06 174.64 10.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.309 -0.245 . . . . 0.0 110.419 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -107.39 27.49 9.05 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 122.37 -0.206 . . . . 0.0 110.858 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.5 mm -122.91 127.35 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.52 HD13 HD11 ' A' ' 48' ' ' LEU . 34.4 pt -124.95 143.79 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -114.93 129.44 56.71 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.486 HD12 HD12 ' A' ' 46' ' ' LEU . 80.9 mt -115.02 152.04 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -174.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.427 HD12 ' CB ' ' A' ' 39' ' ' PRO . 11.4 pt -117.37 155.23 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 167.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.56 165.59 24.21 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.298 -176.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -60.0 -32.04 94.39 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 121.072 1.181 . . . . 0.0 111.576 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.73 167.03 23.54 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.319 -0.238 . . . . 0.0 110.826 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -70.63 104.34 2.79 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.501 HD12 HD22 ' A' ' 44' ' ' LEU . 81.2 mt -59.55 -33.01 70.87 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 122.211 -0.306 . . . . 0.0 111.497 -177.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -62.44 -35.59 79.75 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 122.109 -0.369 . . . . 0.0 110.949 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -78.22 -48.52 15.62 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -62.61 -33.41 74.93 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 122.159 -0.338 . . . . 0.0 111.099 -173.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -107.95 8.33 28.39 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 51.81 45.1 28.75 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 121.096 -1.002 . . . . 0.0 111.934 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -92.67 138.22 31.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.898 -0.501 . . . . 0.0 110.867 -171.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -114.97 159.31 20.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.11 138.18 50.11 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.906 -0.496 . . . . 0.0 111.467 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.63 -22.98 37.45 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.44 156.0 33.76 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-N 118.629 1.214 . . . . 0.0 109.975 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.36 133.87 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.796 HD11 HD11 ' A' ' 46' ' ' LEU . 34.0 pt -128.74 160.52 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -109.75 138.19 46.47 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 pt -112.77 137.58 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.467 ' C ' HD23 ' A' ' 129' ' ' LEU . 9.4 tt . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.2 mm . . . . . 0 N--CA 1.498 1.956 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.445 HG22 HD22 ' A' ' 48' ' ' LEU . 78.8 mt -130.6 147.74 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -110.08 143.96 39.36 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.59 151.56 21.26 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -105.95 142.56 35.46 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 117.231 0.516 . . . . 0.0 110.278 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.5 t -64.78 122.39 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -126.65 149.18 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.728 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 . . . . . 0 N--CA 1.501 2.106 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -65.76 -30.71 71.4 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 122.224 -0.298 . . . . 0.0 110.797 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -68.77 -40.63 79.61 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.645 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.2 mt -81.45 -37.08 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 92' ' ' ALA . 45.7 mt -104.04 -26.25 12.67 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.262 -0.274 . . . . 0.0 111.638 -174.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.77 14.31 73.2 Favored Glycine 0 N--CA 1.494 2.554 0 CA-C-O 119.319 -0.712 . . . . 0.0 111.449 -172.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -152.43 163.46 39.49 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 119.149 1.475 . . . . 0.0 110.691 170.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -94.97 108.42 37.99 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.583 -0.722 . . . . 0.0 109.922 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.418 ' CB ' HD12 ' A' ' 109' ' ' ILE . 65.8 Cg_endo -67.39 159.64 51.42 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 123.32 1.169 . . . . 0.0 110.492 -176.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -74.0 162.55 28.92 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -80.21 79.59 6.76 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.519 0.676 . . . . 0.0 109.662 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.64 171.86 44.13 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 175.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 p -138.0 157.59 46.06 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 117.382 0.591 . . . . 0.0 110.853 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.2 tp -110.47 116.98 32.35 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.416 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.5 m120 -98.97 121.76 41.34 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -176.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 126' ' ' ILE . 65.4 mt -120.49 135.98 54.9 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.72 0.295 . . . . 0.0 110.642 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -96.09 132.06 41.87 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.445 HD22 HG22 ' A' ' 7' ' ' ILE . 83.5 mt -110.6 160.3 16.79 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 120.64 0.257 . . . . 0.0 110.452 -176.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.28 12.85 14.89 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 172.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -145.27 140.48 27.84 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.696 -0.628 . . . . 0.0 109.39 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.33 146.94 52.46 Favored 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.626 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -132.53 137.19 47.06 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 120.724 0.297 . . . . 0.0 110.639 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -138.0 126.9 24.0 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.0 tt -64.37 -23.94 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.135 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -72.74 -3.55 25.88 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 122.006 -0.434 . . . . 0.0 112.053 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -91.12 -13.89 32.19 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 118.815 0.734 . . . . 0.0 111.51 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -114.2 175.08 5.63 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.596 0.634 . . . . 0.0 109.395 173.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -92.06 102.01 14.56 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -109.18 176.88 4.93 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 120.524 0.202 . . . . 0.0 110.574 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -111.0 129.48 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -105.94 140.91 38.21 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.5 p -117.23 134.9 54.24 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 120.721 0.296 . . . . 0.0 110.495 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -75.83 172.69 12.25 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 120.768 0.318 . . . . 0.0 111.472 -170.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -67.71 139.48 56.72 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -139.83 167.44 22.11 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.618 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -124.23 149.12 46.78 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 120.846 0.355 . . . . 0.0 110.528 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -148.24 135.62 20.5 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.82 32.89 10.34 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.739 -0.601 . . . . 0.0 112.098 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.25 16.6 79.38 Favored Glycine 0 N--CA 1.497 2.745 0 CA-C-O 119.606 -0.552 . . . . 0.0 111.907 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -121.99 142.13 50.63 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.74 1.27 . . . . 0.0 109.731 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.3 132.13 37.79 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.431 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -121.84 144.12 49.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -86.41 155.94 20.37 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.483 -168.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.76 159.15 49.13 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -139.24 156.77 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 122.353 -0.498 . . . . 0.0 110.387 -174.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -117.04 136.76 52.72 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.5 t -134.04 141.19 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.9 tp -137.35 125.63 14.57 Favored Pre-proline 0 N--CA 1.497 1.893 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.152 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.22 149.39 91.5 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 120.928 1.085 . . . . 0.0 111.475 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.538 HD13 HG13 ' A' ' 93' ' ' ILE . 43.7 pt -141.79 170.01 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-O 120.638 0.256 . . . . 0.0 110.312 171.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -116.18 130.58 56.86 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 167.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.8 mt -105.74 123.99 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -174.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.526 HD11 HD13 ' A' ' 129' ' ' LEU . 84.9 mt -107.88 117.17 33.41 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.5 mt -130.15 121.95 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.6 -120.05 17.6 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -111.16 17.11 20.65 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 122.418 -0.46 . . . . 0.0 111.78 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -119.65 143.75 47.54 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.558 0.617 . . . . 0.0 110.444 -175.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -123.12 130.0 52.19 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -125.42 145.05 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.77 136.65 43.63 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.86 -167.34 12.92 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.585 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.72 155.85 26.7 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 117.304 0.552 . . . . 0.0 110.387 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.538 HG13 HD13 ' A' ' 80' ' ' ILE . 69.8 mt -108.77 141.13 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.0 t -122.27 131.13 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -143.73 138.25 15.07 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.09 153.24 39.9 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 121.116 1.21 . . . . 0.0 111.842 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -65.4 -33.79 76.79 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 121.061 -0.255 . . . . 0.0 110.581 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -87.42 117.29 26.1 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 m -130.56 134.7 47.23 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -96.98 -50.24 4.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -133.41 170.02 16.09 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.7 m -94.61 153.34 17.89 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 93.6 p -135.09 173.45 11.71 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 120.739 0.304 . . . . 0.0 110.468 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -105.78 24.55 12.12 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 119.71 -0.186 . . . . 0.0 110.891 172.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.9 mm -119.85 127.43 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.9 pt -125.93 145.93 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -115.98 130.17 56.7 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.487 HD12 HD12 ' A' ' 46' ' ' LEU . 81.3 mt -115.18 150.83 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -174.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.418 HD12 ' CB ' ' A' ' 39' ' ' PRO . 11.2 pt -116.22 156.52 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 168.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.52 161.64 45.96 Favored Pre-proline 0 N--CA 1.495 1.806 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.298 -177.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.02 -31.39 93.42 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 121.044 1.163 . . . . 0.0 111.614 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.32 167.13 23.18 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.277 -0.264 . . . . 0.0 110.634 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -74.3 103.87 4.86 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 120.946 0.403 . . . . 0.0 110.176 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 79.0 mt -60.39 -33.25 72.21 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 122.088 -0.383 . . . . 0.0 111.314 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -61.93 -33.3 74.02 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.159 -0.338 . . . . 0.0 110.925 -175.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.24 -50.88 11.06 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -62.63 -32.52 73.56 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.158 -0.339 . . . . 0.0 111.218 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -106.64 8.07 30.94 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.78 47.51 24.65 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.06 -1.025 . . . . 0.0 111.858 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.3 mt -91.15 138.23 31.75 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.874 -0.517 . . . . 0.0 111.094 -169.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -117.55 159.86 22.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.24 138.38 50.44 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.908 -0.495 . . . . 0.0 111.445 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.55 -23.09 37.07 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -65.39 152.7 43.23 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 118.653 1.227 . . . . 0.0 110.061 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -110.81 133.1 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -174.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.783 HD11 HD11 ' A' ' 46' ' ' LEU . 33.5 pt -128.16 160.64 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -108.78 139.46 43.57 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.2 pt -110.09 137.9 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 174.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.526 HD13 HD11 ' A' ' 83' ' ' LEU . 6.2 tp . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -173.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.722 HD12 HD23 ' A' ' 129' ' ' LEU . 36.7 mm . . . . . 0 N--CA 1.498 1.957 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 78.8 mt -130.72 154.38 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -106.13 146.88 29.64 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.47 150.3 20.99 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -106.3 141.34 37.79 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.267 -0.549 . . . . 0.0 110.141 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.8 t -62.89 123.33 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -123.59 153.91 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 N--CA 1.498 1.964 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.321 -178.507 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 . . . . . 0 N--CA 1.504 2.266 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -63.95 -34.15 77.34 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.272 -0.268 . . . . 0.0 110.798 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -67.32 -38.3 84.7 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.607 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.54 HG23 HD12 ' A' ' 60' ' ' ILE . 59.9 mt -81.2 -37.09 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.5 ' CD2' ' HB2' ' A' ' 92' ' ' ALA . 58.3 mt -101.22 -26.37 13.67 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 122.226 -0.296 . . . . 0.0 111.657 -174.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.66 14.14 76.49 Favored Glycine 0 N--CA 1.494 2.52 0 CA-C-O 119.312 -0.716 . . . . 0.0 111.414 -173.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -152.06 161.45 42.61 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 119.117 1.459 . . . . 0.0 110.609 171.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -94.22 106.44 22.96 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-O 118.611 -0.709 . . . . 0.0 109.901 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.418 ' CB ' HD12 ' A' ' 109' ' ' ILE . 71.5 Cg_endo -68.29 158.48 57.35 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 O-C-N 123.303 1.16 . . . . 0.0 110.314 -177.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -73.5 160.92 30.99 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -80.28 79.62 6.83 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.531 0.681 . . . . 0.0 109.538 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.46 177.64 48.35 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 p -138.07 156.04 48.18 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 117.389 0.594 . . . . 0.0 110.931 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.504 HD22 HD12 ' A' ' 114' ' ' LEU . 27.8 tp -109.04 118.59 37.18 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 169.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.537 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.7 m120 -99.0 123.36 43.24 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.228 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.539 HD11 HD11 ' A' ' 126' ' ' ILE . 56.1 mt -120.71 136.08 54.96 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.688 0.28 . . . . 0.0 110.441 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.511 ' HB2' HG11 ' A' ' 12' ' ' VAL . 39.2 tttp -95.81 133.93 39.37 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.554 HD11 HD13 ' A' ' 106' ' ' ILE . 83.7 mt -112.69 160.3 18.05 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 120.62 0.247 . . . . 0.0 110.395 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.01 12.54 15.22 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 173.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -145.69 144.88 30.65 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 118.563 0.62 . . . . 0.0 109.795 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -63.97 150.35 45.34 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 122.222 -0.298 . . . . 0.0 110.477 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -131.86 139.03 48.69 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 120.69 0.281 . . . . 0.0 110.701 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -138.08 122.87 18.79 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.58 -21.13 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.441 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -75.17 -0.77 20.39 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -89.41 -14.47 35.41 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.991 0.814 . . . . 0.0 111.438 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -119.69 175.19 5.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.624 -0.672 . . . . 0.0 109.531 173.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -91.06 103.45 16.15 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -107.27 177.29 4.89 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 122.336 -0.228 . . . . 0.0 110.463 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.54 HD12 HG23 ' A' ' 34' ' ' ILE . 77.0 mt -109.99 131.95 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.99 143.27 34.36 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.0 p -116.07 133.77 55.67 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -76.69 172.58 12.82 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 120.643 0.258 . . . . 0.0 111.316 -172.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -68.42 139.66 55.77 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -142.85 166.58 24.24 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.668 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -122.87 147.31 46.72 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 120.742 0.306 . . . . 0.0 110.525 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -149.65 138.96 21.39 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.9 m120 52.03 30.26 7.23 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.66 -0.65 . . . . 0.0 112.128 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.61 16.21 80.47 Favored Glycine 0 N--CA 1.496 2.697 0 CA-C-O 119.607 -0.552 . . . . 0.0 111.851 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -121.89 143.94 49.14 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 118.685 1.242 . . . . 0.0 109.717 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -93.5 131.72 38.46 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.488 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -121.32 143.82 48.97 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -87.15 155.19 20.21 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.792 0.329 . . . . 0.0 110.378 -170.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.13 160.99 48.16 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.1 m -141.99 160.79 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 122.32 -0.518 . . . . 0.0 110.367 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -116.13 136.76 52.73 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.5 t -132.69 139.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.0 tp -138.3 125.66 13.51 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.136 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -62.68 149.16 92.09 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 O-C-N 123.189 1.099 . . . . 0.0 111.613 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.617 HD13 HG13 ' A' ' 93' ' ' ILE . 43.6 pt -142.16 170.13 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 172.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -118.32 130.29 55.94 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 168.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.38 129.05 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -173.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.62 HD11 HD21 ' A' ' 129' ' ' LEU . 91.7 mt -107.43 117.62 34.58 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 71.7 mt -129.56 121.87 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.68 -119.95 17.15 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -111.08 16.97 20.83 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.412 -0.464 . . . . 0.0 111.872 176.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -120.4 146.13 46.5 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 118.522 0.601 . . . . 0.0 110.521 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -123.13 130.62 53.01 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -125.89 147.57 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.6 139.75 45.73 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -150.3 -165.85 12.98 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.5 ' HB2' ' CD2' ' A' ' 35' ' ' LEU . . . -159.38 155.45 26.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.28 -0.541 . . . . 0.0 110.182 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.617 HG13 HD13 ' A' ' 80' ' ' ILE . 71.5 mt -108.71 141.36 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.05 130.6 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.4 t -142.18 133.92 13.32 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -57.86 153.24 45.08 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 121.046 1.164 . . . . 0.0 111.801 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -65.5 -34.52 78.46 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.587 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -86.78 121.32 29.11 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.3 t -142.98 156.64 44.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.296 -0.253 . . . . 0.0 110.389 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -97.54 -59.95 1.67 Allowed 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -136.3 -172.19 3.08 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.3 p -93.05 149.45 21.21 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.7 m -134.9 173.08 12.11 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 120.576 0.226 . . . . 0.0 110.427 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -107.7 27.18 9.44 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.423 -0.173 . . . . 0.0 110.865 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -122.33 127.84 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.554 HD13 HD11 ' A' ' 48' ' ' LEU . 34.6 pt -124.59 143.71 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -115.04 128.71 56.42 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.51 HD12 HD12 ' A' ' 46' ' ' LEU . 82.2 mt -115.01 152.49 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -173.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.418 HD12 ' CB ' ' A' ' 39' ' ' PRO . 11.6 pt -116.49 156.0 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 168.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.6 163.88 33.79 Favored Pre-proline 0 N--CA 1.496 1.85 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.249 -176.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.02 -32.56 95.08 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.163 1.242 . . . . 0.0 111.572 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -145.01 167.01 23.68 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.275 -0.266 . . . . 0.0 110.994 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -69.5 103.95 2.19 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.632 0.73 . . . . 0.0 110.465 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.504 HD12 HD22 ' A' ' 44' ' ' LEU . 83.4 mt -60.26 -33.0 71.7 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.664 -0.647 . . . . 0.0 111.641 -178.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -61.48 -37.84 85.09 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 122.054 -0.404 . . . . 0.0 111.296 -171.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -78.35 -45.82 21.58 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.36 -34.15 76.11 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.16 -0.337 . . . . 0.0 111.007 -173.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -108.18 8.27 27.89 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.75 48.06 23.57 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.204 -0.935 . . . . 0.0 111.888 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.4 mt -92.11 138.18 31.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.912 -0.493 . . . . 0.0 110.891 -171.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -117.21 156.19 28.13 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.66 138.02 48.14 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.941 -0.474 . . . . 0.0 111.542 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.97 -22.94 37.42 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.41 152.8 43.02 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-N 118.643 1.222 . . . . 0.0 110.019 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -112.77 134.03 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.539 HD11 HD11 ' A' ' 46' ' ' LEU . 34.3 pt -130.29 165.11 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -107.89 139.86 41.86 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.1 pt -117.04 138.76 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.722 HD23 HD12 ' A' ' 6' ' ' ILE . 12.9 mt . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.0 mm . . . . . 0 N--CA 1.499 1.978 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.488 HG22 HD22 ' A' ' 48' ' ' LEU . 72.9 mt -129.67 148.75 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -105.7 140.04 39.36 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.43 150.14 20.17 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -105.93 141.68 36.92 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 117.21 0.505 . . . . 0.0 110.221 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.9 t -63.15 122.61 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -127.23 162.21 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 N--CA 1.5 2.028 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.703 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 N--CA 1.502 2.13 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -65.86 -30.89 71.57 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.736 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -68.69 -40.58 79.97 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.67 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mt -81.39 -36.86 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 92' ' ' ALA . 50.5 mt -103.96 -26.29 12.69 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.213 -0.304 . . . . 0.0 111.678 -174.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.49 14.76 72.91 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-O 119.304 -0.72 . . . . 0.0 111.436 -172.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -151.9 162.18 41.47 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 119.155 1.478 . . . . 0.0 110.659 170.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -94.84 108.61 38.84 Favored Pre-proline 0 N--CA 1.497 1.878 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.894 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.419 ' CB ' HD12 ' A' ' 109' ' ' ILE . 67.1 Cg_endo -67.33 158.54 56.5 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 O-C-N 123.238 1.125 . . . . 0.0 110.55 -176.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -73.81 162.43 29.13 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -80.22 79.67 6.76 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.378 0.609 . . . . 0.0 109.764 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.16 178.94 48.63 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 175.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -137.96 154.37 49.38 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 117.266 0.533 . . . . 0.0 110.801 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.669 HD22 HD12 ' A' ' 114' ' ' LEU . 31.0 tp -109.61 115.47 29.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 168.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.445 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.4 m120 -99.66 122.77 43.16 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.807 HD11 HD11 ' A' ' 126' ' ' ILE . 53.7 mt -120.57 136.26 54.85 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.716 0.293 . . . . 0.0 110.487 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -95.94 132.91 40.76 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.565 HD11 HD13 ' A' ' 106' ' ' ILE . 83.9 mt -112.16 160.28 17.73 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 120.63 0.253 . . . . 0.0 110.508 -175.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.01 12.89 14.25 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 172.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -145.74 142.0 28.53 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 118.594 0.634 . . . . 0.0 109.573 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.04 147.3 51.12 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 122.235 -0.29 . . . . 0.0 110.697 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -131.81 135.87 47.07 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 120.781 0.324 . . . . 0.0 110.675 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -138.06 127.41 24.66 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 173.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.434 HD13 ' HB3' ' A' ' 76' ' ' LYS . 20.1 tt -63.16 -23.49 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.329 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -74.39 -1.08 19.44 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.944 -0.473 . . . . 0.0 112.184 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -91.12 -14.44 31.17 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 118.913 0.779 . . . . 0.0 111.511 170.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -116.28 175.11 5.7 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.593 0.633 . . . . 0.0 109.373 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -91.51 102.14 14.8 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -109.73 179.23 4.18 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 120.526 0.203 . . . . 0.0 110.591 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.5 mt -110.98 132.14 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -105.92 143.56 33.89 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 36.4 p -124.56 135.04 52.83 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 120.83 0.348 . . . . 0.0 110.667 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.88 172.69 12.73 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 120.825 0.345 . . . . 0.0 111.768 -169.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -68.05 141.14 56.27 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -137.52 166.59 23.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 122.195 -0.315 . . . . 0.0 110.656 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -125.78 149.17 48.79 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 120.861 0.362 . . . . 0.0 110.591 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -148.86 135.01 19.22 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 52.17 33.44 12.37 Favored 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.719 -0.613 . . . . 0.0 111.895 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.73 16.25 80.31 Favored Glycine 0 N--CA 1.497 2.709 0 CA-C-O 119.613 -0.548 . . . . 0.0 111.877 176.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -119.94 139.56 52.26 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 118.723 1.262 . . . . 0.0 109.704 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.41 131.82 38.24 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 120.671 0.272 . . . . 0.0 110.416 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -120.21 143.2 48.39 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -86.08 155.05 20.97 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.774 0.321 . . . . 0.0 110.541 -167.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.07 157.29 51.51 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -138.52 159.21 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 122.258 -0.554 . . . . 0.0 110.404 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.434 ' HB3' HD13 ' A' ' 54' ' ' ILE . 96.9 mttt -117.08 135.84 53.43 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.8 t -132.2 139.61 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -176.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.3 tp -136.45 125.64 15.61 Favored Pre-proline 0 N--CA 1.496 1.871 0 CA-C-O 118.579 -0.725 . . . . 0.0 110.004 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.45 149.15 91.87 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 O-C-N 123.172 1.091 . . . . 0.0 111.426 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.592 HD13 HG13 ' A' ' 93' ' ' ILE . 43.3 pt -141.9 169.85 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 171.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -114.98 131.33 56.95 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 168.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.6 mt -105.32 123.2 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -175.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.1 mt -107.5 115.89 30.97 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.7 mt -130.02 121.95 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.12 -120.59 18.77 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -111.14 17.02 20.75 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.344 -0.503 . . . . 0.0 111.888 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -119.77 145.16 46.83 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 118.586 0.63 . . . . 0.0 110.552 -175.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -123.08 129.5 51.55 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 120.741 0.305 . . . . 0.0 110.295 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.3 mt -125.65 143.4 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.04 137.46 43.41 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.1 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.27 -165.15 11.6 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.572 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.46 154.9 25.62 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 117.429 0.615 . . . . 0.0 110.507 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.592 HG13 HD13 ' A' ' 80' ' ' ILE . 68.6 mt -108.7 141.74 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.97 132.49 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -175.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.1 t -145.05 137.05 13.06 Favored Pre-proline 0 N--CA 1.498 1.959 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -58.41 154.59 40.48 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 121.072 1.182 . . . . 0.0 111.687 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -65.17 -34.17 77.74 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.805 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -85.15 116.96 23.81 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.305 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.7 m -131.68 139.57 49.09 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -94.62 -49.61 5.56 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -137.68 172.44 12.95 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -89.22 146.78 24.53 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.0 m -135.03 169.89 16.74 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 120.615 0.245 . . . . 0.0 110.607 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -106.96 27.63 8.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.438 -0.164 . . . . 0.0 110.795 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.5 mm -121.79 126.75 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.565 HD13 HD11 ' A' ' 48' ' ' LEU . 34.0 pt -124.06 143.86 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -115.15 130.88 57.04 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.439 HD12 HD12 ' A' ' 46' ' ' LEU . 81.7 mt -116.11 151.5 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -173.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.419 HD12 ' CB ' ' A' ' 39' ' ' PRO . 13.4 pt -116.59 153.52 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 167.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.53 164.64 29.51 Favored Pre-proline 0 N--CA 1.495 1.807 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.234 -176.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.21 -31.94 93.74 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.042 1.162 . . . . 0.0 111.584 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.59 167.1 23.34 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.29 -0.256 . . . . 0.0 110.716 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -70.8 104.45 2.9 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.669 HD12 HD22 ' A' ' 44' ' ' LEU . 80.9 mt -59.58 -33.13 71.06 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 122.022 -0.424 . . . . 0.0 111.511 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -62.62 -35.37 79.36 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 122.119 -0.363 . . . . 0.0 110.964 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -78.25 -48.31 16.03 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.43 -33.24 74.4 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 122.163 -0.335 . . . . 0.0 111.074 -173.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -107.99 7.83 28.07 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.88 45.8 27.63 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.025 -1.047 . . . . 0.0 111.876 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.3 mt -92.34 138.21 31.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.862 -0.524 . . . . 0.0 110.93 -171.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -114.79 157.54 23.1 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -55.87 137.94 49.32 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.919 -0.488 . . . . 0.0 111.535 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.95 -22.99 37.23 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -177.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -65.44 156.11 33.42 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 118.621 1.21 . . . . 0.0 110.004 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.6 t -112.36 134.07 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.807 HD11 HD11 ' A' ' 46' ' ' LEU . 34.4 pt -128.98 160.59 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -109.78 138.08 46.66 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -175.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.1 pt -112.12 137.57 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.463 ' C ' HD23 ' A' ' 129' ' ' LEU . 8.8 tt . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.4 mm . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.408 HG22 HD22 ' A' ' 48' ' ' LEU . 78.0 mt -130.59 147.61 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 171.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -110.23 143.81 39.83 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.318 -0.239 . . . . 0.0 110.405 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.75 152.45 21.7 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -105.8 140.7 38.44 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 117.242 0.521 . . . . 0.0 110.35 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.0 t -63.43 122.49 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.75 137.24 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 173.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.6 p . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -178.963 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -65.49 -32.79 74.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 122.194 -0.316 . . . . 0.0 110.731 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -67.95 -38.31 82.65 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.671 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.9 mt -80.76 -39.08 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.3 mt -99.55 -26.28 14.15 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 122.263 -0.273 . . . . 0.0 111.541 -174.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.65 14.2 76.36 Favored Glycine 0 N--CA 1.496 2.646 0 CA-C-O 119.363 -0.687 . . . . 0.0 111.428 -174.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -152.05 163.37 39.45 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 119.082 1.441 . . . . 0.0 110.709 171.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -95.44 109.59 46.18 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.744 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.53 163.38 35.08 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 123.288 1.151 . . . . 0.0 110.601 -175.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -74.28 163.16 28.15 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -80.36 79.64 6.92 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.463 0.649 . . . . 0.0 109.858 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.5 172.8 44.03 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 174.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -136.51 156.08 49.09 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 117.285 0.542 . . . . 0.0 110.562 173.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.3 tp -108.88 116.41 31.94 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 172.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.31 122.88 42.02 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.831 HD11 HD11 ' A' ' 126' ' ' ILE . 59.0 mt -120.04 135.84 54.79 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 120.75 0.31 . . . . 0.0 110.554 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -95.47 132.34 40.65 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.478 HD11 ' CD1' ' A' ' 106' ' ' ILE . 83.8 mt -111.95 160.25 17.62 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 120.683 0.278 . . . . 0.0 110.4 -175.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.31 13.17 14.13 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 172.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -145.25 140.38 27.8 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 118.568 0.622 . . . . 0.0 109.479 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.27 146.91 52.44 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 122.254 -0.279 . . . . 0.0 110.679 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -132.0 136.75 47.52 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 120.706 0.289 . . . . 0.0 110.584 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -138.06 125.99 22.62 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.57 -23.92 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.341 -177.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -74.22 -0.93 18.4 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.51 -14.13 33.29 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 118.908 0.776 . . . . 0.0 111.457 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -115.84 175.07 5.7 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 118.613 0.642 . . . . 0.0 109.454 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -92.46 103.46 15.88 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -109.85 176.2 5.16 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 120.512 0.196 . . . . 0.0 110.499 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.3 mt -110.25 129.7 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 175.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -105.9 147.4 28.79 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.2 p -125.24 134.96 52.13 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 120.778 0.323 . . . . 0.0 110.768 175.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -75.14 172.72 11.87 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 120.757 0.313 . . . . 0.0 111.707 -170.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -66.99 139.55 57.69 Favored 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -140.63 166.78 23.79 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 122.215 -0.303 . . . . 0.0 110.633 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -124.45 149.06 47.2 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 120.8 0.333 . . . . 0.0 110.559 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -149.09 135.13 19.05 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 52.15 33.96 13.34 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.705 -0.622 . . . . 0.0 111.881 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.82 15.97 80.59 Favored Glycine 0 N--CA 1.497 2.737 0 CA-C-O 119.589 -0.562 . . . . 0.0 111.875 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -121.19 140.97 51.29 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 118.768 1.284 . . . . 0.0 109.717 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -92.87 130.81 38.35 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.368 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -120.14 143.52 48.14 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -85.96 156.18 20.58 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.307 -169.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.44 157.23 50.12 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -138.88 157.93 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 122.448 -0.443 . . . . 0.0 110.456 -174.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -120.52 137.94 54.11 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.4 t -133.98 141.81 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -176.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.4 tp -137.49 125.7 14.46 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.164 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.24 149.59 90.91 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 120.961 1.107 . . . . 0.0 111.496 177.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.564 HD13 HG13 ' A' ' 93' ' ' ILE . 43.7 pt -141.76 170.15 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 171.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -116.44 129.8 56.42 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 168.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.53 125.39 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.603 HD11 HD13 ' A' ' 129' ' ' LEU . 86.5 mt -107.87 116.59 32.24 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 -178.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.9 mt -129.83 122.02 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.03 -120.54 18.82 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -111.09 17.02 20.8 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 122.29 -0.535 . . . . 0.0 111.988 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -119.89 145.82 46.34 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 118.449 0.568 . . . . 0.0 110.513 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -122.96 130.82 53.31 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.42 145.81 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.51 136.92 44.15 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.05 -167.34 12.99 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 177.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.69 155.08 25.43 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 117.35 0.575 . . . . 0.0 110.363 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.564 HG13 HD13 ' A' ' 80' ' ' ILE . 70.0 mt -108.72 142.62 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.7 t -121.48 131.48 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.7 t -142.53 136.66 14.75 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -58.01 154.97 35.86 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 121.077 1.184 . . . . 0.0 111.81 176.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -65.6 -37.41 86.54 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.317 -0.239 . . . . 0.0 110.43 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -94.64 120.59 35.11 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.0 p -130.22 155.07 46.87 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -98.07 -57.86 2.12 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -136.6 170.87 15.36 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.4 p -85.68 148.22 25.99 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.1 m -135.01 175.01 9.97 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 120.57 0.224 . . . . 0.0 110.489 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -107.4 27.93 8.61 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 122.415 -0.178 . . . . 0.0 110.851 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.0 mm -123.4 126.7 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.478 ' CD1' HD11 ' A' ' 48' ' ' LEU . 34.3 pt -125.64 145.77 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -114.6 131.68 56.61 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.498 HD12 HD12 ' A' ' 46' ' ' LEU . 81.9 mt -117.56 149.31 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 pt -119.13 155.33 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 168.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.56 165.98 22.15 Favored Pre-proline 0 N--CA 1.496 1.846 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.246 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -59.14 -30.34 92.87 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 121.151 1.234 . . . . 0.0 111.716 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.23 167.06 23.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 122.248 -0.282 . . . . 0.0 110.732 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -71.15 105.96 3.59 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.61 -33.4 71.44 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 122.067 -0.396 . . . . 0.0 111.402 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -62.65 -35.34 79.31 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 122.182 -0.324 . . . . 0.0 110.954 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -78.18 -48.07 16.67 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -62.61 -33.64 75.4 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.193 -0.317 . . . . 0.0 111.063 -172.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -108.01 8.15 28.18 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.81 46.03 27.24 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 120.979 -1.076 . . . . 0.0 111.819 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.9 mt -91.98 138.22 31.72 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.89 -0.506 . . . . 0.0 110.961 -171.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -114.92 157.49 23.29 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.72 137.77 48.92 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.888 -0.508 . . . . 0.0 111.491 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.92 -22.88 37.73 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -178.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.44 157.42 29.49 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 118.645 1.222 . . . . 0.0 109.952 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.3 t -112.19 133.17 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -174.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.831 HD11 HD11 ' A' ' 46' ' ' LEU . 33.8 pt -128.51 160.59 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -109.06 139.65 43.66 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.302 -175.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.1 pt -109.87 138.44 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.603 HD13 HD11 ' A' ' 83' ' ' LEU . 6.5 tp . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -172.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.7 mm . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.449 HG22 HD22 ' A' ' 48' ' ' LEU . 78.6 mt -130.76 148.31 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -110.78 144.76 39.27 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.5 151.15 21.42 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -106.77 141.85 37.35 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 117.217 0.508 . . . . 0.0 110.263 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.3 121.16 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.75 148.49 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 177.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.4 p . . . . . 0 N--CA 1.499 1.987 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.662 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.466 ' CE1' HD13 ' A' ' 109' ' ' ILE . 4.2 m-85 . . . . . 0 N--CA 1.502 2.153 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -65.7 -32.63 74.29 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 122.219 -0.301 . . . . 0.0 110.785 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -68.89 -40.25 79.3 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.641 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.0 mt -81.66 -36.37 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' A' ' 92' ' ' ALA . 48.4 mt -104.0 -26.35 12.65 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.197 -0.314 . . . . 0.0 111.622 -173.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.02 15.15 73.22 Favored Glycine 0 N--CA 1.495 2.599 0 CA-C-O 119.371 -0.683 . . . . 0.0 111.459 -172.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -151.42 161.43 42.7 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 119.143 1.472 . . . . 0.0 110.765 170.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -94.15 107.88 31.81 Favored Pre-proline 0 N--CA 1.496 1.865 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.834 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.53 158.16 58.39 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 O-C-N 123.272 1.143 . . . . 0.0 110.403 -176.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -74.07 162.95 28.48 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -80.14 79.63 6.67 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.429 0.633 . . . . 0.0 109.732 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.66 172.1 44.39 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 175.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 p -138.01 156.51 47.74 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 117.391 0.596 . . . . 0.0 110.85 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.9 tp -109.4 117.29 33.65 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.98 122.24 41.98 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -176.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.838 HD11 HD11 ' A' ' 126' ' ' ILE . 61.2 mt -120.58 135.79 54.99 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 120.75 0.31 . . . . 0.0 110.617 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -95.97 133.55 40.04 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.449 HD22 HG22 ' A' ' 7' ' ' ILE . 84.6 mt -112.05 160.3 17.63 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 120.633 0.254 . . . . 0.0 110.544 -176.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.61 13.56 13.74 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 171.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -145.44 139.38 26.85 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 118.552 0.614 . . . . 0.0 109.63 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -62.16 147.24 48.27 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 122.115 -0.366 . . . . 0.0 110.901 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -131.95 136.51 47.4 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 120.766 0.317 . . . . 0.0 110.45 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -137.96 125.6 22.24 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 76' ' ' LYS . 20.2 tt -63.89 -24.73 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.219 -177.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -73.53 -1.83 20.2 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -91.33 -14.04 31.48 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 118.787 0.721 . . . . 0.0 111.484 169.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -114.5 175.13 5.62 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.614 -0.679 . . . . 0.0 109.315 174.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -92.49 101.99 14.44 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -110.54 177.39 4.7 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 120.638 0.256 . . . . 0.0 110.672 -177.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.6 mt -112.09 132.88 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -105.9 143.87 33.43 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.3 p -121.95 136.44 54.92 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 120.624 0.25 . . . . 0.0 110.679 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.55 172.72 12.52 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 120.786 0.327 . . . . 0.0 111.642 -170.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -67.97 140.16 56.39 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -138.6 163.57 31.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.218 -0.301 . . . . 0.0 110.758 -175.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -123.66 147.47 47.37 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 122.281 -0.262 . . . . 0.0 110.401 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -149.77 136.92 19.7 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.7 32.2 9.04 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.82 -0.55 . . . . 0.0 112.162 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.22 17.59 77.82 Favored Glycine 0 N--CA 1.497 2.727 0 CA-C-O 119.614 -0.548 . . . . 0.0 111.823 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -123.08 140.95 52.49 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.577 1.188 . . . . 0.0 109.803 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.86 132.56 38.16 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 120.618 0.247 . . . . 0.0 110.421 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.22 142.7 49.66 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -86.29 157.81 19.83 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 120.737 0.303 . . . . 0.0 110.336 -169.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.5 157.49 50.02 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -139.51 157.13 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 122.388 -0.478 . . . . 0.0 110.488 -174.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HB3' HD13 ' A' ' 54' ' ' ILE . 68.8 mttt -114.22 138.42 50.5 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.6 t -133.63 139.05 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.4 tp -137.09 125.6 14.85 Favored Pre-proline 0 N--CA 1.497 1.887 0 CA-C-O 118.533 -0.746 . . . . 0.0 110.125 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -63.39 149.63 90.67 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 O-C-N 123.158 1.083 . . . . 0.0 111.457 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.54 HD13 HG13 ' A' ' 93' ' ' ILE . 43.5 pt -141.9 170.01 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 122.286 -0.259 . . . . 0.0 110.38 171.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -115.31 130.03 56.78 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 168.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.68 124.17 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.412 HD11 HD13 ' A' ' 129' ' ' LEU . 84.3 mt -107.99 116.82 32.66 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.5 mt -129.93 121.93 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.76 -120.23 18.09 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -111.18 17.1 20.64 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 122.354 -0.498 . . . . 0.0 111.806 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -119.76 144.62 47.18 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 118.604 0.638 . . . . 0.0 110.497 -175.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -123.12 129.91 52.08 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -125.75 146.09 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.59 136.24 43.95 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.74 -168.2 13.02 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.591 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.56 154.98 25.54 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 117.307 0.553 . . . . 0.0 110.369 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.54 HG13 HD13 ' A' ' 80' ' ' ILE . 69.3 mt -108.71 141.53 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.42 130.83 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -141.6 134.37 14.1 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -57.33 154.81 32.96 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 121.055 1.17 . . . . 0.0 111.91 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -64.85 -34.5 78.52 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.688 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -86.71 117.75 25.67 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 m -132.76 139.86 47.78 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -96.23 -57.54 2.31 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -132.6 -176.78 4.21 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.2 p -93.54 150.03 20.76 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.3 m -135.06 170.09 16.44 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.652 0.263 . . . . 0.0 110.294 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -107.82 27.72 8.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.363 -0.211 . . . . 0.0 110.875 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -123.9 127.87 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 27.7 pt -126.19 145.35 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 177.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -114.94 130.61 56.96 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.47 HD12 HD12 ' A' ' 46' ' ' LEU . 82.5 mt -115.7 150.98 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -174.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.466 HD13 ' CE1' ' A' ' 31' ' ' PHE . 11.2 pt -116.47 155.64 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 168.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.49 164.92 27.93 Favored Pre-proline 0 N--CA 1.496 1.83 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.315 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.57 -30.75 93.15 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.071 1.181 . . . . 0.0 111.653 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.43 167.06 23.39 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.322 -0.236 . . . . 0.0 110.773 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -71.29 105.22 3.4 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 120.875 0.369 . . . . 0.0 110.042 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.45 -33.58 71.45 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.043 -0.41 . . . . 0.0 111.535 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -62.96 -35.34 79.82 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 122.11 -0.369 . . . . 0.0 110.929 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -78.3 -47.94 16.75 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -62.54 -34.15 76.36 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 122.221 -0.299 . . . . 0.0 111.028 -172.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -108.1 8.49 28.17 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 51.83 47.23 25.19 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.148 -0.97 . . . . 0.0 111.849 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.9 mt -92.09 138.14 31.78 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.917 -0.49 . . . . 0.0 111.036 -170.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -115.67 158.95 22.0 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -56.06 138.17 49.86 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.893 -0.504 . . . . 0.0 111.506 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.58 -22.95 37.6 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.4 154.93 37.02 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 118.597 1.198 . . . . 0.0 110.026 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.6 t -112.05 133.94 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.838 HD11 HD11 ' A' ' 46' ' ' LEU . 34.8 pt -128.82 160.35 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -109.2 140.3 42.99 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.237 -175.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.0 pt -111.84 138.1 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.412 HD13 HD11 ' A' ' 83' ' ' LEU . 6.2 tp . . . . . 0 N--CA 1.493 1.723 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -173.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.2 mm . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.496 HG22 HD22 ' A' ' 48' ' ' LEU . 70.3 mt -128.16 147.73 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -106.01 138.56 41.98 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.248 -0.283 . . . . 0.0 110.276 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.34 149.09 19.72 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -106.58 142.16 36.69 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 117.237 0.519 . . . . 0.0 110.226 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.19 122.49 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.8 m -124.97 151.27 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 176.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.5 p . . . . . 0 N--CA 1.499 1.985 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -178.578 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CE1' HD13 ' A' ' 109' ' ' ILE . 3.6 m-85 . . . . . 0 N--CA 1.501 2.108 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -65.57 -31.79 73.03 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 122.225 -0.297 . . . . 0.0 110.791 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -68.72 -40.16 80.08 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.586 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.1 mt -81.65 -36.64 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' A' ' 92' ' ' ALA . 46.5 mt -103.91 -26.22 12.74 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.255 -0.278 . . . . 0.0 111.609 -174.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.08 15.46 72.25 Favored Glycine 0 N--CA 1.495 2.595 0 CA-C-O 119.312 -0.715 . . . . 0.0 111.415 -172.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -151.28 160.84 43.59 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.169 1.484 . . . . 0.0 110.751 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -93.53 108.16 31.9 Favored Pre-proline 0 N--CA 1.496 1.857 0 CA-C-O 118.629 -0.701 . . . . 0.0 109.747 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.08 158.2 58.0 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 O-C-N 123.237 1.124 . . . . 0.0 110.534 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -73.6 163.41 28.04 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.29 79.56 6.86 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.541 0.686 . . . . 0.0 109.607 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.39 171.22 43.02 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -138.01 158.46 44.27 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 117.441 0.62 . . . . 0.0 110.818 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.8 tp -109.1 116.01 31.14 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 170.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.456 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.7 m120 -98.26 121.58 40.37 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -177.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.539 HD11 HD11 ' A' ' 126' ' ' ILE . 60.5 mt -120.67 136.81 54.74 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.703 0.287 . . . . 0.0 110.639 -177.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' HG11 ' A' ' 12' ' ' VAL . 65.5 tttt -96.03 131.91 41.93 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.496 HD22 HG22 ' A' ' 7' ' ' ILE . 83.6 mt -110.7 160.25 16.88 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 120.603 0.239 . . . . 0.0 110.472 -176.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.11 13.1 13.91 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 172.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -145.63 141.69 28.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.712 -0.618 . . . . 0.0 109.542 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -64.11 147.04 53.15 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.196 -0.315 . . . . 0.0 110.497 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -131.83 135.67 46.91 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 120.749 0.309 . . . . 0.0 110.543 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -138.04 125.39 21.83 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.3 tt -63.52 -23.13 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.397 -176.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -73.33 -2.85 23.75 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 122.014 -0.429 . . . . 0.0 112.079 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -90.56 -13.93 33.56 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.878 0.763 . . . . 0.0 111.462 171.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -114.75 175.02 5.67 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 118.579 0.627 . . . . 0.0 109.338 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -92.54 101.98 14.42 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -109.32 176.39 5.1 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 120.563 0.221 . . . . 0.0 110.538 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -110.8 131.57 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -105.89 142.89 34.83 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.5 p -121.42 138.68 54.17 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.808 0.337 . . . . 0.0 110.688 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -76.79 172.71 12.65 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 120.858 0.361 . . . . 0.0 111.762 -168.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -67.96 141.22 56.37 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -135.95 167.13 21.79 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.557 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -125.75 149.01 48.9 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.888 0.375 . . . . 0.0 110.6 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -148.86 135.75 19.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 51.96 32.83 10.63 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.69 -0.631 . . . . 0.0 112.114 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.06 17.0 79.04 Favored Glycine 0 N--CA 1.496 2.682 0 CA-C-O 119.635 -0.536 . . . . 0.0 111.846 176.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -121.75 140.62 52.11 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 118.6 1.2 . . . . 0.0 109.699 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -93.57 131.97 38.32 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.393 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -121.25 145.33 47.97 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -85.72 156.61 20.56 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.808 0.337 . . . . 0.0 110.448 -167.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.42 162.93 43.49 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.61 155.52 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 122.4 -0.471 . . . . 0.0 110.38 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -114.43 137.29 52.02 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.2 t -134.0 140.93 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.1 tp -136.84 125.62 15.15 Favored Pre-proline 0 N--CA 1.496 1.86 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.108 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -63.39 149.75 90.35 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 120.971 1.114 . . . . 0.0 111.441 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.528 HD13 HG13 ' A' ' 93' ' ' ILE . 43.5 pt -141.88 170.0 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 120.712 0.291 . . . . 0.0 110.317 171.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -113.95 131.87 56.16 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 167.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.0 mt -106.64 123.17 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -175.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.434 HD11 HD12 ' A' ' 129' ' ' LEU . 85.7 mt -107.94 116.86 32.72 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.3 mt -130.06 121.98 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.28 -119.68 16.66 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -111.09 17.0 20.81 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.373 -0.486 . . . . 0.0 111.841 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -120.42 143.91 48.22 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 118.575 0.625 . . . . 0.0 110.52 -174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -123.1 129.44 51.45 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -125.88 146.54 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.52 136.38 44.09 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.92 -168.52 12.83 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.622 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.54 154.92 25.49 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 117.309 0.554 . . . . 0.0 110.286 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.528 HG13 HD13 ' A' ' 80' ' ' ILE . 67.3 mt -108.62 141.61 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.8 t -120.73 132.28 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -175.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.0 t -142.37 133.27 12.8 Favored Pre-proline 0 N--CA 1.497 1.88 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.54 155.73 29.86 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 121.081 1.187 . . . . 0.0 111.885 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -64.59 -34.05 77.35 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 122.298 -0.251 . . . . 0.0 110.659 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -89.13 111.29 22.03 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.284 -0.26 . . . . 0.0 110.325 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.5 m -131.77 134.73 46.15 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -97.08 -56.16 2.63 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.31 -0.244 . . . . 0.0 110.344 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -121.99 -179.36 4.12 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.7 m -104.87 152.73 22.26 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.7 p -135.01 172.81 12.49 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 120.664 0.269 . . . . 0.0 110.562 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -105.63 24.62 11.93 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.854 172.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.9 mm -121.08 126.98 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.486 ' CD1' HD11 ' A' ' 48' ' ' LEU . 34.5 pt -127.42 148.41 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -116.62 130.86 56.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.517 HD12 HD12 ' A' ' 46' ' ' LEU . 82.4 mt -115.08 150.42 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -175.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.463 HD13 ' CE1' ' A' ' 31' ' ' PHE . 11.0 pt -115.99 155.88 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 168.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.53 165.84 22.95 Favored Pre-proline 0 N--CA 1.496 1.831 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.279 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.37 -30.37 92.54 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 121.084 1.189 . . . . 0.0 111.667 177.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.42 167.05 23.41 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 122.28 -0.262 . . . . 0.0 110.652 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -71.02 105.5 3.34 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.63 -33.93 72.15 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 122.105 -0.372 . . . . 0.0 111.462 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -63.16 -34.75 78.29 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 122.143 -0.348 . . . . 0.0 110.892 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -78.2 -48.99 14.63 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -62.51 -34.09 76.19 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 122.188 -0.32 . . . . 0.0 111.102 -172.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -108.05 8.15 28.1 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.85 50.15 19.25 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 120.986 -1.071 . . . . 0.0 111.917 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 48.2 mt -91.08 138.19 31.79 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.871 -0.518 . . . . 0.0 110.857 -172.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -115.19 156.74 24.77 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.77 137.95 48.84 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.9 -0.5 . . . . 0.0 111.5 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.9 -22.91 37.59 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.39 153.99 39.68 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-N 118.641 1.221 . . . . 0.0 110.005 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.09 134.01 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.539 HD11 HD11 ' A' ' 46' ' ' LEU . 34.7 pt -130.3 162.25 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 174.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -110.02 139.18 45.42 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.365 -174.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 pt -111.73 137.75 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.462 ' C ' HD23 ' A' ' 129' ' ' LEU . 8.5 tt . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -175.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.4 mm . . . . . 0 N--CA 1.499 2.0 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.517 HG22 HD22 ' A' ' 48' ' ' LEU . 72.9 mt -130.02 148.32 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 176.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -105.45 140.95 37.77 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.16 150.71 20.27 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -106.27 141.74 37.12 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 117.176 0.488 . . . . 0.0 110.186 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.15 121.78 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.8 m -126.32 158.84 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 177.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.499 1.988 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.332 -179.007 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 N--CA 1.501 2.114 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -65.33 -36.93 85.53 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 122.151 -0.343 . . . . 0.0 110.366 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -68.24 -38.67 82.09 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.505 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.2 mt -81.16 -35.68 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' A' ' 92' ' ' ALA . 45.3 mt -103.92 -26.26 12.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.102 -0.373 . . . . 0.0 111.696 -173.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.39 12.94 79.7 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -171.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -150.91 160.57 43.82 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 119.068 1.434 . . . . 0.0 110.306 170.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -93.39 109.35 39.87 Favored Pre-proline 0 N--CA 1.496 1.849 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.816 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.422 ' CB ' HD12 ' A' ' 109' ' ' ILE . 64.2 Cg_endo -67.25 159.76 50.73 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 O-C-N 123.274 1.144 . . . . 0.0 110.502 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -73.81 163.29 28.14 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -80.25 79.56 6.81 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.511 0.672 . . . . 0.0 109.64 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.48 172.89 45.32 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 175.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 p -138.09 157.41 46.38 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 117.343 0.571 . . . . 0.0 110.804 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.414 HD22 HD12 ' A' ' 114' ' ' LEU . 32.6 tp -109.61 115.02 29.13 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 170.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.423 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.6 m120 -98.72 120.05 38.49 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.78 HD11 HD11 ' A' ' 126' ' ' ILE . 62.6 mt -119.98 135.95 54.72 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 120.697 0.284 . . . . 0.0 110.631 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HB2' HG11 ' A' ' 12' ' ' VAL . 79.3 tttt -95.98 132.17 41.59 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.517 HD22 HG22 ' A' ' 7' ' ' ILE . 83.8 mt -110.95 160.27 16.96 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 120.605 0.24 . . . . 0.0 110.475 -176.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -88.93 12.73 14.52 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 172.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -145.49 142.44 29.23 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 118.555 0.616 . . . . 0.0 109.466 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -64.43 146.92 53.75 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.413 178.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -134.4 137.14 43.83 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.733 0.301 . . . . 0.0 110.654 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -138.16 129.58 27.71 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.2 tt -63.95 -22.22 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.337 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -74.42 -0.97 19.06 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.933 -0.479 . . . . 0.0 112.235 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -91.04 -14.74 30.78 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 118.918 0.781 . . . . 0.0 111.445 170.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -117.21 175.11 5.76 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 118.679 0.672 . . . . 0.0 109.467 174.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -90.85 102.75 15.51 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -109.67 177.03 4.86 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 120.546 0.212 . . . . 0.0 110.471 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -110.46 130.8 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -106.0 143.75 33.7 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.8 p -121.69 138.02 54.52 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.74 0.305 . . . . 0.0 110.751 177.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.87 172.67 12.76 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 120.864 0.364 . . . . 0.0 111.687 -169.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -67.59 140.79 56.93 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -136.97 167.01 22.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 122.208 -0.308 . . . . 0.0 110.544 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -125.11 149.08 48.22 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 120.861 0.362 . . . . 0.0 110.607 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -148.35 135.24 20.03 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 51.73 33.44 11.07 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.806 -0.559 . . . . 0.0 112.082 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.09 16.94 79.09 Favored Glycine 0 N--CA 1.498 2.771 0 CA-C-O 119.599 -0.556 . . . . 0.0 111.782 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -122.28 140.94 52.04 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 118.694 1.247 . . . . 0.0 109.649 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -93.25 131.85 37.98 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 120.653 0.264 . . . . 0.0 110.493 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -120.76 144.08 48.47 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -86.37 156.72 20.08 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 120.784 0.326 . . . . 0.0 110.481 -168.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.18 161.86 44.12 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.39 156.0 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 122.294 -0.533 . . . . 0.0 110.364 -174.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -116.57 137.19 52.37 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.7 t -134.12 142.1 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.0 tp -137.39 125.64 14.54 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-O 118.61 -0.71 . . . . 0.0 110.094 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -63.43 148.71 92.48 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 120.955 1.103 . . . . 0.0 111.42 177.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.548 HD13 HG13 ' A' ' 93' ' ' ILE . 43.8 pt -141.38 170.06 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 120.674 0.274 . . . . 0.0 110.356 172.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -114.45 131.76 56.5 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 168.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.9 mt -106.25 124.04 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -175.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -109.08 116.26 31.61 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.2 mt -130.0 121.93 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.41 -119.78 16.87 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -111.07 17.0 20.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.208 -0.584 . . . . 0.0 111.868 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -120.79 144.25 48.41 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 118.547 0.612 . . . . 0.0 110.503 -174.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -123.17 130.19 52.42 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -126.45 148.33 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.51 137.58 44.51 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.23 -169.9 14.46 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 177.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.552 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.32 154.88 25.86 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 117.339 0.57 . . . . 0.0 110.235 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.548 HG13 HD13 ' A' ' 80' ' ' ILE . 70.6 mt -108.79 142.26 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.35 131.56 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -142.25 132.53 12.57 Favored Pre-proline 0 N--CA 1.498 1.926 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -58.09 154.86 37.04 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 121.063 1.175 . . . . 0.0 111.796 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -64.99 -33.61 76.45 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.228 -0.295 . . . . 0.0 110.77 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -87.64 114.44 24.26 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 m -132.2 138.83 48.12 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -96.63 -57.04 2.4 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -129.42 -178.73 4.79 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.6 m -98.03 153.04 18.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.7 t -134.98 172.22 13.31 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 120.586 0.232 . . . . 0.0 110.563 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -105.69 24.43 12.27 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.963 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -120.65 127.13 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.465 HD13 HD11 ' A' ' 48' ' ' LEU . 34.4 pt -125.83 145.76 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -115.39 130.91 57.04 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.498 HD12 HD12 ' A' ' 46' ' ' LEU . 81.3 mt -116.47 151.63 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -174.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.422 HD12 ' CB ' ' A' ' 39' ' ' PRO . 11.7 pt -117.73 156.12 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 168.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.52 165.65 24.0 Favored Pre-proline 0 N--CA 1.494 1.75 0 CA-C-O 119.078 -0.487 . . . . 0.0 110.311 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -59.48 -30.8 93.46 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 121.117 1.211 . . . . 0.0 111.576 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.31 167.02 23.44 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 122.299 -0.25 . . . . 0.0 110.701 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -71.57 105.24 3.57 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.414 HD12 HD22 ' A' ' 44' ' ' LEU . 80.3 mt -59.52 -33.67 71.66 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 122.144 -0.347 . . . . 0.0 111.471 -177.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -63.04 -34.91 78.58 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 122.124 -0.36 . . . . 0.0 110.951 -175.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.2 -47.7 17.46 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -62.45 -34.99 77.89 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 122.211 -0.305 . . . . 0.0 111.038 -172.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -108.03 9.94 28.35 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 51.81 47.92 23.84 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.226 -0.921 . . . . 0.0 111.972 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 48.6 mt -91.37 138.25 31.73 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.958 -0.464 . . . . 0.0 110.798 -172.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -114.12 158.62 21.04 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.87 138.07 49.11 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.794 -0.566 . . . . 0.0 111.429 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.53 -22.96 37.59 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.4 155.59 34.93 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-N 118.648 1.224 . . . . 0.0 110.039 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.41 134.09 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -174.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.78 HD11 HD11 ' A' ' 46' ' ' LEU . 34.3 pt -128.76 160.73 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -109.9 137.63 47.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.205 -0.31 . . . . 0.0 110.179 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -113.11 137.25 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 129' ' ' LEU . 9.2 tt . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.0 mm . . . . . 0 N--CA 1.499 1.996 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.2 mt -129.81 149.73 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -105.85 141.87 36.54 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.25 150.45 20.45 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.52 142.18 36.6 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 117.217 0.508 . . . . 0.0 110.278 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.1 t -63.04 123.22 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -122.37 155.13 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 176.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.4 p . . . . . 0 N--CA 1.499 2.001 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.352 -177.302 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 N--CA 1.501 2.109 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -65.76 -32.64 74.29 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.73 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -68.7 -40.15 80.17 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.605 178.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.8 mt -81.56 -35.78 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -176.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.428 HD21 ' HB2' ' A' ' 92' ' ' ALA . 47.1 mt -103.31 -26.29 12.99 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.183 -0.323 . . . . 0.0 111.767 -173.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.7 15.3 75.97 Favored Glycine 0 N--CA 1.493 2.492 0 CA-C-O 119.3 -0.722 . . . . 0.0 111.371 -173.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -150.83 162.31 40.99 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 119.166 1.483 . . . . 0.0 110.775 171.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -94.15 106.74 24.3 Favored Pre-proline 0 N--CA 1.497 1.888 0 CA-C-O 118.707 -0.663 . . . . 0.0 109.854 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.9 158.72 56.77 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 O-C-N 123.245 1.129 . . . . 0.0 110.302 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -73.8 160.4 31.53 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -80.29 79.67 6.83 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.518 0.675 . . . . 0.0 109.778 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.19 175.8 47.66 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 175.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 p -138.02 154.53 49.3 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 117.367 0.584 . . . . 0.0 110.774 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.506 HD22 HD12 ' A' ' 114' ' ' LEU . 30.6 tp -109.32 119.08 38.4 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 170.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.536 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.5 m120 -100.64 122.69 43.73 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.168 -175.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.806 HD11 HD11 ' A' ' 126' ' ' ILE . 56.2 mt -120.53 136.19 54.85 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 120.66 0.267 . . . . 0.0 110.549 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HB2' HG11 ' A' ' 12' ' ' VAL . 63.5 tttt -96.24 133.92 39.98 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.493 HD11 HD13 ' A' ' 106' ' ' ILE . 83.5 mt -111.95 160.22 17.64 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 120.617 0.246 . . . . 0.0 110.465 -176.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.04 12.8 14.55 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 172.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -145.79 141.98 28.45 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.661 -0.649 . . . . 0.0 109.388 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.24 146.81 52.62 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 122.225 -0.297 . . . . 0.0 110.628 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -132.16 137.45 47.65 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 120.699 0.285 . . . . 0.0 110.663 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -138.0 125.53 22.09 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 174.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.2 -22.51 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.384 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -74.48 -1.08 19.69 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.978 -0.451 . . . . 0.0 112.187 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -90.75 -14.48 31.99 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 118.922 0.783 . . . . 0.0 111.524 170.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.96 175.18 5.7 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 118.597 0.635 . . . . 0.0 109.463 174.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -91.74 103.24 15.83 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -110.59 178.84 4.24 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 120.587 0.232 . . . . 0.0 110.435 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -111.74 130.2 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.97 142.65 35.32 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.2 p -122.79 136.35 54.84 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 120.762 0.315 . . . . 0.0 110.78 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -75.34 172.67 12.05 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 120.909 0.385 . . . . 0.0 111.754 -170.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -67.8 141.15 56.6 Favored 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -137.04 167.0 22.37 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.543 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -125.58 149.52 48.28 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 120.907 0.384 . . . . 0.0 110.548 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -147.9 134.15 19.47 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 51.69 33.82 11.69 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.702 -0.624 . . . . 0.0 112.157 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.18 16.64 79.39 Favored Glycine 0 N--CA 1.496 2.682 0 CA-C-O 119.623 -0.543 . . . . 0.0 111.875 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -121.15 139.84 52.81 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.677 1.239 . . . . 0.0 109.623 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.51 132.48 37.76 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 121.091 -0.243 . . . . 0.0 110.505 -176.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -121.24 144.14 48.77 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -86.08 157.04 20.15 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.53 -168.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.56 158.59 49.11 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -176.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.49 154.98 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 122.351 -0.499 . . . . 0.0 110.445 -174.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -116.04 136.43 53.04 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.4 t -133.98 139.95 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -175.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.7 tp -137.12 125.65 14.86 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.053 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -63.4 149.76 90.31 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 O-C-N 123.182 1.096 . . . . 0.0 111.444 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.507 HD13 HG13 ' A' ' 93' ' ' ILE . 43.1 pt -141.7 170.08 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 171.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -113.9 130.42 56.5 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 168.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -105.96 123.64 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -174.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.5 mt -108.52 116.32 31.75 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -129.87 121.91 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.72 -120.29 18.34 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -111.18 17.05 20.69 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 122.316 -0.52 . . . . 0.0 111.932 175.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -119.34 143.99 47.1 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 118.465 0.575 . . . . 0.0 110.498 -175.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -123.16 130.08 52.29 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.3 mt -126.81 146.32 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.83 135.98 43.47 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.01 -167.29 12.12 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.428 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -160.1 155.95 26.03 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 117.374 0.587 . . . . 0.0 110.447 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.507 HG13 HD13 ' A' ' 80' ' ' ILE . 67.5 mt -108.73 141.9 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -121.88 131.42 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.1 t -141.01 133.87 14.41 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -57.82 155.04 34.47 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 120.996 1.131 . . . . 0.0 111.877 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -64.78 -34.52 78.55 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 122.365 -0.209 . . . . 0.0 110.723 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -87.33 118.39 26.73 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.35 -176.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.2 p -131.98 160.37 36.02 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -126.77 -42.91 1.74 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.308 -0.245 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -136.88 176.71 8.46 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.2 m -99.61 147.75 25.04 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.0 m -135.07 171.99 13.64 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 120.594 0.235 . . . . 0.0 110.517 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -107.19 27.14 9.34 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.408 -0.183 . . . . 0.0 110.94 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -122.91 127.19 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.493 HD13 HD11 ' A' ' 48' ' ' LEU . 34.6 pt -124.81 143.75 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 177.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -114.77 131.56 56.75 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.477 HD12 HD12 ' A' ' 46' ' ' LEU . 81.9 mt -117.22 152.05 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -173.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.5 pt -116.18 156.17 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 168.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.59 164.15 32.27 Favored Pre-proline 0 N--CA 1.496 1.827 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.334 -176.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.15 -32.41 94.54 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 121.062 1.175 . . . . 0.0 111.479 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.98 159.26 43.21 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.266 -0.272 . . . . 0.0 110.862 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.6 pttt -62.5 103.92 0.46 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.413 0.625 . . . . 0.0 111.203 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.506 HD12 HD22 ' A' ' 44' ' ' LEU . 82.7 mt -59.6 -32.51 70.46 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.869 -0.519 . . . . 0.0 111.692 -177.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -61.9 -37.28 84.02 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 122.098 -0.376 . . . . 0.0 111.204 -171.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -78.27 -46.41 20.34 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -62.37 -34.59 76.99 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 122.208 -0.307 . . . . 0.0 111.024 -172.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -108.13 8.23 27.97 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 51.72 50.65 18.27 Favored 'General case' 0 N--CA 1.508 2.436 0 CA-C-N 119.309 0.959 . . . . 0.0 111.945 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 48.2 mt -90.39 138.16 31.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.832 -0.542 . . . . 0.0 110.818 -171.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -117.03 155.29 29.46 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 175.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -55.99 138.01 49.8 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.857 -0.527 . . . . 0.0 111.468 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.98 -22.97 37.32 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.31 154.59 37.83 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 118.655 1.227 . . . . 0.0 110.038 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -111.92 133.78 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.806 HD11 HD11 ' A' ' 46' ' ' LEU . 34.4 pt -128.56 160.95 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -109.93 138.13 46.73 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -112.26 137.17 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.463 ' C ' HD23 ' A' ' 129' ' ' LEU . 10.0 tt . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.2 mm . . . . . 0 N--CA 1.499 1.981 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.437 HG22 HD22 ' A' ' 48' ' ' LEU . 77.6 mt -129.69 149.02 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -104.69 140.76 37.58 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.07 150.41 19.98 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -105.63 142.36 35.5 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 117.28 0.54 . . . . 0.0 110.227 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.71 120.99 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.45 137.78 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 122.308 -0.245 . . . . 0.0 110.375 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.882 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 N--CA 1.503 2.186 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -65.3 -32.35 73.96 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.83 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -68.45 -39.33 81.51 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.85 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.544 HG23 HD12 ' A' ' 60' ' ' ILE . 48.3 mt -81.46 -36.82 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -175.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.508 ' CD2' ' HB2' ' A' ' 92' ' ' ALA . 61.0 mt -103.97 -26.22 12.71 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.206 -0.309 . . . . 0.0 111.642 -174.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.7 14.17 73.75 Favored Glycine 0 N--CA 1.495 2.603 0 CA-C-O 119.368 -0.685 . . . . 0.0 111.48 -172.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -152.39 161.68 42.26 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 119.163 1.481 . . . . 0.0 110.554 170.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -94.47 107.45 29.92 Favored Pre-proline 0 N--CA 1.496 1.846 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.8 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -67.38 156.51 65.88 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 O-C-N 123.242 1.127 . . . . 0.0 110.526 -176.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -73.37 162.59 29.15 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -80.31 79.46 6.89 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.537 0.684 . . . . 0.0 109.509 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.85 176.12 47.26 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 p -138.07 157.2 46.81 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 117.349 0.575 . . . . 0.0 110.842 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.458 HD22 HD12 ' A' ' 114' ' ' LEU . 33.8 tp -108.92 118.37 36.62 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.95 122.85 42.74 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -175.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.823 HD11 HD11 ' A' ' 126' ' ' ILE . 61.1 mt -121.29 136.24 55.0 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.732 0.301 . . . . 0.0 110.521 -178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -96.13 132.51 41.45 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.437 HD22 HG22 ' A' ' 7' ' ' ILE . 84.5 mt -111.47 160.23 17.32 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 120.703 0.287 . . . . 0.0 110.382 -176.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -88.94 12.44 15.34 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 173.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -146.39 140.91 26.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.687 -0.633 . . . . 0.0 109.662 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.1 146.9 52.27 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 122.182 -0.324 . . . . 0.0 110.75 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -132.37 138.71 47.83 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.64 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -138.04 123.89 20.01 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 176.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.62 -23.08 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.395 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -74.6 -0.97 19.53 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.897 -0.502 . . . . 0.0 112.214 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -89.92 -14.21 34.65 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 118.961 0.8 . . . . 0.0 111.542 171.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -117.0 175.15 5.72 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 118.603 0.638 . . . . 0.0 109.582 173.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -91.87 104.86 17.24 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -109.49 177.3 4.78 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.544 HD12 HG23 ' A' ' 34' ' ' ILE . 79.4 mt -110.37 133.67 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -105.84 142.1 36.13 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.3 p -116.5 133.23 56.26 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -77.47 172.5 13.24 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 120.75 0.309 . . . . 0.0 111.388 -171.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -69.28 139.86 54.39 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -140.64 164.86 29.05 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.743 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -122.01 146.44 47.16 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 120.699 0.285 . . . . 0.0 110.271 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -150.71 141.83 23.1 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 172.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.2 m120 52.11 29.98 7.06 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.69 -0.631 . . . . 0.0 112.126 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.56 16.08 81.03 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -120.45 143.29 48.57 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 118.706 1.253 . . . . 0.0 109.636 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -92.42 131.76 37.32 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.349 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -119.94 141.0 50.03 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -87.4 151.9 22.69 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 120.843 0.354 . . . . 0.0 110.595 -167.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.68 158.71 51.21 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -142.65 161.48 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 122.252 -0.558 . . . . 0.0 110.514 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -113.5 135.21 54.13 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.8 t -131.07 138.25 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -176.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.7 tp -137.44 125.65 14.49 Favored Pre-proline 0 N--CA 1.496 1.85 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.055 178.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -62.68 149.33 91.56 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 120.98 1.12 . . . . 0.0 111.731 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.581 HD13 HG13 ' A' ' 93' ' ' ILE . 43.6 pt -141.82 170.17 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 122.253 -0.279 . . . . 0.0 110.321 171.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -113.53 130.26 56.39 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 168.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -106.24 123.57 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -108.63 116.99 33.02 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.8 mt -130.1 121.96 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.79 -120.46 18.89 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -111.1 16.97 20.82 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 122.266 -0.55 . . . . 0.0 111.933 175.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -118.68 143.2 47.0 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 118.518 0.599 . . . . 0.0 110.482 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -123.09 129.89 52.06 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -127.06 149.05 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.31 136.01 44.44 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.99 -168.4 12.35 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.508 ' HB2' ' CD2' ' A' ' 35' ' ' LEU . . . -159.35 155.22 26.39 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 117.305 0.553 . . . . 0.0 110.325 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.581 HG13 HD13 ' A' ' 80' ' ' ILE . 73.8 mt -108.71 140.72 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -125.07 129.52 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.7 t -139.92 133.88 15.6 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -56.65 153.67 34.92 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 121.037 1.158 . . . . 0.0 112.046 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -64.5 -34.45 78.24 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 122.269 -0.269 . . . . 0.0 110.606 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.1 tttp -90.97 121.05 32.47 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.2 t -141.84 151.89 43.17 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 122.32 -0.237 . . . . 0.0 110.401 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -98.42 -58.93 1.85 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -134.91 169.77 16.89 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.0 m -82.81 154.39 24.72 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 96.3 p -135.02 175.05 9.94 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 120.645 0.259 . . . . 0.0 110.495 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -104.8 25.0 10.94 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 121.28 -0.168 . . . . 0.0 110.95 172.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -120.89 126.88 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.9 pt -125.36 145.59 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -115.55 130.23 56.8 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.545 HD12 HD12 ' A' ' 46' ' ' LEU . 83.6 mt -116.06 152.27 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -174.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 pt -116.68 155.91 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 168.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.52 162.16 43.39 Favored Pre-proline 0 N--CA 1.495 1.823 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.358 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.54 -30.67 93.02 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 121.075 1.183 . . . . 0.0 111.728 177.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.44 167.0 23.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.279 -0.263 . . . . 0.0 110.933 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -69.92 104.33 2.48 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.458 HD12 HD22 ' A' ' 44' ' ' LEU . 85.0 mt -59.93 -34.25 72.98 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 122.138 -0.351 . . . . 0.0 111.349 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -62.97 -35.57 80.59 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 122.203 -0.311 . . . . 0.0 110.922 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -78.36 -48.76 14.88 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -62.65 -33.63 75.43 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 122.231 -0.293 . . . . 0.0 111.11 -172.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -108.05 7.75 27.9 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 51.8 46.97 25.69 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.108 -0.995 . . . . 0.0 111.878 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.4 mt -92.28 138.19 31.73 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.893 -0.504 . . . . 0.0 111.007 -170.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -115.66 160.61 19.82 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.17 50.17 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.966 -0.459 . . . . 0.0 111.569 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.48 -22.94 37.7 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.59 151.59 46.12 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 118.627 1.213 . . . . 0.0 110.018 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.3 t -110.45 133.66 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -173.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.823 HD11 HD11 ' A' ' 46' ' ' LEU . 34.8 pt -128.46 160.16 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -109.65 138.07 46.55 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.2 pt -113.62 137.87 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.465 ' C ' HD23 ' A' ' 129' ' ' LEU . 9.7 tt . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.7 mm . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.501 HG22 HD22 ' A' ' 48' ' ' LEU . 73.7 mt -129.77 148.9 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -105.37 141.53 36.72 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.73 150.61 20.38 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -106.33 142.1 36.56 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 117.265 0.532 . . . . 0.0 110.301 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.11 121.08 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.22 144.2 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 N--CA 1.499 1.984 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.306 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 N--CA 1.501 2.113 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -66.18 -29.62 69.93 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.735 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -68.89 -40.82 79.0 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.733 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.9 mt -81.31 -38.04 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -175.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 92' ' ' ALA . 46.1 mt -104.01 -26.2 12.71 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.231 -0.293 . . . . 0.0 111.711 -174.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.16 13.66 73.67 Favored Glycine 0 N--CA 1.495 2.592 0 CA-C-O 119.369 -0.684 . . . . 0.0 111.466 -171.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -152.52 165.65 34.46 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 119.158 1.479 . . . . 0.0 110.614 170.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -96.41 112.31 59.57 Favored Pre-proline 0 N--CA 1.496 1.851 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.835 175.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -67.52 159.92 50.33 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 O-C-N 123.266 1.14 . . . . 0.0 110.631 -176.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -74.3 164.54 26.48 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -80.23 79.57 6.78 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.476 0.655 . . . . 0.0 109.729 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.09 170.42 42.14 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 p -138.08 157.41 46.38 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 117.295 0.547 . . . . 0.0 110.674 177.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.5 tp -109.76 116.67 32.11 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 171.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.57 120.9 39.78 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 126' ' ' ILE . 60.6 mt -119.96 135.71 54.8 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.71 0.29 . . . . 0.0 110.656 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -96.21 133.46 40.49 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.501 HD22 HG22 ' A' ' 7' ' ' ILE . 84.7 mt -110.95 160.38 16.86 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 120.649 0.262 . . . . 0.0 110.481 -177.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.09 12.75 14.78 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -145.89 141.4 27.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.701 -0.624 . . . . 0.0 109.488 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -63.32 146.92 52.48 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 122.203 -0.311 . . . . 0.0 110.682 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -132.09 138.17 48.02 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 120.719 0.295 . . . . 0.0 110.622 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -138.02 126.41 23.27 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.9 tt -63.28 -22.73 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.348 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -74.65 -0.94 19.59 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.97 -0.457 . . . . 0.0 112.216 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -90.77 -14.51 31.87 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 118.902 0.774 . . . . 0.0 111.488 171.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -117.63 175.18 5.76 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 118.7 0.682 . . . . 0.0 109.469 174.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -90.64 103.88 16.53 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -177.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -110.42 179.25 4.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.371 -0.206 . . . . 0.0 110.537 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.5 mt -112.6 131.8 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.95 143.17 34.47 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.4 p -123.28 137.07 54.94 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 120.761 0.315 . . . . 0.0 110.769 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -77.3 172.61 13.02 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 120.824 0.345 . . . . 0.0 111.849 -168.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -68.21 141.31 56.0 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -138.69 164.99 28.12 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 122.186 -0.321 . . . . 0.0 110.675 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -124.92 148.31 48.41 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.787 0.327 . . . . 0.0 110.381 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -149.53 136.45 19.6 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 52.23 32.96 11.58 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.747 -0.595 . . . . 0.0 111.832 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 16.42 80.15 Favored Glycine 0 N--CA 1.497 2.733 0 CA-C-O 119.584 -0.565 . . . . 0.0 111.798 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -120.16 138.99 53.28 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 118.728 1.264 . . . . 0.0 109.701 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.19 131.47 38.24 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.358 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -119.69 140.93 49.88 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -86.03 155.9 20.65 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 120.761 0.315 . . . . 0.0 110.388 -168.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.94 156.86 51.64 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -176.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.09 156.86 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 122.347 -0.502 . . . . 0.0 110.486 -173.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -115.79 137.0 52.5 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.2 t -134.06 141.06 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -175.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 tp -137.54 125.72 14.42 Favored Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.082 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -63.31 148.56 92.8 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 120.987 1.125 . . . . 0.0 111.396 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.617 HD13 HG13 ' A' ' 93' ' ' ILE . 43.9 pt -141.78 170.06 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 122.304 -0.248 . . . . 0.0 110.412 173.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -114.28 131.51 56.48 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 168.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.2 mt -105.74 123.33 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.22 116.47 32.02 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.7 mt -129.83 121.92 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.56 -120.16 18.09 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -177.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -111.21 17.04 20.67 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 117.161 0.48 . . . . 0.0 111.784 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -119.43 144.12 47.11 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.557 0.617 . . . . 0.0 110.46 -175.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -123.13 130.15 52.39 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 122.263 -0.273 . . . . 0.0 110.275 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.6 mt -126.35 147.05 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.42 137.46 44.62 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.6 -168.32 13.51 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 178.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.644 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.12 154.26 25.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.266 -0.549 . . . . 0.0 110.258 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.617 HG13 HD13 ' A' ' 80' ' ' ILE . 70.2 mt -108.65 140.62 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -123.07 130.28 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.98 133.9 14.45 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -57.75 153.63 42.17 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 120.996 1.13 . . . . 0.0 111.813 177.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -65.53 -34.91 79.37 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 122.279 -0.263 . . . . 0.0 110.487 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -89.17 121.01 31.07 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.267 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -141.64 151.56 43.17 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -98.01 -55.89 2.65 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -136.84 169.63 17.43 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.1 m -82.19 151.11 27.04 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.0 m -134.91 175.0 9.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.295 -0.253 . . . . 0.0 110.526 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -107.28 27.22 9.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.378 -0.201 . . . . 0.0 110.839 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.1 mm -124.1 127.51 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.5 pt -125.98 145.52 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -114.81 130.08 56.81 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.507 HD12 HD12 ' A' ' 46' ' ' LEU . 83.5 mt -115.04 149.95 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -174.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 pt -115.95 155.57 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 169.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.55 165.97 22.24 Favored Pre-proline 0 N--CA 1.496 1.843 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.326 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.76 -30.94 93.24 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 O-C-N 123.292 1.154 . . . . 0.0 111.623 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.39 167.06 23.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.293 -0.255 . . . . 0.0 110.751 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -70.88 105.24 3.19 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.3 mt -59.52 -33.61 71.59 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 122.151 -0.343 . . . . 0.0 111.449 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -62.83 -35.35 79.65 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 122.108 -0.37 . . . . 0.0 111.006 -174.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -78.11 -48.28 16.37 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.47 -34.3 76.55 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 122.153 -0.342 . . . . 0.0 111.135 -172.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -108.1 8.53 28.18 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 51.79 50.5 18.53 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 121.103 -0.998 . . . . 0.0 111.895 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 47.4 mt -90.3 138.17 31.75 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.879 -0.513 . . . . 0.0 110.899 -171.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -116.19 155.16 28.76 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.48 137.91 47.45 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.906 -0.496 . . . . 0.0 111.533 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.02 -22.98 37.22 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -65.32 154.6 37.81 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-N 118.704 1.252 . . . . 0.0 110.05 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.38 134.03 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -174.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.815 HD11 HD11 ' A' ' 46' ' ' LEU . 34.6 pt -128.9 160.41 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -109.83 138.28 46.43 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.8 pt -114.21 137.61 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 176.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.466 ' C ' HD23 ' A' ' 129' ' ' LEU . 9.2 tt . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.3 mm . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.487 HG22 HD22 ' A' ' 48' ' ' LEU . 73.3 mt -129.97 149.23 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -105.9 142.12 36.15 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.42 150.95 20.4 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -106.16 142.38 35.95 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 117.266 0.533 . . . . 0.0 110.245 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.74 123.6 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -123.24 157.87 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 176.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.499 2.005 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.271 -178.268 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 N--CA 1.503 2.176 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -65.42 -37.51 87.15 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 122.212 -0.305 . . . . 0.0 110.319 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -68.03 -38.26 82.34 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.537 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.7 mt -81.18 -35.81 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.62 -26.1 12.92 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 122.141 -0.349 . . . . 0.0 111.573 -173.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.8 13.12 78.65 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -172.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -151.62 160.56 43.6 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 118.955 1.377 . . . . 0.0 110.222 170.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -93.12 108.0 29.45 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.857 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.456 ' CB ' HD12 ' A' ' 109' ' ' ILE . 66.7 Cg_endo -67.6 160.12 49.47 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 O-C-N 123.249 1.131 . . . . 0.0 110.355 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -73.62 161.62 30.1 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -80.32 79.6 6.88 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.496 0.665 . . . . 0.0 109.654 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.71 172.68 45.01 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 175.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 p -138.04 156.87 47.36 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 117.348 0.574 . . . . 0.0 110.775 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.497 HD22 HD12 ' A' ' 114' ' ' LEU . 30.7 tp -110.71 118.18 35.47 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 170.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.539 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.5 m120 -98.94 122.15 41.82 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -176.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 126' ' ' ILE . 59.3 mt -120.14 136.13 54.72 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 120.662 0.268 . . . . 0.0 110.585 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HB2' HG11 ' A' ' 12' ' ' VAL . 39.8 tttp -96.21 133.27 40.73 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 173.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.487 HD22 HG22 ' A' ' 7' ' ' ILE . 83.0 mt -111.1 160.27 17.04 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 120.664 0.269 . . . . 0.0 110.448 -177.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.14 12.74 14.93 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 172.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -145.76 142.39 28.87 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 118.496 0.589 . . . . 0.0 109.428 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -64.37 146.76 53.93 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 122.196 -0.315 . . . . 0.0 110.324 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -133.11 137.57 46.37 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 120.686 0.279 . . . . 0.0 110.755 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -138.06 128.28 25.98 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 174.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.43 -23.05 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.271 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -74.58 -0.92 19.32 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -90.53 -14.52 32.45 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 118.905 0.775 . . . . 0.0 111.429 170.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -117.79 175.18 5.78 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 118.64 0.654 . . . . 0.0 109.497 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -91.1 103.8 16.45 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -109.81 178.39 4.43 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 120.572 0.225 . . . . 0.0 110.47 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -111.43 131.17 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -105.97 144.56 32.52 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.1 p -124.27 138.09 54.43 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.821 0.343 . . . . 0.0 110.764 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -77.0 172.77 12.66 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 120.902 0.382 . . . . 0.0 111.869 -168.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -67.45 140.82 57.11 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -136.78 167.35 21.6 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.221 -0.299 . . . . 0.0 110.553 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -125.3 149.53 47.97 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 120.836 0.35 . . . . 0.0 110.56 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -148.66 133.65 18.14 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 52.11 33.46 12.24 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.63 -0.668 . . . . 0.0 111.879 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.21 15.77 80.56 Favored Glycine 0 N--CA 1.497 2.721 0 CA-C-O 119.578 -0.568 . . . . 0.0 111.892 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -120.13 140.89 50.4 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.778 1.289 . . . . 0.0 109.691 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.47 132.04 38.11 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 121.081 -0.247 . . . . 0.0 110.489 -176.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -121.19 144.87 48.36 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -86.11 156.18 20.48 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 120.799 0.333 . . . . 0.0 110.508 -167.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.79 159.46 48.88 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -176.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.77 158.17 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 122.355 -0.497 . . . . 0.0 110.338 -174.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -118.35 137.3 53.19 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.03 141.27 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.1 tp -137.25 125.64 14.7 Favored Pre-proline 0 N--CA 1.495 1.823 0 CA-C-O 118.524 -0.75 . . . . 0.0 110.092 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -63.68 149.73 90.15 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 120.965 1.11 . . . . 0.0 111.332 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.536 HD13 HG13 ' A' ' 93' ' ' ILE . 43.1 pt -141.85 170.06 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 120.635 0.255 . . . . 0.0 110.385 171.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -114.35 131.14 56.65 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 168.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.24 123.05 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -174.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.4 mt -107.97 116.4 31.89 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.9 mt -129.85 121.9 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.69 -120.14 17.83 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -111.22 17.08 20.63 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.33 -0.512 . . . . 0.0 111.897 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -119.76 144.21 47.4 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 118.52 0.6 . . . . 0.0 110.435 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -123.06 129.9 52.09 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 120.697 0.284 . . . . 0.0 110.298 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.4 mt -126.43 147.46 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.56 136.71 44.04 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.91 -168.89 13.05 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.49 154.47 24.87 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 117.376 0.588 . . . . 0.0 110.305 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.536 HG13 HD13 ' A' ' 80' ' ' ILE . 69.9 mt -108.79 141.61 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.8 t -124.4 132.09 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -144.95 137.54 13.54 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -58.15 152.84 49.66 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.05 1.166 . . . . 0.0 111.652 175.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -65.89 -34.32 77.85 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.538 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -88.6 117.31 27.47 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.0 m -129.87 143.26 50.72 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -94.05 -54.23 3.67 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -135.94 -179.73 5.84 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.4 m -96.77 151.71 19.38 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.2 p -134.96 172.32 13.17 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 120.747 0.308 . . . . 0.0 110.647 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.56 24.87 11.5 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.811 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.5 mm -120.81 127.72 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.442 HD13 HD11 ' A' ' 48' ' ' LEU . 34.5 pt -125.93 146.08 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 177.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -116.28 129.75 56.43 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 110.037 -0.356 . . . . 0.0 110.037 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.5 HD12 HD12 ' A' ' 46' ' ' LEU . 82.1 mt -115.0 151.55 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.456 HD12 ' CB ' ' A' ' 39' ' ' PRO . 11.9 pt -115.91 156.17 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 168.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.56 165.97 22.22 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.317 -176.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.13 -32.87 95.22 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 121.064 1.176 . . . . 0.0 111.462 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -145.06 160.14 41.86 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.308 -0.245 . . . . 0.0 110.877 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -62.36 104.7 0.52 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.367 0.604 . . . . 0.0 111.229 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.497 HD12 HD22 ' A' ' 44' ' ' LEU . 81.4 mt -59.56 -32.86 70.74 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.94 -0.475 . . . . 0.0 111.662 -176.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -61.87 -37.42 84.5 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 122.07 -0.394 . . . . 0.0 111.199 -171.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -78.27 -45.16 23.51 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -62.25 -34.79 77.21 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 122.143 -0.348 . . . . 0.0 111.085 -173.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -108.15 8.39 28.01 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 51.86 48.27 23.13 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.084 -1.01 . . . . 0.0 111.879 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.3 mt -91.71 138.12 31.82 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.887 -0.508 . . . . 0.0 110.993 -171.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.25 158.99 22.48 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -56.16 138.22 50.29 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.889 -0.507 . . . . 0.0 111.459 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.59 -22.97 37.52 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.43 151.8 45.45 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-N 118.672 1.236 . . . . 0.0 110.011 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.8 t -110.76 133.64 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -174.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.815 HD11 HD11 ' A' ' 46' ' ' LEU . 34.2 pt -128.28 160.38 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -109.72 137.81 47.0 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.5 pt -113.13 137.2 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.466 ' C ' HD23 ' A' ' 129' ' ' LEU . 9.1 tt . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.8 mm . . . . . 0 N--CA 1.499 1.988 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.409 HG22 HD22 ' A' ' 48' ' ' LEU . 74.5 mt -129.67 149.38 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -105.81 141.84 36.56 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.32 150.83 20.59 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -106.19 141.5 37.45 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 117.31 0.555 . . . . 0.0 110.269 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.11 123.51 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.8 m -123.55 156.94 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 N--CA 1.499 1.996 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.284 -178.333 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.433 ' CE1' HD13 ' A' ' 109' ' ' ILE . 3.7 m-85 . . . . . 0 N--CA 1.501 2.116 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -65.71 -31.01 71.77 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 122.197 -0.314 . . . . 0.0 110.814 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -68.93 -40.44 79.03 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.581 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -81.45 -37.04 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -175.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.64 HD21 ' HB2' ' A' ' 92' ' ' ALA . 45.8 mt -104.0 -26.19 12.72 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 122.231 -0.293 . . . . 0.0 111.683 -174.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.39 14.76 73.17 Favored Glycine 0 N--CA 1.495 2.593 0 CA-C-O 119.304 -0.72 . . . . 0.0 111.443 -172.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -151.76 163.05 39.99 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 119.22 1.51 . . . . 0.0 110.748 170.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -94.58 109.07 41.17 Favored Pre-proline 0 N--CA 1.496 1.866 0 CA-C-O 118.589 -0.72 . . . . 0.0 109.827 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.47 159.47 52.3 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 O-C-N 123.219 1.115 . . . . 0.0 110.493 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -73.87 162.85 28.66 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -80.22 79.52 6.78 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.467 0.651 . . . . 0.0 109.726 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.5 172.65 45.06 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 175.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.1 p -138.02 157.67 45.88 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 117.408 0.604 . . . . 0.0 110.806 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.9 tp -109.55 114.98 29.07 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.539 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.7 m120 -98.24 120.12 38.1 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 126' ' ' ILE . 63.8 mt -120.01 135.95 54.73 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 120.708 0.29 . . . . 0.0 110.664 -177.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HB2' HG11 ' A' ' 12' ' ' VAL . 40.4 tttp -95.99 133.04 40.68 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.421 HD11 HD13 ' A' ' 106' ' ' ILE . 83.8 mt -111.71 160.23 17.48 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 120.663 0.268 . . . . 0.0 110.407 -176.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.06 12.88 14.35 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 172.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -145.91 142.19 28.51 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.65 0.659 . . . . 0.0 109.482 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -64.46 146.89 53.83 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 122.218 -0.301 . . . . 0.0 110.424 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -132.37 136.72 47.02 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 120.659 0.266 . . . . 0.0 110.607 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -138.01 126.44 23.32 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.1 tt -64.2 -23.86 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.173 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -74.05 -1.0 18.17 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.888 -0.508 . . . . 0.0 112.128 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.28 -14.44 30.85 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 118.889 0.768 . . . . 0.0 111.429 169.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -115.82 175.09 5.69 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 118.618 0.644 . . . . 0.0 109.463 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -91.64 102.76 15.4 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -177.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -110.45 178.36 4.4 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.34 -0.225 . . . . 0.0 110.546 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.6 mt -112.35 131.76 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -105.94 142.49 35.56 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.6 p -120.7 138.08 54.15 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 120.745 0.307 . . . . 0.0 110.687 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.94 172.58 12.95 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 120.812 0.339 . . . . 0.0 111.795 -168.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -67.9 141.16 56.46 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -137.23 165.96 24.89 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.22 -0.3 . . . . 0.0 110.636 -176.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -125.43 148.29 48.87 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.734 0.302 . . . . 0.0 110.543 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -149.28 137.2 20.51 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 174.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 51.63 33.0 9.97 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.691 -0.631 . . . . 0.0 112.12 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 17.6 78.59 Favored Glycine 0 N--CA 1.497 2.717 0 CA-C-O 119.625 -0.542 . . . . 0.0 111.803 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -122.52 139.89 53.39 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 118.64 1.22 . . . . 0.0 109.646 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -93.26 131.94 37.91 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.37 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -121.06 143.84 48.86 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -86.14 155.95 20.55 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 120.763 0.316 . . . . 0.0 110.474 -168.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.73 160.85 47.17 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.33 156.67 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 122.358 -0.495 . . . . 0.0 110.381 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -114.99 137.17 52.31 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 176.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.7 t -134.05 141.44 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.5 tp -137.76 125.58 14.08 Favored Pre-proline 0 N--CA 1.497 1.915 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.201 177.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -63.31 148.87 92.55 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.939 1.092 . . . . 0.0 111.491 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.57 HD13 HG13 ' A' ' 93' ' ' ILE . 43.3 pt -142.15 170.09 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 122.257 -0.277 . . . . 0.0 110.419 171.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -115.21 131.91 56.78 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 167.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -105.91 123.85 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.8 mt -108.19 116.77 32.57 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.419 HG21 HD11 ' A' ' 120' ' ' LEU . 77.1 mt -130.2 121.94 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.62 -120.12 17.84 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -178.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -111.17 17.08 20.67 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.377 -0.484 . . . . 0.0 111.811 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -119.62 143.65 47.56 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.55 0.614 . . . . 0.0 110.473 -175.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -123.15 129.5 51.52 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -125.85 143.67 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.0 137.98 43.82 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.87 -164.29 11.21 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.64 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.82 156.15 26.98 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 117.328 0.564 . . . . 0.0 110.424 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.57 HG13 HD13 ' A' ' 80' ' ' ILE . 70.2 mt -108.7 141.42 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -123.03 130.63 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -175.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 63.0 t -142.48 135.9 14.25 Favored Pre-proline 0 N--CA 1.497 1.904 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -57.31 153.57 39.6 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 121.093 1.195 . . . . 0.0 111.849 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -65.47 -34.92 79.4 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.512 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -91.42 124.27 35.47 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -142.91 155.21 44.69 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -98.02 -59.99 1.65 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -134.27 -173.38 3.25 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -97.67 149.96 21.7 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m -134.94 175.02 9.96 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 122.307 -0.245 . . . . 0.0 110.379 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -107.35 27.42 9.1 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 122.38 -0.2 . . . . 0.0 110.866 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.7 mm -124.14 127.36 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.421 HD13 HD11 ' A' ' 48' ' ' LEU . 34.3 pt -126.15 145.66 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 177.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -115.38 130.1 56.79 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.492 HD12 HD12 ' A' ' 46' ' ' LEU . 80.9 mt -115.52 151.31 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.433 HD13 ' CE1' ' A' ' 31' ' ' PHE . 12.0 pt -116.38 155.19 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 168.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.46 161.93 44.68 Favored Pre-proline 0 N--CA 1.496 1.874 0 CA-C-O 119.128 -0.463 . . . . 0.0 110.457 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -60.44 -31.54 92.69 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 121.09 1.193 . . . . 0.0 111.613 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.15 167.09 23.24 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.182 -0.324 . . . . 0.0 110.996 -175.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -68.18 105.39 2.08 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.68 -38.47 87.9 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.167 -0.333 . . . . 0.0 111.069 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -64.65 -36.88 85.7 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 122.158 -0.339 . . . . 0.0 110.539 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -78.16 -50.36 12.11 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -62.53 -32.56 73.53 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 122.178 -0.326 . . . . 0.0 111.16 -173.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -108.05 8.11 28.08 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.8 43.73 29.84 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.123 -0.986 . . . . 0.0 111.928 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.419 HD11 HG21 ' A' ' 84' ' ' ILE . 78.5 mt -93.52 138.25 31.99 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.999 -0.438 . . . . 0.0 110.868 -171.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -113.51 160.68 18.23 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.15 50.22 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.874 -0.516 . . . . 0.0 111.508 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.61 -23.18 36.7 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.53 155.15 36.57 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 118.579 1.19 . . . . 0.0 109.914 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.3 t -112.02 134.0 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.813 HD11 HD11 ' A' ' 46' ' ' LEU . 34.3 pt -128.69 160.14 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 174.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -109.36 138.33 45.88 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.2 pt -112.63 137.9 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.467 ' C ' HD23 ' A' ' 129' ' ' LEU . 9.0 tt . . . . . 0 N--CA 1.495 1.792 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mmm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 110.244 -0.28 . . . . 6.64 110.244 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 p -131.51 141.18 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 110.015 -0.365 . . . . 3.33 110.015 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -98.96 122.19 41.9 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.155 -0.313 . . . . 4.02 110.155 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.5 mt -110.96 149.66 30.35 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 110.101 -0.333 . . . . 1.3 110.101 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.7 ttm -138.48 146.88 42.58 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 110.109 -0.33 . . . . 1.71 110.109 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.8 mm -125.83 131.01 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.118 -0.697 . . . . 0.44 109.118 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.532 HG22 HD22 ' A' ' 48' ' ' LEU . 71.9 mt -130.01 149.57 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 108.861 -0.792 . . . . 0.22 108.861 177.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -105.19 141.95 35.82 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.2 -0.296 . . . . 0.86 110.2 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.7 149.41 20.17 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.595 -1.402 . . . . 0.08 109.595 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -106.09 142.09 36.37 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 117.251 0.525 . . . . 0.86 110.185 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.5 t -62.97 122.0 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 N-CA-C 109.82 -0.437 . . . . 0.15 109.82 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.35 157.12 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 110.084 -0.339 . . . . 0.32 110.084 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.2 t -86.14 129.96 34.68 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 110.222 -0.288 . . . . 1.2 110.222 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.99 119.96 0.84 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.559 -1.416 . . . . 1.16 109.559 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.421 ' C ' HD23 ' A' ' 15' ' ' LEU . 6.2 tt -155.16 -46.69 0.08 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.332 -0.511 . . . . 2.47 110.346 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.41 -31.16 79.8 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 110.714 -0.955 . . . . 3.08 110.714 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -64.89 -34.72 79.07 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-N 117.661 0.731 . . . . 3.7 110.32 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.49 130.01 10.1 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.288 -1.525 . . . . 2.32 109.288 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -130.14 102.04 6.06 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 117.257 0.528 . . . . 5.6 110.437 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -155.03 170.66 21.25 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.244 -0.28 . . . . 3.18 110.244 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -112.01 138.32 48.81 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 110.345 -0.243 . . . . 2.45 110.345 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 41' ' ' GLU . 64.2 mt -110.01 -30.43 7.79 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.374 -0.204 . . . . 1.33 111.001 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -60.75 -30.67 70.15 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 122.037 -0.414 . . . . 1.44 111.578 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.0 155.69 82.97 Favored Pre-proline 0 N--CA 1.503 2.22 0 CA-C-O 119.236 -0.412 . . . . 1.67 110.523 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -57.25 -55.79 2.3 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 121.055 1.17 . . . . 0.54 113.195 -172.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.84 -30.79 90.82 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 O-C-N 122.766 0.877 . . . . 0.67 111.633 -162.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -66.37 -45.97 78.27 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 120.862 -0.335 . . . . 1.01 110.204 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.58 -36.17 82.96 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 122.186 -0.321 . . . . 1.97 110.22 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -66.01 -48.24 71.82 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 120.97 -0.292 . . . . 2.31 110.476 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.1 tt -68.7 -36.58 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 C-N-CA 120.693 -0.403 . . . . 0.8 110.06 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -65.87 -44.46 85.3 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 122.051 -0.405 . . . . 0.66 110.325 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -65.77 -29.99 70.57 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 122.205 -0.31 . . . . 1.72 110.78 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -68.97 -40.58 78.76 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 120.689 -0.404 . . . . 2.37 110.609 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.2 mt -81.1 -38.53 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.406 -0.59 . . . . 0.3 109.406 -175.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.1 mt -104.11 -26.14 12.68 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 122.144 -0.348 . . . . 0.25 111.558 -174.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.34 14.74 70.6 Favored Glycine 0 N--CA 1.495 2.589 0 CA-C-O 119.408 -0.662 . . . . 0.32 111.48 -171.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -152.79 164.51 37.67 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 119.057 1.428 . . . . 0.25 110.618 170.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -95.73 113.04 61.14 Favored Pre-proline 0 N--CA 1.497 1.891 0 CA-C-O 118.466 -0.778 . . . . 1.35 109.869 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.408 ' HB3' HD12 ' A' ' 109' ' ' ILE . 68.9 Cg_endo -67.74 159.52 52.36 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 O-C-N 123.314 1.165 . . . . 0.18 110.539 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -74.29 164.52 26.5 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 110.075 -0.343 . . . . 0.4 110.075 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.423 ' HA ' HD13 ' A' ' 22' ' ' LEU . 55.6 mt-10 -80.37 79.58 6.94 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.459 0.647 . . . . 1.41 109.721 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.8 176.54 48.05 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.536 -1.426 . . . . 0.3 109.536 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -137.99 157.53 46.18 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 117.269 0.535 . . . . 0.24 110.763 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.5 HD22 HD12 ' A' ' 114' ' ' LEU . 28.2 tp -110.31 115.05 28.99 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.514 -0.921 . . . . 0.22 108.514 168.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.71 121.31 41.43 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 110.001 -0.37 . . . . 0.15 110.001 -175.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.763 HD11 HD11 ' A' ' 126' ' ' ILE . 62.4 mt -121.49 135.49 55.03 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 120.698 0.285 . . . . 0.08 110.667 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -95.89 133.55 39.93 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.151 -0.685 . . . . 1.33 109.151 172.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.532 HD22 HG22 ' A' ' 7' ' ' ILE . 82.7 mt -111.89 160.2 17.63 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 120.609 0.243 . . . . 0.11 110.411 -176.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.43 13.04 14.68 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 111.911 0.337 . . . . 0.18 111.911 172.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -146.53 141.37 26.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.699 -0.625 . . . . 2.06 109.505 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -62.93 149.27 45.08 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.168 -0.332 . . . . 1.94 110.724 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -131.8 137.83 48.29 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 120.647 0.26 . . . . 0.32 110.545 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -138.03 122.51 18.43 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.809 -0.441 . . . . 1.4 109.809 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.3 tt -63.28 -22.91 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 C-N-CA 120.97 -0.292 . . . . 0.17 111.363 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -74.43 -1.02 19.25 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.982 -0.449 . . . . 0.93 112.143 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -90.61 -14.37 32.54 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 118.902 0.774 . . . . 1.52 111.444 170.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -116.11 175.1 5.7 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.668 0.667 . . . . 0.35 109.512 173.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -92.07 103.93 16.38 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 110.097 -0.335 . . . . 1.8 110.097 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -109.73 176.99 4.87 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 120.517 0.199 . . . . 0.16 110.574 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.19 130.77 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.29 -1.004 . . . . 0.16 108.29 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -105.89 142.73 35.11 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 110.187 -0.301 . . . . 1.23 110.187 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.1 p -119.31 134.2 55.34 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 120.621 0.248 . . . . 0.36 110.443 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.51 172.68 12.57 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 120.716 0.293 . . . . 1.29 111.502 -170.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -67.63 139.18 56.82 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.415 -0.587 . . . . 0.33 109.415 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -139.09 167.82 21.21 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.934 -0.306 . . . . 0.24 110.684 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -125.33 149.61 47.94 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 120.873 0.368 . . . . 0.8 110.506 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -147.79 134.39 19.84 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.197 -0.668 . . . . 0.5 109.197 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 51.67 33.21 10.46 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.69 -0.631 . . . . 1.31 112.089 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.47 16.98 78.58 Favored Glycine 0 N--CA 1.497 2.721 0 CA-C-O 119.601 -0.555 . . . . 0.46 111.925 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -122.29 141.67 51.28 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 118.668 1.234 . . . . 1.89 109.756 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -93.49 133.37 36.85 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 121.021 -0.272 . . . . 1.47 110.55 -176.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -123.04 145.18 48.75 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.887 -0.412 . . . . 0.38 109.887 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -86.98 153.76 21.31 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 120.783 0.325 . . . . 0.38 110.573 -168.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.09 158.62 51.85 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.976 -1.25 . . . . 0.21 109.976 -177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.79 159.18 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 122.228 -0.572 . . . . 0.27 110.53 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -117.66 137.0 52.95 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.7 -0.482 . . . . 0.96 109.7 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.8 t -134.03 141.5 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 109.358 -0.608 . . . . 0.12 109.358 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.4 tp -137.41 125.61 14.49 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.627 -0.701 . . . . 0.14 110.087 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.0 149.91 90.21 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 121.033 1.155 . . . . 0.1 111.472 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.53 HD13 HG13 ' A' ' 93' ' ' ILE . 43.3 pt -141.54 170.0 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 120.716 0.293 . . . . 0.08 110.313 171.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -114.88 130.77 56.96 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.121 -0.696 . . . . 1.42 109.121 168.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.69 123.91 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.836 -0.801 . . . . 0.11 108.836 -174.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.9 mt -108.54 116.96 32.95 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 110.284 -0.265 . . . . 0.15 110.284 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.4 mt -129.86 121.95 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.186 -1.042 . . . . 0.13 108.186 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.76 -120.37 18.58 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.868 -1.293 . . . . 0.16 109.868 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -111.12 17.13 20.66 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 122.382 -0.481 . . . . 2.03 111.831 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -119.83 145.46 46.62 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 118.559 0.618 . . . . 1.36 110.505 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -123.07 130.87 53.35 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 110.251 -0.277 . . . . 1.42 110.251 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.9 mt -126.16 146.55 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 108.737 -0.838 . . . . 0.13 108.737 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.52 136.84 44.13 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 109.902 -0.407 . . . . 0.41 109.902 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.51 -169.25 13.6 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.286 -1.526 . . . . 0.1 109.286 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.17 154.62 25.75 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 117.196 0.498 . . . . 0.1 110.159 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.53 HG13 HD13 ' A' ' 80' ' ' ILE . 68.5 mt -108.66 140.78 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.292 -1.003 . . . . 0.1 108.292 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.79 131.82 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 109.347 -0.612 . . . . 0.15 109.347 -175.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.2 t -143.21 138.6 15.79 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 108.545 -0.909 . . . . 0.2 108.545 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -56.69 155.57 26.25 Favored 'Trans proline' 0 N--CA 1.504 2.097 0 C-N-CA 121.09 1.194 . . . . 0.24 111.942 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -64.38 -34.14 77.49 Favored 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 121.141 -0.224 . . . . 1.19 110.702 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -87.96 116.76 26.36 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 121.001 -0.28 . . . . 2.67 110.254 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.0 m -130.98 136.64 48.71 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.016 -0.364 . . . . 1.43 110.016 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -97.92 -54.63 3.03 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 110.31 -0.256 . . . . 4.61 110.31 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -131.64 179.27 6.15 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 110.306 -0.257 . . . . 3.0 110.306 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.9 m -100.14 148.9 24.08 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 110.135 -0.32 . . . . 1.21 110.135 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.0 m -135.01 175.0 9.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 122.292 -0.255 . . . . 1.17 110.387 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -107.91 27.07 9.6 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.418 -0.176 . . . . 0.94 110.977 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -122.92 127.58 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.047 -0.723 . . . . 0.13 109.047 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.501 HD13 HD11 ' A' ' 48' ' ' LEU . 34.7 pt -125.44 143.68 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 110.109 -0.33 . . . . 0.11 110.109 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -115.03 130.85 57.03 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.963 -0.384 . . . . 1.36 109.963 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.455 HD12 HD12 ' A' ' 46' ' ' LEU . 81.8 mt -115.92 151.39 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.434 -0.58 . . . . 0.11 109.434 -173.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 39' ' ' PRO . 13.8 pt -116.44 154.24 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 109.433 -0.58 . . . . 0.14 109.433 168.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.58 165.59 24.2 Favored Pre-proline 0 N--CA 1.496 1.836 0 CA-C-O 119.043 -0.503 . . . . 0.13 110.222 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.81 -31.41 93.9 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.069 1.179 . . . . 0.19 111.602 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.61 167.07 23.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.35 -0.219 . . . . 0.29 110.664 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -71.65 104.01 3.22 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 109.975 -0.38 . . . . 2.18 109.975 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.5 HD12 HD22 ' A' ' 44' ' ' LEU . 81.6 mt -59.37 -33.03 70.67 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 122.069 -0.394 . . . . 0.25 111.449 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -63.1 -35.02 78.87 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 122.191 -0.318 . . . . 2.52 110.904 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -78.25 -47.86 17.03 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.194 -0.669 . . . . 1.82 109.194 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -62.28 -34.03 75.77 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.194 -0.317 . . . . 1.28 111.112 -172.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -108.06 9.36 28.42 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 112.534 0.568 . . . . 0.26 112.534 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.83 46.24 26.89 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.074 -1.016 . . . . 1.05 111.887 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -91.89 138.2 31.74 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.878 -0.513 . . . . 0.38 110.889 -171.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -114.99 158.2 22.38 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.844 -0.428 . . . . 2.43 109.844 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -55.97 137.94 49.83 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.872 -0.517 . . . . 0.5 111.431 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.95 -22.96 37.36 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 111.151 -0.78 . . . . 0.14 111.151 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -65.45 155.56 35.14 Favored 'General case' 0 N--CA 1.505 2.311 0 CA-C-N 118.631 1.216 . . . . 0.13 109.968 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -112.63 134.25 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.428 -0.582 . . . . 0.11 109.428 -174.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 46' ' ' LEU . 34.2 pt -129.38 161.33 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 109.554 -0.536 . . . . 0.13 109.554 174.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -110.0 138.26 46.62 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 110.141 -0.318 . . . . 1.34 110.141 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.8 pt -114.68 137.15 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 120.845 0.355 . . . . 0.17 110.184 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.466 ' C ' HD23 ' A' ' 129' ' ' LEU . 9.9 tt -109.67 127.59 54.67 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.861 -0.422 . . . . 0.98 109.861 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.69 132.09 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.858 -0.793 . . . . 0.57 108.858 -177.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -93.32 144.69 25.07 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 110.025 -0.361 . . . . 2.1 110.025 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.07 179.88 32.52 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.678 -1.369 . . . . 1.31 109.678 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -148.05 153.66 39.22 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 122.388 -0.478 . . . . 3.15 110.203 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -124.67 131.7 53.45 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 110.105 -0.332 . . . . 7.85 110.105 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.42 -36.35 81.07 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 120.952 -0.299 . . . . 6.5 110.204 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 N--CA 1.506 2.333 0 CA-C-O 118.279 -0.867 . . . . 9.02 111.696 -179.414 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 110.38 -0.229 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.71 157.13 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -129.15 126.49 39.38 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 131' ' ' LYS . 83.7 mt -110.86 151.32 27.99 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 22.4 ttt -134.63 147.27 50.14 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.1 mm -124.91 133.09 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.496 HG22 HD22 ' A' ' 48' ' ' LEU . 74.5 mt -129.7 148.91 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -105.32 140.05 39.03 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.33 151.08 20.42 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -106.83 141.64 37.74 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.346 -0.503 . . . . 0.0 110.26 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.18 122.28 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -124.4 146.03 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.1 m -86.14 103.77 15.1 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.02 132.23 2.46 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.2 mt -101.32 30.5 4.16 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.346 -0.502 . . . . 0.0 110.674 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.93 -171.73 54.39 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -91.26 -45.94 8.34 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.355 -0.497 . . . . 0.0 110.057 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -94.05 -172.89 38.98 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -146.72 156.79 43.43 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 122.315 -0.521 . . . . 0.0 110.428 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -146.36 170.73 16.2 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -109.3 141.14 42.04 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 41' ' ' GLU . 39.2 mt -110.04 -29.29 8.29 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.391 -0.193 . . . . 0.0 111.184 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -60.87 -30.98 70.47 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.993 -0.442 . . . . 0.0 111.58 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 mp -65.18 156.6 80.59 Favored Pre-proline 0 N--CA 1.503 2.177 0 CA-C-O 119.197 -0.43 . . . . 0.0 110.579 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -57.0 -55.9 2.3 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.165 1.243 . . . . 0.0 113.179 -172.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.32 -30.78 91.78 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 O-C-N 122.658 0.82 . . . . 0.0 111.689 -163.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -66.55 -46.59 75.58 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.281 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -65.67 -36.25 83.1 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.177 -0.327 . . . . 0.0 110.275 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.93 -48.52 71.12 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 122.239 -0.288 . . . . 0.0 110.466 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.2 tt -68.72 -37.16 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.006 -176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -66.01 -44.36 84.99 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 122.111 -0.368 . . . . 0.0 110.352 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -65.76 -30.31 70.94 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.24 -0.288 . . . . 0.0 110.814 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -68.94 -40.69 78.85 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.622 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -81.26 -38.02 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' A' ' 92' ' ' ALA . 52.3 mt -103.97 -26.2 12.72 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 122.2 -0.313 . . . . 0.0 111.61 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.03 15.02 70.81 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -172.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -152.83 164.33 38.06 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 119.027 1.413 . . . . 0.0 110.67 170.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -95.07 110.87 52.47 Favored Pre-proline 0 N--CA 1.496 1.844 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.725 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.33 159.9 50.17 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 O-C-N 123.253 1.133 . . . . 0.0 110.526 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -73.96 163.71 27.55 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.447 ' HA ' HD13 ' A' ' 22' ' ' LEU . 55.7 mt-10 -80.29 79.6 6.85 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.488 0.661 . . . . 0.0 109.653 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.16 173.24 45.37 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 p -138.05 157.87 45.47 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 117.241 0.52 . . . . 0.0 110.708 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.2 tp -110.31 114.98 28.88 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.439 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.6 m120 -99.04 119.84 38.47 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.845 HD11 HD11 ' A' ' 126' ' ' ILE . 62.1 mt -119.97 136.1 54.66 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 120.726 0.298 . . . . 0.0 110.717 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HB2' HG11 ' A' ' 12' ' ' VAL . 76.6 tttt -95.9 133.61 39.88 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 173.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.496 HD22 HG22 ' A' ' 7' ' ' ILE . 83.6 mt -112.51 160.25 17.99 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 120.657 0.265 . . . . 0.0 110.417 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.26 13.06 14.3 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 172.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -146.39 142.68 28.44 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 118.533 0.606 . . . . 0.0 109.586 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -64.29 149.43 48.13 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 122.196 -0.315 . . . . 0.0 110.505 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -131.79 138.0 48.37 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 120.701 0.286 . . . . 0.0 110.437 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -138.02 123.07 19.1 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.16 -22.84 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.389 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -74.56 -0.93 19.28 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -90.49 -14.27 33.06 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 118.901 0.773 . . . . 0.0 111.485 171.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -117.19 175.12 5.75 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 118.618 0.645 . . . . 0.0 109.431 173.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -91.31 104.07 16.65 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -110.39 176.65 4.96 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 120.516 0.198 . . . . 0.0 110.532 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -111.16 131.46 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -105.97 144.06 33.22 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.6 p -120.9 134.73 55.29 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.653 0.264 . . . . 0.0 110.547 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -77.01 172.6 12.94 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 120.77 0.319 . . . . 0.0 111.644 -170.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -67.9 140.22 56.5 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -142.34 166.31 25.02 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.699 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -123.67 149.1 45.87 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 120.787 0.327 . . . . 0.0 110.465 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -149.01 135.72 19.63 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 51.7 33.16 10.45 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.724 -0.61 . . . . 0.0 112.095 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.18 17.01 78.88 Favored Glycine 0 N--CA 1.497 2.712 0 CA-C-O 119.613 -0.548 . . . . 0.0 111.896 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -121.82 140.43 52.38 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 118.647 1.223 . . . . 0.0 109.712 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -93.49 131.44 38.71 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.355 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -121.22 141.97 50.36 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -86.93 156.46 19.81 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 120.741 0.305 . . . . 0.0 110.454 -168.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.55 156.53 52.39 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.3 157.81 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 122.329 -0.512 . . . . 0.0 110.471 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -114.97 138.78 50.44 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.6 t -133.96 140.19 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -176.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.7 tp -137.69 125.69 14.23 Favored Pre-proline 0 N--CA 1.496 1.868 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.114 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -62.9 149.14 92.37 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 120.968 1.112 . . . . 0.0 111.586 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.603 HD13 HG13 ' A' ' 93' ' ' ILE . 43.8 pt -141.98 170.06 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 122.28 -0.263 . . . . 0.0 110.322 172.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -114.6 131.77 56.58 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 168.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -106.0 123.97 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -109.28 117.02 32.98 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.5 mt -130.09 121.96 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.38 -119.95 17.55 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -111.19 17.08 20.66 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 122.349 -0.501 . . . . 0.0 111.855 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -119.54 143.04 47.82 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 118.591 0.632 . . . . 0.0 110.482 -175.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -123.16 130.28 52.55 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 120.683 0.277 . . . . 0.0 110.309 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -126.31 144.93 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.83 138.07 44.21 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.92 -165.36 11.91 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.579 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.69 155.64 26.4 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 117.307 0.553 . . . . 0.0 110.236 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.603 HG13 HD13 ' A' ' 80' ' ' ILE . 70.1 mt -108.69 141.22 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.7 t -121.7 130.78 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.3 t -141.11 134.07 14.41 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -57.24 155.42 29.61 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 121.042 1.162 . . . . 0.0 111.939 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -64.35 -34.02 77.18 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 122.321 -0.237 . . . . 0.0 110.685 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -90.11 123.2 33.76 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.337 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.2 m -130.23 142.97 50.52 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -94.9 -60.01 1.79 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -137.75 171.65 14.13 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.5 m -70.85 146.86 49.38 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.8 m -135.01 161.71 34.52 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 120.571 0.224 . . . . 0.0 110.464 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -107.64 27.08 9.51 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.375 -0.203 . . . . 0.0 110.833 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -123.73 127.52 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.491 HD13 HD11 ' A' ' 48' ' ' LEU . 34.5 pt -125.49 143.64 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 178.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -113.84 130.16 56.5 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.49 HD12 HD12 ' A' ' 46' ' ' LEU . 82.1 mt -115.5 150.33 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -174.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.8 pt -117.25 155.94 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 168.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.55 161.15 48.31 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-O 119.073 -0.489 . . . . 0.0 110.29 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.73 -30.88 93.18 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 121.105 1.203 . . . . 0.0 111.74 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.4 167.09 23.3 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.262 -0.274 . . . . 0.0 110.761 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -73.62 103.77 4.34 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.98 -35.39 78.34 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.145 -0.347 . . . . 0.0 111.136 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -62.22 -32.9 73.62 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.13 -0.356 . . . . 0.0 110.944 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -78.23 -50.89 11.05 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -63.06 -32.43 73.8 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.158 -172.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -105.97 7.84 32.2 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.87 47.45 24.75 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.014 -1.054 . . . . 0.0 111.841 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.4 mt -91.52 138.24 31.73 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.896 -0.502 . . . . 0.0 110.923 -170.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -116.82 158.66 23.57 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.22 50.08 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.846 -0.534 . . . . 0.0 111.474 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.77 -22.96 37.46 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.39 154.01 39.62 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 118.608 1.204 . . . . 0.0 110.018 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t -111.81 133.38 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -174.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.845 HD11 HD11 ' A' ' 46' ' ' LEU . 21.6 pt -128.68 160.83 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -109.63 138.09 46.5 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 pt -113.56 137.5 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.467 ' C ' HD23 ' A' ' 129' ' ' LEU . 10.1 tt -109.03 128.5 55.02 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.1 mt -119.45 135.18 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.402 ' HA ' HD23 ' A' ' 4' ' ' LEU . 50.2 mttp -92.96 150.98 20.19 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.02 131.93 3.09 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.63 -33.95 14.89 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 117.192 0.496 . . . . 0.0 110.275 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -97.69 135.61 39.24 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -93.38 117.72 30.42 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.163 -179.925 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.64 155.02 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -102.39 122.19 43.79 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.1 mt -110.88 149.47 30.57 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 20.2 ttt -107.88 143.65 36.19 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.7 mm -126.22 129.92 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.0 mt -129.86 149.58 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -104.96 143.21 33.48 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.286 -0.259 . . . . 0.0 110.37 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.22 151.16 20.68 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.57 142.62 34.99 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 117.253 0.526 . . . . 0.0 110.221 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.7 122.79 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.8 m -126.57 163.39 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 177.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 t -85.19 122.17 28.99 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.02 124.1 1.12 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.443 ' C ' HD23 ' A' ' 15' ' ' LEU . 6.5 tt -154.97 -47.45 0.08 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.32 -0.518 . . . . 0.0 110.367 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.09 35.86 4.59 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -69.82 -35.19 74.59 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 117.275 0.538 . . . . 0.0 109.988 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.3 -139.95 4.5 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -97.85 141.13 31.22 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 117.254 0.527 . . . . 0.0 110.187 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.672 ' CE1' HD12 ' A' ' 22' ' ' LEU . 60.3 t80 -126.16 119.4 27.41 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -148.24 33.67 0.81 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.672 HD12 ' CE1' ' A' ' 20' ' ' TYR . 78.9 mt -63.01 -30.57 71.71 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 122.127 -0.358 . . . . 0.0 111.15 -175.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.9 p -60.95 -26.62 67.65 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 122.115 -0.366 . . . . 0.0 111.629 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.8 mp -65.39 156.67 81.14 Favored Pre-proline 0 N--CA 1.503 2.197 0 CA-C-O 119.188 -0.434 . . . . 0.0 110.501 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -58.05 -56.03 1.9 Allowed 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 121.14 1.227 . . . . 0.0 113.029 -173.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.09 -32.05 91.23 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 O-C-N 122.65 0.816 . . . . 0.0 111.54 -162.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.404 ' O ' HG22 ' A' ' 30' ' ' ILE . 58.7 m-85 -66.32 -43.49 86.04 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.356 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -65.57 -37.53 86.93 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 122.136 -0.352 . . . . 0.0 110.247 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -65.41 -47.11 77.42 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 121.019 -0.273 . . . . 0.0 110.466 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 27' ' ' TYR . 17.9 tt -68.75 -34.34 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.036 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -65.79 -43.62 88.18 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 122.054 -0.403 . . . . 0.0 110.29 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -65.25 -30.92 71.85 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 122.211 -0.306 . . . . 0.0 110.871 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -68.62 -41.21 79.81 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.668 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.3 mt -81.6 -36.46 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.588 HD21 ' HB2' ' A' ' 92' ' ' ALA . 55.8 mt -103.78 -26.13 12.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.192 -0.317 . . . . 0.0 111.668 -174.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.57 14.69 72.84 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -172.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -152.82 162.43 41.29 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 119.062 1.431 . . . . 0.0 110.571 171.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -94.13 108.91 38.98 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.562 -0.733 . . . . 0.0 109.683 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -67.04 159.09 53.65 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 O-C-N 123.254 1.134 . . . . 0.0 110.536 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -73.81 162.97 28.55 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -80.29 79.6 6.84 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.497 0.665 . . . . 0.0 109.672 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.29 171.15 43.49 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -138.05 156.94 47.3 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 117.331 0.566 . . . . 0.0 110.856 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 tp -110.42 117.07 32.61 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 170.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.481 ' O ' HG22 ' A' ' 12' ' ' VAL . 5.9 m120 -99.66 120.87 40.38 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -177.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.737 HD11 HD11 ' A' ' 126' ' ' ILE . 68.3 mt -120.02 135.77 54.8 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 120.728 0.299 . . . . 0.0 110.651 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' HG11 ' A' ' 12' ' ' VAL . 84.7 tttt -96.15 133.55 40.3 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.4 mt -111.59 160.2 17.43 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 120.605 0.24 . . . . 0.0 110.46 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.04 12.95 14.12 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 172.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -145.47 141.89 28.76 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.687 -0.633 . . . . 0.0 109.363 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.37 146.84 53.8 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 122.231 -0.293 . . . . 0.0 110.427 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -131.95 137.36 47.91 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 120.617 0.246 . . . . 0.0 110.553 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -138.02 124.19 20.38 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.49 -22.92 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 122.21 -0.306 . . . . 0.0 111.314 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -72.75 -5.0 34.85 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 122.024 -0.423 . . . . 0.0 112.083 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -90.59 -14.36 32.61 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 118.833 0.742 . . . . 0.0 111.538 172.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -114.64 175.07 5.65 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 118.558 0.617 . . . . 0.0 109.409 173.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -92.1 102.31 14.85 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -109.97 178.64 4.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 122.316 -0.24 . . . . 0.0 110.606 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.0 mt -111.8 130.69 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 174.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -105.93 141.66 36.96 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.0 p -118.07 134.84 54.61 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 120.703 0.287 . . . . 0.0 110.461 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.17 172.71 12.37 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 120.826 0.346 . . . . 0.0 111.535 -170.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -67.29 139.56 57.3 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -138.95 167.13 22.72 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.203 -0.311 . . . . 0.0 110.643 -174.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -124.23 149.19 46.71 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.87 0.367 . . . . 0.0 110.599 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -148.22 134.47 19.44 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 51.76 33.3 10.92 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.736 -0.603 . . . . 0.0 112.142 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.32 16.77 79.06 Favored Glycine 0 N--CA 1.497 2.746 0 CA-C-O 119.664 -0.52 . . . . 0.0 111.937 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -122.33 141.67 51.31 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 118.665 1.233 . . . . 0.0 109.694 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -93.45 132.21 37.92 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 121.13 -0.228 . . . . 0.0 110.483 -176.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -123.18 146.84 47.45 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -86.92 155.21 20.31 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.73 0.3 . . . . 0.0 110.454 -168.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.36 161.18 48.45 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.67 157.09 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 122.372 -0.487 . . . . 0.0 110.412 -174.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -115.48 136.65 52.86 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -134.11 140.19 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.0 tp -137.04 125.65 14.94 Favored Pre-proline 0 N--CA 1.497 1.898 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.057 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -63.6 148.47 92.33 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 121.008 1.139 . . . . 0.0 111.383 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.546 HD13 HG13 ' A' ' 93' ' ' ILE . 43.6 pt -141.96 170.0 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 122.266 -0.271 . . . . 0.0 110.414 172.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -115.07 131.84 56.79 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 167.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.2 mt -105.68 123.7 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.1 mt -108.38 116.99 33.0 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -177.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.4 mt -130.06 121.99 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.24 -120.01 17.94 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -111.2 17.03 20.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.298 -0.531 . . . . 0.0 111.829 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -119.32 143.56 47.31 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.669 -0.644 . . . . 0.0 110.468 -175.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -123.11 129.96 52.14 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 120.671 0.272 . . . . 0.0 110.294 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.6 mt -125.4 143.82 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.82 137.49 43.87 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.98 -165.35 11.93 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.588 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.64 156.62 28.2 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.18 -0.6 . . . . 0.0 110.303 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.546 HG13 HD13 ' A' ' 80' ' ' ILE . 68.8 mt -108.72 142.01 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.5 130.73 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -143.18 136.66 14.15 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -57.22 153.85 37.51 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 121.013 1.142 . . . . 0.0 111.927 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -64.78 -34.38 78.22 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 122.307 -0.246 . . . . 0.0 110.736 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -86.93 116.11 24.77 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.395 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.8 p -131.6 159.53 37.98 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -126.52 -48.34 1.55 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -128.77 175.42 8.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 95.1 p -98.18 149.96 21.99 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.2 m -134.96 170.8 15.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.323 -0.235 . . . . 0.0 110.371 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -107.17 27.08 9.4 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.356 -0.215 . . . . 0.0 110.93 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.0 mm -123.75 127.89 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 pt -126.49 143.1 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -112.83 131.82 55.54 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.48 HD12 HD12 ' A' ' 46' ' ' LEU . 82.9 mt -116.87 150.98 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -174.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.2 pt -116.04 154.32 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.55 166.02 21.99 Favored Pre-proline 0 N--CA 1.494 1.767 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.292 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -60.0 -31.91 94.21 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 121.104 1.203 . . . . 0.0 111.519 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.69 167.09 23.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.305 -0.247 . . . . 0.0 110.69 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -70.61 104.58 2.85 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.64 -33.39 71.46 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 122.099 -0.375 . . . . 0.0 111.463 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -62.75 -35.3 79.36 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 122.155 -0.341 . . . . 0.0 110.907 -174.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.25 -47.85 17.02 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -62.63 -33.69 75.53 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.152 -0.342 . . . . 0.0 111.122 -172.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -108.12 9.27 28.31 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 112.503 0.556 . . . . 0.0 112.503 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.91 45.86 27.55 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.066 -1.021 . . . . 0.0 111.845 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -92.18 138.18 31.75 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.908 -0.495 . . . . 0.0 110.974 -171.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -114.96 160.61 19.36 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.34 49.87 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.918 -0.489 . . . . 0.0 111.482 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.53 -23.49 35.6 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.44 152.65 43.41 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 118.665 1.233 . . . . 0.0 110.076 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.21 133.82 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.737 HD11 HD11 ' A' ' 46' ' ' LEU . 34.1 pt -129.19 161.31 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 174.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -109.91 138.4 46.35 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -112.88 137.93 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 129' ' ' LEU . 8.6 tt -108.74 128.61 55.02 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 36.0 mt -116.46 139.55 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -90.73 149.58 21.98 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.09 175.5 34.55 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -112.27 -35.49 5.59 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 122.266 -0.55 . . . . 0.0 110.453 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -154.27 -59.82 0.12 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -101.68 31.51 3.78 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.281 -0.262 . . . . 0.0 110.566 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.206 -179.089 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 mtt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.404 HG13 ' OD1' ' A' ' 133' ' ' ASP . 27.8 m -108.0 -30.56 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 122.37 -0.206 . . . . 0.0 110.666 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -139.24 109.01 6.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.142 -0.349 . . . . 0.0 110.278 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 131' ' ' LYS . 83.0 mt -110.87 149.59 30.39 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 21.1 ttt -138.42 145.34 40.85 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.479 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.1 mm -126.19 133.69 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.431 HG22 HD22 ' A' ' 48' ' ' LEU . 71.3 mt -130.11 150.09 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.406 ' O ' HD23 ' A' ' 48' ' ' LEU . 51.3 mt-10 -107.08 143.36 35.34 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.55 150.56 20.83 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -106.4 142.9 35.32 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.307 -0.525 . . . . 0.0 110.26 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.73 122.45 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -124.07 142.86 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 175.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.2 t -87.52 130.57 34.67 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.279 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.04 119.94 0.84 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.9 mt -132.96 148.42 52.27 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.349 -0.5 . . . . 0.0 110.196 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.95 36.1 25.98 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -101.91 130.87 48.51 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.255 -0.556 . . . . 0.0 109.948 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.83 -140.01 32.36 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -113.84 132.23 55.96 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 117.234 0.517 . . . . 0.0 110.06 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.472 ' CE1' HD12 ' A' ' 22' ' ' LEU . 65.1 t80 -120.32 121.22 38.14 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -154.81 35.35 0.4 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.472 HD12 ' CE1' ' A' ' 20' ' ' TYR . 78.8 mt -62.12 -27.71 69.12 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 122.088 -0.383 . . . . 0.0 111.154 -175.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.4 m -60.07 -25.51 65.44 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 122.075 -0.391 . . . . 0.0 111.549 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.7 tp -62.81 138.9 97.13 Favored Pre-proline 0 N--CA 1.506 2.349 0 CA-C-O 118.774 -0.631 . . . . 0.0 110.267 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -51.94 -53.7 6.53 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 121.179 1.253 . . . . 0.0 113.913 -174.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.14 -31.12 90.05 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 O-C-N 122.687 0.835 . . . . 0.0 111.446 -164.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.42 ' O ' HG22 ' A' ' 30' ' ' ILE . 15.6 m-85 -65.97 -42.71 89.54 Favored 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.44 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -65.55 -38.35 89.35 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.155 -0.341 . . . . 0.0 110.186 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.46 -46.0 81.54 Favored 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.595 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 27' ' ' TYR . 17.8 tt -69.22 -33.43 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.916 -176.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -65.67 -44.11 87.26 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 122.02 -0.425 . . . . 0.0 110.269 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -65.47 -31.3 72.31 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.783 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -68.56 -40.42 80.63 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.628 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.32 -37.02 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 92' ' ' ALA . 49.0 mt -103.23 -26.29 13.03 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.268 -0.27 . . . . 0.0 111.695 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.98 14.82 74.16 Favored Glycine 0 N--CA 1.493 2.471 0 CA-C-O 119.382 -0.677 . . . . 0.0 111.46 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -151.39 161.45 42.68 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 119.118 1.459 . . . . 0.0 110.651 170.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -94.68 107.84 33.24 Favored Pre-proline 0 N--CA 1.495 1.821 0 CA-C-O 118.637 -0.697 . . . . 0.0 109.856 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -67.31 158.23 57.97 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 O-C-N 123.219 1.115 . . . . 0.0 110.557 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.23 163.76 27.44 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -80.22 79.63 6.76 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.488 0.661 . . . . 0.0 109.675 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.6 172.97 45.37 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 175.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 p -138.05 157.03 47.18 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 117.397 0.599 . . . . 0.0 110.932 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.405 HD22 HD12 ' A' ' 114' ' ' LEU . 22.9 tp -109.63 115.71 30.39 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.436 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.6 m120 -99.26 120.96 40.4 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -176.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.788 HD11 HD11 ' A' ' 126' ' ' ILE . 57.6 mt -120.07 136.01 54.73 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.701 0.286 . . . . 0.0 110.607 -178.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HB2' HG11 ' A' ' 12' ' ' VAL . 48.3 tttm -96.36 134.24 39.75 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 173.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.431 HD22 HG22 ' A' ' 7' ' ' ILE . 84.3 mt -111.53 160.28 17.32 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 120.671 0.272 . . . . 0.0 110.45 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.14 13.0 14.2 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 171.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -145.21 142.27 29.4 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 118.567 0.622 . . . . 0.0 109.416 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -64.5 146.83 53.96 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 122.221 -0.299 . . . . 0.0 110.339 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -132.46 136.67 46.87 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 120.736 0.303 . . . . 0.0 110.602 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -138.04 127.4 24.67 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.33 -23.98 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.385 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -74.27 -1.07 19.05 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.944 -0.472 . . . . 0.0 112.182 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -91.02 -14.26 31.73 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 118.838 0.745 . . . . 0.0 111.481 169.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.404 ' CE1' HG21 ' A' ' 130' ' ' ILE . 77.6 m-85 -116.23 175.06 5.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.665 -0.647 . . . . 0.0 109.43 174.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -91.98 102.93 15.5 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -110.63 178.46 4.36 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 120.579 0.228 . . . . 0.0 110.548 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -112.36 131.64 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 174.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -105.87 144.13 33.04 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.2 p -123.24 138.52 54.61 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 120.783 0.325 . . . . 0.0 110.786 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -77.29 172.71 12.86 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -167.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -67.6 141.36 56.81 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -136.59 167.28 21.68 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.535 -176.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -124.19 146.92 48.39 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 120.807 0.337 . . . . 0.0 110.667 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -149.8 138.65 20.99 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.6 m120 52.14 30.0 7.13 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.708 -0.62 . . . . 0.0 112.135 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.17 16.19 80.87 Favored Glycine 0 N--CA 1.497 2.736 0 CA-C-O 119.528 -0.596 . . . . 0.0 111.749 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -121.08 144.07 48.75 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 118.783 1.291 . . . . 0.0 109.617 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.13 131.36 38.26 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.53 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -120.17 144.72 47.53 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -85.81 156.97 20.35 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 120.845 0.355 . . . . 0.0 110.554 -167.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.43 162.01 44.72 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.42 156.71 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 122.409 -0.465 . . . . 0.0 110.351 -175.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -116.07 137.55 52.02 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.9 t -134.01 140.7 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -176.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.5 tp -136.72 125.65 15.31 Favored Pre-proline 0 N--CA 1.497 1.884 0 CA-C-O 118.553 -0.737 . . . . 0.0 110.109 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -63.78 149.12 91.48 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 120.937 1.091 . . . . 0.0 111.357 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.533 HD13 HG13 ' A' ' 93' ' ' ILE . 43.3 pt -141.79 169.64 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 120.692 0.282 . . . . 0.0 110.298 171.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -114.83 131.26 56.88 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 167.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.4 mt -105.71 123.29 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -175.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.6 mt -107.77 116.48 32.03 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.1 mt -129.75 121.91 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.64 -120.24 18.28 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -111.09 16.98 20.82 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.311 -0.523 . . . . 0.0 111.832 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -119.65 144.4 47.18 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 118.609 0.64 . . . . 0.0 110.464 -175.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -123.12 129.98 52.16 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 120.668 0.271 . . . . 0.0 110.282 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.3 mt -125.54 144.91 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.89 136.83 43.39 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.67 -167.17 12.71 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.59 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.37 155.68 27.15 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 117.277 0.538 . . . . 0.0 110.363 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.533 HG13 HD13 ' A' ' 80' ' ' ILE . 68.1 mt -108.72 141.84 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.03 131.56 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.8 t -141.87 130.63 12.13 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -58.75 155.02 39.76 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 121.02 1.147 . . . . 0.0 111.633 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -64.92 -34.41 78.34 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.301 -0.25 . . . . 0.0 110.574 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -87.98 121.09 29.99 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.3 t -142.38 152.45 42.86 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.344 -0.223 . . . . 0.0 110.407 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -98.9 -58.65 1.9 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -136.76 170.62 15.77 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.1 p -82.74 150.63 26.58 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.1 m -135.17 174.98 10.01 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 120.577 0.227 . . . . 0.0 110.408 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -106.4 27.22 8.95 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.374 -0.204 . . . . 0.0 110.932 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.0 mm -123.73 127.82 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.5 pt -125.2 145.1 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -115.92 130.21 56.73 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.467 HD12 HD12 ' A' ' 46' ' ' LEU . 82.2 mt -115.6 151.02 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -173.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.6 pt -116.56 154.78 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 169.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.59 165.97 22.2 Favored Pre-proline 0 N--CA 1.496 1.829 0 CA-C-O 119.049 -0.5 . . . . 0.0 110.307 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.9 -32.64 95.51 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 121.078 1.185 . . . . 0.0 111.404 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.98 161.54 39.13 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.695 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -63.36 105.81 0.8 Allowed 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 121.267 0.556 . . . . 0.0 111.038 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.405 HD12 HD22 ' A' ' 44' ' ' LEU . 82.4 mt -59.84 -33.35 71.67 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.861 -0.524 . . . . 0.0 111.445 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 93.1 mtm-85 -62.55 -35.36 79.22 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 122.131 -0.355 . . . . 0.0 110.967 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -78.22 -48.03 16.71 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -62.46 -34.24 76.43 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 122.192 -0.318 . . . . 0.0 111.102 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -108.03 9.0 28.56 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 51.85 50.43 18.64 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.137 -0.977 . . . . 0.0 111.934 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.6 mt -90.41 138.12 31.8 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.868 -0.52 . . . . 0.0 110.909 -171.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -116.32 156.96 25.75 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.08 138.04 50.23 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.863 -0.523 . . . . 0.0 111.5 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.68 -22.87 37.91 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -65.38 150.74 47.79 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-N 118.725 1.262 . . . . 0.0 110.041 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.96 133.39 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -173.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.788 HD11 HD11 ' A' ' 46' ' ' LEU . 34.0 pt -128.21 160.39 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -109.3 138.19 46.04 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.0 pt -111.82 136.77 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.462 ' C ' HD23 ' A' ' 129' ' ' LEU . 9.4 tt -110.33 126.17 53.94 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -177.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.404 HG21 ' CE1' ' A' ' 57' ' ' PHE . 48.2 mt -112.1 119.67 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.445 ' HA ' HD23 ' A' ' 4' ' ' LEU . 98.3 mttt -95.45 155.06 16.9 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.11 122.91 1.22 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.404 ' OD1' HG13 ' A' ' 2' ' ' VAL . 19.4 t70 -155.04 -60.05 0.11 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 122.318 -0.519 . . . . 0.0 110.187 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -133.47 143.63 48.94 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -66.44 -37.77 85.9 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.286 -0.259 . . . . 0.0 110.347 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.177 179.465 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.9 mtp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.25 -38.24 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -99.18 104.13 16.07 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.1 mt -110.94 154.21 24.43 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 7.2 tpt -104.37 141.44 36.33 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.2 mm -128.18 130.95 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.511 HG22 HD22 ' A' ' 48' ' ' LEU . 73.2 mt -129.52 148.33 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -105.73 140.39 38.86 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.12 150.51 20.01 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -105.39 142.45 35.13 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 122.354 -0.497 . . . . 0.0 110.205 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.69 123.25 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 45' ' ' ASN . 27.0 m -124.76 163.84 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.3 t -84.66 122.52 29.19 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.22 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.0 140.19 5.92 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.1 tp -155.07 -52.57 0.09 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 117.196 0.498 . . . . 0.0 110.151 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.28 35.59 4.78 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -68.94 -37.87 79.14 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 117.339 0.57 . . . . 0.0 109.843 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.09 -176.34 42.25 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -119.92 34.66 5.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.368 -0.489 . . . . 0.0 110.059 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -120.34 151.52 39.12 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.171 -0.331 . . . . 0.0 110.467 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.79 140.09 47.87 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.3 mt -97.96 0.07 45.73 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.4 p -82.42 -27.32 32.06 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 118.945 0.793 . . . . 0.0 111.399 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.9 mt -65.35 156.17 82.58 Favored Pre-proline 0 N--CA 1.502 2.158 0 CA-C-O 119.108 -0.472 . . . . 0.0 110.77 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -56.95 -55.36 2.71 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.184 1.256 . . . . 0.0 113.168 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.0 -30.15 89.31 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 O-C-N 122.656 0.819 . . . . 0.0 111.626 -163.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.402 ' O ' HG22 ' A' ' 30' ' ' ILE . 15.2 m-85 -65.94 -42.34 90.16 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.452 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -65.39 -38.86 91.27 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 122.068 -0.395 . . . . 0.0 110.26 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.08 -45.61 84.55 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.621 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 27' ' ' TYR . 17.7 tt -69.58 -33.63 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.004 -177.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -65.3 -43.46 91.05 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 122.024 -0.422 . . . . 0.0 110.274 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -65.57 -31.42 72.46 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.225 -0.297 . . . . 0.0 110.855 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -68.71 -40.4 79.98 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.576 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.4 mt -81.35 -36.94 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 92' ' ' ALA . 49.6 mt -104.04 -26.24 12.68 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.228 -0.295 . . . . 0.0 111.611 -174.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.44 14.89 72.7 Favored Glycine 0 N--CA 1.494 2.504 0 CA-C-O 119.322 -0.71 . . . . 0.0 111.421 -172.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -151.84 161.17 43.09 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 119.097 1.449 . . . . 0.0 110.7 170.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -94.1 108.4 35.32 Favored Pre-proline 0 N--CA 1.496 1.874 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.821 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -67.3 157.94 59.37 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 O-C-N 123.279 1.147 . . . . 0.0 110.45 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -73.61 164.0 27.25 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -80.24 79.56 6.79 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.502 0.668 . . . . 0.0 109.612 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.76 172.18 44.44 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 p -138.01 157.18 46.89 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 117.315 0.558 . . . . 0.0 110.691 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.7 tp -109.4 116.14 31.27 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 170.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.54 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.7 m120 -98.34 120.44 38.76 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -177.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.833 HD11 HD11 ' A' ' 126' ' ' ILE . 61.0 mt -120.03 136.15 54.67 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 120.683 0.278 . . . . 0.0 110.658 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HB2' HG11 ' A' ' 12' ' ' VAL . 63.8 tttt -96.05 132.77 41.06 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.511 HD22 HG22 ' A' ' 7' ' ' ILE . 83.6 mt -111.82 160.22 17.56 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 120.681 0.277 . . . . 0.0 110.427 -176.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.1 13.14 13.78 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 172.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -145.86 142.03 28.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.657 -0.652 . . . . 0.0 109.566 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -64.23 148.88 49.13 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 122.297 -0.252 . . . . 0.0 110.395 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -131.78 137.03 48.0 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 120.688 0.28 . . . . 0.0 110.5 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -138.0 124.05 20.25 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.3 tt -64.25 -22.94 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.226 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -72.52 -4.19 29.03 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 118.257 0.48 . . . . 0.0 112.074 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -90.53 -14.26 32.96 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 118.833 0.742 . . . . 0.0 111.427 172.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -115.68 175.08 5.69 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 118.673 0.67 . . . . 0.0 109.34 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -91.42 101.98 14.66 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -108.64 175.96 5.28 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.313 -0.242 . . . . 0.0 110.623 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.7 mt -110.34 131.08 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -105.93 143.12 34.52 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.5 p -122.48 134.53 54.57 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.65 0.262 . . . . 0.0 110.618 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -76.86 172.62 12.84 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 120.803 0.335 . . . . 0.0 111.686 -169.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -67.96 140.29 56.41 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -141.09 165.48 27.42 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.755 -175.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -123.28 149.07 45.26 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.803 0.335 . . . . 0.0 110.533 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -149.87 135.52 18.42 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 51.69 32.91 10.01 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.654 -0.654 . . . . 0.0 112.1 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.27 17.32 78.24 Favored Glycine 0 N--CA 1.498 2.796 0 CA-C-O 119.683 -0.509 . . . . 0.0 111.835 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -122.75 141.13 52.14 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.628 1.214 . . . . 0.0 109.767 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.68 131.73 38.71 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.424 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -121.81 143.96 49.1 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -86.99 155.73 20.05 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 120.812 0.339 . . . . 0.0 110.482 -168.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.45 158.28 51.19 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.3 155.09 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 122.268 -0.548 . . . . 0.0 110.37 -174.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -113.26 137.45 51.47 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.1 t -133.24 140.27 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 tp -137.21 125.71 14.79 Favored Pre-proline 0 N--CA 1.497 1.878 0 CA-C-O 118.522 -0.752 . . . . 0.0 110.073 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -63.21 149.81 90.33 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 120.916 1.077 . . . . 0.0 111.542 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.568 HD13 HG13 ' A' ' 93' ' ' ILE . 43.5 pt -142.13 170.05 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -114.31 131.98 56.34 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 167.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.46 122.88 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -107.47 116.89 32.74 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 74.5 mt -129.97 121.9 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.52 -119.94 17.33 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -111.21 17.01 20.7 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.359 -0.494 . . . . 0.0 111.788 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -119.74 143.94 47.52 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 118.536 0.607 . . . . 0.0 110.468 -175.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -123.14 129.64 51.7 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 120.674 0.273 . . . . 0.0 110.286 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.4 mt -125.53 145.11 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.79 136.72 43.59 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.42 -166.32 12.09 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.72 155.54 26.16 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 117.348 0.574 . . . . 0.0 110.385 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.568 HG13 HD13 ' A' ' 80' ' ' ILE . 69.0 mt -108.73 141.19 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.35 132.11 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.1 t -142.16 129.04 11.17 Favored Pre-proline 0 N--CA 1.498 1.934 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.97 154.35 51.25 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.027 1.151 . . . . 0.0 111.412 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -61.81 -30.84 71.09 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 122.262 -0.274 . . . . 0.0 111.402 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -84.85 107.98 17.28 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.299 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.5 m -131.05 145.41 52.01 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -94.06 -59.74 1.9 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -139.53 170.32 16.14 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.4 m -68.43 145.96 53.63 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.2 m -135.0 166.23 23.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.352 -0.218 . . . . 0.0 110.462 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -107.4 27.1 9.43 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.379 -0.201 . . . . 0.0 110.865 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.7 mm -123.16 127.34 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.467 HD13 HD11 ' A' ' 48' ' ' LEU . 34.2 pt -125.83 144.4 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -114.21 129.58 56.63 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.502 HD12 HD12 ' A' ' 46' ' ' LEU . 82.7 mt -114.78 150.67 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -174.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 pt -116.52 154.85 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 168.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.51 166.07 21.79 Favored Pre-proline 0 N--CA 1.496 1.831 0 CA-C-O 119.099 -0.477 . . . . 0.0 110.257 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.79 -32.12 95.04 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 121.135 1.223 . . . . 0.0 111.468 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.9 160.49 41.22 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.334 -0.229 . . . . 0.0 110.695 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.5 pttt -63.07 105.85 0.76 Allowed 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.297 0.57 . . . . 0.0 111.106 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.7 mt -59.79 -33.44 71.71 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.843 -0.535 . . . . 0.0 111.413 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -62.81 -35.13 78.91 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 122.092 -0.38 . . . . 0.0 111.021 -173.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -78.19 -48.4 15.95 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -62.44 -34.33 76.58 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 122.223 -0.298 . . . . 0.0 111.129 -172.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -108.14 8.87 28.27 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.86 50.39 18.73 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.1 -1.0 . . . . 0.0 111.942 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 45.5 mt -90.35 138.22 31.72 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.757 -0.589 . . . . 0.0 110.952 -171.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -116.39 157.32 25.27 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.99 138.14 49.59 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 121.889 -0.507 . . . . 0.0 111.524 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.68 -22.93 37.65 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -65.47 152.43 43.97 Favored 'General case' 0 N--CA 1.505 2.31 0 CA-C-N 118.597 1.199 . . . . 0.0 110.033 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -111.03 133.93 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -174.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.833 HD11 HD11 ' A' ' 46' ' ' LEU . 34.4 pt -128.85 159.75 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -109.71 137.97 46.76 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 pt -112.82 137.83 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 176.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.466 ' C ' HD23 ' A' ' 129' ' ' LEU . 9.4 tt -109.59 133.38 53.17 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 35.7 mt -125.12 131.74 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -177.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -92.35 137.86 32.01 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.09 165.21 33.16 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -99.23 -34.29 10.4 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 122.38 -0.482 . . . . 0.0 110.377 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -98.15 137.87 36.28 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -97.39 118.58 34.18 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.094 179.794 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 mtt . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.3 t -115.26 133.52 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -100.89 139.07 37.09 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.3 mt -110.81 153.59 25.16 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 41.3 ttm -104.13 141.94 35.36 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.5 mm -126.71 129.78 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.1 mt -129.84 148.75 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -105.11 141.53 36.5 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.26 151.34 20.48 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.77 141.85 36.49 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 117.184 0.492 . . . . 0.0 110.212 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.65 123.86 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 45' ' ' ASN . 27.0 m -123.71 146.43 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 t -87.76 134.98 33.57 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 122.311 -0.243 . . . . 0.0 110.451 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.01 119.81 0.83 Allowed Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.8 mt -143.04 -49.04 0.33 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 117.235 0.517 . . . . 0.0 110.33 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.28 -35.21 90.0 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -67.1 142.62 57.04 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 117.334 0.567 . . . . 0.0 110.377 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.37 -177.95 45.4 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -129.85 140.0 51.08 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 122.304 -0.527 . . . . 0.0 110.1 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -122.57 132.83 54.49 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.285 -0.259 . . . . 0.0 110.526 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -132.04 33.58 3.9 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.68 -30.71 71.78 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 122.185 -0.322 . . . . 0.0 111.1 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.4 p -60.7 -26.52 67.2 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 122.082 -0.386 . . . . 0.0 111.733 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.6 mp -65.15 156.22 81.73 Favored Pre-proline 0 N--CA 1.503 2.185 0 CA-C-O 119.178 -0.439 . . . . 0.0 110.614 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -57.56 -55.95 2.1 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 121.214 1.276 . . . . 0.0 113.083 -173.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.23 -32.15 90.22 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 O-C-N 122.683 0.833 . . . . 0.0 111.546 -163.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.406 ' O ' HG22 ' A' ' 30' ' ' ILE . 47.7 m-85 -66.29 -43.3 86.74 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.4 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -65.36 -37.95 88.57 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 122.105 -0.372 . . . . 0.0 110.324 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -65.18 -46.6 80.13 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.189 -0.319 . . . . 0.0 110.528 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 27' ' ' TYR . 17.8 tt -68.78 -34.04 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.027 -176.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -65.8 -43.52 88.44 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 122.062 -0.399 . . . . 0.0 110.376 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -65.32 -32.39 74.02 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 122.189 -0.319 . . . . 0.0 110.681 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -68.65 -39.57 80.63 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.687 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.7 mt -81.04 -37.52 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -176.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' A' ' 92' ' ' ALA . 46.4 mt -103.42 -26.14 13.0 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.196 -0.315 . . . . 0.0 111.735 -173.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.57 14.75 75.27 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -150.96 160.67 43.77 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 119.107 1.453 . . . . 0.0 110.547 170.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -94.82 108.8 40.11 Favored Pre-proline 0 N--CA 1.495 1.822 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.808 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.23 158.89 54.76 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 O-C-N 123.283 1.149 . . . . 0.0 110.508 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -73.74 163.89 27.36 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -80.21 79.54 6.76 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.544 0.688 . . . . 0.0 109.617 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.06 171.61 43.66 Favored Glycine 0 N--CA 1.496 2.633 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -138.1 157.93 45.34 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 117.356 0.578 . . . . 0.0 110.59 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.545 HD22 ' CD1' ' A' ' 114' ' ' LEU . 28.2 tp -109.9 116.54 31.82 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.533 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.4 m120 -98.94 123.45 43.22 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -176.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.648 HD11 HD11 ' A' ' 126' ' ' ILE . 74.8 mt -120.62 135.57 55.07 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 120.641 0.258 . . . . 0.0 110.602 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HB2' HG11 ' A' ' 12' ' ' VAL . 36.3 ttmt -96.17 133.12 40.86 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.428 HD11 HD13 ' A' ' 106' ' ' ILE . 83.4 mt -112.3 160.27 17.83 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 120.701 0.286 . . . . 0.0 110.464 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -89.57 13.46 13.95 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 172.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -145.41 141.82 28.76 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.763 -0.585 . . . . 0.0 109.423 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -64.47 146.81 53.96 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 122.201 -0.312 . . . . 0.0 110.396 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -134.97 136.41 42.2 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 120.714 0.292 . . . . 0.0 110.588 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -138.04 131.02 30.03 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.48 -23.08 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.533 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -74.86 -0.94 20.12 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.895 -0.503 . . . . 0.0 112.253 -176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -90.04 -14.51 33.71 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 118.946 0.794 . . . . 0.0 111.575 171.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -117.77 175.12 5.8 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.68 -0.637 . . . . 0.0 109.403 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -90.89 103.59 16.28 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -109.73 178.14 4.51 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 120.587 0.232 . . . . 0.0 110.5 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.0 mt -111.15 131.03 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -105.95 146.02 30.56 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.3 p -122.6 137.22 54.96 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 120.688 0.28 . . . . 0.0 110.649 176.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -76.59 172.7 12.59 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 120.895 0.378 . . . . 0.0 111.711 -168.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -67.37 140.23 57.2 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -139.54 166.73 23.81 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 122.221 -0.299 . . . . 0.0 110.598 -174.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -124.22 148.75 47.08 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 120.891 0.377 . . . . 0.0 110.488 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -148.97 136.73 20.52 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.91 32.27 9.67 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.703 -0.623 . . . . 0.0 112.101 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.07 16.85 79.23 Favored Glycine 0 N--CA 1.496 2.692 0 CA-C-O 119.587 -0.563 . . . . 0.0 111.874 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -123.22 143.13 50.24 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 118.651 1.225 . . . . 0.0 109.731 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.37 132.2 37.83 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 121.066 -0.253 . . . . 0.0 110.366 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -121.78 144.91 48.53 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -86.03 156.52 20.39 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.4 -169.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.14 161.22 44.85 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.93 156.92 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 122.354 -0.498 . . . . 0.0 110.327 -174.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -118.77 137.24 53.5 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.8 t -134.04 141.11 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -176.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.4 tp -137.25 125.65 14.7 Favored Pre-proline 0 N--CA 1.496 1.851 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.13 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -63.35 149.46 91.17 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 120.936 1.09 . . . . 0.0 111.477 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.514 HD13 HG13 ' A' ' 93' ' ' ILE . 44.2 pt -141.53 170.09 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 122.209 -0.307 . . . . 0.0 110.256 171.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -114.67 131.56 56.69 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 167.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.05 123.17 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -175.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.1 mt -108.37 117.09 33.24 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.96 121.94 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.29 -119.93 17.58 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -111.16 17.0 20.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.343 -0.504 . . . . 0.0 111.981 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -119.94 144.01 47.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.749 -0.594 . . . . 0.0 110.512 -175.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -123.15 130.76 53.19 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.9 mt -125.78 145.27 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.79 137.83 44.13 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.16 -167.7 13.73 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.424 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.6 156.92 28.82 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 117.354 0.577 . . . . 0.0 110.443 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.514 HG13 HD13 ' A' ' 80' ' ' ILE . 68.7 mt -108.63 141.25 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.98 131.05 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.9 t -143.67 136.52 13.7 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -58.11 154.21 41.0 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 120.989 1.126 . . . . 0.0 111.757 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -65.9 -34.87 79.13 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 122.282 -0.261 . . . . 0.0 110.468 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -92.05 125.7 36.84 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -137.26 155.51 49.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 122.33 -0.231 . . . . 0.0 110.421 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -97.01 -59.43 1.8 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -138.94 170.33 16.18 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.3 p -80.74 147.53 30.51 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.4 m -134.98 174.03 11.07 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 120.583 0.23 . . . . 0.0 110.481 -177.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -107.23 27.61 8.89 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 122.36 -0.212 . . . . 0.0 110.862 177.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -123.3 127.74 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.428 HD13 HD11 ' A' ' 48' ' ' LEU . 34.4 pt -125.97 145.12 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -116.35 130.06 56.58 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.444 HD12 HD12 ' A' ' 46' ' ' LEU . 83.1 mt -114.58 150.41 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -175.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 pt -115.92 153.97 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 169.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.58 166.04 21.82 Favored Pre-proline 0 N--CA 1.494 1.738 0 CA-C-O 119.074 -0.489 . . . . 0.0 110.293 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.75 -31.3 93.88 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.08 1.187 . . . . 0.0 111.68 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.71 167.09 23.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 122.338 -0.226 . . . . 0.0 110.921 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -67.74 107.04 2.43 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.545 ' CD1' HD22 ' A' ' 44' ' ' LEU . 81.3 mt -60.05 -35.82 75.96 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 122.081 -0.387 . . . . 0.0 111.373 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 71.8 mtt85 -62.39 -35.29 78.73 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 122.175 -0.328 . . . . 0.0 110.981 -175.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -78.2 -47.3 18.32 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.6 -34.85 77.83 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 122.191 -0.318 . . . . 0.0 111.036 -172.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -108.01 8.61 28.4 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 51.73 46.81 25.95 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.072 -1.017 . . . . 0.0 111.96 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.37 138.18 31.78 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.956 -0.465 . . . . 0.0 110.969 -170.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -114.79 158.25 22.14 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.78 138.08 48.62 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.866 -0.521 . . . . 0.0 111.541 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.63 -22.93 37.66 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.52 151.86 45.4 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 118.635 1.217 . . . . 0.0 109.982 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.52 134.09 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.648 HD11 HD11 ' A' ' 46' ' ' LEU . 34.2 pt -129.24 161.32 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -110.4 137.89 47.51 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -113.02 137.6 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 176.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.467 ' C ' HD23 ' A' ' 129' ' ' LEU . 9.0 tt -109.71 128.22 55.12 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 37.8 mt -116.41 129.38 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -92.9 149.81 21.0 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.07 169.11 34.14 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.97 -33.52 11.54 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 122.364 -0.492 . . . . 0.0 110.371 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -96.05 138.66 33.35 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -67.85 -35.04 77.87 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.189 179.866 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.1 mtp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p -131.95 141.57 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -102.67 121.61 42.78 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 81.2 mt -110.87 147.44 34.56 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.402 ' O ' HD13 ' A' ' 6' ' ' ILE . 43.6 ttm -113.08 143.67 43.95 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.402 HD13 ' O ' ' A' ' 5' ' ' MET . 50.6 mm -129.35 131.43 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.7 mt -129.58 148.5 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -106.98 142.37 36.7 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 122.27 -0.269 . . . . 0.0 110.466 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.69 151.57 20.95 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -106.07 142.69 35.34 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 117.247 0.524 . . . . 0.0 110.259 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.64 124.32 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 45' ' ' ASN . 27.1 m -123.73 156.12 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.9 t -85.67 131.58 34.31 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.4 -176.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.96 119.89 0.84 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.1 tp -142.62 135.82 28.52 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 117.232 0.516 . . . . 0.0 110.236 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.44 36.87 32.79 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -100.53 140.35 34.91 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.335 -0.509 . . . . 0.0 110.136 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.02 173.96 42.35 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -118.04 33.34 5.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 122.34 -0.506 . . . . 0.0 110.33 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -116.25 144.13 44.61 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.181 -0.324 . . . . 0.0 110.409 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -114.49 139.54 49.46 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.4 mt -98.59 0.04 44.08 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.3 t -83.41 -31.2 26.79 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 119.033 0.833 . . . . 0.0 110.981 -174.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.5 mp -65.62 152.45 92.65 Favored Pre-proline 0 N--CA 1.503 2.195 0 CA-C-O 119.051 -0.499 . . . . 0.0 110.492 -176.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -53.57 -50.77 12.68 Favored 'Trans proline' 0 N--CA 1.501 1.96 0 C-N-CA 121.158 1.238 . . . . 0.0 113.891 -174.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.618 ' O ' HG22 ' A' ' 30' ' ' ILE . 31.2 Cg_exo -55.54 -35.16 91.97 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 120.619 0.879 . . . . 0.0 112.312 -168.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -67.1 -50.23 62.26 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.26 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -64.71 -40.76 95.91 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 122.125 -0.359 . . . . 0.0 110.533 -176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.83 -49.94 64.17 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 122.166 -0.334 . . . . 0.0 110.391 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 26' ' ' PRO . 11.0 tt -70.75 -32.67 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.205 -175.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.81 -40.89 95.95 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 122.019 -0.425 . . . . 0.0 110.285 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -64.51 -31.45 72.68 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 122.157 -0.339 . . . . 0.0 110.767 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -67.98 -40.34 83.12 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.657 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.549 HG23 HD12 ' A' ' 60' ' ' ILE . 59.6 mt -80.94 -37.27 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -175.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 92' ' ' ALA . 58.0 mt -102.53 -26.29 13.29 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 122.189 -0.319 . . . . 0.0 111.568 -174.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.35 14.33 74.34 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-O 119.26 -0.745 . . . . 0.0 111.411 -172.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -152.31 161.23 42.91 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 119.243 1.521 . . . . 0.0 110.641 170.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -94.32 107.95 32.87 Favored Pre-proline 0 N--CA 1.496 1.841 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.737 177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.413 ' CB ' HD12 ' A' ' 109' ' ' ILE . 65.1 Cg_endo -67.4 155.48 70.2 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 O-C-N 123.327 1.172 . . . . 0.0 110.462 -176.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -73.82 164.17 26.98 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.24 79.55 6.8 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.489 0.661 . . . . 0.0 109.663 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.55 171.74 44.03 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 p -138.05 156.74 47.49 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 117.41 0.605 . . . . 0.0 110.884 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.2 tp -109.91 118.58 36.84 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 170.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.545 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.7 m120 -98.95 122.34 42.08 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -176.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.822 HD11 HD11 ' A' ' 126' ' ' ILE . 60.8 mt -119.96 136.08 54.67 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 120.686 0.279 . . . . 0.0 110.562 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HB2' HG11 ' A' ' 12' ' ' VAL . 67.4 tttt -96.23 133.39 40.61 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 173.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.477 HD11 HD13 ' A' ' 106' ' ' ILE . 82.9 mt -112.16 160.18 17.82 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 120.561 0.22 . . . . 0.0 110.482 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.2 13.16 13.94 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -145.34 141.21 28.3 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 118.604 0.638 . . . . 0.0 109.418 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -64.18 146.84 53.59 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 122.253 -0.279 . . . . 0.0 110.392 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -132.02 137.41 47.83 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 120.705 0.288 . . . . 0.0 110.638 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -138.07 128.34 26.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.613 HD13 ' HB3' ' A' ' 76' ' ' LYS . 20.0 tt -63.72 -24.08 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.327 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -74.33 -1.05 19.11 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 122.0 -0.437 . . . . 0.0 112.156 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -91.22 -14.35 31.16 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 118.874 0.761 . . . . 0.0 111.441 169.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -116.07 175.02 5.73 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.644 -0.66 . . . . 0.0 109.396 175.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -92.07 101.97 14.51 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -177.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -110.18 176.71 4.95 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 120.535 0.207 . . . . 0.0 110.489 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.549 HD12 HG23 ' A' ' 34' ' ' ILE . 77.6 mt -110.98 134.43 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -105.75 142.47 35.43 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.3 p -116.7 133.66 55.75 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -77.18 172.63 12.94 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 120.803 0.335 . . . . 0.0 111.345 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -68.6 139.98 55.54 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -138.35 166.6 23.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.251 -0.281 . . . . 0.0 110.67 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -125.44 145.81 49.9 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 120.749 0.309 . . . . 0.0 110.544 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -149.57 141.82 24.12 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.0 m120 52.17 29.95 7.15 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.667 -0.646 . . . . 0.0 112.085 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.41 16.39 80.76 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -121.51 142.54 49.97 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 118.699 1.25 . . . . 0.0 109.666 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -93.14 131.7 37.95 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.477 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -120.85 143.73 48.74 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -86.89 151.9 22.91 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 120.763 0.316 . . . . 0.0 110.382 -169.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.74 167.18 42.01 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.99 162.76 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 122.312 -0.523 . . . . 0.0 110.488 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.613 ' HB3' HD13 ' A' ' 54' ' ' ILE . 61.7 mttp -112.23 137.37 50.42 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 173.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -132.47 138.33 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.2 tp -136.94 125.65 15.06 Favored Pre-proline 0 N--CA 1.497 1.925 0 CA-C-O 118.663 -0.684 . . . . 0.0 110.097 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -63.59 149.39 91.06 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 120.993 1.128 . . . . 0.0 111.395 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.555 HD13 HG13 ' A' ' 93' ' ' ILE . 43.1 pt -142.15 170.03 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 171.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -115.28 131.99 56.75 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 167.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.6 mt -106.26 123.48 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.636 HD11 HD12 ' A' ' 129' ' ' LEU . 85.5 mt -107.86 116.76 32.55 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.4 mt -129.92 121.98 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.35 -120.13 18.26 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -178.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -111.07 16.95 20.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.366 -0.491 . . . . 0.0 111.926 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -119.72 144.0 47.47 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 118.577 0.626 . . . . 0.0 110.496 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -123.1 129.72 51.82 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 120.651 0.262 . . . . 0.0 110.308 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.2 mt -125.96 143.44 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.96 138.2 44.04 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.23 -164.34 11.32 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.541 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.88 156.19 26.92 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 117.351 0.576 . . . . 0.0 110.417 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.555 HG13 HD13 ' A' ' 80' ' ' ILE . 69.7 mt -108.77 141.53 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.57 130.77 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.6 t -140.39 126.8 11.92 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -57.7 155.83 30.27 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 121.024 1.149 . . . . 0.0 111.883 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -63.76 -33.88 76.65 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 122.31 -0.244 . . . . 0.0 110.78 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -86.65 116.15 24.57 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.1 m -130.83 142.64 50.4 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -93.8 -50.37 5.39 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -147.8 -179.48 6.92 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.9 p -91.18 145.52 24.6 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.5 m -135.08 174.96 10.03 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 120.586 0.231 . . . . 0.0 110.562 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -107.07 27.42 9.04 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 122.458 -0.151 . . . . 0.0 110.929 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.7 mm -122.64 127.4 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.477 HD13 HD11 ' A' ' 48' ' ' LEU . 34.5 pt -125.43 144.05 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 110.137 -0.319 . . . . 0.0 110.137 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -114.55 130.15 56.73 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.483 HD12 HD12 ' A' ' 46' ' ' LEU . 82.9 mt -115.28 151.06 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -174.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.413 HD12 ' CB ' ' A' ' 39' ' ' PRO . 12.5 pt -115.74 155.72 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 169.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.48 162.02 44.2 Favored Pre-proline 0 N--CA 1.495 1.791 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.214 -176.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.21 -34.47 94.01 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.065 1.177 . . . . 0.0 111.462 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -145.03 159.07 43.53 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.348 -0.22 . . . . 0.0 110.684 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.7 pttt -63.72 103.97 0.62 Allowed 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.495 0.665 . . . . 0.0 111.23 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.46 -31.98 69.82 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.927 -0.483 . . . . 0.0 111.373 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.411 ' HA ' HD12 ' A' ' 120' ' ' LEU . 76.6 mtm180 -61.29 -34.98 76.1 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.008 -0.432 . . . . 0.0 111.211 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -78.25 -49.07 14.41 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -61.89 -33.8 74.88 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.217 -172.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -108.11 9.02 28.38 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.79 50.54 18.44 Favored 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.005 -1.059 . . . . 0.0 111.85 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 115' ' ' ARG . 44.9 mt -89.49 138.14 31.71 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.878 -0.514 . . . . 0.0 110.951 -169.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -119.52 157.24 28.74 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -55.95 138.51 48.67 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.84 -0.537 . . . . 0.0 111.474 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.53 -23.02 37.33 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -65.32 151.44 46.24 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 118.702 1.251 . . . . 0.0 110.03 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -110.23 133.07 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -174.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.822 HD11 HD11 ' A' ' 46' ' ' LEU . 34.4 pt -128.29 160.13 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -109.25 137.98 46.3 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -175.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.0 pt -110.12 137.6 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.636 HD12 HD11 ' A' ' 83' ' ' LEU . 8.0 tt -110.85 130.76 55.49 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 122.314 -0.241 . . . . 0.0 110.359 -175.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 47.6 mt -115.6 120.01 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -93.56 147.55 22.89 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.15 123.04 1.24 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -154.99 33.31 0.39 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.376 -0.485 . . . . 0.0 110.372 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -135.68 133.72 38.42 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -148.11 169.65 19.53 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.353 -0.217 . . . . 0.0 110.472 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.163 -179.915 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 mtt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.4 t -70.3 -39.17 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -106.27 136.19 46.43 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.465 HD13 HD21 ' A' ' 129' ' ' LEU . 83.6 mt -110.94 160.11 17.1 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.2 ttt -102.37 140.9 36.03 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.3 mm -127.9 130.5 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.495 HG22 HD22 ' A' ' 48' ' ' LEU . 75.3 mt -129.74 148.91 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -105.53 140.14 39.08 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.85 151.1 20.31 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -105.99 141.32 37.57 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 117.229 0.515 . . . . 0.0 110.256 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.3 t -63.22 124.04 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 45' ' ' ASN . 27.0 m -123.88 164.02 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 176.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.9 t -83.71 116.51 22.7 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.194 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.0 133.72 2.91 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.45 HD23 ' C ' ' A' ' 15' ' ' LEU . 6.7 tt -153.55 -60.05 0.13 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 117.297 0.549 . . . . 0.0 110.262 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.27 35.11 5.24 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.21 -31.16 70.48 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 117.375 0.588 . . . . 0.0 110.649 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.55 -177.87 41.27 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -116.55 33.09 5.75 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 122.297 -0.531 . . . . 0.0 110.359 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -117.59 141.79 47.96 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.135 -0.353 . . . . 0.0 110.458 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -114.53 134.39 55.07 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.651 ' O ' HD23 ' A' ' 22' ' ' LEU . 2.3 tt -89.95 -29.42 18.5 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 122.378 -0.201 . . . . 0.0 110.868 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.5 t -52.45 -23.59 6.39 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.604 -0.685 . . . . 0.0 112.439 -175.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.9 mt -66.25 157.7 80.41 Favored Pre-proline 0 N--CA 1.501 2.114 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.208 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -56.24 -55.08 3.13 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 121.159 1.239 . . . . 0.0 113.242 -174.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.93 -30.41 89.92 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 O-C-N 122.723 0.854 . . . . 0.0 111.625 -164.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -66.73 -44.47 81.49 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.309 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -65.94 -37.81 87.0 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 122.108 -0.37 . . . . 0.0 110.195 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.23 -46.85 78.98 Favored 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.592 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.2 tt -69.3 -36.09 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.043 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.424 ' CE2' HD11 ' A' ' 22' ' ' LEU . 3.6 m-85 -65.82 -44.43 85.64 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 122.03 -0.419 . . . . 0.0 110.438 178.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -65.74 -31.63 72.73 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.156 -0.34 . . . . 0.0 110.758 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -68.53 -40.44 80.76 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.578 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -81.44 -36.59 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 92' ' ' ALA . 46.0 mt -103.27 -26.39 12.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 122.14 -0.35 . . . . 0.0 111.693 -174.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.53 15.36 73.84 Favored Glycine 0 N--CA 1.495 2.586 0 CA-C-O 119.362 -0.688 . . . . 0.0 111.411 -173.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -151.14 162.75 40.29 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 119.145 1.473 . . . . 0.0 110.812 170.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.03 106.52 22.79 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.835 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.427 ' CB ' HD12 ' A' ' 109' ' ' ILE . 72.9 Cg_endo -68.48 160.93 47.12 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 O-C-N 123.383 1.201 . . . . 0.0 110.269 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -73.19 160.58 31.73 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -80.23 79.6 6.78 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.479 0.657 . . . . 0.0 109.686 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.28 176.41 47.79 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 p -138.11 156.25 47.95 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 117.331 0.565 . . . . 0.0 110.813 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.501 HD22 HD12 ' A' ' 114' ' ' LEU . 31.6 tp -108.68 116.47 32.05 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 169.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.548 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.6 m120 -98.41 122.13 41.21 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -176.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.796 HD11 HD11 ' A' ' 126' ' ' ILE . 61.4 mt -120.31 135.59 54.96 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 120.653 0.263 . . . . 0.0 110.535 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -95.9 133.09 40.49 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.52 HD11 HD13 ' A' ' 106' ' ' ILE . 83.6 mt -112.31 160.22 17.88 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 120.653 0.263 . . . . 0.0 110.484 -175.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.06 13.0 14.04 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 172.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -145.99 142.89 29.09 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 118.614 0.643 . . . . 0.0 109.557 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.34 148.63 49.91 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.503 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -131.91 137.44 47.99 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 120.701 0.286 . . . . 0.0 110.44 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -138.09 125.0 21.22 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.5 -23.62 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.266 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -74.24 -1.45 20.61 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.976 -0.453 . . . . 0.0 112.109 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.09 -14.5 31.13 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 118.929 0.786 . . . . 0.0 111.453 170.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -116.67 175.15 5.7 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 118.658 0.663 . . . . 0.0 109.343 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -91.31 102.72 15.42 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -109.44 177.35 4.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 122.323 -0.235 . . . . 0.0 110.563 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.2 mt -111.28 130.91 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -105.97 142.4 35.75 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.2 p -120.69 138.8 53.77 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 120.794 0.331 . . . . 0.0 110.743 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -76.75 172.64 12.75 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 120.847 0.356 . . . . 0.0 111.826 -168.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -67.88 141.21 56.47 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -136.67 164.91 27.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.152 -0.342 . . . . 0.0 110.598 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -123.61 145.95 48.54 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 120.732 0.301 . . . . 0.0 110.469 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -149.88 139.39 21.53 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 52.01 30.34 7.28 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.674 -0.642 . . . . 0.0 112.131 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.36 16.59 80.29 Favored Glycine 0 N--CA 1.497 2.725 0 CA-C-O 119.648 -0.529 . . . . 0.0 111.83 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -122.14 143.45 49.54 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.573 1.187 . . . . 0.0 109.614 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.21 131.41 38.33 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.463 -176.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -120.11 143.49 48.14 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -85.76 157.22 20.32 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 120.715 0.293 . . . . 0.0 110.432 -168.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.29 159.66 47.21 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.93 155.88 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 122.404 -0.468 . . . . 0.0 110.473 -174.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -114.69 138.24 50.94 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.3 t -133.88 140.04 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -177.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 tp -137.12 125.64 14.85 Favored Pre-proline 0 N--CA 1.497 1.88 0 CA-C-O 118.518 -0.753 . . . . 0.0 110.089 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.27 149.27 91.77 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.979 1.12 . . . . 0.0 111.482 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.571 HD13 HG13 ' A' ' 93' ' ' ILE . 43.7 pt -141.95 170.03 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 171.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -114.9 131.17 56.95 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 168.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.2 mt -105.62 124.11 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -174.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.75 116.3 31.71 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -130.01 121.95 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.99 -120.49 18.72 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -111.15 17.09 20.68 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 122.33 -0.512 . . . . 0.0 111.806 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -119.61 144.76 46.95 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 118.609 0.641 . . . . 0.0 110.492 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -123.06 131.15 53.58 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.216 -0.303 . . . . 0.0 110.28 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.79 144.87 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.75 136.57 43.65 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.58 -166.49 12.25 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.593 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.41 155.63 26.99 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 117.311 0.555 . . . . 0.0 110.304 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.571 HG13 HD13 ' A' ' 80' ' ' ILE . 69.3 mt -108.7 141.99 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.1 t -121.43 131.35 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -142.44 136.22 14.52 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -57.28 152.32 46.66 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.1 1.2 . . . . 0.0 111.814 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -66.19 -34.85 78.96 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.394 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -93.89 125.19 38.37 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 t -140.91 154.82 46.29 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -97.64 -57.93 2.12 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -134.61 -177.91 4.83 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 92.2 p -95.13 150.87 19.73 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.3 m -135.06 174.64 10.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.309 -0.245 . . . . 0.0 110.419 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -107.39 27.49 9.05 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 122.37 -0.206 . . . . 0.0 110.858 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.5 mm -122.91 127.35 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.52 HD13 HD11 ' A' ' 48' ' ' LEU . 34.4 pt -124.95 143.79 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -114.93 129.44 56.71 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.486 HD12 HD12 ' A' ' 46' ' ' LEU . 80.9 mt -115.02 152.04 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -174.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.427 HD12 ' CB ' ' A' ' 39' ' ' PRO . 11.4 pt -117.37 155.23 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 167.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.56 165.59 24.21 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.298 -176.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -60.0 -32.04 94.39 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 121.072 1.181 . . . . 0.0 111.576 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.73 167.03 23.54 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.319 -0.238 . . . . 0.0 110.826 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -70.63 104.34 2.79 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.501 HD12 HD22 ' A' ' 44' ' ' LEU . 81.2 mt -59.55 -33.01 70.87 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 122.211 -0.306 . . . . 0.0 111.497 -177.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -62.44 -35.59 79.75 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 122.109 -0.369 . . . . 0.0 110.949 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -78.22 -48.52 15.62 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -62.61 -33.41 74.93 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 122.159 -0.338 . . . . 0.0 111.099 -173.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -107.95 8.33 28.39 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 51.81 45.1 28.75 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 121.096 -1.002 . . . . 0.0 111.934 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -92.67 138.22 31.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.898 -0.501 . . . . 0.0 110.867 -171.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -114.97 159.31 20.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.11 138.18 50.11 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.906 -0.496 . . . . 0.0 111.467 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.63 -22.98 37.45 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.44 156.0 33.76 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-N 118.629 1.214 . . . . 0.0 109.975 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.36 133.87 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.796 HD11 HD11 ' A' ' 46' ' ' LEU . 34.0 pt -128.74 160.52 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -109.75 138.19 46.47 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 pt -112.77 137.58 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.467 ' C ' HD23 ' A' ' 129' ' ' LEU . 9.4 tt -110.19 128.76 55.66 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 36.6 mt -117.62 130.02 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.4 ' HG2' HD22 ' A' ' 4' ' ' LEU . 98.5 mttt -93.26 141.1 28.81 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.09 174.1 34.67 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -115.07 31.74 6.5 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.356 -0.497 . . . . 0.0 110.504 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -99.21 139.55 34.69 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 122.12 -0.362 . . . . 0.0 110.21 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -67.52 -34.37 76.97 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 120.726 0.298 . . . . 0.0 110.335 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 N--CA 1.506 2.327 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.759 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.4 mtt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p -132.17 141.1 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -101.83 132.65 47.47 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 131' ' ' LYS . 84.6 mt -110.82 153.01 26.0 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.5 ttm -134.65 145.57 48.7 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.2 mm -126.47 135.46 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -175.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.445 HG22 HD22 ' A' ' 48' ' ' LEU . 78.8 mt -130.6 147.74 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -110.08 143.96 39.36 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.59 151.56 21.26 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -105.95 142.56 35.46 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 117.231 0.516 . . . . 0.0 110.278 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.5 t -64.78 122.39 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -126.65 149.18 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 t -86.6 111.76 20.94 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.07 126.75 1.38 Allowed Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.4 mt -99.4 30.76 3.39 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.326 -0.514 . . . . 0.0 110.677 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.89 177.34 51.49 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -68.68 -34.99 76.61 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 117.219 0.51 . . . . 0.0 109.936 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.38 -175.72 14.03 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -118.7 150.2 40.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.31 -0.523 . . . . 0.0 110.265 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -136.55 167.42 21.42 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -102.5 127.95 49.34 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 120.586 0.232 . . . . 0.0 110.451 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' ' 41' ' ' GLU . 23.9 mt -103.79 -29.66 10.88 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.342 -0.224 . . . . 0.0 110.94 177.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.4 p -60.26 -26.57 66.57 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 122.103 -0.373 . . . . 0.0 111.8 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.7 mt -64.79 155.97 80.74 Favored Pre-proline 0 N--CA 1.503 2.19 0 CA-C-O 119.158 -0.449 . . . . 0.0 110.571 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -57.66 -56.11 1.96 Allowed 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 121.159 1.239 . . . . 0.0 113.129 -172.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.59 -32.73 93.75 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 O-C-N 122.689 0.836 . . . . 0.0 111.574 -162.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -66.51 -44.38 82.7 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.291 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -65.41 -37.81 88.08 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 122.207 -0.308 . . . . 0.0 110.386 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -65.68 -47.44 75.43 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.549 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.1 tt -68.75 -36.52 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.078 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -66.07 -44.95 83.03 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 122.109 -0.369 . . . . 0.0 110.391 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -65.76 -30.71 71.4 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 122.224 -0.298 . . . . 0.0 110.797 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -68.77 -40.63 79.61 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.645 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.2 mt -81.45 -37.08 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 92' ' ' ALA . 45.7 mt -104.04 -26.25 12.67 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.262 -0.274 . . . . 0.0 111.638 -174.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.77 14.31 73.2 Favored Glycine 0 N--CA 1.494 2.554 0 CA-C-O 119.319 -0.712 . . . . 0.0 111.449 -172.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -152.43 163.46 39.49 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 119.149 1.475 . . . . 0.0 110.691 170.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -94.97 108.42 37.99 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.583 -0.722 . . . . 0.0 109.922 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.418 ' CB ' HD12 ' A' ' 109' ' ' ILE . 65.8 Cg_endo -67.39 159.64 51.42 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 123.32 1.169 . . . . 0.0 110.492 -176.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -74.0 162.55 28.92 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.474 ' HA ' HD13 ' A' ' 22' ' ' LEU . 53.7 mt-10 -80.21 79.59 6.76 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.519 0.676 . . . . 0.0 109.662 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.64 171.86 44.13 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 175.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 p -138.0 157.59 46.06 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 117.382 0.591 . . . . 0.0 110.853 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.2 tp -110.47 116.98 32.35 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.416 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.5 m120 -98.97 121.76 41.34 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -176.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 126' ' ' ILE . 65.4 mt -120.49 135.98 54.9 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.72 0.295 . . . . 0.0 110.642 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -96.09 132.06 41.87 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.445 HD22 HG22 ' A' ' 7' ' ' ILE . 83.5 mt -110.6 160.3 16.79 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 120.64 0.257 . . . . 0.0 110.452 -176.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.28 12.85 14.89 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 172.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -145.27 140.48 27.84 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.696 -0.628 . . . . 0.0 109.39 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.33 146.94 52.46 Favored 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.626 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -132.53 137.19 47.06 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 120.724 0.297 . . . . 0.0 110.639 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -138.0 126.9 24.0 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.0 tt -64.37 -23.94 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.135 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -72.74 -3.55 25.88 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 122.006 -0.434 . . . . 0.0 112.053 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -91.12 -13.89 32.19 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 118.815 0.734 . . . . 0.0 111.51 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -114.2 175.08 5.63 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.596 0.634 . . . . 0.0 109.395 173.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -92.06 102.01 14.56 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -109.18 176.88 4.93 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 120.524 0.202 . . . . 0.0 110.574 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -111.0 129.48 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -105.94 140.91 38.21 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.5 p -117.23 134.9 54.24 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 120.721 0.296 . . . . 0.0 110.495 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -75.83 172.69 12.25 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 120.768 0.318 . . . . 0.0 111.472 -170.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -67.71 139.48 56.72 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -139.83 167.44 22.11 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.618 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -124.23 149.12 46.78 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 120.846 0.355 . . . . 0.0 110.528 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -148.24 135.62 20.5 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.82 32.89 10.34 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.739 -0.601 . . . . 0.0 112.098 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.25 16.6 79.38 Favored Glycine 0 N--CA 1.497 2.745 0 CA-C-O 119.606 -0.552 . . . . 0.0 111.907 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -121.99 142.13 50.63 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.74 1.27 . . . . 0.0 109.731 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.3 132.13 37.79 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.431 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -121.84 144.12 49.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -86.41 155.94 20.37 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.483 -168.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.76 159.15 49.13 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -139.24 156.77 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 122.353 -0.498 . . . . 0.0 110.387 -174.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -117.04 136.76 52.72 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.5 t -134.04 141.19 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.9 tp -137.35 125.63 14.57 Favored Pre-proline 0 N--CA 1.497 1.893 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.152 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.22 149.39 91.5 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 120.928 1.085 . . . . 0.0 111.475 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.538 HD13 HG13 ' A' ' 93' ' ' ILE . 43.7 pt -141.79 170.01 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-O 120.638 0.256 . . . . 0.0 110.312 171.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -116.18 130.58 56.86 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 167.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.8 mt -105.74 123.99 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -174.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.526 HD11 HD13 ' A' ' 129' ' ' LEU . 84.9 mt -107.88 117.17 33.41 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.5 mt -130.15 121.95 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.6 -120.05 17.6 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -111.16 17.11 20.65 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 122.418 -0.46 . . . . 0.0 111.78 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -119.65 143.75 47.54 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.558 0.617 . . . . 0.0 110.444 -175.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -123.12 130.0 52.19 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -125.42 145.05 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.77 136.65 43.63 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.86 -167.34 12.92 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.585 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.72 155.85 26.7 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 117.304 0.552 . . . . 0.0 110.387 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.538 HG13 HD13 ' A' ' 80' ' ' ILE . 69.8 mt -108.77 141.13 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.0 t -122.27 131.13 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -143.73 138.25 15.07 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.09 153.24 39.9 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 121.116 1.21 . . . . 0.0 111.842 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -65.4 -33.79 76.79 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 121.061 -0.255 . . . . 0.0 110.581 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -87.42 117.29 26.1 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 m -130.56 134.7 47.23 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -96.98 -50.24 4.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -133.41 170.02 16.09 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.7 m -94.61 153.34 17.89 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 93.6 p -135.09 173.45 11.71 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 120.739 0.304 . . . . 0.0 110.468 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -105.78 24.55 12.12 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 119.71 -0.186 . . . . 0.0 110.891 172.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.9 mm -119.85 127.43 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.9 pt -125.93 145.93 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -115.98 130.17 56.7 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.487 HD12 HD12 ' A' ' 46' ' ' LEU . 81.3 mt -115.18 150.83 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -174.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.418 HD12 ' CB ' ' A' ' 39' ' ' PRO . 11.2 pt -116.22 156.52 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 168.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.52 161.64 45.96 Favored Pre-proline 0 N--CA 1.495 1.806 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.298 -177.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.02 -31.39 93.42 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 121.044 1.163 . . . . 0.0 111.614 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.32 167.13 23.18 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.277 -0.264 . . . . 0.0 110.634 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -74.3 103.87 4.86 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 120.946 0.403 . . . . 0.0 110.176 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 79.0 mt -60.39 -33.25 72.21 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 122.088 -0.383 . . . . 0.0 111.314 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -61.93 -33.3 74.02 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.159 -0.338 . . . . 0.0 110.925 -175.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.24 -50.88 11.06 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -62.63 -32.52 73.56 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.158 -0.339 . . . . 0.0 111.218 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -106.64 8.07 30.94 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.78 47.51 24.65 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.06 -1.025 . . . . 0.0 111.858 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.3 mt -91.15 138.23 31.75 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.874 -0.517 . . . . 0.0 111.094 -169.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -117.55 159.86 22.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.24 138.38 50.44 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.908 -0.495 . . . . 0.0 111.445 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.55 -23.09 37.07 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -65.39 152.7 43.23 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 118.653 1.227 . . . . 0.0 110.061 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -110.81 133.1 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -174.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.783 HD11 HD11 ' A' ' 46' ' ' LEU . 33.5 pt -128.16 160.64 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -108.78 139.46 43.57 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.2 pt -110.09 137.9 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 174.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.526 HD13 HD11 ' A' ' 83' ' ' LEU . 6.2 tp -107.75 134.19 51.07 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -173.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 49.4 mt -125.06 125.49 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.428 ' HA ' HD23 ' A' ' 4' ' ' LEU . 98.9 mttt -94.34 149.04 21.62 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 175.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.09 131.98 3.1 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -94.08 -34.57 12.94 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.306 -0.526 . . . . 0.0 110.165 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -123.58 139.13 54.32 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -93.42 -34.34 13.48 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 120.706 0.288 . . . . 0.0 110.307 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 . . . . . 0 N--CA 1.507 2.38 0 CA-C-O 117.823 -1.084 . . . . 0.0 111.763 -179.44 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 ttm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.9 t -113.61 132.85 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -107.43 122.84 47.42 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.1 mt -110.88 143.26 41.78 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.657 ' O ' HD13 ' A' ' 6' ' ' ILE . 48.1 ttm -144.56 146.87 32.58 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 120.681 0.276 . . . . 0.0 110.567 -178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.722 HD12 HD23 ' A' ' 129' ' ' LEU . 36.7 mm -131.26 124.55 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 78.8 mt -130.72 154.38 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -106.13 146.88 29.64 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.47 150.3 20.99 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -106.3 141.34 37.79 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.267 -0.549 . . . . 0.0 110.141 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.8 t -62.89 123.33 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -123.59 153.91 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.5 t -86.15 125.88 33.82 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.321 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.07 119.94 0.84 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.7 mt -130.41 131.32 45.2 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.345 -0.503 . . . . 0.0 110.259 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.42 35.72 76.42 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -68.68 -36.79 78.97 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 117.245 0.523 . . . . 0.0 109.922 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.66 -178.57 43.77 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -115.03 32.53 5.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 122.32 -0.517 . . . . 0.0 110.46 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -119.36 143.77 47.24 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.099 -0.376 . . . . 0.0 110.368 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -111.13 128.39 55.87 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.408 HD23 ' HB3' ' A' ' 27' ' ' TYR . 85.9 mt -94.84 -15.56 23.62 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.4 m -59.38 -28.7 67.12 Favored 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 118.647 0.658 . . . . 0.0 111.451 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.4 mp -66.77 157.79 82.37 Favored Pre-proline 0 N--CA 1.501 2.089 0 CA-C-O 119.243 -0.408 . . . . 0.0 110.369 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -56.71 -55.92 2.36 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 121.298 1.332 . . . . 0.0 113.366 -174.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.62 ' O ' HG22 ' A' ' 30' ' ' ILE . 14.6 Cg_endo -58.64 -32.45 96.8 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 120.533 0.822 . . . . 0.0 111.936 -162.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.408 ' HB3' HD23 ' A' ' 22' ' ' LEU . 97.1 m-85 -66.33 -47.75 72.51 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.369 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -65.01 -41.82 95.0 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 120.896 -0.321 . . . . 0.0 110.352 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -66.43 -50.17 64.29 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.479 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 26' ' ' PRO . 10.7 tt -71.16 -32.86 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.217 -175.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -65.26 -38.96 91.95 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 122.063 -0.398 . . . . 0.0 110.169 175.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -63.95 -34.15 77.34 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.272 -0.268 . . . . 0.0 110.798 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -67.32 -38.3 84.7 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.607 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.54 HG23 HD12 ' A' ' 60' ' ' ILE . 59.9 mt -81.2 -37.09 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.5 ' CD2' ' HB2' ' A' ' 92' ' ' ALA . 58.3 mt -101.22 -26.37 13.67 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 122.226 -0.296 . . . . 0.0 111.657 -174.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.66 14.14 76.49 Favored Glycine 0 N--CA 1.494 2.52 0 CA-C-O 119.312 -0.716 . . . . 0.0 111.414 -173.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -152.06 161.45 42.61 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 119.117 1.459 . . . . 0.0 110.609 171.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -94.22 106.44 22.96 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-O 118.611 -0.709 . . . . 0.0 109.901 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.418 ' CB ' HD12 ' A' ' 109' ' ' ILE . 71.5 Cg_endo -68.29 158.48 57.35 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 O-C-N 123.303 1.16 . . . . 0.0 110.314 -177.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -73.5 160.92 30.99 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -80.28 79.62 6.83 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.531 0.681 . . . . 0.0 109.538 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.46 177.64 48.35 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 p -138.07 156.04 48.18 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 117.389 0.594 . . . . 0.0 110.931 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.504 HD22 HD12 ' A' ' 114' ' ' LEU . 27.8 tp -109.04 118.59 37.18 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 169.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.537 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.7 m120 -99.0 123.36 43.24 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.228 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.539 HD11 HD11 ' A' ' 126' ' ' ILE . 56.1 mt -120.71 136.08 54.96 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.688 0.28 . . . . 0.0 110.441 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.511 ' HB2' HG11 ' A' ' 12' ' ' VAL . 39.2 tttp -95.81 133.93 39.37 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.554 HD11 HD13 ' A' ' 106' ' ' ILE . 83.7 mt -112.69 160.3 18.05 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 120.62 0.247 . . . . 0.0 110.395 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.01 12.54 15.22 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 173.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -145.69 144.88 30.65 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 118.563 0.62 . . . . 0.0 109.795 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -63.97 150.35 45.34 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 122.222 -0.298 . . . . 0.0 110.477 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -131.86 139.03 48.69 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 120.69 0.281 . . . . 0.0 110.701 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -138.08 122.87 18.79 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.58 -21.13 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.441 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -75.17 -0.77 20.39 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -89.41 -14.47 35.41 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 118.991 0.814 . . . . 0.0 111.438 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -119.69 175.19 5.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.624 -0.672 . . . . 0.0 109.531 173.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -91.06 103.45 16.15 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -107.27 177.29 4.89 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 122.336 -0.228 . . . . 0.0 110.463 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.54 HD12 HG23 ' A' ' 34' ' ' ILE . 77.0 mt -109.99 131.95 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.99 143.27 34.36 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.0 p -116.07 133.77 55.67 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -76.69 172.58 12.82 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 120.643 0.258 . . . . 0.0 111.316 -172.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -68.42 139.66 55.77 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -142.85 166.58 24.24 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.668 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -122.87 147.31 46.72 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 120.742 0.306 . . . . 0.0 110.525 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -149.65 138.96 21.39 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.9 m120 52.03 30.26 7.23 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.66 -0.65 . . . . 0.0 112.128 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.61 16.21 80.47 Favored Glycine 0 N--CA 1.496 2.697 0 CA-C-O 119.607 -0.552 . . . . 0.0 111.851 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -121.89 143.94 49.14 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 118.685 1.242 . . . . 0.0 109.717 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -93.5 131.72 38.46 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.488 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -121.32 143.82 48.97 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -87.15 155.19 20.21 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.792 0.329 . . . . 0.0 110.378 -170.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.13 160.99 48.16 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.1 m -141.99 160.79 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 122.32 -0.518 . . . . 0.0 110.367 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -116.13 136.76 52.73 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.5 t -132.69 139.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.0 tp -138.3 125.66 13.51 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.136 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -62.68 149.16 92.09 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 O-C-N 123.189 1.099 . . . . 0.0 111.613 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.617 HD13 HG13 ' A' ' 93' ' ' ILE . 43.6 pt -142.16 170.13 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 172.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -118.32 130.29 55.94 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 168.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.38 129.05 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -173.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.62 HD11 HD21 ' A' ' 129' ' ' LEU . 91.7 mt -107.43 117.62 34.58 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 71.7 mt -129.56 121.87 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.68 -119.95 17.15 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -111.08 16.97 20.83 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.412 -0.464 . . . . 0.0 111.872 176.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -120.4 146.13 46.5 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 118.522 0.601 . . . . 0.0 110.521 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -123.13 130.62 53.01 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -125.89 147.57 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.6 139.75 45.73 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -150.3 -165.85 12.98 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.5 ' HB2' ' CD2' ' A' ' 35' ' ' LEU . . . -159.38 155.45 26.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.28 -0.541 . . . . 0.0 110.182 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.617 HG13 HD13 ' A' ' 80' ' ' ILE . 71.5 mt -108.71 141.36 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.05 130.6 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.4 t -142.18 133.92 13.32 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -57.86 153.24 45.08 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 121.046 1.164 . . . . 0.0 111.801 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -65.5 -34.52 78.46 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.587 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -86.78 121.32 29.11 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.3 t -142.98 156.64 44.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.296 -0.253 . . . . 0.0 110.389 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -97.54 -59.95 1.67 Allowed 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -136.3 -172.19 3.08 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.3 p -93.05 149.45 21.21 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.7 m -134.9 173.08 12.11 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 120.576 0.226 . . . . 0.0 110.427 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -107.7 27.18 9.44 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.423 -0.173 . . . . 0.0 110.865 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -122.33 127.84 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.554 HD13 HD11 ' A' ' 48' ' ' LEU . 34.6 pt -124.59 143.71 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -115.04 128.71 56.42 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.51 HD12 HD12 ' A' ' 46' ' ' LEU . 82.2 mt -115.01 152.49 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -173.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.418 HD12 ' CB ' ' A' ' 39' ' ' PRO . 11.6 pt -116.49 156.0 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 168.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.6 163.88 33.79 Favored Pre-proline 0 N--CA 1.496 1.85 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.249 -176.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.02 -32.56 95.08 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.163 1.242 . . . . 0.0 111.572 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -145.01 167.01 23.68 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.275 -0.266 . . . . 0.0 110.994 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -69.5 103.95 2.19 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.632 0.73 . . . . 0.0 110.465 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.504 HD12 HD22 ' A' ' 44' ' ' LEU . 83.4 mt -60.26 -33.0 71.7 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.664 -0.647 . . . . 0.0 111.641 -178.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -61.48 -37.84 85.09 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 122.054 -0.404 . . . . 0.0 111.296 -171.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -78.35 -45.82 21.58 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.36 -34.15 76.11 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.16 -0.337 . . . . 0.0 111.007 -173.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -108.18 8.27 27.89 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.75 48.06 23.57 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.204 -0.935 . . . . 0.0 111.888 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.4 mt -92.11 138.18 31.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.912 -0.493 . . . . 0.0 110.891 -171.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -117.21 156.19 28.13 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.66 138.02 48.14 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.941 -0.474 . . . . 0.0 111.542 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.97 -22.94 37.42 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.41 152.8 43.02 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-N 118.643 1.222 . . . . 0.0 110.019 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -112.77 134.03 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.539 HD11 HD11 ' A' ' 46' ' ' LEU . 34.3 pt -130.29 165.11 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -107.89 139.86 41.86 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.1 pt -117.04 138.76 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.722 HD23 HD12 ' A' ' 6' ' ' ILE . 12.9 mt -99.03 141.34 31.91 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.0 mt -129.98 124.09 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -147.09 155.08 41.89 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.06 122.94 1.23 Allowed Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -155.07 78.86 1.05 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 122.282 -0.54 . . . . 0.0 110.315 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -95.03 -44.88 7.48 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.01 -0.431 . . . . 0.0 110.167 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -67.34 -34.88 78.25 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.193 179.806 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.1 mtm . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.299 0.571 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.52 135.82 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -98.13 124.03 42.47 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.7 mt -110.86 150.14 29.59 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.8 ttm -105.47 142.89 34.44 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.0 mm -128.56 132.18 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.488 HG22 HD22 ' A' ' 48' ' ' LEU . 72.9 mt -129.67 148.75 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -105.7 140.04 39.36 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.43 150.14 20.17 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -105.93 141.68 36.92 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 117.21 0.505 . . . . 0.0 110.221 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.9 t -63.15 122.61 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -127.23 162.21 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.1 t -84.88 130.87 34.59 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.99 119.94 0.84 Allowed Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.5 tt -155.11 -45.69 0.08 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 117.081 0.44 . . . . 0.0 110.149 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.35 -29.05 73.38 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -62.76 -30.5 71.5 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-N 117.766 0.783 . . . . 0.0 110.879 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.85 129.97 24.75 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 -117.25 32.6 6.07 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 122.317 -0.52 . . . . 0.0 110.772 -175.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -129.53 153.04 48.41 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.13 -0.356 . . . . 0.0 110.406 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -108.04 120.34 42.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 41' ' ' GLU . 68.1 mt -77.63 -27.35 51.08 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.151 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.3 m -57.1 -24.7 55.89 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.859 -0.525 . . . . 0.0 112.029 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.431 HD21 ' CD2' ' A' ' 67' ' ' PHE . 7.4 tp -63.91 138.92 97.54 Favored Pre-proline 0 N--CA 1.504 2.255 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.273 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -53.48 -49.61 16.76 Favored 'Trans proline' 0 N--CA 1.503 2.045 0 C-N-CA 121.011 1.141 . . . . 0.0 113.748 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.54 -39.11 92.9 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 120.575 0.85 . . . . 0.0 112.257 -169.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -65.41 -43.05 91.8 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 122.227 -0.295 . . . . 0.0 110.691 -175.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -65.43 -40.05 92.83 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 122.085 -0.384 . . . . 0.0 110.262 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -65.33 -46.2 81.21 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.553 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.1 tt -69.92 -34.49 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -176.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -65.5 -44.28 87.52 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 122.08 -0.387 . . . . 0.0 110.347 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -65.86 -30.89 71.57 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.736 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -68.69 -40.58 79.97 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.67 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mt -81.39 -36.86 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 92' ' ' ALA . 50.5 mt -103.96 -26.29 12.69 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.213 -0.304 . . . . 0.0 111.678 -174.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.49 14.76 72.91 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-O 119.304 -0.72 . . . . 0.0 111.436 -172.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -151.9 162.18 41.47 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 119.155 1.478 . . . . 0.0 110.659 170.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -94.84 108.61 38.84 Favored Pre-proline 0 N--CA 1.497 1.878 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.894 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.419 ' CB ' HD12 ' A' ' 109' ' ' ILE . 67.1 Cg_endo -67.33 158.54 56.5 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 O-C-N 123.238 1.125 . . . . 0.0 110.55 -176.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -73.81 162.43 29.13 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.441 ' HA ' HD13 ' A' ' 22' ' ' LEU . 70.2 mt-10 -80.22 79.67 6.76 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.378 0.609 . . . . 0.0 109.764 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.16 178.94 48.63 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 175.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -137.96 154.37 49.38 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 117.266 0.533 . . . . 0.0 110.801 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.669 HD22 HD12 ' A' ' 114' ' ' LEU . 31.0 tp -109.61 115.47 29.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 168.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.445 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.4 m120 -99.66 122.77 43.16 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.807 HD11 HD11 ' A' ' 126' ' ' ILE . 53.7 mt -120.57 136.26 54.85 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.716 0.293 . . . . 0.0 110.487 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -95.94 132.91 40.76 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.565 HD11 HD13 ' A' ' 106' ' ' ILE . 83.9 mt -112.16 160.28 17.73 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 120.63 0.253 . . . . 0.0 110.508 -175.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.01 12.89 14.25 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 172.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -145.74 142.0 28.53 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 118.594 0.634 . . . . 0.0 109.573 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.04 147.3 51.12 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 122.235 -0.29 . . . . 0.0 110.697 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -131.81 135.87 47.07 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 120.781 0.324 . . . . 0.0 110.675 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -138.06 127.41 24.66 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 173.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.434 HD13 ' HB3' ' A' ' 76' ' ' LYS . 20.1 tt -63.16 -23.49 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.329 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -74.39 -1.08 19.44 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.944 -0.473 . . . . 0.0 112.184 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -91.12 -14.44 31.17 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 118.913 0.779 . . . . 0.0 111.511 170.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -116.28 175.11 5.7 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.593 0.633 . . . . 0.0 109.373 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -91.51 102.14 14.8 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -109.73 179.23 4.18 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 120.526 0.203 . . . . 0.0 110.591 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.5 mt -110.98 132.14 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -105.92 143.56 33.89 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 36.4 p -124.56 135.04 52.83 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 120.83 0.348 . . . . 0.0 110.667 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.88 172.69 12.73 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 120.825 0.345 . . . . 0.0 111.768 -169.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -68.05 141.14 56.27 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -137.52 166.59 23.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 122.195 -0.315 . . . . 0.0 110.656 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -125.78 149.17 48.79 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 120.861 0.362 . . . . 0.0 110.591 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.431 ' CD2' HD21 ' A' ' 24' ' ' LEU . 88.3 t80 -148.86 135.01 19.22 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 52.17 33.44 12.37 Favored 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.719 -0.613 . . . . 0.0 111.895 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.73 16.25 80.31 Favored Glycine 0 N--CA 1.497 2.709 0 CA-C-O 119.613 -0.548 . . . . 0.0 111.877 176.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -119.94 139.56 52.26 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 118.723 1.262 . . . . 0.0 109.704 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.41 131.82 38.24 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 120.671 0.272 . . . . 0.0 110.416 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -120.21 143.2 48.39 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -86.08 155.05 20.97 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.774 0.321 . . . . 0.0 110.541 -167.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.07 157.29 51.51 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -138.52 159.21 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 122.258 -0.554 . . . . 0.0 110.404 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.434 ' HB3' HD13 ' A' ' 54' ' ' ILE . 96.9 mttt -117.08 135.84 53.43 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.8 t -132.2 139.61 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -176.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.3 tp -136.45 125.64 15.61 Favored Pre-proline 0 N--CA 1.496 1.871 0 CA-C-O 118.579 -0.725 . . . . 0.0 110.004 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.45 149.15 91.87 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 O-C-N 123.172 1.091 . . . . 0.0 111.426 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.592 HD13 HG13 ' A' ' 93' ' ' ILE . 43.3 pt -141.9 169.85 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 171.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -114.98 131.33 56.95 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 168.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.6 mt -105.32 123.2 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -175.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.1 mt -107.5 115.89 30.97 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.7 mt -130.02 121.95 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.12 -120.59 18.77 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -111.14 17.02 20.75 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.344 -0.503 . . . . 0.0 111.888 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -119.77 145.16 46.83 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 118.586 0.63 . . . . 0.0 110.552 -175.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -123.08 129.5 51.55 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 120.741 0.305 . . . . 0.0 110.295 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.3 mt -125.65 143.4 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.04 137.46 43.41 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.1 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.27 -165.15 11.6 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.572 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.46 154.9 25.62 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 117.429 0.615 . . . . 0.0 110.507 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.592 HG13 HD13 ' A' ' 80' ' ' ILE . 68.6 mt -108.7 141.74 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.97 132.49 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -175.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.1 t -145.05 137.05 13.06 Favored Pre-proline 0 N--CA 1.498 1.959 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -58.41 154.59 40.48 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 121.072 1.182 . . . . 0.0 111.687 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -65.17 -34.17 77.74 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.805 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -85.15 116.96 23.81 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.305 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.7 m -131.68 139.57 49.09 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -94.62 -49.61 5.56 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -137.68 172.44 12.95 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -89.22 146.78 24.53 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.0 m -135.03 169.89 16.74 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 120.615 0.245 . . . . 0.0 110.607 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -106.96 27.63 8.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.438 -0.164 . . . . 0.0 110.795 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.5 mm -121.79 126.75 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.565 HD13 HD11 ' A' ' 48' ' ' LEU . 34.0 pt -124.06 143.86 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -115.15 130.88 57.04 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.439 HD12 HD12 ' A' ' 46' ' ' LEU . 81.7 mt -116.11 151.5 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -173.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.419 HD12 ' CB ' ' A' ' 39' ' ' PRO . 13.4 pt -116.59 153.52 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 167.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.53 164.64 29.51 Favored Pre-proline 0 N--CA 1.495 1.807 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.234 -176.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.21 -31.94 93.74 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.042 1.162 . . . . 0.0 111.584 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.59 167.1 23.34 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.29 -0.256 . . . . 0.0 110.716 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -70.8 104.45 2.9 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.669 HD12 HD22 ' A' ' 44' ' ' LEU . 80.9 mt -59.58 -33.13 71.06 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 122.022 -0.424 . . . . 0.0 111.511 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -62.62 -35.37 79.36 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 122.119 -0.363 . . . . 0.0 110.964 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -78.25 -48.31 16.03 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.43 -33.24 74.4 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 122.163 -0.335 . . . . 0.0 111.074 -173.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -107.99 7.83 28.07 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.88 45.8 27.63 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.025 -1.047 . . . . 0.0 111.876 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.3 mt -92.34 138.21 31.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.862 -0.524 . . . . 0.0 110.93 -171.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -114.79 157.54 23.1 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -55.87 137.94 49.32 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.919 -0.488 . . . . 0.0 111.535 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.95 -22.99 37.23 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -177.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -65.44 156.11 33.42 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 118.621 1.21 . . . . 0.0 110.004 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.6 t -112.36 134.07 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.807 HD11 HD11 ' A' ' 46' ' ' LEU . 34.4 pt -128.98 160.59 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -109.78 138.08 46.66 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -175.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.1 pt -112.12 137.57 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.463 ' C ' HD23 ' A' ' 129' ' ' LEU . 8.8 tt -110.79 131.69 54.83 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -177.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.2 mt -120.47 130.51 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -92.47 153.99 18.77 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.03 178.12 33.58 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -99.72 134.85 42.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 122.276 -0.544 . . . . 0.0 110.265 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -68.28 -45.98 71.64 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -67.52 -34.44 77.12 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 120.731 0.3 . . . . 0.0 110.338 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 . . . . . 0 N--CA 1.506 2.367 0 CA-C-O 118.053 -0.975 . . . . 0.0 111.732 -178.998 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p -133.04 145.26 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -94.52 123.77 38.15 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 131' ' ' LYS . 84.5 mt -110.84 152.92 26.11 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.405 ' O ' HD13 ' A' ' 6' ' ' ILE . 9.3 tpt -125.91 145.68 50.16 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.405 HD13 ' O ' ' A' ' 5' ' ' MET . 45.4 mm -128.34 135.35 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -175.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.408 HG22 HD22 ' A' ' 48' ' ' LEU . 78.0 mt -130.59 147.61 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 171.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -110.23 143.81 39.83 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.318 -0.239 . . . . 0.0 110.405 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.75 152.45 21.7 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -105.8 140.7 38.44 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 117.242 0.521 . . . . 0.0 110.35 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.0 t -63.43 122.49 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.75 137.24 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 173.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.6 p -86.87 101.74 13.67 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.17 173.13 44.17 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.2 mt -121.57 156.8 32.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 122.302 -0.528 . . . . 0.0 109.859 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.43 -40.03 94.3 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -172.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -163.53 100.5 0.92 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 117.417 0.608 . . . . 0.0 110.385 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.88 -139.89 35.44 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -140.96 145.79 36.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.379 -0.483 . . . . 0.0 110.522 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -144.74 161.31 39.55 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -106.48 130.53 54.26 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 120.576 0.226 . . . . 0.0 110.629 -175.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.2 mt -95.39 -27.73 15.29 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 122.364 -0.21 . . . . 0.0 111.059 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.1 p -60.13 -22.37 62.74 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 122.029 -0.419 . . . . 0.0 112.043 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.5 mt -61.92 155.12 64.64 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 121.832 -0.542 . . . . 0.0 110.771 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -56.21 -54.46 3.95 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 121.099 1.199 . . . . 0.0 113.32 -172.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.49 ' O ' HG22 ' A' ' 30' ' ' ILE . 20.0 Cg_endo -62.22 -40.99 37.44 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 O-C-N 122.72 0.853 . . . . 0.0 111.197 -166.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -65.8 -44.55 85.34 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.517 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -66.11 -41.63 90.34 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 122.134 -0.354 . . . . 0.0 110.413 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.88 -50.01 63.82 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.345 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 26' ' ' PRO . 18.7 tt -69.11 -34.27 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.01 -175.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.432 ' HD1' HG23 ' A' ' 30' ' ' ILE . 6.1 m-85 -65.09 -41.85 94.61 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 122.039 -0.413 . . . . 0.0 110.319 176.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -65.49 -32.79 74.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 122.194 -0.316 . . . . 0.0 110.731 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -67.95 -38.31 82.65 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.671 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.9 mt -80.76 -39.08 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.3 mt -99.55 -26.28 14.15 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 122.263 -0.273 . . . . 0.0 111.541 -174.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.65 14.2 76.36 Favored Glycine 0 N--CA 1.496 2.646 0 CA-C-O 119.363 -0.687 . . . . 0.0 111.428 -174.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -152.05 163.37 39.45 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 119.082 1.441 . . . . 0.0 110.709 171.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -95.44 109.59 46.18 Favored Pre-proline 0 N--CA 1.496 1.852 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.744 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.53 163.38 35.08 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 123.288 1.151 . . . . 0.0 110.601 -175.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -74.28 163.16 28.15 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -80.36 79.64 6.92 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.463 0.649 . . . . 0.0 109.858 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.5 172.8 44.03 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 174.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -136.51 156.08 49.09 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 117.285 0.542 . . . . 0.0 110.562 173.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.3 tp -108.88 116.41 31.94 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 172.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.31 122.88 42.02 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.831 HD11 HD11 ' A' ' 126' ' ' ILE . 59.0 mt -120.04 135.84 54.79 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 120.75 0.31 . . . . 0.0 110.554 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -95.47 132.34 40.65 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.478 HD11 ' CD1' ' A' ' 106' ' ' ILE . 83.8 mt -111.95 160.25 17.62 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 120.683 0.278 . . . . 0.0 110.4 -175.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.31 13.17 14.13 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 172.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -145.25 140.38 27.8 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 118.568 0.622 . . . . 0.0 109.479 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.27 146.91 52.44 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 122.254 -0.279 . . . . 0.0 110.679 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -132.0 136.75 47.52 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 120.706 0.289 . . . . 0.0 110.584 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -138.06 125.99 22.62 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.57 -23.92 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.341 -177.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -74.22 -0.93 18.4 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.51 -14.13 33.29 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 118.908 0.776 . . . . 0.0 111.457 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -115.84 175.07 5.7 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 118.613 0.642 . . . . 0.0 109.454 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -92.46 103.46 15.88 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -109.85 176.2 5.16 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 120.512 0.196 . . . . 0.0 110.499 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.3 mt -110.25 129.7 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 175.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -105.9 147.4 28.79 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.2 p -125.24 134.96 52.13 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 120.778 0.323 . . . . 0.0 110.768 175.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -75.14 172.72 11.87 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 120.757 0.313 . . . . 0.0 111.707 -170.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -66.99 139.55 57.69 Favored 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -140.63 166.78 23.79 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 122.215 -0.303 . . . . 0.0 110.633 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -124.45 149.06 47.2 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 120.8 0.333 . . . . 0.0 110.559 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -149.09 135.13 19.05 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 52.15 33.96 13.34 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.705 -0.622 . . . . 0.0 111.881 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.82 15.97 80.59 Favored Glycine 0 N--CA 1.497 2.737 0 CA-C-O 119.589 -0.562 . . . . 0.0 111.875 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -121.19 140.97 51.29 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 118.768 1.284 . . . . 0.0 109.717 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -92.87 130.81 38.35 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.368 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -120.14 143.52 48.14 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -85.96 156.18 20.58 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.307 -169.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.44 157.23 50.12 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -138.88 157.93 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 122.448 -0.443 . . . . 0.0 110.456 -174.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -120.52 137.94 54.11 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.4 t -133.98 141.81 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -176.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.4 tp -137.49 125.7 14.46 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.164 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.24 149.59 90.91 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 120.961 1.107 . . . . 0.0 111.496 177.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.564 HD13 HG13 ' A' ' 93' ' ' ILE . 43.7 pt -141.76 170.15 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 171.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -116.44 129.8 56.42 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 168.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.53 125.39 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.603 HD11 HD13 ' A' ' 129' ' ' LEU . 86.5 mt -107.87 116.59 32.24 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 -178.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.9 mt -129.83 122.02 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.03 -120.54 18.82 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -111.09 17.02 20.8 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 122.29 -0.535 . . . . 0.0 111.988 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -119.89 145.82 46.34 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 118.449 0.568 . . . . 0.0 110.513 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -122.96 130.82 53.31 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -126.42 145.81 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.51 136.92 44.15 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.05 -167.34 12.99 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 177.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.69 155.08 25.43 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 117.35 0.575 . . . . 0.0 110.363 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.564 HG13 HD13 ' A' ' 80' ' ' ILE . 70.0 mt -108.72 142.62 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.7 t -121.48 131.48 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.7 t -142.53 136.66 14.75 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -58.01 154.97 35.86 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 121.077 1.184 . . . . 0.0 111.81 176.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -65.6 -37.41 86.54 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.317 -0.239 . . . . 0.0 110.43 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -94.64 120.59 35.11 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.0 p -130.22 155.07 46.87 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -98.07 -57.86 2.12 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -136.6 170.87 15.36 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.4 p -85.68 148.22 25.99 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.1 m -135.01 175.01 9.97 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 120.57 0.224 . . . . 0.0 110.489 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -107.4 27.93 8.61 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 122.415 -0.178 . . . . 0.0 110.851 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.0 mm -123.4 126.7 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.478 ' CD1' HD11 ' A' ' 48' ' ' LEU . 34.3 pt -125.64 145.77 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -114.6 131.68 56.61 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.498 HD12 HD12 ' A' ' 46' ' ' LEU . 81.9 mt -117.56 149.31 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 pt -119.13 155.33 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 168.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.56 165.98 22.15 Favored Pre-proline 0 N--CA 1.496 1.846 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.246 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -59.14 -30.34 92.87 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 121.151 1.234 . . . . 0.0 111.716 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.23 167.06 23.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 122.248 -0.282 . . . . 0.0 110.732 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -71.15 105.96 3.59 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.61 -33.4 71.44 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 122.067 -0.396 . . . . 0.0 111.402 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -62.65 -35.34 79.31 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 122.182 -0.324 . . . . 0.0 110.954 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -78.18 -48.07 16.67 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -62.61 -33.64 75.4 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.193 -0.317 . . . . 0.0 111.063 -172.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -108.01 8.15 28.18 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.81 46.03 27.24 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 120.979 -1.076 . . . . 0.0 111.819 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.9 mt -91.98 138.22 31.72 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.89 -0.506 . . . . 0.0 110.961 -171.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -114.92 157.49 23.29 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.72 137.77 48.92 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.888 -0.508 . . . . 0.0 111.491 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.92 -22.88 37.73 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -178.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.44 157.42 29.49 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 118.645 1.222 . . . . 0.0 109.952 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.3 t -112.19 133.17 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -174.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.831 HD11 HD11 ' A' ' 46' ' ' LEU . 33.8 pt -128.51 160.59 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -109.06 139.65 43.66 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.302 -175.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.1 pt -109.87 138.44 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.603 HD13 HD11 ' A' ' 83' ' ' LEU . 6.5 tp -108.01 135.56 49.17 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -172.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 52.1 mt -125.5 122.89 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.447 ' HA ' HD23 ' A' ' 4' ' ' LEU . 46.5 mtpt -93.93 147.88 22.68 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 176.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.1 172.41 34.61 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -155.06 173.14 16.99 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 122.355 -0.497 . . . . 0.0 110.353 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -65.01 139.08 58.72 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.674 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -94.39 117.74 30.57 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 N--CA 1.505 2.296 0 CA-C-O 117.912 -1.042 . . . . 0.0 111.707 -179.617 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.7 mtm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.7 t -70.23 -38.9 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -127.14 118.21 23.9 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 131' ' ' LYS . 84.7 mt -110.86 155.01 23.21 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 43.0 ttm -136.2 145.15 45.39 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.7 mm -126.09 134.35 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -176.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.449 HG22 HD22 ' A' ' 48' ' ' LEU . 78.6 mt -130.76 148.31 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -110.78 144.76 39.27 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.5 151.15 21.42 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -106.77 141.85 37.35 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 117.217 0.508 . . . . 0.0 110.263 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.3 121.16 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.75 148.49 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 177.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.4 p -87.08 130.92 34.29 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.05 119.84 0.83 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.1 mt -139.96 33.28 1.96 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 117.205 0.503 . . . . 0.0 110.29 178.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.6 52.49 0.64 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -99.77 32.48 2.86 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 117.179 0.489 . . . . 0.0 110.515 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.21 -139.99 23.25 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -100.94 128.66 46.88 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 117.215 0.507 . . . . 0.0 110.138 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.432 ' HE2' HD11 ' A' ' 22' ' ' LEU . 57.3 t80 -155.0 98.56 2.04 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -108.68 128.9 55.26 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.432 HD11 ' HE2' ' A' ' 20' ' ' TYR . 42.3 mt -100.93 -20.88 15.26 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.7 p -57.51 -23.32 49.5 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.722 -0.611 . . . . 0.0 111.702 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.9 tp -65.51 139.44 97.22 Favored Pre-proline 0 N--CA 1.504 2.253 0 CA-C-O 118.735 -0.65 . . . . 0.0 109.908 174.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -51.25 -54.29 5.67 Favored 'Trans proline' 0 N--CA 1.502 2.019 0 C-N-CA 121.188 1.259 . . . . 0.0 114.155 -175.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.81 -25.94 71.4 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 120.48 0.786 . . . . 0.0 112.303 -163.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -66.31 -47.38 73.75 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.275 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -65.68 -35.57 81.14 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 122.11 -0.369 . . . . 0.0 110.169 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -65.84 -48.3 72.08 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 120.961 -0.295 . . . . 0.0 110.469 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.2 tt -69.06 -36.91 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 C-N-CA 120.64 -0.424 . . . . 0.0 109.936 -176.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.466 ' CE1' HD13 ' A' ' 109' ' ' ILE . 4.2 m-85 -65.65 -42.04 91.86 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 122.18 -0.325 . . . . 0.0 110.479 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -65.7 -32.63 74.29 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 122.219 -0.301 . . . . 0.0 110.785 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -68.89 -40.25 79.3 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.641 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.0 mt -81.66 -36.37 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' A' ' 92' ' ' ALA . 48.4 mt -104.0 -26.35 12.65 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.197 -0.314 . . . . 0.0 111.622 -173.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.02 15.15 73.22 Favored Glycine 0 N--CA 1.495 2.599 0 CA-C-O 119.371 -0.683 . . . . 0.0 111.459 -172.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -151.42 161.43 42.7 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 119.143 1.472 . . . . 0.0 110.765 170.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -94.15 107.88 31.81 Favored Pre-proline 0 N--CA 1.496 1.865 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.834 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.53 158.16 58.39 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 O-C-N 123.272 1.143 . . . . 0.0 110.403 -176.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -74.07 162.95 28.48 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -80.14 79.63 6.67 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.429 0.633 . . . . 0.0 109.732 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.66 172.1 44.39 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 175.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 p -138.01 156.51 47.74 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 117.391 0.596 . . . . 0.0 110.85 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.9 tp -109.4 117.29 33.65 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.98 122.24 41.98 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -176.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.838 HD11 HD11 ' A' ' 126' ' ' ILE . 61.2 mt -120.58 135.79 54.99 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 120.75 0.31 . . . . 0.0 110.617 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -95.97 133.55 40.04 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.449 HD22 HG22 ' A' ' 7' ' ' ILE . 84.6 mt -112.05 160.3 17.63 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 120.633 0.254 . . . . 0.0 110.544 -176.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.61 13.56 13.74 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 171.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -145.44 139.38 26.85 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 118.552 0.614 . . . . 0.0 109.63 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -62.16 147.24 48.27 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 122.115 -0.366 . . . . 0.0 110.901 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -131.95 136.51 47.4 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 120.766 0.317 . . . . 0.0 110.45 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -137.96 125.6 22.24 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 76' ' ' LYS . 20.2 tt -63.89 -24.73 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.219 -177.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -73.53 -1.83 20.2 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -91.33 -14.04 31.48 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 118.787 0.721 . . . . 0.0 111.484 169.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.42 ' CE1' HG21 ' A' ' 130' ' ' ILE . 71.3 m-85 -114.5 175.13 5.62 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.614 -0.679 . . . . 0.0 109.315 174.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -92.49 101.99 14.44 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -110.54 177.39 4.7 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 120.638 0.256 . . . . 0.0 110.672 -177.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.6 mt -112.09 132.88 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -105.9 143.87 33.43 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.3 p -121.95 136.44 54.92 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 120.624 0.25 . . . . 0.0 110.679 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.55 172.72 12.52 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 120.786 0.327 . . . . 0.0 111.642 -170.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -67.97 140.16 56.39 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -138.6 163.57 31.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.218 -0.301 . . . . 0.0 110.758 -175.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -123.66 147.47 47.37 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 122.281 -0.262 . . . . 0.0 110.401 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -149.77 136.92 19.7 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 51.7 32.2 9.04 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.82 -0.55 . . . . 0.0 112.162 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.22 17.59 77.82 Favored Glycine 0 N--CA 1.497 2.727 0 CA-C-O 119.614 -0.548 . . . . 0.0 111.823 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -123.08 140.95 52.49 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.577 1.188 . . . . 0.0 109.803 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.86 132.56 38.16 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 120.618 0.247 . . . . 0.0 110.421 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.22 142.7 49.66 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -86.29 157.81 19.83 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 120.737 0.303 . . . . 0.0 110.336 -169.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.5 157.49 50.02 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -139.51 157.13 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 122.388 -0.478 . . . . 0.0 110.488 -174.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HB3' HD13 ' A' ' 54' ' ' ILE . 68.8 mttt -114.22 138.42 50.5 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.6 t -133.63 139.05 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.4 tp -137.09 125.6 14.85 Favored Pre-proline 0 N--CA 1.497 1.887 0 CA-C-O 118.533 -0.746 . . . . 0.0 110.125 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -63.39 149.63 90.67 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 O-C-N 123.158 1.083 . . . . 0.0 111.457 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.54 HD13 HG13 ' A' ' 93' ' ' ILE . 43.5 pt -141.9 170.01 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 122.286 -0.259 . . . . 0.0 110.38 171.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -115.31 130.03 56.78 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 168.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.68 124.17 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.412 HD11 HD13 ' A' ' 129' ' ' LEU . 84.3 mt -107.99 116.82 32.66 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.5 mt -129.93 121.93 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.76 -120.23 18.09 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -111.18 17.1 20.64 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 122.354 -0.498 . . . . 0.0 111.806 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -119.76 144.62 47.18 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 118.604 0.638 . . . . 0.0 110.497 -175.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -123.12 129.91 52.08 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.8 mt -125.75 146.09 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.59 136.24 43.95 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.74 -168.2 13.02 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.591 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.56 154.98 25.54 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 117.307 0.553 . . . . 0.0 110.369 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.54 HG13 HD13 ' A' ' 80' ' ' ILE . 69.3 mt -108.71 141.53 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.42 130.83 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -141.6 134.37 14.1 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -57.33 154.81 32.96 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 121.055 1.17 . . . . 0.0 111.91 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -64.85 -34.5 78.52 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.688 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -86.71 117.75 25.67 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 m -132.76 139.86 47.78 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -96.23 -57.54 2.31 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -132.6 -176.78 4.21 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.2 p -93.54 150.03 20.76 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.3 m -135.06 170.09 16.44 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.652 0.263 . . . . 0.0 110.294 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -107.82 27.72 8.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.363 -0.211 . . . . 0.0 110.875 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -123.9 127.87 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 27.7 pt -126.19 145.35 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 177.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -114.94 130.61 56.96 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.47 HD12 HD12 ' A' ' 46' ' ' LEU . 82.5 mt -115.7 150.98 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -174.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.466 HD13 ' CE1' ' A' ' 31' ' ' PHE . 11.2 pt -116.47 155.64 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 168.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.49 164.92 27.93 Favored Pre-proline 0 N--CA 1.496 1.83 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.315 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.57 -30.75 93.15 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.071 1.181 . . . . 0.0 111.653 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.43 167.06 23.39 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.322 -0.236 . . . . 0.0 110.773 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -71.29 105.22 3.4 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 120.875 0.369 . . . . 0.0 110.042 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.45 -33.58 71.45 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 122.043 -0.41 . . . . 0.0 111.535 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -62.96 -35.34 79.82 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 122.11 -0.369 . . . . 0.0 110.929 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -78.3 -47.94 16.75 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -62.54 -34.15 76.36 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 122.221 -0.299 . . . . 0.0 111.028 -172.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -108.1 8.49 28.17 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 51.83 47.23 25.19 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.148 -0.97 . . . . 0.0 111.849 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.9 mt -92.09 138.14 31.78 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.917 -0.49 . . . . 0.0 111.036 -170.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -115.67 158.95 22.0 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -56.06 138.17 49.86 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.893 -0.504 . . . . 0.0 111.506 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.58 -22.95 37.6 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.4 154.93 37.02 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 118.597 1.198 . . . . 0.0 110.026 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.6 t -112.05 133.94 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.838 HD11 HD11 ' A' ' 46' ' ' LEU . 34.8 pt -128.82 160.35 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -109.2 140.3 42.99 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.237 -175.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 35.0 pt -111.84 138.1 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.412 HD13 HD11 ' A' ' 83' ' ' LEU . 6.2 tp -109.03 132.78 53.78 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -173.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.42 HG21 ' CE1' ' A' ' 57' ' ' PHE . 48.2 mt -125.75 130.86 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.429 ' HA ' HD23 ' A' ' 4' ' ' LEU . 83.0 mttt -93.09 155.09 17.72 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 173.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -156.95 123.04 1.24 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -141.41 129.31 21.83 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 122.378 -0.484 . . . . 0.0 109.844 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -66.61 -37.74 85.51 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.621 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -67.42 -35.34 79.07 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.285 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.116 179.728 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptp . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.5 t -116.38 135.65 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -127.95 132.24 49.25 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.409 HD22 ' HG2' ' A' ' 131' ' ' LYS . 81.8 mt -110.84 147.51 34.38 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -110.0 141.0 43.4 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.2 mm -126.19 135.59 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.496 HG22 HD22 ' A' ' 48' ' ' LEU . 70.3 mt -128.16 147.73 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -106.01 138.56 41.98 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.248 -0.283 . . . . 0.0 110.276 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.34 149.09 19.72 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -106.58 142.16 36.69 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 117.237 0.519 . . . . 0.0 110.226 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.19 122.49 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.8 m -124.97 151.27 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 176.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.5 p -86.27 135.18 33.65 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.11 119.91 0.84 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.9 tp -155.11 -46.84 0.08 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.333 -0.51 . . . . 0.0 110.399 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.8 -33.11 86.36 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -92.44 135.17 34.27 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 117.344 0.572 . . . . 0.0 109.741 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.48 70.02 1.31 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -176.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -85.49 135.41 33.85 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 122.305 -0.526 . . . . 0.0 110.437 -174.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -155.02 159.21 40.15 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -114.81 127.51 55.76 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.309 -0.244 . . . . 0.0 110.437 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.2 mt -99.84 -25.59 14.3 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 122.368 -0.208 . . . . 0.0 111.296 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.5 p -57.84 -20.22 34.68 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.924 -0.485 . . . . 0.0 112.244 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.6 tp -63.1 138.69 97.4 Favored Pre-proline 0 N--CA 1.504 2.274 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.256 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -52.8 -48.83 19.98 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 121.099 1.199 . . . . 0.0 113.829 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.71 -37.26 95.68 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 120.653 0.902 . . . . 0.0 112.232 -171.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -65.84 -43.35 88.76 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 122.201 -0.312 . . . . 0.0 110.573 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -66.11 -38.73 88.94 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 122.057 -0.402 . . . . 0.0 110.186 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -65.65 -45.83 81.49 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 122.204 -0.31 . . . . 0.0 110.578 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.1 tt -68.91 -34.77 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -177.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CE1' HD13 ' A' ' 109' ' ' ILE . 3.6 m-85 -65.87 -44.67 84.7 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 122.121 -0.362 . . . . 0.0 110.384 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -65.57 -31.79 73.03 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 122.225 -0.297 . . . . 0.0 110.791 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -68.72 -40.16 80.08 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.586 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.1 mt -81.65 -36.64 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' A' ' 92' ' ' ALA . 46.5 mt -103.91 -26.22 12.74 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.255 -0.278 . . . . 0.0 111.609 -174.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.08 15.46 72.25 Favored Glycine 0 N--CA 1.495 2.595 0 CA-C-O 119.312 -0.715 . . . . 0.0 111.415 -172.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -151.28 160.84 43.59 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.169 1.484 . . . . 0.0 110.751 170.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -93.53 108.16 31.9 Favored Pre-proline 0 N--CA 1.496 1.857 0 CA-C-O 118.629 -0.701 . . . . 0.0 109.747 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.08 158.2 58.0 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 O-C-N 123.237 1.124 . . . . 0.0 110.534 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -73.6 163.41 28.04 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.29 79.56 6.86 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.541 0.686 . . . . 0.0 109.607 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.39 171.22 43.02 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 p -138.01 158.46 44.27 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 117.441 0.62 . . . . 0.0 110.818 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.8 tp -109.1 116.01 31.14 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 170.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.456 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.7 m120 -98.26 121.58 40.37 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -177.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.539 HD11 HD11 ' A' ' 126' ' ' ILE . 60.5 mt -120.67 136.81 54.74 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 120.703 0.287 . . . . 0.0 110.639 -177.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' HG11 ' A' ' 12' ' ' VAL . 65.5 tttt -96.03 131.91 41.93 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.496 HD22 HG22 ' A' ' 7' ' ' ILE . 83.6 mt -110.7 160.25 16.88 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 120.603 0.239 . . . . 0.0 110.472 -176.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.11 13.1 13.91 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 172.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -145.63 141.69 28.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.712 -0.618 . . . . 0.0 109.542 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -64.11 147.04 53.15 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.196 -0.315 . . . . 0.0 110.497 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -131.83 135.67 46.91 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 120.749 0.309 . . . . 0.0 110.543 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -138.04 125.39 21.83 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.3 tt -63.52 -23.13 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.397 -176.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -73.33 -2.85 23.75 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 122.014 -0.429 . . . . 0.0 112.079 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -90.56 -13.93 33.56 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.878 0.763 . . . . 0.0 111.462 171.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.443 ' CE1' HG21 ' A' ' 130' ' ' ILE . 75.8 m-85 -114.75 175.02 5.67 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 118.579 0.627 . . . . 0.0 109.338 174.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -92.54 101.98 14.42 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -109.32 176.39 5.1 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 120.563 0.221 . . . . 0.0 110.538 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -110.8 131.57 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -105.89 142.89 34.83 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.5 p -121.42 138.68 54.17 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.808 0.337 . . . . 0.0 110.688 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -76.79 172.71 12.65 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 120.858 0.361 . . . . 0.0 111.762 -168.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -67.96 141.22 56.37 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -135.95 167.13 21.79 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.557 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -125.75 149.01 48.9 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 120.888 0.375 . . . . 0.0 110.6 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -148.86 135.75 19.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 51.96 32.83 10.63 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.69 -0.631 . . . . 0.0 112.114 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.06 17.0 79.04 Favored Glycine 0 N--CA 1.496 2.682 0 CA-C-O 119.635 -0.536 . . . . 0.0 111.846 176.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -121.75 140.62 52.11 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 118.6 1.2 . . . . 0.0 109.699 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -93.57 131.97 38.32 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.393 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -121.25 145.33 47.97 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -85.72 156.61 20.56 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.808 0.337 . . . . 0.0 110.448 -167.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.42 162.93 43.49 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.61 155.52 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 122.4 -0.471 . . . . 0.0 110.38 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -114.43 137.29 52.02 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.2 t -134.0 140.93 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.1 tp -136.84 125.62 15.15 Favored Pre-proline 0 N--CA 1.496 1.86 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.108 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -63.39 149.75 90.35 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 120.971 1.114 . . . . 0.0 111.441 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.528 HD13 HG13 ' A' ' 93' ' ' ILE . 43.5 pt -141.88 170.0 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 120.712 0.291 . . . . 0.0 110.317 171.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -113.95 131.87 56.16 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 167.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.0 mt -106.64 123.17 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -175.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.434 HD11 HD12 ' A' ' 129' ' ' LEU . 85.7 mt -107.94 116.86 32.72 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.3 mt -130.06 121.98 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.28 -119.68 16.66 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -111.09 17.0 20.81 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.373 -0.486 . . . . 0.0 111.841 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -120.42 143.91 48.22 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 118.575 0.625 . . . . 0.0 110.52 -174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -123.1 129.44 51.45 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -125.88 146.54 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.52 136.38 44.09 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.92 -168.52 12.83 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.622 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.54 154.92 25.49 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 117.309 0.554 . . . . 0.0 110.286 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.528 HG13 HD13 ' A' ' 80' ' ' ILE . 67.3 mt -108.62 141.61 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.8 t -120.73 132.28 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -175.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.0 t -142.37 133.27 12.8 Favored Pre-proline 0 N--CA 1.497 1.88 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.54 155.73 29.86 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 121.081 1.187 . . . . 0.0 111.885 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -64.59 -34.05 77.35 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 122.298 -0.251 . . . . 0.0 110.659 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -89.13 111.29 22.03 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.284 -0.26 . . . . 0.0 110.325 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.5 m -131.77 134.73 46.15 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -97.08 -56.16 2.63 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.31 -0.244 . . . . 0.0 110.344 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -121.99 -179.36 4.12 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.7 m -104.87 152.73 22.26 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.7 p -135.01 172.81 12.49 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 120.664 0.269 . . . . 0.0 110.562 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -105.63 24.62 11.93 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.854 172.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.9 mm -121.08 126.98 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.486 ' CD1' HD11 ' A' ' 48' ' ' LEU . 34.5 pt -127.42 148.41 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -116.62 130.86 56.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.517 HD12 HD12 ' A' ' 46' ' ' LEU . 82.4 mt -115.08 150.42 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -175.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.463 HD13 ' CE1' ' A' ' 31' ' ' PHE . 11.0 pt -115.99 155.88 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 168.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.53 165.84 22.95 Favored Pre-proline 0 N--CA 1.496 1.831 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.279 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.37 -30.37 92.54 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 121.084 1.189 . . . . 0.0 111.667 177.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.42 167.05 23.41 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 122.28 -0.262 . . . . 0.0 110.652 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -71.02 105.5 3.34 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.63 -33.93 72.15 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 122.105 -0.372 . . . . 0.0 111.462 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -63.16 -34.75 78.29 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 122.143 -0.348 . . . . 0.0 110.892 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -78.2 -48.99 14.63 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -62.51 -34.09 76.19 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 122.188 -0.32 . . . . 0.0 111.102 -172.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -108.05 8.15 28.1 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.85 50.15 19.25 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 120.986 -1.071 . . . . 0.0 111.917 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 48.2 mt -91.08 138.19 31.79 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.871 -0.518 . . . . 0.0 110.857 -172.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -115.19 156.74 24.77 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 175.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.77 137.95 48.84 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.9 -0.5 . . . . 0.0 111.5 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.9 -22.91 37.59 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.39 153.99 39.68 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-N 118.641 1.221 . . . . 0.0 110.005 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.09 134.01 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.539 HD11 HD11 ' A' ' 46' ' ' LEU . 34.7 pt -130.3 162.25 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 174.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -110.02 139.18 45.42 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.365 -174.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 pt -111.73 137.75 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.462 ' C ' HD23 ' A' ' 129' ' ' LEU . 8.5 tt -111.0 133.36 53.45 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -175.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.443 HG21 ' CE1' ' A' ' 57' ' ' PHE . 43.6 mt -119.98 122.69 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.409 ' HG2' HD22 ' A' ' 4' ' ' LEU . 90.9 mttt -93.53 152.6 18.94 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.07 123.01 1.23 Allowed Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -94.36 -34.33 12.83 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 117.205 0.503 . . . . 0.0 110.282 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -109.62 145.3 36.66 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -138.34 -48.26 0.53 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.42 179.904 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.7 mtp . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 2' ' ' VAL . 12.2 p -152.53 68.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 120.931 0.396 . . . . 0.0 110.043 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -98.91 130.69 45.31 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.121 -0.362 . . . . 0.0 110.165 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.4 mt -110.92 149.54 30.49 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.443 ' O ' HD13 ' A' ' 6' ' ' ILE . 45.5 ttm -106.4 144.51 32.98 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.443 HD13 ' O ' ' A' ' 5' ' ' MET . 48.4 mm -128.9 128.8 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.517 HG22 HD22 ' A' ' 48' ' ' LEU . 72.9 mt -130.02 148.32 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 176.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -105.45 140.95 37.77 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.16 150.71 20.27 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -106.27 141.74 37.12 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 117.176 0.488 . . . . 0.0 110.186 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.15 121.78 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.8 m -126.32 158.84 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 177.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.4 t -86.11 126.12 33.97 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.332 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.06 119.99 0.84 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.3 tp -155.11 -47.8 0.08 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 122.352 -0.499 . . . . 0.0 110.427 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -100.73 37.38 3.61 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -68.52 -35.32 77.29 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 117.306 0.553 . . . . 0.0 109.975 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -150.02 -159.23 8.58 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -97.12 109.49 22.23 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 122.327 -0.513 . . . . 0.0 109.958 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.446 ' CE1' HD21 ' A' ' 22' ' ' LEU . 56.1 t80 -155.03 112.16 3.32 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -179.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.22 135.5 53.84 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.446 HD21 ' CE1' ' A' ' 20' ' ' TYR . 83.2 mt -104.87 0.08 27.61 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.2 p -95.21 24.89 4.62 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 119.008 0.822 . . . . 0.0 111.614 -174.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.3 mp -105.07 157.51 34.11 Favored Pre-proline 0 N--CA 1.496 1.831 0 CA-C-O 118.94 -0.552 . . . . 0.0 109.962 176.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.85 -49.42 16.76 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 121.107 1.205 . . . . 0.0 113.479 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -56.32 -44.81 42.74 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 120.557 0.838 . . . . 0.0 112.183 -171.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -65.34 -41.52 93.84 Favored 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.658 -174.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.02 -40.83 91.39 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 122.033 -0.417 . . . . 0.0 110.311 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -65.26 -45.99 82.31 Favored 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.562 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.2 tt -68.79 -37.02 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.013 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -65.98 -41.89 90.55 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.075 -0.391 . . . . 0.0 110.471 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -65.33 -36.93 85.53 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 122.151 -0.343 . . . . 0.0 110.366 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -68.24 -38.67 82.09 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.505 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.2 mt -81.16 -35.68 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' A' ' 92' ' ' ALA . 45.3 mt -103.92 -26.26 12.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.102 -0.373 . . . . 0.0 111.696 -173.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.39 12.94 79.7 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -171.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -150.91 160.57 43.82 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 119.068 1.434 . . . . 0.0 110.306 170.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -93.39 109.35 39.87 Favored Pre-proline 0 N--CA 1.496 1.849 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.816 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.422 ' CB ' HD12 ' A' ' 109' ' ' ILE . 64.2 Cg_endo -67.25 159.76 50.73 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 O-C-N 123.274 1.144 . . . . 0.0 110.502 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -73.81 163.29 28.14 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -80.25 79.56 6.81 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.511 0.672 . . . . 0.0 109.64 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.48 172.89 45.32 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 175.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 p -138.09 157.41 46.38 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 117.343 0.571 . . . . 0.0 110.804 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.414 HD22 HD12 ' A' ' 114' ' ' LEU . 32.6 tp -109.61 115.02 29.13 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 170.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.423 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.6 m120 -98.72 120.05 38.49 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.78 HD11 HD11 ' A' ' 126' ' ' ILE . 62.6 mt -119.98 135.95 54.72 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 120.697 0.284 . . . . 0.0 110.631 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HB2' HG11 ' A' ' 12' ' ' VAL . 79.3 tttt -95.98 132.17 41.59 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.517 HD22 HG22 ' A' ' 7' ' ' ILE . 83.8 mt -110.95 160.27 16.96 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 120.605 0.24 . . . . 0.0 110.475 -176.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -88.93 12.73 14.52 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 172.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -145.49 142.44 29.23 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 118.555 0.616 . . . . 0.0 109.466 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -64.43 146.92 53.75 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.413 178.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -134.4 137.14 43.83 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.733 0.301 . . . . 0.0 110.654 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -138.16 129.58 27.71 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.2 tt -63.95 -22.22 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.337 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -74.42 -0.97 19.06 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.933 -0.479 . . . . 0.0 112.235 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -91.04 -14.74 30.78 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 118.918 0.781 . . . . 0.0 111.445 170.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -117.21 175.11 5.76 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 118.679 0.672 . . . . 0.0 109.467 174.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -90.85 102.75 15.51 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -109.67 177.03 4.86 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 120.546 0.212 . . . . 0.0 110.471 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -110.46 130.8 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -106.0 143.75 33.7 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.8 p -121.69 138.02 54.52 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 120.74 0.305 . . . . 0.0 110.751 177.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.87 172.67 12.76 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 120.864 0.364 . . . . 0.0 111.687 -169.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -67.59 140.79 56.93 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -136.97 167.01 22.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 122.208 -0.308 . . . . 0.0 110.544 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -125.11 149.08 48.22 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 120.861 0.362 . . . . 0.0 110.607 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -148.35 135.24 20.03 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 51.73 33.44 11.07 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.806 -0.559 . . . . 0.0 112.082 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.09 16.94 79.09 Favored Glycine 0 N--CA 1.498 2.771 0 CA-C-O 119.599 -0.556 . . . . 0.0 111.782 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -122.28 140.94 52.04 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 118.694 1.247 . . . . 0.0 109.649 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -93.25 131.85 37.98 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 120.653 0.264 . . . . 0.0 110.493 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -120.76 144.08 48.47 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -86.37 156.72 20.08 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 120.784 0.326 . . . . 0.0 110.481 -168.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.18 161.86 44.12 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.39 156.0 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 122.294 -0.533 . . . . 0.0 110.364 -174.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -116.57 137.19 52.37 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.7 t -134.12 142.1 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.0 tp -137.39 125.64 14.54 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-O 118.61 -0.71 . . . . 0.0 110.094 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -63.43 148.71 92.48 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 120.955 1.103 . . . . 0.0 111.42 177.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.548 HD13 HG13 ' A' ' 93' ' ' ILE . 43.8 pt -141.38 170.06 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 120.674 0.274 . . . . 0.0 110.356 172.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -114.45 131.76 56.5 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 168.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.9 mt -106.25 124.04 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -175.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -109.08 116.26 31.61 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.2 mt -130.0 121.93 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.41 -119.78 16.87 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -111.07 17.0 20.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.208 -0.584 . . . . 0.0 111.868 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -120.79 144.25 48.41 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 118.547 0.612 . . . . 0.0 110.503 -174.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -123.17 130.19 52.42 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -126.45 148.33 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.51 137.58 44.51 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.23 -169.9 14.46 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 177.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.552 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.32 154.88 25.86 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 117.339 0.57 . . . . 0.0 110.235 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.548 HG13 HD13 ' A' ' 80' ' ' ILE . 70.6 mt -108.79 142.26 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.35 131.56 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -142.25 132.53 12.57 Favored Pre-proline 0 N--CA 1.498 1.926 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -58.09 154.86 37.04 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 121.063 1.175 . . . . 0.0 111.796 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -64.99 -33.61 76.45 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.228 -0.295 . . . . 0.0 110.77 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -87.64 114.44 24.26 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 m -132.2 138.83 48.12 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -96.63 -57.04 2.4 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -129.42 -178.73 4.79 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.6 m -98.03 153.04 18.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.7 t -134.98 172.22 13.31 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 120.586 0.232 . . . . 0.0 110.563 -177.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -105.69 24.43 12.27 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 121.241 -0.184 . . . . 0.0 110.963 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -120.65 127.13 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.465 HD13 HD11 ' A' ' 48' ' ' LEU . 34.4 pt -125.83 145.76 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -115.39 130.91 57.04 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.498 HD12 HD12 ' A' ' 46' ' ' LEU . 81.3 mt -116.47 151.63 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -174.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.422 HD12 ' CB ' ' A' ' 39' ' ' PRO . 11.7 pt -117.73 156.12 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 168.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.52 165.65 24.0 Favored Pre-proline 0 N--CA 1.494 1.75 0 CA-C-O 119.078 -0.487 . . . . 0.0 110.311 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -59.48 -30.8 93.46 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 121.117 1.211 . . . . 0.0 111.576 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.31 167.02 23.44 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 122.299 -0.25 . . . . 0.0 110.701 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -71.57 105.24 3.57 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.414 HD12 HD22 ' A' ' 44' ' ' LEU . 80.3 mt -59.52 -33.67 71.66 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 122.144 -0.347 . . . . 0.0 111.471 -177.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -63.04 -34.91 78.58 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 122.124 -0.36 . . . . 0.0 110.951 -175.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.2 -47.7 17.46 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -62.45 -34.99 77.89 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 122.211 -0.305 . . . . 0.0 111.038 -172.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -108.03 9.94 28.35 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 51.81 47.92 23.84 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.226 -0.921 . . . . 0.0 111.972 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 48.6 mt -91.37 138.25 31.73 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.958 -0.464 . . . . 0.0 110.798 -172.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -114.12 158.62 21.04 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.87 138.07 49.11 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.794 -0.566 . . . . 0.0 111.429 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.53 -22.96 37.59 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.4 155.59 34.93 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-N 118.648 1.224 . . . . 0.0 110.039 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.41 134.09 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -174.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.78 HD11 HD11 ' A' ' 46' ' ' LEU . 34.3 pt -128.76 160.73 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -109.9 137.63 47.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.205 -0.31 . . . . 0.0 110.179 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -113.11 137.25 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 129' ' ' LEU . 9.2 tt -110.26 126.76 54.5 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -178.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.8 mt -114.52 126.67 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.11 145.49 24.36 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.12 174.59 34.69 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -143.88 135.87 26.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 122.362 -0.493 . . . . 0.0 110.199 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -108.5 142.55 38.73 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -98.34 149.89 22.15 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.212 179.927 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.4 t -113.02 133.77 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -99.79 154.97 17.91 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 131' ' ' LYS . 86.0 mt -133.34 150.87 51.83 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.7 ttm -128.35 146.42 50.78 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.0 mm -126.24 133.34 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -177.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.2 mt -129.81 149.73 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -105.85 141.87 36.54 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.25 150.45 20.45 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.52 142.18 36.6 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 117.217 0.508 . . . . 0.0 110.278 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.1 t -63.04 123.22 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -122.37 155.13 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 176.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.4 p -85.48 132.82 34.14 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.352 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.0 119.96 0.84 Allowed Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -153.29 137.92 16.9 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 117.208 0.504 . . . . 0.0 110.239 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.21 36.08 32.18 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -107.86 149.27 28.48 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 117.174 0.487 . . . . 0.0 110.123 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.12 -163.75 39.88 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -141.79 38.69 1.65 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 117.215 0.508 . . . . 0.0 110.432 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -116.59 132.09 56.77 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 122.249 -0.282 . . . . 0.0 110.438 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.45 ' HB2' HD12 ' A' ' 24' ' ' LEU . 97.8 m-85 -104.26 123.81 48.02 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.8 mt -89.34 -27.02 20.77 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 121.171 -0.211 . . . . 0.0 111.34 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.7 p -58.84 -24.07 61.52 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.907 -0.495 . . . . 0.0 111.878 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 21' ' ' PHE . 58.5 mt -64.6 154.9 83.44 Favored Pre-proline 0 N--CA 1.502 2.163 0 CA-C-O 119.087 -0.482 . . . . 0.0 110.648 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -54.74 -49.45 16.7 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 O-C-N 123.429 1.226 . . . . 0.0 113.77 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.13 -45.5 38.7 Favored 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 120.92 1.08 . . . . 0.0 113.166 -169.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -64.83 -42.92 94.55 Favored 'General case' 0 N--CA 1.504 2.275 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.681 -175.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.8 tttp -65.38 -40.14 93.13 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 122.109 -0.369 . . . . 0.0 110.283 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -65.7 -46.63 78.29 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 122.226 -0.296 . . . . 0.0 110.53 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.1 tt -69.21 -35.53 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 C-N-CA 120.632 -0.427 . . . . 0.0 109.989 -176.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -65.89 -43.65 87.64 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 122.195 -0.316 . . . . 0.0 110.589 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -65.76 -32.64 74.29 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.73 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -68.7 -40.15 80.17 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.605 178.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.8 mt -81.56 -35.78 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -176.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.428 HD21 ' HB2' ' A' ' 92' ' ' ALA . 47.1 mt -103.31 -26.29 12.99 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.183 -0.323 . . . . 0.0 111.767 -173.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.7 15.3 75.97 Favored Glycine 0 N--CA 1.493 2.492 0 CA-C-O 119.3 -0.722 . . . . 0.0 111.371 -173.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -150.83 162.31 40.99 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 119.166 1.483 . . . . 0.0 110.775 171.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -94.15 106.74 24.3 Favored Pre-proline 0 N--CA 1.497 1.888 0 CA-C-O 118.707 -0.663 . . . . 0.0 109.854 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.9 158.72 56.77 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 O-C-N 123.245 1.129 . . . . 0.0 110.302 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -73.8 160.4 31.53 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -80.29 79.67 6.83 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.518 0.675 . . . . 0.0 109.778 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.19 175.8 47.66 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 175.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 p -138.02 154.53 49.3 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 117.367 0.584 . . . . 0.0 110.774 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.506 HD22 HD12 ' A' ' 114' ' ' LEU . 30.6 tp -109.32 119.08 38.4 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 170.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.536 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.5 m120 -100.64 122.69 43.73 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.168 -175.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.806 HD11 HD11 ' A' ' 126' ' ' ILE . 56.2 mt -120.53 136.19 54.85 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 120.66 0.267 . . . . 0.0 110.549 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HB2' HG11 ' A' ' 12' ' ' VAL . 63.5 tttt -96.24 133.92 39.98 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.493 HD11 HD13 ' A' ' 106' ' ' ILE . 83.5 mt -111.95 160.22 17.64 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 120.617 0.246 . . . . 0.0 110.465 -176.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -89.04 12.8 14.55 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 172.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -145.79 141.98 28.45 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.661 -0.649 . . . . 0.0 109.388 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.24 146.81 52.62 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 122.225 -0.297 . . . . 0.0 110.628 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -132.16 137.45 47.65 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 120.699 0.285 . . . . 0.0 110.663 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -138.0 125.53 22.09 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 174.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.2 -22.51 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.384 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -74.48 -1.08 19.69 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.978 -0.451 . . . . 0.0 112.187 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -90.75 -14.48 31.99 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 118.922 0.783 . . . . 0.0 111.524 170.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.96 175.18 5.7 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 118.597 0.635 . . . . 0.0 109.463 174.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -91.74 103.24 15.83 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -110.59 178.84 4.24 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 120.587 0.232 . . . . 0.0 110.435 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -111.74 130.2 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.97 142.65 35.32 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.2 p -122.79 136.35 54.84 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 120.762 0.315 . . . . 0.0 110.78 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -75.34 172.67 12.05 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 120.909 0.385 . . . . 0.0 111.754 -170.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -67.8 141.15 56.6 Favored 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -137.04 167.0 22.37 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.543 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -125.58 149.52 48.28 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 120.907 0.384 . . . . 0.0 110.548 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -147.9 134.15 19.47 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 51.69 33.82 11.69 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.702 -0.624 . . . . 0.0 112.157 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.18 16.64 79.39 Favored Glycine 0 N--CA 1.496 2.682 0 CA-C-O 119.623 -0.543 . . . . 0.0 111.875 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -121.15 139.84 52.81 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.677 1.239 . . . . 0.0 109.623 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.51 132.48 37.76 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 121.091 -0.243 . . . . 0.0 110.505 -176.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -121.24 144.14 48.77 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -86.08 157.04 20.15 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.53 -168.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.56 158.59 49.11 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -176.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.49 154.98 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 122.351 -0.499 . . . . 0.0 110.445 -174.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -116.04 136.43 53.04 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.4 t -133.98 139.95 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -175.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.7 tp -137.12 125.65 14.86 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.053 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -63.4 149.76 90.31 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 O-C-N 123.182 1.096 . . . . 0.0 111.444 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.507 HD13 HG13 ' A' ' 93' ' ' ILE . 43.1 pt -141.7 170.08 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 171.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -113.9 130.42 56.5 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 168.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -105.96 123.64 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -174.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.5 mt -108.52 116.32 31.75 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -129.87 121.91 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.72 -120.29 18.34 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -111.18 17.05 20.69 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 122.316 -0.52 . . . . 0.0 111.932 175.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -119.34 143.99 47.1 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 118.465 0.575 . . . . 0.0 110.498 -175.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -123.16 130.08 52.29 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.3 mt -126.81 146.32 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.83 135.98 43.47 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.01 -167.29 12.12 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.428 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -160.1 155.95 26.03 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 117.374 0.587 . . . . 0.0 110.447 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.507 HG13 HD13 ' A' ' 80' ' ' ILE . 67.5 mt -108.73 141.9 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -121.88 131.42 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.1 t -141.01 133.87 14.41 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -57.82 155.04 34.47 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 120.996 1.131 . . . . 0.0 111.877 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -64.78 -34.52 78.55 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 122.365 -0.209 . . . . 0.0 110.723 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -87.33 118.39 26.73 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.35 -176.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.2 p -131.98 160.37 36.02 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -126.77 -42.91 1.74 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.308 -0.245 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -136.88 176.71 8.46 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.2 m -99.61 147.75 25.04 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.0 m -135.07 171.99 13.64 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 120.594 0.235 . . . . 0.0 110.517 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -107.19 27.14 9.34 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.408 -0.183 . . . . 0.0 110.94 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -122.91 127.19 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.493 HD13 HD11 ' A' ' 48' ' ' LEU . 34.6 pt -124.81 143.75 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 177.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -114.77 131.56 56.75 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.477 HD12 HD12 ' A' ' 46' ' ' LEU . 81.9 mt -117.22 152.05 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -173.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.5 pt -116.18 156.17 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 168.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.59 164.15 32.27 Favored Pre-proline 0 N--CA 1.496 1.827 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.334 -176.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.15 -32.41 94.54 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 121.062 1.175 . . . . 0.0 111.479 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.98 159.26 43.21 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.266 -0.272 . . . . 0.0 110.862 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.6 pttt -62.5 103.92 0.46 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.413 0.625 . . . . 0.0 111.203 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.506 HD12 HD22 ' A' ' 44' ' ' LEU . 82.7 mt -59.6 -32.51 70.46 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.869 -0.519 . . . . 0.0 111.692 -177.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -61.9 -37.28 84.02 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 122.098 -0.376 . . . . 0.0 111.204 -171.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -78.27 -46.41 20.34 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -62.37 -34.59 76.99 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 122.208 -0.307 . . . . 0.0 111.024 -172.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -108.13 8.23 27.97 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 51.72 50.65 18.27 Favored 'General case' 0 N--CA 1.508 2.436 0 CA-C-N 119.309 0.959 . . . . 0.0 111.945 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 48.2 mt -90.39 138.16 31.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.832 -0.542 . . . . 0.0 110.818 -171.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -117.03 155.29 29.46 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 175.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -55.99 138.01 49.8 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.857 -0.527 . . . . 0.0 111.468 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.98 -22.97 37.32 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.31 154.59 37.83 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 118.655 1.227 . . . . 0.0 110.038 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -111.92 133.78 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.806 HD11 HD11 ' A' ' 46' ' ' LEU . 34.4 pt -128.56 160.95 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -109.93 138.13 46.73 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 pt -112.26 137.17 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.463 ' C ' HD23 ' A' ' 129' ' ' LEU . 10.0 tt -110.54 126.39 54.35 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -177.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 38.3 mt -114.09 127.96 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.421 ' HA ' HD23 ' A' ' 4' ' ' LEU . 55.2 mttm -94.34 120.88 35.24 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.15 -177.34 30.18 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -134.27 122.19 22.36 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 117.144 0.472 . . . . 0.0 110.11 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -131.23 128.74 40.55 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -100.03 147.07 26.02 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.518 179.801 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mmm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.1 t -117.62 136.2 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -98.36 125.51 43.52 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.452 HD13 HD21 ' A' ' 129' ' ' LEU . 82.9 mt -110.92 154.06 24.61 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 43.1 ttm -103.57 142.74 33.78 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.2 mm -125.55 130.01 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.437 HG22 HD22 ' A' ' 48' ' ' LEU . 77.6 mt -129.69 149.02 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -104.69 140.76 37.58 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.07 150.41 19.98 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -105.63 142.36 35.5 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 117.28 0.54 . . . . 0.0 110.227 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.71 120.99 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.45 137.78 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 122.308 -0.245 . . . . 0.0 110.375 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.1 m -88.04 111.85 21.98 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.06 120.02 0.84 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 tp -139.88 108.01 5.76 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 122.426 -0.455 . . . . 0.0 109.928 177.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.99 51.38 0.53 Allowed Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -99.95 32.64 2.85 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 117.194 0.497 . . . . 0.0 110.357 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.16 -139.92 21.66 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 51.4 mtm180 -92.51 130.63 38.12 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 117.177 0.489 . . . . 0.0 109.988 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -117.86 130.87 56.52 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -153.25 97.85 2.21 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.658 ' O ' HD23 ' A' ' 22' ' ' LEU . 1.7 tt -90.61 -14.32 32.66 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 122.283 -0.261 . . . . 0.0 111.591 177.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 m -54.73 -22.47 14.12 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.334 -0.854 . . . . 0.0 112.285 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.419 HD21 ' CD2' ' A' ' 67' ' ' PHE . 6.0 tp -59.86 137.71 90.44 Favored Pre-proline 0 N--CA 1.507 2.398 0 CA-C-O 118.736 -0.65 . . . . 0.0 110.584 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -51.92 -47.54 26.04 Favored 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 121.099 1.199 . . . . 0.0 113.973 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.629 ' O ' HG22 ' A' ' 30' ' ' ILE . 31.2 Cg_exo -56.18 -32.08 85.99 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 CA-C-N 119.472 0.847 . . . . 0.0 112.09 -172.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -67.47 -52.07 43.69 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.197 -176.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -64.77 -39.83 94.26 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.49 -176.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -66.7 -50.06 64.07 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.417 -176.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 26' ' ' PRO . 10.6 tt -71.37 -32.74 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.229 -174.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -64.72 -41.97 95.58 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 122.079 -0.388 . . . . 0.0 110.257 175.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -65.3 -32.35 73.96 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.83 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -68.45 -39.33 81.51 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.85 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.544 HG23 HD12 ' A' ' 60' ' ' ILE . 48.3 mt -81.46 -36.82 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -175.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.508 ' CD2' ' HB2' ' A' ' 92' ' ' ALA . 61.0 mt -103.97 -26.22 12.71 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.206 -0.309 . . . . 0.0 111.642 -174.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.7 14.17 73.75 Favored Glycine 0 N--CA 1.495 2.603 0 CA-C-O 119.368 -0.685 . . . . 0.0 111.48 -172.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -152.39 161.68 42.26 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 119.163 1.481 . . . . 0.0 110.554 170.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -94.47 107.45 29.92 Favored Pre-proline 0 N--CA 1.496 1.846 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.8 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -67.38 156.51 65.88 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 O-C-N 123.242 1.127 . . . . 0.0 110.526 -176.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -73.37 162.59 29.15 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -80.31 79.46 6.89 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.537 0.684 . . . . 0.0 109.509 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.85 176.12 47.26 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 p -138.07 157.2 46.81 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 117.349 0.575 . . . . 0.0 110.842 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.458 HD22 HD12 ' A' ' 114' ' ' LEU . 33.8 tp -108.92 118.37 36.62 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.95 122.85 42.74 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -175.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.823 HD11 HD11 ' A' ' 126' ' ' ILE . 61.1 mt -121.29 136.24 55.0 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.732 0.301 . . . . 0.0 110.521 -178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -96.13 132.51 41.45 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.437 HD22 HG22 ' A' ' 7' ' ' ILE . 84.5 mt -111.47 160.23 17.32 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 120.703 0.287 . . . . 0.0 110.382 -176.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -88.94 12.44 15.34 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 173.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -146.39 140.91 26.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.687 -0.633 . . . . 0.0 109.662 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.1 146.9 52.27 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 122.182 -0.324 . . . . 0.0 110.75 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -132.37 138.71 47.83 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.64 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -138.04 123.89 20.01 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 176.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.62 -23.08 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.395 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -74.6 -0.97 19.53 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.897 -0.502 . . . . 0.0 112.214 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -89.92 -14.21 34.65 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 118.961 0.8 . . . . 0.0 111.542 171.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -117.0 175.15 5.72 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 118.603 0.638 . . . . 0.0 109.582 173.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -91.87 104.86 17.24 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -109.49 177.3 4.78 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.544 HD12 HG23 ' A' ' 34' ' ' ILE . 79.4 mt -110.37 133.67 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -105.84 142.1 36.13 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.3 p -116.5 133.23 56.26 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -77.47 172.5 13.24 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 120.75 0.309 . . . . 0.0 111.388 -171.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -69.28 139.86 54.39 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -140.64 164.86 29.05 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.743 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -122.01 146.44 47.16 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 120.699 0.285 . . . . 0.0 110.271 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.419 ' CD2' HD21 ' A' ' 24' ' ' LEU . 47.1 t80 -150.71 141.83 23.1 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 172.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.2 m120 52.11 29.98 7.06 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.69 -0.631 . . . . 0.0 112.126 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.56 16.08 81.03 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -120.45 143.29 48.57 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 118.706 1.253 . . . . 0.0 109.636 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -92.42 131.76 37.32 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.349 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -119.94 141.0 50.03 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -87.4 151.9 22.69 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 120.843 0.354 . . . . 0.0 110.595 -167.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.68 158.71 51.21 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -142.65 161.48 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 122.252 -0.558 . . . . 0.0 110.514 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -113.5 135.21 54.13 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.8 t -131.07 138.25 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -176.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.7 tp -137.44 125.65 14.49 Favored Pre-proline 0 N--CA 1.496 1.85 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.055 178.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -62.68 149.33 91.56 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 120.98 1.12 . . . . 0.0 111.731 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.581 HD13 HG13 ' A' ' 93' ' ' ILE . 43.6 pt -141.82 170.17 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 122.253 -0.279 . . . . 0.0 110.321 171.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -113.53 130.26 56.39 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 168.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -106.24 123.57 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.0 mt -108.63 116.99 33.02 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.8 mt -130.1 121.96 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.79 -120.46 18.89 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -111.1 16.97 20.82 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 122.266 -0.55 . . . . 0.0 111.933 175.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -118.68 143.2 47.0 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 118.518 0.599 . . . . 0.0 110.482 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -123.09 129.89 52.06 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -127.06 149.05 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.31 136.01 44.44 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.99 -168.4 12.35 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.508 ' HB2' ' CD2' ' A' ' 35' ' ' LEU . . . -159.35 155.22 26.39 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 117.305 0.553 . . . . 0.0 110.325 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.581 HG13 HD13 ' A' ' 80' ' ' ILE . 73.8 mt -108.71 140.72 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -125.07 129.52 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.7 t -139.92 133.88 15.6 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -56.65 153.67 34.92 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 121.037 1.158 . . . . 0.0 112.046 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -64.5 -34.45 78.24 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 122.269 -0.269 . . . . 0.0 110.606 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.1 tttp -90.97 121.05 32.47 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.2 t -141.84 151.89 43.17 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 122.32 -0.237 . . . . 0.0 110.401 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -98.42 -58.93 1.85 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -134.91 169.77 16.89 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.0 m -82.81 154.39 24.72 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 96.3 p -135.02 175.05 9.94 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 120.645 0.259 . . . . 0.0 110.495 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -104.8 25.0 10.94 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 121.28 -0.168 . . . . 0.0 110.95 172.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -120.89 126.88 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.9 pt -125.36 145.59 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -115.55 130.23 56.8 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.545 HD12 HD12 ' A' ' 46' ' ' LEU . 83.6 mt -116.06 152.27 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -174.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 pt -116.68 155.91 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 168.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.52 162.16 43.39 Favored Pre-proline 0 N--CA 1.495 1.823 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.358 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.54 -30.67 93.02 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 121.075 1.183 . . . . 0.0 111.728 177.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.44 167.0 23.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.279 -0.263 . . . . 0.0 110.933 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -69.92 104.33 2.48 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.458 HD12 HD22 ' A' ' 44' ' ' LEU . 85.0 mt -59.93 -34.25 72.98 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 122.138 -0.351 . . . . 0.0 111.349 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -62.97 -35.57 80.59 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 122.203 -0.311 . . . . 0.0 110.922 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -78.36 -48.76 14.88 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -62.65 -33.63 75.43 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 122.231 -0.293 . . . . 0.0 111.11 -172.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -108.05 7.75 27.9 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 51.8 46.97 25.69 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.108 -0.995 . . . . 0.0 111.878 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.4 mt -92.28 138.19 31.73 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.893 -0.504 . . . . 0.0 111.007 -170.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -115.66 160.61 19.82 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.17 50.17 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.966 -0.459 . . . . 0.0 111.569 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.48 -22.94 37.7 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.59 151.59 46.12 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 118.627 1.213 . . . . 0.0 110.018 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.3 t -110.45 133.66 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -173.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.823 HD11 HD11 ' A' ' 46' ' ' LEU . 34.8 pt -128.46 160.16 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -109.65 138.07 46.55 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.2 pt -113.62 137.87 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.465 ' C ' HD23 ' A' ' 129' ' ' LEU . 9.7 tt -108.99 127.7 54.3 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 32.5 mt -118.31 135.72 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -91.66 149.01 21.84 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.07 -170.26 21.81 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -98.72 168.67 10.0 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 122.334 -0.51 . . . . 0.0 110.176 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -65.02 -36.34 84.08 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 122.253 -0.279 . . . . 0.0 110.619 -177.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -104.69 -32.75 8.74 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 122.332 -0.23 . . . . 0.0 110.654 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.169 179.326 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.2 t -70.08 -40.74 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -134.02 128.31 34.06 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 131' ' ' LYS . 81.3 mt -110.86 148.3 32.73 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 10.7 tpp -109.4 144.01 38.18 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.7 mm -125.77 129.36 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.501 HG22 HD22 ' A' ' 48' ' ' LEU . 73.7 mt -129.77 148.9 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -105.37 141.53 36.72 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.73 150.61 20.38 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -106.33 142.1 36.56 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 117.265 0.532 . . . . 0.0 110.301 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.11 121.08 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.22 144.2 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.5 m -86.48 114.83 23.56 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.07 120.01 0.84 Allowed Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 17' ' ' GLU . 12.7 tp -110.93 137.38 48.64 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 122.341 -0.505 . . . . 0.0 109.904 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.83 -40.08 95.39 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -174.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.595 ' O ' HD23 ' A' ' 15' ' ' LEU . 69.6 mt-10 -123.78 153.85 40.37 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 117.327 0.563 . . . . 0.0 110.411 -177.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.63 -35.32 85.87 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -112.93 144.27 42.78 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 117.217 0.509 . . . . 0.0 109.985 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -124.75 126.73 46.12 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -144.49 96.63 2.9 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.706 ' O ' HD23 ' A' ' 22' ' ' LEU . 1.4 tt -102.92 0.33 32.23 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.2 m -94.65 31.25 1.83 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.26 -0.9 . . . . 0.0 111.533 -172.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.9 tp -88.56 139.88 29.84 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 171.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -50.15 -43.77 41.2 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 121.081 1.187 . . . . 0.0 114.059 -172.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.27 -36.81 99.03 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 CA-C-N 119.567 0.881 . . . . 0.0 111.941 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -66.14 -46.19 78.38 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.469 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -66.06 -37.42 85.77 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.337 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -65.57 -48.92 70.71 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.438 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.6 tt -68.72 -38.63 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.089 -176.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -66.37 -47.07 74.57 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 122.118 -0.363 . . . . 0.0 110.387 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -66.18 -29.62 69.93 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.735 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -68.89 -40.82 79.0 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.733 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.9 mt -81.31 -38.04 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -175.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 92' ' ' ALA . 46.1 mt -104.01 -26.2 12.71 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.231 -0.293 . . . . 0.0 111.711 -174.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.16 13.66 73.67 Favored Glycine 0 N--CA 1.495 2.592 0 CA-C-O 119.369 -0.684 . . . . 0.0 111.466 -171.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -152.52 165.65 34.46 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 119.158 1.479 . . . . 0.0 110.614 170.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -96.41 112.31 59.57 Favored Pre-proline 0 N--CA 1.496 1.851 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.835 175.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -67.52 159.92 50.33 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 O-C-N 123.266 1.14 . . . . 0.0 110.631 -176.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -74.3 164.54 26.48 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -80.23 79.57 6.78 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.476 0.655 . . . . 0.0 109.729 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.09 170.42 42.14 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 174.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 p -138.08 157.41 46.38 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 117.295 0.547 . . . . 0.0 110.674 177.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.5 tp -109.76 116.67 32.11 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 171.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -98.57 120.9 39.78 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 126' ' ' ILE . 60.6 mt -119.96 135.71 54.8 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 120.71 0.29 . . . . 0.0 110.656 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -96.21 133.46 40.49 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.501 HD22 HG22 ' A' ' 7' ' ' ILE . 84.7 mt -110.95 160.38 16.86 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 120.649 0.262 . . . . 0.0 110.481 -177.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.09 12.75 14.78 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -145.89 141.4 27.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.701 -0.624 . . . . 0.0 109.488 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -63.32 146.92 52.48 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 122.203 -0.311 . . . . 0.0 110.682 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -132.09 138.17 48.02 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 120.719 0.295 . . . . 0.0 110.622 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -138.02 126.41 23.27 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.9 tt -63.28 -22.73 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.348 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -74.65 -0.94 19.59 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.97 -0.457 . . . . 0.0 112.216 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -90.77 -14.51 31.87 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 118.902 0.774 . . . . 0.0 111.488 171.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -117.63 175.18 5.76 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 118.7 0.682 . . . . 0.0 109.469 174.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -90.64 103.88 16.53 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -177.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -110.42 179.25 4.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.371 -0.206 . . . . 0.0 110.537 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.5 mt -112.6 131.8 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.95 143.17 34.47 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.4 p -123.28 137.07 54.94 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 120.761 0.315 . . . . 0.0 110.769 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -77.3 172.61 13.02 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 120.824 0.345 . . . . 0.0 111.849 -168.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -68.21 141.31 56.0 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -138.69 164.99 28.12 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 122.186 -0.321 . . . . 0.0 110.675 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -124.92 148.31 48.41 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.787 0.327 . . . . 0.0 110.381 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -149.53 136.45 19.6 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 52.23 32.96 11.58 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.747 -0.595 . . . . 0.0 111.832 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 16.42 80.15 Favored Glycine 0 N--CA 1.497 2.733 0 CA-C-O 119.584 -0.565 . . . . 0.0 111.798 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -120.16 138.99 53.28 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 118.728 1.264 . . . . 0.0 109.701 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -93.19 131.47 38.24 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.358 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -119.69 140.93 49.88 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -86.03 155.9 20.65 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 120.761 0.315 . . . . 0.0 110.388 -168.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.94 156.86 51.64 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -176.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.09 156.86 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 122.347 -0.502 . . . . 0.0 110.486 -173.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -115.79 137.0 52.5 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.2 t -134.06 141.06 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -175.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.9 tp -137.54 125.72 14.42 Favored Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.082 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -63.31 148.56 92.8 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 120.987 1.125 . . . . 0.0 111.396 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.617 HD13 HG13 ' A' ' 93' ' ' ILE . 43.9 pt -141.78 170.06 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 122.304 -0.248 . . . . 0.0 110.412 173.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -114.28 131.51 56.48 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 168.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.2 mt -105.74 123.33 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.22 116.47 32.02 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.7 mt -129.83 121.92 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.56 -120.16 18.09 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -177.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -111.21 17.04 20.67 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 117.161 0.48 . . . . 0.0 111.784 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -119.43 144.12 47.11 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.557 0.617 . . . . 0.0 110.46 -175.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -123.13 130.15 52.39 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 122.263 -0.273 . . . . 0.0 110.275 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.6 mt -126.35 147.05 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.42 137.46 44.62 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.6 -168.32 13.51 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 178.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.644 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.12 154.26 25.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.266 -0.549 . . . . 0.0 110.258 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.617 HG13 HD13 ' A' ' 80' ' ' ILE . 70.2 mt -108.65 140.62 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -123.07 130.28 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.98 133.9 14.45 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -57.75 153.63 42.17 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 120.996 1.13 . . . . 0.0 111.813 177.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -65.53 -34.91 79.37 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 122.279 -0.263 . . . . 0.0 110.487 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -89.17 121.01 31.07 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.267 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -141.64 151.56 43.17 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -98.01 -55.89 2.65 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -136.84 169.63 17.43 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.1 m -82.19 151.11 27.04 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.0 m -134.91 175.0 9.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.295 -0.253 . . . . 0.0 110.526 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -107.28 27.22 9.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.378 -0.201 . . . . 0.0 110.839 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.1 mm -124.1 127.51 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.5 pt -125.98 145.52 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -114.81 130.08 56.81 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.507 HD12 HD12 ' A' ' 46' ' ' LEU . 83.5 mt -115.04 149.95 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -174.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 pt -115.95 155.57 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 169.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.55 165.97 22.24 Favored Pre-proline 0 N--CA 1.496 1.843 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.326 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.76 -30.94 93.24 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 O-C-N 123.292 1.154 . . . . 0.0 111.623 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.39 167.06 23.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.293 -0.255 . . . . 0.0 110.751 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -70.88 105.24 3.19 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.3 mt -59.52 -33.61 71.59 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 122.151 -0.343 . . . . 0.0 111.449 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -62.83 -35.35 79.65 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 122.108 -0.37 . . . . 0.0 111.006 -174.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -78.11 -48.28 16.37 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -62.47 -34.3 76.55 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 122.153 -0.342 . . . . 0.0 111.135 -172.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -108.1 8.53 28.18 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 51.79 50.5 18.53 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 121.103 -0.998 . . . . 0.0 111.895 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 47.4 mt -90.3 138.17 31.75 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.879 -0.513 . . . . 0.0 110.899 -171.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -116.19 155.16 28.76 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.48 137.91 47.45 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.906 -0.496 . . . . 0.0 111.533 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.02 -22.98 37.22 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -65.32 154.6 37.81 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-N 118.704 1.252 . . . . 0.0 110.05 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.38 134.03 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -174.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.815 HD11 HD11 ' A' ' 46' ' ' LEU . 34.6 pt -128.9 160.41 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -109.83 138.28 46.43 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.8 pt -114.21 137.61 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 176.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.466 ' C ' HD23 ' A' ' 129' ' ' LEU . 9.2 tt -109.02 127.75 54.37 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.8 mt -118.57 134.68 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HA ' HD23 ' A' ' 4' ' ' LEU . 49.9 mttp -91.83 133.65 35.45 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.19 175.18 34.69 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -154.96 165.92 35.19 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.336 -0.508 . . . . 0.0 110.501 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -115.9 145.82 42.57 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -138.77 163.98 30.79 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.145 179.993 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.5 mtt . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 p -132.4 142.18 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -140.84 50.58 1.65 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.035 0.445 . . . . 0.0 110.267 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.2 mt -110.9 149.12 31.07 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.089 -0.382 . . . . 0.0 110.088 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 51.6 ttm -107.74 144.76 34.43 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.3 mm -127.72 129.21 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.487 HG22 HD22 ' A' ' 48' ' ' LEU . 73.3 mt -129.97 149.23 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -105.9 142.12 36.15 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.42 150.95 20.4 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -106.16 142.38 35.95 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 117.266 0.533 . . . . 0.0 110.245 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.74 123.6 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.9 m -123.24 157.87 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 176.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -85.07 107.56 17.23 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.271 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.02 120.41 0.86 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.3 tp -81.89 -53.72 5.93 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 117.316 0.558 . . . . 0.0 109.974 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.09 168.79 30.14 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -100.04 -56.47 2.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 122.383 -0.48 . . . . 0.0 109.97 177.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.77 -170.53 41.81 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -100.19 107.68 19.6 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 117.131 0.465 . . . . 0.0 110.13 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -155.01 154.88 33.2 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -128.63 154.03 46.66 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 41' ' ' GLU . 85.8 mt -97.65 -11.82 23.11 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.5 m -61.61 -29.25 69.93 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 118.823 0.738 . . . . 0.0 111.48 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.6 tp -64.22 139.29 97.66 Favored Pre-proline 0 N--CA 1.505 2.309 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.27 -177.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -53.54 -49.34 17.69 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 121.058 1.172 . . . . 0.0 113.706 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -54.84 -33.1 80.2 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 120.634 0.89 . . . . 0.0 112.482 -170.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -66.44 -45.57 79.39 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.465 -177.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -66.5 -37.61 85.42 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 122.101 -0.374 . . . . 0.0 110.251 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -65.61 -47.41 75.78 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 122.201 -0.312 . . . . 0.0 110.454 -178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.2 tt -68.95 -37.96 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.045 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -65.46 -40.36 93.11 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 122.137 -0.352 . . . . 0.0 110.417 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -65.42 -37.51 87.15 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 122.212 -0.305 . . . . 0.0 110.319 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -68.03 -38.26 82.34 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.537 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.7 mt -81.18 -35.81 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.62 -26.1 12.92 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 122.141 -0.349 . . . . 0.0 111.573 -173.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.8 13.12 78.65 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -172.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -151.62 160.56 43.6 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 118.955 1.377 . . . . 0.0 110.222 170.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -93.12 108.0 29.45 Favored Pre-proline 0 N--CA 1.497 1.892 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.857 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.456 ' CB ' HD12 ' A' ' 109' ' ' ILE . 66.7 Cg_endo -67.6 160.12 49.47 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 O-C-N 123.249 1.131 . . . . 0.0 110.355 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -73.62 161.62 30.1 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.438 ' HA ' HD13 ' A' ' 22' ' ' LEU . 70.4 mt-10 -80.32 79.6 6.88 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.496 0.665 . . . . 0.0 109.654 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.71 172.68 45.01 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 175.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 p -138.04 156.87 47.36 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 117.348 0.574 . . . . 0.0 110.775 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.497 HD22 HD12 ' A' ' 114' ' ' LEU . 30.7 tp -110.71 118.18 35.47 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 170.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.539 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.5 m120 -98.94 122.15 41.82 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -176.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 126' ' ' ILE . 59.3 mt -120.14 136.13 54.72 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 120.662 0.268 . . . . 0.0 110.585 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HB2' HG11 ' A' ' 12' ' ' VAL . 39.8 tttp -96.21 133.27 40.73 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 173.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.487 HD22 HG22 ' A' ' 7' ' ' ILE . 83.0 mt -111.1 160.27 17.04 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 120.664 0.269 . . . . 0.0 110.448 -177.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.14 12.74 14.93 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 172.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -145.76 142.39 28.87 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 118.496 0.589 . . . . 0.0 109.428 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -64.37 146.76 53.93 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 122.196 -0.315 . . . . 0.0 110.324 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -133.11 137.57 46.37 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 120.686 0.279 . . . . 0.0 110.755 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -138.06 128.28 25.98 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 174.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.0 tt -63.43 -23.05 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.271 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -74.58 -0.92 19.32 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -90.53 -14.52 32.45 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 118.905 0.775 . . . . 0.0 111.429 170.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -117.79 175.18 5.78 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 118.64 0.654 . . . . 0.0 109.497 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -91.1 103.8 16.45 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -109.81 178.39 4.43 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 120.572 0.225 . . . . 0.0 110.47 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.4 mt -111.43 131.17 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -105.97 144.56 32.52 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.1 p -124.27 138.09 54.43 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.821 0.343 . . . . 0.0 110.764 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -77.0 172.77 12.66 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 120.902 0.382 . . . . 0.0 111.869 -168.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -67.45 140.82 57.11 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -136.78 167.35 21.6 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.221 -0.299 . . . . 0.0 110.553 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -125.3 149.53 47.97 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 120.836 0.35 . . . . 0.0 110.56 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -148.66 133.65 18.14 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 52.11 33.46 12.24 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.63 -0.668 . . . . 0.0 111.879 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.21 15.77 80.56 Favored Glycine 0 N--CA 1.497 2.721 0 CA-C-O 119.578 -0.568 . . . . 0.0 111.892 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -120.13 140.89 50.4 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 118.778 1.289 . . . . 0.0 109.691 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -93.47 132.04 38.11 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 121.081 -0.247 . . . . 0.0 110.489 -176.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -121.19 144.87 48.36 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -86.11 156.18 20.48 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 120.799 0.333 . . . . 0.0 110.508 -167.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.79 159.46 48.88 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -176.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.77 158.17 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 122.355 -0.497 . . . . 0.0 110.338 -174.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -118.35 137.3 53.19 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.03 141.27 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.1 tp -137.25 125.64 14.7 Favored Pre-proline 0 N--CA 1.495 1.823 0 CA-C-O 118.524 -0.75 . . . . 0.0 110.092 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -63.68 149.73 90.15 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 120.965 1.11 . . . . 0.0 111.332 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.536 HD13 HG13 ' A' ' 93' ' ' ILE . 43.1 pt -141.85 170.06 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 120.635 0.255 . . . . 0.0 110.385 171.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -114.35 131.14 56.65 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 168.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.24 123.05 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -174.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.4 mt -107.97 116.4 31.89 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.9 mt -129.85 121.9 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.69 -120.14 17.83 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -111.22 17.08 20.63 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.33 -0.512 . . . . 0.0 111.897 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -119.76 144.21 47.4 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 118.52 0.6 . . . . 0.0 110.435 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -123.06 129.9 52.09 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 120.697 0.284 . . . . 0.0 110.298 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.4 mt -126.43 147.46 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -73.56 136.71 44.04 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.91 -168.89 13.05 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.49 154.47 24.87 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 117.376 0.588 . . . . 0.0 110.305 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.536 HG13 HD13 ' A' ' 80' ' ' ILE . 69.9 mt -108.79 141.61 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.8 t -124.4 132.09 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -144.95 137.54 13.54 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -58.15 152.84 49.66 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.05 1.166 . . . . 0.0 111.652 175.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -65.89 -34.32 77.85 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.538 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -88.6 117.31 27.47 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.0 m -129.87 143.26 50.72 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -94.05 -54.23 3.67 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -135.94 -179.73 5.84 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.4 m -96.77 151.71 19.38 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 95.2 p -134.96 172.32 13.17 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 120.747 0.308 . . . . 0.0 110.647 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -105.56 24.87 11.5 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.811 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.5 mm -120.81 127.72 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.442 HD13 HD11 ' A' ' 48' ' ' LEU . 34.5 pt -125.93 146.08 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 177.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -116.28 129.75 56.43 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 110.037 -0.356 . . . . 0.0 110.037 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.5 HD12 HD12 ' A' ' 46' ' ' LEU . 82.1 mt -115.0 151.55 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.456 HD12 ' CB ' ' A' ' 39' ' ' PRO . 11.9 pt -115.91 156.17 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 168.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.56 165.97 22.22 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.317 -176.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.13 -32.87 95.22 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 121.064 1.176 . . . . 0.0 111.462 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -145.06 160.14 41.86 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.308 -0.245 . . . . 0.0 110.877 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -62.36 104.7 0.52 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.367 0.604 . . . . 0.0 111.229 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.497 HD12 HD22 ' A' ' 44' ' ' LEU . 81.4 mt -59.56 -32.86 70.74 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.94 -0.475 . . . . 0.0 111.662 -176.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -61.87 -37.42 84.5 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 122.07 -0.394 . . . . 0.0 111.199 -171.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -78.27 -45.16 23.51 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -62.25 -34.79 77.21 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 122.143 -0.348 . . . . 0.0 111.085 -173.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -108.15 8.39 28.01 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 51.86 48.27 23.13 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.084 -1.01 . . . . 0.0 111.879 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.3 mt -91.71 138.12 31.82 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.887 -0.508 . . . . 0.0 110.993 -171.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.25 158.99 22.48 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -56.16 138.22 50.29 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.889 -0.507 . . . . 0.0 111.459 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.59 -22.97 37.52 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.43 151.8 45.45 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-N 118.672 1.236 . . . . 0.0 110.011 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.8 t -110.76 133.64 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -174.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.815 HD11 HD11 ' A' ' 46' ' ' LEU . 34.2 pt -128.28 160.38 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -109.72 137.81 47.0 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.5 pt -113.13 137.2 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.466 ' C ' HD23 ' A' ' 129' ' ' LEU . 9.1 tt -109.76 126.58 53.89 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 36.7 mt -115.17 132.32 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -91.56 145.22 24.78 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.09 -171.03 22.68 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -140.0 176.67 8.56 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.315 -0.521 . . . . 0.0 110.398 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -96.24 132.18 41.96 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -67.58 -36.31 80.64 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.174 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.202 179.899 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.1 ttp . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t -114.38 133.55 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -110.12 151.46 27.23 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.1 mt -110.85 149.34 30.73 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.2 ttm -106.75 144.0 34.03 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.8 mm -128.32 130.25 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.409 HG22 HD22 ' A' ' 48' ' ' LEU . 74.5 mt -129.67 149.38 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -105.81 141.84 36.56 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.32 150.83 20.59 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -106.19 141.5 37.45 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 117.31 0.555 . . . . 0.0 110.269 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.11 123.51 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 45' ' ' ASN . 26.8 m -123.55 156.94 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.5 t -85.91 132.43 34.09 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.284 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.08 119.94 0.84 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.8 mt -143.39 -48.68 0.31 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.326 -0.514 . . . . 0.0 110.218 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.22 36.35 4.26 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -93.3 -56.62 2.88 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 117.273 0.537 . . . . 0.0 110.034 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.75 179.36 35.58 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 178.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -130.73 109.74 10.84 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 117.214 0.507 . . . . 0.0 110.124 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -155.03 156.5 36.05 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.54 132.25 55.71 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.4 mt -110.0 0.04 18.32 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.2 m -89.53 -32.11 17.31 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 118.971 0.805 . . . . 0.0 110.92 -173.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.6 mt -65.39 156.06 83.09 Favored Pre-proline 0 N--CA 1.502 2.156 0 CA-C-O 119.146 -0.454 . . . . 0.0 110.599 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -53.72 -50.53 13.45 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 121.2 1.267 . . . . 0.0 113.78 -175.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.92 -35.74 94.63 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 120.577 0.851 . . . . 0.0 112.33 -168.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -66.66 -45.85 77.59 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.414 -175.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -66.23 -36.82 84.03 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 122.043 -0.41 . . . . 0.0 110.239 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.68 -47.7 74.57 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.481 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.9 tt -68.88 -36.31 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -176.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.433 ' CE1' HD13 ' A' ' 109' ' ' ILE . 3.7 m-85 -65.99 -45.25 82.29 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 122.095 -0.378 . . . . 0.0 110.393 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -65.71 -31.01 71.77 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 122.197 -0.314 . . . . 0.0 110.814 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -68.93 -40.44 79.03 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.581 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -81.45 -37.04 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -175.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.64 HD21 ' HB2' ' A' ' 92' ' ' ALA . 45.8 mt -104.0 -26.19 12.72 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 122.231 -0.293 . . . . 0.0 111.683 -174.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.39 14.76 73.17 Favored Glycine 0 N--CA 1.495 2.593 0 CA-C-O 119.304 -0.72 . . . . 0.0 111.443 -172.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -151.76 163.05 39.99 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 119.22 1.51 . . . . 0.0 110.748 170.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -94.58 109.07 41.17 Favored Pre-proline 0 N--CA 1.496 1.866 0 CA-C-O 118.589 -0.72 . . . . 0.0 109.827 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.47 159.47 52.3 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 O-C-N 123.219 1.115 . . . . 0.0 110.493 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -73.87 162.85 28.66 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -80.22 79.52 6.78 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.467 0.651 . . . . 0.0 109.726 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.5 172.65 45.06 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 175.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.1 p -138.02 157.67 45.88 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 117.408 0.604 . . . . 0.0 110.806 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.9 tp -109.55 114.98 29.07 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.539 ' O ' HG22 ' A' ' 12' ' ' VAL . 4.7 m120 -98.24 120.12 38.1 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 126' ' ' ILE . 63.8 mt -120.01 135.95 54.73 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 120.708 0.29 . . . . 0.0 110.664 -177.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HB2' HG11 ' A' ' 12' ' ' VAL . 40.4 tttp -95.99 133.04 40.68 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.421 HD11 HD13 ' A' ' 106' ' ' ILE . 83.8 mt -111.71 160.23 17.48 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 120.663 0.268 . . . . 0.0 110.407 -176.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -89.06 12.88 14.35 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 172.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -145.91 142.19 28.51 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.65 0.659 . . . . 0.0 109.482 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -64.46 146.89 53.83 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 122.218 -0.301 . . . . 0.0 110.424 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -132.37 136.72 47.02 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 120.659 0.266 . . . . 0.0 110.607 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -138.01 126.44 23.32 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.1 tt -64.2 -23.86 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.173 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -74.05 -1.0 18.17 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.888 -0.508 . . . . 0.0 112.128 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.28 -14.44 30.85 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 118.889 0.768 . . . . 0.0 111.429 169.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -115.82 175.09 5.69 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 118.618 0.644 . . . . 0.0 109.463 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -91.64 102.76 15.4 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -177.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -110.45 178.36 4.4 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.34 -0.225 . . . . 0.0 110.546 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.6 mt -112.35 131.76 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -105.94 142.49 35.56 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.6 p -120.7 138.08 54.15 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 120.745 0.307 . . . . 0.0 110.687 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.94 172.58 12.95 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 120.812 0.339 . . . . 0.0 111.795 -168.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -67.9 141.16 56.46 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -137.23 165.96 24.89 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.22 -0.3 . . . . 0.0 110.636 -176.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -125.43 148.29 48.87 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 120.734 0.302 . . . . 0.0 110.543 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -149.28 137.2 20.51 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 174.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 51.63 33.0 9.97 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.691 -0.631 . . . . 0.0 112.12 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 17.6 78.59 Favored Glycine 0 N--CA 1.497 2.717 0 CA-C-O 119.625 -0.542 . . . . 0.0 111.803 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -122.52 139.89 53.39 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 118.64 1.22 . . . . 0.0 109.646 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -93.26 131.94 37.91 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.37 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -121.06 143.84 48.86 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -86.14 155.95 20.55 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 120.763 0.316 . . . . 0.0 110.474 -168.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.73 160.85 47.17 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.33 156.67 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 122.358 -0.495 . . . . 0.0 110.381 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -114.99 137.17 52.31 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 176.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.7 t -134.05 141.44 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.5 tp -137.76 125.58 14.08 Favored Pre-proline 0 N--CA 1.497 1.915 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.201 177.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -63.31 148.87 92.55 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.939 1.092 . . . . 0.0 111.491 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.57 HD13 HG13 ' A' ' 93' ' ' ILE . 43.3 pt -142.15 170.09 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 122.257 -0.277 . . . . 0.0 110.419 171.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -115.21 131.91 56.78 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 167.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.5 mt -105.91 123.85 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.8 mt -108.19 116.77 32.57 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.419 HG21 HD11 ' A' ' 120' ' ' LEU . 77.1 mt -130.2 121.94 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.62 -120.12 17.84 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -178.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -111.17 17.08 20.67 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.377 -0.484 . . . . 0.0 111.811 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -119.62 143.65 47.56 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.55 0.614 . . . . 0.0 110.473 -175.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -123.15 129.5 51.52 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -125.85 143.67 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.0 137.98 43.82 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.87 -164.29 11.21 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.64 ' HB2' HD21 ' A' ' 35' ' ' LEU . . . -159.82 156.15 26.98 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 117.328 0.564 . . . . 0.0 110.424 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.57 HG13 HD13 ' A' ' 80' ' ' ILE . 70.2 mt -108.7 141.42 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -123.03 130.63 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -175.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 63.0 t -142.48 135.9 14.25 Favored Pre-proline 0 N--CA 1.497 1.904 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -57.31 153.57 39.6 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 121.093 1.195 . . . . 0.0 111.849 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -65.47 -34.92 79.4 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.512 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -91.42 124.27 35.47 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -142.91 155.21 44.69 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -98.02 -59.99 1.65 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -134.27 -173.38 3.25 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -97.67 149.96 21.7 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m -134.94 175.02 9.96 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 122.307 -0.245 . . . . 0.0 110.379 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -107.35 27.42 9.1 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 122.38 -0.2 . . . . 0.0 110.866 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.7 mm -124.14 127.36 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.421 HD13 HD11 ' A' ' 48' ' ' LEU . 34.3 pt -126.15 145.66 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 177.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -115.38 130.1 56.79 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.492 HD12 HD12 ' A' ' 46' ' ' LEU . 80.9 mt -115.52 151.31 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.433 HD13 ' CE1' ' A' ' 31' ' ' PHE . 12.0 pt -116.38 155.19 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 168.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.46 161.93 44.68 Favored Pre-proline 0 N--CA 1.496 1.874 0 CA-C-O 119.128 -0.463 . . . . 0.0 110.457 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -60.44 -31.54 92.69 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 121.09 1.193 . . . . 0.0 111.613 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.15 167.09 23.24 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.182 -0.324 . . . . 0.0 110.996 -175.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -68.18 105.39 2.08 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.68 -38.47 87.9 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.167 -0.333 . . . . 0.0 111.069 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -64.65 -36.88 85.7 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 122.158 -0.339 . . . . 0.0 110.539 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -78.16 -50.36 12.11 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -62.53 -32.56 73.53 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 122.178 -0.326 . . . . 0.0 111.16 -173.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -108.05 8.11 28.08 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.7 m120 51.8 43.73 29.84 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.123 -0.986 . . . . 0.0 111.928 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.419 HD11 HG21 ' A' ' 84' ' ' ILE . 78.5 mt -93.52 138.25 31.99 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.999 -0.438 . . . . 0.0 110.868 -171.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -113.51 160.68 18.23 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -56.12 138.15 50.22 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.874 -0.516 . . . . 0.0 111.508 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.61 -23.18 36.7 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.53 155.15 36.57 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-N 118.579 1.19 . . . . 0.0 109.914 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.3 t -112.02 134.0 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.813 HD11 HD11 ' A' ' 46' ' ' LEU . 34.3 pt -128.69 160.14 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 174.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -109.36 138.33 45.88 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.2 pt -112.63 137.9 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.467 ' C ' HD23 ' A' ' 129' ' ' LEU . 9.0 tt -109.41 130.43 55.5 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.6 mt -119.82 129.82 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -177.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -92.43 137.74 32.1 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.21 -176.87 29.76 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -147.63 153.83 39.87 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.353 -0.498 . . . . 0.0 110.137 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.69 -34.71 78.47 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 121.051 -0.259 . . . . 0.0 110.313 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -96.72 143.63 27.49 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 110.243 -0.281 . . . . 0.0 110.243 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.152 -179.959 . . . . . . . . 0 0 . 1 stop_ save_